QueryIDs	chembl_id	molregno	PubChem_ID	DrugBank_ID	Drug_Name	MOA	Action_Type	First_Approval	ChEMBL_TID	TID	UniProt_ID	Desc	Organism	Mesh_Indication	hgnc_symbol	module
P38484	NA	NA	NA	NA	INTERFERON GAMMA-1B	Interferon gamma receptor agonist	AGONIST	1999	CHEMBL2364171	106150	P38484	Interferon gamma receptor 2	Homo sapiens	D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D003550: Cystic Fibrosis,D005185: Fallopian Tube Neoplasms,D005621: Friedreich Ataxia,D006105: Granulomatous Disease, Chronic,D007938: Leukemia,D008103: Liver Cirrhosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009164: Mycobacterium Infections,D009182: Mycosis Fungoides,D009369: Neoplasms,D009447: Neuroblastoma,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011565: Psoriasis,D011658: Pulmonary Fibrosis,D012162: Retinal Degeneration,D012208: Rhabdomyosarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D014605: Uveitis,D014606: Uveitis, Anterior,D014987: Xerostomia,D015270: Mycobacterium avium-intracellulare Infection,D015658: HIV Infections,D016918: Arthritis, Reactive,D016919: Meningitis, Cryptococcal,D018370: Leukocyte-Adhesion Deficiency Syndrome,D019698: Hepatitis C, Chronic,D054990: Idiopathic Pulmonary Fibrosis,D058387: Candidemia,D064129: Prostatic Neoplasms, Castration-Resistant	IFNGR2	M1
P28065	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9	M1
P28065	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9	M1
P28065	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB9	M1
P28702	NA	NA	NA	NA	ETRETINATE	Retinoid receptor agonist	AGONIST	1986	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D011565: Psoriasis	RXRB	M1
P28702	NA	NA	NA	NA	ALITRETINOIN	Retinoid receptor agonist	AGONIST	1999	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D001943: Breast Neoplasms,D004485: Eczema,D006229: Hand Dermatoses,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D009369: Neoplasms,D011565: Psoriasis	RXRB	M1
P28702	NA	NA	NA	NA	BEXAROTENE	Retinoid X receptor agonist	AGONIST	1999	CHEMBL2363070	105765	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D000506: Alopecia Areata,D000544: Alzheimer Disease,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010267: Parapsoriasis,D011565: Psoriasis,D011618: Psychotic Disorders,D012559: Schizophrenia,D012751: Sezary Syndrome,D013964: Thyroid Neoplasms,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D017728: Lymphoma, Large-Cell, Anaplastic,D047748: Pituitary ACTH Hypersecretion	RXRB	M1
P28702	NA	NA	NA	NA	ACITRETIN	Retinoid receptor agonist	AGONIST	1996	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D000544: Alzheimer Disease,D003872: Dermatitis,D008545: Melanoma,D011565: Psoriasis,D015658: HIV Infections	RXRB	M1
Q15116	NA	NA	NA	NA	NIVOLUMAB	Programmed cell death protein 1 inhibitor	INHIBITOR	2015	CHEMBL3307223	108437	Q15116	Programmed cell death protein 1	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080443: Diffuse Intrinsic Pontine Glioma,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D001478: Basal Cell Nevus Syndrome,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D002817: Chordoma,D003110: Colonic Neoplasms,D003699: Hepatitis D,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D007972: Leukoplakia, Oral,D008080: Liposarcoma,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008579: Meningioma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009447: Neuroblastoma,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010911: Pituitary Neoplasms,D011024: Pneumonia, Viral,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012186: Retroperitoneal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018316: Gliosarcoma,D018317: Nerve Sheath Neoplasms,D018805: Sepsis,D019337: Hematologic Neoplasms,D019694: Hepatitis B, Chronic,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D046152: Gastrointestinal Stromal Tumors,D051677: Histiocytoma, Malignant Fibrous,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PDCD1	M1
Q15116	NA	NA	NA	NA	PEMBROLIZUMAB	Programmed cell death protein 1 inhibitor	INHIBITOR	2014	CHEMBL3307223	108437	Q15116	Programmed cell death protein 1	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000306: Adrenal Cortex Neoplasms,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002278: Carcinoma in Situ,D002280: Carcinoma, Basal Cell,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007971: Leukoplakia,D007972: Leukoplakia, Oral,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008577: Meningeal Neoplasms,D008579: Meningioma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009442: Neurilemmoma,D009447: Neuroblastoma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010212: Papilloma,D010307: Parotid Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D011024: Pneumonia, Viral,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018276: Carcinoma, Medullary,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D055756: Meningeal Carcinomatosis,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	PDCD1	M1
Q15116	NA	NA	NA	NA	CEMIPLIMAB	Programmed cell death protein 1 inhibitor	INHIBITOR	2018	CHEMBL3307223	108437	Q15116	Programmed cell death protein 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	PDCD1	M1
Q15116	NA	NA	NA	NA	DOSTARLIMAB	Programmed cell death protein 1 antagonist	ANTAGONIST	2021	CHEMBL3307223	108437	Q15116	Programmed cell death protein 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D008113: Liver Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome	PDCD1	M1
P13942	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P13942	Collagen alpha-2(XI) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL11A2	M1
P13942	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P13942	Collagen alpha-2(XI) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL11A2	M1
P49720	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3	M1
P49720	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3	M1
P49720	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB3	M1
P07947	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P07947	Tyrosine-protein kinase Yes	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	YES1	M1
Q96F46	NA	NA	NA	NA	BRODALUMAB	Interleukin-17 receptor A antagonist	ANTAGONIST	2017	CHEMBL3580485	109781	Q96F46	Interleukin-17 receptor A	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D003424: Crohn Disease,D007154: Immune System Diseases,D011565: Psoriasis,D012595: Scleroderma, Systemic,D013167: Spondylitis, Ankylosing,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa	IL17RA	M1
P39086	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	1996	CHEMBL2109241	104902	P39086	Glutamate receptor ionotropic, kainate 1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIK1	M1
P17948	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M1
P17948	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M1
P17948	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M1
P17948	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M1
P17948	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M1
P17948	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M1
P17948	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FLT1	M1
P17948	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	FLT1	M1
P17948	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	NA	FLT1	M1
P24530	NA	NA	NA	NA	SITAXENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D011507: Proteinuria,D051436: Renal Insufficiency, Chronic,D054144: Heart Failure, Diastolic	EDNRB	M1
P24530	NA	NA	NA	NA	BOSENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2001	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004541: Eisenmenger Complex,D005334: Fever,D005901: Glaucoma,D006333: Heart Failure,D006344: Heart Septal Defects, Atrial,D006973: Hypertension,D006976: Hypertension, Pulmonary,D008103: Liver Cirrhosis,D008545: Melanoma,D008946: Mitral Valve Stenosis,D010190: Pancreatic Neoplasms,D010547: Persistent Fetal Circulation Syndrome,D012595: Scleroderma, Systemic,D014456: Ulcer,D018636: Hypoplastic Left Heart Syndrome,D018917: Optic Neuropathy, Ischemic,D020065: Hepatopulmonary Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M1
P24530	NA	NA	NA	NA	AMBRISENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2007	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D000532: Altitude Sickness,D000755: Anemia, Sickle Cell,D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D014652: Vascular Diseases,D018636: Hypoplastic Left Heart Syndrome,D045169: Severe Acute Respiratory Syndrome,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension	EDNRB	M1
P24530	NA	NA	NA	NA	MACITENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2010	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D005909: Glioblastoma,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D012595: Scleroderma, Systemic,D014456: Ulcer,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M1
P24530	NA	NA	NA	NA	SITAXENTAN SODIUM	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	NA	EDNRB	M1
Q13464	NA	NA	NA	NA	NETARSUDIL DIMESYLATE	Rho-associated protein kinase inhibitor	INHIBITOR	2017	CHEMBL2111459	104981	Q13464	Rho-associated protein kinase 1	Homo sapiens	D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension	ROCK1	M1
P08572	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08572	Collagen alpha-2(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A2	M1
P08572	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08572	Collagen alpha-2(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A2	M1
P26951	NA	NA	NA	NA	TAGRAXOFUSP	Interleukin-3 receptor subunit alpha binding agent	BINDING AGENT	2018	CHEMBL3712987	114948	P26951	Interleukin-3 receptor subunit alpha	Homo sapiens	D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D015470: Leukemia, Myeloid, Acute	IL3RA	M1
P21709	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P21709	Ephrin type-A receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA1	M1
P00813	NA	NA	NA	NA	PENTOSTATIN	Adenosine deaminase inhibitor	INHIBITOR	1991	CHEMBL1910	14	P00813	Adenosine deaminase	Homo sapiens	D000755: Anemia, Sickle Cell,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell	ADA	M1
P02462	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02462	Collagen alpha-1(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A1	M1
P02462	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02462	Collagen alpha-1(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A1	M1
P01589	NA	NA	NA	NA	DENILEUKIN DIFTITOX	Interleukin-2 receptor binding agent	BINDING AGENT	1999	CHEMBL2364167	106146	P01589	Interleukin-2 receptor subunit alpha	Homo sapiens	D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male	IL2RA	M1
P01589	NA	NA	NA	NA	BASILIXIMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1998	CHEMBL2364167	106146	P01589	Interleukin-2 receptor subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003093: Colitis, Ulcerative,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D004646: Emphysema,D005909: Glioblastoma,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007239: Infections,D007674: Kidney Diseases,D007683: Kidney Tubular Necrosis, Acute,D009101: Multiple Myeloma,D009369: Neoplasms,D014511: Uremia,D014605: Uveitis,D015427: Reperfusion Injury,D015470: Leukemia, Myeloid, Acute,D051436: Renal Insufficiency, Chronic	IL2RA	M1
P01589	NA	NA	NA	NA	ALDESLEUKIN	Interleukin-2 receptor agonist	AGONIST	1992	CHEMBL2364167	106146	P01589	Interleukin-2 receptor subunit alpha	Homo sapiens	D000026: Abortion, Habitual,D000081483: Squamous Intraepithelial Lesions,D000163: Acquired Immunodeficiency Syndrome,D000506: Alopecia Areata,D000690: Amyotrophic Lateral Sclerosis,D000744: Anemia, Hemolytic, Autoimmune,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001528: Behcet Syndrome,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003093: Colitis, Ulcerative,D003327: Coronary Disease,D003424: Crohn Disease,D003449: Cryoglobulinemia,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D004660: Encephalitis,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009220: Myositis,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011081: Polychondritis, Relapsing,D011111: Polymyalgia Rheumatica,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012751: Sezary Syndrome,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D019337: Hematologic Neoplasms,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055501: Macrophage Activation Syndrome,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	IL2RA	M1
P01589	NA	NA	NA	NA	DACLIZUMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1997	CHEMBL2364167	106146	P01589	Interleukin-2 receptor subunit alpha	Homo sapiens	D000741: Anemia, Aplastic,D001249: Asthma,D003093: Colitis, Ulcerative,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D011565: Psoriasis,D012010: Red-Cell Aplasia, Pure,D013921: Thrombocytopenia,D014605: Uveitis,D014890: Granulomatosis with Polyangiitis,D015658: HIV Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D051436: Renal Insufficiency, Chronic,D057135: Wet Macular Degeneration	IL2RA	M1
O14788	NA	NA	NA	NA	DENOSUMAB	Tumor necrosis factor ligand superfamily member 11 inhibitor	INHIBITOR	2010	CHEMBL2364162	106141	O14788	Tumor necrosis factor ligand superfamily member 11	Homo sapiens	D000856: Anorexia Nervosa,D001024: Aortic Valve Stenosis,D001172: Arthritis, Rheumatoid,D001847: Bone Diseases,D001851: Bone Diseases, Metabolic,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003424: Crohn Disease,D003920: Diabetes Mellitus,D005870: Giant Cell Tumors,D006073: Gout,D006646: Histiocytosis, Langerhans-Cell,D006934: Hypercalcemia,D006967: Hypersensitivity,D007248: Infertility, Male,D007674: Kidney Diseases,D008175: Lung Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D010013: Osteogenesis Imperfecta,D010024: Osteoporosis,D010051: Ovarian Neoplasms,D012516: Osteosarcoma,D015207: Osteoarthritis, Hip,D015663: Osteoporosis, Postmenopausal,D050723: Fractures, Bone,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TNFSF11	M1
P0DPH7	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBA3C	M1
P0DPH7	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	P0DPH7	Tubulin alpha-3C chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBA3C	M1
P47871	NA	NA	NA	NA	GLUCAGON	Glucagon receptor agonist	AGONIST	1998	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003139: Common Cold,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D007003: Hypoglycemia,D009765: Obesity,D044903: Congenital Hyperinsulinism,D046768: Nesidioblastosis	GCGR	M1
P47871	NA	NA	NA	NA	GLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	AGONIST	1960	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D007003: Hypoglycemia	GCGR	M1
P47871	NA	NA	NA	NA	DASIGLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	AGONIST	2021	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D007003: Hypoglycemia	GCGR	M1
P05108	NA	NA	NA	NA	AMINOGLUTETHIMIDE	Cytochrome P450 11A1 inhibitor	INHIBITOR	1980	CHEMBL2033	32	P05108	Cholesterol side-chain cleavage enzyme, mitochondrial	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CYP11A1	M1
P05108	NA	NA	NA	NA	MITOTANE	Cytochrome P450 11A1 inhibitor	INHIBITOR	1970	CHEMBL2033	32	P05108	Cholesterol side-chain cleavage enzyme, mitochondrial	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D002277: Carcinoma,D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CYP11A1	M1
Q13936	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1C	M1
Q13936	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1C	M1
Q13936	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1C	M1
Q13936	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1C	M1
Q13936	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1C	M1
Q13936	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C	M1
Q13936	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1C	M1
Q13936	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1C	M1
Q13936	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1C	M1
Q13936	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M1
Q13936	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C	M1
Q13936	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1C	M1
Q13936	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M1
Q13936	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1C	M1
Q13936	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M1
Q13936	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M1
Q13936	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation	CACNA1C	M1
Q13936	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1C	M1
Q13936	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1C	M1
Q13936	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C	M1
Q13936	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C	M1
Q14721	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNB1	M1
Q14721	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNB1	M1
Q14721	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	NA	KCNB1	M1
Q14721	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNB1	M1
Q07869	NA	NA	NA	NA	GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	1981	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000740: Anemia,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D009369: Neoplasms,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D015658: HIV Infections,D016540: Smoking Cessation,D017202: Myocardial Ischemia	PPARA	M1
Q07869	NA	NA	NA	NA	CLOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	1967	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D002318: Cardiovascular Diseases,D009203: Myocardial Infarction,D017202: Myocardial Ischemia	PPARA	M1
Q07869	NA	NA	NA	NA	FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	1993	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D000437: Alcoholism,D002056: Burns,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D003930: Diabetic Retinopathy,D006816: Huntington Disease,D006937: Hypercholesterolemia,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006951: Hyperlipoproteinemias,D006952: Hyperlipoproteinemia Type III,D006973: Hypertension,D008060: Lipodystrophy,D008105: Liver Cirrhosis, Biliary,D008659: Metabolic Diseases,D009101: Multiple Myeloma,D009765: Obesity,D015209: Cholangitis, Sclerosing,D015228: Hypertriglyceridemia,D015658: HIV Infections,D024821: Metabolic Syndrome,D050171: Dyslipidemias,D050197: Atherosclerosis,D052439: Lipid Metabolism Disorders,D065626: Non-alcoholic Fatty Liver Disease	PPARA	M1
Q07869	NA	NA	NA	NA	FENOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	2008	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D000437: Alcoholism,D002779: Cholestasis,D008527: Medulloblastoma,D015228: Hypertriglyceridemia	PPARA	M1
Q07869	NA	NA	NA	NA	CHOLINE FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	2008	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D006937: Hypercholesterolemia,D006950: Hyperlipidemia, Familial Combined,D052439: Lipid Metabolism Disorders	PPARA	M1
Q9BY41	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC8	M1
Q9BY41	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC8	M1
Q9BY41	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D009101: Multiple Myeloma	HDAC8	M1
O00483	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O00483	Cytochrome c oxidase subunit NDUFA4	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFA4	M1
O14818	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	O14818	Proteasome subunit alpha type-7	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA7	M1
O14818	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	O14818	Proteasome subunit alpha type-7	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA7	M1
O14818	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	O14818	Proteasome subunit alpha type-7	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMA7	M1
P02766	NA	NA	NA	NA	TAFAMIDIS	Transthyretin stabiliser	STABILISER	2019	CHEMBL3194	12704	P02766	Transthyretin	Homo sapiens	D000686: Amyloidosis,D009202: Cardiomyopathies,D028226: Amyloidosis, Familial,D028227: Amyloid Neuropathies, Familial	TTR	M1
P02766	NA	NA	NA	NA	TAFAMIDIS MEGLUMINE	Transthyretin stabiliser	STABILISER	2019	CHEMBL3194	12704	P02766	Transthyretin	Homo sapiens	D000686: Amyloidosis,D009202: Cardiomyopathies,D011115: Polyneuropathies,D028226: Amyloidosis, Familial,D028227: Amyloid Neuropathies, Familial	TTR	M1
P62333	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6	M1
P62333	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6	M1
P62333	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC6	M1
P22460	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P22460	Potassium voltage-gated channel subfamily A member 5	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA5	M1
P22460	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22460	Potassium voltage-gated channel subfamily A member 5	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA5	M1
P22460	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P22460	Potassium voltage-gated channel subfamily A member 5	Homo sapiens	NA	KCNA5	M1
P22460	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22460	Potassium voltage-gated channel subfamily A member 5	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA5	M1
Q9NZQ7	NA	NA	NA	NA	DURVALUMAB	Programmed cell death 1 ligand 1 inhibitor	INHIBITOR	2017	CHEMBL3580522	109807	Q9NZQ7	Programmed cell death 1 ligand 1	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D001005: Anus Neoplasms,D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D004407: Dysgerminoma,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010954: Plasmacytoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016889: Endometrial Neoplasms,D018239: Seminoma,D018262: Adenocarcinoma, Clear Cell,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018358: Neuroendocrine Tumors,D019337: Hematologic Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	CD274	M1
Q9NZQ7	NA	NA	NA	NA	ATEZOLIZUMAB	Programmed cell death 1 ligand 1 inhibitor	INHIBITOR	2016	CHEMBL3580522	109807	Q9NZQ7	Programmed cell death 1 ligand 1	Homo sapiens	D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	CD274	M1
Q9NZQ7	NA	NA	NA	NA	AVELUMAB	Programmed cell death 1 ligand 1 other	OTHER	2017	CHEMBL3580522	109807	Q9NZQ7	Programmed cell death 1 ligand 1	Homo sapiens	D000230: Adenocarcinoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002817: Chordoma,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007890: Leiomyosarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008579: Meningioma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013945: Thymoma,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D031901: Gestational Trophoblastic Disease,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	CD274	M1
P32745	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR3	M1
P32745	NA	NA	NA	NA	PASIREOTIDE DIASPARTATE	Somatostatin receptor 3 agonist	AGONIST	2012	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	NA	SSTR3	M1
P32745	NA	NA	NA	NA	PASIREOTIDE PAMOATE	Somatostatin receptor 3 agonist	AGONIST	2014	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly	SSTR3	M1
P32745	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR3	M1
Q9Y5N1	NA	NA	NA	NA	PITOLISANT	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D000437: Alcoholism,D007674: Kidney Diseases,D009290: Narcolepsy,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D019966: Substance-Related Disorders	HRH3	M1
Q9Y5N1	NA	NA	NA	NA	PITOLISANT HYDROCHLORIDE	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D006970: Disorders of Excessive Somnolence,D009290: Narcolepsy	HRH3	M1
P29274	NA	NA	NA	NA	ADENOSINE	Adenosine receptor agonist	AGONIST	1989	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D007249: Inflammation,D007511: Ischemia,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D009369: Neoplasms,D010146: Pain,D012128: Respiratory Distress Syndrome,D013614: Tachycardia, Paroxysmal,D013617: Tachycardia, Supraventricular,D014927: Wolff-Parkinson-White Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D023921: Coronary Stenosis,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	ADORA2A	M1
P29274	NA	NA	NA	NA	CAFFEINE	Adenosine receptor antagonist	ANTAGONIST	1948	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D000860: Hypoxia,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001943: Breast Neoplasms,D003093: Colitis, Ulcerative,D003139: Common Cold,D003141: Communicable Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004417: Dyspnea,D006261: Headache,D007024: Hypotension, Orthostatic,D007383: Intermittent Claudication,D008545: Melanoma,D008881: Migraine Disorders,D009290: Narcolepsy,D009369: Neoplasms,D009765: Obesity,D010146: Pain,D010300: Parkinson Disease,D011565: Psoriasis,D013119: Spinal Cord Injuries,D014832: Voice Disorders,D015658: HIV Infections,D017116: Low Back Pain,D018781: Tension-Type Headache,D019547: Neck Pain,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A	M1
P29274	NA	NA	NA	NA	PENTOXIFYLLINE	Adenosine A2 receptor antagonist	ANTAGONIST	1984	CHEMBL2094257	104729	P29274	Adenosine receptor A2a	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A	M1
P29274	NA	NA	NA	NA	ISTRADEFYLLINE	Adenosine A2a receptor antagonist	ANTAGONIST	2019	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D008107: Liver Diseases,D010300: Parkinson Disease,D019966: Substance-Related Disorders	ADORA2A	M1
P29274	NA	NA	NA	NA	THEOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	ADORA2A	M1
P29274	NA	NA	NA	NA	OXTRIPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1981	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D008173: Lung Diseases, Obstructive	ADORA2A	M1
P29274	NA	NA	NA	NA	CAFFEINE, CITRATED	Adenosine receptor antagonist	ANTAGONIST	1999	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D001049: Apnea,D008107: Liver Diseases,D010146: Pain,D012178: Retinopathy of Prematurity,D047928: Premature Birth	ADORA2A	M1
P29274	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Adenosine receptor antagonist	ANTAGONIST	1982	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	NA	ADORA2A	M1
P29274	NA	NA	NA	NA	AMINOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	ADORA2A	M1
P29274	NA	NA	NA	NA	REGADENOSON	Adenosine A2a receptor agonist	AGONIST	2008	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D002318: Cardiovascular Diseases	ADORA2A	M1
P12109	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12109	Collagen alpha-1(VI) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL6A1	M1
P12109	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12109	Collagen alpha-1(VI) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL6A1	M1
Q8NCM2	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q8NCM2	Potassium voltage-gated channel subfamily H member 5	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNH5	M1
Q8NCM2	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8NCM2	Potassium voltage-gated channel subfamily H member 5	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNH5	M1
Q8NCM2	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q8NCM2	Potassium voltage-gated channel subfamily H member 5	Homo sapiens	NA	KCNH5	M1
Q8NCM2	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8NCM2	Potassium voltage-gated channel subfamily H member 5	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNH5	M1
P06213	NA	NA	NA	NA	INSULIN LISPRO	Insulin receptor agonist	AGONIST	1996	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006943: Hyperglycemia	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP EXTENDED RECOMBINANT HUMAN	Insulin receptor agonist	AGONIST	1987	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN GLARGINE	Insulin receptor agonist	AGONIST	2000	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003930: Diabetic Retinopathy,D006937: Hypercholesterolemia,D006943: Hyperglycemia,D006973: Hypertension,D007938: Leukemia,D008223: Lymphoma,D009203: Myocardial Infarction,D011236: Prediabetic State,D050197: Atherosclerosis	INSR	M1
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE SEMISYNTHETIC PURIFIED HUMAN	Insulin receptor agonist	AGONIST	1985	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006943: Hyperglycemia,D006973: Hypertension,D050197: Atherosclerosis	INSR	M1
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D016640: Diabetes, Gestational	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ASPART	Insulin receptor agonist	AGONIST	2000	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D000544: Alzheimer Disease,D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D007938: Leukemia,D008223: Lymphoma,D016640: Diabetes, Gestational,D050197: Atherosclerosis	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ASPART PROTAMINE RECOMBINANT	Insulin receptor agonist	AGONIST	2001	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN LISPRO PROTAMINE RECOMBINANT	Insulin receptor agonist	AGONIST	1999	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	INSR	M1
P06213	NA	NA	NA	NA	INSULIN PURIFIED BEEF	Insulin receptor agonist	AGONIST	1980	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus	INSR	M1
P06213	NA	NA	NA	NA	INSULIN PORK	Insulin receptor agonist	AGONIST	1966	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D007333: Insulin Resistance	INSR	M1
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE PURIFIED PORK	Insulin receptor agonist	AGONIST	1979	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN SUSP PROTAMINE ZINC PURIFIED PORK	Insulin receptor agonist	AGONIST	1979	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP SEMISYNTHETIC PURIFIED HUMAN	Insulin receptor agonist	AGONIST	1983	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D000083242: Ischemic Stroke,D000789: Angina, Unstable,D001714: Bipolar Disorder,D002056: Burns,D002349: Carpal Tunnel Syndrome,D003327: Coronary Disease,D003693: Delirium,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003929: Diabetic Neuropathies,D005901: Glaucoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006943: Hyperglycemia,D006946: Hyperinsulinism,D006947: Hyperkalemia,D006949: Hyperlipidemias,D006973: Hypertension,D007003: Hypoglycemia,D007006: Hypogonadism,D007333: Insulin Resistance,D009203: Myocardial Infarction,D009765: Obesity,D010146: Pain,D010300: Parkinson Disease,D012559: Schizophrenia,D012772: Shock, Septic,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D016640: Diabetes, Gestational,D018923: Persian Gulf Syndrome,D019578: Multiple System Atrophy,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D047928: Premature Birth,D050197: Atherosclerosis,D054058: Acute Coronary Syndrome,D055948: Sarcopenia,D058186: Acute Kidney Injury,D060825: Cognitive Dysfunction,D065626: Non-alcoholic Fatty Liver Disease	INSR	M1
P06213	NA	NA	NA	NA	INSULIN SUSP PROTAMINE ZINC BEEF/PORK	Insulin receptor agonist	AGONIST	1966	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PROMPT PURIFIED PORK	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PURIFIED BEEF/PORK	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE BEEF/PORK	Insulin receptor agonist	AGONIST	1966	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE PURIFIED BEEF	Insulin receptor agonist	AGONIST	1980	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP EXTENDED PURIFIED BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PURIFIED BEEF	Insulin receptor agonist	AGONIST	1980	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PURIFIED PORK	Insulin receptor agonist	AGONIST	1979	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN GLULISINE	Insulin receptor agonist	AGONIST	2004	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D000544: Alzheimer Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004314: Down Syndrome,D009203: Myocardial Infarction	INSR	M1
P06213	NA	NA	NA	NA	INSULIN PURIFIED PORK	Insulin receptor agonist	AGONIST	1979	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP EXTENDED BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN SUSP ISOPHANE RECOMBINANT HUMAN	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006943: Hyperglycemia,D006973: Hypertension,D050197: Atherosclerosis	INSR	M1
P06213	NA	NA	NA	NA	INSULIN SUSP PROTAMINE ZINC PURIFIED BEEF	Insulin receptor agonist	AGONIST	1980	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP PROMPT BEEF	Insulin receptor agonist	AGONIST	1982	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	NA	INSR	M1
P06213	NA	NA	NA	NA	INSULIN ZINC SUSP RECOMBINANT HUMAN	Insulin receptor agonist	AGONIST	1985	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus	INSR	M1
P06213	NA	NA	NA	NA	INSULIN DETEMIR	Insulin receptor agonist	AGONIST	2005	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	INSR	M1
P06213	NA	NA	NA	NA	INSULIN DEGLUDEC	Insulin receptor agonist	AGONIST	2015	CHEMBL1981	35	P06213	Insulin receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2	INSR	M1
Q96DB2	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q96DB2	Histone deacetylase 11	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC11	M1
Q96DB2	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q96DB2	Histone deacetylase 11	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC11	M1
Q96DB2	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q96DB2	Histone deacetylase 11	Homo sapiens	D009101: Multiple Myeloma	HDAC11	M1
P17181	NA	NA	NA	NA	INTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000071960: Breast Carcinoma In Situ,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D003218: Condylomata Acuminata,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008103: Liver Cirrhosis,D008113: Liver Neoplasms,D008224: Lymphoma, Follicular,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012514: Sarcoma, Kaposi,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	IFNAR1	M1
P17181	NA	NA	NA	NA	INTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	1996	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000544: Alzheimer Disease,D001249: Asthma,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D006526: Hepatitis C,D009102: Multiple Organ Failure,D009103: Multiple Sclerosis,D012128: Respiratory Distress Syndrome,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome	IFNAR1	M1
P17181	NA	NA	NA	NA	PEGINTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	2002	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001943: Breast Neoplasms,D003015: Clostridium Infections,D003110: Colonic Neoplasms,D003699: Hepatitis D,D003866: Depressive Disorder,D006505: Hepatitis,D006509: Hepatitis B,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007239: Infections,D007680: Kidney Neoplasms,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011087: Polycythemia Vera,D013920: Thrombocythemia, Essential,D013921: Thrombocytopenia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D055728: Primary Myelofibrosis	IFNAR1	M1
P17181	NA	NA	NA	NA	INTERFERON BETA-1B	Interferon alpha/beta receptor agonist	AGONIST	1993	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D009103: Multiple Sclerosis,D009202: Cardiomyopathies,D015658: HIV Infections,D018352: Coronavirus Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D045169: Severe Acute Respiratory Syndrome	IFNAR1	M1
P17181	NA	NA	NA	NA	INTERFERON ALFACON-1	Interferon alpha/beta receptor agonist	AGONIST	1997	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D006526: Hepatitis C,D007251: Influenza, Human,D019698: Hepatitis C, Chronic	IFNAR1	M1
P17181	NA	NA	NA	NA	PEGINTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	2001	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003397: Craniopharyngioma,D003699: Hepatitis D,D005185: Fallopian Tube Neoplasms,D005910: Glioma,D006258: Head and Neck Neoplasms,D006505: Hepatitis,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D012516: Osteosarcoma,D013920: Thrombocythemia, Essential,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D018281: Cholangiocarcinoma,D018318: Neurofibroma, Plexiform,D019337: Hematologic Neoplasms,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D020522: Lymphoma, Mantle-Cell,D055728: Primary Myelofibrosis	IFNAR1	M1
P17181	NA	NA	NA	NA	INTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D001528: Behcet Syndrome,D002292: Carcinoma, Renal Cell,D006526: Hepatitis C,D007680: Kidney Neoplasms,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011565: Psoriasis,D015658: HIV Infections,D019698: Hepatitis C, Chronic,D031300: Retinal Vasculitis,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	IFNAR1	M1
P17181	NA	NA	NA	NA	PEGINTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	2014	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	IFNAR1	M1
P17181	NA	NA	NA	NA	INTERFERON ALFA-N3	Interferon alpha/beta receptor agonist	AGONIST	1989	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D015658: HIV Infections,D045169: Severe Acute Respiratory Syndrome	IFNAR1	M1
P10826	CHEMBL4068170	2208081	24964084	NA	TRETINOIN	Retinoic acid receptor agonist	AGONIST	1971	CHEMBL2363069	105764	P10826	Retinoic acid receptor beta	Homo sapiens	D000152: Acne Vulgaris,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004646: Emphysema,D006937: Hypercholesterolemia,D007680: Kidney Neoplasms,D007911: Lentigo,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008548: Melanosis,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009447: Neuroblastoma,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012393: Rosacea,D015209: Cholangitis, Sclerosing,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016553: Purpura, Thrombocytopenic, Idiopathic,D017495: Hyperpigmentation,D019337: Hematologic Neoplasms,D045169: Severe Acute Respiratory Syndrome,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	RARB	M1
P10826	NA	NA	NA	NA	ETRETINATE	Retinoid receptor agonist	AGONIST	1986	CHEMBL2363071	105766	P10826	Retinoic acid receptor beta	Homo sapiens	D011565: Psoriasis	RARB	M1
P10826	NA	NA	NA	NA	ISOTRETINOIN	Retinoic acid receptor agonist	AGONIST	1982	CHEMBL2363069	105764	P10826	Retinoic acid receptor beta	Homo sapiens	D000152: Acne Vulgaris,D000544: Alzheimer Disease,D001254: Astrocytoma,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002578: Uterine Cervical Dysplasia,D002583: Uterine Cervical Neoplasms,D004646: Emphysema,D004820: Epidermolysis Bullosa,D005909: Glioblastoma,D005910: Glioma,D005923: Glomerulosclerosis, Focal Segmental,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007057: Ichthyosis,D007239: Infections,D007680: Kidney Neoplasms,D007713: Klinefelter Syndrome,D007938: Leukemia,D008175: Lung Neoplasms,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D012393: Rosacea,D014008: Tinea Pedis,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D018305: Ganglioneuroblastoma,D018316: Gliosarcoma,D045169: Severe Acute Respiratory Syndrome,D053713: Azoospermia,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055623: Keratosis, Actinic,D064129: Prostatic Neoplasms, Castration-Resistant	RARB	M1
P10826	NA	NA	NA	NA	ALITRETINOIN	Retinoid receptor agonist	AGONIST	1999	CHEMBL2363071	105766	P10826	Retinoic acid receptor beta	Homo sapiens	D001943: Breast Neoplasms,D004485: Eczema,D006229: Hand Dermatoses,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D009369: Neoplasms,D011565: Psoriasis	RARB	M1
P10826	NA	NA	NA	NA	ACITRETIN	Retinoid receptor agonist	AGONIST	1996	CHEMBL2363071	105766	P10826	Retinoic acid receptor beta	Homo sapiens	D000544: Alzheimer Disease,D003872: Dermatitis,D008545: Melanoma,D011565: Psoriasis,D015658: HIV Infections	RARB	M1
P10826	NA	NA	NA	NA	ADAPALENE	Retinoic acid receptor agonist	AGONIST	1996	CHEMBL2363069	105764	P10826	Retinoic acid receptor beta	Homo sapiens	D000152: Acne Vulgaris,D012871: Skin Diseases	RARB	M1
P10826	NA	NA	NA	NA	TAZAROTENE	Retinoic acid receptor agonist	AGONIST	1997	CHEMBL2363069	105764	P10826	Retinoic acid receptor beta	Homo sapiens	D000152: Acne Vulgaris,D007911: Lentigo,D011565: Psoriasis,D012871: Skin Diseases,D012878: Skin Neoplasms,D016410: Lymphoma, T-Cell, Cutaneous,D017496: Hypopigmentation	RARB	M1
O96000	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O96000	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFB10	M1
Q9UBN7	NA	NA	NA	NA	VORINOSTAT	Histone deacetylase 6 inhibitor	INHIBITOR	2006	CHEMBL1865	11307	Q9UBN7	Histone deacetylase 6	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001005: Anus Neoplasms,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001927: Brain Diseases,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003424: Crohn Disease,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006689: Hodgkin Disease,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008527: Medulloblastoma,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D009542: Niemann-Pick Diseases,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012559: Schizophrenia,D012751: Sezary Syndrome,D013120: Spinal Cord Neoplasms,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D047748: Pituitary ACTH Hypersecretion,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	HDAC6	M1
Q9UBN7	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9UBN7	Histone deacetylase 6	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC6	M1
Q9UBN7	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9UBN7	Histone deacetylase 6	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC6	M1
Q9UBN7	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9UBN7	Histone deacetylase 6	Homo sapiens	D009101: Multiple Myeloma	HDAC6	M1
P25092	NA	NA	NA	NA	PLECANATIDE	Heat-stable enterotoxin receptor agonist	AGONIST	2017	CHEMBL1795197	104277	P25092	Heat-stable enterotoxin receptor	Homo sapiens	D003248: Constipation,D043183: Irritable Bowel Syndrome	GUCY2C	M1
P25092	NA	NA	NA	NA	LINACLOTIDE	Heat-stable enterotoxin receptor agonist	AGONIST	2012	CHEMBL1795197	104277	P25092	Heat-stable enterotoxin receptor	Homo sapiens	D000236: Adenoma,D003248: Constipation,D043183: Irritable Bowel Syndrome	GUCY2C	M1
P29597	NA	NA	NA	NA	TOFACITINIB CITRATE	Janus Kinase (JAK) inhibitor	INHIBITOR	2012	CHEMBL2363062	105757	P29597	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens	D001172: Arthritis, Rheumatoid,D008179: Lupus Erythematosus, Discoid,D008180: Lupus Erythematosus, Systemic	TYK2	M1
P29597	NA	NA	NA	NA	UPADACITINIB	Janus Kinase (JAK) inhibitor	INHIBITOR	2019	CHEMBL2363062	105757	P29597	Non-receptor tyrosine-protein kinase TYK2	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa	TYK2	M1
P51168	NA	NA	NA	NA	TRIAMTERENE	Amiloride-sensitive sodium channel, ENaC blocker	BLOCKER	1964	CHEMBL2107836	104888	P51168	Amiloride-sensitive sodium channel subunit beta	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004487: Edema,D006333: Heart Failure,D006929: Hyperaldosteronism,D006937: Hypercholesterolemia,D006973: Hypertension,D008103: Liver Cirrhosis,D009404: Nephrotic Syndrome,D016757: Death, Sudden, Cardiac,D050197: Atherosclerosis	SCNN1B	M1
P51168	NA	NA	NA	NA	AMILORIDE HYDROCHLORIDE	Amiloride-sensitive sodium channel, ENaC blocker	BLOCKER	1981	CHEMBL2107836	104888	P51168	Amiloride-sensitive sodium channel subunit beta	Homo sapiens	D001145: Arrhythmias, Cardiac,D003550: Cystic Fibrosis,D006333: Heart Failure,D006973: Hypertension	SCNN1B	M1
P34903	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA3	M1
P34903	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA3	M1
P34903	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA3	M1
P34903	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D004827: Epilepsy	GABRA3	M1
P34903	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA3	M1
P34903	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA3	M1
P34903	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D008881: Migraine Disorders	GABRA3	M1
P34903	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA3	M1
P34903	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA3	M1
P34903	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA3	M1
P34903	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA3	M1
P34903	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA3	M1
P34903	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA3	M1
P34903	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA3	M1
P34903	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000647: Amnesia	GABRA3	M1
P34903	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA3	M1
P34903	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA3	M1
P34903	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA3	M1
P34903	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety	GABRA3	M1
P34903	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety	GABRA3	M1
P34903	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety	GABRA3	M1
P34903	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA3	M1
P34903	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA3	M1
P34903	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA3	M1
P34903	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA3	M1
P34903	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA3	M1
P34903	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA3	M1
P34903	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA3	M1
P34903	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA3	M1
P34903	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D000437: Alcoholism	GABRA3	M1
P34903	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P34903	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA3	M1
P34903	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P34903	Gamma-aminobutyric acid receptor subunit alpha-3	Homo sapiens	NA	GABRA3	M1
P43220	NA	NA	NA	NA	EXENATIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2005	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D000083242: Ischemic Stroke,D000437: Alcoholism,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006943: Hyperglycemia,D009203: Myocardial Infarction,D009765: Obesity,D009767: Obesity, Morbid,D010300: Parkinson Disease,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D015431: Weight Loss,D016540: Smoking Cessation,D019578: Multiple System Atrophy,D019970: Cocaine-Related Disorders,D020521: Stroke,D046768: Nesidioblastosis,D051437: Renal Insufficiency,D065626: Non-alcoholic Fatty Liver Disease	GLP1R	M1
P43220	NA	NA	NA	NA	ALBIGLUTIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2014	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure	GLP1R	M1
P43220	NA	NA	NA	NA	DULAGLUTIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2014	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D016540: Smoking Cessation,D059606: Polydipsia	GLP1R	M1
P43220	NA	NA	NA	NA	LIXISENATIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2016	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D010300: Parkinson Disease,D054058: Acute Coronary Syndrome	GLP1R	M1
P43220	NA	NA	NA	NA	SEMAGLUTIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2017	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D000544: Alzheimer Disease,D001851: Bone Diseases, Metabolic,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity,D010300: Parkinson Disease,D065626: Non-alcoholic Fatty Liver Disease	GLP1R	M1
P43220	NA	NA	NA	NA	LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2010	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D000544: Alzheimer Disease,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D006333: Heart Failure,D006943: Hyperglycemia,D009293: Opioid-Related Disorders,D009765: Obesity,D010300: Parkinson Disease,D011236: Prediabetic State,D012778: Short Bowel Syndrome,D012891: Sleep Apnea Syndromes,D015431: Weight Loss,D016540: Smoking Cessation,D018149: Glucose Intolerance,D019449: Pouchitis,D024821: Metabolic Syndrome,D065626: Non-alcoholic Fatty Liver Disease	GLP1R	M1
Q13370	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE3B	M1
Q13370	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE3B	M1
Q13370	NA	NA	NA	NA	THEOPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1940	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	PDE3B	M1
Q13370	NA	NA	NA	NA	OXTRIPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1981	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE3B	M1
Q13370	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Phosphodiesterase 3 inhibitor	INHIBITOR	1982	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	NA	PDE3B	M1
Q13370	NA	NA	NA	NA	ANAGRELIDE HYDROCHLORIDE	Phosphodiesterase 3 inhibitor	INHIBITOR	1997	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D013920: Thrombocythemia, Essential,D013927: Thrombosis	PDE3B	M1
Q13370	NA	NA	NA	NA	AMINOPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1940	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	PDE3B	M1
Q9UN88	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRQ	M1
Q9UN88	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRQ	M1
Q9UN88	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRQ	M1
Q9UN88	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D004827: Epilepsy	GABRQ	M1
Q9UN88	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRQ	M1
Q9UN88	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRQ	M1
Q9UN88	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D008881: Migraine Disorders	GABRQ	M1
Q9UN88	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRQ	M1
Q9UN88	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRQ	M1
Q9UN88	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRQ	M1
Q9UN88	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRQ	M1
Q9UN88	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRQ	M1
Q9UN88	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRQ	M1
Q9UN88	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRQ	M1
Q9UN88	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000647: Amnesia	GABRQ	M1
Q9UN88	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRQ	M1
Q9UN88	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRQ	M1
Q9UN88	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRQ	M1
Q9UN88	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001007: Anxiety	GABRQ	M1
Q9UN88	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001007: Anxiety	GABRQ	M1
Q9UN88	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001007: Anxiety	GABRQ	M1
Q9UN88	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRQ	M1
Q9UN88	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRQ	M1
Q9UN88	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRQ	M1
Q9UN88	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRQ	M1
Q9UN88	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRQ	M1
Q9UN88	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRQ	M1
Q9UN88	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRQ	M1
Q9UN88	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRQ	M1
Q9UN88	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D000437: Alcoholism	GABRQ	M1
Q9UN88	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q9UN88	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRQ	M1
Q9UN88	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	Q9UN88	Gamma-aminobutyric acid receptor subunit theta	Homo sapiens	NA	GABRQ	M1
Q8TCU5	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN3A	M1
Q8TCU5	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN3A	M1
Q8TCU5	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN3A	M1
Q8TCU5	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN3A	M1
Q8TCU5	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN3A	M1
Q8TCU5	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D010146: Pain	GRIN3A	M1
Q8TCU5	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D010300: Parkinson Disease	GRIN3A	M1
Q8TCU5	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000437: Alcoholism	GRIN3A	M1
Q8TCU5	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN3A	M1
P21964	NA	NA	NA	NA	ENTACAPONE	Catechol O-methyltransferase inhibitor	INHIBITOR	1999	CHEMBL2023	91	P21964	Catechol O-methyltransferase	Homo sapiens	D004827: Epilepsy,D009765: Obesity,D010300: Parkinson Disease,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D046152: Gastrointestinal Stromal Tumors	COMT	M1
P21964	NA	NA	NA	NA	TOLCAPONE	Catechol O-methyltransferase inhibitor	INHIBITOR	1998	CHEMBL2023	91	P21964	Catechol O-methyltransferase	Homo sapiens	D000437: Alcoholism,D001930: Brain Injuries,D005715: Gambling,D009447: Neuroblastoma,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019970: Cocaine-Related Disorders,D020774: Pick Disease of the Brain	COMT	M1
P21964	NA	NA	NA	NA	OPICAPONE	Catechol O-methyltransferase inhibitor	INHIBITOR	2020	CHEMBL2023	91	P21964	Catechol O-methyltransferase	Homo sapiens	D010300: Parkinson Disease	COMT	M1
P43681	NA	NA	NA	NA	NICOTINE	Neuronal acetylcholine receptor; alpha4/beta2 agonist	AGONIST	1984	CHEMBL1907589	104283	P43681	Neuronal acetylcholine receptor subunit alpha-4	Homo sapiens	D000375: Aging,D000428: Alcohol Drinking,D001289: Attention Deficit Disorder with Hyperactivity,D002189: Marijuana Abuse,D002278: Carcinoma in Situ,D002583: Uterine Cervical Neoplasms,D003866: Depressive Disorder,D006333: Heart Failure,D008175: Lung Neoplasms,D008569: Memory Disorders,D010300: Parkinson Disease,D012507: Sarcoidosis,D012509: Sarcoma,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D014376: Tuberculosis,D014947: Wounds and Injuries,D016540: Smoking Cessation,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D060825: Cognitive Dysfunction	CHRNA4	M1
P43681	NA	NA	NA	NA	NICOTINE POLACRILEX	Neuronal acetylcholine receptor; alpha4/beta2 agonist	AGONIST	1984	CHEMBL1907589	104283	P43681	Neuronal acetylcholine receptor subunit alpha-4	Homo sapiens	D003866: Depressive Disorder,D014029: Tobacco Use Disorder	CHRNA4	M1
P43681	NA	NA	NA	NA	VARENICLINE TARTRATE	Neuronal acetylcholine receptor; alpha4/beta2 agonist	AGONIST	2006	CHEMBL1907589	104283	P43681	Neuronal acetylcholine receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D014029: Tobacco Use Disorder,D016540: Smoking Cessation	CHRNA4	M1
P28472	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRB3	M1
P28472	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRB3	M1
P28472	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRB3	M1
P28472	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy	GABRB3	M1
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRB3	M1
P28472	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRB3	M1
P28472	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D008881: Migraine Disorders	GABRB3	M1
P28472	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRB3	M1
P28472	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRB3	M1
P28472	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRB3	M1
P28472	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRB3	M1
P28472	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRB3	M1
P28472	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRB3	M1
P28472	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRB3	M1
P28472	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia	GABRB3	M1
P28472	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRB3	M1
P28472	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRB3	M1
P28472	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRB3	M1
P28472	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M1
P28472	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M1
P28472	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M1
P28472	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRB3	M1
P28472	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRB3	M1
P28472	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRB3	M1
P28472	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRB3	M1
P28472	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRB3	M1
P28472	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRB3	M1
P28472	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRB3	M1
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRB3	M1
P28472	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism	GABRB3	M1
P28472	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
P28472	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRB3	M1
P28472	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M1
O00329	NA	NA	NA	NA	IDELALISIB	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2014	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D000686: Amyloidosis,D006255: Rhinitis, Allergic, Seasonal,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	PIK3CD	M1
O00329	NA	NA	NA	NA	DUVELISIB	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2018	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D002294: Carcinoma, Squamous Cell,D007938: Leukemia,D008107: Liver Diseases,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009182: Mycosis Fungoides,D009369: Neoplasms,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016411: Lymphoma, T-Cell, Peripheral,D019337: Hematologic Neoplasms,D045169: Severe Acute Respiratory Syndrome	PIK3CD	M1
O00329	NA	NA	NA	NA	COPANLISIB	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2017	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D005706: Gallbladder Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D018281: Cholangiocarcinoma,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PIK3CD	M1
O00329	NA	NA	NA	NA	COPANLISIB HYDROCHLORIDE	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2017	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D001943: Breast Neoplasms,D008224: Lymphoma, Follicular,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse	PIK3CD	M1
O00329	NA	NA	NA	NA	UMBRALISIB TOSYLATE	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2021	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D004938: Esophageal Neoplasms,D006689: Hodgkin Disease,D008224: Lymphoma, Follicular,D010190: Pancreatic Neoplasms,D011087: Polycythemia Vera,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D046152: Gastrointestinal Stromal Tumors,D055728: Primary Myelofibrosis	PIK3CD	M1
P30872	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P30872	Somatostatin receptor type 1	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR1	M1
P30872	NA	NA	NA	NA	PASIREOTIDE DIASPARTATE	Somatostatin receptor 1 agonist	AGONIST	2012	CHEMBL1917	12786	P30872	Somatostatin receptor type 1	Homo sapiens	NA	SSTR1	M1
P30872	NA	NA	NA	NA	PASIREOTIDE PAMOATE	Somatostatin receptor 1 agonist	AGONIST	2014	CHEMBL1917	12786	P30872	Somatostatin receptor type 1	Homo sapiens	D000172: Acromegaly	SSTR1	M1
P30872	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P30872	Somatostatin receptor type 1	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR1	M1
Q99500	NA	NA	NA	NA	FINGOLIMOD HYDROCHLORIDE	Sphingosine 1-phosphate receptor agonist	AGONIST	2010	CHEMBL2363041	105736	Q99500	Sphingosine 1-phosphate receptor 3	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001943: Breast Neoplasms,D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting	S1PR3	M1
P24394	NA	NA	NA	NA	DUPILUMAB	Interleukin-4 receptor subunit alpha antagonist	ANTAGONIST	2017	CHEMBL3580490	109786	P24394	Interleukin-4 receptor subunit alpha	Homo sapiens	D000506: Alopecia Areata,D000799: Angioedema,D001229: Aspergillosis, Allergic Bronchopulmonary,D001249: Asthma,D003233: Conjunctivitis, Allergic,D003872: Dermatitis,D003876: Dermatitis, Atopic,D004485: Eczema,D006255: Rhinitis, Allergic, Seasonal,D009298: Nasal Polyps,D009450: Neurodermatitis,D010391: Pemphigoid, Bullous,D011537: Pruritus,D012140: Respiratory Tract Diseases,D012594: Scleroderma, Localized,D012852: Sinusitis,D014581: Urticaria,D021183: Peanut Hypersensitivity,D029424: Pulmonary Disease, Chronic Obstructive,D056770: Netherton Syndrome,D057765: Eosinophilic Esophagitis,D064129: Prostatic Neoplasms, Castration-Resistant	IL4R	M1
Q9P0J0	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q9P0J0	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFA13	M1
Q14031	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	Q14031	Collagen alpha-6(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A6	M1
Q14031	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	Q14031	Collagen alpha-6(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A6	M1
P31391	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P31391	Somatostatin receptor type 4	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR4	M1
P31391	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P31391	Somatostatin receptor type 4	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR4	M1
P07948	NA	NA	NA	NA	BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	INHIBITOR	2010	CHEMBL3905	11842	P07948	Tyrosine-protein kinase Lyn	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	LYN	M1
P07948	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P07948	Tyrosine-protein kinase Lyn	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	LYN	M1
P42345	NA	NA	NA	NA	PERHEXILINE MALEATE	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	1974	CHEMBL2842	11400	P42345	Serine/threonine-protein kinase mTOR	Homo sapiens	NA	MTOR	M1
P07202	NA	NA	NA	NA	METHIMAZOLE	Thyroid peroxidase inhibitor	INHIBITOR	1950	CHEMBL1839	40	P07202	Thyroid peroxidase	Homo sapiens	D003882: Dermatomyositis,D005909: Glioblastoma,D013959: Thyroid Diseases,D049970: Graves Ophthalmopathy	TPO	M1
P07202	NA	NA	NA	NA	PROPYLTHIOURACIL	Thyroid peroxidase inhibitor	INHIBITOR	1947	CHEMBL1839	40	P07202	Thyroid peroxidase	Homo sapiens	D013959: Thyroid Diseases,D013971: Thyrotoxicosis,D049970: Graves Ophthalmopathy	TPO	M1
Q969S8	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC10	M1
Q969S8	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC10	M1
Q969S8	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D009101: Multiple Myeloma	HDAC10	M1
O43242	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	O43242	26S proteasome non-ATPase regulatory subunit 3	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD3	M1
O43242	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	O43242	26S proteasome non-ATPase regulatory subunit 3	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD3	M1
O43242	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	O43242	26S proteasome non-ATPase regulatory subunit 3	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD3	M1
P08123	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08123	Collagen alpha-2(I) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL1A2	M1
P08123	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08123	Collagen alpha-2(I) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL1A2	M1
Q15759	NA	NA	NA	NA	REGORAFENIB	MAP kinase p38 beta inhibitor	INHIBITOR	2012	CHEMBL3961	10120	Q15759	Mitogen-activated protein kinase 11	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	MAPK11	M1
P23219	NA	NA	NA	NA	INDOMETHACIN	Cyclooxygenase inhibitor	INHIBITOR	1965	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000081483: Squamous Intraepithelial Lesions,D000544: Alzheimer Disease,D001249: Asthma,D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D002318: Cardiovascular Diseases,D004374: Ductus Arteriosus, Patent,D005128: Eye Diseases,D006073: Gout,D006470: Hemorrhage,D006646: Histiocytosis, Langerhans-Cell,D007024: Hypotension, Orthostatic,D007249: Inflammation,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008545: Melanoma,D010003: Osteoarthritis,D010146: Pain,D010195: Pancreatitis,D011471: Prostatic Neoplasms,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D014098: Toothache,D015210: Arthritis, Gouty,D018771: Arthralgia,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D050500: Pancreatitis, Chronic,D056844: Renal Colic,D059787: Acute Pain,D063806: Myalgia,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS1	M1
P23219	NA	NA	NA	NA	SULFASALAZINE	Cyclooxygenase inhibitor	INHIBITOR	1950	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D005909: Glioblastoma,D006976: Hypertension, Pulmonary,D007415: Intestinal Obstruction,D009325: Nausea,D010019: Osteomyelitis,D010523: Peripheral Nervous System Diseases,D013167: Spondylitis, Ankylosing,D015209: Cholangitis, Sclerosing,D015535: Arthritis, Psoriatic	PTGS1	M1
P23219	CHEMBL25	1280	2244	DB00945	ASPIRIN	Cyclooxygenase inhibitor	INHIBITOR	1950	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000026: Abortion, Habitual,D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000077192: Adenocarcinoma of Lung,D000083242: Ischemic Stroke,D000236: Adenoma,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001249: Asthma,D001281: Atrial Fibrillation,D001471: Barrett Esophagus,D001714: Bipolar Disorder,D001766: Blindness,D001778: Blood Coagulation Disorders,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D002386: Cataract,D002532: Intracranial Aneurysm,D002537: Intracranial Arteriosclerosis,D002544: Cerebral Infarction,D002546: Ischemic Attack, Transient,D002561: Cerebrovascular Disorders,D002583: Uterine Cervical Neoplasms,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D003139: Common Cold,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D003930: Diabetic Retinopathy,D004066: Digestive System Diseases,D004211: Disseminated Intravascular Coagulation,D004381: Duodenal Ulcer,D004938: Esophageal Neoplasms,D005221: Fatigue,D005317: Fetal Growth Retardation,D005334: Fever,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006261: Headache,D006331: Heart Diseases,D006333: Heart Failure,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D006528: Carcinoma, Hepatocellular,D006561: Herpes Simplex,D006562: Herpes Zoster,D006937: Hypercholesterolemia,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007511: Ischemia,D007972: Leukoplakia, Oral,D008180: Lupus Erythematosus, Systemic,D008268: Macular Degeneration,D008545: Melanoma,D008581: Meningitis,D008881: Migraine Disorders,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010003: Osteoarthritis,D010020: Osteonecrosis,D010051: Ovarian Neoplasms,D010146: Pain,D010437: Peptic Ulcer,D010518: Periodontitis,D010612: Pharyngitis,D010927: Placental Insufficiency,D011014: Pneumonia,D011024: Pneumonia, Viral,D011087: Polycythemia Vera,D011125: Adenomatous Polyposis Coli,D011225: Pre-Eclampsia,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011618: Psychotic Disorders,D012004: Rectal Neoplasms,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012170: Retinal Vein Occlusion,D012214: Rheumatic Heart Disease,D012559: Schizophrenia,D013035: Spasm,D013274: Stomach Neoplasms,D013276: Stomach Ulcer,D013920: Thrombocythemia, Essential,D013927: Thrombosis,D014029: Tobacco Use Disorder,D014376: Tuberculosis,D014456: Ulcer,D014647: Varicose Ulcer,D014652: Vascular Diseases,D014808: Vitamin D Deficiency,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015228: Hypertriglyceridemia,D015356: Retinal Artery Occlusion,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016889: Endometrial Neoplasms,D016893: Carotid Stenosis,D017116: Low Back Pain,D017202: Myocardial Ischemia,D018781: Tension-Type Headache,D018805: Sepsis,D019851: Thrombophilia,D020246: Venous Thrombosis,D020520: Brain Infarction,D020521: Stroke,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D050197: Atherosclerosis,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D055371: Acute Lung Injury,D056586: Acute Chest Syndrome,D058729: Peripheral Arterial Disease,D060050: Angina, Stable,D061218: Depressive Disorder, Treatment-Resistant,D062788: Adenomyosis,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS1	M1
P23219	CHEMBL521	11674	3672	DB01050	IBUPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1974	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000532: Altitude Sickness,D000544: Alzheimer Disease,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D001943: Breast Neoplasms,D001997: Bronchopulmonary Dysplasia,D002056: Burns,D002318: Cardiovascular Diseases,D002422: Causalgia,D002547: Cerebral Palsy,D003139: Common Cold,D003865: Depressive Disorder, Major,D003922: Diabetes Mellitus, Type 1,D004374: Ductus Arteriosus, Patent,D004412: Dysmenorrhea,D004646: Emphysema,D004828: Epilepsies, Partial,D005334: Fever,D005910: Glioma,D006105: Granulomatous Disease, Chronic,D006255: Rhinitis, Allergic, Seasonal,D006261: Headache,D006470: Hemorrhage,D006973: Hypertension,D007021: Hypospadias,D007024: Hypotension, Orthostatic,D007239: Infections,D007251: Influenza, Human,D008288: Malaria,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009135: Muscular Diseases,D010003: Osteoarthritis,D010146: Pain,D010195: Pancreatitis,D010437: Peptic Ulcer,D010518: Periodontitis,D011225: Pre-Eclampsia,D011671: Pulpitis,D012128: Respiratory Distress Syndrome,D012178: Retinopathy of Prematurity,D012216: Rheumatic Diseases,D012772: Shock, Septic,D012852: Sinusitis,D013180: Sprains and Strains,D013281: Stomatitis, Aphthous,D013471: Sunburn,D013705: Temporomandibular Joint Disorders,D014076: Tooth Diseases,D014098: Toothache,D014376: Tuberculosis,D014627: Vaginitis,D014657: Vasculitis,D014947: Wounds and Injuries,D015658: HIV Infections,D017116: Low Back Pain,D018771: Arthralgia,D018781: Tension-Type Headache,D019547: Neck Pain,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D020388: Muscular Dystrophy, Duchenne,D020968: Brachial Plexus Neuritis,D025242: Spondylarthropathies,D047928: Premature Birth,D050723: Fractures, Bone,D055009: Spondylosis,D059350: Chronic Pain,D059787: Acute Pain,D060825: Cognitive Dysfunction,D063806: Myalgia,D064386: Ankle Fractures	PTGS1	M1
P23219	NA	NA	NA	NA	PIROXICAM	Cyclooxygenase inhibitor	INHIBITOR	1982	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D001172: Arthritis, Rheumatoid,D005128: Eye Diseases,D010003: Osteoarthritis,D012216: Rheumatic Diseases,D013716: Tennis Elbow,D018771: Arthralgia,D020370: Osteoarthritis, Knee,D056844: Renal Colic,D063806: Myalgia	PTGS1	M1
P23219	NA	NA	NA	NA	PHENYLBUTAZONE	Cyclooxygenase inhibitor	INHIBITOR	1980	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D012216: Rheumatic Diseases,D018771: Arthralgia,D063806: Myalgia	PTGS1	M1
P23219	NA	NA	NA	NA	FLURBIPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1986	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000740: Anemia,D001172: Arthritis, Rheumatoid,D003924: Diabetes Mellitus, Type 2,D005128: Eye Diseases,D010146: Pain,D010518: Periodontitis,D010612: Pharyngitis,D012216: Rheumatic Diseases,D015658: HIV Infections,D017116: Low Back Pain,D018771: Arthralgia,D028361: Mitochondrial Diseases,D063806: Myalgia	PTGS1	M1
P23219	CHEMBL112	16450	1983	DB00316	ACETAMINOPHEN	Cyclooxygenase inhibitor	INHIBITOR	1968	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000070636: Rotator Cuff Injuries,D000744: Anemia, Hemolytic, Autoimmune,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D001883: Borderline Personality Disorder,D001924: Brain Concussion,D001930: Brain Injuries,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002972: Cleft Palate,D003139: Common Cold,D003424: Crohn Disease,D003693: Delirium,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003929: Diabetic Neuropathies,D004066: Digestive System Diseases,D004374: Ductus Arteriosus, Patent,D004412: Dysmenorrhea,D005334: Fever,D005901: Glaucoma,D005910: Glioma,D006009: Glycogen Storage Disease Type II,D006086: Graft vs Host Disease,D006261: Headache,D006470: Hemorrhage,D006973: Hypertension,D006984: Hypertrophy,D007021: Hypospadias,D007154: Immune System Diseases,D007239: Infections,D007251: Influenza, Human,D007669: Kidney Calculi,D007674: Kidney Diseases,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008545: Melanoma,D008881: Migraine Disorders,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009216: Myopia,D009325: Nausea,D009369: Neoplasms,D009422: Nervous System Diseases,D009437: Neuralgia,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010300: Parkinson Disease,D010392: Pemphigus,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011537: Pruritus,D011671: Pulpitis,D012141: Respiratory Tract Infections,D012600: Scoliosis,D012852: Sinusitis,D013290: Streptococcal Infections,D014069: Tonsillitis,D014076: Tooth Diseases,D014098: Toothache,D014839: Vomiting,D014947: Wounds and Injuries,D015207: Osteoarthritis, Hip,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015458: Leukemia, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D015746: Abdominal Pain,D016403: Lymphoma, Large B-Cell, Diffuse,D016553: Purpura, Thrombocytopenic, Idiopathic,D016920: Meningitis, Bacterial,D017116: Low Back Pain,D018781: Tension-Type Headache,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D020250: Postoperative Nausea and Vomiting,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D050723: Fractures, Bone,D052016: Mucositis,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D055959: Intervertebral Disc Degeneration,D056844: Renal Colic,D059350: Chronic Pain,D059787: Acute Pain,D064386: Ankle Fractures	PTGS1	M1
P23219	NA	NA	NA	NA	SULINDAC	Cyclooxygenase inhibitor	INHIBITOR	1978	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D008545: Melanoma,D011125: Adenomatous Polyposis Coli,D011230: Precancerous Conditions,D012216: Rheumatic Diseases,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018222: Fibromatosis, Aggressive	PTGS1	M1
P23219	NA	NA	NA	NA	FENCLOFENAC	Cyclooxygenase inhibitor	INHIBITOR	1978	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	NA	PTGS1	M1
P23219	NA	NA	NA	NA	KETOPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1986	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D002062: Bursitis,D007249: Inflammation,D007669: Kidney Calculi,D008881: Migraine Disorders,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010518: Periodontitis,D012216: Rheumatic Diseases,D013180: Sprains and Strains,D014947: Wounds and Injuries,D017116: Low Back Pain,D018771: Arthralgia,D020250: Postoperative Nausea and Vomiting,D020370: Osteoarthritis, Knee,D052256: Tendinopathy,D056844: Renal Colic,D059787: Acute Pain,D063806: Myalgia	PTGS1	M1
P23219	NA	NA	NA	NA	INDOPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1979	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D012216: Rheumatic Diseases	PTGS1	M1
P23219	NA	NA	NA	NA	DICLOFENAC	Cyclooxygenase inhibitor	INHIBITOR	1988	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000375: Aging,D001172: Arthritis, Rheumatoid,D002277: Carcinoma,D002280: Carcinoma, Basal Cell,D003866: Depressive Disorder,D005128: Eye Diseases,D007246: Infertility,D009369: Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010518: Periodontitis,D011655: Pulmonary Embolism,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D013180: Sprains and Strains,D013276: Stomach Ulcer,D014098: Toothache,D015207: Osteoarthritis, Hip,D018771: Arthralgia,D020370: Osteoarthritis, Knee,D055623: Keratosis, Actinic,D056844: Renal Colic,D059373: Mastodynia,D059787: Acute Pain,D063806: Myalgia	PTGS1	M1
P23219	NA	NA	NA	NA	MEFENAMIC ACID	Cyclooxygenase inhibitor	INHIBITOR	1967	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D003920: Diabetes Mellitus,D004412: Dysmenorrhea,D006470: Hemorrhage,D010146: Pain,D012216: Rheumatic Diseases	PTGS1	M1
P23219	NA	NA	NA	NA	MESALAMINE	Cyclooxygenase inhibitor	INHIBITOR	1987	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000076385: Diverticular Diseases,D000236: Adenoma,D001607: Berylliosis,D003092: Colitis,D003093: Colitis, Ulcerative,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D003424: Crohn Disease,D004238: Diverticulitis,D004241: Diverticulum, Colon,D011349: Proctitis,D015179: Colorectal Neoplasms,D015658: HIV Infections,D043183: Irritable Bowel Syndrome,D044342: Malnutrition,D046729: Colitis, Collagenous,D046730: Colitis, Lymphocytic	PTGS1	M1
P23219	NA	NA	NA	NA	BROMFENAC SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1997	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	NA	PTGS1	M1
P23219	NA	NA	NA	NA	NAPROXEN	Cyclooxygenase inhibitor	INHIBITOR	1976	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000544: Alzheimer Disease,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D001943: Breast Neoplasms,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D004381: Duodenal Ulcer,D004412: Dysmenorrhea,D006073: Gout,D006261: Headache,D007249: Inflammation,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D010437: Peptic Ulcer,D010996: Pleural Effusion,D011471: Prostatic Neoplasms,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D013276: Stomach Ulcer,D014098: Toothache,D014627: Vaginitis,D015207: Osteoarthritis, Hip,D015210: Arthritis, Gouty,D017116: Low Back Pain,D018771: Arthralgia,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D049310: Distal Myopathies,D059787: Acute Pain,D063806: Myalgia	PTGS1	M1
P23219	NA	NA	NA	NA	DIFLUNISAL	Cyclooxygenase inhibitor	INHIBITOR	1982	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D003924: Diabetes Mellitus, Type 2,D005334: Fever,D010146: Pain,D028227: Amyloid Neuropathies, Familial	PTGS1	M1
P23219	NA	NA	NA	NA	SUPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1985	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D012216: Rheumatic Diseases	PTGS1	M1
P23219	NA	NA	NA	NA	NEPAFENAC	Cyclooxygenase inhibitor	INHIBITOR	2005	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D002386: Cataract,D005128: Eye Diseases,D007249: Inflammation,D008269: Macular Edema,D015877: Miosis	PTGS1	M1
P23219	NA	NA	NA	NA	DICLOFENAC SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1988	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000740: Anemia,D001172: Arthritis, Rheumatoid,D001749: Urinary Bladder Neoplasms,D006073: Gout,D006470: Hemorrhage,D007249: Inflammation,D009135: Muscular Diseases,D010003: Osteoarthritis,D010032: Otitis Externa,D010146: Pain,D011843: Radiculopathy,D013180: Sprains and Strains,D013471: Sunburn,D014098: Toothache,D017116: Low Back Pain,D020370: Osteoarthritis, Knee,D055623: Keratosis, Actinic,D059350: Chronic Pain	PTGS1	M1
P23219	NA	NA	NA	NA	OXAPROZIN	Cyclooxygenase inhibitor	INHIBITOR	1992	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D012216: Rheumatic Diseases	PTGS1	M1
P23219	NA	NA	NA	NA	BISMUTH SUBSALICYLATE	Cyclooxygenase inhibitor	INHIBITOR	1996	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D008223: Lymphoma,D016481: Helicobacter Infections	PTGS1	M1
P23219	NA	NA	NA	NA	PIRPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1987	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D012216: Rheumatic Diseases	PTGS1	M1
P23219	NA	NA	NA	NA	OXAPROZIN POTASSIUM	Cyclooxygenase inhibitor	INHIBITOR	2002	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	NA	PTGS1	M1
P23219	NA	NA	NA	NA	TOLMETIN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1976	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	NA	PTGS1	M1
P23219	NA	NA	NA	NA	BALSALAZIDE DISODIUM	Cyclooxygenase inhibitor	INHIBITOR	2000	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D003093: Colitis, Ulcerative	PTGS1	M1
P23219	NA	NA	NA	NA	DICLOFENAC POTASSIUM	Cyclooxygenase inhibitor	INHIBITOR	1993	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D001172: Arthritis, Rheumatoid,D004412: Dysmenorrhea,D008881: Migraine Disorders,D010003: Osteoarthritis,D010146: Pain,D011671: Pulpitis,D013276: Stomach Ulcer,D014098: Toothache,D059787: Acute Pain	PTGS1	M1
P23219	NA	NA	NA	NA	NAPROXEN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1980	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D000544: Alzheimer Disease,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D002062: Bursitis,D004412: Dysmenorrhea,D006073: Gout,D008881: Migraine Disorders,D010003: Osteoarthritis,D010146: Pain,D010612: Pharyngitis,D013167: Spondylitis, Ankylosing,D013276: Stomach Ulcer,D014098: Toothache,D020370: Osteoarthritis, Knee,D052256: Tendinopathy,D059787: Acute Pain	PTGS1	M1
P23219	NA	NA	NA	NA	OLSALAZINE SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1990	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D003093: Colitis, Ulcerative	PTGS1	M1
P23219	NA	NA	NA	NA	KETOROLAC TROMETHAMINE	Cyclooxygenase inhibitor	INHIBITOR	1989	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D001416: Back Pain,D002386: Cataract,D002539: Cerebral Arterial Diseases,D006255: Rhinitis, Allergic, Seasonal,D006331: Heart Diseases,D007249: Inflammation,D007669: Kidney Calculi,D008269: Macular Edema,D008881: Migraine Disorders,D010146: Pain,D011671: Pulpitis,D019534: Shoulder Impingement Syndrome,D056844: Renal Colic,D059787: Acute Pain	PTGS1	M1
P23219	NA	NA	NA	NA	IBUPROFEN LYSINE	Cyclooxygenase inhibitor	INHIBITOR	2006	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D004374: Ductus Arteriosus, Patent	PTGS1	M1
P23219	NA	NA	NA	NA	DICLOFENAC EPOLAMINE	Cyclooxygenase inhibitor	INHIBITOR	2007	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D001943: Breast Neoplasms,D010195: Pancreatitis,D013180: Sprains and Strains,D059787: Acute Pain	PTGS1	M1
P23219	NA	NA	NA	NA	MECLOFENAMATE SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1980	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	NA	PTGS1	M1
P23219	NA	NA	NA	NA	FENOPROFEN CALCIUM	Cyclooxygenase inhibitor	INHIBITOR	1976	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	NA	PTGS1	M1
P23219	NA	NA	NA	NA	IBUPROFEN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	2012	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D010146: Pain	PTGS1	M1
P23219	NA	NA	NA	NA	INDOMETHACIN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1985	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D007249: Inflammation	PTGS1	M1
P23219	NA	NA	NA	NA	OXYPHENBUTAZONE	Cyclooxygenase inhibitor	INHIBITOR	1960	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	D005128: Eye Diseases,D012216: Rheumatic Diseases,D018771: Arthralgia,D063806: Myalgia	PTGS1	M1
P23219	NA	NA	NA	NA	FLURBIPROFEN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1986	CHEMBL2094253	104725	P23219	Prostaglandin G/H synthase 1	Homo sapiens	NA	PTGS1	M1
P62942	NA	NA	NA	NA	SIROLIMUS	FK506-binding protein 1A inhibitor	INHIBITOR	1999	CHEMBL1902	80	P62942	Peptidyl-prolyl cis-trans isomerase FKBP1A	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000375: Aging,D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001991: Bronchitis,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002532: Intracranial Aneurysm,D002538: Intracranial Arteriovenous Malformations,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D003930: Diabetic Retinopathy,D005128: Eye Diseases,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005350: Fibroma,D005355: Fibrosis,D005733: Gangliosidoses,D005776: Gaucher Disease,D005871: Castleman Disease,D005909: Glioblastoma,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006009: Glycogen Storage Disease Type II,D006086: Graft vs Host Disease,D006105: Granulomatous Disease, Chronic,D006402: Hematologic Diseases,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006937: Hypercholesterolemia,D006946: Hyperinsulinism,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007154: Immune System Diseases,D007674: Kidney Diseases,D007690: Polycystic Kidney Diseases,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008268: Macular Degeneration,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009442: Neurilemmoma,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010300: Parkinson Disease,D010392: Pemphigus,D010871: Pinealoma,D011125: Adenomatous Polyposis Coli,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012128: Respiratory Distress Syndrome,D012509: Sarcoma,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012878: Skin Neoplasms,D013341: Sturge-Weber Syndrome,D013964: Thyroid Neoplasms,D014606: Uveitis, Anterior,D015352: Dry Eye Syndromes,D015423: Scleritis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015866: Uveitis, Posterior,D015867: Uveitis, Intermediate,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016511: Severe Combined Immunodeficiency,D016543: Central Nervous System Neoplasms,D016891: Polycystic Kidney, Autosomal Dominant,D017086: beta-Thalassemia,D017676: Lichen Planus, Oral,D018192: Lymphangioleiomyomatosis,D018222: Fibromatosis, Aggressive,D018316: Gliosarcoma,D018376: Cardiovascular Abnormalities,D018979: Myositis, Inclusion Body,D019337: Hematologic Neoplasms,D019339: Port-Wine Stain,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D053549: Pachyonychia Congenita,D054079: Vascular Malformations,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055371: Acute Lung Injury,D055752: Small Cell Lung Carcinoma,D055948: Sarcopenia,D057135: Wet Macular Degeneration,D057180: Frontotemporal Dementia,D058249: Birt-Hogg-Dube Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	FKBP1A	M1
P62942	NA	NA	NA	NA	PIMECROLIMUS	FK506-binding protein 1A inhibitor	INHIBITOR	2001	CHEMBL1902	80	P62942	Peptidyl-prolyl cis-trans isomerase FKBP1A	Homo sapiens	D003872: Dermatitis,D003876: Dermatitis, Atopic,D004485: Eczema,D008010: Lichen Planus,D012628: Dermatitis, Seborrheic,D014820: Vitiligo,D015352: Dry Eye Syndromes,D017676: Lichen Planus, Oral,D018459: Lichen Sclerosus et Atrophicus,D019557: Dermatitis, Perioral,D056770: Netherton Syndrome	FKBP1A	M1
P62942	NA	NA	NA	NA	TEMSIROLIMUS	FK506-binding protein 1A inhibitor	INHIBITOR	2007	CHEMBL1902	80	P62942	Peptidyl-prolyl cis-trans isomerase FKBP1A	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000230: Adenocarcinoma,D000236: Adenoma,D001172: Arthritis, Rheumatoid,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007340: Insulinoma,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013005: Somatostatinoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018269: Carcinoma, Endometrioid,D018273: Carcinoma, Islet Cell,D018305: Ganglioneuroblastoma,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D064129: Prostatic Neoplasms, Castration-Resistant	FKBP1A	M1
P62942	NA	NA	NA	NA	EVEROLIMUS	FK506-binding protein 1A inhibitor	INHIBITOR	2009	CHEMBL1902	80	P62942	Peptidyl-prolyl cis-trans isomerase FKBP1A	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000230: Adenocarcinoma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D002813: Chondrosarcoma,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D003586: Cytomegalovirus Infections,D004694: Endocardial Cushion Defects,D004714: Endometrial Hyperplasia,D004806: Ependymoma,D004827: Epilepsy,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006223: Hamartoma Syndrome, Multiple,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006929: Hyperaldosteronism,D007154: Immune System Diseases,D007239: Infections,D007516: Adenoma, Islet Cell,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007690: Polycystic Kidney Diseases,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008303: Malignant Carcinoid Syndrome,D008545: Melanoma,D008579: Meningioma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009442: Neurilemmoma,D009456: Neurofibromatosis 1,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010580: Peutz-Jeghers Syndrome,D011371: Progeria,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013953: Thymus Neoplasms,D013964: Thyroid Neoplasms,D014376: Tuberculosis,D014402: Tuberous Sclerosis,D014594: Uterine Neoplasms,D014605: Uveitis,D015179: Colorectal Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016518: Neurofibromatosis 2,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D016891: Polycystic Kidney, Autosomal Dominant,D018192: Lymphangioleiomyomatosis,D018207: Angiomyolipoma,D018276: Carcinoma, Medullary,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D018442: Lymphoma, B-Cell, Marginal Zone,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023903: Coronary Restenosis,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	FKBP1A	M1
P62942	NA	NA	NA	NA	TACROLIMUS	FK506-binding protein 1A inhibitor	INHIBITOR	1994	CHEMBL1902	80	P62942	Peptidyl-prolyl cis-trans isomerase FKBP1A	Homo sapiens	D004485: Eczema,D007154: Immune System Diseases	FKBP1A	M1
P08913	NA	NA	NA	NA	METHYLDOPA	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D006973: Hypertension,D011225: Pre-Eclampsia	ADRA2A	M1
P08913	NA	NA	NA	NA	CLONIDINE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001930: Brain Injuries,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002318: Cardiovascular Diseases,D002545: Brain Ischemia,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D005242: Fecal Incontinence,D005901: Glaucoma,D006556: Heroin Dependence,D006939: Hyperemesis Gravidarum,D006973: Hypertension,D007024: Hypotension, Orthostatic,D008881: Migraine Disorders,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009369: Neoplasms,D010146: Pain,D011183: Postoperative Complications,D011247: Pregnancy,D012600: Scoliosis,D013280: Stomatitis,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D054971: Orthostatic Intolerance	ADRA2A	M1
P08913	NA	NA	NA	NA	MIRTAZAPINE	Adrenergic receptor alpha-2 antagonist	ANTAGONIST	1996	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	ADRA2A	M1
P08913	NA	NA	NA	NA	LEVONORDEFRIN	Adrenergic receptor alpha-2 agonist	AGONIST	1960	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRA2A	M1
P08913	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1985	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	CLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D006973: Hypertension,D010146: Pain	ADRA2A	M1
P08913	NA	NA	NA	NA	NAPHAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1971	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003139: Common Cold,D007249: Inflammation,D007251: Influenza, Human,D011625: Pterygium	ADRA2A	M1
P08913	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRA2A	M1
P08913	NA	NA	NA	NA	TIZANIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001930: Brain Injuries,D008545: Melanoma,D009128: Muscle Spasticity,D011843: Radiculopathy	ADRA2A	M1
P08913	NA	NA	NA	NA	APRACLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1987	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	TETRAHYDROZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1979	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D007249: Inflammation,D011625: Pterygium	ADRA2A	M1
P08913	NA	NA	NA	NA	METHYLDOPATE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	GUANFACINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1986	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	ADRA2A	M1
P08913	NA	NA	NA	NA	GUANABENZ ACETATE	Adrenergic receptor alpha-2 agonist	AGONIST	1982	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	PHENOXYBENZAMINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	OXYMETAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1986	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D006255: Rhinitis, Allergic, Seasonal,D011305: Presbyopia,D012393: Rosacea	ADRA2A	M1
P08913	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	PHENTOLAMINE MESYLATE	Adrenergic receptor alpha antagonist	ANTAGONIST	1952	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA2A	M1
P08913	NA	NA	NA	NA	ALSEROXYLON	Adrenergic receptor alpha antagonist	ANTAGONIST	1982	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D010146: Pain	ADRA2A	M1
P08913	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRA2A	M1
P08913	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001249: Asthma	ADRA2A	M1
P08913	NA	NA	NA	NA	LOFEXIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	2018	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D009293: Opioid-Related Disorders,D013375: Substance Withdrawal Syndrome	ADRA2A	M1
P08913	NA	NA	NA	NA	BRIMONIDINE TARTRATE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D005483: Flushing,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006940: Hyperemia,D007429: Intraocular Pressure,D009798: Ocular Hypertension,D012393: Rosacea,D015352: Dry Eye Syndromes,D015715: Corneal Edema,D019973: Alcohol-Related Disorders,D060831: Hand-Foot Syndrome	ADRA2A	M1
P08913	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRA2A	M1
P08913	NA	NA	NA	NA	DEXMEDETOMIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1999	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000647: Amnesia,D001930: Brain Injuries,D010146: Pain,D011618: Psychotic Disorders,D012559: Schizophrenia	ADRA2A	M1
P08913	NA	NA	NA	NA	ERGOLOID MESYLATES	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	ADRA2A	M1
P08913	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Adrenergic receptor alpha agonist	AGONIST	1948	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D008881: Migraine Disorders	ADRA2A	M1
P08913	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M1
P08913	NA	NA	NA	NA	RAUWOLFIA SERPENTINA	Adrenergic receptor alpha antagonist	ANTAGONIST	1954	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D006331: Heart Diseases,D006973: Hypertension	ADRA2A	M1
Q15054	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD3	M1
Q15054	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLD3	M1
Q15054	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLD3	M1
Q15054	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD3	M1
O14649	NA	NA	NA	NA	HALOTHANE	Potassium channel subfamily K member 3 opener	OPENER	1958	CHEMBL2321613	105602	O14649	Potassium channel subfamily K member 3	Homo sapiens	NA	KCNK3	M1
O14649	NA	NA	NA	NA	ISOFLURANE	Potassium channel subfamily K member 3 opener	OPENER	1979	CHEMBL2321613	105602	O14649	Potassium channel subfamily K member 3	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	KCNK3	M1
O14649	NA	NA	NA	NA	ENFLURANE	Potassium channel subfamily K member 3 opener	OPENER	1972	CHEMBL2321613	105602	O14649	Potassium channel subfamily K member 3	Homo sapiens	NA	KCNK3	M1
O14649	NA	NA	NA	NA	SEVOFLURANE	Potassium channel subfamily K member 3 opener	OPENER	1995	CHEMBL2321613	105602	O14649	Potassium channel subfamily K member 3	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	KCNK3	M1
O14649	NA	NA	NA	NA	DESFLURANE	Potassium channel subfamily K member 3 opener	OPENER	1992	CHEMBL2321613	105602	O14649	Potassium channel subfamily K member 3	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	KCNK3	M1
O14649	NA	NA	NA	NA	DOXAPRAM HYDROCHLORIDE	Potassium channel subfamily K member 3 blocker	BLOCKER	1965	CHEMBL2321613	105602	O14649	Potassium channel subfamily K member 3	Homo sapiens	D016584: Panic Disorder	KCNK3	M1
Q08499	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE4D	M1
Q08499	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE4D	M1
Q08499	NA	NA	NA	NA	AMLEXANOX	Phosphodiesterase 4 inhibitor	INHIBITOR	1996	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D008173: Lung Diseases, Obstructive,D013280: Stomatitis	PDE4D	M1
Q08499	NA	NA	NA	NA	ROFLUMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2011	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D001249: Asthma,D001987: Bronchiectasis,D003704: Dementia,D003865: Depressive Disorder, Major,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D008173: Lung Diseases, Obstructive,D008223: Lymphoma,D009369: Neoplasms,D009422: Nervous System Diseases,D009765: Obesity,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D060825: Cognitive Dysfunction,D065626: Non-alcoholic Fatty Liver Disease	PDE4D	M1
Q08499	NA	NA	NA	NA	THEOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	PDE4D	M1
Q08499	NA	NA	NA	NA	APREMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2014	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D000152: Acne Vulgaris,D000437: Alcoholism,D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D003093: Colitis, Ulcerative,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004485: Eczema,D006073: Gout,D007154: Immune System Diseases,D008010: Lichen Planus,D008179: Lupus Erythematosus, Discoid,D011472: Prostatitis,D011565: Psoriasis,D012393: Rosacea,D013167: Spondylitis, Ankylosing,D013281: Stomatitis, Aphthous,D014605: Uveitis,D014820: Vitiligo,D015535: Arthritis, Psoriatic,D017449: Dermatitis, Allergic Contact,D017497: Hidradenitis Suppurativa,D017676: Lichen Planus, Oral,D045169: Severe Acute Respiratory Syndrome	PDE4D	M1
Q08499	NA	NA	NA	NA	CRISABOROLE	Phosphodiesterase 4 inhibitor	INHIBITOR	2016	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D000506: Alopecia Areata,D003872: Dermatitis,D003876: Dermatitis, Atopic,D004485: Eczema,D011565: Psoriasis,D012594: Scleroderma, Localized	PDE4D	M1
Q08499	NA	NA	NA	NA	DYPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1951	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4D	M1
Q08499	NA	NA	NA	NA	OXTRIPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1981	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4D	M1
Q08499	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Phosphodiesterase 4 inhibitor	INHIBITOR	1982	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	NA	PDE4D	M1
Q08499	NA	NA	NA	NA	FLAVOXATE HYDROCHLORIDE	Phosphodiesterase 4 inhibitor	INHIBITOR	1970	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	NA	PDE4D	M1
Q08499	NA	NA	NA	NA	AMINOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	Q08499	cAMP-specific 3',5'-cyclic phosphodiesterase 4D	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	PDE4D	M1
Q14123	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q14123	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE1C	M1
Q14123	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q14123	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE1C	M1
Q99436	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M1
Q99436	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M1
Q99436	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB7	M1
Q8IZS8	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA2D3	M1
Q8IZS8	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA2D3	M1
Q8IZS8	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D002318: Cardiovascular Diseases	CACNA2D3	M1
Q8IZS8	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	NA	CACNA2D3	M1
Q8IZS8	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	NA	CACNA2D3	M1
Q8IZS8	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA2D3	M1
Q02156	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	Q02156	Protein kinase C epsilon type	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKCE	M1
Q13003	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	1996	CHEMBL2109241	104902	Q13003	Glutamate receptor ionotropic, kainate 3	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIK3	M1
P22888	NA	NA	NA	NA	CHORIOGONADOTROPIN ALFA	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	2000	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D007246: Infertility,D011085: Polycystic Ovary Syndrome,D016471: Ovarian Hyperstimulation Syndrome	LHCGR	M1
P22888	NA	NA	NA	NA	LUTROPIN ALFA	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	2004	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D007006: Hypogonadism,D007246: Infertility,D007247: Infertility, Female	LHCGR	M1
P22888	NA	NA	NA	NA	GONADOTROPIN, CHORIONIC	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	1973	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D000858: Anovulation,D001943: Breast Neoplasms,D006058: Gonadal Disorders,D007006: Hypogonadism,D007246: Infertility,D011085: Polycystic Ovary Syndrome,D011247: Pregnancy,D053713: Azoospermia	LHCGR	M1
P22888	NA	NA	NA	NA	LH (MENOTROPINS)	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	1975	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D007246: Infertility	LHCGR	M1
P22888	NA	NA	NA	NA	MENOTROPINS	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	1975	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D006058: Gonadal Disorders,D007006: Hypogonadism,D007246: Infertility,D007247: Infertility, Female,D011085: Polycystic Ovary Syndrome,D011247: Pregnancy,D017436: Kallmann Syndrome,D053713: Azoospermia	LHCGR	M1
P29320	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P29320	Ephrin type-A receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA3	M1
Q8TAE7	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q8TAE7	Potassium voltage-gated channel subfamily G member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG3	M1
Q8TAE7	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TAE7	Potassium voltage-gated channel subfamily G member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG3	M1
Q8TAE7	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q8TAE7	Potassium voltage-gated channel subfamily G member 3	Homo sapiens	NA	KCNG3	M1
Q8TAE7	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TAE7	Potassium voltage-gated channel subfamily G member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG3	M1
O75762	NA	NA	NA	NA	MENTHOL	Transient receptor potential cation channel subfamily A member 1 opener	OPENER	2008	CHEMBL6007	101412	O75762	Transient receptor potential cation channel subfamily A member 1	Homo sapiens	D001168: Arthritis,D001416: Back Pain,D002062: Bursitis,D003139: Common Cold,D003371: Cough,D003680: Deglutition Disorders,D003929: Diabetic Neuropathies,D006973: Hypertension,D009120: Muscle Cramp,D010003: Osteoarthritis,D010146: Pain,D010612: Pharyngitis,D013274: Stomach Neoplasms,D014029: Tobacco Use Disorder,D052256: Tendinopathy,D063806: Myalgia	TRPA1	M1
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1955	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001714: Bipolar Disorder,D005910: Glioma,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D012559: Schizophrenia,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020521: Stroke	SLC18A2	M1
Q05940	NA	NA	NA	NA	RESERPINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D002561: Cerebrovascular Disorders,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006937: Hypercholesterolemia,D006973: Hypertension,D006976: Hypertension, Pulmonary,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis	SLC18A2	M1
Q05940	NA	NA	NA	NA	TETRABENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2008	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders	SLC18A2	M1
Q05940	NA	NA	NA	NA	RESCINNAMINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1956	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D006973: Hypertension	SLC18A2	M1
Q05940	NA	NA	NA	NA	DESERPIDINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1957	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D006973: Hypertension	SLC18A2	M1
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE ADIPATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1975	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	NA	SLC18A2	M1
Q05940	NA	NA	NA	NA	LISDEXAMFETAMINE DIMESYLATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2007	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001068: Feeding and Eating Disorders,D001289: Attention Deficit Disorder with Hyperactivity,D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity,D012559: Schizophrenia,D052018: Bulimia Nervosa,D056912: Binge-Eating Disorder	SLC18A2	M1
Q05940	NA	NA	NA	NA	VALBENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders	SLC18A2	M1
Q05940	NA	NA	NA	NA	DUTETRABENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D002547: Cerebral Palsy,D002819: Chorea,D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders,D020821: Dystonic Disorders	SLC18A2	M1
Q05940	NA	NA	NA	NA	BENZPHETAMINE HYDROCHLORIDE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	NA	SLC18A2	M1
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE SULFATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC18A2	M1
Q05940	NA	NA	NA	NA	VALBENAZINE TOSYLATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D000071057: Tardive Dyskinesia	SLC18A2	M1
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE SACCHARATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1996	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC18A2	M1
P08588	NA	NA	NA	NA	ATENOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1981	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002561: Cerebrovascular Disorders,D006331: Heart Diseases,D006333: Heart Failure,D006391: Hemangioma,D006973: Hypertension,D008382: Marfan Syndrome,D008946: Mitral Valve Stenosis,D009203: Myocardial Infarction,D010024: Osteoporosis,D013313: Stress Disorders, Post-Traumatic,D017202: Myocardial Ischemia,D017379: Hypertrophy, Left Ventricular,D060050: Angina, Stable	ADRB1	M1
P08588	NA	NA	NA	NA	TIMOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB1	M1
P08588	NA	NA	NA	NA	PINDOLOL	Beta-1 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB1	M1
P08588	NA	NA	NA	NA	NADOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB1	M1
P08588	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB1	M1
P08588	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB1	M1
P08588	NA	NA	NA	NA	DOPAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1974	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010300: Parkinson Disease	ADRB1	M1
P08588	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB1	M1
P08588	NA	NA	NA	NA	BETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension	ADRB1	M1
P08588	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1	M1
P08588	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB1	M1
P08588	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB1	M1
P08588	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	ACEBUTOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001145: Arrhythmias, Cardiac,D006973: Hypertension	ADRB1	M1
P08588	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	LEVOBETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2000	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D009798: Ocular Hypertension	ADRB1	M1
P08588	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB1	M1
P08588	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB1	M1
P08588	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1	M1
P08588	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB1	M1
P08588	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB1	M1
P08588	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB1	M1
P08588	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1990	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB1	M1
P08588	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB1	M1
P08588	NA	NA	NA	NA	BISOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D020388: Muscular Dystrophy, Duchenne	ADRB1	M1
P08588	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB1	M1
P08588	NA	NA	NA	NA	METOPROLOL TARTRATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006331: Heart Diseases,D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction	ADRB1	M1
P08588	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB1	M1
P08588	NA	NA	NA	NA	METOPROLOL SUCCINATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000787: Angina Pectoris,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D002312: Cardiomyopathy, Hypertrophic,D006333: Heart Failure,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008944: Mitral Valve Insufficiency,D029424: Pulmonary Disease, Chronic Obstructive	ADRB1	M1
P08588	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P08588	NA	NA	NA	NA	METOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M1
P31785	NA	NA	NA	NA	DENILEUKIN DIFTITOX	Interleukin-2 receptor binding agent	BINDING AGENT	1999	CHEMBL2364167	106146	P31785	Cytokine receptor common subunit gamma	Homo sapiens	D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male	IL2RG	M1
P31785	NA	NA	NA	NA	BASILIXIMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1998	CHEMBL2364167	106146	P31785	Cytokine receptor common subunit gamma	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003093: Colitis, Ulcerative,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D004646: Emphysema,D005909: Glioblastoma,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007239: Infections,D007674: Kidney Diseases,D007683: Kidney Tubular Necrosis, Acute,D009101: Multiple Myeloma,D009369: Neoplasms,D014511: Uremia,D014605: Uveitis,D015427: Reperfusion Injury,D015470: Leukemia, Myeloid, Acute,D051436: Renal Insufficiency, Chronic	IL2RG	M1
P31785	NA	NA	NA	NA	ALDESLEUKIN	Interleukin-2 receptor agonist	AGONIST	1992	CHEMBL2364167	106146	P31785	Cytokine receptor common subunit gamma	Homo sapiens	D000026: Abortion, Habitual,D000081483: Squamous Intraepithelial Lesions,D000163: Acquired Immunodeficiency Syndrome,D000506: Alopecia Areata,D000690: Amyotrophic Lateral Sclerosis,D000744: Anemia, Hemolytic, Autoimmune,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001528: Behcet Syndrome,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003093: Colitis, Ulcerative,D003327: Coronary Disease,D003424: Crohn Disease,D003449: Cryoglobulinemia,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D004660: Encephalitis,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009220: Myositis,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011081: Polychondritis, Relapsing,D011111: Polymyalgia Rheumatica,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012751: Sezary Syndrome,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D019337: Hematologic Neoplasms,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055501: Macrophage Activation Syndrome,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	IL2RG	M1
P31785	NA	NA	NA	NA	DACLIZUMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1997	CHEMBL2364167	106146	P31785	Cytokine receptor common subunit gamma	Homo sapiens	D000741: Anemia, Aplastic,D001249: Asthma,D003093: Colitis, Ulcerative,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D011565: Psoriasis,D012010: Red-Cell Aplasia, Pure,D013921: Thrombocytopenia,D014605: Uveitis,D014890: Granulomatosis with Polyangiitis,D015658: HIV Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D051436: Renal Insufficiency, Chronic,D057135: Wet Macular Degeneration	IL2RG	M1
P16233	NA	NA	NA	NA	ORLISTAT	Pancreatic lipase inhibitor	INHIBITOR	1999	CHEMBL1812	77	P16233	Pancreatic triacylglycerol lipase	Homo sapiens	D007246: Infertility,D008072: Hyperlipoproteinemia Type I,D009765: Obesity,D011085: Polycystic Ovary Syndrome,D024821: Metabolic Syndrome	PNLIP	M1
P10275	NA	NA	NA	NA	BICALUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	1995	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001943: Breast Neoplasms,D005185: Fallopian Tube Neoplasms,D006177: Gynecomastia,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D011629: Puberty, Precocious,D012468: Salivary Gland Neoplasms,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M1
P10275	NA	NA	NA	NA	FLUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	1989	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M1
P10275	NA	NA	NA	NA	TESTOSTERONE PROPIONATE	Androgen Receptor agonist	AGONIST	1974	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D059268: Atrophic Vaginitis	AR	M1
P10275	NA	NA	NA	NA	NILUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	1996	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D009369: Neoplasms,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M1
P10275	NA	NA	NA	NA	METHYLTESTOSTERONE	Androgen Receptor agonist	AGONIST	1973	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D008593: Menopause	AR	M1
P10275	NA	NA	NA	NA	TESTOSTERONE	Androgen Receptor agonist	AGONIST	1972	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000375: Aging,D000856: Anorexia Nervosa,D002539: Cerebral Arterial Diseases,D003327: Coronary Disease,D004392: Dwarfism,D004414: Dyspareunia,D006333: Heart Failure,D006620: Hip Fractures,D007006: Hypogonadism,D007172: Erectile Dysfunction,D007246: Infertility,D007333: Insulin Resistance,D007713: Klinefelter Syndrome,D008593: Menopause,D009103: Multiple Sclerosis,D009135: Muscular Diseases,D009369: Neoplasms,D009765: Obesity,D009920: Orchitis,D010411: Penile Induration,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D012735: Sexual Dysfunction, Physiological,D013119: Spinal Cord Injuries,D013736: Testicular Neoplasms,D017436: Kallmann Syndrome,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D055948: Sarcopenia,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M1
P10275	NA	NA	NA	NA	FLUOXYMESTERONE	Androgen Receptor agonist	AGONIST	1956	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001943: Breast Neoplasms	AR	M1
P10275	NA	NA	NA	NA	DANAZOL	Androgen Receptor agonist	AGONIST	1976	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000741: Anemia, Aplastic,D004715: Endometriosis,D005199: Fanconi Anemia,D005348: Fibrocystic Breast Disease,D007246: Infertility,D009190: Myelodysplastic Syndromes,D011697: Purpura, Thrombotic Thrombocytopenic,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D019871: Dyskeratosis Congenita,D059373: Mastodynia	AR	M1
P10275	NA	NA	NA	NA	ENZALUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	2012	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D014594: Uterine Neoplasms,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M1
P10275	NA	NA	NA	NA	TESTOSTERONE ENANTHATE	Androgen Receptor agonist	AGONIST	1953	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D007006: Hypogonadism,D011471: Prostatic Neoplasms,D015431: Weight Loss,D019247: HIV Wasting Syndrome,D020391: Muscular Dystrophy, Facioscapulohumeral,D029424: Pulmonary Disease, Chronic Obstructive,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M1
P10275	NA	NA	NA	NA	NANDROLONE PHENPROPIONATE	Androgen Receptor agonist	AGONIST	1959	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D005128: Eye Diseases	AR	M1
P10275	NA	NA	NA	NA	OXANDROLONE	Androgen Receptor agonist	AGONIST	1964	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D002056: Burns,D003668: Pressure Ulcer,D005199: Fanconi Anemia,D007713: Klinefelter Syndrome,D009369: Neoplasms,D014424: Turner Syndrome,D044342: Malnutrition	AR	M1
P10275	NA	NA	NA	NA	OXYMETHOLONE	Androgen Receptor agonist	AGONIST	1972	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR	M1
P10275	NA	NA	NA	NA	ETHYLESTRENOL	Androgen Receptor agonist	AGONIST	1964	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR	M1
P10275	NA	NA	NA	NA	NANDROLONE DECANOATE	Androgen Receptor agonist	AGONIST	1983	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D005128: Eye Diseases,D006620: Hip Fractures,D019247: HIV Wasting Syndrome,D044342: Malnutrition	AR	M1
P10275	NA	NA	NA	NA	DROMOSTANOLONE PROPIONATE	Androgen Receptor agonist	AGONIST	1982	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR	M1
P10275	NA	NA	NA	NA	TESTOSTERONE CYPIONATE	Androgen Receptor agonist	AGONIST	1978	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D003929: Diabetic Neuropathies,D007006: Hypogonadism,D011471: Prostatic Neoplasms,D012735: Sexual Dysfunction, Physiological,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M1
P10275	NA	NA	NA	NA	STANOZOLOL	Androgen Receptor agonist	AGONIST	1962	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR	M1
P10275	NA	NA	NA	NA	TESTOSTERONE UNDECANOATE	Androgen Receptor agonist	AGONIST	2014	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000375: Aging,D002292: Carcinoma, Renal Cell,D003327: Coronary Disease,D007006: Hypogonadism,D012131: Respiratory Insufficiency,D012735: Sexual Dysfunction, Physiological,D013119: Spinal Cord Injuries,D044342: Malnutrition	AR	M1
P10275	NA	NA	NA	NA	APALUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	2018	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D008107: Liver Diseases,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M1
P10275	NA	NA	NA	NA	CLASCOTERONE	Androgen Receptor antagonist	ANTAGONIST	2020	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000152: Acne Vulgaris,D000505: Alopecia	AR	M1
P10275	NA	NA	NA	NA	DAROLUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	2019	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M1
P06401	NA	NA	NA	NA	PROGESTERONE	Progesterone receptor agonist	AGONIST	1976	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000544: Alzheimer Disease,D000568: Amenorrhea,D000789: Angina, Unstable,D000856: Anorexia Nervosa,D001851: Bone Diseases, Metabolic,D001930: Brain Injuries,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004714: Endometrial Hyperplasia,D004827: Epilepsy,D006937: Hypercholesterolemia,D006973: Hypertension,D007246: Infertility,D007247: Infertility, Female,D007724: Vulvar Lichen Sclerosus,D007889: Leiomyoma,D008569: Memory Disorders,D008593: Menopause,D010024: Osteoporosis,D010923: Placenta Previa,D011085: Polycystic Ovary Syndrome,D011225: Pre-Eclampsia,D011247: Pregnancy,D013927: Thrombosis,D014029: Tobacco Use Disorder,D014592: Uterine Hemorrhage,D015658: HIV Infections,D016471: Ovarian Hyperstimulation Syndrome,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D018290: Cervical Intraepithelial Neoplasia,D019052: Depression, Postpartum,D019970: Cocaine-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D052018: Bulimia Nervosa,D054971: Orthostatic Intolerance	PGR	M1
P06401	NA	NA	NA	NA	MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	AGONIST	1959	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000544: Alzheimer Disease,D002292: Carcinoma, Renal Cell,D003327: Coronary Disease,D003920: Diabetes Mellitus,D004714: Endometrial Hyperplasia,D004715: Endometriosis,D006331: Heart Diseases,D006470: Hemorrhage,D006937: Hypercholesterolemia,D006973: Hypertension,D007246: Infertility,D007680: Kidney Neoplasms,D008180: Lupus Erythematosus, Systemic,D008593: Menopause,D008595: Menorrhagia,D009369: Neoplasms,D010024: Osteoporosis,D010146: Pain,D011247: Pregnancy,D011471: Prostatic Neoplasms,D012891: Sleep Apnea Syndromes,D013927: Thrombosis,D014424: Turner Syndrome,D015658: HIV Infections,D016649: Primary Ovarian Insufficiency,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019584: Hot Flashes	PGR	M1
P06401	NA	NA	NA	NA	NORETHINDRONE	Progesterone receptor agonist	AGONIST	1962	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D004412: Dysmenorrhea,D004715: Endometriosis,D006526: Hepatitis C,D008593: Menopause,D009369: Neoplasms,D010146: Pain,D012735: Sexual Dysfunction, Physiological,D015427: Reperfusion Injury,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	PGR	M1
P06401	NA	NA	NA	NA	NORETHYNODREL	Progesterone receptor agonist	AGONIST	1961	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	NA	PGR	M1
P06401	NA	NA	NA	NA	LEVONORGESTREL	Progesterone receptor agonist	AGONIST	1982	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000856: Anorexia Nervosa,D001851: Bone Diseases, Metabolic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004714: Endometrial Hyperplasia,D004715: Endometriosis,D006470: Hemorrhage,D008595: Menorrhagia,D008881: Migraine Disorders,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D062788: Adenomyosis	PGR	M1
P06401	NA	NA	NA	NA	DANAZOL	Progesterone receptor agonist	AGONIST	1976	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000741: Anemia, Aplastic,D004715: Endometriosis,D005199: Fanconi Anemia,D005348: Fibrocystic Breast Disease,D007246: Infertility,D009190: Myelodysplastic Syndromes,D011697: Purpura, Thrombotic Thrombocytopenic,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D019871: Dyskeratosis Congenita,D059373: Mastodynia	PGR	M1
P06401	NA	NA	NA	NA	DROSPIRENONE	Progesterone receptor agonist	AGONIST	2001	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000152: Acne Vulgaris,D002032: Bulimia,D003866: Depressive Disorder,D004412: Dysmenorrhea,D011085: Polycystic Ovary Syndrome,D011293: Premenstrual Syndrome,D017497: Hidradenitis Suppurativa,D052018: Bulimia Nervosa	PGR	M1
P06401	NA	NA	NA	NA	ETONOGESTREL	Progesterone receptor agonist	AGONIST	2001	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D004412: Dysmenorrhea,D011470: Prostatic Hyperplasia,D015658: HIV Infections	PGR	M1
P06401	NA	NA	NA	NA	DESOGESTREL	Progesterone receptor agonist	AGONIST	1992	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000568: Amenorrhea,D006470: Hemorrhage,D011085: Polycystic Ovary Syndrome,D020182: Sleep Apnea, Central	PGR	M1
P06401	NA	NA	NA	NA	ULIPRISTAL ACETATE	Progesterone receptor modulator	MODULATOR	2010	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D001943: Breast Neoplasms,D002607: Charcot-Marie-Tooth Disease,D003866: Depressive Disorder,D006470: Hemorrhage,D007889: Leiomyoma,D008593: Menopause,D011293: Premenstrual Syndrome,D062788: Adenomyosis	PGR	M1
P06401	NA	NA	NA	NA	ETHYNODIOL DIACETATE	Progesterone receptor agonist	AGONIST	1966	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	NA	PGR	M1
P06401	NA	NA	NA	NA	NORELGESTROMIN	Progesterone receptor agonist	AGONIST	2001	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D008796: Metrorrhagia,D011247: Pregnancy,D015658: HIV Infections	PGR	M1
P06401	NA	NA	NA	NA	HYDROXYPROGESTERONE CAPROATE	Progesterone receptor agonist	AGONIST	1975	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D011247: Pregnancy,D047928: Premature Birth	PGR	M1
P06401	NA	NA	NA	NA	DYDROGESTERONE	Progesterone receptor agonist	AGONIST	1982	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000026: Abortion, Habitual,D004714: Endometrial Hyperplasia,D007246: Infertility,D007247: Infertility, Female,D008593: Menopause,D010048: Ovarian Cysts,D011247: Pregnancy,D047928: Premature Birth	PGR	M1
P06401	NA	NA	NA	NA	NORGESTIMATE	Progesterone receptor agonist	AGONIST	1989	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000152: Acne Vulgaris,D003550: Cystic Fibrosis,D006526: Hepatitis C,D008796: Metrorrhagia,D008881: Migraine Disorders,D009436: Neural Tube Defects,D010024: Osteoporosis,D015658: HIV Infections	PGR	M1
P06401	NA	NA	NA	NA	MEGESTROL ACETATE	Progesterone receptor agonist	AGONIST	1971	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000855: Anorexia,D001943: Breast Neoplasms,D002100: Cachexia,D002278: Carcinoma in Situ,D003704: Dementia,D004714: Endometrial Hyperplasia,D006258: Head and Neck Neoplasms,D008113: Liver Neoplasms,D009369: Neoplasms,D014594: Uterine Neoplasms,D016889: Endometrial Neoplasms,D019247: HIV Wasting Syndrome,D019584: Hot Flashes,D029424: Pulmonary Disease, Chronic Obstructive	PGR	M1
P06401	NA	NA	NA	NA	NORETHINDRONE ACETATE	Progesterone receptor agonist	AGONIST	1973	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000152: Acne Vulgaris,D001943: Breast Neoplasms,D003550: Cystic Fibrosis,D004714: Endometrial Hyperplasia,D004715: Endometriosis,D006470: Hemorrhage,D007006: Hypogonadism,D007889: Leiomyoma,D008223: Lymphoma,D010146: Pain,D011247: Pregnancy,D016649: Primary Ovarian Insufficiency	PGR	M1
P06401	NA	NA	NA	NA	MIFEPRISTONE	Progesterone receptor antagonist	ANTAGONIST	2000	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000022: Abortion, Spontaneous,D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D003480: Cushing Syndrome,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D004715: Endometriosis,D005185: Fallopian Tube Neoplasms,D006526: Hepatitis C,D007889: Leiomyoma,D008579: Meningioma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015658: HIV Infections,D016889: Endometrial Neoplasms,D018567: Breast Neoplasms, Male,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D047748: Pituitary ACTH Hypersecretion,D056833: Central Serous Chorioretinopathy,D062788: Adenomyosis,D064129: Prostatic Neoplasms, Castration-Resistant	PGR	M1
P06401	NA	NA	NA	NA	NORGESTREL	Progesterone receptor agonist	AGONIST	1968	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D016889: Endometrial Neoplasms	PGR	M1
P06401	NA	NA	NA	NA	SEGESTERONE ACETATE	Progesterone receptor agonist	AGONIST	2018	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	NA	PGR	M1
O75899	NA	NA	NA	NA	BACLOFEN	GABA-B receptor agonist	AGONIST	1977	CHEMBL2111463	104988	O75899	Gamma-aminobutyric acid type B receptor subunit 2	Homo sapiens	D000437: Alcoholism,D001321: Autistic Disorder,D002189: Marijuana Abuse,D002547: Cerebral Palsy,D002607: Charcot-Marie-Tooth Disease,D005764: Gastroesophageal Reflux,D006528: Carcinoma, Hepatocellular,D008104: Liver Cirrhosis, Alcoholic,D009103: Multiple Sclerosis,D009119: Muscle Contraction,D009127: Muscle Rigidity,D009128: Muscle Spasticity,D009765: Obesity,D010145: Paget Disease, Extramammary,D010146: Pain,D013118: Spinal Cord Diseases,D013375: Substance Withdrawal Syndrome,D014029: Tobacco Use Disorder,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders	GABBR2	M1
O75899	NA	NA	NA	NA	SODIUM OXYBATE	GABA-B receptor agonist	AGONIST	2002	CHEMBL2111463	104988	O75899	Gamma-aminobutyric acid type B receptor subunit 2	Homo sapiens	D001068: Feeding and Eating Disorders,D005356: Fibromyalgia,D006429: Hemiplegia,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D010146: Pain,D010300: Parkinson Disease,D014202: Tremor,D020329: Essential Tremor	GABBR2	M1
O75899	NA	NA	NA	NA	CALCIUM OXYBATE	GABA-B receptor agonist	AGONIST	2020	CHEMBL2111463	104988	O75899	Gamma-aminobutyric acid type B receptor subunit 2	Homo sapiens	NA	GABBR2	M1
O75899	NA	NA	NA	NA	MAGNESIUM OXYBATE	GABA-B receptor agonist	AGONIST	2020	CHEMBL2111463	104988	O75899	Gamma-aminobutyric acid type B receptor subunit 2	Homo sapiens	NA	GABBR2	M1
O75899	NA	NA	NA	NA	POTASSIUM OXYBATE	GABA-B receptor agonist	AGONIST	2020	CHEMBL2111463	104988	O75899	Gamma-aminobutyric acid type B receptor subunit 2	Homo sapiens	NA	GABBR2	M1
A4D0S4	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	A4D0S4	Laminin subunit beta-4	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMB4	M1
Q9NZV8	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9NZV8	Potassium voltage-gated channel subfamily D member 2	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCND2	M1
Q9NZV8	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9NZV8	Potassium voltage-gated channel subfamily D member 2	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCND2	M1
Q9NZV8	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9NZV8	Potassium voltage-gated channel subfamily D member 2	Homo sapiens	NA	KCND2	M1
Q9NZV8	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9NZV8	Potassium voltage-gated channel subfamily D member 2	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCND2	M1
O15554	NA	NA	NA	NA	CHLORZOXAZONE	Intermediate conductance calcium-activated potassium channel protein 4 opener	OPENER	1958	CHEMBL4305	10992	O15554	Intermediate conductance calcium-activated potassium channel protein 4	Homo sapiens	NA	KCNN4	M1
P48058	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	1996	CHEMBL2096670	104825	P48058	Glutamate receptor 4	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIA4	M1
P48058	NA	NA	NA	NA	PERAMPANEL	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	2012	CHEMBL2096670	104825	P48058	Glutamate receptor 4	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D008881: Migraine Disorders,D009437: Neuralgia,D010300: Parkinson Disease,D010523: Peripheral Nervous System Diseases,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014103: Torticollis,D020329: Essential Tremor,D065768: Lennox Gastaut Syndrome	GRIA4	M1
P19971	NA	NA	NA	NA	TIPIRACIL HYDROCHLORIDE	Thymidine phosphorylase inhibitor	INHIBITOR	2015	CHEMBL3106	11723	P19971	Thymidine phosphorylase	Homo sapiens	D012004: Rectal Neoplasms,D015179: Colorectal Neoplasms	TYMP	M1
P09758	NA	NA	NA	NA	SACITUZUMAB GOVITECAN	Tumor-associated calcium signal transducer 2 binding agent	BINDING AGENT	2020	CHEMBL3856163	116939	P09758	Tumor-associated calcium signal transducer 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D016889: Endometrial Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TACSTD2	M1
P08631	NA	NA	NA	NA	BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	INHIBITOR	2010	CHEMBL3234	11785	P08631	Tyrosine-protein kinase HCK	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	HCK	M1
P08631	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P08631	Tyrosine-protein kinase HCK	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	HCK	M1
Q07343	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE4B	M1
Q07343	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE4B	M1
Q07343	NA	NA	NA	NA	AMLEXANOX	Phosphodiesterase 4 inhibitor	INHIBITOR	1996	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D008173: Lung Diseases, Obstructive,D013280: Stomatitis	PDE4B	M1
Q07343	NA	NA	NA	NA	ROFLUMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2011	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D001249: Asthma,D001987: Bronchiectasis,D003704: Dementia,D003865: Depressive Disorder, Major,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D008173: Lung Diseases, Obstructive,D008223: Lymphoma,D009369: Neoplasms,D009422: Nervous System Diseases,D009765: Obesity,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D060825: Cognitive Dysfunction,D065626: Non-alcoholic Fatty Liver Disease	PDE4B	M1
Q07343	NA	NA	NA	NA	THEOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	PDE4B	M1
Q07343	NA	NA	NA	NA	APREMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2014	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000152: Acne Vulgaris,D000437: Alcoholism,D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D003093: Colitis, Ulcerative,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004485: Eczema,D006073: Gout,D007154: Immune System Diseases,D008010: Lichen Planus,D008179: Lupus Erythematosus, Discoid,D011472: Prostatitis,D011565: Psoriasis,D012393: Rosacea,D013167: Spondylitis, Ankylosing,D013281: Stomatitis, Aphthous,D014605: Uveitis,D014820: Vitiligo,D015535: Arthritis, Psoriatic,D017449: Dermatitis, Allergic Contact,D017497: Hidradenitis Suppurativa,D017676: Lichen Planus, Oral,D045169: Severe Acute Respiratory Syndrome	PDE4B	M1
Q07343	NA	NA	NA	NA	CRISABOROLE	Phosphodiesterase 4 inhibitor	INHIBITOR	2016	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000506: Alopecia Areata,D003872: Dermatitis,D003876: Dermatitis, Atopic,D004485: Eczema,D011565: Psoriasis,D012594: Scleroderma, Localized	PDE4B	M1
Q07343	NA	NA	NA	NA	DYPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1951	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4B	M1
Q07343	NA	NA	NA	NA	OXTRIPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1981	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4B	M1
Q07343	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Phosphodiesterase 4 inhibitor	INHIBITOR	1982	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	NA	PDE4B	M1
Q07343	NA	NA	NA	NA	FLAVOXATE HYDROCHLORIDE	Phosphodiesterase 4 inhibitor	INHIBITOR	1970	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	NA	PDE4B	M1
Q07343	NA	NA	NA	NA	AMINOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	Q07343	cAMP-specific 3',5'-cyclic phosphodiesterase 4B	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	PDE4B	M1
P51679	NA	NA	NA	NA	MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CROSS-LINKING AGENT	2018	CHEMBL2414	10579	P51679	C-C chemokine receptor type 4	Homo sapiens	D001249: Asthma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D006528: Carcinoma, Hepatocellular,D009182: Mycosis Fungoides,D009369: Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D015493: Paraparesis, Tropical Spastic,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral	CCR4	M1
Q9UIX4	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG1	M1
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG1	M1
Q9UIX4	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	NA	KCNG1	M1
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG1	M1
P05091	NA	NA	NA	NA	DISULFIRAM	Aldehyde dehydrogenase inhibitor	INHIBITOR	1951	CHEMBL1935	30	P05091	Aldehyde dehydrogenase, mitochondrial	Homo sapiens	D000437: Alcoholism,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004478: Ectoparasitic Infestations,D005909: Glioblastoma,D008545: Melanoma,D009101: Multiple Myeloma,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D015658: HIV Infections,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	ALDH2	M1
Q7LG56	NA	NA	NA	NA	HYDROXYUREA	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1967	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D000755: Anemia, Sickle Cell,D002277: Carcinoma,D004938: Esophageal Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006432: Hemochromatosis,D006450: Hemoglobin SC Disease,D006976: Hypertension, Pulmonary,D007822: Laryngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008579: Meningioma,D009062: Mouth Neoplasms,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010255: Paranasal Sinus Neoplasms,D010610: Pharyngeal Neoplasms,D011087: Polycythemia Vera,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D017086: beta-Thalassemia,D018222: Fibromatosis, Aggressive,D018316: Gliosarcoma,D020521: Stroke,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	RRM2B	M1
Q7LG56	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1996	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	RRM2B	M1
Q7LG56	NA	NA	NA	NA	CLOFARABINE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	2004	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	RRM2B	M1
Q7LG56	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	RRM2B	M1
Q7LG56	NA	NA	NA	NA	GALLIUM NITRATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D003550: Cystic Fibrosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009164: Mycobacterium Infections,D009447: Neuroblastoma,D012509: Sarcoma	RRM2B	M1
P20138	NA	NA	NA	NA	GEMTUZUMAB OZOGAMICIN	Myeloid cell surface antigen CD33 binding agent	BINDING AGENT	2000	CHEMBL1842	81	P20138	Myeloid cell surface antigen CD33	Homo sapiens	D007938: Leukemia,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile	CD33	M1
Q16790	CHEMBL18	1096	3295	DB00311	ETHOXZOLAMIDE	Carbonic anhydrase inhibitor	INHIBITOR	1982	CHEMBL2095180	104764	Q16790	Carbonic anhydrase 9	Homo sapiens	NA	CA9	M1
Q9H2M3	NA	NA	NA	NA	BETAINE	Betaine-homocysteine S-methyltransferase substrate	SUBSTRATE	1996	CHEMBL3391661	109554	Q9H2M3	S-methylmethionine--homocysteine S-methyltransferase BHMT2	Homo sapiens	D003866: Depressive Disorder,D006526: Hepatitis C,D006712: Homocystinuria,D006960: Hyperoxaluria, Primary,D007248: Infertility, Male,D009765: Obesity,D019698: Hepatitis C, Chronic,D065626: Non-alcoholic Fatty Liver Disease	BHMT2	M1
O43526	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	O43526	Potassium voltage-gated channel subfamily KQT member 2	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNQ2	M1
O43526	NA	NA	NA	NA	EZOGABINE	KCNQ (Kv7) potassium channel blocker	BLOCKER	2011	CHEMBL2363063	105758	O43526	Potassium voltage-gated channel subfamily KQT member 2	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D006562: Herpes Zoster,D012640: Seizures	KCNQ2	M1
O43526	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	O43526	Potassium voltage-gated channel subfamily KQT member 2	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNQ2	M1
O43526	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	O43526	Potassium voltage-gated channel subfamily KQT member 2	Homo sapiens	NA	KCNQ2	M1
O43526	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	O43526	Potassium voltage-gated channel subfamily KQT member 2	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNQ2	M1
P01031	NA	NA	NA	NA	ECULIZUMAB	Complement C5 inhibitor	INHIBITOR	2007	CHEMBL2364163	106142	P01031	Complement C5	Homo sapiens	D003882: Dermatomyositis,D003920: Diabetes Mellitus,D006086: Graft vs Host Disease,D006457: Hemoglobinuria, Paroxysmal,D006461: Hemolysis,D006463: Hemolytic-Uremic Syndrome,D007154: Immune System Diseases,D007938: Leukemia,D008268: Macular Degeneration,D009157: Myasthenia Gravis,D009471: Neuromyelitis Optica,D013921: Thrombocytopenia,D015432: Glomerulonephritis, Membranoproliferative,D020275: Guillain-Barre Syndrome,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,D058625: End Stage Liver Disease,D065766: Atypical Hemolytic Uremic Syndrome	C5	M1
P01031	NA	NA	NA	NA	RAVULIZUMAB	Complement C5 inhibitor	INHIBITOR	2018	CHEMBL2364163	106142	P01031	Complement C5	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D006457: Hemoglobinuria, Paroxysmal,D007154: Immune System Diseases,D009157: Myasthenia Gravis,D009471: Neuromyelitis Optica,D011024: Pneumonia, Viral,D012128: Respiratory Distress Syndrome,D055371: Acute Lung Injury,D057049: Thrombotic Microangiopathies,D065766: Atypical Hemolytic Uremic Syndrome	C5	M1
Q16552	NA	NA	NA	NA	IXEKIZUMAB	Interleukin 17A inhibitor	INHIBITOR	2016	CHEMBL3390822	109547	Q16552	Interleukin-17A	Homo sapiens	D001172: Arthritis, Rheumatoid,D003922: Diabetes Mellitus, Type 1,D007154: Immune System Diseases,D010391: Pemphigoid, Bullous,D011565: Psoriasis,D011711: Pyoderma,D013167: Spondylitis, Ankylosing,D015535: Arthritis, Psoriatic,D045169: Severe Acute Respiratory Syndrome	IL17A	M1
Q16552	NA	NA	NA	NA	SECUKINUMAB	Interleukin 17A inhibitor	INHIBITOR	2015	CHEMBL3390822	109547	Q16552	Interleukin-17A	Homo sapiens	D000506: Alopecia Areata,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001528: Behcet Syndrome,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D007154: Immune System Diseases,D008179: Lupus Erythematosus, Discoid,D008181: Lupus Nephritis,D009103: Multiple Sclerosis,D009335: Necrobiosis Lipoidica,D010003: Osteoarthritis,D011111: Polymyalgia Rheumatica,D011565: Psoriasis,D011711: Pyoderma,D012393: Rosacea,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014605: Uveitis,D015352: Dry Eye Syndromes,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa,D020529: Multiple Sclerosis, Relapsing-Remitting,D025242: Spondylarthropathies,D049970: Graves Ophthalmopathy,D052256: Tendinopathy	IL17A	M1
P09884	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	P09884	DNA polymerase alpha catalytic subunit	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLA1	M1
P09884	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	P09884	DNA polymerase alpha catalytic subunit	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLA1	M1
P09884	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	P09884	DNA polymerase alpha catalytic subunit	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLA1	M1
P09884	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	P09884	DNA polymerase alpha catalytic subunit	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLA1	M1
P30926	NA	NA	NA	NA	TRIMETHAPHAN CAMSYLATE	Neuronal acetylcholine receptor; alpha3/beta4 antagonist	ANTAGONIST	1982	CHEMBL1907594	104288	P30926	Neuronal acetylcholine receptor subunit beta-4	Homo sapiens	NA	CHRNB4	M1
P30926	NA	NA	NA	NA	MECAMYLAMINE HYDROCHLORIDE	Neuronal acetylcholine receptor; alpha3/beta4 negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1956	CHEMBL1907594	104288	P30926	Neuronal acetylcholine receptor subunit beta-4	Homo sapiens	D003866: Depressive Disorder	CHRNB4	M1
P30926	NA	NA	NA	NA	PENTOLINIUM TARTRATE	Neuronal acetylcholine receptor; alpha3/beta4 antagonist	ANTAGONIST	1982	CHEMBL1907594	104288	P30926	Neuronal acetylcholine receptor subunit beta-4	Homo sapiens	NA	CHRNB4	M1
O95168	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O95168	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFB4	M1
P14416	NA	NA	NA	NA	CLOZAPINE	Dopamine D2 receptor antagonist	ANTAGONIST	1989	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D003704: Dementia,D003866: Depressive Disorder,D008607: Intellectual Disability,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	HALOPERIDOL	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	DRD2	M1
P14416	NA	NA	NA	NA	THIORIDAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	DRD2	M1
P14416	NA	NA	NA	NA	CHLORPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	DRD2	M1
P14416	NA	NA	NA	NA	RISPERIDONE	Dopamine D2 receptor antagonist	ANTAGONIST	1993	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005879: Tourette Syndrome,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009293: Opioid-Related Disorders,D011618: Psychotic Disorders,D012559: Schizophrenia,D012569: Schizotypal Personality Disorder,D013313: Stress Disorders, Post-Traumatic,D015140: Dementia, Vascular,D015518: Rett Syndrome,D019955: Conduct Disorder,D019958: Attention Deficit and Disruptive Behavior Disorders,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome,D065886: Neurodevelopmental Disorders	DRD2	M1
P14416	NA	NA	NA	NA	ILOPERIDONE	Dopamine D2 receptor antagonist	ANTAGONIST	2009	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D008107: Liver Diseases,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	DRD2	M1
P14416	NA	NA	NA	NA	PERPHENAZINE	Dopamine D2 receptor antagonist	ANTAGONIST	1957	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D019970: Cocaine-Related Disorders	DRD2	M1
P14416	NA	NA	NA	NA	TRIFLUPROMAZINE	Dopamine D2 receptor antagonist	ANTAGONIST	1957	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders	DRD2	M1
P14416	NA	NA	NA	NA	REMOXIPRIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1990	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders	DRD2	M1
P14416	NA	NA	NA	NA	OLANZAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1996	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	DRD2	M1
P14416	NA	NA	NA	NA	PROCHLORPERAZINE	Dopamine D2 receptor antagonist	ANTAGONIST	1956	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D006261: Headache,D008881: Migraine Disorders,D009325: Nausea,D011618: Psychotic Disorders,D020250: Postoperative Nausea and Vomiting,D066126: Cardiotoxicity	DRD2	M1
P14416	NA	NA	NA	NA	LOXAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	DRD2	M1
P14416	NA	NA	NA	NA	CHLORPROTHIXENE	Dopamine D2 receptor antagonist	ANTAGONIST	1967	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	DROPERIDOL	D2-like dopamine receptor antagonist	ANTAGONIST	1970	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	DRD2	M1
P14416	NA	NA	NA	NA	ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	2002	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000544: Alzheimer Disease,D000856: Anorexia Nervosa,D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005600: Fragile X Syndrome,D005879: Tourette Syndrome,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome	DRD2	M1
P14416	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P14416	D(2) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD2	M1
P14416	NA	NA	NA	NA	THIOTHIXENE	Dopamine D2 receptor antagonist	ANTAGONIST	1967	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders	DRD2	M1
P14416	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	ROTIGOTINE	D2-like dopamine receptor agonist	AGONIST	2007	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000544: Alzheimer Disease,D005356: Fibromyalgia,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D020521: Stroke	DRD2	M1
P14416	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P14416	D(2) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	AMISULPRIDE	Dopamine receptors; D2 & D3 antagonist	ANTAGONIST	2020	CHEMBL2095169	104754	P14416	D(2) dopamine receptor	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	DRD2	M1
P14416	NA	NA	NA	NA	APOMORPHINE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	2004	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D009369: Neoplasms,D010024: Osteoporosis,D010300: Parkinson Disease	DRD2	M1
P14416	NA	NA	NA	NA	PALIPERIDONE	Dopamine D2 receptor antagonist	ANTAGONIST	2006	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	LEVOMEPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1982	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	ROPINIROLE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D010300: Parkinson Disease	DRD2	M1
P14416	NA	NA	NA	NA	MOLINDONE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1974	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1956	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	BROMOCRIPTINE MESYLATE	D2-like dopamine receptor agonist	AGONIST	1978	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000172: Acromegaly,D003924: Diabetes Mellitus, Type 2,D006966: Hyperprolactinemia,D007006: Hypogonadism,D007246: Infertility,D010300: Parkinson Disease	DRD2	M1
P14416	NA	NA	NA	NA	BENZQUINAMIDE HYDROCHLORIDE	Dopamine D2 receptor modulator	MODULATOR	1974	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	FLUPHENAZINE DECANOATE	Dopamine D2 receptor antagonist	ANTAGONIST	1972	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011565: Psoriasis,D011618: Psychotic Disorders	DRD2	M1
P14416	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	METOCLOPRAMIDE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1979	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D014839: Vomiting,D020250: Postoperative Nausea and Vomiting	DRD2	M1
P14416	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1979	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	FLUPHENAZINE ENANTHATE	Dopamine D2 receptor antagonist	ANTAGONIST	1967	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011565: Psoriasis,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	HALOPERIDOL DECANOATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1986	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	MESORIDAZINE BESYLATE	Dopamine D2 receptor antagonist	ANTAGONIST	1970	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1976	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	CABERGOLINE	Dopamine D2 receptor agonist	AGONIST	1996	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003920: Diabetes Mellitus,D004715: Endometriosis,D007246: Infertility,D009765: Obesity,D010145: Paget Disease, Extramammary,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D016471: Ovarian Hyperstimulation Syndrome,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D047748: Pituitary ACTH Hypersecretion	DRD2	M1
P14416	NA	NA	NA	NA	TRIFLUPROMAZINE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1957	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	PROCHLORPERAZINE EDISYLATE	Dopamine D2 receptor antagonist	ANTAGONIST	1957	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	LOXAPINE SUCCINATE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1959	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	PROCHLORPERAZINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1956	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	ZIPRASIDONE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	2001	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder	DRD2	M1
P14416	NA	NA	NA	NA	FLUPHENAZINE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1959	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D009101: Multiple Myeloma	DRD2	M1
P14416	NA	NA	NA	NA	LURASIDONE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	2010	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	CARIPRAZINE HYDROCHLORIDE	Dopamine D2 receptor modulator	MODULATOR	2015	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	VERALIPRIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1979	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders	DRD2	M1
P14416	NA	NA	NA	NA	BREXPIPRAZOLE	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	2015	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012893: Sleep Wake Disorders,D013313: Stress Disorders, Post-Traumatic	DRD2	M1
P14416	NA	NA	NA	NA	PALIPERIDONE PALMITATE	Dopamine D2 receptor antagonist	ANTAGONIST	2009	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	ARIPIPRAZOLE LAUROXIL	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	2015	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P14416	D(2) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD2	M1
P14416	NA	NA	NA	NA	CARPHENAZINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1982	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	THIETHYLPERAZINE MALATE	Dopamine D2 receptor antagonist	ANTAGONIST	1961	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	ACETOPHENAZINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1961	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	PRAMIPEXOLE DIHYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D010300: Parkinson Disease	DRD2	M1
P14416	NA	NA	NA	NA	QUETIAPINE FUMARATE	Dopamine D2 receptor antagonist	ANTAGONIST	1997	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000072861: Phobia, Social,D000437: Alcoholism,D001007: Anxiety,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009103: Multiple Sclerosis,D009497: Neurotic Disorders,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	DRD2	M1
P14416	NA	NA	NA	NA	LUMATEPERONE	Dopamine D2 receptor antagonist	ANTAGONIST	2019	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000544: Alzheimer Disease,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	ASENAPINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	2009	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	THIETHYLPERAZINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1961	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	REMOXIPRIDE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1990	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	OLANZAPINE PAMOATE	D2-like dopamine receptor antagonist	ANTAGONIST	2009	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	THIOTHIXENE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1970	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M1
P14416	NA	NA	NA	NA	ZIPRASIDONE MESYLATE	Dopamine D2 receptor antagonist	ANTAGONIST	2002	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	DRD2	M1
P14416	NA	NA	NA	NA	HALOPERIDOL LACTATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M1
P25103	NA	NA	NA	NA	NETUPITANT	Neurokinin 1 receptor antagonist	ANTAGONIST	2014	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D009369: Neoplasms,D020250: Postoperative Nausea and Vomiting	TACR1	M1
P25103	NA	NA	NA	NA	APREPITANT	Neurokinin 1 receptor antagonist	ANTAGONIST	2003	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D000437: Alcoholism,D002189: Marijuana Abuse,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D005909: Glioblastoma,D006556: Heroin Dependence,D009101: Multiple Myeloma,D009293: Opioid-Related Disorders,D009325: Nausea,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010146: Pain,D011537: Pruritus,D014839: Vomiting,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D018589: Gastroparesis,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D045169: Severe Acute Respiratory Syndrome	TACR1	M1
P25103	NA	NA	NA	NA	FOSAPREPITANT DIMEGLUMINE	Neurokinin 1 receptor antagonist	ANTAGONIST	2008	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D012509: Sarcoma,D020250: Postoperative Nausea and Vomiting	TACR1	M1
P25103	NA	NA	NA	NA	ROLAPITANT HYDROCHLORIDE	Neurokinin 1 receptor antagonist	ANTAGONIST	2015	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D012509: Sarcoma,D020250: Postoperative Nausea and Vomiting	TACR1	M1
P25103	NA	NA	NA	NA	FOSNETUPITANT CHLORIDE HYDROCHLORIDE	Neurokinin 1 receptor antagonist	ANTAGONIST	2018	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D014839: Vomiting	TACR1	M1
P35372	NA	NA	NA	NA	FENTANYL	Mu opioid receptor agonist	AGONIST	1968	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D000038: Abscess,D000236: Adenoma,D001930: Brain Injuries,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D003693: Delirium,D003929: Diabetic Neuropathies,D007021: Hypospadias,D007022: Hypotension,D008107: Liver Diseases,D008881: Migraine Disorders,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010146: Pain,D010190: Pancreatic Neoplasms,D011671: Pulpitis,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D013274: Stomach Neoplasms,D013345: Subarachnoid Hemorrhage,D017116: Low Back Pain,D020181: Sleep Apnea, Obstructive,D043183: Irritable Bowel Syndrome,D050723: Fractures, Bone,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M1
P35372	CHEMBL128201	214599	10295681	NA	NALTREXONE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001883: Borderline Personality Disorder,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002659: Child Development Disorders, Pervasive,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D004715: Endometriosis,D005356: Fibromyalgia,D005715: Gambling,D006556: Heroin Dependence,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014256: Trichotillomania,D015352: Dry Eye Syndromes,D015658: HIV Infections,D018352: Coronavirus Infections,D018856: Cystitis, Interstitial,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRM1	M1
P35372	NA	NA	NA	NA	OXYCODONE	Mu opioid receptor agonist	AGONIST	1950	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D001416: Back Pain,D003929: Diabetic Neuropathies,D007021: Hypospadias,D007592: Joint Diseases,D007669: Kidney Calculi,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009748: Nutrition Disorders,D010003: Osteoarthritis,D010146: Pain,D010300: Parkinson Disease,D011225: Pre-Eclampsia,D011537: Pruritus,D012131: Respiratory Insufficiency,D012148: Restless Legs Syndrome,D012852: Sinusitis,D013119: Spinal Cord Injuries,D014098: Toothache,D015179: Colorectal Neoplasms,D015207: Osteoarthritis, Hip,D017116: Low Back Pain,D019547: Neck Pain,D019966: Substance-Related Disorders,D020370: Osteoarthritis, Knee,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	OPRM1	M1
P35372	NA	NA	NA	NA	FENTANYL CITRATE	Mu opioid receptor agonist	AGONIST	1968	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D004417: Dyspnea,D009369: Neoplasms,D009437: Neuralgia,D010146: Pain,D011671: Pulpitis,D017116: Low Back Pain,D017563: Lung Diseases, Interstitial,D059350: Chronic Pain,D059390: Breakthrough Pain	OPRM1	M1
P35372	NA	NA	NA	NA	BUTORPHANOL TARTRATE	Mu opioid receptor partial agonist	PARTIAL AGONIST	1978	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	ALVIMOPAN	Mu opioid receptor antagonist	ANTAGONIST	2008	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003248: Constipation,D005185: Fallopian Tube Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms	OPRM1	M1
P35372	NA	NA	NA	NA	BUPRENORPHINE	Mu opioid receptor agonist	AGONIST	1981	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000755: Anemia, Sickle Cell,D001416: Back Pain,D002294: Carcinoma, Squamous Cell,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006526: Hepatitis C,D006556: Heroin Dependence,D009021: Morphine Dependence,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D013313: Stress Disorders, Post-Traumatic,D013375: Substance Withdrawal Syndrome,D014098: Toothache,D015658: HIV Infections,D017116: Low Back Pain,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	DEZOCINE	Mu opioid receptor partial agonist	PARTIAL AGONIST	1989	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M1
P35372	NA	NA	NA	NA	MEPERIDINE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1942	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D007022: Hypotension,D010146: Pain	OPRM1	M1
P35372	NA	NA	NA	NA	LOPERAMIDE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1976	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D003967: Diarrhea	OPRM1	M1
P35372	NA	NA	NA	NA	NALOXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1971	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D003248: Constipation,D005715: Gambling,D007415: Intestinal Obstruction,D009293: Opioid-Related Disorders,D010146: Pain	OPRM1	M1
P35372	NA	NA	NA	NA	ALFENTANIL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1986	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D000758: Anesthesia	OPRM1	M1
P35372	NA	NA	NA	NA	ANILERIDINE PHOSPHATE	Mu opioid receptor agonist	AGONIST	1982	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	DIFENOXIN HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1978	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	DIPHENOXYLATE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1960	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	OXYMORPHONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1959	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	LEVOMETHADYL ACETATE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1993	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	METHADONE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1947	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain,D015658: HIV Infections,D055959: Intervertebral Disc Degeneration,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	OXYCODONE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1950	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain,D010149: Pain, Postoperative,D015207: Osteoarthritis, Hip,D017116: Low Back Pain,D020370: Osteoarthritis, Knee,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	ANILERIDINE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1982	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	CODEINE PHOSPHATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1952	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D003371: Cough,D008881: Migraine Disorders,D010146: Pain,D013035: Spasm,D015658: HIV Infections	OPRM1	M1
P35372	NA	NA	NA	NA	REMIFENTANIL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1996	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	NALBUPHINE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1979	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D003693: Delirium,D008107: Liver Diseases,D009293: Opioid-Related Disorders,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D015470: Leukemia, Myeloid, Acute	OPRM1	M1
P35372	NA	NA	NA	NA	NALTREXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D001068: Feeding and Eating Disorders,D002607: Charcot-Marie-Tooth Disease,D009293: Opioid-Related Disorders,D010146: Pain,D019969: Amphetamine-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRM1	M1
P35372	NA	NA	NA	NA	NALMEFENE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1995	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D000437: Alcoholism	OPRM1	M1
P35372	NA	NA	NA	NA	FENTANYL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	2006	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M1
P35372	NA	NA	NA	NA	SUFENTANIL CITRATE	Mu opioid receptor agonist	AGONIST	1984	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	CODEINE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1985	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D003371: Cough	OPRM1	M1
P35372	NA	NA	NA	NA	HYDROCODONE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1987	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	METHYLNALTREXONE BROMIDE	Mu opioid receptor antagonist	ANTAGONIST	2008	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D003248: Constipation,D010190: Pancreatic Neoplasms	OPRM1	M1
P35372	NA	NA	NA	NA	TAPENTADOL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	2008	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D009437: Neuralgia,D010146: Pain,D017116: Low Back Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	HYDROMORPHONE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1984	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D001416: Back Pain,D008107: Liver Diseases,D009369: Neoplasms,D010146: Pain,D015207: Osteoarthritis, Hip,D019966: Substance-Related Disorders,D020370: Osteoarthritis, Knee,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	TRAMADOL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1995	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D009369: Neoplasms,D010146: Pain,D014098: Toothache,D017116: Low Back Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	PROPOXYPHENE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1957	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M1
P35372	NA	NA	NA	NA	DIHYDROCODEINE BITARTRATE	Mu opioid receptor agonist	AGONIST	1983	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M1
P35372	NA	NA	NA	NA	LEVALLORPHAN TARTRATE	Mu opioid receptor antagonist	ANTAGONIST	1982	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	MORPHINE SULFATE	Mu opioid receptor agonist	AGONIST	1984	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D000755: Anemia, Sickle Cell,D006215: Hallux Valgus,D006976: Hypertension, Pulmonary,D009203: Myocardial Infarction,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009369: Neoplasms,D010146: Pain,D011537: Pruritus,D017116: Low Back Pain,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D054990: Idiopathic Pulmonary Fibrosis,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	NALDEMEDINE	Mu opioid receptor antagonist	ANTAGONIST	2017	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D003248: Constipation	OPRM1	M1
P35372	NA	NA	NA	NA	ELUXADOLINE	Mu opioid receptor agonist	AGONIST	2015	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D043183: Irritable Bowel Syndrome	OPRM1	M1
P35372	NA	NA	NA	NA	NALOXEGOL OXALATE	Mu opioid receptor antagonist	ANTAGONIST	2014	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	BUPRENORPHINE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1981	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D009293: Opioid-Related Disorders,D019966: Substance-Related Disorders	OPRM1	M1
P35372	NA	NA	NA	NA	OLICERIDINE	Mu opioid receptor agonist	AGONIST	2020	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	NALDEMEDINE TOSYLATE	Mu opioid receptor antagonist	ANTAGONIST	2017	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D003248: Constipation	OPRM1	M1
P35372	NA	NA	NA	NA	BENZHYDROCODONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2018	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	HYDROCODONE BITARTRATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1943	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D007674: Kidney Diseases,D008107: Liver Diseases,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D014947: Wounds and Injuries,D017116: Low Back Pain,D019966: Substance-Related Disorders,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M1
P35372	NA	NA	NA	NA	PROPOXYPHENE NAPSYLATE	Mu opioid receptor agonist	AGONIST	1971	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M1
P35372	NA	NA	NA	NA	LEVORPHANOL TARTRATE	Mu opioid receptor agonist	AGONIST	1991	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M1
P35372	NA	NA	NA	NA	OXYCODONE TEREPHTHALATE	Mu opioid receptor agonist	AGONIST	1950	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M1
P35372	NA	NA	NA	NA	CODEINE SULFATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2009	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M1
O60674	NA	NA	NA	NA	FEDRATINIB	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	2019	CHEMBL2971	10938	O60674	Tyrosine-protein kinase JAK2	Homo sapiens	D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D011087: Polycythemia Vera,D055728: Primary Myelofibrosis	JAK2	M1
O60674	NA	NA	NA	NA	RUXOLITINIB PHOSPHATE	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	2011	CHEMBL2971	10938	O60674	Tyrosine-protein kinase JAK2	Homo sapiens	D001943: Breast Neoplasms,D008288: Malaria,D011087: Polycythemia Vera,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D018269: Carcinoma, Endometrioid,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	JAK2	M1
O60674	NA	NA	NA	NA	TOFACITINIB CITRATE	Janus Kinase (JAK) inhibitor	INHIBITOR	2012	CHEMBL2363062	105757	O60674	Tyrosine-protein kinase JAK2	Homo sapiens	D001172: Arthritis, Rheumatoid,D008179: Lupus Erythematosus, Discoid,D008180: Lupus Erythematosus, Systemic	JAK2	M1
O60674	NA	NA	NA	NA	BARICITINIB	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	2018	CHEMBL2971	10938	O60674	Tyrosine-protein kinase JAK2	Homo sapiens	D000506: Alopecia Areata,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008105: Liver Cirrhosis, Biliary,D008180: Lupus Erythematosus, Systemic,D009220: Myositis,D011014: Pneumonia,D011565: Psoriasis,D013700: Giant Cell Arteritis,D014605: Uveitis,D017449: Dermatitis, Allergic Contact,D045169: Severe Acute Respiratory Syndrome	JAK2	M1
O60674	NA	NA	NA	NA	UPADACITINIB	Janus Kinase (JAK) inhibitor	INHIBITOR	2019	CHEMBL2363062	105757	O60674	Tyrosine-protein kinase JAK2	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa	JAK2	M1
O60674	NA	NA	NA	NA	FEDRATINIB HYDROCHLORIDE	Tyrosine-protein kinase JAK2 inhibitor	INHIBITOR	2019	CHEMBL2971	10938	O60674	Tyrosine-protein kinase JAK2	Homo sapiens	D055728: Primary Myelofibrosis	JAK2	M1
P15509	NA	NA	NA	NA	SARGRAMOSTIM	Granulocyte-macrophage colony-stimulating factor receptor agonist	AGONIST	1991	CHEMBL2364169	106148	P15509	Granulocyte-macrophage colony-stimulating factor receptor subunit alpha	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000544: Alzheimer Disease,D000754: Anemia, Refractory, with Excess of Blasts,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003424: Crohn Disease,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005334: Fever,D005706: Gallbladder Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007239: Infections,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008637: Mesenchymoma,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009503: Neutropenia,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010300: Parkinson Disease,D010518: Periodontitis,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D011649: Pulmonary Alveolar Proteinosis,D012004: Rectal Neoplasms,D012128: Respiratory Distress Syndrome,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016889: Endometrial Neoplasms,D017726: Cytomegalovirus Retinitis,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018305: Ganglioneuroblastoma,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D018805: Sepsis,D019337: Hematologic Neoplasms,D019694: Hepatitis B, Chronic,D020522: Lymphoma, Mantle-Cell,D045169: Severe Acute Respiratory Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	CSF2RA	M1
P48169	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA4	M1
P48169	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA4	M1
P48169	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA4	M1
P48169	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy	GABRA4	M1
P48169	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA4	M1
P48169	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA4	M1
P48169	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D008881: Migraine Disorders	GABRA4	M1
P48169	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA4	M1
P48169	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA4	M1
P48169	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA4	M1
P48169	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA4	M1
P48169	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA4	M1
P48169	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA4	M1
P48169	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA4	M1
P48169	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia	GABRA4	M1
P48169	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA4	M1
P48169	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA4	M1
P48169	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA4	M1
P48169	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4	M1
P48169	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4	M1
P48169	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4	M1
P48169	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA4	M1
P48169	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA4	M1
P48169	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA4	M1
P48169	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA4	M1
P48169	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA4	M1
P48169	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA4	M1
P48169	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA4	M1
P48169	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA4	M1
P48169	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism	GABRA4	M1
P48169	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
P48169	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA4	M1
P48169	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M1
Q92953	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q92953	Potassium voltage-gated channel subfamily B member 2	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNB2	M1
Q92953	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q92953	Potassium voltage-gated channel subfamily B member 2	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNB2	M1
Q92953	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q92953	Potassium voltage-gated channel subfamily B member 2	Homo sapiens	NA	KCNB2	M1
Q92953	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q92953	Potassium voltage-gated channel subfamily B member 2	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNB2	M1
Q9UBN1	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNG4	M1
Q9UBN1	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNG4	M1
Q9UBN1	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D002318: Cardiovascular Diseases	CACNG4	M1
Q9UBN1	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	NA	CACNG4	M1
Q9UBN1	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	NA	CACNG4	M1
Q9UBN1	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNG4	M1
Q16363	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	Q16363	Laminin subunit alpha-4	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMA4	M1
P07327	NA	NA	NA	NA	FOMEPIZOLE	Alcohol dehydrogenase class I inhibitor	INHIBITOR	1997	CHEMBL2363044	105739	P07327	Alcohol dehydrogenase 1A	Homo sapiens	D008268: Macular Degeneration	ADH1A	M1
P15391	NA	NA	NA	NA	BLINATUMOMAB	B-lymphocyte antigen CD19 cross-linking agent	CROSS-LINKING AGENT	2014	CHEMBL3390821	109546	P15391	B-lymphocyte antigen CD19	Homo sapiens	D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015452: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,D015456: Leukemia, Biphenotypic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D019337: Hematologic Neoplasms,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	CD19	M1
P15391	NA	NA	NA	NA	INEBILIZUMAB	B-lymphocyte antigen CD19 binding agent	BINDING AGENT	2020	CHEMBL3390821	109546	P15391	B-lymphocyte antigen CD19	Homo sapiens	D000077733: Immunoglobulin G4-Related Disease,D004672: Encephalitis, Japanese,D007154: Immune System Diseases,D008223: Lymphoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009369: Neoplasms,D009471: Neuromyelitis Optica,D012594: Scleroderma, Localized,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D019337: Hematologic Neoplasms	CD19	M1
P15391	NA	NA	NA	NA	LONCASTUXIMAB TESIRINE	B-lymphocyte antigen CD19 binding agent	BINDING AGENT	2021	CHEMBL3390821	109546	P15391	B-lymphocyte antigen CD19	Homo sapiens	D008224: Lymphoma, Follicular,D016393: Lymphoma, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	CD19	M1
P15391	NA	NA	NA	NA	TAFASITAMAB	B-lymphocyte antigen CD19 binding agent	BINDING AGENT	2020	CHEMBL3390821	109546	P15391	B-lymphocyte antigen CD19	Homo sapiens	D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	CD19	M1
Q14957	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN2C	M1
Q14957	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN2C	M1
Q14957	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN2C	M1
Q14957	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN2C	M1
Q14957	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN2C	M1
Q14957	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D010146: Pain	GRIN2C	M1
Q14957	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D010300: Parkinson Disease	GRIN2C	M1
Q14957	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D000437: Alcoholism	GRIN2C	M1
Q14957	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN2C	M1
Q9NSA0	NA	NA	NA	NA	PROBENECID	Solute carrier family 22 member 11 inhibitor	INHIBITOR	1951	CHEMBL2073677	104618	Q9NSA0	Solute carrier family 22 member 11	Homo sapiens	D000437: Alcoholism,D001930: Brain Injuries,D002481: Cellulitis,D002805: Chondrocalcinosis,D003924: Diabetes Mellitus, Type 2,D005585: Influenza in Birds,D006073: Gout,D006333: Heart Failure,D007239: Infections,D009369: Neoplasms,D009765: Obesity,D014552: Urinary Tract Infections,D054143: Heart Failure, Systolic	SLC22A11	M1
Q969P6	NA	NA	NA	NA	TOPOTECAN HYDROCHLORIDE	DNA topoisomerase I, mitochondrial inhibitor	INHIBITOR	1996	CHEMBL2362989	105701	Q969P6	DNA topoisomerase I, mitochondrial	Homo sapiens	D001254: Astrocytoma,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D005910: Glioma,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008479: Mediastinal Neoplasms,D008545: Melanoma,D008577: Meningeal Neoplasms,D008582: Meningitis, Aseptic,D008637: Mesenchymoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018269: Carcinoma, Endometrioid,D018288: Carcinoma, Small Cell,D018293: Cystadenoma, Serous,D018305: Ganglioneuroblastoma,D018316: Gliosarcoma,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TOP1MT	M1
P20618	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P20618	Proteasome subunit beta type-1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB1	M1
P20618	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P20618	Proteasome subunit beta type-1	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB1	M1
P20618	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P20618	Proteasome subunit beta type-1	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB1	M1
P54709	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P54709	Sodium/potassium-transporting ATPase subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1B3	M1
P54709	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P54709	Sodium/potassium-transporting ATPase subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1B3	M1
P54709	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P54709	Sodium/potassium-transporting ATPase subunit beta-3	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1B3	M1
P54709	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P54709	Sodium/potassium-transporting ATPase subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1B3	M1
P13637	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A3	M1
P13637	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3	M1
P13637	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A3	M1
P13637	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3	M1
P08235	NA	NA	NA	NA	SPIRONOLACTONE	Mineralocorticoid receptor antagonist	ANTAGONIST	1960	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D000152: Acne Vulgaris,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D002825: Chorioretinitis,D003920: Diabetes Mellitus,D003928: Diabetic Nephropathies,D005234: Fatty Liver,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007938: Leukemia,D008223: Lymphoma,D008268: Macular Degeneration,D008548: Melanosis,D009203: Myocardial Infarction,D009369: Neoplasms,D009404: Nephrotic Syndrome,D011085: Polycystic Ovary Syndrome,D011629: Puberty, Precocious,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D019571: Arrhythmogenic Right Ventricular Dysplasia,D020388: Muscular Dystrophy, Duchenne,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054144: Heart Failure, Diastolic,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	NR3C2	M1
P08235	NA	NA	NA	NA	NIMODIPINE	Mineralocorticoid receptor antagonist	ANTAGONIST	1988	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	NR3C2	M1
P08235	NA	NA	NA	NA	FELODIPINE	Mineralocorticoid receptor antagonist	ANTAGONIST	1991	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	NR3C2	M1
P08235	NA	NA	NA	NA	DROSPIRENONE	Mineralocorticoid receptor antagonist	ANTAGONIST	2001	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000152: Acne Vulgaris,D002032: Bulimia,D003866: Depressive Disorder,D004412: Dysmenorrhea,D011085: Polycystic Ovary Syndrome,D011293: Premenstrual Syndrome,D017497: Hidradenitis Suppurativa,D052018: Bulimia Nervosa	NR3C2	M1
P08235	NA	NA	NA	NA	EPLERENONE	Mineralocorticoid receptor antagonist	ANTAGONIST	2002	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D006333: Heart Failure,D006973: Hypertension,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D020388: Muscular Dystrophy, Duchenne,D049950: Hyperparathyroidism, Primary,D051436: Renal Insufficiency, Chronic,D056833: Central Serous Chorioretinopathy	NR3C2	M1
P08235	NA	NA	NA	NA	DESOXYCORTICOSTERONE ACETATE	Mineralocorticoid receptor agonist	AGONIST	1939	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	NA	NR3C2	M1
P08235	NA	NA	NA	NA	DESOXYCORTICOSTERONE PIVALATE	Mineralocorticoid receptor agonist	AGONIST	1982	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	NA	NR3C2	M1
P08235	NA	NA	NA	NA	FLUDROCORTISONE ACETATE	Mineralocorticoid receptor agonist	AGONIST	1955	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000224: Addison Disease,D000312: Adrenal Hyperplasia, Congenital,D003866: Depressive Disorder,D006319: Hearing Loss, Sensorineural,D008545: Melanoma,D010300: Parkinson Disease,D012772: Shock, Septic,D016471: Ovarian Hyperstimulation Syndrome,D047808: Adrenogenital Syndrome	NR3C2	M1
P08069	NA	NA	NA	NA	MECASERMIN RINFABATE	Insulin-like growth factor I receptor agonist	AGONIST	2005	CHEMBL1957	234	P08069	Insulin-like growth factor 1 receptor	Homo sapiens	D009223: Myotonic Dystrophy,D012178: Retinopathy of Prematurity,D046150: Laron Syndrome	IGF1R	M1
P08069	NA	NA	NA	NA	MECASERMIN	Insulin-like growth factor I receptor agonist	AGONIST	2005	CHEMBL1957	234	P08069	Insulin-like growth factor 1 receptor	Homo sapiens	D000375: Aging,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001847: Bone Diseases,D003424: Crohn Disease,D003920: Diabetes Mellitus,D006946: Hyperinsulinism,D009103: Multiple Sclerosis,D009634: Noonan Syndrome,D015518: Rett Syndrome,D039682: HIV-Associated Lipodystrophy Syndrome,D046150: Laron Syndrome,D052256: Tendinopathy	IGF1R	M1
P08069	NA	NA	NA	NA	TEPROTUMUMAB	Insulin-like growth factor I receptor antagonist	ANTAGONIST	2020	CHEMBL1957	234	P08069	Insulin-like growth factor 1 receptor	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009369: Neoplasms,D012509: Sarcoma,D045743: Scleroderma, Diffuse,D049970: Graves Ophthalmopathy	IGF1R	M1
P29459	NA	NA	NA	NA	USTEKINUMAB	Interleukin-12 inhibitor	INHIBITOR	2009	CHEMBL2364153	106132	P29459	Interleukin-12 subunit alpha	Homo sapiens	D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D003092: Colitis,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007057: Ichthyosis,D007154: Immune System Diseases,D008105: Liver Cirrhosis, Biliary,D008180: Lupus Erythematosus, Systemic,D009103: Multiple Sclerosis,D010391: Pemphigoid, Bullous,D011565: Psoriasis,D012507: Sarcoidosis,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014605: Uveitis,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa,D019337: Hematologic Neoplasms,D019449: Pouchitis	IL12A	M1
P02679	NA	NA	NA	NA	FIBRINOLYSIN, HUMAN	Fibrinogen inhibitor	INHIBITOR	1964	CHEMBL2364709	106205	P02679	Fibrinogen gamma chain	Homo sapiens	D000083242: Ischemic Stroke,D013927: Thrombosis	FGG	M1
P25788	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P25788	Proteasome subunit alpha type-3	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA3	M1
P25788	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P25788	Proteasome subunit alpha type-3	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA3	M1
P25788	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P25788	Proteasome subunit alpha type-3	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMA3	M1
Q16288	NA	NA	NA	NA	ENTRECTINIB	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2019	CHEMBL3559684	109739	Q16288	NT-3 growth factor receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D008545: Melanoma,D009369: Neoplasms,D018275: Carcinoma, Lobular	NTRK3	M1
Q16288	NA	NA	NA	NA	LAROTRECTINIB	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2018	CHEMBL3559684	109739	Q16288	NT-3 growth factor receptor	Homo sapiens	D005910: Glioma,D009369: Neoplasms	NTRK3	M1
Q16288	NA	NA	NA	NA	LAROTRECTINIB SULFATE	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2018	CHEMBL3559684	109739	Q16288	NT-3 growth factor receptor	Homo sapiens	D009362: Neoplasm Metastasis,D009369: Neoplasms	NTRK3	M1
Q16288	NA	NA	NA	NA	CENEGERMIN	Neurotrophic tyrosine kinase receptor agonist	AGONIST	2018	CHEMBL3559684	109739	Q16288	NT-3 growth factor receptor	Homo sapiens	D005128: Eye Diseases,D007634: Keratitis	NTRK3	M1
P00374	NA	NA	NA	NA	METHOTREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000506: Alopecia Areata,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001168: Arthritis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002294: Carcinoma, Squamous Cell,D002318: Cardiovascular Diseases,D002583: Uterine Cervical Neoplasms,D002822: Choriocarcinoma,D003093: Colitis, Ulcerative,D003251: Constriction, Pathologic,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005199: Fanconi Anemia,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006319: Hearing Loss, Sensorineural,D006457: Hemoglobinuria, Paroxysmal,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006828: Hydatidiform Mole,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007249: Inflammation,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008105: Liver Cirrhosis, Biliary,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008269: Macular Edema,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009203: Myocardial Infarction,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D010003: Osteoarthritis,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010391: Pemphigoid, Bullous,D011087: Polycythemia Vera,D011271: Pregnancy, Ectopic,D011565: Psoriasis,D012507: Sarcoidosis,D012509: Sarcoma,D012516: Osteosarcoma,D012559: Schizophrenia,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014523: Urethral Neoplasms,D014581: Urticaria,D014605: Uveitis,D014657: Vasculitis,D014820: Vitiligo,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015658: HIV Infections,D015867: Uveitis, Intermediate,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016511: Severe Combined Immunodeficiency,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018242: Neuroectodermal Tumors, Primitive,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D056833: Central Serous Chorioretinopathy	DHFR	M1
P00374	NA	NA	NA	NA	PRALATREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	2009	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic	DHFR	M1
P00374	NA	NA	NA	NA	PEMETREXED DISODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	2004	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013945: Thymoma,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018287: Carcinoma, Large Cell,D031901: Gestational Trophoblastic Disease,D064129: Prostatic Neoplasms, Castration-Resistant	DHFR	M1
P00374	NA	NA	NA	NA	METHOTREXATE SODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	M1
P01579	NA	NA	NA	NA	EMAPALUMAB	Interferon gamma inhibitor	INHIBITOR	2018	CHEMBL3286073	108375	P01579	Interferon gamma	Homo sapiens	D006086: Graft vs Host Disease,D007154: Immune System Diseases,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic	IFNG	M1
P15260	NA	NA	NA	NA	INTERFERON GAMMA-1B	Interferon gamma receptor agonist	AGONIST	1999	CHEMBL2364171	106150	P15260	Interferon gamma receptor 1	Homo sapiens	D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D003550: Cystic Fibrosis,D005185: Fallopian Tube Neoplasms,D005621: Friedreich Ataxia,D006105: Granulomatous Disease, Chronic,D007938: Leukemia,D008103: Liver Cirrhosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009164: Mycobacterium Infections,D009182: Mycosis Fungoides,D009369: Neoplasms,D009447: Neuroblastoma,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011565: Psoriasis,D011658: Pulmonary Fibrosis,D012162: Retinal Degeneration,D012208: Rhabdomyosarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D014605: Uveitis,D014606: Uveitis, Anterior,D014987: Xerostomia,D015270: Mycobacterium avium-intracellulare Infection,D015658: HIV Infections,D016918: Arthritis, Reactive,D016919: Meningitis, Cryptococcal,D018370: Leukocyte-Adhesion Deficiency Syndrome,D019698: Hepatitis C, Chronic,D054990: Idiopathic Pulmonary Fibrosis,D058387: Candidemia,D064129: Prostatic Neoplasms, Castration-Resistant	IFNGR1	M1
P28222	NA	NA	NA	NA	SUMATRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	1992	CHEMBL1898	106	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	D008881: Migraine Disorders,D009765: Obesity,D020325: Migraine with Aura,D020326: Migraine without Aura	HTR1B	M1
P28222	NA	NA	NA	NA	ZOLMITRIPTAN	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	1997	CHEMBL1898	106	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	D008881: Migraine Disorders	HTR1B	M1
P28222	NA	NA	NA	NA	AMISULPRIDE	Serotonin (5-HT) receptor antagonist	ANTAGONIST	2020	CHEMBL2096904	104841	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	HTR1B	M1
P28222	NA	NA	NA	NA	ALMOTRIPTAN MALATE	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	2001	CHEMBL1898	106	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	D008881: Migraine Disorders	HTR1B	M1
P28222	NA	NA	NA	NA	NARATRIPTAN HYDROCHLORIDE	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	1998	CHEMBL1898	106	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	D006261: Headache,D008881: Migraine Disorders	HTR1B	M1
P28222	NA	NA	NA	NA	ELETRIPTAN HYDROBROMIDE	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	2002	CHEMBL1898	106	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	NA	HTR1B	M1
P28222	NA	NA	NA	NA	RIZATRIPTAN BENZOATE	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	1998	CHEMBL1898	106	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	D008881: Migraine Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura	HTR1B	M1
P28222	NA	NA	NA	NA	SUMATRIPTAN SUCCINATE	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	1992	CHEMBL1898	106	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	D008881: Migraine Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura	HTR1B	M1
P28222	NA	NA	NA	NA	FROVATRIPTAN SUCCINATE	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	2001	CHEMBL1898	106	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	NA	HTR1B	M1
P28222	NA	NA	NA	NA	ERGOLOID MESYLATES	Serotonin 1b (5-HT1b) receptor agonist	AGONIST	1953	CHEMBL1898	106	P28222	5-hydroxytryptamine receptor 1B	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	HTR1B	M1
P04350	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB4A	M1
P04350	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M1
P04350	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M1
P04350	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB4A	M1
P04350	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M1
P04350	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M1
P04350	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M1
P04350	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB4A	M1
P04350	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB4A	M1
P04350	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB4A	M1
P04350	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB4A	M1
P04350	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M1
P04350	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB4A	M1
P04350	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB4A	M1
P14867	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA1	M1
P14867	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA1	M1
P14867	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA1	M1
P14867	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D004827: Epilepsy	GABRA1	M1
P14867	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA1	M1
P14867	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA1	M1
P14867	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D008881: Migraine Disorders	GABRA1	M1
P14867	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA1	M1
P14867	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA1	M1
P14867	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA1	M1
P14867	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA1	M1
P14867	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA1	M1
P14867	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA1	M1
P14867	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA1	M1
P14867	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000647: Amnesia	GABRA1	M1
P14867	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA1	M1
P14867	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA1	M1
P14867	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA1	M1
P14867	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety	GABRA1	M1
P14867	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety	GABRA1	M1
P14867	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety	GABRA1	M1
P14867	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA1	M1
P14867	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA1	M1
P14867	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA1	M1
P14867	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA1	M1
P14867	NA	NA	NA	NA	ZALEPLON	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1999	CHEMBL2111392	105087	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia	GABRA1	M1
P14867	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA1	M1
P14867	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA1	M1
P14867	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA1	M1
P14867	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA1	M1
P14867	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism	GABRA1	M1
P14867	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P14867	NA	NA	NA	NA	ZOLPIDEM TARTRATE	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2111392	105087	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity	GABRA1	M1
P14867	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA1	M1
P14867	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M1
P12107	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12107	Collagen alpha-1(XI) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL11A1	M1
P12107	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12107	Collagen alpha-1(XI) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL11A1	M1
P57789	NA	NA	NA	NA	HALOTHANE	Potassium channel subfamily K member 10 opener	OPENER	1958	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	NA	KCNK10	M1
P57789	NA	NA	NA	NA	ISOFLURANE	Potassium channel subfamily K member 10 opener	OPENER	1979	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	KCNK10	M1
P57789	NA	NA	NA	NA	ENFLURANE	Potassium channel subfamily K member 10 opener	OPENER	1972	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	NA	KCNK10	M1
P57789	NA	NA	NA	NA	SEVOFLURANE	Potassium channel subfamily K member 10 opener	OPENER	1995	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	KCNK10	M1
P57789	NA	NA	NA	NA	DESFLURANE	Potassium channel subfamily K member 10 opener	OPENER	1992	CHEMBL2331041	105637	P57789	Potassium channel subfamily K member 10	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	KCNK10	M1
P35916	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M1
P35916	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M1
P35916	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M1
P35916	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M1
P35916	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M1
P35916	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M1
P35916	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FLT4	M1
P35916	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	FLT4	M1
P35916	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	NA	FLT4	M1
P07101	NA	NA	NA	NA	METYROSINE	Tyrosine 3-hydroxylase inhibitor	INHIBITOR	1979	CHEMBL1969	39	P07101	Tyrosine 3-monooxygenase	Homo sapiens	D006973: Hypertension,D011618: Psychotic Disorders	TH	M1
Q15303	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	Q15303	Receptor tyrosine-protein kinase erbB-4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB4	M1
Q15303	NA	NA	NA	NA	NERATINIB	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	2017	CHEMBL3009	12699	Q15303	Receptor tyrosine-protein kinase erbB-4	Homo sapiens	D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006394: Hemangiosarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms,D015179: Colorectal Neoplasms	ERBB4	M1
Q15303	NA	NA	NA	NA	AFATINIB DIMALEATE	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	2013	CHEMBL3009	12699	Q15303	Receptor tyrosine-protein kinase erbB-4	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma	ERBB4	M1
Q15303	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	2018	CHEMBL3009	12699	Q15303	Receptor tyrosine-protein kinase erbB-4	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	ERBB4	M1
Q15303	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	2018	CHEMBL3009	12699	Q15303	Receptor tyrosine-protein kinase erbB-4	Homo sapiens	D001932: Brain Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008107: Liver Diseases,D008175: Lung Neoplasms,D009062: Mouth Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010412: Penile Neoplasms,D015179: Colorectal Neoplasms	ERBB4	M1
Q15303	NA	NA	NA	NA	NERATINIB MALEATE	Receptor protein-tyrosine kinase erbB-4 inhibitor	INHIBITOR	2017	CHEMBL3009	12699	Q15303	Receptor tyrosine-protein kinase erbB-4	Homo sapiens	D001943: Breast Neoplasms	ERBB4	M1
Q16099	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	1996	CHEMBL2109241	104902	Q16099	Glutamate receptor ionotropic, kainate 4	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIK4	M1
Q16620	NA	NA	NA	NA	ENTRECTINIB	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2019	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D008545: Melanoma,D009369: Neoplasms,D018275: Carcinoma, Lobular	NTRK2	M1
Q16620	NA	NA	NA	NA	LAROTRECTINIB	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2018	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D005910: Glioma,D009369: Neoplasms	NTRK2	M1
Q16620	NA	NA	NA	NA	LAROTRECTINIB SULFATE	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2018	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D009362: Neoplasm Metastasis,D009369: Neoplasms	NTRK2	M1
Q16620	NA	NA	NA	NA	CENEGERMIN	Neurotrophic tyrosine kinase receptor agonist	AGONIST	2018	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D005128: Eye Diseases,D007634: Keratitis	NTRK2	M1
P30988	NA	NA	NA	NA	CALCITONIN SALMON RECOMBINANT	Calcitonin receptor agonist	AGONIST	2005	CHEMBL1832	119	P30988	Calcitonin receptor	Homo sapiens	D001851: Bone Diseases, Metabolic,D010024: Osteoporosis,D010279: Parathyroid Diseases,D015663: Osteoporosis, Postmenopausal	CALCR	M1
P30988	NA	NA	NA	NA	PRAMLINTIDE ACETATE	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	2005	CHEMBL2111189	104908	P30988	Calcitonin receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity	CALCR	M1
P30988	NA	NA	NA	NA	CALCITONIN SALMON	Calcitonin receptor agonist	AGONIST	1978	CHEMBL1832	119	P30988	Calcitonin receptor	Homo sapiens	D006934: Hypercalcemia,D008593: Menopause,D010001: Osteitis Deformans,D010024: Osteoporosis,D015663: Osteoporosis, Postmenopausal	CALCR	M1
P30988	NA	NA	NA	NA	CALCITONIN HUMAN	Calcitonin receptor agonist	AGONIST	1986	CHEMBL1832	119	P30988	Calcitonin receptor	Homo sapiens	D010279: Parathyroid Diseases	CALCR	M1
P35368	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRA1B	M1
P35368	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1995	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA1B	M1
P35368	NA	NA	NA	NA	PRAZOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1976	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRA1B	M1
P35368	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1985	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	NA	ADRA1B	M1
P35368	NA	NA	NA	NA	NAPHAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1971	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D003139: Common Cold,D007249: Inflammation,D007251: Influenza, Human,D011625: Pterygium	ADRA1B	M1
P35368	NA	NA	NA	NA	ALFUZOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	2003	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D007669: Kidney Calculi,D011470: Prostatic Hyperplasia,D053039: Ureterolithiasis	ADRA1B	M1
P35368	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRA1B	M1
P35368	NA	NA	NA	NA	PHENYLEPHRINE HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	1952	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D001145: Arrhythmias, Cardiac,D002318: Cardiovascular Diseases,D002386: Cataract,D003139: Common Cold,D006255: Rhinitis, Allergic, Seasonal,D007239: Infections,D012141: Respiratory Tract Infections,D012220: Rhinitis,D012223: Rhinitis, Vasomotor,D012852: Sinusitis,D013274: Stomach Neoplasms,D055371: Acute Lung Injury	ADRA1B	M1
P35368	NA	NA	NA	NA	TETRAHYDROZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1979	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D007249: Inflammation,D011625: Pterygium	ADRA1B	M1
P35368	NA	NA	NA	NA	MIDODRINE HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	1996	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D007024: Hypotension, Orthostatic,D012772: Shock, Septic,D018805: Sepsis,D020521: Stroke	ADRA1B	M1
P35368	NA	NA	NA	NA	DOXAZOSIN MESYLATE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1990	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRA1B	M1
P35368	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P35368	Alpha-1B adrenergic receptor	Homo sapiens	NA	ADRA1B	M1
P35368	NA	NA	NA	NA	PHENOXYBENZAMINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	NA	ADRA1B	M1
P35368	NA	NA	NA	NA	OXYMETAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1986	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D006255: Rhinitis, Allergic, Seasonal,D011305: Presbyopia,D012393: Rosacea	ADRA1B	M1
P35368	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P35368	Alpha-1B adrenergic receptor	Homo sapiens	NA	ADRA1B	M1
P35368	NA	NA	NA	NA	PHENTOLAMINE MESYLATE	Adrenergic receptor alpha antagonist	ANTAGONIST	1952	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA1B	M1
P35368	NA	NA	NA	NA	TAMSULOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1997	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D001750: Urinary Bladder, Neurogenic,D006973: Hypertension,D011183: Postoperative Complications,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011472: Prostatitis,D016055: Urinary Retention	ADRA1B	M1
P35368	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1979	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	NA	ADRA1B	M1
P35368	NA	NA	NA	NA	METHOXAMINE HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	1982	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D005242: Fecal Incontinence	ADRA1B	M1
P35368	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	2006	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRA1B	M1
P35368	NA	NA	NA	NA	ALSEROXYLON	Adrenergic receptor alpha antagonist	ANTAGONIST	1982	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	NA	ADRA1B	M1
P35368	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D010146: Pain	ADRA1B	M1
P35368	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRA1B	M1
P35368	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D001249: Asthma	ADRA1B	M1
P35368	NA	NA	NA	NA	METARAMINOL BITARTRATE	Adrenergic receptor alpha-1 agonist	AGONIST	1954	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	NA	ADRA1B	M1
P35368	NA	NA	NA	NA	PHENYLEPHRINE BITARTRATE	Adrenergic receptor alpha-1 agonist	AGONIST	1973	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	NA	ADRA1B	M1
P35368	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRA1B	M1
P35368	NA	NA	NA	NA	ERGOLOID MESYLATES	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	ADRA1B	M1
P35368	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Adrenergic receptor alpha agonist	AGONIST	1948	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D008881: Migraine Disorders	ADRA1B	M1
P35368	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P35368	Alpha-1B adrenergic receptor	Homo sapiens	NA	ADRA1B	M1
P35368	NA	NA	NA	NA	RAUWOLFIA SERPENTINA	Adrenergic receptor alpha antagonist	ANTAGONIST	1954	CHEMBL2095203	104787	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D006331: Heart Diseases,D006973: Hypertension	ADRA1B	M1
P35368	NA	NA	NA	NA	TERAZOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1987	CHEMBL2094251	104723	P35368	Alpha-1B adrenergic receptor	Homo sapiens	D003704: Dementia	ADRA1B	M1
P21728	NA	NA	NA	NA	FENOLDOPAM MESYLATE	Dopamine D1 receptor agonist	AGONIST	1997	CHEMBL2056	88	P21728	D(1A) dopamine receptor	Homo sapiens	D058186: Acute Kidney Injury	DRD1	M1
P21728	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P21728	D(1A) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD1	M1
P21728	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P21728	D(1A) dopamine receptor	Homo sapiens	NA	DRD1	M1
P21728	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P21728	D(1A) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD1	M1
P21728	NA	NA	NA	NA	METHYLERGONOVINE MALEATE	Dopamine D1 receptor antagonist	ANTAGONIST	1946	CHEMBL2056	88	P21728	D(1A) dopamine receptor	Homo sapiens	D006470: Hemorrhage	DRD1	M1
P21728	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P21728	D(1A) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD1	M1
Q09470	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA1	M1
Q09470	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA1	M1
Q09470	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	NA	KCNA1	M1
Q09470	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA1	M1
P36507	NA	NA	NA	NA	SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2020	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D000230: Adenocarcinoma,D001254: Astrocytoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D005706: Gallbladder Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D009456: Neurofibromatosis 1,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018318: Neurofibroma, Plexiform,D020339: Optic Nerve Glioma,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064726: Triple Negative Breast Neoplasms	MAP2K2	M1
P36507	NA	NA	NA	NA	SELUMETINIB SULFATE	Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor	INHIBITOR	2020	CHEMBL2111289	104912	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D001254: Astrocytoma,D008545: Melanoma,D009456: Neurofibromatosis 1,D010190: Pancreatic Neoplasms	MAP2K2	M1
P36507	NA	NA	NA	NA	TRAMETINIB DIMETHYL SULFOXIDE	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2013	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D031249: Erdheim-Chester Disease	MAP2K2	M1
P36507	NA	NA	NA	NA	COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2015	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003397: Craniopharyngioma,D004938: Esophageal Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D021441: Carcinoma, Pancreatic Ductal	MAP2K2	M1
P36507	NA	NA	NA	NA	COBIMETINIB FUMARATE	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2015	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D008545: Melanoma	MAP2K2	M1
P36507	NA	NA	NA	NA	BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2018	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D001172: Arthritis, Rheumatoid,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D006332: Cardiomegaly,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008107: Liver Diseases,D008175: Lung Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D046152: Gastrointestinal Stromal Tumors	MAP2K2	M1
O14561	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O14561	Acyl carrier protein, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFAB1	M1
P61073	NA	NA	NA	NA	PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	PARTIAL AGONIST	2008	CHEMBL2107	10473	P61073	C-X-C chemokine receptor type 4	Homo sapiens	D000755: Anemia, Sickle Cell,D003922: Diabetes Mellitus, Type 1,D005199: Fanconi Anemia,D006086: Graft vs Host Disease,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008231: Lymphopenia,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009503: Neutropenia,D010190: Pancreatic Neoplasms,D012509: Sarcoma,D012595: Scleroderma, Systemic,D013789: Thalassemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D017719: Diabetic Foot,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058625: End Stage Liver Disease	CXCR4	M1
O43497	NA	NA	NA	NA	TRIMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1946	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D004827: Epilepsy	CACNA1G	M1
O43497	NA	NA	NA	NA	ETHOSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1960	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D003866: Depressive Disorder,D004827: Epilepsy,D004832: Epilepsy, Absence,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome	CACNA1G	M1
O43497	NA	NA	NA	NA	METHSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1957	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D004827: Epilepsy	CACNA1G	M1
O43497	NA	NA	NA	NA	PHENSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1982	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D004827: Epilepsy	CACNA1G	M1
O43497	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1G	M1
O43497	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1G	M1
O43497	NA	NA	NA	NA	PARAMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1949	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D004827: Epilepsy	CACNA1G	M1
O43497	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1G	M1
O43497	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	NA	CACNA1G	M1
O43497	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	NA	CACNA1G	M1
O43497	NA	NA	NA	NA	MIBEFRADIL DIHYDROCHLORIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1997	CHEMBL2362995	105707	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	NA	CACNA1G	M1
O43497	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O43497	Voltage-dependent T-type calcium channel subunit alpha-1G	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1G	M1
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN POLISTIREX	Sigma opioid receptor agonist	AGONIST	1982	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D002659: Child Development Disorders, Pervasive	SIGMAR1	M1
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN HYDROBROMIDE	Sigma opioid receptor agonist	AGONIST	1984	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D003139: Common Cold,D003371: Cough,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006967: Hypersensitivity,D008881: Migraine Disorders,D009369: Neoplasms,D010146: Pain,D011471: Prostatic Neoplasms,D012852: Sinusitis	SIGMAR1	M1
Q99720	NA	NA	NA	NA	FENFLURAMINE HYDROCHLORIDE	Sigma opioid receptor antagonist	ANTAGONIST	2020	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D004831: Epilepsies, Myoclonic,D020195: Epilepsy, Reflex	SIGMAR1	M1
Q99720	NA	NA	NA	NA	PENTAZOCINE LACTATE	Sigma opioid receptor modulator	MODULATOR	1967	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	NA	SIGMAR1	M1
Q99720	NA	NA	NA	NA	PENTAZOCINE HYDROCHLORIDE	Sigma opioid receptor modulator	MODULATOR	1969	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D010146: Pain	SIGMAR1	M1
Q15858	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN9A	M1
Q15858	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN9A	M1
Q15858	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN9A	M1
Q15858	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN9A	M1
Q15858	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN9A	M1
Q15858	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN9A	M1
Q15858	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN9A	M1
Q15858	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN9A	M1
Q15858	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN9A	M1
Q15858	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN9A	M1
Q15858	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN9A	M1
Q15858	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN9A	M1
Q15858	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN9A	M1
Q15858	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN9A	M1
Q15858	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN9A	M1
Q15858	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN9A	M1
Q15858	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN9A	M1
Q15858	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN9A	M1
Q15858	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D010146: Pain	SCN9A	M1
Q15858	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN9A	M1
Q15858	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN9A	M1
Q15858	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN9A	M1
Q15858	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN9A	M1
Q15858	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN9A	M1
Q15858	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN9A	M1
Q15858	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN9A	M1
Q15858	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN9A	M1
Q15858	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN9A	M1
Q15858	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN9A	M1
Q15858	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN9A	M1
Q15858	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN9A	M1
Q15858	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	NA	SCN9A	M1
Q15858	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN9A	M1
Q15858	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q15858	Sodium channel protein type 9 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN9A	M1
P11802	NA	NA	NA	NA	PALBOCICLIB	Cyclin-dependent kinase 4/cyclin D1 inhibitor	INHIBITOR	2015	CHEMBL1907601	104295	P11802	Cyclin-dependent kinase 4	Homo sapiens	D000230: Adenocarcinoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002817: Chordoma,D003110: Colonic Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008080: Liposarcoma,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012509: Sarcoma,D012512: Sarcoma, Ewing,D013953: Thymus Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018358: Neuroendocrine Tumors,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D044584: Carcinoma, Ductal,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	CDK4	M1
P11802	NA	NA	NA	NA	ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2017	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D009837: Oligodendroglioma,D010190: Pancreatic Neoplasms,D012208: Rhabdomyosarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018335: Rhabdoid Tumor,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D064129: Prostatic Neoplasms, Castration-Resistant	CDK4	M1
P11802	NA	NA	NA	NA	RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2017	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008080: Liposarcoma,D008223: Lymphoma,D008545: Melanoma,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013724: Teratoma,D013953: Thymus Neoplasms,D014594: Uterine Neoplasms,D018335: Rhabdoid Tumor,D018358: Neuroendocrine Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	CDK4	M1
P11802	NA	NA	NA	NA	RIBOCICLIB SUCCINATE	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2017	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms	CDK4	M1
P11802	NA	NA	NA	NA	TRILACICLIB	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2021	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D001943: Breast Neoplasms,D006394: Hemangiosarcoma,D055752: Small Cell Lung Carcinoma,D064726: Triple Negative Breast Neoplasms	CDK4	M1
P11802	NA	NA	NA	NA	TRILACICLIB DIHYDROCHLORIDE	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2021	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D055752: Small Cell Lung Carcinoma	CDK4	M1
P06729	NA	NA	NA	NA	ALEFACEPT	T-cell surface antigen CD2 inhibitor	INHIBITOR	2003	CHEMBL2040	196	P06729	T-cell surface antigen CD2	Homo sapiens	D000741: Anemia, Aplastic,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008010: Lichen Planus,D008223: Lymphoma,D011565: Psoriasis,D015535: Arthritis, Psoriatic,D051437: Renal Insufficiency	CD2	M1
P10721	NA	NA	NA	NA	DASATINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M1
P10721	NA	NA	NA	NA	SUNITINIB MALATE	Stem cell growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M1
P10721	NA	NA	NA	NA	IMATINIB MESYLATE	Stem cell growth factor receptor inhibitor	INHIBITOR	2001	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000755: Anemia, Sickle Cell,D001249: Asthma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002813: Chondrosarcoma,D003110: Colonic Neoplasms,D003922: Diabetes Mellitus, Type 1,D004802: Eosinophilia,D005185: Fallopian Tube Neoplasms,D005354: Fibrosarcoma,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006976: Hypertension, Pulmonary,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009103: Multiple Sclerosis,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009442: Neurilemmoma,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011668: Pulmonary Veno-Occlusive Disease,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012594: Scleroderma, Localized,D012595: Scleroderma, Systemic,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017681: Hypereosinophilic Syndrome,D018192: Lymphangioleiomyomatosis,D018222: Fibromatosis, Aggressive,D018223: Dermatofibrosarcoma,D018316: Gliosarcoma,D018318: Neurofibroma, Plexiform,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054989: Nephrogenic Fibrosing Dermopathy,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D057135: Wet Macular Degeneration,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M1
P10721	NA	NA	NA	NA	MIDOSTAURIN	Stem cell growth factor receptor inhibitor	INHIBITOR	2017	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	KIT	M1
P10721	NA	NA	NA	NA	SORAFENIB TOSYLATE	Stem cell growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M1
P10721	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Stem cell growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M1
P10721	NA	NA	NA	NA	REGORAFENIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	KIT	M1
P10721	NA	NA	NA	NA	PEXIDARTINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2019	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001172: Arthritis, Rheumatoid,D001943: Breast Neoplasms,D005870: Giant Cell Tumors,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D008107: Liver Diseases,D008545: Melanoma,D009369: Neoplasms,D009442: Neurilemmoma,D011471: Prostatic Neoplasms,D013586: Synovitis, Pigmented Villonodular,D015470: Leukemia, Myeloid, Acute,D046152: Gastrointestinal Stromal Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M1
P10721	NA	NA	NA	NA	PEXIDARTINIB HYDROCHLORIDE	Stem cell growth factor receptor inhibitor	INHIBITOR	2019	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000070779: Giant Cell Tumor of Tendon Sheath	KIT	M1
P10721	NA	NA	NA	NA	AVAPRITINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D005910: Glioma,D007946: Leukemia, Mast-Cell,D009369: Neoplasms,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors	KIT	M1
P10721	NA	NA	NA	NA	RIPRETINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D009369: Neoplasms,D046152: Gastrointestinal Stromal Tumors	KIT	M1
P30968	NA	NA	NA	NA	GANIRELIX ACETATE	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	1999	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D002539: Cerebral Arterial Diseases,D007246: Infertility,D011085: Polycystic Ovary Syndrome,D054971: Orthostatic Intolerance	GNRHR	M1
P30968	NA	NA	NA	NA	ABARELIX	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	2003	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	GNRHR	M1
P30968	NA	NA	NA	NA	ELAGOLIX SODIUM	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	2018	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D004715: Endometriosis	GNRHR	M1
P30968	NA	NA	NA	NA	GOSERELIN ACETATE	Gonadotropin-releasing hormone receptor agonist	AGONIST	1989	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D001943: Breast Neoplasms,D005185: Fallopian Tube Neoplasms,D007246: Infertility,D008593: Menopause,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D018567: Breast Neoplasms, Male,D024821: Metabolic Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	GNRHR	M1
P30968	NA	NA	NA	NA	HISTRELIN ACETATE	Gonadotropin-releasing hormone receptor agonist	AGONIST	1991	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D011471: Prostatic Neoplasms	GNRHR	M1
P30968	NA	NA	NA	NA	GONADORELIN ACETATE	Gonadotropin-releasing hormone receptor agonist	AGONIST	1989	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D001943: Breast Neoplasms,D007006: Hypogonadism,D007246: Infertility,D011471: Prostatic Neoplasms,D017436: Kallmann Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	GNRHR	M1
P30968	NA	NA	NA	NA	GONADORELIN HYDROCHLORIDE	Gonadotropin-releasing hormone receptor agonist	AGONIST	1982	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	NA	GNRHR	M1
P30968	NA	NA	NA	NA	TRIPTORELIN PAMOATE	Gonadotropin-releasing hormone receptor agonist	AGONIST	2000	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D001943: Breast Neoplasms,D004715: Endometriosis,D011471: Prostatic Neoplasms,D011629: Puberty, Precocious,D064129: Prostatic Neoplasms, Castration-Resistant	GNRHR	M1
P30968	NA	NA	NA	NA	NAFARELIN ACETATE	Gonadotropin-releasing hormone receptor agonist	AGONIST	1990	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	NA	GNRHR	M1
P30968	NA	NA	NA	NA	LEUPROLIDE ACETATE	Gonadotropin-releasing hormone receptor agonist	AGONIST	1985	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D000544: Alzheimer Disease,D001943: Breast Neoplasms,D004715: Endometriosis,D006689: Hodgkin Disease,D006973: Hypertension,D007248: Infertility, Male,D007889: Leiomyoma,D009101: Multiple Myeloma,D009369: Neoplasms,D009765: Obesity,D011471: Prostatic Neoplasms,D011629: Puberty, Precocious,D019052: Depression, Postpartum,D020522: Lymphoma, Mantle-Cell,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant	GNRHR	M1
P30968	NA	NA	NA	NA	ELAGOLIX	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	2018	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D004715: Endometriosis,D007889: Leiomyoma,D011085: Polycystic Ovary Syndrome	GNRHR	M1
P30968	NA	NA	NA	NA	RELUGOLIX	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	2020	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D004715: Endometriosis,D007889: Leiomyoma,D010146: Pain,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	GNRHR	M1
P30968	NA	NA	NA	NA	DEGARELIX ACETATE	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	2008	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D011471: Prostatic Neoplasms	GNRHR	M1
P30968	NA	NA	NA	NA	CETRORELIX ACETATE	Gonadotropin-releasing hormone receptor antagonist	ANTAGONIST	2000	CHEMBL1855	118	P30968	Gonadotropin-releasing hormone receptor	Homo sapiens	D007246: Infertility,D011085: Polycystic Ovary Syndrome	GNRHR	M1
P00747	NA	NA	NA	NA	TRANEXAMIC ACID	Plasminogen inhibitor	INHIBITOR	1986	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000740: Anemia,D001254: Astrocytoma,D001416: Back Pain,D001749: Urinary Bladder Neoplasms,D001778: Blood Coagulation Disorders,D001859: Bone Neoplasms,D001930: Brain Injuries,D002543: Cerebral Hemorrhage,D003327: Coronary Disease,D004844: Epistaxis,D005265: Femoral Neck Fractures,D005910: Glioma,D006258: Head and Neck Neoplasms,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D006473: Postpartum Hemorrhage,D006620: Hip Fractures,D007022: Hypotension,D007592: Joint Diseases,D007889: Leiomyoma,D008548: Melanosis,D008579: Meningioma,D008595: Menorrhagia,D009298: Nasal Polyps,D009369: Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010921: Placenta Accreta,D010923: Placenta Previa,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D012878: Skin Neoplasms,D013345: Subarachnoid Hemorrhage,D013683: Telangiectasia, Hereditary Hemorrhagic,D013921: Thrombocytopenia,D014947: Wounds and Injuries,D017544: Aortic Aneurysm, Abdominal,D019337: Hematologic Neoplasms,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050723: Fractures, Bone,D054179: Angioedemas, Hereditary,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse	PLG	M1
P00747	NA	NA	NA	NA	AMINOCAPROIC ACID	Plasminogen inhibitor	INHIBITOR	1964	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001018: Aortic Diseases,D003398: Craniosynostoses,D006470: Hemorrhage,D007249: Inflammation,D012393: Rosacea	PLG	M1
P00747	NA	NA	NA	NA	ALTEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000038: Abscess,D000083242: Ischemic Stroke,D001991: Bronchitis,D002543: Cerebral Hemorrhage,D002544: Cerebral Infarction,D002545: Brain Ischemia,D004653: Empyema,D005128: Eye Diseases,D006333: Heart Failure,D006470: Hemorrhage,D009203: Myocardial Infarction,D009369: Neoplasms,D009422: Nervous System Diseases,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012170: Retinal Vein Occlusion,D013345: Subarachnoid Hemorrhage,D013924: Thrombophlebitis,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016055: Urinary Retention,D016724: Empyema, Pleural,D017202: Myocardial Ischemia,D018784: Abdominal Abscess,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D060050: Angina, Stable	PLG	M1
P00747	NA	NA	NA	NA	UROKINASE	Plasminogen activator	ACTIVATOR	2007	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D004653: Empyema,D007239: Infections,D011655: Pulmonary Embolism,D013927: Thrombosis,D016724: Empyema, Pleural,D020521: Stroke	PLG	M1
P00747	NA	NA	NA	NA	APROTININ	Plasminogen inhibitor	INHIBITOR	1993	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001943: Breast Neoplasms,D006470: Hemorrhage,D010195: Pancreatitis	PLG	M1
P00747	NA	NA	NA	NA	RETEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D009203: Myocardial Infarction,D013927: Thrombosis,D020521: Stroke	PLG	M1
P00747	NA	NA	NA	NA	STREPTOKINASE	Plasminogen activator	ACTIVATOR	1997	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000083242: Ischemic Stroke,D009203: Myocardial Infarction,D010195: Pancreatitis,D013927: Thrombosis,D017202: Myocardial Ischemia,D020246: Venous Thrombosis	PLG	M1
P00747	NA	NA	NA	NA	TENECTEPLASE	Plasminogen activator	ACTIVATOR	2000	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D002544: Cerebral Infarction,D002545: Brain Ischemia,D009203: Myocardial Infarction,D009422: Nervous System Diseases,D010996: Pleural Effusion,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016757: Death, Sudden, Cardiac,D020521: Stroke	PLG	M1
P00747	NA	NA	NA	NA	DEFIBROTIDE SODIUM	Plasminogen activator	ACTIVATOR	2016	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D006504: Hepatic Veno-Occlusive Disease	PLG	M1
P54753	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54753	Ephrin type-B receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHB3	M1
P07942	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	P07942	Laminin subunit beta-1	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMB1	M1
Q9NPC2	NA	NA	NA	NA	HALOTHANE	Potassium channel subfamily K member 9 opener	OPENER	1958	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	NA	KCNK9	M1
Q9NPC2	NA	NA	NA	NA	ISOFLURANE	Potassium channel subfamily K member 9 opener	OPENER	1979	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	KCNK9	M1
Q9NPC2	NA	NA	NA	NA	ENFLURANE	Potassium channel subfamily K member 9 opener	OPENER	1972	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	NA	KCNK9	M1
Q9NPC2	NA	NA	NA	NA	SEVOFLURANE	Potassium channel subfamily K member 9 opener	OPENER	1995	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	KCNK9	M1
Q9NPC2	NA	NA	NA	NA	DESFLURANE	Potassium channel subfamily K member 9 opener	OPENER	1992	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	KCNK9	M1
Q9NPC2	NA	NA	NA	NA	DOXAPRAM HYDROCHLORIDE	Potassium channel subfamily K member 9 blocker	BLOCKER	1965	CHEMBL2321614	105603	Q9NPC2	Potassium channel subfamily K member 9	Homo sapiens	D016584: Panic Disorder	KCNK9	M1
P09693	NA	NA	NA	NA	MUROMONAB-CD3	T cell surface glycoprotein CD3 inhibitor	INHIBITOR	1986	CHEMBL2364168	106147	P09693	T-cell surface glycoprotein CD3 gamma chain	Homo sapiens	D003093: Colitis, Ulcerative,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D008545: Melanoma,D009369: Neoplasms,D016543: Central Nervous System Neoplasms,D065626: Non-alcoholic Fatty Liver Disease	CD3G	M1
P09693	NA	NA	NA	NA	BLINATUMOMAB	T cell surface glycoprotein CD3 cross-linking agent	CROSS-LINKING AGENT	2014	CHEMBL2364168	106147	P09693	T-cell surface glycoprotein CD3 gamma chain	Homo sapiens	D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015452: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,D015456: Leukemia, Biphenotypic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D019337: Hematologic Neoplasms,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	CD3G	M1
P20839	NA	NA	NA	NA	THIOGUANINE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1966	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001932: Brain Neoplasms,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	IMPDH1	M1
P20839	NA	NA	NA	NA	MYCOPHENOLIC ACID	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	2004	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D009404: Nephrotic Syndrome,D012595: Scleroderma, Systemic,D015352: Dry Eye Syndromes,D015470: Leukemia, Myeloid, Acute,D015867: Uveitis, Intermediate,D051436: Renal Insufficiency, Chronic	IMPDH1	M1
P20839	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1995	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000690: Amyotrophic Lateral Sclerosis,D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001327: Autoimmune Diseases,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D004062: DiGeorge Syndrome,D004820: Epidermolysis Bullosa,D005199: Fanconi Anemia,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006073: Gout,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006331: Heart Diseases,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006519: Hepatitis, Alcoholic,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006973: Hypertension,D007119: Immunoblastic Lymphadenopathy,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009472: Neuronal Ceroid-Lipofuscinoses,D010190: Pancreatic Neoplasms,D010390: Pemphigoid, Benign Mucous Membrane,D010391: Pemphigoid, Bullous,D010392: Pemphigus,D011087: Polycythemia Vera,D011128: Polyradiculopathy,D011565: Psoriasis,D011695: Purpura, Schoenlein-Henoch,D012010: Red-Cell Aplasia, Pure,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012859: Sjogren's Syndrome,D013625: Takayasu Arteritis,D014605: Uveitis,D014657: Vasculitis,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017563: Lung Diseases, Interstitial,D017565: Sarcoidosis, Pulmonary,D017728: Lymphoma, Large-Cell, Anaplastic,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D045743: Scleroderma, Diffuse,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D055953: Microscopic Polyangiitis,D056486: Chemical and Drug Induced Liver Injury,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	IMPDH1	M1
P20839	NA	NA	NA	NA	RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	INHIBITOR	1985	CHEMBL1822	84	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D001943: Breast Neoplasms,D003699: Hepatitis D,D003866: Depressive Disorder,D004672: Encephalitis, Japanese,D005355: Fibrosis,D006480: Hemorrhagic Fever with Renal Syndrome,D006505: Hepatitis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D008103: Liver Cirrhosis,D009369: Neoplasms,D013921: Thrombocytopenia,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D018357: Respiratory Syncytial Virus Infections,D019142: Hemorrhagic Fever, Ebola,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome	IMPDH1	M1
P20839	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1998	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	NA	IMPDH1	M1
P11047	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	P11047	Laminin subunit gamma-1	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMC1	M1
Q01726	NA	NA	NA	NA	AFAMELANOTIDE	Melanocortin receptor 1 agonist	AGONIST	2019	CHEMBL3795	11869	Q01726	Melanocyte-stimulating hormone receptor	Homo sapiens	D014581: Urticaria,D014820: Vitiligo,D046351: Protoporphyria, Erythropoietic	MC1R	M1
P48039	NA	NA	NA	NA	RAMELTEON	Melatonin receptor agonist	AGONIST	2005	CHEMBL2094268	104733	P48039	Melatonin receptor type 1A	Homo sapiens	D001714: Bipolar Disorder,D002056: Burns,D002189: Marijuana Abuse,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012893: Sleep Wake Disorders,D014029: Tobacco Use Disorder,D019966: Substance-Related Disorders,D020181: Sleep Apnea, Obstructive,D020325: Migraine with Aura,D020326: Migraine without Aura,D029424: Pulmonary Disease, Chronic Obstructive	MTNR1A	M1
P48039	NA	NA	NA	NA	TASIMELTEON	Melatonin receptor agonist	AGONIST	2014	CHEMBL2094268	104733	P48039	Melatonin receptor type 1A	Homo sapiens	D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D007674: Kidney Diseases,D008107: Liver Diseases,D012893: Sleep Wake Disorders,D020178: Sleep Disorders, Circadian Rhythm,D058496: Smith-Magenis Syndrome	MTNR1A	M1
P00750	NA	NA	NA	NA	AMINOCAPROIC ACID	Tissue-type plasminogen activator inhibitor	INHIBITOR	1964	CHEMBL1873	11399	P00750	Tissue-type plasminogen activator	Homo sapiens	D001018: Aortic Diseases,D003398: Craniosynostoses,D006470: Hemorrhage,D007249: Inflammation,D012393: Rosacea	PLAT	M1
P48764	NA	NA	NA	NA	TENAPANOR HYDROCHLORIDE	Sodium/hydrogen exchanger 3 inhibitor	INHIBITOR	2019	CHEMBL3273	12588	P48764	Sodium/hydrogen exchanger 3	Homo sapiens	D043183: Irritable Bowel Syndrome,D051436: Renal Insufficiency, Chronic,D054559: Hyperphosphatemia	SLC9A3	M1
Q9Y6M9	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q9Y6M9	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFB9	M1
Q92731	NA	NA	NA	NA	RALOXIFENE HYDROCHLORIDE	Estrogen receptor beta modulator	MODULATOR	1997	CHEMBL242	174	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D011471: Prostatic Neoplasms	ESR2	M1
Q92731	NA	NA	NA	NA	FULVESTRANT	Estrogen receptor antagonist	ANTAGONIST	2002	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005359: Fibrous Dysplasia, Polyostotic,D005833: Genital Neoplasms, Female,D006976: Hypertension, Pulmonary,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018203: Sarcoma, Endometrial Stromal,D018275: Carcinoma, Lobular,D044584: Carcinoma, Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	ESR2	M1
Q92731	NA	NA	NA	NA	DIETHYLSTILBESTROL DIPHOSPHATE	Estrogen receptor agonist	AGONIST	1982	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D009369: Neoplasms	ESR2	M1
Q92731	NA	NA	NA	NA	TOREMIFENE CITRATE	Estrogen receptor modulator	MODULATOR	1997	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D010024: Osteoporosis,D050723: Fractures, Bone	ESR2	M1
Q92731	NA	NA	NA	NA	ESTRAMUSTINE PHOSPHATE SODIUM	Estrogen receptor beta modulator	MODULATOR	1981	CHEMBL242	174	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D007680: Kidney Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ESR2	M1
Q92731	NA	NA	NA	NA	CHLOROTRIANISENE	Estrogen receptor beta modulator	MODULATOR	1982	CHEMBL242	174	Q92731	Estrogen receptor beta	Homo sapiens	D006528: Carcinoma, Hepatocellular,D008113: Liver Neoplasms	ESR2	M1
Q92731	NA	NA	NA	NA	QUINESTROL	Estrogen receptor agonist	AGONIST	1982	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	NA	ESR2	M1
Q92731	NA	NA	NA	NA	ESTROGENS, CONJUGATED SYNTHETIC A	Estrogen receptor agonist	AGONIST	1999	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	NA	ESR2	M1
Q92731	NA	NA	NA	NA	ESTROGENS, ESTERIFIED	Estrogen receptor agonist	AGONIST	1977	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D008593: Menopause	ESR2	M1
Q92731	NA	NA	NA	NA	SYNTHETIC CONJUGATED ESTROGENS, B	Estrogen receptor agonist	AGONIST	2004	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D008593: Menopause	ESR2	M1
Q92731	NA	NA	NA	NA	ESTROGENS, CONJUGATED	Estrogen receptor agonist	AGONIST	1942	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D000544: Alzheimer Disease,D000789: Angina, Unstable,D000856: Anorexia Nervosa,D001851: Bone Diseases, Metabolic,D001930: Brain Injuries,D001943: Breast Neoplasms,D003110: Colonic Neoplasms,D003327: Coronary Disease,D003920: Diabetes Mellitus,D004714: Endometrial Hyperplasia,D006937: Hypercholesterolemia,D006973: Hypertension,D008180: Lupus Erythematosus, Systemic,D008569: Memory Disorders,D008593: Menopause,D009203: Myocardial Infarction,D010024: Osteoporosis,D011471: Prostatic Neoplasms,D012769: Shock,D013927: Thrombosis,D014424: Turner Syndrome,D015427: Reperfusion Injury,D015663: Osteoporosis, Postmenopausal,D016649: Primary Ovarian Insufficiency,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019584: Hot Flashes,D020521: Stroke,D053201: Urinary Bladder, Overactive,D064129: Prostatic Neoplasms, Castration-Resistant	ESR2	M1
Q92731	NA	NA	NA	NA	ESTETROL	Estrogen receptor agonist	AGONIST	2021	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D008593: Menopause,D011247: Pregnancy,D011471: Prostatic Neoplasms,D045169: Severe Acute Respiratory Syndrome	ESR2	M1
Q92731	NA	NA	NA	NA	OSPEMIFENE	Estrogen receptor modulator	MODULATOR	2013	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001284: Atrophy,D004414: Dyspareunia,D010145: Paget Disease, Extramammary	ESR2	M1
Q92731	NA	NA	NA	NA	BAZEDOXIFENE ACETATE	Estrogen receptor modulator	MODULATOR	2009	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D008593: Menopause,D010024: Osteoporosis,D015663: Osteoporosis, Postmenopausal,D020529: Multiple Sclerosis, Relapsing-Remitting	ESR2	M1
P10828	NA	NA	NA	NA	DEXTROTHYROXINE	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D002318: Cardiovascular Diseases,D004314: Down Syndrome	THRB	M1
P10828	NA	NA	NA	NA	LIOTHYRONINE	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D003866: Depressive Disorder,D007037: Hypothyroidism,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	THRB	M1
P10828	NA	NA	NA	NA	LIOTHYRONINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D006258: Head and Neck Neoplasms,D006330: Heart Defects, Congenital,D007037: Hypothyroidism,D009103: Multiple Sclerosis,D013964: Thyroid Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D065630: Hernias, Diaphragmatic, Congenital	THRB	M1
P10828	NA	NA	NA	NA	LEVOTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	2000	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001714: Bipolar Disorder,D003409: Congenital Hypothyroidism,D007037: Hypothyroidism,D010146: Pain,D013964: Thyroid Neoplasms	THRB	M1
P10828	NA	NA	NA	NA	DEXTROTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D009203: Myocardial Infarction,D017202: Myocardial Ischemia	THRB	M1
P50993	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A2	M1
P50993	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A2	M1
P50993	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A2	M1
P50993	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A2	M1
P19235	NA	NA	NA	NA	EPOETIN ALFA	Erythropoietin receptor agonist	AGONIST	1989	CHEMBL1817	201	P19235	Erythropoietin receptor	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000740: Anemia,D000751: Anemia, Neonatal,D001237: Asphyxia,D001930: Brain Injuries,D001943: Breast Neoplasms,D002545: Brain Ischemia,D002583: Uterine Cervical Neoplasms,D003327: Coronary Disease,D005221: Fatigue,D005621: Friedreich Ataxia,D006258: Head and Neck Neoplasms,D006323: Heart Arrest,D006526: Hepatitis C,D007676: Kidney Failure, Chronic,D008175: Lung Neoplasms,D009190: Myelodysplastic Syndromes,D009203: Myocardial Infarction,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D017086: beta-Thalassemia,D019966: Substance-Related Disorders,D020246: Venous Thrombosis,D020521: Stroke,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	EPOR	M1
P19235	NA	NA	NA	NA	DARBEPOETIN ALFA	Erythropoietin receptor agonist	AGONIST	2001	CHEMBL1817	201	P19235	Erythropoietin receptor	Homo sapiens	D000740: Anemia,D001930: Brain Injuries,D001943: Breast Neoplasms,D002545: Brain Ischemia,D004407: Dysgerminoma,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D009190: Myelodysplastic Syndromes,D009203: Myocardial Infarction,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D019337: Hematologic Neoplasms,D051436: Renal Insufficiency, Chronic,D055752: Small Cell Lung Carcinoma,D058186: Acute Kidney Injury	EPOR	M1
P19235	NA	NA	NA	NA	PEGINESATIDE ACETATE	Erythropoietin receptor agonist	AGONIST	2012	CHEMBL1817	201	P19235	Erythropoietin receptor	Homo sapiens	D000740: Anemia	EPOR	M1
P12259	NA	NA	NA	NA	DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor V inhibitor	INHIBITOR	2001	CHEMBL3618	11387	P12259	Coagulation factor V	Homo sapiens	D007022: Hypotension,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013927: Thrombosis,D018805: Sepsis,D020521: Stroke,D051436: Renal Insufficiency, Chronic	F5	M1
Q13753	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	Q13753	Laminin subunit gamma-2	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMC2	M1
Q08881	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Tyrosine-protein kinase ITK/TSK inhibitor	INHIBITOR	2009	CHEMBL2959	10918	Q08881	Tyrosine-protein kinase ITK/TSK	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	ITK	M1
Q13200	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q13200	26S proteasome non-ATPase regulatory subunit 2	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD2	M1
Q13200	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q13200	26S proteasome non-ATPase regulatory subunit 2	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD2	M1
Q13200	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q13200	26S proteasome non-ATPase regulatory subunit 2	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD2	M1
Q16602	NA	NA	NA	NA	RIMEGEPANT	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	2020	CHEMBL3798	19904	Q16602	Calcitonin gene-related peptide type 1 receptor	Homo sapiens	D008881: Migraine Disorders,D011565: Psoriasis,D014277: Trigeminal Neuralgia	CALCRL	M1
Q16602	NA	NA	NA	NA	RIMEGEPANT SULFATE	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	2020	CHEMBL3798	19904	Q16602	Calcitonin gene-related peptide type 1 receptor	Homo sapiens	D008881: Migraine Disorders	CALCRL	M1
Q16602	NA	NA	NA	NA	UBROGEPANT	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	2019	CHEMBL3798	19904	Q16602	Calcitonin gene-related peptide type 1 receptor	Homo sapiens	D008881: Migraine Disorders	CALCRL	M1
Q16602	NA	NA	NA	NA	ERENUMAB	Calcitonin gene-related peptide type 1 receptor antagonist	ANTAGONIST	2018	CHEMBL3798	19904	Q16602	Calcitonin gene-related peptide type 1 receptor	Homo sapiens	D008881: Migraine Disorders,D014277: Trigeminal Neuralgia,D060050: Angina, Stable	CALCRL	M1
Q9NS40	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9NS40	Potassium voltage-gated channel subfamily H member 7	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNH7	M1
Q9NS40	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9NS40	Potassium voltage-gated channel subfamily H member 7	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNH7	M1
Q9NS40	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9NS40	Potassium voltage-gated channel subfamily H member 7	Homo sapiens	NA	KCNH7	M1
Q9NS40	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9NS40	Potassium voltage-gated channel subfamily H member 7	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNH7	M1
P08922	NA	NA	NA	NA	ENTRECTINIB	Proto-oncogene tyrosine-protein kinase ROS inhibitor	INHIBITOR	2019	CHEMBL5568	101019	P08922	Proto-oncogene tyrosine-protein kinase ROS	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D008545: Melanoma,D009369: Neoplasms,D018275: Carcinoma, Lobular	ROS1	M1
P20701	NA	NA	NA	NA	EFALIZUMAB	Integrin alpha-L/beta-2 (LFA-1) inhibitor	INHIBITOR	2003	CHEMBL2364172	106151	P20701	Integrin alpha-L	Homo sapiens	D000505: Alopecia,D001172: Arthritis, Rheumatoid,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D007154: Immune System Diseases,D008268: Macular Degeneration,D011565: Psoriasis,D012859: Sjogren's Syndrome,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa,D051436: Renal Insufficiency, Chronic	ITGAL	M1
P20701	NA	NA	NA	NA	LIFITEGRAST	Integrin alpha-L/beta-2 (LFA-1) antagonist	ANTAGONIST	2016	CHEMBL2364172	106151	P20701	Integrin alpha-L	Homo sapiens	D003233: Conjunctivitis, Allergic,D005128: Eye Diseases,D006086: Graft vs Host Disease,D015352: Dry Eye Syndromes	ITGAL	M1
Q16445	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA6	M1
Q16445	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA6	M1
Q16445	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA6	M1
Q16445	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D004827: Epilepsy	GABRA6	M1
Q16445	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA6	M1
Q16445	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA6	M1
Q16445	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D008881: Migraine Disorders	GABRA6	M1
Q16445	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA6	M1
Q16445	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA6	M1
Q16445	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA6	M1
Q16445	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA6	M1
Q16445	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA6	M1
Q16445	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA6	M1
Q16445	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA6	M1
Q16445	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000647: Amnesia	GABRA6	M1
Q16445	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA6	M1
Q16445	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA6	M1
Q16445	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA6	M1
Q16445	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety	GABRA6	M1
Q16445	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety	GABRA6	M1
Q16445	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety	GABRA6	M1
Q16445	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA6	M1
Q16445	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA6	M1
Q16445	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA6	M1
Q16445	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA6	M1
Q16445	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA6	M1
Q16445	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA6	M1
Q16445	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA6	M1
Q16445	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA6	M1
Q16445	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism	GABRA6	M1
Q16445	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
Q16445	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA6	M1
Q16445	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M1
P17568	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	P17568	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFB7	M1
Q9NR82	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9NR82	Potassium voltage-gated channel subfamily KQT member 5	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNQ5	M1
Q9NR82	NA	NA	NA	NA	EZOGABINE	KCNQ (Kv7) potassium channel blocker	BLOCKER	2011	CHEMBL2363063	105758	Q9NR82	Potassium voltage-gated channel subfamily KQT member 5	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D006562: Herpes Zoster,D012640: Seizures	KCNQ5	M1
Q9NR82	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9NR82	Potassium voltage-gated channel subfamily KQT member 5	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNQ5	M1
Q9NR82	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9NR82	Potassium voltage-gated channel subfamily KQT member 5	Homo sapiens	NA	KCNQ5	M1
Q9NR82	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9NR82	Potassium voltage-gated channel subfamily KQT member 5	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNQ5	M1
P31327	NA	NA	NA	NA	CARGLUMIC ACID	Carbamoyl-phosphate synthase [ammonia], mitochondrial positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2010	CHEMBL2362990	105702	P31327	Carbamoyl-phosphate synthase [ammonia], mitochondrial	Homo sapiens	D008661: Metabolism, Inborn Errors,D022124: Hyperammonemia,D056693: Propionic Acidemia	CPS1	M1
P47869	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA2	M1
P47869	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA2	M1
P47869	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA2	M1
P47869	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D004827: Epilepsy	GABRA2	M1
P47869	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA2	M1
P47869	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA2	M1
P47869	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D008881: Migraine Disorders	GABRA2	M1
P47869	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA2	M1
P47869	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA2	M1
P47869	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA2	M1
P47869	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA2	M1
P47869	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA2	M1
P47869	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA2	M1
P47869	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA2	M1
P47869	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000647: Amnesia	GABRA2	M1
P47869	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA2	M1
P47869	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA2	M1
P47869	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA2	M1
P47869	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001007: Anxiety	GABRA2	M1
P47869	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001007: Anxiety	GABRA2	M1
P47869	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001007: Anxiety	GABRA2	M1
P47869	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA2	M1
P47869	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA2	M1
P47869	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA2	M1
P47869	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA2	M1
P47869	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA2	M1
P47869	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA2	M1
P47869	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA2	M1
P47869	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA2	M1
P47869	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D000437: Alcoholism	GABRA2	M1
P47869	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
P47869	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA2	M1
P47869	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P47869	Gamma-aminobutyric acid receptor subunit alpha-2	Homo sapiens	NA	GABRA2	M1
Q16739	NA	NA	NA	NA	MIGLUSTAT	Ceramide glucosyltransferase inhibitor	INHIBITOR	2003	CHEMBL2063	286	Q16739	Ceramide glucosyltransferase	Homo sapiens	D003550: Cystic Fibrosis,D005776: Gaucher Disease,D006008: Glycogen Storage Disease,D012497: Sandhoff Disease,D015419: Spastic Paraplegia, Hereditary,D015658: HIV Infections,D020143: Gangliosidoses, GM2,D052556: Niemann-Pick Disease, Type C	UGCG	M1
Q16739	NA	NA	NA	NA	ELIGLUSTAT TARTRATE	Ceramide glucosyltransferase inhibitor	INHIBITOR	2014	CHEMBL2063	286	Q16739	Ceramide glucosyltransferase	Homo sapiens	D005776: Gaucher Disease	UGCG	M1
P11473	NA	NA	NA	NA	CALCITRIOL	Vitamin D receptor agonist	AGONIST	1978	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D005350: Fibroma,D006973: Hypertension,D006996: Hypocalcemia,D007011: Hypoparathyroidism,D007676: Kidney Failure, Chronic,D007713: Klinefelter Syndrome,D008180: Lupus Erythematosus, Systemic,D008545: Melanoma,D009062: Mouth Neoplasms,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D010024: Osteoporosis,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012080: Chronic Kidney Disease-Mineral and Bone Disorder,D015663: Osteoporosis, Postmenopausal,D016543: Central Nervous System Neoplasms,D018281: Cholangiocarcinoma,D018805: Sepsis,D051436: Renal Insufficiency, Chronic,D053098: Familial Hypophosphatemic Rickets,D058186: Acute Kidney Injury,D064129: Prostatic Neoplasms, Castration-Resistant	VDR	M1
P11473	NA	NA	NA	NA	CHOLECALCIFEROL	Vitamin D receptor agonist	AGONIST	1999	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000236: Adenoma,D000326: Adrenoleukodystrophy,D000375: Aging,D000740: Anemia,D000755: Anemia, Sickle Cell,D001171: Arthritis, Juvenile,D001249: Asthma,D001321: Autistic Disorder,D001471: Barrett Esophagus,D001851: Bone Diseases, Metabolic,D001943: Breast Neoplasms,D001988: Bronchiolitis,D002056: Burns,D002278: Carcinoma in Situ,D002285: Carcinoma, Intraductal, Noninfiltrating,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003139: Common Cold,D003233: Conjunctivitis, Allergic,D003424: Crohn Disease,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D005891: Gingivitis,D005909: Glioblastoma,D006333: Heart Failure,D006526: Hepatitis C,D006620: Hip Fractures,D006949: Hyperlipidemias,D006967: Hypersensitivity,D007006: Hypogonadism,D007239: Infections,D007248: Infertility, Male,D007251: Influenza, Human,D008180: Lupus Erythematosus, Systemic,D008545: Melanoma,D009103: Multiple Sclerosis,D009369: Neoplasms,D009456: Neurofibromatosis 1,D009765: Obesity,D009902: Optic Neuritis,D010001: Osteitis Deformans,D010024: Osteoporosis,D010051: Ovarian Neoplasms,D010212: Papilloma,D010300: Parkinson Disease,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011565: Psoriasis,D011618: Psychotic Disorders,D012004: Rectal Neoplasms,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012878: Skin Neoplasms,D013203: Staphylococcal Infections,D013978: Tibial Fractures,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014581: Urticaria,D014808: Vitamin D Deficiency,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D016481: Helicobacter Infections,D016640: Diabetes, Gestational,D018149: Glucose Intolerance,D018798: Anemia, Iron-Deficiency,D019337: Hematologic Neoplasms,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D043183: Irritable Bowel Syndrome,D044342: Malnutrition,D045169: Severe Acute Respiratory Syndrome,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D055623: Keratosis, Actinic,D055948: Sarcopenia,D060825: Cognitive Dysfunction,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	VDR	M1
P11473	NA	NA	NA	NA	ERGOCALCIFEROL	Vitamin D receptor agonist	AGONIST	1941	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000071698: Latent Autoimmune Diabetes in Adults,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001249: Asthma,D001778: Blood Coagulation Disorders,D001851: Bone Diseases, Metabolic,D001943: Breast Neoplasms,D002056: Burns,D002583: Uterine Cervical Neoplasms,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003929: Diabetic Neuropathies,D004211: Disseminated Intravascular Coagulation,D005265: Femoral Neck Fractures,D005870: Giant Cell Tumors,D006333: Heart Failure,D006526: Hepatitis C,D006620: Hip Fractures,D006966: Hyperprolactinemia,D006996: Hypocalcemia,D007011: Hypoparathyroidism,D007015: Hypophosphatemia, Familial,D007333: Insulin Resistance,D007938: Leukemia,D008175: Lung Neoplasms,D008178: Lupus Erythematosus, Cutaneous,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008593: Menopause,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009369: Neoplasms,D009765: Obesity,D009902: Optic Neuritis,D010001: Osteitis Deformans,D010013: Osteogenesis Imperfecta,D010024: Osteoporosis,D010146: Pain,D010411: Penile Induration,D011085: Polycystic Ovary Syndrome,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012148: Restless Legs Syndrome,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014808: Vitamin D Deficiency,D015179: Colorectal Neoplasms,D015212: Inflammatory Bowel Diseases,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D016640: Diabetes, Gestational,D016757: Death, Sudden, Cardiac,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019698: Hepatitis C, Chronic,D019964: Mood Disorders,D020370: Osteoarthritis, Knee,D044342: Malnutrition,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D049950: Hyperparathyroidism, Primary,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D053098: Familial Hypophosphatemic Rickets,D055948: Sarcopenia,D063730: Rickets, Hypophosphatemic,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	VDR	M1
P11473	NA	NA	NA	NA	PARICALCITOL	Vitamin D receptor agonist	AGONIST	1998	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000419: Albuminuria,D001943: Breast Neoplasms,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D005922: Glomerulonephritis, IGA,D006962: Hyperparathyroidism, Secondary,D006996: Hypocalcemia,D007674: Kidney Diseases,D009101: Multiple Myeloma,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D010279: Parathyroid Diseases,D011507: Proteinuria,D012004: Rectal Neoplasms,D017379: Hypertrophy, Left Ventricular,D021441: Carcinoma, Pancreatic Ductal,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	VDR	M1
P11473	NA	NA	NA	NA	CALCIPOTRIENE	Vitamin D receptor agonist	AGONIST	1993	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000152: Acne Vulgaris,D003876: Dermatitis, Atopic,D004485: Eczema,D011565: Psoriasis,D011855: Radiodermatitis,D012594: Scleroderma, Localized,D012871: Skin Diseases,D014820: Vitiligo,D055623: Keratosis, Actinic	VDR	M1
P11473	NA	NA	NA	NA	DOXERCALCIFEROL	Vitamin D receptor agonist	AGONIST	1999	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D009369: Neoplasms,D010279: Parathyroid Diseases,D011565: Psoriasis,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	VDR	M1
P11473	NA	NA	NA	NA	CALCIFEDIOL	Vitamin D receptor agonist	AGONIST	1980	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D006962: Hyperparathyroidism, Secondary,D009203: Myocardial Infarction,D010279: Parathyroid Diseases,D014808: Vitamin D Deficiency,D020181: Sleep Apnea, Obstructive,D045169: Severe Acute Respiratory Syndrome,D058186: Acute Kidney Injury	VDR	M1
P07949	NA	NA	NA	NA	VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2011	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	RET	M1
P07949	NA	NA	NA	NA	SUNITINIB MALATE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2006	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	RET	M1
P07949	NA	NA	NA	NA	SORAFENIB TOSYLATE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2005	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	RET	M1
P07949	NA	NA	NA	NA	REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2012	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	RET	M1
P07949	NA	NA	NA	NA	ALECTINIB HYDROCHLORIDE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2015	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	RET	M1
P07949	NA	NA	NA	NA	SELPERCATINIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2020	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D013964: Thyroid Neoplasms,D018276: Carcinoma, Medullary	RET	M1
P07949	NA	NA	NA	NA	PRALSETINIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2020	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D013964: Thyroid Neoplasms	RET	M1
P05106	NA	NA	NA	NA	EPTIFIBATIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D009203: Myocardial Infarction,D011014: Pneumonia,D012772: Shock, Septic,D013927: Thrombosis,D020520: Brain Infarction,D020521: Stroke,D054058: Acute Coronary Syndrome	ITGB3	M1
P05106	NA	NA	NA	NA	ABCIXIMAB	Integrin alpha-V/beta-3 inhibitor	INHIBITOR	1993	CHEMBL1907598	104292	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000208: Acute Disease,D000789: Angina, Unstable,D002545: Brain Ischemia,D009203: Myocardial Infarction,D013927: Thrombosis,D016893: Carotid Stenosis,D020521: Stroke,D060050: Angina, Stable	ITGB3	M1
P05106	NA	NA	NA	NA	TIROFIBAN HYDROCHLORIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	NA	ITGB3	M1
Q99835	NA	NA	NA	NA	VISMODEGIB	Smoothened homolog inhibitor	INHIBITOR	2012	CHEMBL5971	101400	Q99835	Smoothened homolog	Homo sapiens	D001478: Basal Cell Nevus Syndrome,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D005909: Glioblastoma,D005910: Glioma,D008527: Medulloblastoma,D008579: Meningioma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D015470: Leukemia, Myeloid, Acute,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	SMO	M1
Q99835	NA	NA	NA	NA	GLASDEGIB	Smoothened homolog antagonist	ANTAGONIST	2018	CHEMBL5971	101400	Q99835	Smoothened homolog	Homo sapiens	D005909: Glioblastoma,D006086: Graft vs Host Disease,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012509: Sarcoma,D015470: Leukemia, Myeloid, Acute	SMO	M1
Q99835	NA	NA	NA	NA	SONIDEGIB PHOSPHATE	Smoothened homolog inhibitor	INHIBITOR	2015	CHEMBL5971	101400	Q99835	Smoothened homolog	Homo sapiens	D002280: Carcinoma, Basal Cell	SMO	M1
Q99835	NA	NA	NA	NA	GLASDEGIB MALEATE	Smoothened homolog antagonist	ANTAGONIST	2018	CHEMBL5971	101400	Q99835	Smoothened homolog	Homo sapiens	D015470: Leukemia, Myeloid, Acute	SMO	M1
P04275	NA	NA	NA	NA	CAPLACIZUMAB	von Willebrand factor inhibitor	INHIBITOR	2019	CHEMBL2021748	104515	P04275	von Willebrand factor	Homo sapiens	D011697: Purpura, Thrombotic Thrombocytopenic,D013927: Thrombosis	VWF	M1
Q13621	NA	NA	NA	NA	FUROSEMIDE	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	1966	CHEMBL1874	167	Q13621	Solute carrier family 12 member 1	Homo sapiens	D000075222: Essential Hypertension,D001988: Bronchiolitis,D001997: Bronchopulmonary Dysplasia,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004417: Dyspnea,D004487: Edema,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D007674: Kidney Diseases,D007938: Leukemia,D008103: Liver Cirrhosis,D008171: Lung Diseases,D009298: Nasal Polyps,D009369: Neoplasms,D009404: Nephrotic Syndrome,D011225: Pre-Eclampsia,D011655: Pulmonary Embolism,D012559: Schizophrenia,D014860: Warts,D015470: Leukemia, Myeloid, Acute,D046110: Hypertension, Pregnancy-Induced,D047928: Premature Birth,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D055371: Acute Lung Injury,D055623: Keratosis, Actinic,D058186: Acute Kidney Injury,D059246: Tachypnea	SLC12A1	M1
Q13621	NA	NA	NA	NA	ETHACRYNIC ACID	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	1967	CHEMBL1874	167	Q13621	Solute carrier family 12 member 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002318: Cardiovascular Diseases,D005901: Glaucoma	SLC12A1	M1
Q13621	NA	NA	NA	NA	BUMETANIDE	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	1983	CHEMBL1874	167	Q13621	Solute carrier family 12 member 1	Homo sapiens	D001321: Autistic Disorder,D002318: Cardiovascular Diseases,D002659: Child Development Disorders, Pervasive,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D009404: Nephrotic Syndrome,D012640: Seizures,D020514: Hypokalemic Periodic Paralysis,D051436: Renal Insufficiency, Chronic	SLC12A1	M1
Q13621	NA	NA	NA	NA	TORSEMIDE	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	1993	CHEMBL1874	167	Q13621	Solute carrier family 12 member 1	Homo sapiens	D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006973: Hypertension,D011225: Pre-Eclampsia	SLC12A1	M1
Q13621	NA	NA	NA	NA	ETHACRYNATE SODIUM	Sodium-(potassium)-chloride cotransporter 2 inhibitor	INHIBITOR	1967	CHEMBL1874	167	Q13621	Solute carrier family 12 member 1	Homo sapiens	NA	SLC12A1	M1
P21802	NA	NA	NA	NA	PALIFERMIN	Fibroblast growth factor receptor 2 agonist	AGONIST	2005	CHEMBL4142	10264	P21802	Fibroblast growth factor receptor 2	Homo sapiens	D000505: Alopecia,D001249: Asthma,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009190: Myelodysplastic Syndromes,D013262: Stevens-Johnson Syndrome,D013280: Stomatitis,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D018302: Neoplasms, Neuroepithelial,D019337: Hematologic Neoplasms,D052016: Mucositis,D053632: X-Linked Combined Immunodeficiency Diseases	FGFR2	M1
P21802	NA	NA	NA	NA	REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	INHIBITOR	2012	CHEMBL4142	10264	P21802	Fibroblast growth factor receptor 2	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FGFR2	M1
P21802	NA	NA	NA	NA	NINTEDANIB ESYLATE	Fibroblast growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095217	104793	P21802	Fibroblast growth factor receptor 2	Homo sapiens	NA	FGFR2	M1
P21802	NA	NA	NA	NA	ERDAFITINIB	Fibroblast growth factor receptor inhibitor	INHIBITOR	2019	CHEMBL2095217	104793	P21802	Fibroblast growth factor receptor 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D006528: Carcinoma, Hepatocellular,D008107: Liver Diseases,D008223: Lymphoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D014565: Urogenital Neoplasms	FGFR2	M1
P21802	NA	NA	NA	NA	PEMIGATINIB	Fibroblast growth factor receptor 2 inhibitor	INHIBITOR	2020	CHEMBL4142	10264	P21802	Fibroblast growth factor receptor 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D014565: Urogenital Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma	FGFR2	M1
P00797	NA	NA	NA	NA	ALISKIREN FUMARATE	Renin inhibitor	INHIBITOR	2007	CHEMBL286	11225	P00797	Renin	Homo sapiens	D006973: Hypertension	REN	M1
P22459	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA4	M1
P22459	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA4	M1
P22459	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	NA	KCNA4	M1
P22459	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA4	M1
P61812	NA	NA	NA	NA	LUSPATERCEPT	Transforming growth factor beta inhibitor	INHIBITOR	2019	CHEMBL3988637	117291	P61812	Transforming growth factor beta-2 proprotein	Homo sapiens	D000740: Anemia,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D011087: Polycythemia Vera,D013789: Thalassemia,D017086: beta-Thalassemia,D055728: Primary Myelofibrosis	TGFB2	M1
P63027	NA	NA	NA	NA	BOTULINUM TOXIN TYPE B	Vesicle-associated membrane protein 2 inhibitor	INHIBITOR	2000	CHEMBL2364160	106139	P63027	Vesicle-associated membrane protein 2	Homo sapiens	D001281: Atrial Fibrillation,D002349: Carpal Tunnel Syndrome,D002547: Cerebral Palsy,D003704: Dementia,D006945: Hyperhidrosis,D012798: Sialorrhea,D012883: Skin Ulcer,D014103: Torticollis	VAMP2	M1
P42262	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	1996	CHEMBL2096670	104825	P42262	Glutamate receptor 2	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIA2	M1
P42262	NA	NA	NA	NA	PERAMPANEL	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	2012	CHEMBL2096670	104825	P42262	Glutamate receptor 2	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D008881: Migraine Disorders,D009437: Neuralgia,D010300: Parkinson Disease,D010523: Peripheral Nervous System Diseases,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014103: Torticollis,D020329: Essential Tremor,D065768: Lennox Gastaut Syndrome	GRIA2	M1
Q14432	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE3A	M1
Q14432	NA	NA	NA	NA	CILOSTAZOL	Phosphodiesterase 3A inhibitor	INHIBITOR	1999	CHEMBL241	170	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D002318: Cardiovascular Diseases,D002544: Cerebral Infarction,D002561: Cerebrovascular Disorders,D003327: Coronary Disease,D005234: Fatty Liver,D007383: Intermittent Claudication,D010003: Osteoarthritis,D010146: Pain,D013927: Thrombosis,D016491: Peripheral Vascular Diseases,D020521: Stroke,D046589: CADASIL,D050197: Atherosclerosis,D058729: Peripheral Arterial Disease,D059345: Cerebral Small Vessel Diseases,D060825: Cognitive Dysfunction	PDE3A	M1
Q14432	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE3A	M1
Q14432	NA	NA	NA	NA	THEOPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1940	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	PDE3A	M1
Q14432	NA	NA	NA	NA	DYPHYLLINE	Phosphodiesterase 3A inhibitor	INHIBITOR	1951	CHEMBL241	170	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE3A	M1
Q14432	NA	NA	NA	NA	OXTRIPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1981	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE3A	M1
Q14432	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Phosphodiesterase 3 inhibitor	INHIBITOR	1982	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	NA	PDE3A	M1
Q14432	NA	NA	NA	NA	ANAGRELIDE HYDROCHLORIDE	Phosphodiesterase 3 inhibitor	INHIBITOR	1997	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D013920: Thrombocythemia, Essential,D013927: Thrombosis	PDE3A	M1
Q14432	NA	NA	NA	NA	MILRINONE LACTATE	Phosphodiesterase 3A inhibitor	INHIBITOR	1987	CHEMBL241	170	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	NA	PDE3A	M1
Q14432	NA	NA	NA	NA	AMINOPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1940	CHEMBL2094125	104707	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	PDE3A	M1
Q14432	NA	NA	NA	NA	INAMRINONE LACTATE	Phosphodiesterase 3A inhibitor	INHIBITOR	1984	CHEMBL241	170	Q14432	cGMP-inhibited 3',5'-cyclic phosphodiesterase A	Homo sapiens	NA	PDE3A	M1
P08172	NA	NA	NA	NA	OXYBUTYNIN CHLORIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1975	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D011471: Prostatic Neoplasms,D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM2	M1
P08172	NA	NA	NA	NA	OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1975	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D001750: Urinary Bladder, Neurogenic,D006255: Rhinitis, Allergic, Seasonal,D006945: Hyperhidrosis,D010145: Paget Disease, Extramammary,D011115: Polyneuropathies,D011141: Polyuria,D012891: Sleep Apnea Syndromes,D014549: Urinary Incontinence,D020181: Sleep Apnea, Obstructive,D053201: Urinary Bladder, Overactive	CHRM2	M1
P08172	NA	NA	NA	NA	PROPANTHELINE BROMIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1953	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM2	M1
P08172	NA	NA	NA	NA	ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1960	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D001778: Blood Coagulation Disorders,D001919: Bradycardia,D001943: Breast Neoplasms,D004066: Digestive System Diseases,D004393: Dwarfism, Pituitary,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006470: Hemorrhage,D007003: Hypoglycemia,D007021: Hypospadias,D007024: Hypotension, Orthostatic,D007333: Insulin Resistance,D009216: Myopia,D010146: Pain,D011183: Postoperative Complications,D011236: Prediabetic State,D013285: Strabismus,D053717: Pneumonia, Ventilator-Associated,D054971: Orthostatic Intolerance	CHRM2	M1
P08172	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	1986	CHEMBL2094109	104691	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2	M1
P08172	NA	NA	NA	NA	BETHANECHOL CHLORIDE	Muscarinic acetylcholine receptor M2 agonist	AGONIST	1948	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2	M1
P08172	NA	NA	NA	NA	SOLIFENACIN SUCCINATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D011470: Prostatic Hyperplasia,D053201: Urinary Bladder, Overactive	CHRM2	M1
P08172	NA	NA	NA	NA	DARIFENACIN HYDROBROMIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2	M1
P08172	NA	NA	NA	NA	FESOTERODINE FUMARATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2008	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM2	M1
P08172	NA	NA	NA	NA	TOLTERODINE TARTRATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1998	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM2	M1
P08172	NA	NA	NA	NA	ATROPINE SULFATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1960	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal,D009216: Myopia,D010300: Parkinson Disease,D010437: Peptic Ulcer,D011183: Postoperative Complications,D015878: Mydriasis,D062025: Organophosphate Poisoning	CHRM2	M1
P08172	NA	NA	NA	NA	TROSPIUM CHLORIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D053201: Urinary Bladder, Overactive	CHRM2	M1
P16109	NA	NA	NA	NA	CRIZANLIZUMAB	P-selectin blocker	BLOCKER	2019	CHEMBL5378	12723	P16109	P-selectin	Homo sapiens	D000755: Anemia, Sickle Cell,D011317: Priapism,D045169: Severe Acute Respiratory Syndrome,D055728: Primary Myelofibrosis	SELP	M1
Q13509	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB3	M1
Q13509	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M1
Q13509	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M1
Q13509	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB3	M1
Q13509	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M1
Q13509	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M1
Q13509	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M1
Q13509	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB3	M1
Q13509	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB3	M1
Q13509	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB3	M1
Q13509	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB3	M1
Q13509	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M1
Q13509	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB3	M1
Q13509	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB3	M1
P49005	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2	M1
P49005	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLD2	M1
P49005	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLD2	M1
P49005	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2	M1
P06881	NA	NA	NA	NA	GALCANEZUMAB	Calcitonin gene-related peptide inhibitor	INHIBITOR	2018	CHEMBL3832947	116903	P06881	Calcitonin gene-related peptide 1	Homo sapiens	D008881: Migraine Disorders,D010146: Pain,D020370: Osteoarthritis, Knee	CALCA	M1
P06881	NA	NA	NA	NA	EPTINEZUMAB	Calcitonin gene-related peptide inhibitor	INHIBITOR	2020	CHEMBL3832947	116903	P06881	Calcitonin gene-related peptide 1	Homo sapiens	D008881: Migraine Disorders,D010146: Pain	CALCA	M1
P06881	NA	NA	NA	NA	FREMANEZUMAB	Calcitonin gene-related peptide antagonist	ANTAGONIST	2018	CHEMBL3832947	116903	P06881	Calcitonin gene-related peptide 1	Homo sapiens	D005356: Fibromyalgia,D008881: Migraine Disorders,D010146: Pain,D018856: Cystitis, Interstitial	CALCA	M1
P05997	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P05997	Collagen alpha-2(V) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL5A2	M1
P05997	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P05997	Collagen alpha-2(V) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL5A2	M1
P35968	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M1
P35968	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M1
P35968	NA	NA	NA	NA	MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	2017	CHEMBL279	10980	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	KDR	M1
P35968	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M1
P35968	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M1
P35968	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M1
P35968	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M1
P35968	NA	NA	NA	NA	RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	2014	CHEMBL279	10980	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000230: Adenocarcinoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005706: Gallbladder Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013945: Thymoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D020522: Lymphoma, Mantle-Cell,D058405: Desmoplastic Small Round Cell Tumor,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M1
P35968	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	KDR	M1
P35968	NA	NA	NA	NA	CABOZANTINIB S-MALATE	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	2012	CHEMBL279	10980	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001254: Astrocytoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005909: Glioblastoma,D005910: Glioma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010673: Pheochromocytoma,D013964: Thyroid Neoplasms,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018288: Carcinoma, Small Cell,D018316: Gliosarcoma	KDR	M1
P35968	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	KDR	M1
P35968	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	NA	KDR	M1
P06748	NA	NA	NA	NA	CRIZOTINIB	NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)	INHIBITOR	2011	CHEMBL2111387	105079	P06748	Nucleophosmin	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000080443: Diffuse Intrinsic Pontine Glioma,D000230: Adenocarcinoma,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006104: Granuloma, Plasma Cell,D007674: Kidney Diseases,D008175: Lung Neoplasms,D009101: Multiple Myeloma,D009369: Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016518: Neurofibromatosis 2,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D064129: Prostatic Neoplasms, Castration-Resistant	NPM1	M1
P06748	NA	NA	NA	NA	CERITINIB	NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)	INHIBITOR	2014	CHEMBL2111387	105079	P06748	Nucleophosmin	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006104: Granuloma, Plasma Cell,D008107: Liver Diseases,D008545: Melanoma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D013964: Thyroid Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma	NPM1	M1
P49642	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	P49642	DNA primase small subunit	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	PRIM1	M1
P49642	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	P49642	DNA primase small subunit	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PRIM1	M1
P49642	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	P49642	DNA primase small subunit	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRIM1	M1
P49642	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	P49642	DNA primase small subunit	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	PRIM1	M1
Q9BVA1	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB2B	M1
Q9BVA1	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9BVA1	Tubulin beta-2B chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB2B	M1
P07550	NA	NA	NA	NA	TIMOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB2	M1
P07550	NA	NA	NA	NA	PINDOLOL	Beta-2 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB2	M1
P07550	NA	NA	NA	NA	NADOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB2	M1
P07550	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB2	M1
P07550	NA	NA	NA	NA	ALBUTEROL	Beta-2 adrenergic receptor agonist	AGONIST	1981	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D001988: Bronchiolitis,D003371: Cough,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D004402: Dysautonomia, Familial,D006009: Glycogen Storage Disease Type II,D006255: Rhinitis, Allergic, Seasonal,D006333: Heart Failure,D006967: Hypersensitivity,D006976: Hypertension, Pulmonary,D008171: Lung Diseases,D008173: Lung Diseases, Obstructive,D008569: Memory Disorders,D011654: Pulmonary Edema,D012131: Respiratory Insufficiency,D013119: Spinal Cord Injuries,D013224: Status Asthmaticus,D018192: Lymphangioleiomyomatosis,D020294: Myasthenic Syndromes, Congenital,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D062025: Organophosphate Poisoning,D065627: Familial Primary Pulmonary Hypertension	ADRB2	M1
P07550	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB2	M1
P07550	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB2	M1
P07550	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M1
P07550	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	SALMETEROL XINAFOATE	Beta-2 adrenergic receptor agonist	AGONIST	1994	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001989: Bronchiolitis Obliterans,D004646: Emphysema,D009765: Obesity,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M1
P07550	NA	NA	NA	NA	VILANTEROL TRIFENATATE	Beta-2 adrenergic receptor agonist	AGONIST	2013	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M1
P07550	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB2	M1
P07550	NA	NA	NA	NA	BITOLTEROL MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB2	M1
P07550	NA	NA	NA	NA	PIRBUTEROL ACETATE	Beta-2 adrenergic receptor agonist	AGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M1
P07550	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB2	M1
P07550	NA	NA	NA	NA	PROTOKYLOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	ISOETHARINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB2	M1
P07550	NA	NA	NA	NA	LEVALBUTEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1999	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001986: Bronchial Spasm	ADRB2	M1
P07550	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M1
P07550	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB2	M1
P07550	NA	NA	NA	NA	ISOETHARINE MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB2	M1
P07550	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB2	M1
P07550	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1990	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB2	M1
P07550	NA	NA	NA	NA	TERBUTALINE SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1974	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M1
P07550	NA	NA	NA	NA	RITODRINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1991	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB2	M1
P07550	NA	NA	NA	NA	ALBUTEROL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D002318: Cardiovascular Diseases,D008171: Lung Diseases,D012128: Respiratory Distress Syndrome,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M1
P07550	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M1
P07550	NA	NA	NA	NA	METAPROTERENOL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1973	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D019966: Substance-Related Disorders	ADRB2	M1
P07550	NA	NA	NA	NA	INDACATEROL MALEATE	Beta-2 adrenergic receptor agonist	AGONIST	2011	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M1
P07550	NA	NA	NA	NA	ARFORMOTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2006	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001991: Bronchitis,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M1
P07550	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB2	M1
P07550	NA	NA	NA	NA	OLODATEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	2014	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M1
P07550	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M1
P07550	NA	NA	NA	NA	LEVALBUTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2005	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm	ADRB2	M1
P07550	NA	NA	NA	NA	FORMOTEROL FUMARATE	Beta-2 adrenergic receptor agonist	AGONIST	2001	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm,D001987: Bronchiectasis,D001989: Bronchiolitis Obliterans,D001991: Bronchitis,D004646: Emphysema,D006967: Hypersensitivity,D008175: Lung Neoplasms,D012128: Respiratory Distress Syndrome,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D045169: Severe Acute Respiratory Syndrome	ADRB2	M1
P55157	NA	NA	NA	NA	LOMITAPIDE MESYLATE	Microsomal triglyceride transfer protein inhibitor	INHIBITOR	2012	CHEMBL2364681	106181	P55157	Microsomal triglyceride transfer protein large subunit	Homo sapiens	D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias	MTTP	M1
O95259	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	O95259	Potassium voltage-gated channel subfamily H member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNH1	M1
O95259	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	O95259	Potassium voltage-gated channel subfamily H member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNH1	M1
O95259	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	O95259	Potassium voltage-gated channel subfamily H member 1	Homo sapiens	NA	KCNH1	M1
O95259	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	O95259	Potassium voltage-gated channel subfamily H member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNH1	M1
P54756	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54756	Ephrin type-A receptor 5	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA5	M1
P23975	NA	NA	NA	NA	AMPHETAMINE	Norepinephrine transporter releasing agent	RELEASING AGENT	1955	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D019970: Cocaine-Related Disorders	SLC6A2	M1
P23975	NA	NA	NA	NA	AMPHETAMINE SULFATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1960	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy,D019970: Cocaine-Related Disorders	SLC6A2	M1
P23975	NA	NA	NA	NA	DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	RELEASING AGENT	1955	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001714: Bipolar Disorder,D005910: Glioma,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D012559: Schizophrenia,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020521: Stroke	SLC6A2	M1
P23975	NA	NA	NA	NA	MAZINDOL	Monoamine transporter inhibitor	INHIBITOR	1973	CHEMBL2363064	105759	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009765: Obesity,D019970: Cocaine-Related Disorders	SLC6A2	M1
P23975	NA	NA	NA	NA	METHYLPHENIDATE	Norepinephrine transporter inhibitor	INHIBITOR	1955	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001289: Attention Deficit Disorder with Hyperactivity,D001714: Bipolar Disorder,D001930: Brain Injuries,D001932: Brain Neoplasms,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005221: Fatigue,D007024: Hypotension, Orthostatic,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D010300: Parkinson Disease,D011183: Postoperative Complications,D011471: Prostatic Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D019337: Hematologic Neoplasms,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D064129: Prostatic Neoplasms, Castration-Resistant	SLC6A2	M1
P23975	NA	NA	NA	NA	DEXMETHYLPHENIDATE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2001	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	SLC6A2	M1
P23975	NA	NA	NA	NA	AMOXAPINE	Norepinephrine transporter inhibitor	INHIBITOR	1980	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A2	M1
P23975	NA	NA	NA	NA	DESVENLAFAXINE	Norepinephrine transporter inhibitor	INHIBITOR	2008	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D019698: Hepatitis C, Chronic	SLC6A2	M1
P23975	NA	NA	NA	NA	GUANETHIDINE MONOSULFATE	Norepinephrine transporter substrate	SUBSTRATE	1960	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	PHENTERMINE	Norepinephrine transporter releasing agent	RELEASING AGENT	1959	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003920: Diabetes Mellitus,D007674: Kidney Diseases,D008107: Liver Diseases,D009765: Obesity,D009767: Obesity, Morbid,D019966: Substance-Related Disorders,D052018: Bulimia Nervosa	SLC6A2	M1
P23975	NA	NA	NA	NA	IMIPRAMINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1959	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A2	M1
P23975	NA	NA	NA	NA	DIETHYLPROPION HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1959	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	DESIPRAMINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1964	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001416: Back Pain,D003866: Depressive Disorder,D055752: Small Cell Lung Carcinoma	SLC6A2	M1
P23975	NA	NA	NA	NA	BUPROPION HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1985	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006527: Hepatolenticular Degeneration,D008175: Lung Neoplasms,D009765: Obesity,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D016574: Seasonal Affective Disorder,D019964: Mood Disorders	SLC6A2	M1
P23975	NA	NA	NA	NA	ATOMOXETINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2002	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000544: Alzheimer Disease,D001289: Attention Deficit Disorder with Hyperactivity,D019958: Attention Deficit and Disruptive Behavior Disorders,D019969: Amphetamine-Related Disorders	SLC6A2	M1
P23975	NA	NA	NA	NA	METHYLPHENIDATE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1955	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D003866: Depressive Disorder,D005221: Fatigue,D009369: Neoplasms,D012893: Sleep Wake Disorders,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	SLC6A2	M1
P23975	NA	NA	NA	NA	BRETYLIUM TOSYLATE	Norepinephrine transporter substrate	SUBSTRATE	1986	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001145: Arrhythmias, Cardiac	SLC6A2	M1
P23975	NA	NA	NA	NA	DULOXETINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2004	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001007: Anxiety,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D005356: Fibromyalgia,D009103: Multiple Sclerosis,D010003: Osteoarthritis,D010146: Pain,D013313: Stress Disorders, Post-Traumatic,D014549: Urinary Incontinence,D015179: Colorectal Neoplasms	SLC6A2	M1
P23975	NA	NA	NA	NA	PROTRIPTYLINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1967	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	AMPHETAMINE ASPARTATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1996	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	SLC6A2	M1
P23975	NA	NA	NA	NA	AMPHETAMINE ADIPATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1975	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	ORPHENADRINE CITRATE	Norepinephrine transporter inhibitor	INHIBITOR	1959	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D010146: Pain	SLC6A2	M1
P23975	NA	NA	NA	NA	PHENMETRAZINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1982	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	NEFAZODONE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1994	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	PHENYLPROPANOLAMINE HYDROCHLORIDE	Norepinephrine transporter releasing agent	RELEASING AGENT	1958	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	PSEUDOEPHEDRINE HYDROCHLORIDE	Norepinephrine transporter releasing agent	RELEASING AGENT	1975	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003139: Common Cold,D003371: Cough,D006255: Rhinitis, Allergic, Seasonal,D006967: Hypersensitivity,D007251: Influenza, Human,D008881: Migraine Disorders,D010146: Pain,D012852: Sinusitis	SLC6A2	M1
P23975	NA	NA	NA	NA	DEXTROAMPHETAMINE ADIPATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1975	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	PHENTERMINE HYDROCHLORIDE	Norepinephrine transporter releasing agent	RELEASING AGENT	1973	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D009765: Obesity	SLC6A2	M1
P23975	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Norepinephrine transporter inhibitor	INHIBITOR	1979	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	METHAMPHETAMINE HYDROCHLORIDE	Monoamine transporter inhibitor	INHIBITOR	1943	CHEMBL2363064	105759	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	AMITRIPTYLINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1961	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003866: Depressive Disorder,D010523: Peripheral Nervous System Diseases,D011537: Pruritus	SLC6A2	M1
P23975	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1957	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D010300: Parkinson Disease	SLC6A2	M1
P23975	NA	NA	NA	NA	VENLAFAXINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1993	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000072861: Phobia, Social,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D008575: Meniere Disease,D009437: Neuralgia,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D016584: Panic Disorder,D019547: Neck Pain,D019584: Hot Flashes,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	SLC6A2	M1
P23975	NA	NA	NA	NA	NORTRIPTYLINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1964	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003876: Dermatitis, Atopic,D011565: Psoriasis,D018288: Carcinoma, Small Cell,D018589: Gastroparesis	SLC6A2	M1
P23975	NA	NA	NA	NA	LISDEXAMFETAMINE DIMESYLATE	Norepinephrine transporter releasing agent	RELEASING AGENT	2007	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001068: Feeding and Eating Disorders,D001289: Attention Deficit Disorder with Hyperactivity,D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity,D012559: Schizophrenia,D052018: Bulimia Nervosa,D056912: Binge-Eating Disorder	SLC6A2	M1
P23975	NA	NA	NA	NA	PHENYLPROPANOLAMINE POLISTIREX	Norepinephrine transporter releasing agent	RELEASING AGENT	1984	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	PSEUDOEPHEDRINE POLISTIREX	Norepinephrine transporter releasing agent	RELEASING AGENT	1987	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	DESVENLAFAXINE SUCCINATE	Norepinephrine transporter inhibitor	INHIBITOR	2008	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D005356: Fibromyalgia,D008593: Menopause,D019584: Hot Flashes	SLC6A2	M1
P23975	NA	NA	NA	NA	BUPROPION HYDROBROMIDE	Norepinephrine transporter inhibitor	INHIBITOR	2008	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder	SLC6A2	M1
P23975	NA	NA	NA	NA	TAPENTADOL HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2008	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D009437: Neuralgia,D010146: Pain,D017116: Low Back Pain,D059350: Chronic Pain,D059787: Acute Pain	SLC6A2	M1
P23975	NA	NA	NA	NA	MAPROTILINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1980	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	NOMIFENSINE MALEATE	Monoamine transporter inhibitor	INHIBITOR	1984	CHEMBL2363064	105759	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	IOBENGUANE I 131	Norepinephrine transporter substrate	SUBSTRATE	2018	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D002276: Carcinoid Tumor,D009447: Neuroblastoma,D010235: Paraganglioma,D010673: Pheochromocytoma	SLC6A2	M1
P23975	NA	NA	NA	NA	DOXEPIN HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1969	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D010146: Pain,D013280: Stomatitis	SLC6A2	M1
P23975	NA	NA	NA	NA	PHENDIMETRAZINE TARTRATE	Norepinephrine transporter inhibitor	INHIBITOR	1976	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	LEVOMILNACIPRAN HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2013	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000083242: Ischemic Stroke,D003865: Depressive Disorder, Major	SLC6A2	M1
P23975	NA	NA	NA	NA	VILOXAZINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2021	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	SLC6A2	M1
P23975	NA	NA	NA	NA	BETHANIDINE SULFATE	Norepinephrine transporter substrate	SUBSTRATE	1982	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	GUANADREL SULFATE	Norepinephrine transporter substrate	SUBSTRATE	1982	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	BENZPHETAMINE HYDROCHLORIDE	Norepinephrine transporter releasing agent	RELEASING AGENT	1960	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	DEXTROAMPHETAMINE SULFATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1960	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC6A2	M1
P23975	NA	NA	NA	NA	SIBUTRAMINE HYDROCHLORIDE	Monoamine transporter inhibitor	INHIBITOR	1997	CHEMBL2363064	105759	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D009765: Obesity	SLC6A2	M1
P23975	NA	NA	NA	NA	DEXTROAMPHETAMINE SACCHARATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1996	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC6A2	M1
P23975	NA	NA	NA	NA	IMIPRAMINE PAMOATE	Norepinephrine transporter inhibitor	INHIBITOR	1973	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M1
P23975	NA	NA	NA	NA	PSEUDOEPHEDRINE SULFATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1963	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal	SLC6A2	M1
P23975	NA	NA	NA	NA	DESVENLAFAXINE FUMARATE	Norepinephrine transporter inhibitor	INHIBITOR	2013	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003865: Depressive Disorder, Major	SLC6A2	M1
P23975	NA	NA	NA	NA	MILNACIPRAN HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2009	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001416: Back Pain,D005356: Fibromyalgia	SLC6A2	M1
P23975	NA	NA	NA	NA	SERDEXMETHYLPHENIDATE CHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2021	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	SLC6A2	M1
Q15878	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1E	M1
Q15878	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1E	M1
Q15878	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1E	M1
Q15878	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	NA	CACNA1E	M1
Q15878	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	NA	CACNA1E	M1
Q15878	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q15878	Voltage-dependent R-type calcium channel subunit alpha-1E	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1E	M1
P12268	NA	NA	NA	NA	THIOGUANINE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1966	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001932: Brain Neoplasms,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	IMPDH2	M1
P12268	NA	NA	NA	NA	MYCOPHENOLIC ACID	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	2004	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D009404: Nephrotic Syndrome,D012595: Scleroderma, Systemic,D015352: Dry Eye Syndromes,D015470: Leukemia, Myeloid, Acute,D015867: Uveitis, Intermediate,D051436: Renal Insufficiency, Chronic	IMPDH2	M1
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1995	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000690: Amyotrophic Lateral Sclerosis,D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001327: Autoimmune Diseases,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D004062: DiGeorge Syndrome,D004820: Epidermolysis Bullosa,D005199: Fanconi Anemia,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006073: Gout,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006331: Heart Diseases,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006519: Hepatitis, Alcoholic,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006973: Hypertension,D007119: Immunoblastic Lymphadenopathy,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009472: Neuronal Ceroid-Lipofuscinoses,D010190: Pancreatic Neoplasms,D010390: Pemphigoid, Benign Mucous Membrane,D010391: Pemphigoid, Bullous,D010392: Pemphigus,D011087: Polycythemia Vera,D011128: Polyradiculopathy,D011565: Psoriasis,D011695: Purpura, Schoenlein-Henoch,D012010: Red-Cell Aplasia, Pure,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012859: Sjogren's Syndrome,D013625: Takayasu Arteritis,D014605: Uveitis,D014657: Vasculitis,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017563: Lung Diseases, Interstitial,D017565: Sarcoidosis, Pulmonary,D017728: Lymphoma, Large-Cell, Anaplastic,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D045743: Scleroderma, Diffuse,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D055953: Microscopic Polyangiitis,D056486: Chemical and Drug Induced Liver Injury,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	IMPDH2	M1
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1998	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	NA	IMPDH2	M1
O60359	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNG3	M1
O60359	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNG3	M1
O60359	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D002318: Cardiovascular Diseases	CACNG3	M1
O60359	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	NA	CACNG3	M1
O60359	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	NA	CACNG3	M1
O60359	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNG3	M1
P04035	NA	NA	NA	NA	LOVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1987	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D002537: Intracranial Arteriosclerosis,D002538: Intracranial Arteriovenous Malformations,D005600: Fragile X Syndrome,D006331: Heart Diseases,D006937: Hypercholesterolemia,D007249: Inflammation,D007383: Intermittent Claudication,D007859: Learning Disabilities,D008545: Melanoma,D008659: Metabolic Diseases,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010300: Parkinson Disease,D015470: Leukemia, Myeloid, Acute,D015518: Rett Syndrome,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D017499: Porokeratosis,D019294: Xanthomatosis, Cerebrotendinous,D020521: Stroke,D029424: Pulmonary Disease, Chronic Obstructive,D052439: Lipid Metabolism Disorders,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M1
P04035	NA	NA	NA	NA	PRAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003922: Diabetes Mellitus, Type 1,D006937: Hypercholesterolemia,D006950: Hyperlipidemia, Familial Combined,D007938: Leukemia,D008060: Lipodystrophy,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D015658: HIV Infections	HMGCR	M1
P04035	NA	NA	NA	NA	SIMVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000075222: Essential Hypertension,D000083242: Ischemic Stroke,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002311: Cardiomyopathy, Dilated,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002543: Cerebral Hemorrhage,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003550: Cystic Fibrosis,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D003930: Diabetic Retinopathy,D004827: Epilepsy,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007383: Intermittent Claudication,D007414: Intestinal Neoplasms,D007889: Leiomyoma,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D008881: Migraine Disorders,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009369: Neoplasms,D009634: Noonan Syndrome,D009902: Optic Neuritis,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010195: Pancreatitis,D010300: Parkinson Disease,D010518: Periodontitis,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012772: Shock, Septic,D012852: Sinusitis,D012893: Sleep Wake Disorders,D013274: Stomach Neoplasms,D013345: Subarachnoid Hemorrhage,D014605: Uveitis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015209: Cholangitis, Sclerosing,D015228: Hypertriglyceridemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D015794: Choroideremia,D016540: Smoking Cessation,D017202: Myocardial Ischemia,D018805: Sepsis,D019082: Smith-Lemli-Opitz Syndrome,D019694: Hepatitis B, Chronic,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D020786: Hemangioma, Cavernous, Central Nervous System,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D052016: Mucositis,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M1
P04035	NA	NA	NA	NA	ATORVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	1996	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D000082882: Bicuspid Aortic Valve Disease,D000083242: Ischemic Stroke,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D000787: Angina Pectoris,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002532: Intracranial Aneurysm,D002544: Cerebral Infarction,D003251: Constriction, Pathologic,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003424: Crohn Disease,D003919: Diabetes Insipidus,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004489: Edema, Cardiac,D004827: Epilepsy,D005909: Glioblastoma,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006333: Heart Failure,D006526: Hepatitis C,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006952: Hyperlipoproteinemia Type III,D006953: Hyperlipoproteinemia Type IV,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007251: Influenza, Human,D007674: Kidney Diseases,D007938: Leukemia,D008180: Lupus Erythematosus, Systemic,D008228: Lymphoma, Non-Hodgkin,D008268: Macular Degeneration,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009303: Nasopharyngeal Neoplasms,D009336: Necrosis,D009369: Neoplasms,D010020: Osteonecrosis,D010518: Periodontitis,D011085: Polycystic Ovary Syndrome,D011225: Pre-Eclampsia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012507: Sarcoidosis,D012594: Scleroderma, Localized,D012893: Sleep Wake Disorders,D014376: Tuberculosis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015228: Hypertriglyceridemia,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D056586: Acute Chest Syndrome,D058186: Acute Kidney Injury,D058922: Inflammatory Breast Neoplasms,D060050: Angina, Stable,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	HMGCR	M1
P04035	NA	NA	NA	NA	CERIVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1997	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	NA	HMGCR	M1
P04035	NA	NA	NA	NA	PITAVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2009	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006937: Hypercholesterolemia,D006949: Hyperlipidemias,D050171: Dyslipidemias,D052439: Lipid Metabolism Disorders	HMGCR	M1
P04035	NA	NA	NA	NA	ROSUVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2003	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D015228: Hypertriglyceridemia,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome	HMGCR	M1
P04035	NA	NA	NA	NA	FLUVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1993	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001943: Breast Neoplasms,D006937: Hypercholesterolemia	HMGCR	M1
P04035	NA	NA	NA	NA	PITAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M1
P04035	NA	NA	NA	NA	PITAVASTATIN MAGNESIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M1
O94806	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	O94806	Serine/threonine-protein kinase D3	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKD3	M1
O00555	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O00555	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1A	M1
O00555	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O00555	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1A	M1
O00555	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O00555	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1A	M1
O00555	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O00555	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	Homo sapiens	NA	CACNA1A	M1
O00555	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O00555	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	Homo sapiens	NA	CACNA1A	M1
O00555	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O00555	Voltage-dependent P/Q-type calcium channel subunit alpha-1A	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1A	M1
O15399	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN2D	M1
O15399	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN2D	M1
O15399	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN2D	M1
O15399	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN2D	M1
O15399	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN2D	M1
O15399	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D010146: Pain	GRIN2D	M1
O15399	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D010300: Parkinson Disease	GRIN2D	M1
O15399	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D000437: Alcoholism	GRIN2D	M1
O15399	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN2D	M1
Q16881	NA	NA	NA	NA	ARSENIC TRIOXIDE	Thioredoxin reductase 1 inhibitor	INHIBITOR	2000	CHEMBL1927	172	Q16881	Thioredoxin reductase 1, cytoplasmic	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006086: Graft vs Host Disease,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010190: Pancreatic Neoplasms,D011087: Polycythemia Vera,D013920: Thrombocythemia, Essential,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018316: Gliosarcoma,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TXNRD1	M1
Q15375	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	Q15375	Ephrin type-A receptor 7	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA7	M1
P05113	NA	NA	NA	NA	RESLIZUMAB	Interleukin-5 inhibitor	INHIBITOR	2016	CHEMBL1169600	103470	P05113	Interleukin-5	Homo sapiens	D001249: Asthma,D001991: Bronchitis,D008118: Loiasis,D008173: Lung Diseases, Obstructive,D012852: Sinusitis,D017681: Hypereosinophilic Syndrome,D019966: Substance-Related Disorders,D057765: Eosinophilic Esophagitis	IL5	M1
P05113	NA	NA	NA	NA	MEPOLIZUMAB	Interleukin-5 inhibitor	INHIBITOR	2015	CHEMBL1169600	103470	P05113	Interleukin-5	Homo sapiens	D001249: Asthma,D003876: Dermatitis, Atopic,D004802: Eosinophilia,D008173: Lung Diseases, Obstructive,D009298: Nasal Polyps,D014581: Urticaria,D015267: Churg-Strauss Syndrome,D017681: Hypereosinophilic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D057765: Eosinophilic Esophagitis	IL5	M1
O95298	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O95298	NADH dehydrogenase [ubiquinone] 1 subunit C2	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFC2	M1
O43924	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6D	M1
O43924	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6D	M1
Q14524	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN5A	M1
Q14524	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN5A	M1
Q14524	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN5A	M1
Q14524	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN5A	M1
Q14524	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN5A	M1
Q14524	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN5A	M1
Q14524	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN5A	M1
Q14524	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN5A	M1
Q14524	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN5A	M1
Q14524	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN5A	M1
Q14524	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN5A	M1
Q14524	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN5A	M1
Q14524	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN5A	M1
Q14524	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN5A	M1
Q14524	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN5A	M1
Q14524	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN5A	M1
Q14524	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN5A	M1
Q14524	NA	NA	NA	NA	RANOLAZINE	Sodium channel protein type V alpha subunit blocker	BLOCKER	2006	CHEMBL1980	11480	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000787: Angina Pectoris,D001281: Atrial Fibrillation,D002311: Cardiomyopathy, Dilated,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003924: Diabetes Mellitus, Type 2,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D008133: Long QT Syndrome,D014652: Vascular Diseases,D017202: Myocardial Ischemia,D020967: Myotonic Disorders,D043183: Irritable Bowel Syndrome,D054058: Acute Coronary Syndrome,D054144: Heart Failure, Diastolic,D060050: Angina, Stable	SCN5A	M1
Q14524	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN5A	M1
Q14524	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D010146: Pain	SCN5A	M1
Q14524	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN5A	M1
Q14524	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN5A	M1
Q14524	NA	NA	NA	NA	DIBUCAINE HYDROCHLORIDE	Sodium channel protein type V alpha subunit blocker	BLOCKER	1982	CHEMBL1980	11480	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	FLECAINIDE ACETATE	Sodium channel protein type V alpha subunit blocker	BLOCKER	1985	CHEMBL1980	11480	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D010146: Pain	SCN5A	M1
Q14524	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN5A	M1
Q14524	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN5A	M1
Q14524	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN5A	M1
Q14524	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN5A	M1
Q14524	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN5A	M1
Q14524	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN5A	M1
Q14524	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN5A	M1
Q14524	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN5A	M1
Q14524	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN5A	M1
Q14524	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN5A	M1
Q14524	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M1
Q14524	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN5A	M1
Q14524	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN5A	M1
P30556	NA	NA	NA	NA	LOSARTAN POTASSIUM	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1995	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D006973: Hypertension,D007674: Kidney Diseases,D008382: Marfan Syndrome,D010190: Pancreatic Neoplasms,D011225: Pre-Eclampsia,D011507: Proteinuria,D017379: Hypertrophy, Left Ventricular,D021441: Carcinoma, Pancreatic Ductal,D057765: Eosinophilic Esophagitis,D065626: Non-alcoholic Fatty Liver Disease	AGTR1	M1
P30556	NA	NA	NA	NA	CANDESARTAN CILEXETIL	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1998	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006978: Hypertension, Renovascular,D010146: Pain,D011507: Proteinuria,D012078: Renal Artery Obstruction,D020521: Stroke,D050197: Atherosclerosis	AGTR1	M1
P30556	NA	NA	NA	NA	TELMISARTAN	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1998	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D000419: Albuminuria,D000544: Alzheimer Disease,D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D006331: Heart Diseases,D006973: Hypertension,D007690: Polycystic Kidney Diseases,D015658: HIV Infections,D020181: Sleep Apnea, Obstructive,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders	AGTR1	M1
P30556	NA	NA	NA	NA	VALSARTAN	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1996	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D007674: Kidney Diseases,D009203: Myocardial Infarction,D009394: Nephritis, Hereditary,D018487: Ventricular Dysfunction, Left,D024821: Metabolic Syndrome,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome	AGTR1	M1
P30556	NA	NA	NA	NA	IRBESARTAN	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1997	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D004535: Ehlers-Danlos Syndrome,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D008382: Marfan Syndrome,D017202: Myocardial Ischemia,D018805: Sepsis,D019142: Hemorrhagic Fever, Ebola,D019698: Hepatitis C, Chronic,D051436: Renal Insufficiency, Chronic	AGTR1	M1
P30556	NA	NA	NA	NA	SARALASIN ACETATE	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1982	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	NA	AGTR1	M1
P30556	NA	NA	NA	NA	OLMESARTAN MEDOXOMIL	Type-1 angiotensin II receptor antagonist	ANTAGONIST	2002	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D005921: Glomerulonephritis,D006333: Heart Failure,D006973: Hypertension,D007674: Kidney Diseases,D011507: Proteinuria,D050197: Atherosclerosis	AGTR1	M1
P30556	NA	NA	NA	NA	EPROSARTAN MESYLATE	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1997	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D006973: Hypertension	AGTR1	M1
P30556	NA	NA	NA	NA	AZILSARTAN KAMEDOXOMIL	Type-1 angiotensin II receptor antagonist	ANTAGONIST	2011	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D006973: Hypertension	AGTR1	M1
P30556	NA	NA	NA	NA	ANGIOTENSIN II ACETATE	Type-1 angiotensin II receptor agonist	AGONIST	2017	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D012772: Shock, Septic	AGTR1	M1
Q13002	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	1996	CHEMBL2109241	104902	Q13002	Glutamate receptor ionotropic, kainate 2	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIK2	M1
P11229	NA	NA	NA	NA	PILOCARPINE	Muscarinic acetylcholine receptor M1 agonist	AGONIST	1974	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension,D011305: Presbyopia,D014549: Urinary Incontinence,D014987: Xerostomia	CHRM1	M1
P11229	NA	NA	NA	NA	TRIHEXYPHENIDYL HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1949	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	PROPANTHELINE BROMIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1953	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM1	M1
P11229	NA	NA	NA	NA	DIPHENIDOL HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1967	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	ATROPINE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1960	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D001778: Blood Coagulation Disorders,D001919: Bradycardia,D001943: Breast Neoplasms,D004066: Digestive System Diseases,D004393: Dwarfism, Pituitary,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006470: Hemorrhage,D007003: Hypoglycemia,D007021: Hypospadias,D007024: Hypotension, Orthostatic,D007333: Insulin Resistance,D009216: Myopia,D010146: Pain,D011183: Postoperative Complications,D011236: Prediabetic State,D013285: Strabismus,D053717: Pneumonia, Ventilator-Associated,D054971: Orthostatic Intolerance	CHRM1	M1
P11229	NA	NA	NA	NA	ANISOTROPINE METHYLBROMIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1962	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	1986	CHEMBL2094109	104691	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	MEPENZOLATE BROMIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1956	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	SCOPOLAMINE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1979	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D000072861: Phobia, Social,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009041: Motion Sickness,D009325: Nausea,D010146: Pain,D020250: Postoperative Nausea and Vomiting,D056844: Renal Colic	CHRM1	M1
P11229	NA	NA	NA	NA	PROCYCLIDINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1955	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	PILOCARPINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 agonist	AGONIST	1984	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D006258: Head and Neck Neoplasms	CHRM1	M1
P11229	NA	NA	NA	NA	ISOPROPAMIDE IODIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1957	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	BENZTROPINE MESYLATE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1954	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D001416: Back Pain,D010300: Parkinson Disease,D010523: Peripheral Nervous System Diseases	CHRM1	M1
P11229	NA	NA	NA	NA	METHIXENE HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1982	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	DICYCLOMINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1950	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	TRIDIHEXETHYL CHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1954	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	CYCRIMINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1982	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	DIPHEMANIL METHYLSULFATE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1982	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	OXYPHENCYCLIMINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1982	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	OXYPHENONIUM BROMIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1982	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	CLIDINIUM BROMIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1982	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D004066: Digestive System Diseases	CHRM1	M1
P11229	NA	NA	NA	NA	ETHOPROPAZINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1982	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	GLYCOPYRROLATE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1961	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D001249: Asthma,D002056: Burns,D003866: Depressive Disorder,D004066: Digestive System Diseases,D006945: Hyperhidrosis,D007674: Kidney Diseases,D008173: Lung Diseases, Obstructive,D012798: Sialorrhea,D029424: Pulmonary Disease, Chronic Obstructive	CHRM1	M1
P11229	NA	NA	NA	NA	BIPERIDEN HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1959	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	BIPERIDEN LACTATE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1961	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D001930: Brain Injuries	CHRM1	M1
P11229	NA	NA	NA	NA	METHSCOPOLAMINE BROMIDE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1953	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	HEXOCYCLIUM METHYLSULFATE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1982	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
P11229	NA	NA	NA	NA	ATROPINE SULFATE	Muscarinic acetylcholine receptor M1 antagonist	ANTAGONIST	1960	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal,D009216: Myopia,D010300: Parkinson Disease,D010437: Peptic Ulcer,D011183: Postoperative Complications,D015878: Mydriasis,D062025: Organophosphate Poisoning	CHRM1	M1
P11229	NA	NA	NA	NA	CEVIMELINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M1 agonist	AGONIST	2000	CHEMBL216	61	P11229	Muscarinic acetylcholine receptor M1	Homo sapiens	NA	CHRM1	M1
Q01344	NA	NA	NA	NA	BENRALIZUMAB	Interleukin-5 receptor subunit alpha inhibitor	INHIBITOR	2017	CHEMBL3580483	109779	Q01344	Interleukin-5 receptor subunit alpha	Homo sapiens	D001249: Asthma,D003876: Dermatitis, Atopic,D006402: Hematologic Diseases,D008173: Lung Diseases, Obstructive,D009298: Nasal Polyps,D010391: Pemphigoid, Bullous,D012852: Sinusitis,D014581: Urticaria,D017681: Hypereosinophilic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D057765: Eosinophilic Esophagitis	IL5RA	M1
Q96SW2	NA	NA	NA	NA	THALIDOMIDE	CRL4(CRBN) E3 ubiquitin ligase inhibitor	INHIBITOR	1998	CHEMBL3833061	116917	Q96SW2	Protein cereblon	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000544: Alzheimer Disease,D000686: Amyloidosis,D000690: Amyotrophic Lateral Sclerosis,D001063: Appendiceal Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003371: Cough,D003424: Crohn Disease,D004715: Endometriosis,D004827: Epilepsy,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008179: Lupus Erythematosus, Discoid,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010146: Pain,D010534: Peritoneal Neoplasms,D011349: Proctitis,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012192: Retroviridae Infections,D012507: Sarcoidosis,D012509: Sarcoma,D012595: Scleroderma, Systemic,D013167: Spondylitis, Ankylosing,D013789: Thalassemia,D015179: Colorectal Neoplasms,D015209: Cholangitis, Sclerosing,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D018358: Neuroendocrine Tumors,D018442: Lymphoma, B-Cell, Marginal Zone,D019247: HIV Wasting Syndrome,D020295: Brain Stem Neoplasms,D020522: Lymphoma, Mantle-Cell,D028226: Amyloidosis, Familial,D045169: Severe Acute Respiratory Syndrome,D050500: Pancreatitis, Chronic,D054079: Vascular Malformations,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	CRBN	M1
Q96SW2	NA	NA	NA	NA	POMALIDOMIDE	CRL4(CRBN) E3 ubiquitin ligase inhibitor	INHIBITOR	2013	CHEMBL3833061	116917	Q96SW2	Protein cereblon	Homo sapiens	D000686: Amyloidosis,D000755: Anemia, Sickle Cell,D005871: Castleman Disease,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007952: Leukemia, Plasma Cell,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D010954: Plasmacytoma,D011087: Polycythemia Vera,D011658: Pulmonary Fibrosis,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D012595: Scleroderma, Systemic,D013683: Telangiectasia, Hereditary Hemorrhagic,D016403: Lymphoma, Large B-Cell, Diffuse,D017563: Lung Diseases, Interstitial,D028226: Amyloidosis, Familial,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	CRBN	M1
Q96SW2	NA	NA	NA	NA	LENALIDOMIDE	CRL4(CRBN) E3 ubiquitin ligase inhibitor	INHIBITOR	2005	CHEMBL3833061	116917	Q96SW2	Protein cereblon	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000080443: Diffuse Intrinsic Pontine Glioma,D000686: Amyloidosis,D000740: Anemia,D001254: Astrocytoma,D001321: Autistic Disorder,D001749: Urinary Bladder Neoplasms,D002051: Burkitt Lymphoma,D002100: Cachexia,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003424: Crohn Disease,D005185: Fallopian Tube Neoplasms,D005910: Glioma,D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011843: Radiculopathy,D012004: Rectal Neoplasms,D012514: Sarcoma, Kaposi,D013920: Thrombocythemia, Essential,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016393: Lymphoma, B-Cell,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D016543: Central Nervous System Neoplasms,D016878: POEMS Syndrome,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020031: Epstein-Barr Virus Infections,D020522: Lymphoma, Mantle-Cell,D020918: Complex Regional Pain Syndromes,D021441: Carcinoma, Pancreatic Ductal,D028226: Amyloidosis, Familial,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	CRBN	M1
P28072	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB6	M1
P28072	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB6	M1
P28072	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB6	M1
P48357	NA	NA	NA	NA	METRELEPTIN	Leptin receptor agonist	AGONIST	2014	CHEMBL5913	102709	P48357	Leptin receptor	Homo sapiens	D000568: Amenorrhea,D003922: Diabetes Mellitus, Type 1,D007333: Insulin Resistance,D008060: Lipodystrophy,D009765: Obesity,D024821: Metabolic Syndrome,D039682: HIV-Associated Lipodystrophy Syndrome,D052496: Lipodystrophy, Familial Partial,D065626: Non-alcoholic Fatty Liver Disease	LEPR	M1
Q9Y6F1	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP3	M1
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP3	M1
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP3	M1
P55036	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD4	M1
P55036	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD4	M1
P55036	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD4	M1
Q9BQE3	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBA1C	M1
Q9BQE3	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBA1C	M1
P35498	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN1A	M1
P35498	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN1A	M1
P35498	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN1A	M1
P35498	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN1A	M1
P35498	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN1A	M1
P35498	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN1A	M1
P35498	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN1A	M1
P35498	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN1A	M1
P35498	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN1A	M1
P35498	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN1A	M1
P35498	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN1A	M1
P35498	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN1A	M1
P35498	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN1A	M1
P35498	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN1A	M1
P35498	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN1A	M1
P35498	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN1A	M1
P35498	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN1A	M1
P35498	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN1A	M1
P35498	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D010146: Pain	SCN1A	M1
P35498	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN1A	M1
P35498	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN1A	M1
P35498	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN1A	M1
P35498	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN1A	M1
P35498	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN1A	M1
P35498	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN1A	M1
P35498	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN1A	M1
P35498	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN1A	M1
P35498	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN1A	M1
P35498	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN1A	M1
P35498	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN1A	M1
P35498	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN1A	M1
P35498	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M1
P35498	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN1A	M1
P35498	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN1A	M1
Q9NY46	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN3A	M1
Q9NY46	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN3A	M1
Q9NY46	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN3A	M1
Q9NY46	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN3A	M1
Q9NY46	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN3A	M1
Q9NY46	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN3A	M1
Q9NY46	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN3A	M1
Q9NY46	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN3A	M1
Q9NY46	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN3A	M1
Q9NY46	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN3A	M1
Q9NY46	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D010146: Pain	SCN3A	M1
Q9NY46	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN3A	M1
Q9NY46	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN3A	M1
Q9NY46	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN3A	M1
Q9NY46	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN3A	M1
Q9NY46	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN3A	M1
Q9NY46	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN3A	M1
Q9NY46	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN3A	M1
Q9NY46	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN3A	M1
Q9NY46	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN3A	M1
Q9NY46	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	NA	SCN3A	M1
Q9NY46	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN3A	M1
Q9NY46	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q9NY46	Sodium channel protein type 3 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN3A	M1
P04626	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M1
P04626	NA	NA	NA	NA	NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006394: Hemangiosarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M1
P04626	NA	NA	NA	NA	LAPATINIB DITOSYLATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2007	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010190: Pancreatic Neoplasms,D013964: Thyroid Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M1
P04626	NA	NA	NA	NA	TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	1998	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D001005: Anus Neoplasms,D001063: Appendiceal Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001927: Brain Diseases,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D004806: Ependymoma,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D007340: Insulinoma,D007938: Leukemia,D008175: Lung Neoplasms,D008228: Lymphoma, Non-Hodgkin,D009182: Mycosis Fungoides,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010282: Parathyroid Neoplasms,D010490: Pericardial Effusion,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013005: Somatostatinoma,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018567: Breast Neoplasms, Male,D044584: Carcinoma, Ductal,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M1
P04626	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	ERBB2	M1
P04626	NA	NA	NA	NA	PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2012	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D018278: Carcinoma, Neuroendocrine,D018567: Breast Neoplasms, Male,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M1
P04626	NA	NA	NA	NA	AFATINIB DIMALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma	ERBB2	M1
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	ERBB2	M1
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001932: Brain Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008107: Liver Diseases,D008175: Lung Neoplasms,D009062: Mouth Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010412: Penile Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M1
P04626	NA	NA	NA	NA	MARGETUXIMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2	M1
P04626	NA	NA	NA	NA	TUCATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D006394: Hemangiosarcoma,D008107: Liver Diseases,D009369: Neoplasms	ERBB2	M1
P04626	NA	NA	NA	NA	NERATINIB MALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2	M1
P04626	NA	NA	NA	NA	TRASTUZUMAB DERUXTECAN	Receptor protein-tyrosine kinase erbB-2 binding agent	BINDING AGENT	2019	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004067: Digestive System Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M1
P54284	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNB3	M1
P54284	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNB3	M1
P54284	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases	CACNB3	M1
P54284	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	NA	CACNB3	M1
P54284	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	NA	CACNB3	M1
P54284	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNB3	M1
P42336	NA	NA	NA	NA	ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	2019	CHEMBL4005	11362	P42336	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D006258: Head and Neck Neoplasms,D008107: Liver Diseases,D008579: Meningioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D046152: Gastrointestinal Stromal Tumors	PIK3CA	M1
P42336	NA	NA	NA	NA	COPANLISIB	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	2017	CHEMBL4005	11362	P42336	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	Homo sapiens	D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D005706: Gallbladder Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D018281: Cholangiocarcinoma,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PIK3CA	M1
P42336	NA	NA	NA	NA	COPANLISIB HYDROCHLORIDE	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	2017	CHEMBL4005	11362	P42336	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	Homo sapiens	D001943: Breast Neoplasms,D008224: Lymphoma, Follicular,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse	PIK3CA	M1
P40259	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	B-cell antigen receptor complex-associated protein beta chain binding agent	BINDING AGENT	2019	CHEMBL3712852	114813	P40259	B-cell antigen receptor complex-associated protein beta chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	CD79B	M1
P56524	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC4	M1
P56524	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC4	M1
P56524	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D009101: Multiple Myeloma	HDAC4	M1
Q14654	NA	NA	NA	NA	GLYBURIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D000083242: Ischemic Stroke,D001930: Brain Injuries,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D013119: Spinal Cord Injuries,D016640: Diabetes, Gestational,D020521: Stroke,D060050: Angina, Stable	KCNJ11	M1
Q14654	NA	NA	NA	NA	CHLORPROPAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1958	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	KCNJ11	M1
Q14654	NA	NA	NA	NA	TOLBUTAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D008223: Lymphoma,D009369: Neoplasms,D019698: Hepatitis C, Chronic,D059350: Chronic Pain	KCNJ11	M1
Q14654	NA	NA	NA	NA	NATEGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	2000	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	KCNJ11	M1
Q14654	NA	NA	NA	NA	MINOXIDIL	Sulfonylurea receptor 2, Kir6.2 opener	OPENER	1979	CHEMBL2095198	104782	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D000505: Alopecia,D006973: Hypertension	KCNJ11	M1
Q14654	NA	NA	NA	NA	TOLAZAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1966	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	KCNJ11	M1
Q14654	NA	NA	NA	NA	GLIPIZIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic	KCNJ11	M1
Q14654	NA	NA	NA	NA	REPAGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1997	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D010300: Parkinson Disease,D028361: Mitochondrial Diseases,D046152: Gastrointestinal Stromal Tumors,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	KCNJ11	M1
Q14654	NA	NA	NA	NA	DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	OPENER	1973	CHEMBL1886	285	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006946: Hyperinsulinism,D006973: Hypertension,D007003: Hypoglycemia,D009765: Obesity	KCNJ11	M1
Q14654	NA	NA	NA	NA	GLIMEPIRIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1995	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003327: Coronary Disease,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	KCNJ11	M1
Q14654	NA	NA	NA	NA	ACETOHEXAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1964	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D002386: Cataract,D003920: Diabetes Mellitus	KCNJ11	M1
Q14654	NA	NA	NA	NA	PINACIDIL	Sulfonylurea receptor 2, Kir6.2 opener	OPENER	1989	CHEMBL2095198	104782	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D006973: Hypertension	KCNJ11	M1
Q14654	NA	NA	NA	NA	TOLBUTAMIDE SODIUM, STERILE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	NA	KCNJ11	M1
Q01118	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN7A	M1
Q01118	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN7A	M1
Q01118	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN7A	M1
Q01118	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN7A	M1
Q01118	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN7A	M1
Q01118	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN7A	M1
Q01118	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN7A	M1
Q01118	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN7A	M1
Q01118	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN7A	M1
Q01118	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN7A	M1
Q01118	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN7A	M1
Q01118	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN7A	M1
Q01118	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN7A	M1
Q01118	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN7A	M1
Q01118	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN7A	M1
Q01118	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN7A	M1
Q01118	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN7A	M1
Q01118	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN7A	M1
Q01118	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D010146: Pain	SCN7A	M1
Q01118	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN7A	M1
Q01118	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN7A	M1
Q01118	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN7A	M1
Q01118	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN7A	M1
Q01118	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN7A	M1
Q01118	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN7A	M1
Q01118	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN7A	M1
Q01118	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN7A	M1
Q01118	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN7A	M1
Q01118	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN7A	M1
Q01118	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN7A	M1
Q01118	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN7A	M1
Q01118	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	NA	SCN7A	M1
Q01118	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN7A	M1
Q01118	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q01118	Sodium channel protein type 7 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN7A	M1
Q09428	NA	NA	NA	NA	GLYBURIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D000083242: Ischemic Stroke,D001930: Brain Injuries,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D013119: Spinal Cord Injuries,D016640: Diabetes, Gestational,D020521: Stroke,D060050: Angina, Stable	ABCC8	M1
Q09428	NA	NA	NA	NA	CHLORPROPAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1958	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	ABCC8	M1
Q09428	NA	NA	NA	NA	TOLBUTAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D008223: Lymphoma,D009369: Neoplasms,D019698: Hepatitis C, Chronic,D059350: Chronic Pain	ABCC8	M1
Q09428	NA	NA	NA	NA	NATEGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	2000	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	ABCC8	M1
Q09428	NA	NA	NA	NA	TOLAZAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1966	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	ABCC8	M1
Q09428	NA	NA	NA	NA	GLIPIZIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic	ABCC8	M1
Q09428	NA	NA	NA	NA	REPAGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1997	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D010300: Parkinson Disease,D028361: Mitochondrial Diseases,D046152: Gastrointestinal Stromal Tumors,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ABCC8	M1
Q09428	NA	NA	NA	NA	GLIMEPIRIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1995	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D003327: Coronary Disease,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	ABCC8	M1
Q09428	NA	NA	NA	NA	ACETOHEXAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1964	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	D002386: Cataract,D003920: Diabetes Mellitus	ABCC8	M1
Q09428	NA	NA	NA	NA	TOLBUTAMIDE SODIUM, STERILE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q09428	ATP-binding cassette sub-family C member 8	Homo sapiens	NA	ABCC8	M1
P51681	NA	NA	NA	NA	MARAVIROC	C-C chemokine receptor type 5 antagonist	ANTAGONIST	2007	CHEMBL274	10580	P51681	C-C chemokine receptor type 5	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001172: Arthritis, Rheumatoid,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007239: Infections,D008224: Lymphoma, Follicular,D009190: Myelodysplastic Syndromes,D012514: Sarcoma, Kaposi,D014777: Virus Diseases,D015228: Hypertriglyceridemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015526: AIDS Dementia Complex,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D019337: Hematologic Neoplasms,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome	CCR5	M1
P29322	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P29322	Ephrin type-A receptor 8	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA8	M1
P21860	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	P21860	Receptor tyrosine-protein kinase erbB-3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB3	M1
Q01668	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1D	M1
Q01668	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1D	M1
Q01668	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1D	M1
Q01668	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1D	M1
Q01668	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1D	M1
Q01668	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1D	M1
Q01668	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1D	M1
Q01668	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1D	M1
Q01668	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1D	M1
Q01668	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M1
Q01668	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1D	M1
Q01668	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1D	M1
Q01668	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M1
Q01668	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1D	M1
Q01668	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M1
Q01668	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M1
Q01668	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001281: Atrial Fibrillation	CACNA1D	M1
Q01668	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1D	M1
Q01668	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1D	M1
Q01668	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D006973: Hypertension	CACNA1D	M1
Q01668	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D006973: Hypertension	CACNA1D	M1
Q16322	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q16322	Potassium voltage-gated channel subfamily A member 10	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA10	M1
Q16322	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q16322	Potassium voltage-gated channel subfamily A member 10	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA10	M1
Q16322	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q16322	Potassium voltage-gated channel subfamily A member 10	Homo sapiens	NA	KCNA10	M1
Q16322	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q16322	Potassium voltage-gated channel subfamily A member 10	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA10	M1
P22001	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA3	M1
P22001	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA3	M1
P22001	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	NA	KCNA3	M1
P22001	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA3	M1
P16389	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P16389	Potassium voltage-gated channel subfamily A member 2	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA2	M1
P16389	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P16389	Potassium voltage-gated channel subfamily A member 2	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA2	M1
P16389	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P16389	Potassium voltage-gated channel subfamily A member 2	Homo sapiens	NA	KCNA2	M1
P16389	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P16389	Potassium voltage-gated channel subfamily A member 2	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA2	M1
P45452	NA	NA	NA	NA	DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	INHIBITOR	1967	CHEMBL280	11024	P45452	Collagenase 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D000544: Alzheimer Disease,D000686: Amyloidosis,D000783: Aneurysm,D000881: Anthrax,D001762: Blepharitis,D002289: Carcinoma, Non-Small-Cell Lung,D002690: Chlamydia Infections,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003550: Cystic Fibrosis,D003876: Dermatitis, Atopic,D003930: Diabetic Retinopathy,D004485: Eczema,D004605: Elephantiasis, Filarial,D005126: Eye Burns,D006470: Hemorrhage,D007239: Infections,D008193: Lyme Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008368: Mansonelliasis,D008382: Marfan Syndrome,D008545: Melanoma,D009182: Mycosis Fungoides,D009203: Myocardial Infarction,D009369: Neoplasms,D010003: Osteoarthritis,D010019: Osteomyelitis,D010146: Pain,D010190: Pancreatic Neoplasms,D010518: Periodontitis,D010930: Plague,D010996: Pleural Effusion,D011014: Pneumonia,D011125: Adenomatous Polyposis Coli,D012393: Rosacea,D012612: Scrub Typhus,D012640: Seizures,D012751: Sezary Syndrome,D012871: Skin Diseases,D013587: Syphilis,D014376: Tuberculosis,D014526: Urethritis,D015179: Colorectal Neoplasms,D015352: Dry Eye Syndromes,D015427: Reperfusion Injury,D016410: Lymphoma, T-Cell, Cutaneous,D016918: Arthritis, Reactive,D017544: Aortic Aneurysm, Abdominal,D017676: Lichen Planus, Oral,D017719: Diabetic Foot,D018923: Persian Gulf Syndrome,D028226: Amyloidosis, Familial,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D054990: Idiopathic Pulmonary Fibrosis	MMP13	M1
P45452	NA	NA	NA	NA	DOXYCYCLINE CALCIUM	Matrix metalloproteinase 13 inhibitor	INHIBITOR	1974	CHEMBL280	11024	P45452	Collagenase 3	Homo sapiens	D010019: Osteomyelitis	MMP13	M1
P45452	NA	NA	NA	NA	DOXYCYCLINE HYCLATE	Matrix metalloproteinase 13 inhibitor	INHIBITOR	1967	CHEMBL280	11024	P45452	Collagenase 3	Homo sapiens	D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D002690: Chlamydia Infections,D008268: Macular Degeneration,D010518: Periodontitis,D012393: Rosacea,D013683: Telangiectasia, Hereditary Hemorrhagic,D013716: Tennis Elbow,D015231: Sexually Transmitted Diseases, Bacterial,D052016: Mucositis	MMP13	M1
O95069	NA	NA	NA	NA	HALOTHANE	Potassium channel subfamily K member 2 opener	OPENER	1958	CHEMBL2321615	105604	O95069	Potassium channel subfamily K member 2	Homo sapiens	NA	KCNK2	M1
O95069	NA	NA	NA	NA	ISOFLURANE	Potassium channel subfamily K member 2 opener	OPENER	1979	CHEMBL2321615	105604	O95069	Potassium channel subfamily K member 2	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	KCNK2	M1
O95069	NA	NA	NA	NA	ENFLURANE	Potassium channel subfamily K member 2 opener	OPENER	1972	CHEMBL2321615	105604	O95069	Potassium channel subfamily K member 2	Homo sapiens	NA	KCNK2	M1
O95069	NA	NA	NA	NA	SEVOFLURANE	Potassium channel subfamily K member 2 opener	OPENER	1995	CHEMBL2321615	105604	O95069	Potassium channel subfamily K member 2	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	KCNK2	M1
O95069	NA	NA	NA	NA	DESFLURANE	Potassium channel subfamily K member 2 opener	OPENER	1992	CHEMBL2321615	105604	O95069	Potassium channel subfamily K member 2	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	KCNK2	M1
P54762	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54762	Ephrin type-B receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHB1	M1
Q99460	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD1	M1
Q99460	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD1	M1
Q99460	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD1	M1
P31350	NA	NA	NA	NA	HYDROXYUREA	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1967	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D000755: Anemia, Sickle Cell,D002277: Carcinoma,D004938: Esophageal Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006432: Hemochromatosis,D006450: Hemoglobin SC Disease,D006976: Hypertension, Pulmonary,D007822: Laryngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008579: Meningioma,D009062: Mouth Neoplasms,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010255: Paranasal Sinus Neoplasms,D010610: Pharyngeal Neoplasms,D011087: Polycythemia Vera,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D017086: beta-Thalassemia,D018222: Fibromatosis, Aggressive,D018316: Gliosarcoma,D020521: Stroke,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	RRM2	M1
P31350	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1996	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	RRM2	M1
P31350	NA	NA	NA	NA	CLOFARABINE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	2004	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	RRM2	M1
P31350	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	RRM2	M1
P31350	NA	NA	NA	NA	GALLIUM NITRATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D003550: Cystic Fibrosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009164: Mycobacterium Infections,D009447: Neuroblastoma,D012509: Sarcoma	RRM2	M1
P11926	NA	NA	NA	NA	EFLORNITHINE HYDROCHLORIDE	Ornithine decarboxylase inhibitor	INHIBITOR	1990	CHEMBL1869	272	P11926	Ornithine decarboxylase	Homo sapiens	D009447: Neuroblastoma,D011125: Adenomatous Polyposis Coli,D018305: Ganglioneuroblastoma	ODC1	M1
Q02880	NA	NA	NA	NA	ETOPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1983	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000163: Acquired Immunodeficiency Syndrome,D000306: Adrenal Cortex Neoplasms,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002822: Choriocarcinoma,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005910: Glioma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006402: Hematologic Diseases,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008479: Mediastinal Neoplasms,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009396: Wilms Tumor,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009503: Neutropenia,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016393: Lymphoma, B-Cell,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018236: Carcinoma, Embryonal,D018239: Seminoma,D018240: Endodermal Sinus Tumor,D018242: Neuroectodermal Tumors, Primitive,D018273: Carcinoma, Islet Cell,D018278: Carcinoma, Neuroendocrine,D018302: Neoplasms, Neuroepithelial,D018305: Ganglioneuroblastoma,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020339: Optic Nerve Glioma,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TOP2B	M1
Q02880	NA	NA	NA	NA	TENIPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1992	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D007938: Leukemia,D008223: Lymphoma,D009369: Neoplasms,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	TOP2B	M1
Q9H244	NA	NA	NA	NA	TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2011	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D007511: Ischemia,D007674: Kidney Diseases,D009203: Myocardial Infarction,D011014: Pneumonia,D013927: Thrombosis,D016893: Carotid Stenosis,D017544: Aortic Aneurysm, Abdominal,D020521: Stroke,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D058729: Peripheral Arterial Disease,D060050: Angina, Stable	P2RY12	M1
Q9H244	NA	NA	NA	NA	TICLOPIDINE HYDROCHLORIDE	Purinergic receptor P2Y12 antagonist	ANTAGONIST	1991	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	NA	P2RY12	M1
Q9H244	NA	NA	NA	NA	CANGRELOR TETRASODIUM	Purinergic receptor P2Y12 antagonist	ANTAGONIST	2015	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D009203: Myocardial Infarction,D013927: Thrombosis	P2RY12	M1
Q9H244	NA	NA	NA	NA	CLOPIDOGREL BISULFATE	Purinergic receptor P2Y12 antagonist	ANTAGONIST	1997	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D000789: Angina, Unstable,D001943: Breast Neoplasms,D003327: Coronary Disease,D006471: Gastrointestinal Hemorrhage,D007511: Ischemia,D009203: Myocardial Infarction,D020521: Stroke,D054058: Acute Coronary Syndrome,D058729: Peripheral Arterial Disease	P2RY12	M1
Q9H244	NA	NA	NA	NA	PRASUGREL HYDROCHLORIDE	Purinergic receptor P2Y12 antagonist	ANTAGONIST	2009	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D054058: Acute Coronary Syndrome	P2RY12	M1
P18054	NA	NA	NA	NA	BENOXAPROFEN	Arachidonate 12-lipoxygenase inhibitor	INHIBITOR	1982	CHEMBL3687	11134	P18054	Polyunsaturated fatty acid lipoxygenase ALOX12	Homo sapiens	D012216: Rheumatic Diseases	ALOX12	M1
P06239	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P06239	Tyrosine-protein kinase Lck	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	LCK	M1
P06239	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Tyrosine-protein kinase LCK inhibitor	INHIBITOR	2009	CHEMBL258	10140	P06239	Tyrosine-protein kinase Lck	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	LCK	M1
Q13547	NA	NA	NA	NA	VORINOSTAT	Histone deacetylase 1 inhibitor	INHIBITOR	2006	CHEMBL325	12697	Q13547	Histone deacetylase 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001005: Anus Neoplasms,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001927: Brain Diseases,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003424: Crohn Disease,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006689: Hodgkin Disease,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008527: Medulloblastoma,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D009542: Niemann-Pick Diseases,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012559: Schizophrenia,D012751: Sezary Syndrome,D013120: Spinal Cord Neoplasms,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D047748: Pituitary ACTH Hypersecretion,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	HDAC1	M1
Q13547	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q13547	Histone deacetylase 1	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC1	M1
Q13547	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q13547	Histone deacetylase 1	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC1	M1
Q13547	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q13547	Histone deacetylase 1	Homo sapiens	D009101: Multiple Myeloma	HDAC1	M1
P02751	NA	NA	NA	NA	OCRIPLASMIN	Fibronectin proteolytic enzyme	PROTEOLYTIC ENZYME	2010	CHEMBL3810	17040	P02751	Fibronectin	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	FN1	M1
O43920	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O43920	NADH dehydrogenase [ubiquinone] iron-sulfur protein 5	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFS5	M1
Q9UQL6	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9UQL6	Histone deacetylase 5	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC5	M1
Q9UQL6	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9UQL6	Histone deacetylase 5	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC5	M1
Q9UQL6	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9UQL6	Histone deacetylase 5	Homo sapiens	D009101: Multiple Myeloma	HDAC5	M1
O60894	NA	NA	NA	NA	PRAMLINTIDE ACETATE	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	2005	CHEMBL2111189	104908	O60894	Receptor activity-modifying protein 1	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity	RAMP1	M1
O14980	NA	NA	NA	NA	SELINEXOR	Exportin-1 inhibitor	INHIBITOR	2019	CHEMBL5661	101280	O14980	Exportin-1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D008080: Liposarcoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015179: Colorectal Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D017719: Diabetic Foot,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D045169: Severe Acute Respiratory Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	XPO1	M1
P09769	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P09769	Tyrosine-protein kinase Fgr	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FGR	M1
P40238	NA	NA	NA	NA	ROMIPLOSTIM	Thrombopoietin receptor agonist	AGONIST	2008	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D000741: Anemia, Aplastic,D002277: Carcinoma,D006470: Hemorrhage,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011696: Purpura, Thrombocytopenic,D011697: Purpura, Thrombotic Thrombocytopenic,D013921: Thrombocytopenia,D014923: Wiskott-Aldrich Syndrome,D016553: Purpura, Thrombocytopenic, Idiopathic	MPL	M1
P40238	NA	NA	NA	NA	AVATROMBOPAG	Thrombopoietin receptor agonist	AGONIST	2018	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D000741: Anemia, Aplastic,D001791: Blood Platelet Disorders,D006470: Hemorrhage,D008107: Liver Diseases,D013921: Thrombocytopenia,D016553: Purpura, Thrombocytopenic, Idiopathic	MPL	M1
P40238	NA	NA	NA	NA	AVATROMBOPAG MALEATE	Thrombopoietin receptor agonist	AGONIST	2018	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D013921: Thrombocytopenia	MPL	M1
P40238	NA	NA	NA	NA	LUSUTROMBOPAG	Thrombopoietin receptor agonist	AGONIST	2018	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D006470: Hemorrhage,D013921: Thrombocytopenia,D016553: Purpura, Thrombocytopenic, Idiopathic	MPL	M1
P40238	NA	NA	NA	NA	ELTROMBOPAG OLAMINE	Thrombopoietin receptor agonist	AGONIST	2008	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D000741: Anemia, Aplastic,D009190: Myelodysplastic Syndromes,D013921: Thrombocytopenia,D016553: Purpura, Thrombocytopenic, Idiopathic,D019698: Hepatitis C, Chronic	MPL	M1
Q13698	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1S	M1
Q13698	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1S	M1
Q13698	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1S	M1
Q13698	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1S	M1
Q13698	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1S	M1
Q13698	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1S	M1
Q13698	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1S	M1
Q13698	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1S	M1
Q13698	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1S	M1
Q13698	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	NA	CACNA1S	M1
Q13698	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1S	M1
Q13698	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1S	M1
Q13698	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	NA	CACNA1S	M1
Q13698	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1S	M1
Q13698	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	NA	CACNA1S	M1
Q13698	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	NA	CACNA1S	M1
Q13698	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D001281: Atrial Fibrillation	CACNA1S	M1
Q13698	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1S	M1
Q13698	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1S	M1
Q13698	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D006973: Hypertension	CACNA1S	M1
Q13698	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D006973: Hypertension	CACNA1S	M1
P43115	NA	NA	NA	NA	DINOPROSTONE	Prostaglandin E2 receptor agonist	AGONIST	1977	CHEMBL2363068	105763	P43115	Prostaglandin E2 receptor EP3 subtype	Homo sapiens	D010146: Pain,D011247: Pregnancy	PTGER3	M1
P43115	NA	NA	NA	NA	MISOPROSTOL	Prostanoid EP3 receptor agonist	AGONIST	1988	CHEMBL3710	10329	P43115	Prostaglandin E2 receptor EP3 subtype	Homo sapiens	D000022: Abortion, Spontaneous,D000027: Abortion, Incomplete,D003015: Clostridium Infections,D005764: Gastroesophageal Reflux,D006470: Hemorrhage,D006473: Postpartum Hemorrhage,D007239: Infections,D007889: Leiomyoma,D008595: Menorrhagia,D009120: Muscle Cramp,D009765: Obesity,D010003: Osteoarthritis,D010146: Pain,D010437: Peptic Ulcer,D011225: Pre-Eclampsia,D011247: Pregnancy,D013167: Spondylitis, Ankylosing,D013276: Stomach Ulcer,D014591: Uterine Diseases,D047928: Premature Birth	PTGER3	M1
P28221	NA	NA	NA	NA	SUMATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1992	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders,D009765: Obesity,D020325: Migraine with Aura,D020326: Migraine without Aura	HTR1D	M1
P28221	NA	NA	NA	NA	ZOLMITRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1997	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders	HTR1D	M1
P28221	NA	NA	NA	NA	AMISULPRIDE	Serotonin (5-HT) receptor antagonist	ANTAGONIST	2020	CHEMBL2096904	104841	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	HTR1D	M1
P28221	NA	NA	NA	NA	DIHYDROERGOTAMINE MESYLATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1946	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders	HTR1D	M1
P28221	NA	NA	NA	NA	ALMOTRIPTAN MALATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	2001	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders	HTR1D	M1
P28221	NA	NA	NA	NA	NARATRIPTAN HYDROCHLORIDE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1998	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D006261: Headache,D008881: Migraine Disorders	HTR1D	M1
P28221	NA	NA	NA	NA	ELETRIPTAN HYDROBROMIDE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	2002	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	NA	HTR1D	M1
P28221	NA	NA	NA	NA	RIZATRIPTAN BENZOATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1998	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura	HTR1D	M1
P28221	NA	NA	NA	NA	SUMATRIPTAN SUCCINATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1992	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura	HTR1D	M1
P28221	NA	NA	NA	NA	FENFLURAMINE HYDROCHLORIDE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	2020	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D004831: Epilepsies, Myoclonic,D020195: Epilepsy, Reflex	HTR1D	M1
P28221	NA	NA	NA	NA	FROVATRIPTAN SUCCINATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	2001	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	NA	HTR1D	M1
P28221	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1948	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders	HTR1D	M1
P21917	NA	NA	NA	NA	HALOPERIDOL	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	DRD4	M4
P21917	NA	NA	NA	NA	THIORIDAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	DRD4	M4
P21917	NA	NA	NA	NA	CHLORPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	DRD4	M4
P21917	NA	NA	NA	NA	OLANZAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1996	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	DRD4	M4
P21917	NA	NA	NA	NA	LOXAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	DRD4	M4
P21917	NA	NA	NA	NA	DROPERIDOL	D2-like dopamine receptor antagonist	ANTAGONIST	1970	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	DRD4	M4
P21917	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD4	M4
P21917	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M4
P21917	NA	NA	NA	NA	ROTIGOTINE	D2-like dopamine receptor agonist	AGONIST	2007	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000544: Alzheimer Disease,D005356: Fibromyalgia,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D020521: Stroke	DRD4	M4
P21917	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4	M4
P21917	NA	NA	NA	NA	APOMORPHINE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	2004	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D009369: Neoplasms,D010024: Osteoporosis,D010300: Parkinson Disease	DRD4	M4
P21917	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M4
P21917	NA	NA	NA	NA	LEVOMEPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1982	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4	M4
P21917	NA	NA	NA	NA	ROPINIROLE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D010300: Parkinson Disease	DRD4	M4
P21917	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1956	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M4
P21917	NA	NA	NA	NA	BROMOCRIPTINE MESYLATE	D2-like dopamine receptor agonist	AGONIST	1978	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000172: Acromegaly,D003924: Diabetes Mellitus, Type 2,D006966: Hyperprolactinemia,D007006: Hypogonadism,D007246: Infertility,D010300: Parkinson Disease	DRD4	M4
P21917	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M4
P21917	NA	NA	NA	NA	HALOPERIDOL DECANOATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1986	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4	M4
P21917	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1976	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M4
P21917	NA	NA	NA	NA	LOXAPINE SUCCINATE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M4
P21917	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1959	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M4
P21917	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD4	M4
P21917	NA	NA	NA	NA	PRAMIPEXOLE DIHYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D010300: Parkinson Disease	DRD4	M4
P21917	NA	NA	NA	NA	OLANZAPINE PAMOATE	D2-like dopamine receptor antagonist	ANTAGONIST	2009	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D012559: Schizophrenia	DRD4	M4
P21917	NA	NA	NA	NA	HALOPERIDOL LACTATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4	M4
P28065	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9	M4
P28065	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9	M4
P28065	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB9	M4
P01375	NA	NA	NA	NA	ETANERCEPT	TNF-alpha inhibitor	INHIBITOR	1998	CHEMBL1825	185	P01375	Tumor necrosis factor	Homo sapiens	D000544: Alzheimer Disease,D000686: Amyloidosis,D000855: Anorexia,D001168: Arthritis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001249: Asthma,D002100: Cachexia,D003882: Dermatomyositis,D003922: Diabetes Mellitus, Type 1,D005199: Fanconi Anemia,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D007249: Inflammation,D007938: Leukemia,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D008181: Lupus Nephritis,D009080: Mucocutaneous Lymph Node Syndrome,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010392: Pemphigus,D011014: Pneumonia,D011111: Polymyalgia Rheumatica,D011565: Psoriasis,D011658: Pulmonary Fibrosis,D011843: Radiculopathy,D012585: Sciatica,D012859: Sjogren's Syndrome,D013167: Spondylitis, Ankylosing,D013262: Stevens-Johnson Syndrome,D013280: Stomatitis,D013345: Subarachnoid Hemorrhage,D013585: Synovitis,D013705: Temporomandibular Joint Disorders,D014012: Tinnitus,D014581: Urticaria,D014820: Vitiligo,D014890: Granulomatosis with Polyangiitis,D015427: Reperfusion Injury,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D015658: HIV Infections,D017497: Hidradenitis Suppurativa,D018923: Persian Gulf Syndrome,D018979: Myositis, Inclusion Body,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	TNF	M4
P01375	NA	NA	NA	NA	ADALIMUMAB	TNF-alpha inhibitor	INHIBITOR	2002	CHEMBL1825	185	P01375	Tumor necrosis factor	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001528: Behcet Syndrome,D003092: Colitis,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D004387: Dupuytren Contracture,D005923: Glomerulosclerosis, Focal Segmental,D007154: Immune System Diseases,D007249: Inflammation,D009083: Mucopolysaccharidoses,D010003: Osteoarthritis,D011565: Psoriasis,D011711: Pyoderma,D012507: Sarcoidosis,D012585: Sciatica,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D013964: Thyroid Neoplasms,D014605: Uveitis,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa,D018856: Cystitis, Interstitial,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D056770: Netherton Syndrome,D057135: Wet Macular Degeneration	TNF	M4
P01375	NA	NA	NA	NA	INFLIXIMAB	TNF-alpha inhibitor	INHIBITOR	1998	CHEMBL1825	185	P01375	Tumor necrosis factor	Homo sapiens	D000855: Anorexia,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D001607: Berylliosis,D001714: Bipolar Disorder,D002100: Cachexia,D003092: Colitis,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003882: Dermatomyositis,D003922: Diabetes Mellitus, Type 1,D004715: Endometriosis,D005221: Fatigue,D006086: Graft vs Host Disease,D006105: Granulomatous Disease, Chronic,D006526: Hepatitis C,D007154: Immune System Diseases,D008175: Lung Neoplasms,D009080: Mucocutaneous Lymph Node Syndrome,D009190: Myelodysplastic Syndromes,D009220: Myositis,D010003: Osteoarthritis,D010267: Parapsoriasis,D010392: Pemphigus,D011111: Polymyalgia Rheumatica,D011565: Psoriasis,D012507: Sarcoidosis,D013167: Spondylitis, Ankylosing,D013262: Stevens-Johnson Syndrome,D013625: Takayasu Arteritis,D013700: Giant Cell Arteritis,D014890: Granulomatosis with Polyangiitis,D015212: Inflammatory Bowel Diseases,D015423: Scleritis,D015427: Reperfusion Injury,D015493: Paraparesis, Tropical Spastic,D015535: Arthritis, Psoriatic,D016918: Arthritis, Reactive,D017116: Low Back Pain,D017497: Hidradenitis Suppurativa,D019698: Hepatitis C, Chronic,D025242: Spondylarthropathies,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D055953: Microscopic Polyangiitis,D057135: Wet Macular Degeneration,D057765: Eosinophilic Esophagitis	TNF	M4
P01375	NA	NA	NA	NA	CERTOLIZUMAB PEGOL	TNF-alpha inhibitor	INHIBITOR	2008	CHEMBL1825	185	P01375	Tumor necrosis factor	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D007154: Immune System Diseases,D011565: Psoriasis,D013167: Spondylitis, Ankylosing,D015535: Arthritis, Psoriatic,D018856: Cystitis, Interstitial	TNF	M4
P01375	NA	NA	NA	NA	GOLIMUMAB	TNF-alpha inhibitor	INHIBITOR	2009	CHEMBL1825	185	P01375	Tumor necrosis factor	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001249: Asthma,D003093: Colitis, Ulcerative,D003922: Diabetes Mellitus, Type 1,D007154: Immune System Diseases,D007759: Labyrinth Diseases,D010003: Osteoarthritis,D012507: Sarcoidosis,D013167: Spondylitis, Ankylosing,D015535: Arthritis, Psoriatic,D025242: Spondylarthropathies	TNF	M4
P49720	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3	M4
P49720	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3	M4
P49720	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB3	M4
P43686	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC4	M4
P43686	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC4	M4
P43686	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC4	M4
P17948	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M4
P17948	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M4
P17948	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M4
P17948	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M4
P17948	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M4
P17948	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	FLT1	M4
P17948	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FLT1	M4
P17948	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	FLT1	M4
P17948	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P17948	Vascular endothelial growth factor receptor 1	Homo sapiens	NA	FLT1	M4
P24530	NA	NA	NA	NA	SITAXENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D011507: Proteinuria,D051436: Renal Insufficiency, Chronic,D054144: Heart Failure, Diastolic	EDNRB	M4
P24530	NA	NA	NA	NA	BOSENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2001	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004541: Eisenmenger Complex,D005334: Fever,D005901: Glaucoma,D006333: Heart Failure,D006344: Heart Septal Defects, Atrial,D006973: Hypertension,D006976: Hypertension, Pulmonary,D008103: Liver Cirrhosis,D008545: Melanoma,D008946: Mitral Valve Stenosis,D010190: Pancreatic Neoplasms,D010547: Persistent Fetal Circulation Syndrome,D012595: Scleroderma, Systemic,D014456: Ulcer,D018636: Hypoplastic Left Heart Syndrome,D018917: Optic Neuropathy, Ischemic,D020065: Hepatopulmonary Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M4
P24530	NA	NA	NA	NA	AMBRISENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2007	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D000532: Altitude Sickness,D000755: Anemia, Sickle Cell,D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D014652: Vascular Diseases,D018636: Hypoplastic Left Heart Syndrome,D045169: Severe Acute Respiratory Syndrome,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension	EDNRB	M4
P24530	NA	NA	NA	NA	MACITENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2010	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D005909: Glioblastoma,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D012595: Scleroderma, Systemic,D014456: Ulcer,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M4
P24530	NA	NA	NA	NA	SITAXENTAN SODIUM	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	NA	EDNRB	M4
P08572	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08572	Collagen alpha-2(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A2	M4
P08572	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08572	Collagen alpha-2(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A2	M4
P21709	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P21709	Ephrin type-A receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA1	M4
P00813	NA	NA	NA	NA	PENTOSTATIN	Adenosine deaminase inhibitor	INHIBITOR	1991	CHEMBL1910	14	P00813	Adenosine deaminase	Homo sapiens	D000755: Anemia, Sickle Cell,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell	ADA	M4
P28331	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	P28331	NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFS1	M4
P00742	NA	NA	NA	NA	RIVAROXABAN	Coagulation factor X inhibitor	INHIBITOR	2011	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D000082862: Aortic Valve Disease,D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D001281: Atrial Fibrillation,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006406: Hematoma,D006470: Hemorrhage,D007511: Ischemia,D008103: Liver Cirrhosis,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D009767: Obesity, Morbid,D011655: Pulmonary Embolism,D012214: Rheumatic Heart Disease,D013921: Thrombocytopenia,D013923: Thromboembolism,D013927: Thrombosis,D016736: Antiphospholipid Syndrome,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D058729: Peripheral Arterial Disease	F10	M4
P00742	NA	NA	NA	NA	APIXABAN	Coagulation factor X inhibitor	INHIBITOR	2012	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D001282: Atrial Flutter,D006406: Hematoma,D006470: Hemorrhage,D007511: Ischemia,D009404: Nephrotic Syndrome,D011655: Pulmonary Embolism,D013923: Thromboembolism,D013927: Thrombosis,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054092: Foramen Ovale, Patent,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054549: Takotsubo Cardiomyopathy,D054556: Venous Thromboembolism	F10	M4
P00742	NA	NA	NA	NA	BETRIXABAN	Coagulation factor X inhibitor	INHIBITOR	2017	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D001281: Atrial Fibrillation,D001282: Atrial Flutter,D006470: Hemorrhage,D007674: Kidney Diseases,D008107: Liver Diseases,D013923: Thromboembolism,D013927: Thrombosis,D054556: Venous Thromboembolism	F10	M4
P00742	NA	NA	NA	NA	EDOXABAN TOSYLATE	Coagulation factor X inhibitor	INHIBITOR	2015	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D001281: Atrial Fibrillation,D004617: Embolism,D011655: Pulmonary Embolism,D013927: Thrombosis,D020246: Venous Thrombosis,D020521: Stroke,D054556: Venous Thromboembolism	F10	M4
P00742	NA	NA	NA	NA	EMICIZUMAB	Coagulation factor IX and X other	OTHER	2017	CHEMBL2111424	104934	P00742	Coagulation factor X	Homo sapiens	D006467: Hemophilia A,D006470: Hemorrhage	F10	M4
P47871	NA	NA	NA	NA	GLUCAGON	Glucagon receptor agonist	AGONIST	1998	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003139: Common Cold,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D007003: Hypoglycemia,D009765: Obesity,D044903: Congenital Hyperinsulinism,D046768: Nesidioblastosis	GCGR	M4
P47871	NA	NA	NA	NA	GLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	AGONIST	1960	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D007003: Hypoglycemia	GCGR	M4
P47871	NA	NA	NA	NA	DASIGLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	AGONIST	2021	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D007003: Hypoglycemia	GCGR	M4
P05108	NA	NA	NA	NA	AMINOGLUTETHIMIDE	Cytochrome P450 11A1 inhibitor	INHIBITOR	1980	CHEMBL2033	32	P05108	Cholesterol side-chain cleavage enzyme, mitochondrial	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CYP11A1	M4
P05108	NA	NA	NA	NA	MITOTANE	Cytochrome P450 11A1 inhibitor	INHIBITOR	1970	CHEMBL2033	32	P05108	Cholesterol side-chain cleavage enzyme, mitochondrial	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D002277: Carcinoma,D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CYP11A1	M4
Q13936	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1C	M4
Q13936	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1C	M4
Q13936	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1C	M4
Q13936	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1C	M4
Q13936	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1C	M4
Q13936	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C	M4
Q13936	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1C	M4
Q13936	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1C	M4
Q13936	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1C	M4
Q13936	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M4
Q13936	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C	M4
Q13936	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1C	M4
Q13936	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M4
Q13936	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1C	M4
Q13936	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M4
Q13936	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M4
Q13936	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation	CACNA1C	M4
Q13936	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1C	M4
Q13936	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1C	M4
Q13936	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C	M4
Q13936	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C	M4
P27338	NA	NA	NA	NA	SAFINAMIDE MESYLATE	Monoamine oxidase B inhibitor	INHIBITOR	2017	CHEMBL2039	104	P27338	Amine oxidase [flavin-containing] B	Homo sapiens	D010300: Parkinson Disease	MAOB	M4
P27338	NA	NA	NA	NA	SELEGILINE	Monoamine oxidase B inhibitor	INHIBITOR	1989	CHEMBL2039	104	P27338	Amine oxidase [flavin-containing] B	Homo sapiens	D001883: Borderline Personality Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders	MAOB	M4
P27338	NA	NA	NA	NA	SAFINAMIDE	Monoamine oxidase B inhibitor	INHIBITOR	2017	CHEMBL2039	104	P27338	Amine oxidase [flavin-containing] B	Homo sapiens	D007674: Kidney Diseases,D008107: Liver Diseases,D010300: Parkinson Disease,D019578: Multiple System Atrophy	MAOB	M4
P27338	NA	NA	NA	NA	PARGYLINE HYDROCHLORIDE	Monoamine oxidase inhibitor	INHIBITOR	1982	CHEMBL2095205	104789	P27338	Amine oxidase [flavin-containing] B	Homo sapiens	NA	MAOB	M4
P27338	NA	NA	NA	NA	PHENELZINE SULFATE	Monoamine oxidase inhibitor	INHIBITOR	1961	CHEMBL2095205	104789	P27338	Amine oxidase [flavin-containing] B	Homo sapiens	D001943: Breast Neoplasms,D011471: Prostatic Neoplasms	MAOB	M4
P27338	NA	NA	NA	NA	SELEGILINE HYDROCHLORIDE	Monoamine oxidase B inhibitor	INHIBITOR	1989	CHEMBL2039	104	P27338	Amine oxidase [flavin-containing] B	Homo sapiens	D000544: Alzheimer Disease,D002189: Marijuana Abuse	MAOB	M4
P27338	NA	NA	NA	NA	RASAGILINE MESYLATE	Monoamine oxidase B inhibitor	INHIBITOR	2006	CHEMBL2039	104	P27338	Amine oxidase [flavin-containing] B	Homo sapiens	D010300: Parkinson Disease,D019578: Multiple System Atrophy	MAOB	M4
P27338	NA	NA	NA	NA	ISOCARBOXAZID	Monoamine oxidase inhibitor	INHIBITOR	1959	CHEMBL2095205	104789	P27338	Amine oxidase [flavin-containing] B	Homo sapiens	D000544: Alzheimer Disease,D003866: Depressive Disorder	MAOB	M4
P27338	NA	NA	NA	NA	TRANYLCYPROMINE SULFATE	Monoamine oxidase inhibitor	INHIBITOR	1961	CHEMBL2095205	104789	P27338	Amine oxidase [flavin-containing] B	Homo sapiens	NA	MAOB	M4
Q9BY41	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC8	M4
Q9BY41	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC8	M4
Q9BY41	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D009101: Multiple Myeloma	HDAC8	M4
P28223	NA	NA	NA	NA	CLOZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1989	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D003704: Dementia,D003866: Depressive Disorder,D008607: Intellectual Disability,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	HALOPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	HTR2A	M4
P28223	NA	NA	NA	NA	THIORIDAZINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1962	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	HTR2A	M4
P28223	NA	NA	NA	NA	CHLORPROMAZINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1957	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	HTR2A	M4
P28223	NA	NA	NA	NA	RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1993	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005879: Tourette Syndrome,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009293: Opioid-Related Disorders,D011618: Psychotic Disorders,D012559: Schizophrenia,D012569: Schizotypal Personality Disorder,D013313: Stress Disorders, Post-Traumatic,D015140: Dementia, Vascular,D015518: Rett Syndrome,D019955: Conduct Disorder,D019958: Attention Deficit and Disruptive Behavior Disorders,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome,D065886: Neurodevelopmental Disorders	HTR2A	M4
P28223	NA	NA	NA	NA	ILOPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D008107: Liver Diseases,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	HTR2A	M4
P28223	NA	NA	NA	NA	MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1996	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	HTR2A	M4
P28223	NA	NA	NA	NA	OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1996	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	HTR2A	M4
P28223	NA	NA	NA	NA	LOXAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1975	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	HTR2A	M4
P28223	NA	NA	NA	NA	CHLORPROTHIXENE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	DROPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	HTR2A	M4
P28223	NA	NA	NA	NA	ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2002	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000544: Alzheimer Disease,D000856: Anorexia Nervosa,D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005600: Fragile X Syndrome,D005879: Tourette Syndrome,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome	HTR2A	M4
P28223	NA	NA	NA	NA	THIOTHIXENE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders	HTR2A	M4
P28223	NA	NA	NA	NA	PIMOZIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1984	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	AMISULPRIDE	Serotonin (5-HT) receptor antagonist	ANTAGONIST	2020	CHEMBL2096904	104841	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	HTR2A	M4
P28223	NA	NA	NA	NA	PALIPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2006	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1957	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	MOLINDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1974	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1956	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	NEFAZODONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1994	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	CYCLOBENZAPRINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1977	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D002547: Cerebral Palsy,D008881: Migraine Disorders,D009128: Muscle Spasticity,D013035: Spasm,D013118: Spinal Cord Diseases,D063806: Myalgia	HTR2A	M4
P28223	NA	NA	NA	NA	TRAZODONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1981	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	HTR2A	M4
P28223	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1962	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1979	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	HALOPERIDOL DECANOATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1986	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	MESORIDAZINE BESYLATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1976	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	LOXAPINE SUCCINATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1975	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1959	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	ZIPRASIDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2001	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder	HTR2A	M4
P28223	NA	NA	NA	NA	LURASIDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2010	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	BREXPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2015	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012893: Sleep Wake Disorders,D013313: Stress Disorders, Post-Traumatic	HTR2A	M4
P28223	NA	NA	NA	NA	PALIPERIDONE PALMITATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	ARIPIPRAZOLE LAUROXIL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2015	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	CARPHENAZINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1982	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	PIMAVANSERIN TARTRATE	Serotonin 2a (5-HT2a) receptor inverse agonist	INVERSE AGONIST	2016	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000544: Alzheimer Disease,D010300: Parkinson Disease,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	QUETIAPINE FUMARATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1997	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000072861: Phobia, Social,D000437: Alcoholism,D001007: Anxiety,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009103: Multiple Sclerosis,D009497: Neurotic Disorders,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	HTR2A	M4
P28223	NA	NA	NA	NA	LUMATEPERONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2019	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000544: Alzheimer Disease,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	ASENAPINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	OLANZAPINE PAMOATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	THIOTHIXENE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M4
P28223	NA	NA	NA	NA	ZIPRASIDONE MESYLATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2002	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	HTR2A	M4
P28223	NA	NA	NA	NA	HALOPERIDOL LACTATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M4
P17658	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P17658	Potassium voltage-gated channel subfamily A member 6	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA6	M4
P17658	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P17658	Potassium voltage-gated channel subfamily A member 6	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA6	M4
P17658	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P17658	Potassium voltage-gated channel subfamily A member 6	Homo sapiens	NA	KCNA6	M4
P17658	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P17658	Potassium voltage-gated channel subfamily A member 6	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA6	M4
P62333	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6	M4
P62333	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6	M4
P62333	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC6	M4
P14784	NA	NA	NA	NA	DENILEUKIN DIFTITOX	Interleukin-2 receptor binding agent	BINDING AGENT	1999	CHEMBL2364167	106146	P14784	Interleukin-2 receptor subunit beta	Homo sapiens	D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male	IL2RB	M4
P14784	NA	NA	NA	NA	BASILIXIMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1998	CHEMBL2364167	106146	P14784	Interleukin-2 receptor subunit beta	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003093: Colitis, Ulcerative,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D004646: Emphysema,D005909: Glioblastoma,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007239: Infections,D007674: Kidney Diseases,D007683: Kidney Tubular Necrosis, Acute,D009101: Multiple Myeloma,D009369: Neoplasms,D014511: Uremia,D014605: Uveitis,D015427: Reperfusion Injury,D015470: Leukemia, Myeloid, Acute,D051436: Renal Insufficiency, Chronic	IL2RB	M4
P14784	NA	NA	NA	NA	ALDESLEUKIN	Interleukin-2 receptor agonist	AGONIST	1992	CHEMBL2364167	106146	P14784	Interleukin-2 receptor subunit beta	Homo sapiens	D000026: Abortion, Habitual,D000081483: Squamous Intraepithelial Lesions,D000163: Acquired Immunodeficiency Syndrome,D000506: Alopecia Areata,D000690: Amyotrophic Lateral Sclerosis,D000744: Anemia, Hemolytic, Autoimmune,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001528: Behcet Syndrome,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003093: Colitis, Ulcerative,D003327: Coronary Disease,D003424: Crohn Disease,D003449: Cryoglobulinemia,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D004660: Encephalitis,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009220: Myositis,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011081: Polychondritis, Relapsing,D011111: Polymyalgia Rheumatica,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012751: Sezary Syndrome,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D019337: Hematologic Neoplasms,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055501: Macrophage Activation Syndrome,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	IL2RB	M4
P14784	NA	NA	NA	NA	DACLIZUMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1997	CHEMBL2364167	106146	P14784	Interleukin-2 receptor subunit beta	Homo sapiens	D000741: Anemia, Aplastic,D001249: Asthma,D003093: Colitis, Ulcerative,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D011565: Psoriasis,D012010: Red-Cell Aplasia, Pure,D013921: Thrombocytopenia,D014605: Uveitis,D014890: Granulomatosis with Polyangiitis,D015658: HIV Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D051436: Renal Insufficiency, Chronic,D057135: Wet Macular Degeneration	IL2RB	M4
P32745	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR3	M4
P32745	NA	NA	NA	NA	PASIREOTIDE DIASPARTATE	Somatostatin receptor 3 agonist	AGONIST	2012	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	NA	SSTR3	M4
P32745	NA	NA	NA	NA	PASIREOTIDE PAMOATE	Somatostatin receptor 3 agonist	AGONIST	2014	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly	SSTR3	M4
P32745	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR3	M4
Q9Y5N1	NA	NA	NA	NA	PITOLISANT	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D000437: Alcoholism,D007674: Kidney Diseases,D009290: Narcolepsy,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D019966: Substance-Related Disorders	HRH3	M4
Q9Y5N1	NA	NA	NA	NA	PITOLISANT HYDROCHLORIDE	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D006970: Disorders of Excessive Somnolence,D009290: Narcolepsy	HRH3	M4
P29274	NA	NA	NA	NA	ADENOSINE	Adenosine receptor agonist	AGONIST	1989	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D007249: Inflammation,D007511: Ischemia,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D009369: Neoplasms,D010146: Pain,D012128: Respiratory Distress Syndrome,D013614: Tachycardia, Paroxysmal,D013617: Tachycardia, Supraventricular,D014927: Wolff-Parkinson-White Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D023921: Coronary Stenosis,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	ADORA2A	M4
P29274	NA	NA	NA	NA	CAFFEINE	Adenosine receptor antagonist	ANTAGONIST	1948	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D000860: Hypoxia,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001943: Breast Neoplasms,D003093: Colitis, Ulcerative,D003139: Common Cold,D003141: Communicable Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004417: Dyspnea,D006261: Headache,D007024: Hypotension, Orthostatic,D007383: Intermittent Claudication,D008545: Melanoma,D008881: Migraine Disorders,D009290: Narcolepsy,D009369: Neoplasms,D009765: Obesity,D010146: Pain,D010300: Parkinson Disease,D011565: Psoriasis,D013119: Spinal Cord Injuries,D014832: Voice Disorders,D015658: HIV Infections,D017116: Low Back Pain,D018781: Tension-Type Headache,D019547: Neck Pain,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A	M4
P29274	NA	NA	NA	NA	PENTOXIFYLLINE	Adenosine A2 receptor antagonist	ANTAGONIST	1984	CHEMBL2094257	104729	P29274	Adenosine receptor A2a	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A	M4
P29274	NA	NA	NA	NA	ISTRADEFYLLINE	Adenosine A2a receptor antagonist	ANTAGONIST	2019	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D008107: Liver Diseases,D010300: Parkinson Disease,D019966: Substance-Related Disorders	ADORA2A	M4
P29274	NA	NA	NA	NA	THEOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	ADORA2A	M4
P29274	NA	NA	NA	NA	OXTRIPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1981	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D008173: Lung Diseases, Obstructive	ADORA2A	M4
P29274	NA	NA	NA	NA	CAFFEINE, CITRATED	Adenosine receptor antagonist	ANTAGONIST	1999	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D001049: Apnea,D008107: Liver Diseases,D010146: Pain,D012178: Retinopathy of Prematurity,D047928: Premature Birth	ADORA2A	M4
P29274	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Adenosine receptor antagonist	ANTAGONIST	1982	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	NA	ADORA2A	M4
P29274	NA	NA	NA	NA	AMINOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	ADORA2A	M4
P29274	NA	NA	NA	NA	REGADENOSON	Adenosine A2a receptor agonist	AGONIST	2008	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D002318: Cardiovascular Diseases	ADORA2A	M4
Q9Y275	NA	NA	NA	NA	BELIMUMAB	Tumor necrosis factor ligand superfamily member 13B inhibitor	INHIBITOR	2011	CHEMBL2364158	106137	Q9Y275	Tumor necrosis factor ligand superfamily member 13B	Homo sapiens	D001172: Arthritis, Rheumatoid,D004646: Emphysema,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D007674: Kidney Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D009103: Multiple Sclerosis,D009220: Myositis,D012595: Scleroderma, Systemic,D012859: Sjogren's Syndrome,D014657: Vasculitis,D015433: Glomerulonephritis, Membranous,D016553: Purpura, Thrombocytopenic, Idiopathic	TNFSF13B	M4
P48551	NA	NA	NA	NA	INTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D000071960: Breast Carcinoma In Situ,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D003218: Condylomata Acuminata,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008103: Liver Cirrhosis,D008113: Liver Neoplasms,D008224: Lymphoma, Follicular,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012514: Sarcoma, Kaposi,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	IFNAR2	M4
P48551	NA	NA	NA	NA	INTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	1996	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D000544: Alzheimer Disease,D001249: Asthma,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D006526: Hepatitis C,D009102: Multiple Organ Failure,D009103: Multiple Sclerosis,D012128: Respiratory Distress Syndrome,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome	IFNAR2	M4
P48551	NA	NA	NA	NA	PEGINTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	2002	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001943: Breast Neoplasms,D003015: Clostridium Infections,D003110: Colonic Neoplasms,D003699: Hepatitis D,D003866: Depressive Disorder,D006505: Hepatitis,D006509: Hepatitis B,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007239: Infections,D007680: Kidney Neoplasms,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011087: Polycythemia Vera,D013920: Thrombocythemia, Essential,D013921: Thrombocytopenia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D055728: Primary Myelofibrosis	IFNAR2	M4
P48551	NA	NA	NA	NA	INTERFERON BETA-1B	Interferon alpha/beta receptor agonist	AGONIST	1993	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D009103: Multiple Sclerosis,D009202: Cardiomyopathies,D015658: HIV Infections,D018352: Coronavirus Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D045169: Severe Acute Respiratory Syndrome	IFNAR2	M4
P48551	NA	NA	NA	NA	INTERFERON ALFACON-1	Interferon alpha/beta receptor agonist	AGONIST	1997	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D006526: Hepatitis C,D007251: Influenza, Human,D019698: Hepatitis C, Chronic	IFNAR2	M4
P48551	NA	NA	NA	NA	PEGINTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	2001	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003397: Craniopharyngioma,D003699: Hepatitis D,D005185: Fallopian Tube Neoplasms,D005910: Glioma,D006258: Head and Neck Neoplasms,D006505: Hepatitis,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D012516: Osteosarcoma,D013920: Thrombocythemia, Essential,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D018281: Cholangiocarcinoma,D018318: Neurofibroma, Plexiform,D019337: Hematologic Neoplasms,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D020522: Lymphoma, Mantle-Cell,D055728: Primary Myelofibrosis	IFNAR2	M4
P48551	NA	NA	NA	NA	INTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D001528: Behcet Syndrome,D002292: Carcinoma, Renal Cell,D006526: Hepatitis C,D007680: Kidney Neoplasms,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011565: Psoriasis,D015658: HIV Infections,D019698: Hepatitis C, Chronic,D031300: Retinal Vasculitis,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	IFNAR2	M4
P48551	NA	NA	NA	NA	PEGINTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	2014	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	IFNAR2	M4
P48551	NA	NA	NA	NA	INTERFERON ALFA-N3	Interferon alpha/beta receptor agonist	AGONIST	1989	CHEMBL2364170	106149	P48551	Interferon alpha/beta receptor 2	Homo sapiens	D015658: HIV Infections,D045169: Severe Acute Respiratory Syndrome	IFNAR2	M4
P17181	NA	NA	NA	NA	INTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000071960: Breast Carcinoma In Situ,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D003218: Condylomata Acuminata,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008103: Liver Cirrhosis,D008113: Liver Neoplasms,D008224: Lymphoma, Follicular,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012514: Sarcoma, Kaposi,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	IFNAR1	M4
P17181	NA	NA	NA	NA	INTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	1996	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000544: Alzheimer Disease,D001249: Asthma,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D006526: Hepatitis C,D009102: Multiple Organ Failure,D009103: Multiple Sclerosis,D012128: Respiratory Distress Syndrome,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome	IFNAR1	M4
P17181	NA	NA	NA	NA	PEGINTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	2002	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001943: Breast Neoplasms,D003015: Clostridium Infections,D003110: Colonic Neoplasms,D003699: Hepatitis D,D003866: Depressive Disorder,D006505: Hepatitis,D006509: Hepatitis B,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007239: Infections,D007680: Kidney Neoplasms,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011087: Polycythemia Vera,D013920: Thrombocythemia, Essential,D013921: Thrombocytopenia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D055728: Primary Myelofibrosis	IFNAR1	M4
P17181	NA	NA	NA	NA	INTERFERON BETA-1B	Interferon alpha/beta receptor agonist	AGONIST	1993	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D009103: Multiple Sclerosis,D009202: Cardiomyopathies,D015658: HIV Infections,D018352: Coronavirus Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D045169: Severe Acute Respiratory Syndrome	IFNAR1	M4
P17181	NA	NA	NA	NA	INTERFERON ALFACON-1	Interferon alpha/beta receptor agonist	AGONIST	1997	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D006526: Hepatitis C,D007251: Influenza, Human,D019698: Hepatitis C, Chronic	IFNAR1	M4
P17181	NA	NA	NA	NA	PEGINTERFERON ALFA-2B	Interferon alpha/beta receptor agonist	AGONIST	2001	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D002276: Carcinoid Tumor,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003397: Craniopharyngioma,D003699: Hepatitis D,D005185: Fallopian Tube Neoplasms,D005910: Glioma,D006258: Head and Neck Neoplasms,D006505: Hepatitis,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D007938: Leukemia,D008103: Liver Cirrhosis,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D012516: Osteosarcoma,D013920: Thrombocythemia, Essential,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D018281: Cholangiocarcinoma,D018318: Neurofibroma, Plexiform,D019337: Hematologic Neoplasms,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D020522: Lymphoma, Mantle-Cell,D055728: Primary Myelofibrosis	IFNAR1	M4
P17181	NA	NA	NA	NA	INTERFERON ALFA-2A	Interferon alpha/beta receptor agonist	AGONIST	1986	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D001528: Behcet Syndrome,D002292: Carcinoma, Renal Cell,D006526: Hepatitis C,D007680: Kidney Neoplasms,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011565: Psoriasis,D015658: HIV Infections,D019698: Hepatitis C, Chronic,D031300: Retinal Vasculitis,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	IFNAR1	M4
P17181	NA	NA	NA	NA	PEGINTERFERON BETA-1A	Interferon alpha/beta receptor agonist	AGONIST	2014	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	IFNAR1	M4
P17181	NA	NA	NA	NA	INTERFERON ALFA-N3	Interferon alpha/beta receptor agonist	AGONIST	1989	CHEMBL2364170	106149	P17181	Interferon alpha/beta receptor 1	Homo sapiens	D015658: HIV Infections,D045169: Severe Acute Respiratory Syndrome	IFNAR1	M4
Q9H4B7	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB1	M4
Q9H4B7	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB1	M4
P27815	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE4A	M4
P27815	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE4A	M4
P27815	NA	NA	NA	NA	AMLEXANOX	Phosphodiesterase 4 inhibitor	INHIBITOR	1996	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D008173: Lung Diseases, Obstructive,D013280: Stomatitis	PDE4A	M4
P27815	NA	NA	NA	NA	ROFLUMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2011	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D001249: Asthma,D001987: Bronchiectasis,D003704: Dementia,D003865: Depressive Disorder, Major,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D008173: Lung Diseases, Obstructive,D008223: Lymphoma,D009369: Neoplasms,D009422: Nervous System Diseases,D009765: Obesity,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D060825: Cognitive Dysfunction,D065626: Non-alcoholic Fatty Liver Disease	PDE4A	M4
P27815	NA	NA	NA	NA	THEOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	PDE4A	M4
P27815	NA	NA	NA	NA	APREMILAST	Phosphodiesterase 4 inhibitor	INHIBITOR	2014	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000152: Acne Vulgaris,D000437: Alcoholism,D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D003093: Colitis, Ulcerative,D003872: Dermatitis,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004485: Eczema,D006073: Gout,D007154: Immune System Diseases,D008010: Lichen Planus,D008179: Lupus Erythematosus, Discoid,D011472: Prostatitis,D011565: Psoriasis,D012393: Rosacea,D013167: Spondylitis, Ankylosing,D013281: Stomatitis, Aphthous,D014605: Uveitis,D014820: Vitiligo,D015535: Arthritis, Psoriatic,D017449: Dermatitis, Allergic Contact,D017497: Hidradenitis Suppurativa,D017676: Lichen Planus, Oral,D045169: Severe Acute Respiratory Syndrome	PDE4A	M4
P27815	NA	NA	NA	NA	CRISABOROLE	Phosphodiesterase 4 inhibitor	INHIBITOR	2016	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000506: Alopecia Areata,D003872: Dermatitis,D003876: Dermatitis, Atopic,D004485: Eczema,D011565: Psoriasis,D012594: Scleroderma, Localized	PDE4A	M4
P27815	NA	NA	NA	NA	DYPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1951	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4A	M4
P27815	NA	NA	NA	NA	OXTRIPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1981	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE4A	M4
P27815	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Phosphodiesterase 4 inhibitor	INHIBITOR	1982	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	NA	PDE4A	M4
P27815	NA	NA	NA	NA	FLAVOXATE HYDROCHLORIDE	Phosphodiesterase 4 inhibitor	INHIBITOR	1970	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	NA	PDE4A	M4
P27815	NA	NA	NA	NA	AMINOPHYLLINE	Phosphodiesterase 4 inhibitor	INHIBITOR	1940	CHEMBL2093863	104679	P27815	cAMP-specific 3',5'-cyclic phosphodiesterase 4A	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	PDE4A	M4
Q13370	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE3B	M4
Q13370	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE3B	M4
Q13370	NA	NA	NA	NA	THEOPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1940	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	PDE3B	M4
Q13370	NA	NA	NA	NA	OXTRIPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1981	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D008173: Lung Diseases, Obstructive	PDE3B	M4
Q13370	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Phosphodiesterase 3 inhibitor	INHIBITOR	1982	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	NA	PDE3B	M4
Q13370	NA	NA	NA	NA	ANAGRELIDE HYDROCHLORIDE	Phosphodiesterase 3 inhibitor	INHIBITOR	1997	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D013920: Thrombocythemia, Essential,D013927: Thrombosis	PDE3B	M4
Q13370	NA	NA	NA	NA	AMINOPHYLLINE	Phosphodiesterase 3 inhibitor	INHIBITOR	1940	CHEMBL2094125	104707	Q13370	cGMP-inhibited 3',5'-cyclic phosphodiesterase B	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	PDE3B	M4
Q8TCU5	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN3A	M4
Q8TCU5	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN3A	M4
Q8TCU5	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN3A	M4
Q8TCU5	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN3A	M4
Q8TCU5	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN3A	M4
Q8TCU5	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D010146: Pain	GRIN3A	M4
Q8TCU5	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D010300: Parkinson Disease	GRIN3A	M4
Q8TCU5	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000437: Alcoholism	GRIN3A	M4
Q8TCU5	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN3A	M4
Q13882	NA	NA	NA	NA	VANDETANIB	Tyrosine-protein kinase BRK inhibitor	INHIBITOR	2011	CHEMBL4601	30026	Q13882	Protein-tyrosine kinase 6	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PTK6	M4
P28472	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRB3	M4
P28472	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRB3	M4
P28472	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRB3	M4
P28472	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy	GABRB3	M4
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRB3	M4
P28472	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRB3	M4
P28472	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D008881: Migraine Disorders	GABRB3	M4
P28472	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRB3	M4
P28472	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRB3	M4
P28472	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRB3	M4
P28472	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRB3	M4
P28472	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRB3	M4
P28472	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRB3	M4
P28472	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRB3	M4
P28472	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia	GABRB3	M4
P28472	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRB3	M4
P28472	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRB3	M4
P28472	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRB3	M4
P28472	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M4
P28472	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M4
P28472	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M4
P28472	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRB3	M4
P28472	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRB3	M4
P28472	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRB3	M4
P28472	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRB3	M4
P28472	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRB3	M4
P28472	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRB3	M4
P28472	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRB3	M4
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRB3	M4
P28472	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism	GABRB3	M4
P28472	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
P28472	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRB3	M4
P28472	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M4
Q99500	NA	NA	NA	NA	FINGOLIMOD HYDROCHLORIDE	Sphingosine 1-phosphate receptor agonist	AGONIST	2010	CHEMBL2363041	105736	Q99500	Sphingosine 1-phosphate receptor 3	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001943: Breast Neoplasms,D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting	S1PR3	M4
P62191	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P62191	26S proteasome regulatory subunit 4	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC1	M4
P62191	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P62191	26S proteasome regulatory subunit 4	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC1	M4
P62191	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P62191	26S proteasome regulatory subunit 4	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC1	M4
P07948	NA	NA	NA	NA	BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	INHIBITOR	2010	CHEMBL3905	11842	P07948	Tyrosine-protein kinase Lyn	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	LYN	M4
P07948	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P07948	Tyrosine-protein kinase Lyn	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	LYN	M4
P42345	NA	NA	NA	NA	PERHEXILINE MALEATE	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	1974	CHEMBL2842	11400	P42345	Serine/threonine-protein kinase mTOR	Homo sapiens	NA	MTOR	M4
Q969S8	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC10	M4
Q969S8	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC10	M4
Q969S8	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D009101: Multiple Myeloma	HDAC10	M4
P08123	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08123	Collagen alpha-2(I) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL1A2	M4
P08123	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08123	Collagen alpha-2(I) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL1A2	M4
Q15759	NA	NA	NA	NA	REGORAFENIB	MAP kinase p38 beta inhibitor	INHIBITOR	2012	CHEMBL3961	10120	Q15759	Mitogen-activated protein kinase 11	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	MAPK11	M4
P10912	NA	NA	NA	NA	SOMATREM	Growth hormone receptor agonist	AGONIST	1985	CHEMBL1976	60	P10912	Growth hormone receptor	Homo sapiens	NA	GHR	M4
P10912	NA	NA	NA	NA	PEGVISOMANT	Growth hormone receptor antagonist	ANTAGONIST	2003	CHEMBL1976	60	P10912	Growth hormone receptor	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D005359: Fibrous Dysplasia, Polyostotic,D008175: Lung Neoplasms,D010900: Pituitary Diseases,D011471: Prostatic Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms	GHR	M4
P10912	NA	NA	NA	NA	SOMATROPIN	Growth hormone receptor agonist	AGONIST	1976	CHEMBL1976	60	P10912	Growth hormone receptor	Homo sapiens	D000375: Aging,D000690: Amyotrophic Lateral Sclerosis,D001930: Brain Injuries,D002056: Burns,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D004392: Dwarfism,D004393: Dwarfism, Pituitary,D004700: Endocrine System Diseases,D005317: Fetal Growth Retardation,D006130: Growth Disorders,D006333: Heart Failure,D007018: Hypopituitarism,D007236: Infant, Small for Gestational Age,D007246: Infertility,D007247: Infertility, Female,D008103: Liver Cirrhosis,D009087: Mucopolysaccharidosis VI,D009134: Muscular Atrophy, Spinal,D009634: Noonan Syndrome,D009765: Obesity,D010013: Osteogenesis Imperfecta,D010900: Pituitary Diseases,D011218: Prader-Willi Syndrome,D012778: Short Bowel Syndrome,D013119: Spinal Cord Injuries,D013978: Tibial Fractures,D014424: Turner Syndrome,D015658: HIV Infections,D019247: HIV Wasting Syndrome,D020370: Osteoarthritis, Knee,D020391: Muscular Dystrophy, Facioscapulohumeral,D051436: Renal Insufficiency, Chronic,D052256: Tendinopathy,D055948: Sarcopenia,D060825: Cognitive Dysfunction	GHR	M4
P10912	NA	NA	NA	NA	SOMAPACITAN	Growth hormone receptor agonist	AGONIST	2020	CHEMBL1976	60	P10912	Growth hormone receptor	Homo sapiens	D004393: Dwarfism, Pituitary	GHR	M4
P08913	NA	NA	NA	NA	METHYLDOPA	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D006973: Hypertension,D011225: Pre-Eclampsia	ADRA2A	M4
P08913	NA	NA	NA	NA	CLONIDINE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001930: Brain Injuries,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002318: Cardiovascular Diseases,D002545: Brain Ischemia,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D005242: Fecal Incontinence,D005901: Glaucoma,D006556: Heroin Dependence,D006939: Hyperemesis Gravidarum,D006973: Hypertension,D007024: Hypotension, Orthostatic,D008881: Migraine Disorders,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009369: Neoplasms,D010146: Pain,D011183: Postoperative Complications,D011247: Pregnancy,D012600: Scoliosis,D013280: Stomatitis,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D054971: Orthostatic Intolerance	ADRA2A	M4
P08913	NA	NA	NA	NA	MIRTAZAPINE	Adrenergic receptor alpha-2 antagonist	ANTAGONIST	1996	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	ADRA2A	M4
P08913	NA	NA	NA	NA	LEVONORDEFRIN	Adrenergic receptor alpha-2 agonist	AGONIST	1960	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRA2A	M4
P08913	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1985	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	CLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D006973: Hypertension,D010146: Pain	ADRA2A	M4
P08913	NA	NA	NA	NA	NAPHAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1971	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003139: Common Cold,D007249: Inflammation,D007251: Influenza, Human,D011625: Pterygium	ADRA2A	M4
P08913	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRA2A	M4
P08913	NA	NA	NA	NA	TIZANIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001930: Brain Injuries,D008545: Melanoma,D009128: Muscle Spasticity,D011843: Radiculopathy	ADRA2A	M4
P08913	NA	NA	NA	NA	APRACLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1987	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	TETRAHYDROZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1979	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D007249: Inflammation,D011625: Pterygium	ADRA2A	M4
P08913	NA	NA	NA	NA	METHYLDOPATE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	GUANFACINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1986	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	ADRA2A	M4
P08913	NA	NA	NA	NA	GUANABENZ ACETATE	Adrenergic receptor alpha-2 agonist	AGONIST	1982	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	PHENOXYBENZAMINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	OXYMETAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1986	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D006255: Rhinitis, Allergic, Seasonal,D011305: Presbyopia,D012393: Rosacea	ADRA2A	M4
P08913	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	PHENTOLAMINE MESYLATE	Adrenergic receptor alpha antagonist	ANTAGONIST	1952	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA2A	M4
P08913	NA	NA	NA	NA	ALSEROXYLON	Adrenergic receptor alpha antagonist	ANTAGONIST	1982	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D010146: Pain	ADRA2A	M4
P08913	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRA2A	M4
P08913	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001249: Asthma	ADRA2A	M4
P08913	NA	NA	NA	NA	LOFEXIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	2018	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D009293: Opioid-Related Disorders,D013375: Substance Withdrawal Syndrome	ADRA2A	M4
P08913	NA	NA	NA	NA	BRIMONIDINE TARTRATE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D005483: Flushing,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006940: Hyperemia,D007429: Intraocular Pressure,D009798: Ocular Hypertension,D012393: Rosacea,D015352: Dry Eye Syndromes,D015715: Corneal Edema,D019973: Alcohol-Related Disorders,D060831: Hand-Foot Syndrome	ADRA2A	M4
P08913	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRA2A	M4
P08913	NA	NA	NA	NA	DEXMEDETOMIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1999	CHEMBL2095158	104743	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D000647: Amnesia,D001930: Brain Injuries,D010146: Pain,D011618: Psychotic Disorders,D012559: Schizophrenia	ADRA2A	M4
P08913	NA	NA	NA	NA	ERGOLOID MESYLATES	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	ADRA2A	M4
P08913	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Adrenergic receptor alpha agonist	AGONIST	1948	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D008881: Migraine Disorders	ADRA2A	M4
P08913	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P08913	Alpha-2A adrenergic receptor	Homo sapiens	NA	ADRA2A	M4
P08913	NA	NA	NA	NA	RAUWOLFIA SERPENTINA	Adrenergic receptor alpha antagonist	ANTAGONIST	1954	CHEMBL2095203	104787	P08913	Alpha-2A adrenergic receptor	Homo sapiens	D006331: Heart Diseases,D006973: Hypertension	ADRA2A	M4
Q9Y698	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNG2	M4
Q9Y698	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNG2	M4
Q9Y698	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	D002318: Cardiovascular Diseases	CACNG2	M4
Q9Y698	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	NA	CACNG2	M4
Q9Y698	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	NA	CACNG2	M4
Q9Y698	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q9Y698	Voltage-dependent calcium channel gamma-2 subunit	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNG2	M4
Q15054	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD3	M4
Q15054	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLD3	M4
Q15054	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLD3	M4
Q15054	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	Q15054	DNA polymerase delta subunit 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD3	M4
P31645	NA	NA	NA	NA	MAZINDOL	Monoamine transporter inhibitor	INHIBITOR	1973	CHEMBL2363064	105759	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009765: Obesity,D019970: Cocaine-Related Disorders	SLC6A4	M4
P31645	NA	NA	NA	NA	AMOXAPINE	Serotonin transporter inhibitor	INHIBITOR	1980	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A4	M4
P31645	NA	NA	NA	NA	DESVENLAFAXINE	Serotonin transporter inhibitor	INHIBITOR	2008	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D019698: Hepatitis C, Chronic	SLC6A4	M4
P31645	NA	NA	NA	NA	FLUVOXAMINE MALEATE	Serotonin transporter inhibitor	INHIBITOR	1994	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D009771: Obsessive-Compulsive Disorder,D016584: Panic Disorder,D045169: Severe Acute Respiratory Syndrome	SLC6A4	M4
P31645	NA	NA	NA	NA	IMIPRAMINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1959	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A4	M4
P31645	NA	NA	NA	NA	PAROXETINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1992	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001007: Anxiety,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D016584: Panic Disorder	SLC6A4	M4
P31645	NA	NA	NA	NA	SERTRALINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1991	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008607: Intellectual Disability,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder	SLC6A4	M4
P31645	NA	NA	NA	NA	ESCITALOPRAM OXALATE	Serotonin transporter inhibitor	INHIBITOR	2002	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001008: Anxiety Disorders,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D013119: Spinal Cord Injuries,D016584: Panic Disorder	SLC6A4	M4
P31645	NA	NA	NA	NA	DULOXETINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	2004	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001007: Anxiety,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D005356: Fibromyalgia,D009103: Multiple Sclerosis,D010003: Osteoarthritis,D010146: Pain,D013313: Stress Disorders, Post-Traumatic,D014549: Urinary Incontinence,D015179: Colorectal Neoplasms	SLC6A4	M4
P31645	NA	NA	NA	NA	PROTRIPTYLINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1967	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M4
P31645	NA	NA	NA	NA	NEFAZODONE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1994	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M4
P31645	NA	NA	NA	NA	CHLORPHENTERMINE HYDROCHLORIDE	Serotonin transporter substrate	SUBSTRATE	1982	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M4
P31645	NA	NA	NA	NA	PAROXETINE MESYLATE	Serotonin transporter inhibitor	INHIBITOR	2003	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D008593: Menopause,D019584: Hot Flashes	SLC6A4	M4
P31645	NA	NA	NA	NA	CLOMIPRAMINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1989	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A4	M4
P31645	NA	NA	NA	NA	CITALOPRAM HYDROBROMIDE	Serotonin transporter inhibitor	INHIBITOR	1998	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001321: Autistic Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D016584: Panic Disorder,D019584: Hot Flashes	SLC6A4	M4
P31645	NA	NA	NA	NA	TRAZODONE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1981	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	SLC6A4	M4
P31645	NA	NA	NA	NA	METHAMPHETAMINE HYDROCHLORIDE	Monoamine transporter inhibitor	INHIBITOR	1943	CHEMBL2363064	105759	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M4
P31645	NA	NA	NA	NA	AMITRIPTYLINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1961	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003866: Depressive Disorder,D010523: Peripheral Nervous System Diseases,D011537: Pruritus	SLC6A4	M4
P31645	NA	NA	NA	NA	VENLAFAXINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1993	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D000072861: Phobia, Social,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D008575: Meniere Disease,D009437: Neuralgia,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D016584: Panic Disorder,D019547: Neck Pain,D019584: Hot Flashes,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	SLC6A4	M4
P31645	NA	NA	NA	NA	FLUOXETINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1987	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D016584: Panic Disorder	SLC6A4	M4
P31645	NA	NA	NA	NA	NORTRIPTYLINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1964	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003876: Dermatitis, Atopic,D011565: Psoriasis,D018288: Carcinoma, Small Cell,D018589: Gastroparesis	SLC6A4	M4
P31645	NA	NA	NA	NA	DESVENLAFAXINE SUCCINATE	Serotonin transporter inhibitor	INHIBITOR	2008	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D005356: Fibromyalgia,D008593: Menopause,D019584: Hot Flashes	SLC6A4	M4
P31645	NA	NA	NA	NA	NOMIFENSINE MALEATE	Monoamine transporter inhibitor	INHIBITOR	1984	CHEMBL2363064	105759	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M4
P31645	NA	NA	NA	NA	VILAZODONE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	2011	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major	SLC6A4	M4
P31645	NA	NA	NA	NA	LEVOMILNACIPRAN HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	2013	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D000083242: Ischemic Stroke,D003865: Depressive Disorder, Major	SLC6A4	M4
P31645	NA	NA	NA	NA	VORTIOXETINE HYDROBROMIDE	Serotonin transporter inhibitor	INHIBITOR	2013	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major	SLC6A4	M4
P31645	NA	NA	NA	NA	LUMATEPERONE	Serotonin transporter inhibitor	INHIBITOR	2019	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D000544: Alzheimer Disease,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D012559: Schizophrenia	SLC6A4	M4
P31645	NA	NA	NA	NA	SIBUTRAMINE HYDROCHLORIDE	Monoamine transporter inhibitor	INHIBITOR	1997	CHEMBL2363064	105759	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D009765: Obesity	SLC6A4	M4
P31645	NA	NA	NA	NA	IMIPRAMINE PAMOATE	Serotonin transporter inhibitor	INHIBITOR	1973	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M4
P31645	NA	NA	NA	NA	DESVENLAFAXINE FUMARATE	Serotonin transporter inhibitor	INHIBITOR	2013	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major	SLC6A4	M4
P31645	NA	NA	NA	NA	MILNACIPRAN HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	2009	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001416: Back Pain,D005356: Fibromyalgia	SLC6A4	M4
P11387	NA	NA	NA	NA	SACITUZUMAB GOVITECAN	DNA topoisomerase I inhibitor	INHIBITOR	2020	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D016889: Endometrial Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TOP1	M4
P11387	NA	NA	NA	NA	IRINOTECAN HYDROCHLORIDE	DNA topoisomerase I inhibitor	INHIBITOR	1996	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001005: Anus Neoplasms,D001063: Appendiceal Neoplasms,D001254: Astrocytoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002276: Carcinoid Tumor,D002277: Carcinoma,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D003967: Diarrhea,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007012: Hypopharyngeal Neoplasms,D007119: Immunoblastic Lymphadenopathy,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008527: Medulloblastoma,D008545: Melanoma,D008579: Meningioma,D008637: Mesenchymoma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009503: Neutropenia,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018278: Carcinoma, Neuroendocrine,D018289: Carcinoma, Verrucous,D018304: Esthesioneuroblastoma, Olfactory,D018305: Ganglioneuroblastoma,D018308: Papilloma, Inverted,D018316: Gliosarcoma,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TOP1	M4
P11387	NA	NA	NA	NA	TRASTUZUMAB DERUXTECAN	DNA topoisomerase I inhibitor	INHIBITOR	2019	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004067: Digestive System Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms	TOP1	M4
P29317	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P29317	Ephrin type-A receptor 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA2	M4
P29317	NA	NA	NA	NA	DASATINIB	Ephrin type-A receptor 2 inhibitor	INHIBITOR	2006	CHEMBL2068	30008	P29317	Ephrin type-A receptor 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA2	M4
P29317	NA	NA	NA	NA	REGORAFENIB	Ephrin type-A receptor 2	INHIBITOR	2012	CHEMBL2068	30008	P29317	Ephrin type-A receptor 2	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	EPHA2	M4
P14679	NA	NA	NA	NA	MEQUINOL	Tyrosinase inhibitor	INHIBITOR	1999	CHEMBL1973	73	P14679	Tyrosinase	Homo sapiens	NA	TYR	M4
P14679	NA	NA	NA	NA	MONOBENZONE	Tyrosinase inhibitor	INHIBITOR	1952	CHEMBL1973	73	P14679	Tyrosinase	Homo sapiens	NA	TYR	M4
P26010	NA	NA	NA	NA	NATALIZUMAB	Integrin alpha-4/beta-7 inhibitor	INHIBITOR	2004	CHEMBL2095184	104768	P26010	Integrin beta-7	Homo sapiens	D000083242: Ischemic Stroke,D001172: Arthritis, Rheumatoid,D003424: Crohn Disease,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D012516: Osteosarcoma,D012559: Schizophrenia,D018979: Myositis, Inclusion Body,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	ITGB7	M4
P26010	NA	NA	NA	NA	VEDOLIZUMAB	Integrin alpha-4/beta-7 inhibitor	INHIBITOR	2014	CHEMBL2095184	104768	P26010	Integrin beta-7	Homo sapiens	D002446: Celiac Disease,D003092: Colitis,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D007154: Immune System Diseases,D007239: Infections,D008545: Melanoma,D015212: Inflammatory Bowel Diseases,D015658: HIV Infections	ITGB7	M4
Q99436	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M4
Q99436	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M4
Q99436	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB7	M4
P07451	CHEMBL18	1096	3295	DB00311	ETHOXZOLAMIDE	Carbonic anhydrase inhibitor	INHIBITOR	1982	CHEMBL2095180	104764	P07451	Carbonic anhydrase 3	Homo sapiens	NA	CA3	M4
P29320	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P29320	Ephrin type-A receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA3	M4
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1955	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001714: Bipolar Disorder,D005910: Glioma,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D012559: Schizophrenia,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020521: Stroke	SLC18A2	M4
Q05940	NA	NA	NA	NA	RESERPINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D002561: Cerebrovascular Disorders,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006937: Hypercholesterolemia,D006973: Hypertension,D006976: Hypertension, Pulmonary,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis	SLC18A2	M4
Q05940	NA	NA	NA	NA	TETRABENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2008	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders	SLC18A2	M4
Q05940	NA	NA	NA	NA	RESCINNAMINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1956	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D006973: Hypertension	SLC18A2	M4
Q05940	NA	NA	NA	NA	DESERPIDINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1957	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D006973: Hypertension	SLC18A2	M4
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE ADIPATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1975	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	NA	SLC18A2	M4
Q05940	NA	NA	NA	NA	LISDEXAMFETAMINE DIMESYLATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2007	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001068: Feeding and Eating Disorders,D001289: Attention Deficit Disorder with Hyperactivity,D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity,D012559: Schizophrenia,D052018: Bulimia Nervosa,D056912: Binge-Eating Disorder	SLC18A2	M4
Q05940	NA	NA	NA	NA	VALBENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders	SLC18A2	M4
Q05940	NA	NA	NA	NA	DUTETRABENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D002547: Cerebral Palsy,D002819: Chorea,D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders,D020821: Dystonic Disorders	SLC18A2	M4
Q05940	NA	NA	NA	NA	BENZPHETAMINE HYDROCHLORIDE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	NA	SLC18A2	M4
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE SULFATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC18A2	M4
Q05940	NA	NA	NA	NA	VALBENAZINE TOSYLATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D000071057: Tardive Dyskinesia	SLC18A2	M4
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE SACCHARATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1996	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC18A2	M4
P13631	CHEMBL4068170	2208081	24964084	NA	TRETINOIN	Retinoic acid receptor agonist	AGONIST	1971	CHEMBL2363069	105764	P13631	Retinoic acid receptor gamma	Homo sapiens	D000152: Acne Vulgaris,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004646: Emphysema,D006937: Hypercholesterolemia,D007680: Kidney Neoplasms,D007911: Lentigo,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008548: Melanosis,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009447: Neuroblastoma,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012393: Rosacea,D015209: Cholangitis, Sclerosing,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016553: Purpura, Thrombocytopenic, Idiopathic,D017495: Hyperpigmentation,D019337: Hematologic Neoplasms,D045169: Severe Acute Respiratory Syndrome,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	RARG	M4
P13631	NA	NA	NA	NA	ETRETINATE	Retinoid receptor agonist	AGONIST	1986	CHEMBL2363071	105766	P13631	Retinoic acid receptor gamma	Homo sapiens	D011565: Psoriasis	RARG	M4
P13631	NA	NA	NA	NA	ISOTRETINOIN	Retinoic acid receptor agonist	AGONIST	1982	CHEMBL2363069	105764	P13631	Retinoic acid receptor gamma	Homo sapiens	D000152: Acne Vulgaris,D000544: Alzheimer Disease,D001254: Astrocytoma,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002578: Uterine Cervical Dysplasia,D002583: Uterine Cervical Neoplasms,D004646: Emphysema,D004820: Epidermolysis Bullosa,D005909: Glioblastoma,D005910: Glioma,D005923: Glomerulosclerosis, Focal Segmental,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007057: Ichthyosis,D007239: Infections,D007680: Kidney Neoplasms,D007713: Klinefelter Syndrome,D007938: Leukemia,D008175: Lung Neoplasms,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D012393: Rosacea,D014008: Tinea Pedis,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D018305: Ganglioneuroblastoma,D018316: Gliosarcoma,D045169: Severe Acute Respiratory Syndrome,D053713: Azoospermia,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055623: Keratosis, Actinic,D064129: Prostatic Neoplasms, Castration-Resistant	RARG	M4
P13631	NA	NA	NA	NA	ALITRETINOIN	Retinoid receptor agonist	AGONIST	1999	CHEMBL2363071	105766	P13631	Retinoic acid receptor gamma	Homo sapiens	D001943: Breast Neoplasms,D004485: Eczema,D006229: Hand Dermatoses,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D009369: Neoplasms,D011565: Psoriasis	RARG	M4
P13631	NA	NA	NA	NA	ACITRETIN	Retinoid receptor agonist	AGONIST	1996	CHEMBL2363071	105766	P13631	Retinoic acid receptor gamma	Homo sapiens	D000544: Alzheimer Disease,D003872: Dermatitis,D008545: Melanoma,D011565: Psoriasis,D015658: HIV Infections	RARG	M4
P13631	NA	NA	NA	NA	ADAPALENE	Retinoic acid receptor agonist	AGONIST	1996	CHEMBL2363069	105764	P13631	Retinoic acid receptor gamma	Homo sapiens	D000152: Acne Vulgaris,D012871: Skin Diseases	RARG	M4
P13631	NA	NA	NA	NA	TAZAROTENE	Retinoic acid receptor agonist	AGONIST	1997	CHEMBL2363069	105764	P13631	Retinoic acid receptor gamma	Homo sapiens	D000152: Acne Vulgaris,D007911: Lentigo,D011565: Psoriasis,D012871: Skin Diseases,D012878: Skin Neoplasms,D016410: Lymphoma, T-Cell, Cutaneous,D017496: Hypopigmentation	RARG	M4
P13631	NA	NA	NA	NA	TRIFAROTENE	Retinoic acid receptor gamma agonist	AGONIST	2019	CHEMBL2003	240	P13631	Retinoic acid receptor gamma	Homo sapiens	D000152: Acne Vulgaris,D008223: Lymphoma	RARG	M4
Q8IWU9	NA	NA	NA	NA	TELOTRISTAT ETHYL	Tryptophan 5-hydroxylase inhibitor	INHIBITOR	2017	CHEMBL3831287	116867	Q8IWU9	Tryptophan 5-hydroxylase 2	Homo sapiens	D001661: Biliary Tract Neoplasms,D002275: Carcinoid Heart Disease,D008107: Liver Diseases,D008303: Malignant Carcinoid Syndrome,D018358: Neuroendocrine Tumors	TPH2	M4
Q8IWU9	NA	NA	NA	NA	TELOTRISTAT ETIPRATE	Tryptophan 5-hydroxylase inhibitor	INHIBITOR	2017	CHEMBL3831287	116867	Q8IWU9	Tryptophan 5-hydroxylase 2	Homo sapiens	D003967: Diarrhea	TPH2	M4
P08588	NA	NA	NA	NA	ATENOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1981	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002561: Cerebrovascular Disorders,D006331: Heart Diseases,D006333: Heart Failure,D006391: Hemangioma,D006973: Hypertension,D008382: Marfan Syndrome,D008946: Mitral Valve Stenosis,D009203: Myocardial Infarction,D010024: Osteoporosis,D013313: Stress Disorders, Post-Traumatic,D017202: Myocardial Ischemia,D017379: Hypertrophy, Left Ventricular,D060050: Angina, Stable	ADRB1	M4
P08588	NA	NA	NA	NA	TIMOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB1	M4
P08588	NA	NA	NA	NA	PINDOLOL	Beta-1 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB1	M4
P08588	NA	NA	NA	NA	NADOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB1	M4
P08588	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB1	M4
P08588	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB1	M4
P08588	NA	NA	NA	NA	DOPAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1974	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010300: Parkinson Disease	ADRB1	M4
P08588	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB1	M4
P08588	NA	NA	NA	NA	BETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension	ADRB1	M4
P08588	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1	M4
P08588	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB1	M4
P08588	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB1	M4
P08588	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	ACEBUTOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001145: Arrhythmias, Cardiac,D006973: Hypertension	ADRB1	M4
P08588	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	LEVOBETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2000	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D009798: Ocular Hypertension	ADRB1	M4
P08588	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB1	M4
P08588	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB1	M4
P08588	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1	M4
P08588	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB1	M4
P08588	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB1	M4
P08588	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB1	M4
P08588	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1990	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB1	M4
P08588	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB1	M4
P08588	NA	NA	NA	NA	BISOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D020388: Muscular Dystrophy, Duchenne	ADRB1	M4
P08588	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB1	M4
P08588	NA	NA	NA	NA	METOPROLOL TARTRATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006331: Heart Diseases,D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction	ADRB1	M4
P08588	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB1	M4
P08588	NA	NA	NA	NA	METOPROLOL SUCCINATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000787: Angina Pectoris,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D002312: Cardiomyopathy, Hypertrophic,D006333: Heart Failure,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008944: Mitral Valve Insufficiency,D029424: Pulmonary Disease, Chronic Obstructive	ADRB1	M4
P08588	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
P08588	NA	NA	NA	NA	METOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M4
Q00975	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1B	M4
Q00975	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1B	M4
Q00975	NA	NA	NA	NA	LEVETIRACETAM	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	1999	CHEMBL4478	10511	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001037: Aphasia,D001714: Bipolar Disorder,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D005909: Glioblastoma,D005910: Glioma,D006562: Herpes Zoster,D009069: Movement Disorders,D009293: Opioid-Related Disorders,D009447: Neuroblastoma,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D011115: Polyneuropathies,D011618: Psychotic Disorders,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D013375: Substance Withdrawal Syndrome,D014103: Torticollis,D015470: Leukemia, Myeloid, Acute,D016584: Panic Disorder,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020329: Essential Tremor,D020521: Stroke,D060825: Cognitive Dysfunction	CACNA1B	M4
Q00975	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1B	M4
Q00975	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	NA	CACNA1B	M4
Q00975	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	NA	CACNA1B	M4
Q00975	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1B	M4
Q00975	NA	NA	NA	NA	ZICONOTIDE ACETATE	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	2004	CHEMBL4478	10511	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D005334: Fever,D010146: Pain	CACNA1B	M4
Q00975	NA	NA	NA	NA	ZICONOTIDE	Voltage-gated N-type calcium channel alpha-1B subunit blocker	BLOCKER	2004	CHEMBL4478	10511	Q00975	Voltage-dependent N-type calcium channel subunit alpha-1B	Homo sapiens	D005334: Fever,D010146: Pain	CACNA1B	M4
O60840	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1F	M4
O60840	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1F	M4
O60840	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1F	M4
O60840	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1F	M4
O60840	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1F	M4
O60840	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1F	M4
O60840	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1F	M4
O60840	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1F	M4
O60840	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1F	M4
O60840	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	NA	CACNA1F	M4
O60840	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1F	M4
O60840	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1F	M4
O60840	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	NA	CACNA1F	M4
O60840	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1F	M4
O60840	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	NA	CACNA1F	M4
O60840	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	NA	CACNA1F	M4
O60840	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D001281: Atrial Fibrillation	CACNA1F	M4
O60840	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1F	M4
O60840	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1F	M4
O60840	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D006973: Hypertension	CACNA1F	M4
O60840	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D006973: Hypertension	CACNA1F	M4
P23786	NA	NA	NA	NA	PERHEXILINE MALEATE	Carnitine palmitoyltransferase 2 inhibitor	INHIBITOR	1974	CHEMBL3238	10765	P23786	Carnitine O-palmitoyltransferase 2, mitochondrial	Homo sapiens	NA	CPT2	M4
P09758	NA	NA	NA	NA	SACITUZUMAB GOVITECAN	Tumor-associated calcium signal transducer 2 binding agent	BINDING AGENT	2020	CHEMBL3856163	116939	P09758	Tumor-associated calcium signal transducer 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D016889: Endometrial Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TACSTD2	M4
P51679	NA	NA	NA	NA	MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CROSS-LINKING AGENT	2018	CHEMBL2414	10579	P51679	C-C chemokine receptor type 4	Homo sapiens	D001249: Asthma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D006528: Carcinoma, Hepatocellular,D009182: Mycosis Fungoides,D009369: Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D015493: Paraparesis, Tropical Spastic,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral	CCR4	M4
Q9UIX4	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG1	M4
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG1	M4
Q9UIX4	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	NA	KCNG1	M4
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG1	M4
P05091	NA	NA	NA	NA	DISULFIRAM	Aldehyde dehydrogenase inhibitor	INHIBITOR	1951	CHEMBL1935	30	P05091	Aldehyde dehydrogenase, mitochondrial	Homo sapiens	D000437: Alcoholism,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004478: Ectoparasitic Infestations,D005909: Glioblastoma,D008545: Melanoma,D009101: Multiple Myeloma,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D015658: HIV Infections,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	ALDH2	M4
Q9H2M3	NA	NA	NA	NA	BETAINE	Betaine-homocysteine S-methyltransferase substrate	SUBSTRATE	1996	CHEMBL3391661	109554	Q9H2M3	S-methylmethionine--homocysteine S-methyltransferase BHMT2	Homo sapiens	D003866: Depressive Disorder,D006526: Hepatitis C,D006712: Homocystinuria,D006960: Hyperoxaluria, Primary,D007248: Infertility, Male,D009765: Obesity,D019698: Hepatitis C, Chronic,D065626: Non-alcoholic Fatty Liver Disease	BHMT2	M4
P01031	NA	NA	NA	NA	ECULIZUMAB	Complement C5 inhibitor	INHIBITOR	2007	CHEMBL2364163	106142	P01031	Complement C5	Homo sapiens	D003882: Dermatomyositis,D003920: Diabetes Mellitus,D006086: Graft vs Host Disease,D006457: Hemoglobinuria, Paroxysmal,D006461: Hemolysis,D006463: Hemolytic-Uremic Syndrome,D007154: Immune System Diseases,D007938: Leukemia,D008268: Macular Degeneration,D009157: Myasthenia Gravis,D009471: Neuromyelitis Optica,D013921: Thrombocytopenia,D015432: Glomerulonephritis, Membranoproliferative,D020275: Guillain-Barre Syndrome,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis,D058625: End Stage Liver Disease,D065766: Atypical Hemolytic Uremic Syndrome	C5	M4
P01031	NA	NA	NA	NA	RAVULIZUMAB	Complement C5 inhibitor	INHIBITOR	2018	CHEMBL2364163	106142	P01031	Complement C5	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D006457: Hemoglobinuria, Paroxysmal,D007154: Immune System Diseases,D009157: Myasthenia Gravis,D009471: Neuromyelitis Optica,D011024: Pneumonia, Viral,D012128: Respiratory Distress Syndrome,D055371: Acute Lung Injury,D057049: Thrombotic Microangiopathies,D065766: Atypical Hemolytic Uremic Syndrome	C5	M4
P14416	NA	NA	NA	NA	CLOZAPINE	Dopamine D2 receptor antagonist	ANTAGONIST	1989	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D003704: Dementia,D003866: Depressive Disorder,D008607: Intellectual Disability,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	HALOPERIDOL	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	DRD2	M4
P14416	NA	NA	NA	NA	THIORIDAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	DRD2	M4
P14416	NA	NA	NA	NA	CHLORPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	DRD2	M4
P14416	NA	NA	NA	NA	RISPERIDONE	Dopamine D2 receptor antagonist	ANTAGONIST	1993	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005879: Tourette Syndrome,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009293: Opioid-Related Disorders,D011618: Psychotic Disorders,D012559: Schizophrenia,D012569: Schizotypal Personality Disorder,D013313: Stress Disorders, Post-Traumatic,D015140: Dementia, Vascular,D015518: Rett Syndrome,D019955: Conduct Disorder,D019958: Attention Deficit and Disruptive Behavior Disorders,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome,D065886: Neurodevelopmental Disorders	DRD2	M4
P14416	NA	NA	NA	NA	ILOPERIDONE	Dopamine D2 receptor antagonist	ANTAGONIST	2009	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D008107: Liver Diseases,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	DRD2	M4
P14416	NA	NA	NA	NA	PERPHENAZINE	Dopamine D2 receptor antagonist	ANTAGONIST	1957	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D019970: Cocaine-Related Disorders	DRD2	M4
P14416	NA	NA	NA	NA	TRIFLUPROMAZINE	Dopamine D2 receptor antagonist	ANTAGONIST	1957	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders	DRD2	M4
P14416	NA	NA	NA	NA	REMOXIPRIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1990	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders	DRD2	M4
P14416	NA	NA	NA	NA	OLANZAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1996	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	DRD2	M4
P14416	NA	NA	NA	NA	PROCHLORPERAZINE	Dopamine D2 receptor antagonist	ANTAGONIST	1956	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D006261: Headache,D008881: Migraine Disorders,D009325: Nausea,D011618: Psychotic Disorders,D020250: Postoperative Nausea and Vomiting,D066126: Cardiotoxicity	DRD2	M4
P14416	NA	NA	NA	NA	LOXAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	DRD2	M4
P14416	NA	NA	NA	NA	CHLORPROTHIXENE	Dopamine D2 receptor antagonist	ANTAGONIST	1967	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	DROPERIDOL	D2-like dopamine receptor antagonist	ANTAGONIST	1970	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	DRD2	M4
P14416	NA	NA	NA	NA	ARIPIPRAZOLE	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	2002	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000544: Alzheimer Disease,D000856: Anorexia Nervosa,D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005600: Fragile X Syndrome,D005879: Tourette Syndrome,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome	DRD2	M4
P14416	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P14416	D(2) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD2	M4
P14416	NA	NA	NA	NA	THIOTHIXENE	Dopamine D2 receptor antagonist	ANTAGONIST	1967	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders	DRD2	M4
P14416	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	ROTIGOTINE	D2-like dopamine receptor agonist	AGONIST	2007	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000544: Alzheimer Disease,D005356: Fibromyalgia,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D020521: Stroke	DRD2	M4
P14416	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P14416	D(2) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	AMISULPRIDE	Dopamine receptors; D2 & D3 antagonist	ANTAGONIST	2020	CHEMBL2095169	104754	P14416	D(2) dopamine receptor	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	DRD2	M4
P14416	NA	NA	NA	NA	APOMORPHINE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	2004	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D009369: Neoplasms,D010024: Osteoporosis,D010300: Parkinson Disease	DRD2	M4
P14416	NA	NA	NA	NA	PALIPERIDONE	Dopamine D2 receptor antagonist	ANTAGONIST	2006	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	LEVOMEPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1982	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	ROPINIROLE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D010300: Parkinson Disease	DRD2	M4
P14416	NA	NA	NA	NA	MOLINDONE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1974	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1956	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	BROMOCRIPTINE MESYLATE	D2-like dopamine receptor agonist	AGONIST	1978	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000172: Acromegaly,D003924: Diabetes Mellitus, Type 2,D006966: Hyperprolactinemia,D007006: Hypogonadism,D007246: Infertility,D010300: Parkinson Disease	DRD2	M4
P14416	NA	NA	NA	NA	BENZQUINAMIDE HYDROCHLORIDE	Dopamine D2 receptor modulator	MODULATOR	1974	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	FLUPHENAZINE DECANOATE	Dopamine D2 receptor antagonist	ANTAGONIST	1972	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011565: Psoriasis,D011618: Psychotic Disorders	DRD2	M4
P14416	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	METOCLOPRAMIDE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1979	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D014839: Vomiting,D020250: Postoperative Nausea and Vomiting	DRD2	M4
P14416	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1979	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	FLUPHENAZINE ENANTHATE	Dopamine D2 receptor antagonist	ANTAGONIST	1967	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011565: Psoriasis,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	HALOPERIDOL DECANOATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1986	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	MESORIDAZINE BESYLATE	Dopamine D2 receptor antagonist	ANTAGONIST	1970	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1976	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	CABERGOLINE	Dopamine D2 receptor agonist	AGONIST	1996	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003920: Diabetes Mellitus,D004715: Endometriosis,D007246: Infertility,D009765: Obesity,D010145: Paget Disease, Extramammary,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D016471: Ovarian Hyperstimulation Syndrome,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D047748: Pituitary ACTH Hypersecretion	DRD2	M4
P14416	NA	NA	NA	NA	TRIFLUPROMAZINE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1957	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	PROCHLORPERAZINE EDISYLATE	Dopamine D2 receptor antagonist	ANTAGONIST	1957	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	LOXAPINE SUCCINATE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1959	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	PROCHLORPERAZINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1956	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	ZIPRASIDONE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	2001	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder	DRD2	M4
P14416	NA	NA	NA	NA	FLUPHENAZINE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1959	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D009101: Multiple Myeloma	DRD2	M4
P14416	NA	NA	NA	NA	LURASIDONE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	2010	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	CARIPRAZINE HYDROCHLORIDE	Dopamine D2 receptor modulator	MODULATOR	2015	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	VERALIPRIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1979	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders	DRD2	M4
P14416	NA	NA	NA	NA	BREXPIPRAZOLE	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	2015	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012893: Sleep Wake Disorders,D013313: Stress Disorders, Post-Traumatic	DRD2	M4
P14416	NA	NA	NA	NA	PALIPERIDONE PALMITATE	Dopamine D2 receptor antagonist	ANTAGONIST	2009	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	ARIPIPRAZOLE LAUROXIL	Dopamine D2 receptor partial agonist	PARTIAL AGONIST	2015	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P14416	D(2) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD2	M4
P14416	NA	NA	NA	NA	CARPHENAZINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1982	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	THIETHYLPERAZINE MALATE	Dopamine D2 receptor antagonist	ANTAGONIST	1961	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	ACETOPHENAZINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1961	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	PRAMIPEXOLE DIHYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D010300: Parkinson Disease	DRD2	M4
P14416	NA	NA	NA	NA	QUETIAPINE FUMARATE	Dopamine D2 receptor antagonist	ANTAGONIST	1997	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000072861: Phobia, Social,D000437: Alcoholism,D001007: Anxiety,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009103: Multiple Sclerosis,D009497: Neurotic Disorders,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	DRD2	M4
P14416	NA	NA	NA	NA	LUMATEPERONE	Dopamine D2 receptor antagonist	ANTAGONIST	2019	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D000544: Alzheimer Disease,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	ASENAPINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	2009	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	THIETHYLPERAZINE MALEATE	Dopamine D2 receptor antagonist	ANTAGONIST	1961	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	REMOXIPRIDE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1990	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	OLANZAPINE PAMOATE	D2-like dopamine receptor antagonist	ANTAGONIST	2009	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	THIOTHIXENE HYDROCHLORIDE	Dopamine D2 receptor antagonist	ANTAGONIST	1970	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	NA	DRD2	M4
P14416	NA	NA	NA	NA	ZIPRASIDONE MESYLATE	Dopamine D2 receptor antagonist	ANTAGONIST	2002	CHEMBL217	72	P14416	D(2) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	DRD2	M4
P14416	NA	NA	NA	NA	HALOPERIDOL LACTATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P14416	D(2) dopamine receptor	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD2	M4
P25103	NA	NA	NA	NA	NETUPITANT	Neurokinin 1 receptor antagonist	ANTAGONIST	2014	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D009369: Neoplasms,D020250: Postoperative Nausea and Vomiting	TACR1	M4
P25103	NA	NA	NA	NA	APREPITANT	Neurokinin 1 receptor antagonist	ANTAGONIST	2003	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D000437: Alcoholism,D002189: Marijuana Abuse,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D005909: Glioblastoma,D006556: Heroin Dependence,D009101: Multiple Myeloma,D009293: Opioid-Related Disorders,D009325: Nausea,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010146: Pain,D011537: Pruritus,D014839: Vomiting,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D018589: Gastroparesis,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D045169: Severe Acute Respiratory Syndrome	TACR1	M4
P25103	NA	NA	NA	NA	FOSAPREPITANT DIMEGLUMINE	Neurokinin 1 receptor antagonist	ANTAGONIST	2008	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D012509: Sarcoma,D020250: Postoperative Nausea and Vomiting	TACR1	M4
P25103	NA	NA	NA	NA	ROLAPITANT HYDROCHLORIDE	Neurokinin 1 receptor antagonist	ANTAGONIST	2015	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D012509: Sarcoma,D020250: Postoperative Nausea and Vomiting	TACR1	M4
P25103	NA	NA	NA	NA	FOSNETUPITANT CHLORIDE HYDROCHLORIDE	Neurokinin 1 receptor antagonist	ANTAGONIST	2018	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D014839: Vomiting	TACR1	M4
P48169	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA4	M4
P48169	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA4	M4
P48169	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA4	M4
P48169	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy	GABRA4	M4
P48169	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA4	M4
P48169	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA4	M4
P48169	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D008881: Migraine Disorders	GABRA4	M4
P48169	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA4	M4
P48169	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA4	M4
P48169	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA4	M4
P48169	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA4	M4
P48169	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA4	M4
P48169	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA4	M4
P48169	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA4	M4
P48169	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia	GABRA4	M4
P48169	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA4	M4
P48169	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA4	M4
P48169	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA4	M4
P48169	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4	M4
P48169	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4	M4
P48169	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4	M4
P48169	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA4	M4
P48169	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA4	M4
P48169	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA4	M4
P48169	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA4	M4
P48169	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA4	M4
P48169	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA4	M4
P48169	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA4	M4
P48169	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA4	M4
P48169	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism	GABRA4	M4
P48169	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
P48169	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA4	M4
P48169	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M4
Q9UBN1	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNG4	M4
Q9UBN1	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNG4	M4
Q9UBN1	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D002318: Cardiovascular Diseases	CACNG4	M4
Q9UBN1	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	NA	CACNG4	M4
Q9UBN1	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	NA	CACNG4	M4
Q9UBN1	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q9UBN1	Voltage-dependent calcium channel gamma-4 subunit	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNG4	M4
P07327	NA	NA	NA	NA	FOMEPIZOLE	Alcohol dehydrogenase class I inhibitor	INHIBITOR	1997	CHEMBL2363044	105739	P07327	Alcohol dehydrogenase 1A	Homo sapiens	D008268: Macular Degeneration	ADH1A	M4
P06276	NA	NA	NA	NA	RIVASTIGMINE	Cholinesterases; ACHE & BCHE inhibitor	INHIBITOR	2000	CHEMBL2095233	104805	P06276	Cholinesterase	Homo sapiens	D000544: Alzheimer Disease,D001007: Anxiety,D001930: Brain Injuries,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D004314: Down Syndrome,D010300: Parkinson Disease,D012559: Schizophrenia,D013494: Supranuclear Palsy, Progressive,D015140: Dementia, Vascular,D019954: Neurobehavioral Manifestations,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D060825: Cognitive Dysfunction	BCHE	M4
P06276	NA	NA	NA	NA	RIVASTIGMINE TARTRATE	Cholinesterases; ACHE & BCHE inhibitor	INHIBITOR	2000	CHEMBL2095233	104805	P06276	Cholinesterase	Homo sapiens	D003704: Dementia,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease	BCHE	M4
P06276	NA	NA	NA	NA	TACRINE HYDROCHLORIDE	Cholinesterases; ACHE & BCHE inhibitor	INHIBITOR	1993	CHEMBL2095233	104805	P06276	Cholinesterase	Homo sapiens	NA	BCHE	M4
Q14957	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN2C	M4
Q14957	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN2C	M4
Q14957	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN2C	M4
Q14957	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN2C	M4
Q14957	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN2C	M4
Q14957	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D010146: Pain	GRIN2C	M4
Q14957	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D010300: Parkinson Disease	GRIN2C	M4
Q14957	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D000437: Alcoholism	GRIN2C	M4
Q14957	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q14957	Glutamate receptor ionotropic, NMDA 2C	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN2C	M4
Q9NSA0	NA	NA	NA	NA	PROBENECID	Solute carrier family 22 member 11 inhibitor	INHIBITOR	1951	CHEMBL2073677	104618	Q9NSA0	Solute carrier family 22 member 11	Homo sapiens	D000437: Alcoholism,D001930: Brain Injuries,D002481: Cellulitis,D002805: Chondrocalcinosis,D003924: Diabetes Mellitus, Type 2,D005585: Influenza in Birds,D006073: Gout,D006333: Heart Failure,D007239: Infections,D009369: Neoplasms,D009765: Obesity,D014552: Urinary Tract Infections,D054143: Heart Failure, Systolic	SLC22A11	M4
P21817	NA	NA	NA	NA	DANTROLENE SODIUM	Ryanodine receptor 1 antagonist	ANTAGONIST	1974	CHEMBL1846	89	P21817	Ryanodine receptor 1	Homo sapiens	D014929: Wolfram Syndrome,D018883: Heat Stroke	RYR1	M4
O00231	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	O00231	26S proteasome non-ATPase regulatory subunit 11	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD11	M4
O00231	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	O00231	26S proteasome non-ATPase regulatory subunit 11	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD11	M4
O00231	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	O00231	26S proteasome non-ATPase regulatory subunit 11	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD11	M4
Q969P6	NA	NA	NA	NA	TOPOTECAN HYDROCHLORIDE	DNA topoisomerase I, mitochondrial inhibitor	INHIBITOR	1996	CHEMBL2362989	105701	Q969P6	DNA topoisomerase I, mitochondrial	Homo sapiens	D001254: Astrocytoma,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D005910: Glioma,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008479: Mediastinal Neoplasms,D008545: Melanoma,D008577: Meningeal Neoplasms,D008582: Meningitis, Aseptic,D008637: Mesenchymoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018269: Carcinoma, Endometrioid,D018288: Carcinoma, Small Cell,D018293: Cystadenoma, Serous,D018305: Ganglioneuroblastoma,D018316: Gliosarcoma,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TOP1MT	M4
P00519	NA	NA	NA	NA	BOSUTINIB	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	2010	CHEMBL1862	8	P00519	Tyrosine-protein kinase ABL1	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABL1	M4
P00519	NA	NA	NA	NA	DASATINIB	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	2006	CHEMBL1862	8	P00519	Tyrosine-protein kinase ABL1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ABL1	M4
P00519	NA	NA	NA	NA	IMATINIB MESYLATE	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	2001	CHEMBL1862	8	P00519	Tyrosine-protein kinase ABL1	Homo sapiens	D000755: Anemia, Sickle Cell,D001249: Asthma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002813: Chondrosarcoma,D003110: Colonic Neoplasms,D003922: Diabetes Mellitus, Type 1,D004802: Eosinophilia,D005185: Fallopian Tube Neoplasms,D005354: Fibrosarcoma,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006976: Hypertension, Pulmonary,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009103: Multiple Sclerosis,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009442: Neurilemmoma,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011668: Pulmonary Veno-Occlusive Disease,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012594: Scleroderma, Localized,D012595: Scleroderma, Systemic,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017681: Hypereosinophilic Syndrome,D018192: Lymphangioleiomyomatosis,D018222: Fibromatosis, Aggressive,D018223: Dermatofibrosarcoma,D018316: Gliosarcoma,D018318: Neurofibroma, Plexiform,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054989: Nephrogenic Fibrosing Dermopathy,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D057135: Wet Macular Degeneration,D064129: Prostatic Neoplasms, Castration-Resistant	ABL1	M4
P00519	NA	NA	NA	NA	NILOTINIB HYDROCHLORIDE MONOHYDRATE	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	2007	CHEMBL1862	8	P00519	Tyrosine-protein kinase ABL1	Homo sapiens	D001943: Breast Neoplasms,D010300: Parkinson Disease,D012595: Scleroderma, Systemic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive	ABL1	M4
P00519	NA	NA	NA	NA	REGORAFENIB	Tyrosine-protein kinase ABL inhibitor	INHIBITOR	2012	CHEMBL1862	8	P00519	Tyrosine-protein kinase ABL1	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	ABL1	M4
P00519	NA	NA	NA	NA	PONATINIB HYDROCHLORIDE	Bcr/Abl fusion protein inhibitor	INHIBITOR	2012	CHEMBL2096618	104811	P00519	Tyrosine-protein kinase ABL1	Homo sapiens	D001752: Blast Crisis,D009369: Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	ABL1	M4
P68871	NA	NA	NA	NA	VOXELOTOR	Hemoglobin HbA positive modulator	POSITIVE MODULATOR	2019	CHEMBL2095168	104753	P68871	Hemoglobin subunit beta	Homo sapiens	D000755: Anemia, Sickle Cell,D007674: Kidney Diseases,D008107: Liver Diseases,D054990: Idiopathic Pulmonary Fibrosis	HBB	M4
P13637	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A3	M4
P13637	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3	M4
P13637	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A3	M4
P13637	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3	M4
P11511	NA	NA	NA	NA	AMINOGLUTETHIMIDE	Cytochrome P450 19A1 inhibitor	INHIBITOR	1980	CHEMBL1978	65	P11511	Aromatase	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CYP19A1	M4
P11511	NA	NA	NA	NA	ANASTROZOLE	Cytochrome P450 19A1 inhibitor	INHIBITOR	1995	CHEMBL1978	65	P11511	Aromatase	Homo sapiens	D000375: Aging,D000858: Anovulation,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D004715: Endometriosis,D005359: Fibrous Dysplasia, Polyostotic,D006177: Gynecomastia,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007006: Hypogonadism,D007018: Hypopituitarism,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011629: Puberty, Precocious,D016889: Endometrial Neoplasms,D017436: Kallmann Syndrome,D018275: Carcinoma, Lobular,D018567: Breast Neoplasms, Male,D024821: Metabolic Syndrome,D064726: Triple Negative Breast Neoplasms	CYP19A1	M4
P11511	NA	NA	NA	NA	LETROZOLE	Cytochrome P450 19A1 inhibitor	INHIBITOR	1997	CHEMBL1978	65	P11511	Aromatase	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D000858: Anovulation,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D004392: Dwarfism,D004715: Endometriosis,D005185: Fallopian Tube Neoplasms,D007006: Hypogonadism,D007246: Infertility,D007889: Leiomyoma,D007890: Leiomyosarcoma,D008228: Lymphoma, Non-Hodgkin,D008593: Menopause,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010024: Osteoporosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011085: Polycystic Ovary Syndrome,D011247: Pregnancy,D014594: Uterine Neoplasms,D016471: Ovarian Hyperstimulation Syndrome,D016889: Endometrial Neoplasms,D018192: Lymphangioleiomyomatosis,D018275: Carcinoma, Lobular,D020065: Hepatopulmonary Syndrome,D053713: Azoospermia,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D062788: Adenomyosis	CYP19A1	M4
P11511	NA	NA	NA	NA	TESTOLACTONE	Cytochrome P450 19A1 inhibitor	INHIBITOR	1969	CHEMBL1978	65	P11511	Aromatase	Homo sapiens	D011629: Puberty, Precocious	CYP19A1	M4
P11511	NA	NA	NA	NA	EXEMESTANE	Cytochrome P450 19A1 inhibitor	INHIBITOR	1999	CHEMBL1978	65	P11511	Aromatase	Homo sapiens	D000071960: Breast Carcinoma In Situ,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D008223: Lymphoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D016889: Endometrial Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	CYP19A1	M4
P01584	NA	NA	NA	NA	RILONACEPT	Interleukin-1 beta inhibitor	INHIBITOR	2008	CHEMBL1909490	104335	P01584	Interleukin-1 beta	Homo sapiens	D001171: Arthritis, Juvenile,D003922: Diabetes Mellitus, Type 1,D006073: Gout,D006519: Hepatitis, Alcoholic,D007154: Immune System Diseases,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D034381: Hearing Loss,D045743: Scleroderma, Diffuse,D056587: Cryopyrin-Associated Periodic Syndromes	IL1B	M4
P01584	NA	NA	NA	NA	CANAKINUMAB	Interleukin-1 beta inhibitor	INHIBITOR	2009	CHEMBL1909490	104335	P01584	Interleukin-1 beta	Homo sapiens	D000755: Anemia, Sickle Cell,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D005334: Fever,D006073: Gout,D006519: Hepatitis, Alcoholic,D007154: Immune System Diseases,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008545: Melanoma,D009080: Mucocutaneous Lymph Node Syndrome,D009190: Myelodysplastic Syndromes,D010003: Osteoarthritis,D010505: Familial Mediterranean Fever,D011014: Pneumonia,D011111: Polymyalgia Rheumatica,D011711: Pyoderma,D014581: Urticaria,D015352: Dry Eye Syndromes,D016706: Still's Disease, Adult-Onset,D017544: Aortic Aneurysm, Abdominal,D017565: Sarcoidosis, Pulmonary,D021441: Carcinoma, Pancreatic Ductal,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D050197: Atherosclerosis,D054078: Mevalonate Kinase Deficiency,D056587: Cryopyrin-Associated Periodic Syndromes,D058729: Peripheral Arterial Disease	IL1B	M4
P00374	NA	NA	NA	NA	METHOTREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000506: Alopecia Areata,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001168: Arthritis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002294: Carcinoma, Squamous Cell,D002318: Cardiovascular Diseases,D002583: Uterine Cervical Neoplasms,D002822: Choriocarcinoma,D003093: Colitis, Ulcerative,D003251: Constriction, Pathologic,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005199: Fanconi Anemia,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006319: Hearing Loss, Sensorineural,D006457: Hemoglobinuria, Paroxysmal,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006828: Hydatidiform Mole,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007249: Inflammation,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008105: Liver Cirrhosis, Biliary,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008269: Macular Edema,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009203: Myocardial Infarction,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D010003: Osteoarthritis,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010391: Pemphigoid, Bullous,D011087: Polycythemia Vera,D011271: Pregnancy, Ectopic,D011565: Psoriasis,D012507: Sarcoidosis,D012509: Sarcoma,D012516: Osteosarcoma,D012559: Schizophrenia,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014523: Urethral Neoplasms,D014581: Urticaria,D014605: Uveitis,D014657: Vasculitis,D014820: Vitiligo,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015658: HIV Infections,D015867: Uveitis, Intermediate,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016511: Severe Combined Immunodeficiency,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018242: Neuroectodermal Tumors, Primitive,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D056833: Central Serous Chorioretinopathy	DHFR	M4
P00374	NA	NA	NA	NA	PRALATREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	2009	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic	DHFR	M4
P00374	NA	NA	NA	NA	PEMETREXED DISODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	2004	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013945: Thymoma,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018287: Carcinoma, Large Cell,D031901: Gestational Trophoblastic Disease,D064129: Prostatic Neoplasms, Castration-Resistant	DHFR	M4
P00374	NA	NA	NA	NA	METHOTREXATE SODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	M4
P18089	NA	NA	NA	NA	METHYLDOPA	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D006973: Hypertension,D011225: Pre-Eclampsia	ADRA2B	M4
P18089	NA	NA	NA	NA	CLONIDINE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001930: Brain Injuries,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002318: Cardiovascular Diseases,D002545: Brain Ischemia,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D005242: Fecal Incontinence,D005901: Glaucoma,D006556: Heroin Dependence,D006939: Hyperemesis Gravidarum,D006973: Hypertension,D007024: Hypotension, Orthostatic,D008881: Migraine Disorders,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009369: Neoplasms,D010146: Pain,D011183: Postoperative Complications,D011247: Pregnancy,D012600: Scoliosis,D013280: Stomatitis,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D054971: Orthostatic Intolerance	ADRA2B	M4
P18089	NA	NA	NA	NA	MIRTAZAPINE	Adrenergic receptor alpha-2 antagonist	ANTAGONIST	1996	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	ADRA2B	M4
P18089	NA	NA	NA	NA	LEVONORDEFRIN	Adrenergic receptor alpha-2 agonist	AGONIST	1960	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRA2B	M4
P18089	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1985	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	CLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D006973: Hypertension,D010146: Pain	ADRA2B	M4
P18089	NA	NA	NA	NA	NAPHAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1971	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D003139: Common Cold,D007249: Inflammation,D007251: Influenza, Human,D011625: Pterygium	ADRA2B	M4
P18089	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRA2B	M4
P18089	NA	NA	NA	NA	TIZANIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001930: Brain Injuries,D008545: Melanoma,D009128: Muscle Spasticity,D011843: Radiculopathy	ADRA2B	M4
P18089	NA	NA	NA	NA	APRACLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1987	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	TETRAHYDROZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1979	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D007249: Inflammation,D011625: Pterygium	ADRA2B	M4
P18089	NA	NA	NA	NA	METHYLDOPATE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	GUANFACINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1986	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	ADRA2B	M4
P18089	NA	NA	NA	NA	GUANABENZ ACETATE	Adrenergic receptor alpha-2 agonist	AGONIST	1982	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	PHENOXYBENZAMINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	OXYMETAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1986	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D006255: Rhinitis, Allergic, Seasonal,D011305: Presbyopia,D012393: Rosacea	ADRA2B	M4
P18089	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	PHENTOLAMINE MESYLATE	Adrenergic receptor alpha antagonist	ANTAGONIST	1952	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA2B	M4
P18089	NA	NA	NA	NA	ALSEROXYLON	Adrenergic receptor alpha antagonist	ANTAGONIST	1982	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D010146: Pain	ADRA2B	M4
P18089	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRA2B	M4
P18089	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001249: Asthma	ADRA2B	M4
P18089	NA	NA	NA	NA	LOFEXIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	2018	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D009293: Opioid-Related Disorders,D013375: Substance Withdrawal Syndrome	ADRA2B	M4
P18089	NA	NA	NA	NA	BRIMONIDINE TARTRATE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D005483: Flushing,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006940: Hyperemia,D007429: Intraocular Pressure,D009798: Ocular Hypertension,D012393: Rosacea,D015352: Dry Eye Syndromes,D015715: Corneal Edema,D019973: Alcohol-Related Disorders,D060831: Hand-Foot Syndrome	ADRA2B	M4
P18089	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRA2B	M4
P18089	NA	NA	NA	NA	DEXMEDETOMIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1999	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D000647: Amnesia,D001930: Brain Injuries,D010146: Pain,D011618: Psychotic Disorders,D012559: Schizophrenia	ADRA2B	M4
P18089	NA	NA	NA	NA	ERGOLOID MESYLATES	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	ADRA2B	M4
P18089	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Adrenergic receptor alpha agonist	AGONIST	1948	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D008881: Migraine Disorders	ADRA2B	M4
P18089	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M4
P18089	NA	NA	NA	NA	RAUWOLFIA SERPENTINA	Adrenergic receptor alpha antagonist	ANTAGONIST	1954	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D006331: Heart Diseases,D006973: Hypertension	ADRA2B	M4
P04350	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB4A	M4
P04350	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M4
P04350	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M4
P04350	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB4A	M4
P04350	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M4
P04350	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M4
P04350	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M4
P04350	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB4A	M4
P04350	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB4A	M4
P04350	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB4A	M4
P04350	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB4A	M4
P04350	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M4
P04350	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB4A	M4
P04350	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB4A	M4
P14867	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA1	M4
P14867	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA1	M4
P14867	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA1	M4
P14867	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D004827: Epilepsy	GABRA1	M4
P14867	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA1	M4
P14867	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA1	M4
P14867	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D008881: Migraine Disorders	GABRA1	M4
P14867	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA1	M4
P14867	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA1	M4
P14867	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA1	M4
P14867	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA1	M4
P14867	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA1	M4
P14867	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA1	M4
P14867	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA1	M4
P14867	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000647: Amnesia	GABRA1	M4
P14867	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA1	M4
P14867	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA1	M4
P14867	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA1	M4
P14867	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety	GABRA1	M4
P14867	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety	GABRA1	M4
P14867	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety	GABRA1	M4
P14867	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA1	M4
P14867	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA1	M4
P14867	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA1	M4
P14867	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA1	M4
P14867	NA	NA	NA	NA	ZALEPLON	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1999	CHEMBL2111392	105087	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia	GABRA1	M4
P14867	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA1	M4
P14867	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA1	M4
P14867	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA1	M4
P14867	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA1	M4
P14867	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D000437: Alcoholism	GABRA1	M4
P14867	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P14867	NA	NA	NA	NA	ZOLPIDEM TARTRATE	GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2111392	105087	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity	GABRA1	M4
P14867	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA1	M4
P14867	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P14867	Gamma-aminobutyric acid receptor subunit alpha-1	Homo sapiens	NA	GABRA1	M4
P35916	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M4
P35916	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M4
P35916	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M4
P35916	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M4
P35916	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M4
P35916	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M4
P35916	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FLT4	M4
P35916	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	FLT4	M4
P35916	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	NA	FLT4	M4
P07101	NA	NA	NA	NA	METYROSINE	Tyrosine 3-hydroxylase inhibitor	INHIBITOR	1979	CHEMBL1969	39	P07101	Tyrosine 3-monooxygenase	Homo sapiens	D006973: Hypertension,D011618: Psychotic Disorders	TH	M4
P69905	NA	NA	NA	NA	VOXELOTOR	Hemoglobin HbA positive modulator	POSITIVE MODULATOR	2019	CHEMBL2095168	104753	P69905	Hemoglobin subunit alpha	Homo sapiens	D000755: Anemia, Sickle Cell,D007674: Kidney Diseases,D008107: Liver Diseases,D054990: Idiopathic Pulmonary Fibrosis	HBA2	M4
Q16099	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	1996	CHEMBL2109241	104902	Q16099	Glutamate receptor ionotropic, kainate 4	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIK4	M4
Q16620	NA	NA	NA	NA	ENTRECTINIB	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2019	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D008545: Melanoma,D009369: Neoplasms,D018275: Carcinoma, Lobular	NTRK2	M4
Q16620	NA	NA	NA	NA	LAROTRECTINIB	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2018	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D005910: Glioma,D009369: Neoplasms	NTRK2	M4
Q16620	NA	NA	NA	NA	LAROTRECTINIB SULFATE	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2018	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D009362: Neoplasm Metastasis,D009369: Neoplasms	NTRK2	M4
Q16620	NA	NA	NA	NA	CENEGERMIN	Neurotrophic tyrosine kinase receptor agonist	AGONIST	2018	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D005128: Eye Diseases,D007634: Keratitis	NTRK2	M4
P30988	NA	NA	NA	NA	CALCITONIN SALMON RECOMBINANT	Calcitonin receptor agonist	AGONIST	2005	CHEMBL1832	119	P30988	Calcitonin receptor	Homo sapiens	D001851: Bone Diseases, Metabolic,D010024: Osteoporosis,D010279: Parathyroid Diseases,D015663: Osteoporosis, Postmenopausal	CALCR	M4
P30988	NA	NA	NA	NA	PRAMLINTIDE ACETATE	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	2005	CHEMBL2111189	104908	P30988	Calcitonin receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity	CALCR	M4
P30988	NA	NA	NA	NA	CALCITONIN SALMON	Calcitonin receptor agonist	AGONIST	1978	CHEMBL1832	119	P30988	Calcitonin receptor	Homo sapiens	D006934: Hypercalcemia,D008593: Menopause,D010001: Osteitis Deformans,D010024: Osteoporosis,D015663: Osteoporosis, Postmenopausal	CALCR	M4
P30988	NA	NA	NA	NA	CALCITONIN HUMAN	Calcitonin receptor agonist	AGONIST	1986	CHEMBL1832	119	P30988	Calcitonin receptor	Homo sapiens	D010279: Parathyroid Diseases	CALCR	M4
Q86Y39	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q86Y39	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFA11	M4
P30411	NA	NA	NA	NA	ICATIBANT ACETATE	Bradykinin B2 receptor antagonist	ANTAGONIST	2011	CHEMBL3157	10034	P30411	B2 bradykinin receptor	Homo sapiens	D007249: Inflammation,D054179: Angioedemas, Hereditary	BDKRB2	M4
P61073	NA	NA	NA	NA	PLERIXAFOR	C-X-C chemokine receptor type 4 partial agonist	PARTIAL AGONIST	2008	CHEMBL2107	10473	P61073	C-X-C chemokine receptor type 4	Homo sapiens	D000755: Anemia, Sickle Cell,D003922: Diabetes Mellitus, Type 1,D005199: Fanconi Anemia,D006086: Graft vs Host Disease,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008231: Lymphopenia,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009503: Neutropenia,D010190: Pancreatic Neoplasms,D012509: Sarcoma,D012595: Scleroderma, Systemic,D013789: Thalassemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D017719: Diabetic Foot,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058625: End Stage Liver Disease	CXCR4	M4
P00915	CHEMBL17	1085	3038	DB01144	DICHLORPHENAMIDE	Carbonic anhydrase I inhibitor	INHIBITOR	1958	CHEMBL261	10193	P00915	Carbonic anhydrase 1	Homo sapiens	D005901: Glaucoma,D020513: Paralysis, Hyperkalemic Periodic,D020514: Hypokalemic Periodic Paralysis,D020967: Myotonic Disorders	CA1	M4
P00915	CHEMBL18	1096	3295	DB00311	ETHOXZOLAMIDE	Carbonic anhydrase inhibitor	INHIBITOR	1982	CHEMBL2095180	104764	P00915	Carbonic anhydrase 1	Homo sapiens	NA	CA1	M4
P00915	CHEMBL19	1124	NA	NA	METHAZOLAMIDE	Carbonic anhydrase I inhibitor	INHIBITOR	1959	CHEMBL261	10193	P00915	Carbonic anhydrase 1	Homo sapiens	D000532: Altitude Sickness,D002583: Uterine Cervical Neoplasms,D005901: Glaucoma	CA1	M4
P00915	NA	NA	NA	NA	ACETAZOLAMIDE	Carbonic anhydrase I inhibitor	INHIBITOR	1953	CHEMBL261	10193	P00915	Carbonic anhydrase 1	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D003551: Cysticercosis,D004487: Edema,D005901: Glaucoma,D006333: Heart Failure,D006528: Carcinoma, Hepatocellular,D006850: Hydrocephalus, Normal Pressure,D006976: Hypertension, Pulmonary,D007024: Hypotension, Orthostatic,D007674: Kidney Diseases,D008269: Macular Edema,D009103: Multiple Sclerosis,D011559: Pseudotumor Cerebri,D012640: Seizures,D013226: Status Epilepticus,D015812: Glaucoma, Angle-Closure,D016481: Helicobacter Infections,D018887: Landau-Kleffner Syndrome,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D050030: Andersen Syndrome,D055752: Small Cell Lung Carcinoma,D059350: Chronic Pain	CA1	M4
P00915	CHEMBL1200814	674765	13290219, 90469712	NA	ACETAZOLAMIDE SODIUM	Carbonic anhydrase I inhibitor	INHIBITOR	1990	CHEMBL261	10193	P00915	Carbonic anhydrase 1	Homo sapiens	D004487: Edema,D005901: Glaucoma,D012640: Seizures,D015812: Glaucoma, Angle-Closure	CA1	M4
P00915	CHEMBL1201117	675068	4107	DB00423	METHOCARBAMOL	Carbonic anhydrase I inhibitor	INHIBITOR	1957	CHEMBL261	10193	P00915	Carbonic anhydrase 1	Homo sapiens	D008103: Liver Cirrhosis,D010146: Pain	CA1	M4
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN POLISTIREX	Sigma opioid receptor agonist	AGONIST	1982	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D002659: Child Development Disorders, Pervasive	SIGMAR1	M4
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN HYDROBROMIDE	Sigma opioid receptor agonist	AGONIST	1984	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D003139: Common Cold,D003371: Cough,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006967: Hypersensitivity,D008881: Migraine Disorders,D009369: Neoplasms,D010146: Pain,D011471: Prostatic Neoplasms,D012852: Sinusitis	SIGMAR1	M4
Q99720	NA	NA	NA	NA	FENFLURAMINE HYDROCHLORIDE	Sigma opioid receptor antagonist	ANTAGONIST	2020	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D004831: Epilepsies, Myoclonic,D020195: Epilepsy, Reflex	SIGMAR1	M4
Q99720	NA	NA	NA	NA	PENTAZOCINE LACTATE	Sigma opioid receptor modulator	MODULATOR	1967	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	NA	SIGMAR1	M4
Q99720	NA	NA	NA	NA	PENTAZOCINE HYDROCHLORIDE	Sigma opioid receptor modulator	MODULATOR	1969	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D010146: Pain	SIGMAR1	M4
P22748	CHEMBL17	1085	3038	DB01144	DICHLORPHENAMIDE	Carbonic anhydrase IV inhibitor	INHIBITOR	1958	CHEMBL3729	12896	P22748	Carbonic anhydrase 4	Homo sapiens	D005901: Glaucoma,D020513: Paralysis, Hyperkalemic Periodic,D020514: Hypokalemic Periodic Paralysis,D020967: Myotonic Disorders	CA4	M4
P22748	CHEMBL18	1096	3295	DB00311	ETHOXZOLAMIDE	Carbonic anhydrase inhibitor	INHIBITOR	1982	CHEMBL2095180	104764	P22748	Carbonic anhydrase 4	Homo sapiens	NA	CA4	M4
P22748	CHEMBL19	1124	NA	NA	METHAZOLAMIDE	Carbonic anhydrase IV inhibitor	INHIBITOR	1959	CHEMBL3729	12896	P22748	Carbonic anhydrase 4	Homo sapiens	D000532: Altitude Sickness,D002583: Uterine Cervical Neoplasms,D005901: Glaucoma	CA4	M4
P22748	NA	NA	NA	NA	ACETAZOLAMIDE	Carbonic anhydrase IV inhibitor	INHIBITOR	1953	CHEMBL3729	12896	P22748	Carbonic anhydrase 4	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D003551: Cysticercosis,D004487: Edema,D005901: Glaucoma,D006333: Heart Failure,D006528: Carcinoma, Hepatocellular,D006850: Hydrocephalus, Normal Pressure,D006976: Hypertension, Pulmonary,D007024: Hypotension, Orthostatic,D007674: Kidney Diseases,D008269: Macular Edema,D009103: Multiple Sclerosis,D011559: Pseudotumor Cerebri,D012640: Seizures,D013226: Status Epilepticus,D015812: Glaucoma, Angle-Closure,D016481: Helicobacter Infections,D018887: Landau-Kleffner Syndrome,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D050030: Andersen Syndrome,D055752: Small Cell Lung Carcinoma,D059350: Chronic Pain	CA4	M4
P22748	NA	NA	NA	NA	TOPIRAMATE	Carbonic anhydrase IV inhibitor	INHIBITOR	1996	CHEMBL3729	12896	P22748	Carbonic anhydrase 4	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	CA4	M4
P22748	CHEMBL1200814	674765	13290219, 90469712	NA	ACETAZOLAMIDE SODIUM	Carbonic anhydrase IV inhibitor	INHIBITOR	1990	CHEMBL3729	12896	P22748	Carbonic anhydrase 4	Homo sapiens	D004487: Edema,D005901: Glaucoma,D012640: Seizures,D015812: Glaucoma, Angle-Closure	CA4	M4
P11802	NA	NA	NA	NA	PALBOCICLIB	Cyclin-dependent kinase 4/cyclin D1 inhibitor	INHIBITOR	2015	CHEMBL1907601	104295	P11802	Cyclin-dependent kinase 4	Homo sapiens	D000230: Adenocarcinoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002817: Chordoma,D003110: Colonic Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008080: Liposarcoma,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012509: Sarcoma,D012512: Sarcoma, Ewing,D013953: Thymus Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018358: Neuroendocrine Tumors,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D044584: Carcinoma, Ductal,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	CDK4	M4
P11802	NA	NA	NA	NA	ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2017	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D009837: Oligodendroglioma,D010190: Pancreatic Neoplasms,D012208: Rhabdomyosarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018335: Rhabdoid Tumor,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D064129: Prostatic Neoplasms, Castration-Resistant	CDK4	M4
P11802	NA	NA	NA	NA	RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2017	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008080: Liposarcoma,D008223: Lymphoma,D008545: Melanoma,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013724: Teratoma,D013953: Thymus Neoplasms,D014594: Uterine Neoplasms,D018335: Rhabdoid Tumor,D018358: Neuroendocrine Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	CDK4	M4
P11802	NA	NA	NA	NA	RIBOCICLIB SUCCINATE	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2017	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms	CDK4	M4
P11802	NA	NA	NA	NA	TRILACICLIB	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2021	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D001943: Breast Neoplasms,D006394: Hemangiosarcoma,D055752: Small Cell Lung Carcinoma,D064726: Triple Negative Breast Neoplasms	CDK4	M4
P11802	NA	NA	NA	NA	TRILACICLIB DIHYDROCHLORIDE	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2021	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D055752: Small Cell Lung Carcinoma	CDK4	M4
P06729	NA	NA	NA	NA	ALEFACEPT	T-cell surface antigen CD2 inhibitor	INHIBITOR	2003	CHEMBL2040	196	P06729	T-cell surface antigen CD2	Homo sapiens	D000741: Anemia, Aplastic,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008010: Lichen Planus,D008223: Lymphoma,D011565: Psoriasis,D015535: Arthritis, Psoriatic,D051437: Renal Insufficiency	CD2	M4
P10721	NA	NA	NA	NA	DASATINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M4
P10721	NA	NA	NA	NA	SUNITINIB MALATE	Stem cell growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M4
P10721	NA	NA	NA	NA	IMATINIB MESYLATE	Stem cell growth factor receptor inhibitor	INHIBITOR	2001	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000755: Anemia, Sickle Cell,D001249: Asthma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002813: Chondrosarcoma,D003110: Colonic Neoplasms,D003922: Diabetes Mellitus, Type 1,D004802: Eosinophilia,D005185: Fallopian Tube Neoplasms,D005354: Fibrosarcoma,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006976: Hypertension, Pulmonary,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009103: Multiple Sclerosis,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009442: Neurilemmoma,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011668: Pulmonary Veno-Occlusive Disease,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012594: Scleroderma, Localized,D012595: Scleroderma, Systemic,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017681: Hypereosinophilic Syndrome,D018192: Lymphangioleiomyomatosis,D018222: Fibromatosis, Aggressive,D018223: Dermatofibrosarcoma,D018316: Gliosarcoma,D018318: Neurofibroma, Plexiform,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054989: Nephrogenic Fibrosing Dermopathy,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D057135: Wet Macular Degeneration,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M4
P10721	NA	NA	NA	NA	MIDOSTAURIN	Stem cell growth factor receptor inhibitor	INHIBITOR	2017	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	KIT	M4
P10721	NA	NA	NA	NA	SORAFENIB TOSYLATE	Stem cell growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M4
P10721	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Stem cell growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M4
P10721	NA	NA	NA	NA	REGORAFENIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	KIT	M4
P10721	NA	NA	NA	NA	PEXIDARTINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2019	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001172: Arthritis, Rheumatoid,D001943: Breast Neoplasms,D005870: Giant Cell Tumors,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D008107: Liver Diseases,D008545: Melanoma,D009369: Neoplasms,D009442: Neurilemmoma,D011471: Prostatic Neoplasms,D013586: Synovitis, Pigmented Villonodular,D015470: Leukemia, Myeloid, Acute,D046152: Gastrointestinal Stromal Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M4
P10721	NA	NA	NA	NA	PEXIDARTINIB HYDROCHLORIDE	Stem cell growth factor receptor inhibitor	INHIBITOR	2019	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000070779: Giant Cell Tumor of Tendon Sheath	KIT	M4
P10721	NA	NA	NA	NA	AVAPRITINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D005910: Glioma,D007946: Leukemia, Mast-Cell,D009369: Neoplasms,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors	KIT	M4
P10721	NA	NA	NA	NA	RIPRETINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D009369: Neoplasms,D046152: Gastrointestinal Stromal Tumors	KIT	M4
P00747	NA	NA	NA	NA	TRANEXAMIC ACID	Plasminogen inhibitor	INHIBITOR	1986	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000740: Anemia,D001254: Astrocytoma,D001416: Back Pain,D001749: Urinary Bladder Neoplasms,D001778: Blood Coagulation Disorders,D001859: Bone Neoplasms,D001930: Brain Injuries,D002543: Cerebral Hemorrhage,D003327: Coronary Disease,D004844: Epistaxis,D005265: Femoral Neck Fractures,D005910: Glioma,D006258: Head and Neck Neoplasms,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D006473: Postpartum Hemorrhage,D006620: Hip Fractures,D007022: Hypotension,D007592: Joint Diseases,D007889: Leiomyoma,D008548: Melanosis,D008579: Meningioma,D008595: Menorrhagia,D009298: Nasal Polyps,D009369: Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010921: Placenta Accreta,D010923: Placenta Previa,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D012878: Skin Neoplasms,D013345: Subarachnoid Hemorrhage,D013683: Telangiectasia, Hereditary Hemorrhagic,D013921: Thrombocytopenia,D014947: Wounds and Injuries,D017544: Aortic Aneurysm, Abdominal,D019337: Hematologic Neoplasms,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050723: Fractures, Bone,D054179: Angioedemas, Hereditary,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse	PLG	M4
P00747	NA	NA	NA	NA	AMINOCAPROIC ACID	Plasminogen inhibitor	INHIBITOR	1964	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001018: Aortic Diseases,D003398: Craniosynostoses,D006470: Hemorrhage,D007249: Inflammation,D012393: Rosacea	PLG	M4
P00747	NA	NA	NA	NA	ALTEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000038: Abscess,D000083242: Ischemic Stroke,D001991: Bronchitis,D002543: Cerebral Hemorrhage,D002544: Cerebral Infarction,D002545: Brain Ischemia,D004653: Empyema,D005128: Eye Diseases,D006333: Heart Failure,D006470: Hemorrhage,D009203: Myocardial Infarction,D009369: Neoplasms,D009422: Nervous System Diseases,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012170: Retinal Vein Occlusion,D013345: Subarachnoid Hemorrhage,D013924: Thrombophlebitis,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016055: Urinary Retention,D016724: Empyema, Pleural,D017202: Myocardial Ischemia,D018784: Abdominal Abscess,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D060050: Angina, Stable	PLG	M4
P00747	NA	NA	NA	NA	UROKINASE	Plasminogen activator	ACTIVATOR	2007	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D004653: Empyema,D007239: Infections,D011655: Pulmonary Embolism,D013927: Thrombosis,D016724: Empyema, Pleural,D020521: Stroke	PLG	M4
P00747	NA	NA	NA	NA	APROTININ	Plasminogen inhibitor	INHIBITOR	1993	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001943: Breast Neoplasms,D006470: Hemorrhage,D010195: Pancreatitis	PLG	M4
P00747	NA	NA	NA	NA	RETEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D009203: Myocardial Infarction,D013927: Thrombosis,D020521: Stroke	PLG	M4
P00747	NA	NA	NA	NA	STREPTOKINASE	Plasminogen activator	ACTIVATOR	1997	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000083242: Ischemic Stroke,D009203: Myocardial Infarction,D010195: Pancreatitis,D013927: Thrombosis,D017202: Myocardial Ischemia,D020246: Venous Thrombosis	PLG	M4
P00747	NA	NA	NA	NA	TENECTEPLASE	Plasminogen activator	ACTIVATOR	2000	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D002544: Cerebral Infarction,D002545: Brain Ischemia,D009203: Myocardial Infarction,D009422: Nervous System Diseases,D010996: Pleural Effusion,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016757: Death, Sudden, Cardiac,D020521: Stroke	PLG	M4
P00747	NA	NA	NA	NA	DEFIBROTIDE SODIUM	Plasminogen activator	ACTIVATOR	2016	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D006504: Hepatic Veno-Occlusive Disease	PLG	M4
P37288	NA	NA	NA	NA	VASOPRESSIN	Vasopressin receptor agonist	AGONIST	2014	CHEMBL2363078	105773	P37288	Vasopressin V1a receptor	Homo sapiens	D001321: Autistic Disorder,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003919: Diabetes Insipidus,D006323: Heart Arrest,D006331: Heart Diseases,D006976: Hypertension, Pulmonary,D007022: Hypotension,D007889: Leiomyoma,D009214: Myoma,D010146: Pain,D010996: Pleural Effusion,D012769: Shock,D012772: Shock, Septic,D016757: Death, Sudden, Cardiac,D018805: Sepsis,D055371: Acute Lung Injury,D065630: Hernias, Diaphragmatic, Congenital	AVPR1A	M4
P37288	NA	NA	NA	NA	DESMOPRESSIN ACETATE	Vasopressin receptor agonist	AGONIST	1978	CHEMBL2363078	105773	P37288	Vasopressin V1a receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D006470: Hemorrhage,D006973: Hypertension,D011183: Postoperative Complications	AVPR1A	M4
P37288	NA	NA	NA	NA	LYPRESSIN	Vasopressin receptor agonist	AGONIST	1982	CHEMBL2363078	105773	P37288	Vasopressin V1a receptor	Homo sapiens	NA	AVPR1A	M4
P37288	NA	NA	NA	NA	CONIVAPTAN HYDROCHLORIDE	Vasopressin V1a receptor antagonist	ANTAGONIST	2005	CHEMBL1889	134	P37288	Vasopressin V1a receptor	Homo sapiens	D007010: Hyponatremia,D008107: Liver Diseases	AVPR1A	M4
P37288	NA	NA	NA	NA	VASOPRESSIN TANNATE	Vasopressin V1a receptor agonist	AGONIST	1982	CHEMBL1889	134	P37288	Vasopressin V1a receptor	Homo sapiens	NA	AVPR1A	M4
P07942	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	P07942	Laminin subunit beta-1	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMB1	M4
P34981	NA	NA	NA	NA	PROTIRELIN	Thyrotropin-releasing hormone receptor agonist	AGONIST	1976	CHEMBL1810	260	P34981	Thyrotropin-releasing hormone receptor	Homo sapiens	D009369: Neoplasms,D012128: Respiratory Distress Syndrome	TRHR	M4
P09619	NA	NA	NA	NA	DASATINIB	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	2006	CHEMBL1913	197	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB	M4
P09619	NA	NA	NA	NA	SUNITINIB MALATE	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB	M4
P09619	NA	NA	NA	NA	IMATINIB MESYLATE	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	2001	CHEMBL1913	197	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D000755: Anemia, Sickle Cell,D001249: Asthma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002813: Chondrosarcoma,D003110: Colonic Neoplasms,D003922: Diabetes Mellitus, Type 1,D004802: Eosinophilia,D005185: Fallopian Tube Neoplasms,D005354: Fibrosarcoma,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006976: Hypertension, Pulmonary,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009103: Multiple Sclerosis,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009442: Neurilemmoma,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011668: Pulmonary Veno-Occlusive Disease,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012594: Scleroderma, Localized,D012595: Scleroderma, Systemic,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017681: Hypereosinophilic Syndrome,D018192: Lymphangioleiomyomatosis,D018222: Fibromatosis, Aggressive,D018223: Dermatofibrosarcoma,D018316: Gliosarcoma,D018318: Neurofibroma, Plexiform,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054989: Nephrogenic Fibrosing Dermopathy,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D057135: Wet Macular Degeneration,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB	M4
P09619	NA	NA	NA	NA	MIDOSTAURIN	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2017	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PDGFRB	M4
P09619	NA	NA	NA	NA	SORAFENIB TOSYLATE	Platelet-derived growth factor receptor beta inhibitor	INHIBITOR	2005	CHEMBL1913	197	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB	M4
P09619	NA	NA	NA	NA	BECAPLERMIN	Platelet-derived growth factor receptor agonist	AGONIST	1997	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D012883: Skin Ulcer,D014456: Ulcer,D017719: Diabetic Foot	PDGFRB	M4
P09619	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	PDGFRB	M4
P09619	NA	NA	NA	NA	REGORAFENIB	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	PDGFRB	M4
P09619	NA	NA	NA	NA	NINTEDANIB ESYLATE	Platelet-derived growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095189	104773	P09619	Platelet-derived growth factor receptor beta	Homo sapiens	NA	PDGFRB	M4
P35462	NA	NA	NA	NA	HALOPERIDOL	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	DRD3	M4
P35462	NA	NA	NA	NA	THIORIDAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	DRD3	M4
P35462	NA	NA	NA	NA	CHLORPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	DRD3	M4
P35462	NA	NA	NA	NA	OLANZAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1996	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	DRD3	M4
P35462	NA	NA	NA	NA	LOXAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	DRD3	M4
P35462	NA	NA	NA	NA	CHLORPROTHIXENE	Dopamine D3 receptor antagonist	ANTAGONIST	1967	CHEMBL234	130	P35462	D(3) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M4
P35462	NA	NA	NA	NA	LEVODOPA	Dopamine D3 receptor agonist	AGONIST	1970	CHEMBL234	130	P35462	D(3) dopamine receptor	Homo sapiens	D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D001037: Aphasia,D001249: Asthma,D001930: Brain Injuries,D002659: Child Development Disorders, Pervasive,D005879: Tourette Syndrome,D007024: Hypotension, Orthostatic,D008268: Macular Degeneration,D010146: Pain,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D012174: Retinitis Pigmentosa,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D016115: Albinism, Oculocutaneous,D017204: Angelman Syndrome,D019970: Cocaine-Related Disorders,D020521: Stroke	DRD3	M4
P35462	NA	NA	NA	NA	DROPERIDOL	D2-like dopamine receptor antagonist	ANTAGONIST	1970	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	DRD3	M4
P35462	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P35462	D(3) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD3	M4
P35462	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M4
P35462	NA	NA	NA	NA	ROTIGOTINE	D2-like dopamine receptor agonist	AGONIST	2007	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000544: Alzheimer Disease,D005356: Fibromyalgia,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D020521: Stroke	DRD3	M4
P35462	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P35462	D(3) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M4
P35462	NA	NA	NA	NA	AMISULPRIDE	Dopamine receptors; D2 & D3 antagonist	ANTAGONIST	2020	CHEMBL2095169	104754	P35462	D(3) dopamine receptor	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	DRD3	M4
P35462	NA	NA	NA	NA	APOMORPHINE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	2004	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D009369: Neoplasms,D010024: Osteoporosis,D010300: Parkinson Disease	DRD3	M4
P35462	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M4
P35462	NA	NA	NA	NA	LEVOMEPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1982	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M4
P35462	NA	NA	NA	NA	ROPINIROLE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D010300: Parkinson Disease	DRD3	M4
P35462	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1956	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M4
P35462	NA	NA	NA	NA	BROMOCRIPTINE MESYLATE	D2-like dopamine receptor agonist	AGONIST	1978	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000172: Acromegaly,D003924: Diabetes Mellitus, Type 2,D006966: Hyperprolactinemia,D007006: Hypogonadism,D007246: Infertility,D010300: Parkinson Disease	DRD3	M4
P35462	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M4
P35462	NA	NA	NA	NA	HALOPERIDOL DECANOATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1986	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M4
P35462	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1976	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M4
P35462	NA	NA	NA	NA	LOXAPINE SUCCINATE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M4
P35462	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1959	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M4
P35462	NA	NA	NA	NA	CARIPRAZINE HYDROCHLORIDE	Dopamine D3 receptor modulator	MODULATOR	2015	CHEMBL234	130	P35462	D(3) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	DRD3	M4
P35462	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P35462	D(3) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD3	M4
P35462	NA	NA	NA	NA	PRAMIPEXOLE DIHYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D010300: Parkinson Disease	DRD3	M4
P35462	NA	NA	NA	NA	OLANZAPINE PAMOATE	D2-like dopamine receptor antagonist	ANTAGONIST	2009	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D012559: Schizophrenia	DRD3	M4
P35462	NA	NA	NA	NA	HALOPERIDOL LACTATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M4
P08581	NA	NA	NA	NA	CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000080443: Diffuse Intrinsic Pontine Glioma,D000230: Adenocarcinoma,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006104: Granuloma, Plasma Cell,D007674: Kidney Diseases,D008175: Lung Neoplasms,D009101: Multiple Myeloma,D009369: Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016518: Neurofibromatosis 2,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D064129: Prostatic Neoplasms, Castration-Resistant	MET	M4
P08581	NA	NA	NA	NA	CABOZANTINIB S-MALATE	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D001254: Astrocytoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005909: Glioblastoma,D005910: Glioma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010673: Pheochromocytoma,D013964: Thyroid Neoplasms,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018288: Carcinoma, Small Cell,D018316: Gliosarcoma	MET	M4
P08581	NA	NA	NA	NA	CAPMATINIB	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008107: Liver Diseases,D008175: Lung Neoplasms,D008545: Melanoma,D009369: Neoplasms,D012509: Sarcoma	MET	M4
P08581	NA	NA	NA	NA	TEPOTINIB	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D006528: Carcinoma, Hepatocellular,D008107: Liver Diseases,D009369: Neoplasms,D015179: Colorectal Neoplasms	MET	M4
P08581	NA	NA	NA	NA	CAPMATINIB HYDROCHLORIDE	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	MET	M4
P08581	NA	NA	NA	NA	TEPOTINIB HYDROCHLORIDE	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D009369: Neoplasms	MET	M4
P25787	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P25787	Proteasome subunit alpha type-2	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA2	M4
P25787	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P25787	Proteasome subunit alpha type-2	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA2	M4
P25787	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P25787	Proteasome subunit alpha type-2	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMA2	M4
Q8TDN2	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q8TDN2	Potassium voltage-gated channel subfamily V member 2	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNV2	M4
Q8TDN2	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TDN2	Potassium voltage-gated channel subfamily V member 2	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNV2	M4
Q8TDN2	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q8TDN2	Potassium voltage-gated channel subfamily V member 2	Homo sapiens	NA	KCNV2	M4
Q8TDN2	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TDN2	Potassium voltage-gated channel subfamily V member 2	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNV2	M4
P10828	NA	NA	NA	NA	DEXTROTHYROXINE	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D002318: Cardiovascular Diseases,D004314: Down Syndrome	THRB	M4
P10828	NA	NA	NA	NA	LIOTHYRONINE	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D003866: Depressive Disorder,D007037: Hypothyroidism,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	THRB	M4
P10828	NA	NA	NA	NA	LIOTHYRONINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D006258: Head and Neck Neoplasms,D006330: Heart Defects, Congenital,D007037: Hypothyroidism,D009103: Multiple Sclerosis,D013964: Thyroid Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D065630: Hernias, Diaphragmatic, Congenital	THRB	M4
P10828	NA	NA	NA	NA	LEVOTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	2000	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001714: Bipolar Disorder,D003409: Congenital Hypothyroidism,D007037: Hypothyroidism,D010146: Pain,D013964: Thyroid Neoplasms	THRB	M4
P10828	NA	NA	NA	NA	DEXTROTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D009203: Myocardial Infarction,D017202: Myocardial Ischemia	THRB	M4
P50993	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A2	M4
P50993	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A2	M4
P50993	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A2	M4
P50993	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A2	M4
P68363	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1B	M4
P68363	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1B	M4
P68363	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1B	M4
P68363	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBA1B	M4
P68363	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1B	M4
P68363	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1B	M4
P68363	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1B	M4
P68363	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1B	M4
P68363	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBA1B	M4
P68363	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBA1B	M4
P68363	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBA1B	M4
P68363	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1B	M4
P68363	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBA1B	M4
P68363	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	P68363	Tubulin alpha-1B chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBA1B	M4
P19235	NA	NA	NA	NA	EPOETIN ALFA	Erythropoietin receptor agonist	AGONIST	1989	CHEMBL1817	201	P19235	Erythropoietin receptor	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000740: Anemia,D000751: Anemia, Neonatal,D001237: Asphyxia,D001930: Brain Injuries,D001943: Breast Neoplasms,D002545: Brain Ischemia,D002583: Uterine Cervical Neoplasms,D003327: Coronary Disease,D005221: Fatigue,D005621: Friedreich Ataxia,D006258: Head and Neck Neoplasms,D006323: Heart Arrest,D006526: Hepatitis C,D007676: Kidney Failure, Chronic,D008175: Lung Neoplasms,D009190: Myelodysplastic Syndromes,D009203: Myocardial Infarction,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D017086: beta-Thalassemia,D019966: Substance-Related Disorders,D020246: Venous Thrombosis,D020521: Stroke,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	EPOR	M4
P19235	NA	NA	NA	NA	DARBEPOETIN ALFA	Erythropoietin receptor agonist	AGONIST	2001	CHEMBL1817	201	P19235	Erythropoietin receptor	Homo sapiens	D000740: Anemia,D001930: Brain Injuries,D001943: Breast Neoplasms,D002545: Brain Ischemia,D004407: Dysgerminoma,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D009190: Myelodysplastic Syndromes,D009203: Myocardial Infarction,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D019337: Hematologic Neoplasms,D051436: Renal Insufficiency, Chronic,D055752: Small Cell Lung Carcinoma,D058186: Acute Kidney Injury	EPOR	M4
P19235	NA	NA	NA	NA	PEGINESATIDE ACETATE	Erythropoietin receptor agonist	AGONIST	2012	CHEMBL1817	201	P19235	Erythropoietin receptor	Homo sapiens	D000740: Anemia	EPOR	M4
P12259	NA	NA	NA	NA	DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor V inhibitor	INHIBITOR	2001	CHEMBL3618	11387	P12259	Coagulation factor V	Homo sapiens	D007022: Hypotension,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013927: Thrombosis,D018805: Sepsis,D020521: Stroke,D051436: Renal Insufficiency, Chronic	F5	M4
P25786	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P25786	Proteasome subunit alpha type-1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA1	M4
P25786	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P25786	Proteasome subunit alpha type-1	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA1	M4
P25786	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P25786	Proteasome subunit alpha type-1	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMA1	M4
O95263	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	O95263	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE8B	M4
O95263	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	O95263	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE8B	M4
O95263	NA	NA	NA	NA	FLAVOXATE HYDROCHLORIDE	Phosphodiesterase 8 inhibitor	INHIBITOR	1970	CHEMBL2363067	105762	O95263	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	Homo sapiens	NA	PDE8B	M4
P62937	NA	NA	NA	NA	CYCLOSPORINE	Cyclophilin A modulator	MODULATOR	1983	CHEMBL1949	180	P62937	Peptidyl-prolyl cis-trans isomerase A	Homo sapiens	D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001528: Behcet Syndrome,D001930: Brain Injuries,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D003233: Conjunctivitis, Allergic,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004062: DiGeorge Syndrome,D004485: Eczema,D004694: Endocardial Cushion Defects,D004820: Epidermolysis Bullosa,D005128: Eye Diseases,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005901: Glaucoma,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006105: Granulomatous Disease, Chronic,D006323: Heart Arrest,D006331: Heart Diseases,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007239: Infections,D007249: Inflammation,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007766: Lacrimal Apparatus Diseases,D007918: Leprosy,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008171: Lung Diseases,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D009083: Mucopolysaccharidoses,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009203: Myocardial Infarction,D009205: Myocarditis,D009220: Myositis,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009503: Neutropenia,D010013: Osteogenesis Imperfecta,D010051: Ovarian Neoplasms,D010518: Periodontitis,D011565: Psoriasis,D011625: Pterygium,D011697: Purpura, Thrombotic Thrombocytopenic,D012010: Red-Cell Aplasia, Pure,D012175: Retinoblastoma,D012509: Sarcoma,D012751: Sezary Syndrome,D012878: Skin Neoplasms,D013262: Stevens-Johnson Syndrome,D014581: Urticaria,D014605: Uveitis,D015179: Colorectal Neoplasms,D015352: Dry Eye Syndromes,D015427: Reperfusion Injury,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015493: Paraparesis, Tropical Spastic,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016483: Lymphoma, AIDS-Related,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017544: Aortic Aneurysm, Abdominal,D018302: Neoplasms, Neuroepithelial,D018357: Respiratory Syncytial Virus Infections,D018746: Systemic Inflammatory Response Syndrome,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D019693: Hepatitis, Autoimmune,D019698: Hepatitis C, Chronic,D020522: Lymphoma, Mantle-Cell,D029242: Optic Atrophy, Hereditary, Leber,D029424: Pulmonary Disease, Chronic Obstructive,D031300: Retinal Vasculitis,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054179: Angioedemas, Hereditary,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054556: Venous Thromboembolism,D058186: Acute Kidney Injury,D064129: Prostatic Neoplasms, Castration-Resistant	PPIA	M4
P08922	NA	NA	NA	NA	ENTRECTINIB	Proto-oncogene tyrosine-protein kinase ROS inhibitor	INHIBITOR	2019	CHEMBL5568	101019	P08922	Proto-oncogene tyrosine-protein kinase ROS	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D008545: Melanoma,D009369: Neoplasms,D018275: Carcinoma, Lobular	ROS1	M4
P20701	NA	NA	NA	NA	EFALIZUMAB	Integrin alpha-L/beta-2 (LFA-1) inhibitor	INHIBITOR	2003	CHEMBL2364172	106151	P20701	Integrin alpha-L	Homo sapiens	D000505: Alopecia,D001172: Arthritis, Rheumatoid,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D007154: Immune System Diseases,D008268: Macular Degeneration,D011565: Psoriasis,D012859: Sjogren's Syndrome,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa,D051436: Renal Insufficiency, Chronic	ITGAL	M4
P20701	NA	NA	NA	NA	LIFITEGRAST	Integrin alpha-L/beta-2 (LFA-1) antagonist	ANTAGONIST	2016	CHEMBL2364172	106151	P20701	Integrin alpha-L	Homo sapiens	D003233: Conjunctivitis, Allergic,D005128: Eye Diseases,D006086: Graft vs Host Disease,D015352: Dry Eye Syndromes	ITGAL	M4
Q16445	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA6	M4
Q16445	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA6	M4
Q16445	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA6	M4
Q16445	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D004827: Epilepsy	GABRA6	M4
Q16445	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA6	M4
Q16445	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA6	M4
Q16445	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D008881: Migraine Disorders	GABRA6	M4
Q16445	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA6	M4
Q16445	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA6	M4
Q16445	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA6	M4
Q16445	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA6	M4
Q16445	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA6	M4
Q16445	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA6	M4
Q16445	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA6	M4
Q16445	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000647: Amnesia	GABRA6	M4
Q16445	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA6	M4
Q16445	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA6	M4
Q16445	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA6	M4
Q16445	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety	GABRA6	M4
Q16445	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety	GABRA6	M4
Q16445	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety	GABRA6	M4
Q16445	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA6	M4
Q16445	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA6	M4
Q16445	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA6	M4
Q16445	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA6	M4
Q16445	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA6	M4
Q16445	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA6	M4
Q16445	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA6	M4
Q16445	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA6	M4
Q16445	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D000437: Alcoholism	GABRA6	M4
Q16445	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
Q16445	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA6	M4
Q16445	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	Q16445	Gamma-aminobutyric acid receptor subunit alpha-6	Homo sapiens	NA	GABRA6	M4
O43678	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O43678	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFA2	M4
Q16739	NA	NA	NA	NA	MIGLUSTAT	Ceramide glucosyltransferase inhibitor	INHIBITOR	2003	CHEMBL2063	286	Q16739	Ceramide glucosyltransferase	Homo sapiens	D003550: Cystic Fibrosis,D005776: Gaucher Disease,D006008: Glycogen Storage Disease,D012497: Sandhoff Disease,D015419: Spastic Paraplegia, Hereditary,D015658: HIV Infections,D020143: Gangliosidoses, GM2,D052556: Niemann-Pick Disease, Type C	UGCG	M4
Q16739	NA	NA	NA	NA	ELIGLUSTAT TARTRATE	Ceramide glucosyltransferase inhibitor	INHIBITOR	2014	CHEMBL2063	286	Q16739	Ceramide glucosyltransferase	Homo sapiens	D005776: Gaucher Disease	UGCG	M4
Q9Y375	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q9Y375	Complex I intermediate-associated protein 30, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFAF1	M4
P05106	NA	NA	NA	NA	EPTIFIBATIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D009203: Myocardial Infarction,D011014: Pneumonia,D012772: Shock, Septic,D013927: Thrombosis,D020520: Brain Infarction,D020521: Stroke,D054058: Acute Coronary Syndrome	ITGB3	M4
P05106	NA	NA	NA	NA	ABCIXIMAB	Integrin alpha-V/beta-3 inhibitor	INHIBITOR	1993	CHEMBL1907598	104292	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000208: Acute Disease,D000789: Angina, Unstable,D002545: Brain Ischemia,D009203: Myocardial Infarction,D013927: Thrombosis,D016893: Carotid Stenosis,D020521: Stroke,D060050: Angina, Stable	ITGB3	M4
P05106	NA	NA	NA	NA	TIROFIBAN HYDROCHLORIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	NA	ITGB3	M4
P21802	NA	NA	NA	NA	PALIFERMIN	Fibroblast growth factor receptor 2 agonist	AGONIST	2005	CHEMBL4142	10264	P21802	Fibroblast growth factor receptor 2	Homo sapiens	D000505: Alopecia,D001249: Asthma,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009190: Myelodysplastic Syndromes,D013262: Stevens-Johnson Syndrome,D013280: Stomatitis,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D018302: Neoplasms, Neuroepithelial,D019337: Hematologic Neoplasms,D052016: Mucositis,D053632: X-Linked Combined Immunodeficiency Diseases	FGFR2	M4
P21802	NA	NA	NA	NA	REGORAFENIB	Fibroblast growth factor receptor 2 inhibitor	INHIBITOR	2012	CHEMBL4142	10264	P21802	Fibroblast growth factor receptor 2	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FGFR2	M4
P21802	NA	NA	NA	NA	NINTEDANIB ESYLATE	Fibroblast growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095217	104793	P21802	Fibroblast growth factor receptor 2	Homo sapiens	NA	FGFR2	M4
P21802	NA	NA	NA	NA	ERDAFITINIB	Fibroblast growth factor receptor inhibitor	INHIBITOR	2019	CHEMBL2095217	104793	P21802	Fibroblast growth factor receptor 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D006528: Carcinoma, Hepatocellular,D008107: Liver Diseases,D008223: Lymphoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D014565: Urogenital Neoplasms	FGFR2	M4
P21802	NA	NA	NA	NA	PEMIGATINIB	Fibroblast growth factor receptor 2 inhibitor	INHIBITOR	2020	CHEMBL4142	10264	P21802	Fibroblast growth factor receptor 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D014565: Urogenital Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma	FGFR2	M4
P00797	NA	NA	NA	NA	ALISKIREN FUMARATE	Renin inhibitor	INHIBITOR	2007	CHEMBL286	11225	P00797	Renin	Homo sapiens	D006973: Hypertension	REN	M4
P22459	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA4	M4
P22459	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA4	M4
P22459	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	NA	KCNA4	M4
P22459	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22459	Potassium voltage-gated channel subfamily A member 4	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA4	M4
Q9NRF9	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	Q9NRF9	DNA polymerase epsilon subunit 3	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLE3	M4
Q9NRF9	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	Q9NRF9	DNA polymerase epsilon subunit 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLE3	M4
Q9NRF9	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	Q9NRF9	DNA polymerase epsilon subunit 3	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLE3	M4
Q9NRF9	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	Q9NRF9	DNA polymerase epsilon subunit 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLE3	M4
Q15008	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q15008	26S proteasome non-ATPase regulatory subunit 6	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD6	M4
Q15008	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q15008	26S proteasome non-ATPase regulatory subunit 6	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD6	M4
Q15008	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q15008	26S proteasome non-ATPase regulatory subunit 6	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD6	M4
P35913	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	P35913	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6B	M4
P35913	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	P35913	Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit beta	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6B	M4
P63027	NA	NA	NA	NA	BOTULINUM TOXIN TYPE B	Vesicle-associated membrane protein 2 inhibitor	INHIBITOR	2000	CHEMBL2364160	106139	P63027	Vesicle-associated membrane protein 2	Homo sapiens	D001281: Atrial Fibrillation,D002349: Carpal Tunnel Syndrome,D002547: Cerebral Palsy,D003704: Dementia,D006945: Hyperhidrosis,D012798: Sialorrhea,D012883: Skin Ulcer,D014103: Torticollis	VAMP2	M4
Q13733	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	Q13733	Sodium/potassium-transporting ATPase subunit alpha-4	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A4	M4
Q13733	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	Q13733	Sodium/potassium-transporting ATPase subunit alpha-4	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A4	M4
Q13733	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	Q13733	Sodium/potassium-transporting ATPase subunit alpha-4	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A4	M4
Q13733	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	Q13733	Sodium/potassium-transporting ATPase subunit alpha-4	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A4	M4
P05231	NA	NA	NA	NA	SILTUXIMAB	Interleukin-6 inhibitor	ANTAGONIST	2014	CHEMBL1795129	104209	P05231	Interleukin-6	Homo sapiens	D002292: Carcinoma, Renal Cell,D003922: Diabetes Mellitus, Type 1,D005871: Castleman Disease,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D010265: Paraproteinemias,D011471: Prostatic Neoplasms,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	IL6	M4
Q14145	NA	NA	NA	NA	MONOMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	INHIBITOR	2020	CHEMBL2069156	104593	Q14145	Kelch-like ECH-associated protein 1	Homo sapiens	D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting	KEAP1	M4
Q14145	NA	NA	NA	NA	DIMETHYL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	INHIBITOR	2013	CHEMBL2069156	104593	Q14145	Kelch-like ECH-associated protein 1	Homo sapiens	D001172: Arthritis, Rheumatoid,D007154: Immune System Diseases,D009103: Multiple Sclerosis,D011565: Psoriasis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015535: Arthritis, Psoriatic,D016410: Lymphoma, T-Cell, Cutaneous,D018316: Gliosarcoma,D020181: Sleep Apnea, Obstructive,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D045169: Severe Acute Respiratory Syndrome	KEAP1	M4
Q14145	NA	NA	NA	NA	DIROXIMEL FUMARATE	Kelch-like ECH-associated protein 1 inhibitor	INHIBITOR	2019	CHEMBL2069156	104593	Q14145	Kelch-like ECH-associated protein 1	Homo sapiens	D009103: Multiple Sclerosis,D020529: Multiple Sclerosis, Relapsing-Remitting	KEAP1	M4
P54764	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54764	Ephrin type-A receptor 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA4	M4
P08172	NA	NA	NA	NA	OXYBUTYNIN CHLORIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1975	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D011471: Prostatic Neoplasms,D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM2	M4
P08172	NA	NA	NA	NA	OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1975	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D001750: Urinary Bladder, Neurogenic,D006255: Rhinitis, Allergic, Seasonal,D006945: Hyperhidrosis,D010145: Paget Disease, Extramammary,D011115: Polyneuropathies,D011141: Polyuria,D012891: Sleep Apnea Syndromes,D014549: Urinary Incontinence,D020181: Sleep Apnea, Obstructive,D053201: Urinary Bladder, Overactive	CHRM2	M4
P08172	NA	NA	NA	NA	PROPANTHELINE BROMIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1953	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM2	M4
P08172	NA	NA	NA	NA	ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1960	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D001778: Blood Coagulation Disorders,D001919: Bradycardia,D001943: Breast Neoplasms,D004066: Digestive System Diseases,D004393: Dwarfism, Pituitary,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006470: Hemorrhage,D007003: Hypoglycemia,D007021: Hypospadias,D007024: Hypotension, Orthostatic,D007333: Insulin Resistance,D009216: Myopia,D010146: Pain,D011183: Postoperative Complications,D011236: Prediabetic State,D013285: Strabismus,D053717: Pneumonia, Ventilator-Associated,D054971: Orthostatic Intolerance	CHRM2	M4
P08172	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	1986	CHEMBL2094109	104691	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2	M4
P08172	NA	NA	NA	NA	BETHANECHOL CHLORIDE	Muscarinic acetylcholine receptor M2 agonist	AGONIST	1948	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2	M4
P08172	NA	NA	NA	NA	SOLIFENACIN SUCCINATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D011470: Prostatic Hyperplasia,D053201: Urinary Bladder, Overactive	CHRM2	M4
P08172	NA	NA	NA	NA	DARIFENACIN HYDROBROMIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2	M4
P08172	NA	NA	NA	NA	FESOTERODINE FUMARATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2008	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM2	M4
P08172	NA	NA	NA	NA	TOLTERODINE TARTRATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1998	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM2	M4
P08172	NA	NA	NA	NA	ATROPINE SULFATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1960	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal,D009216: Myopia,D010300: Parkinson Disease,D010437: Peptic Ulcer,D011183: Postoperative Complications,D015878: Mydriasis,D062025: Organophosphate Poisoning	CHRM2	M4
P08172	NA	NA	NA	NA	TROSPIUM CHLORIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D053201: Urinary Bladder, Overactive	CHRM2	M4
Q02643	NA	NA	NA	NA	SERMORELIN ACETATE	Growth hormone-releasing hormone receptor agonist	AGONIST	1990	CHEMBL2032	158	Q02643	Growth hormone-releasing hormone receptor	Homo sapiens	NA	GHRHR	M4
Q02643	NA	NA	NA	NA	TESAMORELIN ACETATE	Growth hormone-releasing hormone receptor agonist	AGONIST	2010	CHEMBL2032	158	Q02643	Growth hormone-releasing hormone receptor	Homo sapiens	D039682: HIV-Associated Lipodystrophy Syndrome	GHRHR	M4
Q13509	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB3	M4
Q13509	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M4
Q13509	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M4
Q13509	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB3	M4
Q13509	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M4
Q13509	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M4
Q13509	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M4
Q13509	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB3	M4
Q13509	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB3	M4
Q13509	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB3	M4
Q13509	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB3	M4
Q13509	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB3	M4
Q13509	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB3	M4
Q13509	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q13509	Tubulin beta-3 chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB3	M4
P49005	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2	M4
P49005	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLD2	M4
P49005	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLD2	M4
P49005	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2	M4
Q9BQ31	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNS3	M4
Q9BQ31	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNS3	M4
Q9BQ31	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	NA	KCNS3	M4
Q9BQ31	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNS3	M4
Q12879	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN2A	M4
Q12879	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN2A	M4
Q12879	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN2A	M4
Q12879	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN2A	M4
Q12879	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN2A	M4
Q12879	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D010146: Pain	GRIN2A	M4
Q12879	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D010300: Parkinson Disease	GRIN2A	M4
Q12879	NA	NA	NA	NA	DEXTROMETHORPHAN POLISTIREX	Glutamate [NMDA] receptor subunit epsilon 1 antagonist	ANTAGONIST	1982	CHEMBL1972	166	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D002659: Child Development Disorders, Pervasive	GRIN2A	M4
Q12879	NA	NA	NA	NA	DEXTROMETHORPHAN HYDROBROMIDE	Glutamate [NMDA] receptor subunit epsilon 1 antagonist	ANTAGONIST	1984	CHEMBL1972	166	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D003139: Common Cold,D003371: Cough,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006967: Hypersensitivity,D008881: Migraine Disorders,D009369: Neoplasms,D010146: Pain,D011471: Prostatic Neoplasms,D012852: Sinusitis	GRIN2A	M4
Q12879	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D000437: Alcoholism	GRIN2A	M4
Q12879	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN2A	M4
P35968	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M4
P35968	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M4
P35968	NA	NA	NA	NA	MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	2017	CHEMBL279	10980	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	KDR	M4
P35968	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M4
P35968	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M4
P35968	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M4
P35968	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M4
P35968	NA	NA	NA	NA	RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	2014	CHEMBL279	10980	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000230: Adenocarcinoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005706: Gallbladder Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013945: Thymoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D020522: Lymphoma, Mantle-Cell,D058405: Desmoplastic Small Round Cell Tumor,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M4
P35968	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	KDR	M4
P35968	NA	NA	NA	NA	CABOZANTINIB S-MALATE	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	2012	CHEMBL279	10980	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001254: Astrocytoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005909: Glioblastoma,D005910: Glioma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010673: Pheochromocytoma,D013964: Thyroid Neoplasms,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018288: Carcinoma, Small Cell,D018316: Gliosarcoma	KDR	M4
P35968	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	KDR	M4
P35968	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	NA	KDR	M4
P07550	NA	NA	NA	NA	TIMOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB2	M4
P07550	NA	NA	NA	NA	PINDOLOL	Beta-2 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB2	M4
P07550	NA	NA	NA	NA	NADOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB2	M4
P07550	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB2	M4
P07550	NA	NA	NA	NA	ALBUTEROL	Beta-2 adrenergic receptor agonist	AGONIST	1981	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D001988: Bronchiolitis,D003371: Cough,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D004402: Dysautonomia, Familial,D006009: Glycogen Storage Disease Type II,D006255: Rhinitis, Allergic, Seasonal,D006333: Heart Failure,D006967: Hypersensitivity,D006976: Hypertension, Pulmonary,D008171: Lung Diseases,D008173: Lung Diseases, Obstructive,D008569: Memory Disorders,D011654: Pulmonary Edema,D012131: Respiratory Insufficiency,D013119: Spinal Cord Injuries,D013224: Status Asthmaticus,D018192: Lymphangioleiomyomatosis,D020294: Myasthenic Syndromes, Congenital,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D062025: Organophosphate Poisoning,D065627: Familial Primary Pulmonary Hypertension	ADRB2	M4
P07550	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB2	M4
P07550	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB2	M4
P07550	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M4
P07550	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	SALMETEROL XINAFOATE	Beta-2 adrenergic receptor agonist	AGONIST	1994	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001989: Bronchiolitis Obliterans,D004646: Emphysema,D009765: Obesity,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M4
P07550	NA	NA	NA	NA	VILANTEROL TRIFENATATE	Beta-2 adrenergic receptor agonist	AGONIST	2013	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M4
P07550	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB2	M4
P07550	NA	NA	NA	NA	BITOLTEROL MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB2	M4
P07550	NA	NA	NA	NA	PIRBUTEROL ACETATE	Beta-2 adrenergic receptor agonist	AGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M4
P07550	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB2	M4
P07550	NA	NA	NA	NA	PROTOKYLOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	ISOETHARINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB2	M4
P07550	NA	NA	NA	NA	LEVALBUTEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1999	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001986: Bronchial Spasm	ADRB2	M4
P07550	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M4
P07550	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB2	M4
P07550	NA	NA	NA	NA	ISOETHARINE MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB2	M4
P07550	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB2	M4
P07550	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1990	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB2	M4
P07550	NA	NA	NA	NA	TERBUTALINE SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1974	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M4
P07550	NA	NA	NA	NA	RITODRINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1991	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB2	M4
P07550	NA	NA	NA	NA	ALBUTEROL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D002318: Cardiovascular Diseases,D008171: Lung Diseases,D012128: Respiratory Distress Syndrome,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M4
P07550	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M4
P07550	NA	NA	NA	NA	METAPROTERENOL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1973	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D019966: Substance-Related Disorders	ADRB2	M4
P07550	NA	NA	NA	NA	INDACATEROL MALEATE	Beta-2 adrenergic receptor agonist	AGONIST	2011	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M4
P07550	NA	NA	NA	NA	ARFORMOTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2006	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001991: Bronchitis,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M4
P07550	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB2	M4
P07550	NA	NA	NA	NA	OLODATEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	2014	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M4
P07550	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M4
P07550	NA	NA	NA	NA	LEVALBUTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2005	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm	ADRB2	M4
P07550	NA	NA	NA	NA	FORMOTEROL FUMARATE	Beta-2 adrenergic receptor agonist	AGONIST	2001	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm,D001987: Bronchiectasis,D001989: Bronchiolitis Obliterans,D001991: Bronchitis,D004646: Emphysema,D006967: Hypersensitivity,D008175: Lung Neoplasms,D012128: Respiratory Distress Syndrome,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D045169: Severe Acute Respiratory Syndrome	ADRB2	M4
Q13885	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB2A	M4
Q13885	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M4
Q13885	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M4
Q13885	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB2A	M4
Q13885	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M4
Q13885	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M4
Q13885	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M4
Q13885	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB2A	M4
Q13885	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB2A	M4
Q13885	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB2A	M4
Q13885	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB2A	M4
Q13885	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M4
Q13885	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB2A	M4
Q13885	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB2A	M4
P03956	NA	NA	NA	NA	DOXYCYCLINE	Matrix metalloproteinase-1 inhibitor	INHIBITOR	1967	CHEMBL332	13000	P03956	Interstitial collagenase	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D000544: Alzheimer Disease,D000686: Amyloidosis,D000783: Aneurysm,D000881: Anthrax,D001762: Blepharitis,D002289: Carcinoma, Non-Small-Cell Lung,D002690: Chlamydia Infections,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003550: Cystic Fibrosis,D003876: Dermatitis, Atopic,D003930: Diabetic Retinopathy,D004485: Eczema,D004605: Elephantiasis, Filarial,D005126: Eye Burns,D006470: Hemorrhage,D007239: Infections,D008193: Lyme Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008368: Mansonelliasis,D008382: Marfan Syndrome,D008545: Melanoma,D009182: Mycosis Fungoides,D009203: Myocardial Infarction,D009369: Neoplasms,D010003: Osteoarthritis,D010019: Osteomyelitis,D010146: Pain,D010190: Pancreatic Neoplasms,D010518: Periodontitis,D010930: Plague,D010996: Pleural Effusion,D011014: Pneumonia,D011125: Adenomatous Polyposis Coli,D012393: Rosacea,D012612: Scrub Typhus,D012640: Seizures,D012751: Sezary Syndrome,D012871: Skin Diseases,D013587: Syphilis,D014376: Tuberculosis,D014526: Urethritis,D015179: Colorectal Neoplasms,D015352: Dry Eye Syndromes,D015427: Reperfusion Injury,D016410: Lymphoma, T-Cell, Cutaneous,D016918: Arthritis, Reactive,D017544: Aortic Aneurysm, Abdominal,D017676: Lichen Planus, Oral,D017719: Diabetic Foot,D018923: Persian Gulf Syndrome,D028226: Amyloidosis, Familial,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D054990: Idiopathic Pulmonary Fibrosis	MMP1	M4
P03956	NA	NA	NA	NA	DOXYCYCLINE CALCIUM	Matrix metalloproteinase-1 inhibitor	INHIBITOR	1974	CHEMBL332	13000	P03956	Interstitial collagenase	Homo sapiens	D010019: Osteomyelitis	MMP1	M4
P03956	NA	NA	NA	NA	DOXYCYCLINE HYCLATE	Matrix metalloproteinase-1 inhibitor	INHIBITOR	1967	CHEMBL332	13000	P03956	Interstitial collagenase	Homo sapiens	D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D002690: Chlamydia Infections,D008268: Macular Degeneration,D010518: Periodontitis,D012393: Rosacea,D013683: Telangiectasia, Hereditary Hemorrhagic,D013716: Tennis Elbow,D015231: Sexually Transmitted Diseases, Bacterial,D052016: Mucositis	MMP1	M4
Q9H3M0	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9H3M0	Potassium voltage-gated channel subfamily F member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNF1	M4
Q9H3M0	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9H3M0	Potassium voltage-gated channel subfamily F member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNF1	M4
Q9H3M0	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9H3M0	Potassium voltage-gated channel subfamily F member 1	Homo sapiens	NA	KCNF1	M4
Q9H3M0	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9H3M0	Potassium voltage-gated channel subfamily F member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNF1	M4
P18545	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	P18545	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6G	M4
P18545	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	P18545	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6G	M4
P43304	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor	INHIBITOR	1995	CHEMBL3391681	109555	P43304	Glycerol-3-phosphate dehydrogenase, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	GPD2	M4
P12268	NA	NA	NA	NA	THIOGUANINE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1966	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001932: Brain Neoplasms,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	IMPDH2	M4
P12268	NA	NA	NA	NA	MYCOPHENOLIC ACID	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	2004	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D009404: Nephrotic Syndrome,D012595: Scleroderma, Systemic,D015352: Dry Eye Syndromes,D015470: Leukemia, Myeloid, Acute,D015867: Uveitis, Intermediate,D051436: Renal Insufficiency, Chronic	IMPDH2	M4
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1995	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000690: Amyotrophic Lateral Sclerosis,D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001327: Autoimmune Diseases,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D004062: DiGeorge Syndrome,D004820: Epidermolysis Bullosa,D005199: Fanconi Anemia,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006073: Gout,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006331: Heart Diseases,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006519: Hepatitis, Alcoholic,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006973: Hypertension,D007119: Immunoblastic Lymphadenopathy,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009472: Neuronal Ceroid-Lipofuscinoses,D010190: Pancreatic Neoplasms,D010390: Pemphigoid, Benign Mucous Membrane,D010391: Pemphigoid, Bullous,D010392: Pemphigus,D011087: Polycythemia Vera,D011128: Polyradiculopathy,D011565: Psoriasis,D011695: Purpura, Schoenlein-Henoch,D012010: Red-Cell Aplasia, Pure,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012859: Sjogren's Syndrome,D013625: Takayasu Arteritis,D014605: Uveitis,D014657: Vasculitis,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017563: Lung Diseases, Interstitial,D017565: Sarcoidosis, Pulmonary,D017728: Lymphoma, Large-Cell, Anaplastic,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D045743: Scleroderma, Diffuse,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D055953: Microscopic Polyangiitis,D056486: Chemical and Drug Induced Liver Injury,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	IMPDH2	M4
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1998	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	NA	IMPDH2	M4
O60359	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNG3	M4
O60359	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNG3	M4
O60359	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D002318: Cardiovascular Diseases	CACNG3	M4
O60359	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	NA	CACNG3	M4
O60359	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	NA	CACNG3	M4
O60359	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNG3	M4
P23921	NA	NA	NA	NA	HYDROXYUREA	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1967	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D000755: Anemia, Sickle Cell,D002277: Carcinoma,D004938: Esophageal Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006432: Hemochromatosis,D006450: Hemoglobin SC Disease,D006976: Hypertension, Pulmonary,D007822: Laryngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008579: Meningioma,D009062: Mouth Neoplasms,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010255: Paranasal Sinus Neoplasms,D010610: Pharyngeal Neoplasms,D011087: Polycythemia Vera,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D017086: beta-Thalassemia,D018222: Fibromatosis, Aggressive,D018316: Gliosarcoma,D020521: Stroke,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	RRM1	M4
P23921	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1996	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	RRM1	M4
P23921	NA	NA	NA	NA	CLOFARABINE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	2004	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	RRM1	M4
P23921	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	RRM1	M4
P23921	NA	NA	NA	NA	GALLIUM NITRATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D003550: Cystic Fibrosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009164: Mycobacterium Infections,D009447: Neuroblastoma,D012509: Sarcoma	RRM1	M4
P04035	NA	NA	NA	NA	LOVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1987	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D002537: Intracranial Arteriosclerosis,D002538: Intracranial Arteriovenous Malformations,D005600: Fragile X Syndrome,D006331: Heart Diseases,D006937: Hypercholesterolemia,D007249: Inflammation,D007383: Intermittent Claudication,D007859: Learning Disabilities,D008545: Melanoma,D008659: Metabolic Diseases,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010300: Parkinson Disease,D015470: Leukemia, Myeloid, Acute,D015518: Rett Syndrome,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D017499: Porokeratosis,D019294: Xanthomatosis, Cerebrotendinous,D020521: Stroke,D029424: Pulmonary Disease, Chronic Obstructive,D052439: Lipid Metabolism Disorders,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M4
P04035	NA	NA	NA	NA	PRAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003922: Diabetes Mellitus, Type 1,D006937: Hypercholesterolemia,D006950: Hyperlipidemia, Familial Combined,D007938: Leukemia,D008060: Lipodystrophy,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D015658: HIV Infections	HMGCR	M4
P04035	NA	NA	NA	NA	SIMVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000075222: Essential Hypertension,D000083242: Ischemic Stroke,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002311: Cardiomyopathy, Dilated,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002543: Cerebral Hemorrhage,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003550: Cystic Fibrosis,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D003930: Diabetic Retinopathy,D004827: Epilepsy,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007383: Intermittent Claudication,D007414: Intestinal Neoplasms,D007889: Leiomyoma,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D008881: Migraine Disorders,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009369: Neoplasms,D009634: Noonan Syndrome,D009902: Optic Neuritis,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010195: Pancreatitis,D010300: Parkinson Disease,D010518: Periodontitis,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012772: Shock, Septic,D012852: Sinusitis,D012893: Sleep Wake Disorders,D013274: Stomach Neoplasms,D013345: Subarachnoid Hemorrhage,D014605: Uveitis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015209: Cholangitis, Sclerosing,D015228: Hypertriglyceridemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D015794: Choroideremia,D016540: Smoking Cessation,D017202: Myocardial Ischemia,D018805: Sepsis,D019082: Smith-Lemli-Opitz Syndrome,D019694: Hepatitis B, Chronic,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D020786: Hemangioma, Cavernous, Central Nervous System,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D052016: Mucositis,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M4
P04035	NA	NA	NA	NA	ATORVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	1996	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D000082882: Bicuspid Aortic Valve Disease,D000083242: Ischemic Stroke,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D000787: Angina Pectoris,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002532: Intracranial Aneurysm,D002544: Cerebral Infarction,D003251: Constriction, Pathologic,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003424: Crohn Disease,D003919: Diabetes Insipidus,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004489: Edema, Cardiac,D004827: Epilepsy,D005909: Glioblastoma,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006333: Heart Failure,D006526: Hepatitis C,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006952: Hyperlipoproteinemia Type III,D006953: Hyperlipoproteinemia Type IV,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007251: Influenza, Human,D007674: Kidney Diseases,D007938: Leukemia,D008180: Lupus Erythematosus, Systemic,D008228: Lymphoma, Non-Hodgkin,D008268: Macular Degeneration,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009303: Nasopharyngeal Neoplasms,D009336: Necrosis,D009369: Neoplasms,D010020: Osteonecrosis,D010518: Periodontitis,D011085: Polycystic Ovary Syndrome,D011225: Pre-Eclampsia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012507: Sarcoidosis,D012594: Scleroderma, Localized,D012893: Sleep Wake Disorders,D014376: Tuberculosis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015228: Hypertriglyceridemia,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D056586: Acute Chest Syndrome,D058186: Acute Kidney Injury,D058922: Inflammatory Breast Neoplasms,D060050: Angina, Stable,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	HMGCR	M4
P04035	NA	NA	NA	NA	CERIVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1997	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	NA	HMGCR	M4
P04035	NA	NA	NA	NA	PITAVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2009	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006937: Hypercholesterolemia,D006949: Hyperlipidemias,D050171: Dyslipidemias,D052439: Lipid Metabolism Disorders	HMGCR	M4
P04035	NA	NA	NA	NA	ROSUVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2003	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D015228: Hypertriglyceridemia,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome	HMGCR	M4
P04035	NA	NA	NA	NA	FLUVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1993	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001943: Breast Neoplasms,D006937: Hypercholesterolemia	HMGCR	M4
P04035	NA	NA	NA	NA	PITAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M4
P04035	NA	NA	NA	NA	PITAVASTATIN MAGNESIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M4
O94806	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	O94806	Serine/threonine-protein kinase D3	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKD3	M4
Q8TDN1	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q8TDN1	Potassium voltage-gated channel subfamily G member 4	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG4	M4
Q8TDN1	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TDN1	Potassium voltage-gated channel subfamily G member 4	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG4	M4
Q8TDN1	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q8TDN1	Potassium voltage-gated channel subfamily G member 4	Homo sapiens	NA	KCNG4	M4
Q8TDN1	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TDN1	Potassium voltage-gated channel subfamily G member 4	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG4	M4
O43924	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6D	M4
O43924	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6D	M4
P63252	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Inward rectifier potassium channel 2 blocker	BLOCKER	2009	CHEMBL1914276	104372	P63252	Inward rectifier potassium channel 2	Homo sapiens	D001281: Atrial Fibrillation	KCNJ2	M4
P47872	NA	NA	NA	NA	SECRETIN SYNTHETIC HUMAN	Secretin receptor agonist	AGONIST	2004	CHEMBL1925	147	P47872	Secretin receptor	Homo sapiens	D001321: Autistic Disorder,D009771: Obsessive-Compulsive Disorder	SCTR	M4
P47872	NA	NA	NA	NA	SECRETIN SYNTHETIC PORCINE	Secretin receptor agonist	AGONIST	2002	CHEMBL1925	147	P47872	Secretin receptor	Homo sapiens	D001321: Autistic Disorder	SCTR	M4
P47872	NA	NA	NA	NA	SECRETIN	Secretin receptor agonist	AGONIST	2002	CHEMBL1925	147	P47872	Secretin receptor	Homo sapiens	D001321: Autistic Disorder,D004415: Dyspepsia,D009765: Obesity,D010195: Pancreatitis,D012559: Schizophrenia,D050500: Pancreatitis, Chronic	SCTR	M4
Q9UQD0	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D010146: Pain	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	NA	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN8A	M4
Q9UQD0	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q9UQD0	Sodium channel protein type 8 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN8A	M4
P30556	NA	NA	NA	NA	LOSARTAN POTASSIUM	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1995	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D006973: Hypertension,D007674: Kidney Diseases,D008382: Marfan Syndrome,D010190: Pancreatic Neoplasms,D011225: Pre-Eclampsia,D011507: Proteinuria,D017379: Hypertrophy, Left Ventricular,D021441: Carcinoma, Pancreatic Ductal,D057765: Eosinophilic Esophagitis,D065626: Non-alcoholic Fatty Liver Disease	AGTR1	M4
P30556	NA	NA	NA	NA	CANDESARTAN CILEXETIL	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1998	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006978: Hypertension, Renovascular,D010146: Pain,D011507: Proteinuria,D012078: Renal Artery Obstruction,D020521: Stroke,D050197: Atherosclerosis	AGTR1	M4
P30556	NA	NA	NA	NA	TELMISARTAN	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1998	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D000419: Albuminuria,D000544: Alzheimer Disease,D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D006331: Heart Diseases,D006973: Hypertension,D007690: Polycystic Kidney Diseases,D015658: HIV Infections,D020181: Sleep Apnea, Obstructive,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders	AGTR1	M4
P30556	NA	NA	NA	NA	VALSARTAN	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1996	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D007674: Kidney Diseases,D009203: Myocardial Infarction,D009394: Nephritis, Hereditary,D018487: Ventricular Dysfunction, Left,D024821: Metabolic Syndrome,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome	AGTR1	M4
P30556	NA	NA	NA	NA	IRBESARTAN	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1997	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D004535: Ehlers-Danlos Syndrome,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D008382: Marfan Syndrome,D017202: Myocardial Ischemia,D018805: Sepsis,D019142: Hemorrhagic Fever, Ebola,D019698: Hepatitis C, Chronic,D051436: Renal Insufficiency, Chronic	AGTR1	M4
P30556	NA	NA	NA	NA	SARALASIN ACETATE	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1982	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	NA	AGTR1	M4
P30556	NA	NA	NA	NA	OLMESARTAN MEDOXOMIL	Type-1 angiotensin II receptor antagonist	ANTAGONIST	2002	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D005921: Glomerulonephritis,D006333: Heart Failure,D006973: Hypertension,D007674: Kidney Diseases,D011507: Proteinuria,D050197: Atherosclerosis	AGTR1	M4
P30556	NA	NA	NA	NA	EPROSARTAN MESYLATE	Type-1 angiotensin II receptor antagonist	ANTAGONIST	1997	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D000075222: Essential Hypertension,D006973: Hypertension	AGTR1	M4
P30556	NA	NA	NA	NA	AZILSARTAN KAMEDOXOMIL	Type-1 angiotensin II receptor antagonist	ANTAGONIST	2011	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D006973: Hypertension	AGTR1	M4
P30556	NA	NA	NA	NA	ANGIOTENSIN II ACETATE	Type-1 angiotensin II receptor agonist	AGONIST	2017	CHEMBL227	115	P30556	Type-1 angiotensin II receptor	Homo sapiens	D012772: Shock, Septic	AGTR1	M4
P08473	NA	NA	NA	NA	SACUBITRIL	Neprilysin inhibitor	INHIBITOR	2015	CHEMBL1944	236	P08473	Neprilysin	Homo sapiens	D002312: Cardiomyopathy, Hypertrophic,D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction	MME	M4
P28072	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB6	M4
P28072	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB6	M4
P28072	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB6	M4
Q9Y6F1	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP3	M4
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP3	M4
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP3	M4
P55036	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD4	M4
P55036	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD4	M4
P55036	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD4	M4
Q9BQE3	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBA1C	M4
Q9BQE3	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBA1C	M4
Q9Y5Y9	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D010146: Pain	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	DIBUCAINE HYDROCHLORIDE	Sodium channel protein type X alpha subunit blocker	BLOCKER	1982	CHEMBL5451	18080	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN10A	M4
Q9Y5Y9	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN10A	M4
P04626	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M4
P04626	NA	NA	NA	NA	NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006394: Hemangiosarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M4
P04626	NA	NA	NA	NA	LAPATINIB DITOSYLATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2007	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010190: Pancreatic Neoplasms,D013964: Thyroid Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M4
P04626	NA	NA	NA	NA	TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	1998	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D001005: Anus Neoplasms,D001063: Appendiceal Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001927: Brain Diseases,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D004806: Ependymoma,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D007340: Insulinoma,D007938: Leukemia,D008175: Lung Neoplasms,D008228: Lymphoma, Non-Hodgkin,D009182: Mycosis Fungoides,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010282: Parathyroid Neoplasms,D010490: Pericardial Effusion,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013005: Somatostatinoma,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018567: Breast Neoplasms, Male,D044584: Carcinoma, Ductal,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M4
P04626	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	ERBB2	M4
P04626	NA	NA	NA	NA	PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2012	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D018278: Carcinoma, Neuroendocrine,D018567: Breast Neoplasms, Male,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M4
P04626	NA	NA	NA	NA	AFATINIB DIMALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma	ERBB2	M4
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	ERBB2	M4
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001932: Brain Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008107: Liver Diseases,D008175: Lung Neoplasms,D009062: Mouth Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010412: Penile Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M4
P04626	NA	NA	NA	NA	MARGETUXIMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2	M4
P04626	NA	NA	NA	NA	TUCATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D006394: Hemangiosarcoma,D008107: Liver Diseases,D009369: Neoplasms	ERBB2	M4
P04626	NA	NA	NA	NA	NERATINIB MALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2	M4
P04626	NA	NA	NA	NA	TRASTUZUMAB DERUXTECAN	Receptor protein-tyrosine kinase erbB-2 binding agent	BINDING AGENT	2019	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004067: Digestive System Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M4
P40259	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	B-cell antigen receptor complex-associated protein beta chain binding agent	BINDING AGENT	2019	CHEMBL3712852	114813	P40259	B-cell antigen receptor complex-associated protein beta chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	CD79B	M4
P56524	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC4	M4
P56524	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC4	M4
P56524	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D009101: Multiple Myeloma	HDAC4	M4
P51681	NA	NA	NA	NA	MARAVIROC	C-C chemokine receptor type 5 antagonist	ANTAGONIST	2007	CHEMBL274	10580	P51681	C-C chemokine receptor type 5	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001172: Arthritis, Rheumatoid,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007239: Infections,D008224: Lymphoma, Follicular,D009190: Myelodysplastic Syndromes,D012514: Sarcoma, Kaposi,D014777: Virus Diseases,D015228: Hypertriglyceridemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015526: AIDS Dementia Complex,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D019337: Hematologic Neoplasms,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome	CCR5	M4
P07237	NA	NA	NA	NA	LOMITAPIDE MESYLATE	Microsomal triglyceride transfer protein inhibitor	INHIBITOR	2012	CHEMBL2364681	106181	P07237	Protein disulfide-isomerase	Homo sapiens	D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias	P4HB	M4
P29322	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P29322	Ephrin type-A receptor 8	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA8	M4
P21860	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	P21860	Receptor tyrosine-protein kinase erbB-3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB3	M4
Q01668	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1D	M4
Q01668	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1D	M4
Q01668	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1D	M4
Q01668	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1D	M4
Q01668	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1D	M4
Q01668	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1D	M4
Q01668	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1D	M4
Q01668	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1D	M4
Q01668	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1D	M4
Q01668	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M4
Q01668	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1D	M4
Q01668	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1D	M4
Q01668	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M4
Q01668	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1D	M4
Q01668	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M4
Q01668	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M4
Q01668	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001281: Atrial Fibrillation	CACNA1D	M4
Q01668	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1D	M4
Q01668	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1D	M4
Q01668	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D006973: Hypertension	CACNA1D	M4
Q01668	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D006973: Hypertension	CACNA1D	M4
P22001	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA3	M4
P22001	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA3	M4
P22001	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	NA	KCNA3	M4
P22001	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA3	M4
P27487	NA	NA	NA	NA	ALOGLIPTIN BENZOATE	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2013	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D003924: Diabetes Mellitus, Type 2	DPP4	M4
P27487	NA	NA	NA	NA	LINAGLIPTIN	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2011	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004938: Esophageal Neoplasms,D006973: Hypertension,D012140: Respiratory Tract Diseases,D012559: Schizophrenia,D013274: Stomach Neoplasms,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency	DPP4	M4
P27487	NA	NA	NA	NA	SITAGLIPTIN PHOSPHATE	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2006	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006949: Hyperlipidemias,D009203: Myocardial Infarction,D020521: Stroke,D051437: Renal Insufficiency	DPP4	M4
P27487	NA	NA	NA	NA	SAXAGLIPTIN HYDROCHLORIDE	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2009	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D003924: Diabetes Mellitus, Type 2	DPP4	M4
P54762	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54762	Ephrin type-B receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHB1	M4
P31350	NA	NA	NA	NA	HYDROXYUREA	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1967	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D000755: Anemia, Sickle Cell,D002277: Carcinoma,D004938: Esophageal Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006432: Hemochromatosis,D006450: Hemoglobin SC Disease,D006976: Hypertension, Pulmonary,D007822: Laryngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008579: Meningioma,D009062: Mouth Neoplasms,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010255: Paranasal Sinus Neoplasms,D010610: Pharyngeal Neoplasms,D011087: Polycythemia Vera,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D017086: beta-Thalassemia,D018222: Fibromatosis, Aggressive,D018316: Gliosarcoma,D020521: Stroke,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	RRM2	M4
P31350	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1996	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	RRM2	M4
P31350	NA	NA	NA	NA	CLOFARABINE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	2004	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	RRM2	M4
P31350	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	RRM2	M4
P31350	NA	NA	NA	NA	GALLIUM NITRATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D003550: Cystic Fibrosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009164: Mycobacterium Infections,D009447: Neuroblastoma,D012509: Sarcoma	RRM2	M4
P11926	NA	NA	NA	NA	EFLORNITHINE HYDROCHLORIDE	Ornithine decarboxylase inhibitor	INHIBITOR	1990	CHEMBL1869	272	P11926	Ornithine decarboxylase	Homo sapiens	D009447: Neuroblastoma,D011125: Adenomatous Polyposis Coli,D018305: Ganglioneuroblastoma	ODC1	M4
Q02880	NA	NA	NA	NA	ETOPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1983	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000163: Acquired Immunodeficiency Syndrome,D000306: Adrenal Cortex Neoplasms,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002822: Choriocarcinoma,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005910: Glioma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006402: Hematologic Diseases,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008479: Mediastinal Neoplasms,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009396: Wilms Tumor,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009503: Neutropenia,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016393: Lymphoma, B-Cell,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018236: Carcinoma, Embryonal,D018239: Seminoma,D018240: Endodermal Sinus Tumor,D018242: Neuroectodermal Tumors, Primitive,D018273: Carcinoma, Islet Cell,D018278: Carcinoma, Neuroendocrine,D018302: Neoplasms, Neuroepithelial,D018305: Ganglioneuroblastoma,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020339: Optic Nerve Glioma,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TOP2B	M4
Q02880	NA	NA	NA	NA	TENIPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1992	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D007938: Leukemia,D008223: Lymphoma,D009369: Neoplasms,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	TOP2B	M4
Q9H244	NA	NA	NA	NA	TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2011	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D007511: Ischemia,D007674: Kidney Diseases,D009203: Myocardial Infarction,D011014: Pneumonia,D013927: Thrombosis,D016893: Carotid Stenosis,D017544: Aortic Aneurysm, Abdominal,D020521: Stroke,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D058729: Peripheral Arterial Disease,D060050: Angina, Stable	P2RY12	M4
Q9H244	NA	NA	NA	NA	TICLOPIDINE HYDROCHLORIDE	Purinergic receptor P2Y12 antagonist	ANTAGONIST	1991	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	NA	P2RY12	M4
Q9H244	NA	NA	NA	NA	CANGRELOR TETRASODIUM	Purinergic receptor P2Y12 antagonist	ANTAGONIST	2015	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D009203: Myocardial Infarction,D013927: Thrombosis	P2RY12	M4
Q9H244	NA	NA	NA	NA	CLOPIDOGREL BISULFATE	Purinergic receptor P2Y12 antagonist	ANTAGONIST	1997	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D000789: Angina, Unstable,D001943: Breast Neoplasms,D003327: Coronary Disease,D006471: Gastrointestinal Hemorrhage,D007511: Ischemia,D009203: Myocardial Infarction,D020521: Stroke,D054058: Acute Coronary Syndrome,D058729: Peripheral Arterial Disease	P2RY12	M4
Q9H244	NA	NA	NA	NA	PRASUGREL HYDROCHLORIDE	Purinergic receptor P2Y12 antagonist	ANTAGONIST	2009	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D054058: Acute Coronary Syndrome	P2RY12	M4
P18054	NA	NA	NA	NA	BENOXAPROFEN	Arachidonate 12-lipoxygenase inhibitor	INHIBITOR	1982	CHEMBL3687	11134	P18054	Polyunsaturated fatty acid lipoxygenase ALOX12	Homo sapiens	D012216: Rheumatic Diseases	ALOX12	M4
O43613	NA	NA	NA	NA	SUVOREXANT	Orexin receptor antagonist	ANTAGONIST	2014	CHEMBL3307226	108439	O43613	Orexin receptor type 1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D003693: Delirium,D007319: Sleep Initiation and Maintenance Disorders,D009293: Opioid-Related Disorders,D012148: Restless Legs Syndrome,D012891: Sleep Apnea Syndromes,D012893: Sleep Wake Disorders,D014029: Tobacco Use Disorder,D016540: Smoking Cessation	HCRTR1	M4
O43613	NA	NA	NA	NA	LEMBOREXANT	Orexin receptor 1 antagonist	ANTAGONIST	2020	CHEMBL5113	10009	O43613	Orexin receptor type 1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders,D007674: Kidney Diseases,D008107: Liver Diseases,D020178: Sleep Disorders, Circadian Rhythm,D020181: Sleep Apnea, Obstructive	HCRTR1	M4
P08887	NA	NA	NA	NA	TOCILIZUMAB	Interleukin-6 receptor alpha subunit inhibitor	INHIBITOR	2005	CHEMBL2364155	106134	P08887	Interleukin-6 receptor subunit alpha	Homo sapiens	D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003882: Dermatomyositis,D003922: Diabetes Mellitus, Type 1,D005334: Fever,D005357: Fibrous Dysplasia of Bone,D005871: Castleman Disease,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006528: Carcinoma, Hepatocellular,D006976: Hypertension, Pulmonary,D007154: Immune System Diseases,D007938: Leukemia,D008113: Liver Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D009471: Neuromyelitis Optica,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010505: Familial Mediterranean Fever,D011014: Pneumonia,D011024: Pneumonia, Viral,D011081: Polychondritis, Relapsing,D011111: Polymyalgia Rheumatica,D011471: Prostatic Neoplasms,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D012595: Scleroderma, Systemic,D013167: Spondylitis, Ankylosing,D013625: Takayasu Arteritis,D013700: Giant Cell Arteritis,D014605: Uveitis,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015866: Uveitis, Posterior,D015867: Uveitis, Intermediate,D016403: Lymphoma, Large B-Cell, Diffuse,D016706: Still's Disease, Adult-Onset,D019337: Hematologic Neoplasms,D031249: Erdheim-Chester Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055501: Macrophage Activation Syndrome	IL6R	M4
P08887	NA	NA	NA	NA	SARILUMAB	Interleukin-6 receptor alpha subunit antagonist	ANTAGONIST	2017	CHEMBL2364155	106134	P08887	Interleukin-6 receptor subunit alpha	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D007154: Immune System Diseases,D011111: Polymyalgia Rheumatica,D012594: Scleroderma, Localized,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014605: Uveitis,D034721: Mastocytosis, Systemic,D045169: Severe Acute Respiratory Syndrome	IL6R	M4
P08887	NA	NA	NA	NA	SATRALIZUMAB	IL6Ralpha/GP130 antagonist	ANTAGONIST	2020	CHEMBL3137266	108122	P08887	Interleukin-6 receptor subunit alpha	Homo sapiens	D007154: Immune System Diseases,D009471: Neuromyelitis Optica	IL6R	M4
P09874	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	P09874	Poly [ADP-ribose] polymerase 1	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP1	M4
P09874	NA	NA	NA	NA	NIRAPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	INHIBITOR	2017	CHEMBL3105	11663	P09874	Poly [ADP-ribose] polymerase 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012512: Sarcoma, Ewing,D013274: Stomach Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP1	M4
P09874	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	P09874	Poly [ADP-ribose] polymerase 1	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP1	M4
P09874	NA	NA	NA	NA	TALAZOPARIB TOSYLATE	Poly [ADP-ribose] polymerase-1 inhibitor	INHIBITOR	2018	CHEMBL3105	11663	P09874	Poly [ADP-ribose] polymerase 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009369: Neoplasms,D015470: Leukemia, Myeloid, Acute,D064726: Triple Negative Breast Neoplasms	PARP1	M4
P09874	NA	NA	NA	NA	TALAZOPARIB	Poly [ADP-ribose] polymerase-1 inhibitor	INHIBITOR	2018	CHEMBL3105	11663	P09874	Poly [ADP-ribose] polymerase 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006394: Hemangiosarcoma,D007938: Leukemia,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP1	M4
P09874	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	P09874	Poly [ADP-ribose] polymerase 1	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP1	M4
P09874	NA	NA	NA	NA	NIRAPARIB TOSYLATE	Poly [ADP-ribose] polymerase-1 inhibitor	INHIBITOR	2017	CHEMBL3105	11663	P09874	Poly [ADP-ribose] polymerase 1	Homo sapiens	D005185: Fallopian Tube Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms	PARP1	M4
Q9UQL6	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9UQL6	Histone deacetylase 5	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC5	M4
Q9UQL6	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9UQL6	Histone deacetylase 5	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC5	M4
Q9UQL6	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9UQL6	Histone deacetylase 5	Homo sapiens	D009101: Multiple Myeloma	HDAC5	M4
O60894	NA	NA	NA	NA	PRAMLINTIDE ACETATE	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	2005	CHEMBL2111189	104908	O60894	Receptor activity-modifying protein 1	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity	RAMP1	M4
O14980	NA	NA	NA	NA	SELINEXOR	Exportin-1 inhibitor	INHIBITOR	2019	CHEMBL5661	101280	O14980	Exportin-1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D008080: Liposarcoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015179: Colorectal Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D017719: Diabetic Foot,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D045169: Severe Acute Respiratory Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	XPO1	M4
P35354	NA	NA	NA	NA	INDOMETHACIN	Cyclooxygenase inhibitor	INHIBITOR	1965	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000081483: Squamous Intraepithelial Lesions,D000544: Alzheimer Disease,D001249: Asthma,D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D002318: Cardiovascular Diseases,D004374: Ductus Arteriosus, Patent,D005128: Eye Diseases,D006073: Gout,D006470: Hemorrhage,D006646: Histiocytosis, Langerhans-Cell,D007024: Hypotension, Orthostatic,D007249: Inflammation,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008545: Melanoma,D010003: Osteoarthritis,D010146: Pain,D010195: Pancreatitis,D011471: Prostatic Neoplasms,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D014098: Toothache,D015210: Arthritis, Gouty,D018771: Arthralgia,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D050500: Pancreatitis, Chronic,D056844: Renal Colic,D059787: Acute Pain,D063806: Myalgia,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS2	M4
P35354	NA	NA	NA	NA	SULFASALAZINE	Cyclooxygenase inhibitor	INHIBITOR	1950	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D005909: Glioblastoma,D006976: Hypertension, Pulmonary,D007415: Intestinal Obstruction,D009325: Nausea,D010019: Osteomyelitis,D010523: Peripheral Nervous System Diseases,D013167: Spondylitis, Ankylosing,D015209: Cholangitis, Sclerosing,D015535: Arthritis, Psoriatic	PTGS2	M4
P35354	CHEMBL25	1280	2244	DB00945	ASPIRIN	Cyclooxygenase inhibitor	INHIBITOR	1950	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000026: Abortion, Habitual,D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000077192: Adenocarcinoma of Lung,D000083242: Ischemic Stroke,D000236: Adenoma,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001249: Asthma,D001281: Atrial Fibrillation,D001471: Barrett Esophagus,D001714: Bipolar Disorder,D001766: Blindness,D001778: Blood Coagulation Disorders,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D002386: Cataract,D002532: Intracranial Aneurysm,D002537: Intracranial Arteriosclerosis,D002544: Cerebral Infarction,D002546: Ischemic Attack, Transient,D002561: Cerebrovascular Disorders,D002583: Uterine Cervical Neoplasms,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D003139: Common Cold,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D003930: Diabetic Retinopathy,D004066: Digestive System Diseases,D004211: Disseminated Intravascular Coagulation,D004381: Duodenal Ulcer,D004938: Esophageal Neoplasms,D005221: Fatigue,D005317: Fetal Growth Retardation,D005334: Fever,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006261: Headache,D006331: Heart Diseases,D006333: Heart Failure,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D006528: Carcinoma, Hepatocellular,D006561: Herpes Simplex,D006562: Herpes Zoster,D006937: Hypercholesterolemia,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007511: Ischemia,D007972: Leukoplakia, Oral,D008180: Lupus Erythematosus, Systemic,D008268: Macular Degeneration,D008545: Melanoma,D008581: Meningitis,D008881: Migraine Disorders,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010003: Osteoarthritis,D010020: Osteonecrosis,D010051: Ovarian Neoplasms,D010146: Pain,D010437: Peptic Ulcer,D010518: Periodontitis,D010612: Pharyngitis,D010927: Placental Insufficiency,D011014: Pneumonia,D011024: Pneumonia, Viral,D011087: Polycythemia Vera,D011125: Adenomatous Polyposis Coli,D011225: Pre-Eclampsia,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011618: Psychotic Disorders,D012004: Rectal Neoplasms,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012170: Retinal Vein Occlusion,D012214: Rheumatic Heart Disease,D012559: Schizophrenia,D013035: Spasm,D013274: Stomach Neoplasms,D013276: Stomach Ulcer,D013920: Thrombocythemia, Essential,D013927: Thrombosis,D014029: Tobacco Use Disorder,D014376: Tuberculosis,D014456: Ulcer,D014647: Varicose Ulcer,D014652: Vascular Diseases,D014808: Vitamin D Deficiency,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015228: Hypertriglyceridemia,D015356: Retinal Artery Occlusion,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016889: Endometrial Neoplasms,D016893: Carotid Stenosis,D017116: Low Back Pain,D017202: Myocardial Ischemia,D018781: Tension-Type Headache,D018805: Sepsis,D019851: Thrombophilia,D020246: Venous Thrombosis,D020520: Brain Infarction,D020521: Stroke,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D050197: Atherosclerosis,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D055371: Acute Lung Injury,D056586: Acute Chest Syndrome,D058729: Peripheral Arterial Disease,D060050: Angina, Stable,D061218: Depressive Disorder, Treatment-Resistant,D062788: Adenomyosis,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS2	M4
P35354	CHEMBL521	11674	3672	DB01050	IBUPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1974	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000532: Altitude Sickness,D000544: Alzheimer Disease,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D001943: Breast Neoplasms,D001997: Bronchopulmonary Dysplasia,D002056: Burns,D002318: Cardiovascular Diseases,D002422: Causalgia,D002547: Cerebral Palsy,D003139: Common Cold,D003865: Depressive Disorder, Major,D003922: Diabetes Mellitus, Type 1,D004374: Ductus Arteriosus, Patent,D004412: Dysmenorrhea,D004646: Emphysema,D004828: Epilepsies, Partial,D005334: Fever,D005910: Glioma,D006105: Granulomatous Disease, Chronic,D006255: Rhinitis, Allergic, Seasonal,D006261: Headache,D006470: Hemorrhage,D006973: Hypertension,D007021: Hypospadias,D007024: Hypotension, Orthostatic,D007239: Infections,D007251: Influenza, Human,D008288: Malaria,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009135: Muscular Diseases,D010003: Osteoarthritis,D010146: Pain,D010195: Pancreatitis,D010437: Peptic Ulcer,D010518: Periodontitis,D011225: Pre-Eclampsia,D011671: Pulpitis,D012128: Respiratory Distress Syndrome,D012178: Retinopathy of Prematurity,D012216: Rheumatic Diseases,D012772: Shock, Septic,D012852: Sinusitis,D013180: Sprains and Strains,D013281: Stomatitis, Aphthous,D013471: Sunburn,D013705: Temporomandibular Joint Disorders,D014076: Tooth Diseases,D014098: Toothache,D014376: Tuberculosis,D014627: Vaginitis,D014657: Vasculitis,D014947: Wounds and Injuries,D015658: HIV Infections,D017116: Low Back Pain,D018771: Arthralgia,D018781: Tension-Type Headache,D019547: Neck Pain,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D020388: Muscular Dystrophy, Duchenne,D020968: Brachial Plexus Neuritis,D025242: Spondylarthropathies,D047928: Premature Birth,D050723: Fractures, Bone,D055009: Spondylosis,D059350: Chronic Pain,D059787: Acute Pain,D060825: Cognitive Dysfunction,D063806: Myalgia,D064386: Ankle Fractures	PTGS2	M4
P35354	NA	NA	NA	NA	PIROXICAM	Cyclooxygenase inhibitor	INHIBITOR	1982	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001172: Arthritis, Rheumatoid,D005128: Eye Diseases,D010003: Osteoarthritis,D012216: Rheumatic Diseases,D013716: Tennis Elbow,D018771: Arthralgia,D020370: Osteoarthritis, Knee,D056844: Renal Colic,D063806: Myalgia	PTGS2	M4
P35354	NA	NA	NA	NA	PHENYLBUTAZONE	Cyclooxygenase inhibitor	INHIBITOR	1980	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases,D018771: Arthralgia,D063806: Myalgia	PTGS2	M4
P35354	NA	NA	NA	NA	FLURBIPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1986	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000740: Anemia,D001172: Arthritis, Rheumatoid,D003924: Diabetes Mellitus, Type 2,D005128: Eye Diseases,D010146: Pain,D010518: Periodontitis,D010612: Pharyngitis,D012216: Rheumatic Diseases,D015658: HIV Infections,D017116: Low Back Pain,D018771: Arthralgia,D028361: Mitochondrial Diseases,D063806: Myalgia	PTGS2	M4
P35354	CHEMBL112	16450	1983	DB00316	ACETAMINOPHEN	Cyclooxygenase inhibitor	INHIBITOR	1968	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000070636: Rotator Cuff Injuries,D000744: Anemia, Hemolytic, Autoimmune,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D001883: Borderline Personality Disorder,D001924: Brain Concussion,D001930: Brain Injuries,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002972: Cleft Palate,D003139: Common Cold,D003424: Crohn Disease,D003693: Delirium,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003929: Diabetic Neuropathies,D004066: Digestive System Diseases,D004374: Ductus Arteriosus, Patent,D004412: Dysmenorrhea,D005334: Fever,D005901: Glaucoma,D005910: Glioma,D006009: Glycogen Storage Disease Type II,D006086: Graft vs Host Disease,D006261: Headache,D006470: Hemorrhage,D006973: Hypertension,D006984: Hypertrophy,D007021: Hypospadias,D007154: Immune System Diseases,D007239: Infections,D007251: Influenza, Human,D007669: Kidney Calculi,D007674: Kidney Diseases,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008545: Melanoma,D008881: Migraine Disorders,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009216: Myopia,D009325: Nausea,D009369: Neoplasms,D009422: Nervous System Diseases,D009437: Neuralgia,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010300: Parkinson Disease,D010392: Pemphigus,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011537: Pruritus,D011671: Pulpitis,D012141: Respiratory Tract Infections,D012600: Scoliosis,D012852: Sinusitis,D013290: Streptococcal Infections,D014069: Tonsillitis,D014076: Tooth Diseases,D014098: Toothache,D014839: Vomiting,D014947: Wounds and Injuries,D015207: Osteoarthritis, Hip,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015458: Leukemia, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015658: HIV Infections,D015746: Abdominal Pain,D016403: Lymphoma, Large B-Cell, Diffuse,D016553: Purpura, Thrombocytopenic, Idiopathic,D016920: Meningitis, Bacterial,D017116: Low Back Pain,D018781: Tension-Type Headache,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D020250: Postoperative Nausea and Vomiting,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D050723: Fractures, Bone,D052016: Mucositis,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D055959: Intervertebral Disc Degeneration,D056844: Renal Colic,D059350: Chronic Pain,D059787: Acute Pain,D064386: Ankle Fractures	PTGS2	M4
P35354	NA	NA	NA	NA	SULINDAC	Cyclooxygenase inhibitor	INHIBITOR	1978	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D008545: Melanoma,D011125: Adenomatous Polyposis Coli,D011230: Precancerous Conditions,D012216: Rheumatic Diseases,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018222: Fibromatosis, Aggressive	PTGS2	M4
P35354	NA	NA	NA	NA	FENCLOFENAC	Cyclooxygenase inhibitor	INHIBITOR	1978	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2	M4
P35354	NA	NA	NA	NA	KETOPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1986	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D002062: Bursitis,D007249: Inflammation,D007669: Kidney Calculi,D008881: Migraine Disorders,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010518: Periodontitis,D012216: Rheumatic Diseases,D013180: Sprains and Strains,D014947: Wounds and Injuries,D017116: Low Back Pain,D018771: Arthralgia,D020250: Postoperative Nausea and Vomiting,D020370: Osteoarthritis, Knee,D052256: Tendinopathy,D056844: Renal Colic,D059787: Acute Pain,D063806: Myalgia	PTGS2	M4
P35354	NA	NA	NA	NA	INDOPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1979	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2	M4
P35354	NA	NA	NA	NA	CELECOXIB	Cyclooxygenase-2 inhibitor	INHIBITOR	1998	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000070636: Rotator Cuff Injuries,D000071960: Breast Carcinoma In Situ,D000077195: Squamous Cell Carcinoma of Head and Neck,D000081483: Squamous Intraepithelial Lesions,D000236: Adenoma,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001714: Bipolar Disorder,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004412: Dysmenorrhea,D004938: Esophageal Neoplasms,D005157: Facial Pain,D005909: Glioblastoma,D005910: Glioma,D006073: Gout,D006258: Head and Neck Neoplasms,D006470: Hemorrhage,D006527: Hepatolenticular Degeneration,D006528: Carcinoma, Hepatocellular,D006973: Hypertension,D007024: Hypotension, Orthostatic,D007249: Inflammation,D007251: Influenza, Human,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008527: Medulloblastoma,D008545: Melanoma,D008569: Memory Disorders,D008881: Migraine Disorders,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009437: Neuralgia,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010003: Osteoarthritis,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010212: Papilloma,D010265: Paraproteinemias,D010437: Peptic Ulcer,D010534: Peritoneal Neoplasms,D010612: Pharyngitis,D011125: Adenomatous Polyposis Coli,D011225: Pre-Eclampsia,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012216: Rheumatic Diseases,D012509: Sarcoma,D012559: Schizophrenia,D013167: Spondylitis, Ankylosing,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014098: Toothache,D014376: Tuberculosis,D014594: Uterine Neoplasms,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015207: Osteoarthritis, Hip,D016543: Central Nervous System Neoplasms,D017116: Low Back Pain,D018192: Lymphangioleiomyomatosis,D019052: Depression, Postpartum,D020370: Osteoarthritis, Knee,D030361: Papillomavirus Infections,D049970: Graves Ophthalmopathy,D055623: Keratosis, Actinic,D059350: Chronic Pain,D059787: Acute Pain,D060831: Hand-Foot Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS2	M4
P35354	NA	NA	NA	NA	MELOXICAM	Cyclooxygenase-2 inhibitor	INHIBITOR	2000	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D004412: Dysmenorrhea,D008180: Lupus Erythematosus, Systemic,D008881: Migraine Disorders,D010003: Osteoarthritis,D010146: Pain,D010612: Pharyngitis,D011471: Prostatic Neoplasms,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D014098: Toothache,D014376: Tuberculosis,D017116: Low Back Pain,D020069: Shoulder Pain	PTGS2	M4
P35354	NA	NA	NA	NA	ROFECOXIB	Cyclooxygenase-2 inhibitor	INHIBITOR	1999	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000236: Adenoma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D007592: Joint Diseases,D010003: Osteoarthritis,D010146: Pain,D012216: Rheumatic Diseases,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D020370: Osteoarthritis, Knee,D064129: Prostatic Neoplasms, Castration-Resistant	PTGS2	M4
P35354	NA	NA	NA	NA	ETODOLAC	Cyclooxygenase-2 inhibitor	INHIBITOR	1991	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001172: Arthritis, Rheumatoid,D006528: Carcinoma, Hepatocellular,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009135: Muscular Diseases,D010003: Osteoarthritis,D010146: Pain,D010190: Pancreatic Neoplasms,D012216: Rheumatic Diseases,D013180: Sprains and Strains,D015179: Colorectal Neoplasms,D059787: Acute Pain	PTGS2	M4
P35354	NA	NA	NA	NA	DICLOFENAC	Cyclooxygenase inhibitor	INHIBITOR	1988	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000375: Aging,D001172: Arthritis, Rheumatoid,D002277: Carcinoma,D002280: Carcinoma, Basal Cell,D003866: Depressive Disorder,D005128: Eye Diseases,D007246: Infertility,D009369: Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010518: Periodontitis,D011655: Pulmonary Embolism,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D013180: Sprains and Strains,D013276: Stomach Ulcer,D014098: Toothache,D015207: Osteoarthritis, Hip,D018771: Arthralgia,D020370: Osteoarthritis, Knee,D055623: Keratosis, Actinic,D056844: Renal Colic,D059373: Mastodynia,D059787: Acute Pain,D063806: Myalgia	PTGS2	M4
P35354	NA	NA	NA	NA	MEFENAMIC ACID	Cyclooxygenase inhibitor	INHIBITOR	1967	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D003920: Diabetes Mellitus,D004412: Dysmenorrhea,D006470: Hemorrhage,D010146: Pain,D012216: Rheumatic Diseases	PTGS2	M4
P35354	NA	NA	NA	NA	MESALAMINE	Cyclooxygenase inhibitor	INHIBITOR	1987	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000076385: Diverticular Diseases,D000236: Adenoma,D001607: Berylliosis,D003092: Colitis,D003093: Colitis, Ulcerative,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D003424: Crohn Disease,D004238: Diverticulitis,D004241: Diverticulum, Colon,D011349: Proctitis,D015179: Colorectal Neoplasms,D015658: HIV Infections,D043183: Irritable Bowel Syndrome,D044342: Malnutrition,D046729: Colitis, Collagenous,D046730: Colitis, Lymphocytic	PTGS2	M4
P35354	NA	NA	NA	NA	BROMFENAC SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1997	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2	M4
P35354	NA	NA	NA	NA	NAPROXEN	Cyclooxygenase inhibitor	INHIBITOR	1976	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000544: Alzheimer Disease,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D001943: Breast Neoplasms,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D004381: Duodenal Ulcer,D004412: Dysmenorrhea,D006073: Gout,D006261: Headache,D007249: Inflammation,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D010437: Peptic Ulcer,D010996: Pleural Effusion,D011471: Prostatic Neoplasms,D012216: Rheumatic Diseases,D013167: Spondylitis, Ankylosing,D013276: Stomach Ulcer,D014098: Toothache,D014627: Vaginitis,D015207: Osteoarthritis, Hip,D015210: Arthritis, Gouty,D017116: Low Back Pain,D018771: Arthralgia,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D049310: Distal Myopathies,D059787: Acute Pain,D063806: Myalgia	PTGS2	M4
P35354	NA	NA	NA	NA	VALDECOXIB	Cyclooxygenase-2 inhibitor	INHIBITOR	2001	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D010003: Osteoarthritis,D010146: Pain,D010195: Pancreatitis,D010612: Pharyngitis,D012216: Rheumatic Diseases,D020370: Osteoarthritis, Knee	PTGS2	M4
P35354	NA	NA	NA	NA	DIFLUNISAL	Cyclooxygenase inhibitor	INHIBITOR	1982	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D003924: Diabetes Mellitus, Type 2,D005334: Fever,D010146: Pain,D028227: Amyloid Neuropathies, Familial	PTGS2	M4
P35354	NA	NA	NA	NA	SUPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1985	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2	M4
P35354	NA	NA	NA	NA	NEPAFENAC	Cyclooxygenase inhibitor	INHIBITOR	2005	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D002386: Cataract,D005128: Eye Diseases,D007249: Inflammation,D008269: Macular Edema,D015877: Miosis	PTGS2	M4
P35354	NA	NA	NA	NA	DICLOFENAC SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1988	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000740: Anemia,D001172: Arthritis, Rheumatoid,D001749: Urinary Bladder Neoplasms,D006073: Gout,D006470: Hemorrhage,D007249: Inflammation,D009135: Muscular Diseases,D010003: Osteoarthritis,D010032: Otitis Externa,D010146: Pain,D011843: Radiculopathy,D013180: Sprains and Strains,D013471: Sunburn,D014098: Toothache,D017116: Low Back Pain,D020370: Osteoarthritis, Knee,D055623: Keratosis, Actinic,D059350: Chronic Pain	PTGS2	M4
P35354	NA	NA	NA	NA	NABUMETONE	Cyclooxygenase-2 inhibitor	INHIBITOR	1991	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2	M4
P35354	NA	NA	NA	NA	OXAPROZIN	Cyclooxygenase inhibitor	INHIBITOR	1992	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2	M4
P35354	NA	NA	NA	NA	BISMUTH SUBSALICYLATE	Cyclooxygenase inhibitor	INHIBITOR	1996	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D008223: Lymphoma,D016481: Helicobacter Infections	PTGS2	M4
P35354	NA	NA	NA	NA	CARPROFEN	Cyclooxygenase-2 inhibitor	INHIBITOR	1987	CHEMBL230	126	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2	M4
P35354	NA	NA	NA	NA	PIRPROFEN	Cyclooxygenase inhibitor	INHIBITOR	1987	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D012216: Rheumatic Diseases	PTGS2	M4
P35354	NA	NA	NA	NA	OXAPROZIN POTASSIUM	Cyclooxygenase inhibitor	INHIBITOR	2002	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2	M4
P35354	NA	NA	NA	NA	TOLMETIN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1976	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2	M4
P35354	NA	NA	NA	NA	BALSALAZIDE DISODIUM	Cyclooxygenase inhibitor	INHIBITOR	2000	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D003093: Colitis, Ulcerative	PTGS2	M4
P35354	NA	NA	NA	NA	DICLOFENAC POTASSIUM	Cyclooxygenase inhibitor	INHIBITOR	1993	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001172: Arthritis, Rheumatoid,D004412: Dysmenorrhea,D008881: Migraine Disorders,D010003: Osteoarthritis,D010146: Pain,D011671: Pulpitis,D013276: Stomach Ulcer,D014098: Toothache,D059787: Acute Pain	PTGS2	M4
P35354	NA	NA	NA	NA	NAPROXEN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1980	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D000544: Alzheimer Disease,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001416: Back Pain,D002062: Bursitis,D004412: Dysmenorrhea,D006073: Gout,D008881: Migraine Disorders,D010003: Osteoarthritis,D010146: Pain,D010612: Pharyngitis,D013167: Spondylitis, Ankylosing,D013276: Stomach Ulcer,D014098: Toothache,D020370: Osteoarthritis, Knee,D052256: Tendinopathy,D059787: Acute Pain	PTGS2	M4
P35354	NA	NA	NA	NA	OLSALAZINE SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1990	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D003093: Colitis, Ulcerative	PTGS2	M4
P35354	NA	NA	NA	NA	KETOROLAC TROMETHAMINE	Cyclooxygenase inhibitor	INHIBITOR	1989	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001416: Back Pain,D002386: Cataract,D002539: Cerebral Arterial Diseases,D006255: Rhinitis, Allergic, Seasonal,D006331: Heart Diseases,D007249: Inflammation,D007669: Kidney Calculi,D008269: Macular Edema,D008881: Migraine Disorders,D010146: Pain,D011671: Pulpitis,D019534: Shoulder Impingement Syndrome,D056844: Renal Colic,D059787: Acute Pain	PTGS2	M4
P35354	NA	NA	NA	NA	IBUPROFEN LYSINE	Cyclooxygenase inhibitor	INHIBITOR	2006	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D004374: Ductus Arteriosus, Patent	PTGS2	M4
P35354	NA	NA	NA	NA	DICLOFENAC EPOLAMINE	Cyclooxygenase inhibitor	INHIBITOR	2007	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D001943: Breast Neoplasms,D010195: Pancreatitis,D013180: Sprains and Strains,D059787: Acute Pain	PTGS2	M4
P35354	NA	NA	NA	NA	MECLOFENAMATE SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1980	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2	M4
P35354	NA	NA	NA	NA	FENOPROFEN CALCIUM	Cyclooxygenase inhibitor	INHIBITOR	1976	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2	M4
P35354	NA	NA	NA	NA	IBUPROFEN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	2012	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D010146: Pain	PTGS2	M4
P35354	NA	NA	NA	NA	INDOMETHACIN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1985	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D007249: Inflammation	PTGS2	M4
P35354	NA	NA	NA	NA	OXYPHENBUTAZONE	Cyclooxygenase inhibitor	INHIBITOR	1960	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	D005128: Eye Diseases,D012216: Rheumatic Diseases,D018771: Arthralgia,D063806: Myalgia	PTGS2	M4
P35354	NA	NA	NA	NA	FLURBIPROFEN SODIUM	Cyclooxygenase inhibitor	INHIBITOR	1986	CHEMBL2094253	104725	P35354	Prostaglandin G/H synthase 2	Homo sapiens	NA	PTGS2	M4
P01008	NA	NA	NA	NA	FONDAPARINUX SODIUM	Antithrombin-III activator	ACTIVATOR	2001	CHEMBL1950	16	P01008	Antithrombin-III	Homo sapiens	D011655: Pulmonary Embolism,D013923: Thromboembolism,D020246: Venous Thrombosis,D051437: Renal Insufficiency,D054556: Venous Thromboembolism	SERPINC1	M4
P01008	NA	NA	NA	NA	ENOXAPARIN SODIUM	Antithrombin-III activator	ACTIVATOR	1993	CHEMBL1950	16	P01008	Antithrombin-III	Homo sapiens	D000026: Abortion, Habitual,D000072657: ST Elevation Myocardial Infarction,D001281: Atrial Fibrillation,D001778: Blood Coagulation Disorders,D002289: Carcinoma, Non-Small-Cell Lung,D004938: Esophageal Neoplasms,D005317: Fetal Growth Retardation,D006470: Hemorrhage,D006620: Hip Fractures,D007239: Infections,D007674: Kidney Diseases,D008103: Liver Cirrhosis,D008223: Lymphoma,D009203: Myocardial Infarction,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009765: Obesity,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011655: Pulmonary Embolism,D013203: Staphylococcal Infections,D013923: Thromboembolism,D013927: Thrombosis,D017202: Myocardial Ischemia,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D055752: Small Cell Lung Carcinoma	SERPINC1	M4
P01008	NA	NA	NA	NA	ARDEPARIN SODIUM	Antithrombin-III activator	ACTIVATOR	1997	CHEMBL1950	16	P01008	Antithrombin-III	Homo sapiens	NA	SERPINC1	M4
P01008	NA	NA	NA	NA	HEPARIN CALCIUM	Antithrombin-III activator	ACTIVATOR	1982	CHEMBL1950	16	P01008	Antithrombin-III	Homo sapiens	D000026: Abortion, Habitual,D005128: Eye Diseases,D011695: Purpura, Schoenlein-Henoch,D013927: Thrombosis,D014648: Varicose Veins	SERPINC1	M4
P01008	NA	NA	NA	NA	HEPARIN SODIUM	Antithrombin-III activator	ACTIVATOR	1939	CHEMBL1950	16	P01008	Antithrombin-III	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000789: Angina, Unstable,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D001424: Bacterial Infections,D002056: Burns,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D005128: Eye Diseases,D006331: Heart Diseases,D006470: Hemorrhage,D006620: Hip Fractures,D007239: Infections,D007246: Infertility,D009203: Myocardial Infarction,D009369: Neoplasms,D009765: Obesity,D011014: Pneumonia,D011225: Pre-Eclampsia,D011247: Pregnancy,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012769: Shock,D012772: Shock, Septic,D013280: Stomatitis,D013345: Subarachnoid Hemorrhage,D013923: Thromboembolism,D013924: Thrombophlebitis,D013927: Thrombosis,D014552: Urinary Tract Infections,D014648: Varicose Veins,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D016470: Bacteremia,D017202: Myocardial Ischemia,D018630: Vitreoretinopathy, Proliferative,D018805: Sepsis,D018856: Cystitis, Interstitial,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D058186: Acute Kidney Injury,D060050: Angina, Stable	SERPINC1	M4
P01008	NA	NA	NA	NA	TINZAPARIN SODIUM	Antithrombin-III activator	ACTIVATOR	2000	CHEMBL1950	16	P01008	Antithrombin-III	Homo sapiens	D000083242: Ischemic Stroke,D002289: Carcinoma, Non-Small-Cell Lung,D007680: Kidney Neoplasms,D009101: Multiple Myeloma,D011014: Pneumonia,D013923: Thromboembolism,D013927: Thrombosis,D015179: Colorectal Neoplasms,D020246: Venous Thrombosis,D045169: Severe Acute Respiratory Syndrome	SERPINC1	M4
P01008	NA	NA	NA	NA	DALTEPARIN SODIUM	Antithrombin-III activator	ACTIVATOR	1994	CHEMBL1950	16	P01008	Antithrombin-III	Homo sapiens	D000026: Abortion, Habitual,D000755: Anemia, Sickle Cell,D001930: Brain Injuries,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D006504: Hepatic Veno-Occlusive Disease,D008175: Lung Neoplasms,D009101: Multiple Myeloma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D012772: Shock, Septic,D013923: Thromboembolism,D013927: Thrombosis,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D017719: Diabetic Foot,D019851: Thrombophilia,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054556: Venous Thromboembolism,D064129: Prostatic Neoplasms, Castration-Resistant	SERPINC1	M4
P01008	NA	NA	NA	NA	DANAPAROID SODIUM	Antithrombin-III activator	ACTIVATOR	1996	CHEMBL1950	16	P01008	Antithrombin-III	Homo sapiens	D013921: Thrombocytopenia,D013927: Thrombosis	SERPINC1	M4
P40238	NA	NA	NA	NA	ROMIPLOSTIM	Thrombopoietin receptor agonist	AGONIST	2008	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D000741: Anemia, Aplastic,D002277: Carcinoma,D006470: Hemorrhage,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011696: Purpura, Thrombocytopenic,D011697: Purpura, Thrombotic Thrombocytopenic,D013921: Thrombocytopenia,D014923: Wiskott-Aldrich Syndrome,D016553: Purpura, Thrombocytopenic, Idiopathic	MPL	M4
P40238	NA	NA	NA	NA	AVATROMBOPAG	Thrombopoietin receptor agonist	AGONIST	2018	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D000741: Anemia, Aplastic,D001791: Blood Platelet Disorders,D006470: Hemorrhage,D008107: Liver Diseases,D013921: Thrombocytopenia,D016553: Purpura, Thrombocytopenic, Idiopathic	MPL	M4
P40238	NA	NA	NA	NA	AVATROMBOPAG MALEATE	Thrombopoietin receptor agonist	AGONIST	2018	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D013921: Thrombocytopenia	MPL	M4
P40238	NA	NA	NA	NA	LUSUTROMBOPAG	Thrombopoietin receptor agonist	AGONIST	2018	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D006470: Hemorrhage,D013921: Thrombocytopenia,D016553: Purpura, Thrombocytopenic, Idiopathic	MPL	M4
P40238	NA	NA	NA	NA	ELTROMBOPAG OLAMINE	Thrombopoietin receptor agonist	AGONIST	2008	CHEMBL1864	265	P40238	Thrombopoietin receptor	Homo sapiens	D000741: Anemia, Aplastic,D009190: Myelodysplastic Syndromes,D013921: Thrombocytopenia,D016553: Purpura, Thrombocytopenic, Idiopathic,D019698: Hepatitis C, Chronic	MPL	M4
P21917	NA	NA	NA	NA	HALOPERIDOL	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	DRD4	M5
P21917	NA	NA	NA	NA	THIORIDAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	DRD4	M5
P21917	NA	NA	NA	NA	CHLORPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	DRD4	M5
P21917	NA	NA	NA	NA	OLANZAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1996	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	DRD4	M5
P21917	NA	NA	NA	NA	LOXAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	DRD4	M5
P21917	NA	NA	NA	NA	DROPERIDOL	D2-like dopamine receptor antagonist	ANTAGONIST	1970	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	DRD4	M5
P21917	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD4	M5
P21917	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M5
P21917	NA	NA	NA	NA	ROTIGOTINE	D2-like dopamine receptor agonist	AGONIST	2007	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000544: Alzheimer Disease,D005356: Fibromyalgia,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D020521: Stroke	DRD4	M5
P21917	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4	M5
P21917	NA	NA	NA	NA	APOMORPHINE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	2004	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D009369: Neoplasms,D010024: Osteoporosis,D010300: Parkinson Disease	DRD4	M5
P21917	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M5
P21917	NA	NA	NA	NA	LEVOMEPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1982	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4	M5
P21917	NA	NA	NA	NA	ROPINIROLE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D010300: Parkinson Disease	DRD4	M5
P21917	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1956	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M5
P21917	NA	NA	NA	NA	BROMOCRIPTINE MESYLATE	D2-like dopamine receptor agonist	AGONIST	1978	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000172: Acromegaly,D003924: Diabetes Mellitus, Type 2,D006966: Hyperprolactinemia,D007006: Hypogonadism,D007246: Infertility,D010300: Parkinson Disease	DRD4	M5
P21917	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M5
P21917	NA	NA	NA	NA	HALOPERIDOL DECANOATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1986	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4	M5
P21917	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1976	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M5
P21917	NA	NA	NA	NA	LOXAPINE SUCCINATE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M5
P21917	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1959	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	NA	DRD4	M5
P21917	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P21917	D(4) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD4	M5
P21917	NA	NA	NA	NA	PRAMIPEXOLE DIHYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D010300: Parkinson Disease	DRD4	M5
P21917	NA	NA	NA	NA	OLANZAPINE PAMOATE	D2-like dopamine receptor antagonist	ANTAGONIST	2009	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D012559: Schizophrenia	DRD4	M5
P21917	NA	NA	NA	NA	HALOPERIDOL LACTATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P21917	D(4) dopamine receptor	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD4	M5
P28065	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9	M5
P28065	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9	M5
P28065	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB9	M5
P28702	NA	NA	NA	NA	ETRETINATE	Retinoid receptor agonist	AGONIST	1986	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D011565: Psoriasis	RXRB	M5
P28702	NA	NA	NA	NA	ALITRETINOIN	Retinoid receptor agonist	AGONIST	1999	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D001943: Breast Neoplasms,D004485: Eczema,D006229: Hand Dermatoses,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D009369: Neoplasms,D011565: Psoriasis	RXRB	M5
P28702	NA	NA	NA	NA	BEXAROTENE	Retinoid X receptor agonist	AGONIST	1999	CHEMBL2363070	105765	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D000506: Alopecia Areata,D000544: Alzheimer Disease,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010267: Parapsoriasis,D011565: Psoriasis,D011618: Psychotic Disorders,D012559: Schizophrenia,D012751: Sezary Syndrome,D013964: Thyroid Neoplasms,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D017728: Lymphoma, Large-Cell, Anaplastic,D047748: Pituitary ACTH Hypersecretion	RXRB	M5
P28702	NA	NA	NA	NA	ACITRETIN	Retinoid receptor agonist	AGONIST	1996	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D000544: Alzheimer Disease,D003872: Dermatitis,D008545: Melanoma,D011565: Psoriasis,D015658: HIV Infections	RXRB	M5
Q15116	NA	NA	NA	NA	NIVOLUMAB	Programmed cell death protein 1 inhibitor	INHIBITOR	2015	CHEMBL3307223	108437	Q15116	Programmed cell death protein 1	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080443: Diffuse Intrinsic Pontine Glioma,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D001478: Basal Cell Nevus Syndrome,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D002817: Chordoma,D003110: Colonic Neoplasms,D003699: Hepatitis D,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D007972: Leukoplakia, Oral,D008080: Liposarcoma,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008579: Meningioma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009447: Neuroblastoma,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010911: Pituitary Neoplasms,D011024: Pneumonia, Viral,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012186: Retroperitoneal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018316: Gliosarcoma,D018317: Nerve Sheath Neoplasms,D018805: Sepsis,D019337: Hematologic Neoplasms,D019694: Hepatitis B, Chronic,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D046152: Gastrointestinal Stromal Tumors,D051677: Histiocytoma, Malignant Fibrous,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PDCD1	M5
Q15116	NA	NA	NA	NA	PEMBROLIZUMAB	Programmed cell death protein 1 inhibitor	INHIBITOR	2014	CHEMBL3307223	108437	Q15116	Programmed cell death protein 1	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000306: Adrenal Cortex Neoplasms,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002278: Carcinoma in Situ,D002280: Carcinoma, Basal Cell,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007971: Leukoplakia,D007972: Leukoplakia, Oral,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008577: Meningeal Neoplasms,D008579: Meningioma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009442: Neurilemmoma,D009447: Neuroblastoma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010212: Papilloma,D010307: Parotid Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D011024: Pneumonia, Viral,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018276: Carcinoma, Medullary,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D055756: Meningeal Carcinomatosis,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	PDCD1	M5
Q15116	NA	NA	NA	NA	CEMIPLIMAB	Programmed cell death protein 1 inhibitor	INHIBITOR	2018	CHEMBL3307223	108437	Q15116	Programmed cell death protein 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	PDCD1	M5
Q15116	NA	NA	NA	NA	DOSTARLIMAB	Programmed cell death protein 1 antagonist	ANTAGONIST	2021	CHEMBL3307223	108437	Q15116	Programmed cell death protein 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D008113: Liver Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome	PDCD1	M5
P49720	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3	M5
P49720	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3	M5
P49720	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB3	M5
P39086	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	1996	CHEMBL2109241	104902	P39086	Glutamate receptor ionotropic, kainate 1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIK1	M5
P24530	NA	NA	NA	NA	SITAXENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D011507: Proteinuria,D051436: Renal Insufficiency, Chronic,D054144: Heart Failure, Diastolic	EDNRB	M5
P24530	NA	NA	NA	NA	BOSENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2001	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004541: Eisenmenger Complex,D005334: Fever,D005901: Glaucoma,D006333: Heart Failure,D006344: Heart Septal Defects, Atrial,D006973: Hypertension,D006976: Hypertension, Pulmonary,D008103: Liver Cirrhosis,D008545: Melanoma,D008946: Mitral Valve Stenosis,D010190: Pancreatic Neoplasms,D010547: Persistent Fetal Circulation Syndrome,D012595: Scleroderma, Systemic,D014456: Ulcer,D018636: Hypoplastic Left Heart Syndrome,D018917: Optic Neuropathy, Ischemic,D020065: Hepatopulmonary Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M5
P24530	NA	NA	NA	NA	AMBRISENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2007	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D000532: Altitude Sickness,D000755: Anemia, Sickle Cell,D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D014652: Vascular Diseases,D018636: Hypoplastic Left Heart Syndrome,D045169: Severe Acute Respiratory Syndrome,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension	EDNRB	M5
P24530	NA	NA	NA	NA	MACITENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2010	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D005909: Glioblastoma,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D012595: Scleroderma, Systemic,D014456: Ulcer,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M5
P24530	NA	NA	NA	NA	SITAXENTAN SODIUM	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	NA	EDNRB	M5
P08572	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08572	Collagen alpha-2(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A2	M5
P08572	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08572	Collagen alpha-2(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A2	M5
P12110	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12110	Collagen alpha-2(VI) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL6A2	M5
P12110	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12110	Collagen alpha-2(VI) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL6A2	M5
P00813	NA	NA	NA	NA	PENTOSTATIN	Adenosine deaminase inhibitor	INHIBITOR	1991	CHEMBL1910	14	P00813	Adenosine deaminase	Homo sapiens	D000755: Anemia, Sickle Cell,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell	ADA	M5
P02462	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02462	Collagen alpha-1(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A1	M5
P02462	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02462	Collagen alpha-1(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A1	M5
P32245	NA	NA	NA	NA	BREMELANOTIDE	Melanocortin receptor 4 agonist	AGONIST	2019	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D009325: Nausea,D012735: Sexual Dysfunction, Physiological	MC4R	M5
P32245	NA	NA	NA	NA	SETMELANOTIDE	Melanocortin receptor 4 agonist	AGONIST	2020	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D009765: Obesity,D009767: Obesity, Morbid,D011218: Prader-Willi Syndrome,D051437: Renal Insufficiency,D058496: Smith-Magenis Syndrome	MC4R	M5
P32245	NA	NA	NA	NA	BREMELANOTIDE ACETATE	Melanocortin receptor 4 agonist	AGONIST	2019	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D020018: Sexual Dysfunctions, Psychological	MC4R	M5
P32245	NA	NA	NA	NA	SETMELANOTIDE ACETATE	Melanocortin receptor 4 agonist	AGONIST	2020	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D009765: Obesity	MC4R	M5
P00742	NA	NA	NA	NA	RIVAROXABAN	Coagulation factor X inhibitor	INHIBITOR	2011	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D000082862: Aortic Valve Disease,D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D001281: Atrial Fibrillation,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006406: Hematoma,D006470: Hemorrhage,D007511: Ischemia,D008103: Liver Cirrhosis,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D009767: Obesity, Morbid,D011655: Pulmonary Embolism,D012214: Rheumatic Heart Disease,D013921: Thrombocytopenia,D013923: Thromboembolism,D013927: Thrombosis,D016736: Antiphospholipid Syndrome,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D058729: Peripheral Arterial Disease	F10	M5
P00742	NA	NA	NA	NA	APIXABAN	Coagulation factor X inhibitor	INHIBITOR	2012	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D001282: Atrial Flutter,D006406: Hematoma,D006470: Hemorrhage,D007511: Ischemia,D009404: Nephrotic Syndrome,D011655: Pulmonary Embolism,D013923: Thromboembolism,D013927: Thrombosis,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054092: Foramen Ovale, Patent,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054549: Takotsubo Cardiomyopathy,D054556: Venous Thromboembolism	F10	M5
P00742	NA	NA	NA	NA	BETRIXABAN	Coagulation factor X inhibitor	INHIBITOR	2017	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D001281: Atrial Fibrillation,D001282: Atrial Flutter,D006470: Hemorrhage,D007674: Kidney Diseases,D008107: Liver Diseases,D013923: Thromboembolism,D013927: Thrombosis,D054556: Venous Thromboembolism	F10	M5
P00742	NA	NA	NA	NA	EDOXABAN TOSYLATE	Coagulation factor X inhibitor	INHIBITOR	2015	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D001281: Atrial Fibrillation,D004617: Embolism,D011655: Pulmonary Embolism,D013927: Thrombosis,D020246: Venous Thrombosis,D020521: Stroke,D054556: Venous Thromboembolism	F10	M5
P00742	NA	NA	NA	NA	EMICIZUMAB	Coagulation factor IX and X other	OTHER	2017	CHEMBL2111424	104934	P00742	Coagulation factor X	Homo sapiens	D006467: Hemophilia A,D006470: Hemorrhage	F10	M5
Q13936	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1C	M5
Q13936	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1C	M5
Q13936	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1C	M5
Q13936	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1C	M5
Q13936	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1C	M5
Q13936	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C	M5
Q13936	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1C	M5
Q13936	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1C	M5
Q13936	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1C	M5
Q13936	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M5
Q13936	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C	M5
Q13936	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1C	M5
Q13936	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M5
Q13936	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1C	M5
Q13936	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M5
Q13936	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M5
Q13936	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation	CACNA1C	M5
Q13936	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1C	M5
Q13936	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1C	M5
Q13936	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C	M5
Q13936	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C	M5
Q07869	NA	NA	NA	NA	GEMFIBROZIL	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	1981	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000740: Anemia,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D009369: Neoplasms,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D015658: HIV Infections,D016540: Smoking Cessation,D017202: Myocardial Ischemia	PPARA	M5
Q07869	NA	NA	NA	NA	CLOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	1967	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D002318: Cardiovascular Diseases,D009203: Myocardial Infarction,D017202: Myocardial Ischemia	PPARA	M5
Q07869	NA	NA	NA	NA	FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	1993	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D000437: Alcoholism,D002056: Burns,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D003930: Diabetic Retinopathy,D006816: Huntington Disease,D006937: Hypercholesterolemia,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006951: Hyperlipoproteinemias,D006952: Hyperlipoproteinemia Type III,D006973: Hypertension,D008060: Lipodystrophy,D008105: Liver Cirrhosis, Biliary,D008659: Metabolic Diseases,D009101: Multiple Myeloma,D009765: Obesity,D015209: Cholangitis, Sclerosing,D015228: Hypertriglyceridemia,D015658: HIV Infections,D024821: Metabolic Syndrome,D050171: Dyslipidemias,D050197: Atherosclerosis,D052439: Lipid Metabolism Disorders,D065626: Non-alcoholic Fatty Liver Disease	PPARA	M5
Q07869	NA	NA	NA	NA	FENOFIBRIC ACID	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	2008	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D000437: Alcoholism,D002779: Cholestasis,D008527: Medulloblastoma,D015228: Hypertriglyceridemia	PPARA	M5
Q07869	NA	NA	NA	NA	CHOLINE FENOFIBRATE	Peroxisome proliferator-activated receptor alpha agonist	AGONIST	2008	CHEMBL239	163	Q07869	Peroxisome proliferator-activated receptor alpha	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D006937: Hypercholesterolemia,D006950: Hyperlipidemia, Familial Combined,D052439: Lipid Metabolism Disorders	PPARA	M5
Q9Y271	NA	NA	NA	NA	ZAFIRLUKAST	Cysteinyl leukotriene receptor 1 antagonist	ANTAGONIST	1996	CHEMBL1798	179	Q9Y271	Cysteinyl leukotriene receptor 1	Homo sapiens	D001249: Asthma,D001943: Breast Neoplasms,D008173: Lung Diseases, Obstructive,D010051: Ovarian Neoplasms	CYSLTR1	M5
Q9Y271	NA	NA	NA	NA	MONTELUKAST SODIUM	Cysteinyl leukotriene receptor 1 antagonist	ANTAGONIST	1998	CHEMBL1798	179	Q9Y271	Cysteinyl leukotriene receptor 1	Homo sapiens	D000071074: Neonatal Sepsis,D001249: Asthma,D001250: Asthma, Exercise-Induced,D001988: Bronchiolitis,D001989: Bronchiolitis Obliterans,D006255: Rhinitis, Allergic, Seasonal,D012220: Rhinitis,D012221: Rhinitis, Allergic, Perennial,D029424: Pulmonary Disease, Chronic Obstructive,D057765: Eosinophilic Esophagitis,D065631: Rhinitis, Allergic	CYSLTR1	M5
P62333	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6	M5
P62333	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6	M5
P62333	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC6	M5
P32745	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR3	M5
P32745	NA	NA	NA	NA	PASIREOTIDE DIASPARTATE	Somatostatin receptor 3 agonist	AGONIST	2012	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	NA	SSTR3	M5
P32745	NA	NA	NA	NA	PASIREOTIDE PAMOATE	Somatostatin receptor 3 agonist	AGONIST	2014	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly	SSTR3	M5
P32745	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR3	M5
Q9Y5N1	NA	NA	NA	NA	PITOLISANT	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D000437: Alcoholism,D007674: Kidney Diseases,D009290: Narcolepsy,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D019966: Substance-Related Disorders	HRH3	M5
Q9Y5N1	NA	NA	NA	NA	PITOLISANT HYDROCHLORIDE	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D006970: Disorders of Excessive Somnolence,D009290: Narcolepsy	HRH3	M5
P29274	NA	NA	NA	NA	ADENOSINE	Adenosine receptor agonist	AGONIST	1989	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D007249: Inflammation,D007511: Ischemia,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D009369: Neoplasms,D010146: Pain,D012128: Respiratory Distress Syndrome,D013614: Tachycardia, Paroxysmal,D013617: Tachycardia, Supraventricular,D014927: Wolff-Parkinson-White Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D023921: Coronary Stenosis,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	ADORA2A	M5
P29274	NA	NA	NA	NA	CAFFEINE	Adenosine receptor antagonist	ANTAGONIST	1948	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D000860: Hypoxia,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001943: Breast Neoplasms,D003093: Colitis, Ulcerative,D003139: Common Cold,D003141: Communicable Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004417: Dyspnea,D006261: Headache,D007024: Hypotension, Orthostatic,D007383: Intermittent Claudication,D008545: Melanoma,D008881: Migraine Disorders,D009290: Narcolepsy,D009369: Neoplasms,D009765: Obesity,D010146: Pain,D010300: Parkinson Disease,D011565: Psoriasis,D013119: Spinal Cord Injuries,D014832: Voice Disorders,D015658: HIV Infections,D017116: Low Back Pain,D018781: Tension-Type Headache,D019547: Neck Pain,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A	M5
P29274	NA	NA	NA	NA	PENTOXIFYLLINE	Adenosine A2 receptor antagonist	ANTAGONIST	1984	CHEMBL2094257	104729	P29274	Adenosine receptor A2a	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A	M5
P29274	NA	NA	NA	NA	ISTRADEFYLLINE	Adenosine A2a receptor antagonist	ANTAGONIST	2019	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D008107: Liver Diseases,D010300: Parkinson Disease,D019966: Substance-Related Disorders	ADORA2A	M5
P29274	NA	NA	NA	NA	THEOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	ADORA2A	M5
P29274	NA	NA	NA	NA	OXTRIPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1981	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D008173: Lung Diseases, Obstructive	ADORA2A	M5
P29274	NA	NA	NA	NA	CAFFEINE, CITRATED	Adenosine receptor antagonist	ANTAGONIST	1999	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D001049: Apnea,D008107: Liver Diseases,D010146: Pain,D012178: Retinopathy of Prematurity,D047928: Premature Birth	ADORA2A	M5
P29274	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Adenosine receptor antagonist	ANTAGONIST	1982	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	NA	ADORA2A	M5
P29274	NA	NA	NA	NA	AMINOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	ADORA2A	M5
P29274	NA	NA	NA	NA	REGADENOSON	Adenosine A2a receptor agonist	AGONIST	2008	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D002318: Cardiovascular Diseases	ADORA2A	M5
P13639	NA	NA	NA	NA	DENILEUKIN DIFTITOX	Elongation factor 2 inhibitor	INHIBITOR	1999	CHEMBL1795108	104188	P13639	Elongation factor 2	Homo sapiens	D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male	EEF2	M5
P13639	NA	NA	NA	NA	MOXETUMOMAB PASUDOTOX	Elongation factor 2 inhibitor	INHIBITOR	2018	CHEMBL1795108	104188	P13639	Elongation factor 2	Homo sapiens	D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	EEF2	M5
P13639	NA	NA	NA	NA	TAGRAXOFUSP	Elongation factor 2 inhibitor	INHIBITOR	2018	CHEMBL1795108	104188	P13639	Elongation factor 2	Homo sapiens	D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D015470: Leukemia, Myeloid, Acute	EEF2	M5
Q9UBN7	NA	NA	NA	NA	VORINOSTAT	Histone deacetylase 6 inhibitor	INHIBITOR	2006	CHEMBL1865	11307	Q9UBN7	Histone deacetylase 6	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001005: Anus Neoplasms,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001927: Brain Diseases,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003424: Crohn Disease,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006689: Hodgkin Disease,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008527: Medulloblastoma,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D009542: Niemann-Pick Diseases,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012559: Schizophrenia,D012751: Sezary Syndrome,D013120: Spinal Cord Neoplasms,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D047748: Pituitary ACTH Hypersecretion,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	HDAC6	M5
Q9UBN7	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9UBN7	Histone deacetylase 6	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC6	M5
Q9UBN7	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9UBN7	Histone deacetylase 6	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC6	M5
Q9UBN7	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9UBN7	Histone deacetylase 6	Homo sapiens	D009101: Multiple Myeloma	HDAC6	M5
P25092	NA	NA	NA	NA	PLECANATIDE	Heat-stable enterotoxin receptor agonist	AGONIST	2017	CHEMBL1795197	104277	P25092	Heat-stable enterotoxin receptor	Homo sapiens	D003248: Constipation,D043183: Irritable Bowel Syndrome	GUCY2C	M5
P25092	NA	NA	NA	NA	LINACLOTIDE	Heat-stable enterotoxin receptor agonist	AGONIST	2012	CHEMBL1795197	104277	P25092	Heat-stable enterotoxin receptor	Homo sapiens	D000236: Adenoma,D003248: Constipation,D043183: Irritable Bowel Syndrome	GUCY2C	M5
Q9H4B7	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB1	M5
Q9H4B7	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB1	M5
P43220	NA	NA	NA	NA	EXENATIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2005	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D000083242: Ischemic Stroke,D000437: Alcoholism,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006943: Hyperglycemia,D009203: Myocardial Infarction,D009765: Obesity,D009767: Obesity, Morbid,D010300: Parkinson Disease,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D015431: Weight Loss,D016540: Smoking Cessation,D019578: Multiple System Atrophy,D019970: Cocaine-Related Disorders,D020521: Stroke,D046768: Nesidioblastosis,D051437: Renal Insufficiency,D065626: Non-alcoholic Fatty Liver Disease	GLP1R	M5
P43220	NA	NA	NA	NA	ALBIGLUTIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2014	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure	GLP1R	M5
P43220	NA	NA	NA	NA	DULAGLUTIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2014	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D016540: Smoking Cessation,D059606: Polydipsia	GLP1R	M5
P43220	NA	NA	NA	NA	LIXISENATIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2016	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D010300: Parkinson Disease,D054058: Acute Coronary Syndrome	GLP1R	M5
P43220	NA	NA	NA	NA	SEMAGLUTIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2017	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D000544: Alzheimer Disease,D001851: Bone Diseases, Metabolic,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity,D010300: Parkinson Disease,D065626: Non-alcoholic Fatty Liver Disease	GLP1R	M5
P43220	NA	NA	NA	NA	LIRAGLUTIDE	Glucagon-like peptide 1 receptor agonist	AGONIST	2010	CHEMBL1784	11758	P43220	Glucagon-like peptide 1 receptor	Homo sapiens	D000544: Alzheimer Disease,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D006333: Heart Failure,D006943: Hyperglycemia,D009293: Opioid-Related Disorders,D009765: Obesity,D010300: Parkinson Disease,D011236: Prediabetic State,D012778: Short Bowel Syndrome,D012891: Sleep Apnea Syndromes,D015431: Weight Loss,D016540: Smoking Cessation,D018149: Glucose Intolerance,D019449: Pouchitis,D024821: Metabolic Syndrome,D065626: Non-alcoholic Fatty Liver Disease	GLP1R	M5
Q8TCU5	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN3A	M5
Q8TCU5	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN3A	M5
Q8TCU5	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN3A	M5
Q8TCU5	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN3A	M5
Q8TCU5	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN3A	M5
Q8TCU5	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D010146: Pain	GRIN3A	M5
Q8TCU5	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D010300: Parkinson Disease	GRIN3A	M5
Q8TCU5	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000437: Alcoholism	GRIN3A	M5
Q8TCU5	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN3A	M5
P39059	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P39059	Collagen alpha-1(XV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL15A1	M5
P39059	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P39059	Collagen alpha-1(XV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL15A1	M5
Q13882	NA	NA	NA	NA	VANDETANIB	Tyrosine-protein kinase BRK inhibitor	INHIBITOR	2011	CHEMBL4601	30026	Q13882	Protein-tyrosine kinase 6	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PTK6	M5
P28472	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRB3	M5
P28472	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRB3	M5
P28472	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRB3	M5
P28472	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy	GABRB3	M5
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRB3	M5
P28472	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRB3	M5
P28472	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D008881: Migraine Disorders	GABRB3	M5
P28472	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRB3	M5
P28472	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRB3	M5
P28472	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRB3	M5
P28472	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRB3	M5
P28472	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRB3	M5
P28472	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRB3	M5
P28472	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRB3	M5
P28472	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia	GABRB3	M5
P28472	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRB3	M5
P28472	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRB3	M5
P28472	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRB3	M5
P28472	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M5
P28472	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M5
P28472	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M5
P28472	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRB3	M5
P28472	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRB3	M5
P28472	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRB3	M5
P28472	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRB3	M5
P28472	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRB3	M5
P28472	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRB3	M5
P28472	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRB3	M5
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRB3	M5
P28472	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism	GABRB3	M5
P28472	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
P28472	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRB3	M5
P28472	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M5
O00329	NA	NA	NA	NA	IDELALISIB	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2014	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D000686: Amyloidosis,D006255: Rhinitis, Allergic, Seasonal,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	PIK3CD	M5
O00329	NA	NA	NA	NA	DUVELISIB	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2018	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D002294: Carcinoma, Squamous Cell,D007938: Leukemia,D008107: Liver Diseases,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009182: Mycosis Fungoides,D009369: Neoplasms,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016411: Lymphoma, T-Cell, Peripheral,D019337: Hematologic Neoplasms,D045169: Severe Acute Respiratory Syndrome	PIK3CD	M5
O00329	NA	NA	NA	NA	COPANLISIB	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2017	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D005706: Gallbladder Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D018281: Cholangiocarcinoma,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PIK3CD	M5
O00329	NA	NA	NA	NA	COPANLISIB HYDROCHLORIDE	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2017	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D001943: Breast Neoplasms,D008224: Lymphoma, Follicular,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse	PIK3CD	M5
O00329	NA	NA	NA	NA	UMBRALISIB TOSYLATE	PI3-kinase p110-delta subunit inhibitor	INHIBITOR	2021	CHEMBL3130	11177	O00329	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform	Homo sapiens	D004938: Esophageal Neoplasms,D006689: Hodgkin Disease,D008224: Lymphoma, Follicular,D010190: Pancreatic Neoplasms,D011087: Polycythemia Vera,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D046152: Gastrointestinal Stromal Tumors,D055728: Primary Myelofibrosis	PIK3CD	M5
P20711	NA	NA	NA	NA	CARBIDOPA	DOPA decarboxylase inhibitor	INHIBITOR	1975	CHEMBL1843	83	P20711	Aromatic-L-amino-acid decarboxylase	Homo sapiens	D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D001037: Aphasia,D001249: Asthma,D001289: Attention Deficit Disorder with Hyperactivity,D004402: Dysautonomia, Familial,D005356: Fibromyalgia,D006973: Hypertension,D007024: Hypotension, Orthostatic,D008268: Macular Degeneration,D009103: Multiple Sclerosis,D010146: Pain,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D012174: Retinitis Pigmentosa,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D014029: Tobacco Use Disorder,D016115: Albinism, Oculocutaneous,D017204: Angelman Syndrome,D019970: Cocaine-Related Disorders,D020521: Stroke	DDC	M5
Q14031	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	Q14031	Collagen alpha-6(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A6	M5
Q14031	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	Q14031	Collagen alpha-6(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A6	M5
P42345	NA	NA	NA	NA	PERHEXILINE MALEATE	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	1974	CHEMBL2842	11400	P42345	Serine/threonine-protein kinase mTOR	Homo sapiens	NA	MTOR	M5
P07202	NA	NA	NA	NA	METHIMAZOLE	Thyroid peroxidase inhibitor	INHIBITOR	1950	CHEMBL1839	40	P07202	Thyroid peroxidase	Homo sapiens	D003882: Dermatomyositis,D005909: Glioblastoma,D013959: Thyroid Diseases,D049970: Graves Ophthalmopathy	TPO	M5
P07202	NA	NA	NA	NA	PROPYLTHIOURACIL	Thyroid peroxidase inhibitor	INHIBITOR	1947	CHEMBL1839	40	P07202	Thyroid peroxidase	Homo sapiens	D013959: Thyroid Diseases,D013971: Thyrotoxicosis,D049970: Graves Ophthalmopathy	TPO	M5
Q969S8	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC10	M5
Q969S8	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC10	M5
Q969S8	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D009101: Multiple Myeloma	HDAC10	M5
P08123	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08123	Collagen alpha-2(I) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL1A2	M5
P08123	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08123	Collagen alpha-2(I) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL1A2	M5
P60900	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P60900	Proteasome subunit alpha type-6	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA6	M5
P60900	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P60900	Proteasome subunit alpha type-6	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA6	M5
P60900	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P60900	Proteasome subunit alpha type-6	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMA6	M5
P31645	NA	NA	NA	NA	MAZINDOL	Monoamine transporter inhibitor	INHIBITOR	1973	CHEMBL2363064	105759	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009765: Obesity,D019970: Cocaine-Related Disorders	SLC6A4	M5
P31645	NA	NA	NA	NA	AMOXAPINE	Serotonin transporter inhibitor	INHIBITOR	1980	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A4	M5
P31645	NA	NA	NA	NA	DESVENLAFAXINE	Serotonin transporter inhibitor	INHIBITOR	2008	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D019698: Hepatitis C, Chronic	SLC6A4	M5
P31645	NA	NA	NA	NA	FLUVOXAMINE MALEATE	Serotonin transporter inhibitor	INHIBITOR	1994	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D009771: Obsessive-Compulsive Disorder,D016584: Panic Disorder,D045169: Severe Acute Respiratory Syndrome	SLC6A4	M5
P31645	NA	NA	NA	NA	IMIPRAMINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1959	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A4	M5
P31645	NA	NA	NA	NA	PAROXETINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1992	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001007: Anxiety,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D016584: Panic Disorder	SLC6A4	M5
P31645	NA	NA	NA	NA	SERTRALINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1991	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008607: Intellectual Disability,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder	SLC6A4	M5
P31645	NA	NA	NA	NA	ESCITALOPRAM OXALATE	Serotonin transporter inhibitor	INHIBITOR	2002	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001008: Anxiety Disorders,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D013119: Spinal Cord Injuries,D016584: Panic Disorder	SLC6A4	M5
P31645	NA	NA	NA	NA	DULOXETINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	2004	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001007: Anxiety,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D005356: Fibromyalgia,D009103: Multiple Sclerosis,D010003: Osteoarthritis,D010146: Pain,D013313: Stress Disorders, Post-Traumatic,D014549: Urinary Incontinence,D015179: Colorectal Neoplasms	SLC6A4	M5
P31645	NA	NA	NA	NA	PROTRIPTYLINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1967	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M5
P31645	NA	NA	NA	NA	NEFAZODONE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1994	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M5
P31645	NA	NA	NA	NA	CHLORPHENTERMINE HYDROCHLORIDE	Serotonin transporter substrate	SUBSTRATE	1982	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M5
P31645	NA	NA	NA	NA	PAROXETINE MESYLATE	Serotonin transporter inhibitor	INHIBITOR	2003	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D008593: Menopause,D019584: Hot Flashes	SLC6A4	M5
P31645	NA	NA	NA	NA	CLOMIPRAMINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1989	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A4	M5
P31645	NA	NA	NA	NA	CITALOPRAM HYDROBROMIDE	Serotonin transporter inhibitor	INHIBITOR	1998	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001321: Autistic Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D016584: Panic Disorder,D019584: Hot Flashes	SLC6A4	M5
P31645	NA	NA	NA	NA	TRAZODONE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1981	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	SLC6A4	M5
P31645	NA	NA	NA	NA	METHAMPHETAMINE HYDROCHLORIDE	Monoamine transporter inhibitor	INHIBITOR	1943	CHEMBL2363064	105759	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M5
P31645	NA	NA	NA	NA	AMITRIPTYLINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1961	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003866: Depressive Disorder,D010523: Peripheral Nervous System Diseases,D011537: Pruritus	SLC6A4	M5
P31645	NA	NA	NA	NA	VENLAFAXINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1993	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D000072861: Phobia, Social,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D008575: Meniere Disease,D009437: Neuralgia,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D016584: Panic Disorder,D019547: Neck Pain,D019584: Hot Flashes,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	SLC6A4	M5
P31645	NA	NA	NA	NA	FLUOXETINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1987	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D016584: Panic Disorder	SLC6A4	M5
P31645	NA	NA	NA	NA	NORTRIPTYLINE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	1964	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003876: Dermatitis, Atopic,D011565: Psoriasis,D018288: Carcinoma, Small Cell,D018589: Gastroparesis	SLC6A4	M5
P31645	NA	NA	NA	NA	DESVENLAFAXINE SUCCINATE	Serotonin transporter inhibitor	INHIBITOR	2008	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D005356: Fibromyalgia,D008593: Menopause,D019584: Hot Flashes	SLC6A4	M5
P31645	NA	NA	NA	NA	NOMIFENSINE MALEATE	Monoamine transporter inhibitor	INHIBITOR	1984	CHEMBL2363064	105759	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M5
P31645	NA	NA	NA	NA	VILAZODONE HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	2011	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major	SLC6A4	M5
P31645	NA	NA	NA	NA	LEVOMILNACIPRAN HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	2013	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D000083242: Ischemic Stroke,D003865: Depressive Disorder, Major	SLC6A4	M5
P31645	NA	NA	NA	NA	VORTIOXETINE HYDROBROMIDE	Serotonin transporter inhibitor	INHIBITOR	2013	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major	SLC6A4	M5
P31645	NA	NA	NA	NA	LUMATEPERONE	Serotonin transporter inhibitor	INHIBITOR	2019	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D000544: Alzheimer Disease,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D012559: Schizophrenia	SLC6A4	M5
P31645	NA	NA	NA	NA	SIBUTRAMINE HYDROCHLORIDE	Monoamine transporter inhibitor	INHIBITOR	1997	CHEMBL2363064	105759	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D009765: Obesity	SLC6A4	M5
P31645	NA	NA	NA	NA	IMIPRAMINE PAMOATE	Serotonin transporter inhibitor	INHIBITOR	1973	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	NA	SLC6A4	M5
P31645	NA	NA	NA	NA	DESVENLAFAXINE FUMARATE	Serotonin transporter inhibitor	INHIBITOR	2013	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D003865: Depressive Disorder, Major	SLC6A4	M5
P31645	NA	NA	NA	NA	MILNACIPRAN HYDROCHLORIDE	Serotonin transporter inhibitor	INHIBITOR	2009	CHEMBL228	121	P31645	Sodium-dependent serotonin transporter	Homo sapiens	D001416: Back Pain,D005356: Fibromyalgia	SLC6A4	M5
P11387	NA	NA	NA	NA	SACITUZUMAB GOVITECAN	DNA topoisomerase I inhibitor	INHIBITOR	2020	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D016889: Endometrial Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TOP1	M5
P11387	NA	NA	NA	NA	IRINOTECAN HYDROCHLORIDE	DNA topoisomerase I inhibitor	INHIBITOR	1996	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001005: Anus Neoplasms,D001063: Appendiceal Neoplasms,D001254: Astrocytoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002276: Carcinoid Tumor,D002277: Carcinoma,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D003967: Diarrhea,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007012: Hypopharyngeal Neoplasms,D007119: Immunoblastic Lymphadenopathy,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008527: Medulloblastoma,D008545: Melanoma,D008579: Meningioma,D008637: Mesenchymoma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009503: Neutropenia,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018278: Carcinoma, Neuroendocrine,D018289: Carcinoma, Verrucous,D018304: Esthesioneuroblastoma, Olfactory,D018305: Ganglioneuroblastoma,D018308: Papilloma, Inverted,D018316: Gliosarcoma,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TOP1	M5
P11387	NA	NA	NA	NA	TRASTUZUMAB DERUXTECAN	DNA topoisomerase I inhibitor	INHIBITOR	2019	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004067: Digestive System Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms	TOP1	M5
Q99436	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M5
Q99436	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M5
Q99436	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB7	M5
P25116	NA	NA	NA	NA	VORAPAXAR SULFATE	Proteinase-activated receptor 1 antagonist	ANTAGONIST	2014	CHEMBL3974	10653	P25116	Proteinase-activated receptor 1	Homo sapiens	D009203: Myocardial Infarction,D020521: Stroke,D054058: Acute Coronary Syndrome,D058729: Peripheral Arterial Disease	F2R	M5
P29320	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P29320	Ephrin type-A receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA3	M5
P20908	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P20908	Collagen alpha-1(V) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL5A1	M5
P20908	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P20908	Collagen alpha-1(V) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL5A1	M5
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1955	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001714: Bipolar Disorder,D005910: Glioma,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D012559: Schizophrenia,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020521: Stroke	SLC18A2	M5
Q05940	NA	NA	NA	NA	RESERPINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D002561: Cerebrovascular Disorders,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006937: Hypercholesterolemia,D006973: Hypertension,D006976: Hypertension, Pulmonary,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis	SLC18A2	M5
Q05940	NA	NA	NA	NA	TETRABENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2008	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders	SLC18A2	M5
Q05940	NA	NA	NA	NA	RESCINNAMINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1956	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D006973: Hypertension	SLC18A2	M5
Q05940	NA	NA	NA	NA	DESERPIDINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1957	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D006973: Hypertension	SLC18A2	M5
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE ADIPATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1975	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	NA	SLC18A2	M5
Q05940	NA	NA	NA	NA	LISDEXAMFETAMINE DIMESYLATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2007	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001068: Feeding and Eating Disorders,D001289: Attention Deficit Disorder with Hyperactivity,D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity,D012559: Schizophrenia,D052018: Bulimia Nervosa,D056912: Binge-Eating Disorder	SLC18A2	M5
Q05940	NA	NA	NA	NA	VALBENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders	SLC18A2	M5
Q05940	NA	NA	NA	NA	DUTETRABENAZINE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D002547: Cerebral Palsy,D002819: Chorea,D005879: Tourette Syndrome,D006816: Huntington Disease,D009069: Movement Disorders,D020821: Dystonic Disorders	SLC18A2	M5
Q05940	NA	NA	NA	NA	BENZPHETAMINE HYDROCHLORIDE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	NA	SLC18A2	M5
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE SULFATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1960	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC18A2	M5
Q05940	NA	NA	NA	NA	VALBENAZINE TOSYLATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	2017	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D000071057: Tardive Dyskinesia	SLC18A2	M5
Q05940	NA	NA	NA	NA	DEXTROAMPHETAMINE SACCHARATE	Synaptic vesicular amine transporter inhibitor	INHIBITOR	1996	CHEMBL1893	162	Q05940	Synaptic vesicular amine transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC18A2	M5
P08588	NA	NA	NA	NA	ATENOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1981	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002561: Cerebrovascular Disorders,D006331: Heart Diseases,D006333: Heart Failure,D006391: Hemangioma,D006973: Hypertension,D008382: Marfan Syndrome,D008946: Mitral Valve Stenosis,D009203: Myocardial Infarction,D010024: Osteoporosis,D013313: Stress Disorders, Post-Traumatic,D017202: Myocardial Ischemia,D017379: Hypertrophy, Left Ventricular,D060050: Angina, Stable	ADRB1	M5
P08588	NA	NA	NA	NA	TIMOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB1	M5
P08588	NA	NA	NA	NA	PINDOLOL	Beta-1 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB1	M5
P08588	NA	NA	NA	NA	NADOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB1	M5
P08588	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB1	M5
P08588	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB1	M5
P08588	NA	NA	NA	NA	DOPAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1974	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010300: Parkinson Disease	ADRB1	M5
P08588	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB1	M5
P08588	NA	NA	NA	NA	BETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension	ADRB1	M5
P08588	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1	M5
P08588	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB1	M5
P08588	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB1	M5
P08588	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	ACEBUTOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001145: Arrhythmias, Cardiac,D006973: Hypertension	ADRB1	M5
P08588	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	LEVOBETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2000	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D009798: Ocular Hypertension	ADRB1	M5
P08588	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB1	M5
P08588	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB1	M5
P08588	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1	M5
P08588	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB1	M5
P08588	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB1	M5
P08588	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB1	M5
P08588	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1990	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB1	M5
P08588	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB1	M5
P08588	NA	NA	NA	NA	BISOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D020388: Muscular Dystrophy, Duchenne	ADRB1	M5
P08588	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB1	M5
P08588	NA	NA	NA	NA	METOPROLOL TARTRATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006331: Heart Diseases,D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction	ADRB1	M5
P08588	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB1	M5
P08588	NA	NA	NA	NA	METOPROLOL SUCCINATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000787: Angina Pectoris,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D002312: Cardiomyopathy, Hypertrophic,D006333: Heart Failure,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008944: Mitral Valve Insufficiency,D029424: Pulmonary Disease, Chronic Obstructive	ADRB1	M5
P08588	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P08588	NA	NA	NA	NA	METOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M5
P10275	NA	NA	NA	NA	BICALUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	1995	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001943: Breast Neoplasms,D005185: Fallopian Tube Neoplasms,D006177: Gynecomastia,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D011629: Puberty, Precocious,D012468: Salivary Gland Neoplasms,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M5
P10275	NA	NA	NA	NA	FLUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	1989	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M5
P10275	NA	NA	NA	NA	TESTOSTERONE PROPIONATE	Androgen Receptor agonist	AGONIST	1974	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D059268: Atrophic Vaginitis	AR	M5
P10275	NA	NA	NA	NA	NILUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	1996	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D009369: Neoplasms,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M5
P10275	NA	NA	NA	NA	METHYLTESTOSTERONE	Androgen Receptor agonist	AGONIST	1973	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D008593: Menopause	AR	M5
P10275	NA	NA	NA	NA	TESTOSTERONE	Androgen Receptor agonist	AGONIST	1972	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000375: Aging,D000856: Anorexia Nervosa,D002539: Cerebral Arterial Diseases,D003327: Coronary Disease,D004392: Dwarfism,D004414: Dyspareunia,D006333: Heart Failure,D006620: Hip Fractures,D007006: Hypogonadism,D007172: Erectile Dysfunction,D007246: Infertility,D007333: Insulin Resistance,D007713: Klinefelter Syndrome,D008593: Menopause,D009103: Multiple Sclerosis,D009135: Muscular Diseases,D009369: Neoplasms,D009765: Obesity,D009920: Orchitis,D010411: Penile Induration,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D012735: Sexual Dysfunction, Physiological,D013119: Spinal Cord Injuries,D013736: Testicular Neoplasms,D017436: Kallmann Syndrome,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D055948: Sarcopenia,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M5
P10275	NA	NA	NA	NA	FLUOXYMESTERONE	Androgen Receptor agonist	AGONIST	1956	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001943: Breast Neoplasms	AR	M5
P10275	NA	NA	NA	NA	DANAZOL	Androgen Receptor agonist	AGONIST	1976	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000741: Anemia, Aplastic,D004715: Endometriosis,D005199: Fanconi Anemia,D005348: Fibrocystic Breast Disease,D007246: Infertility,D009190: Myelodysplastic Syndromes,D011697: Purpura, Thrombotic Thrombocytopenic,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D019871: Dyskeratosis Congenita,D059373: Mastodynia	AR	M5
P10275	NA	NA	NA	NA	ENZALUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	2012	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D014594: Uterine Neoplasms,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M5
P10275	NA	NA	NA	NA	TESTOSTERONE ENANTHATE	Androgen Receptor agonist	AGONIST	1953	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D007006: Hypogonadism,D011471: Prostatic Neoplasms,D015431: Weight Loss,D019247: HIV Wasting Syndrome,D020391: Muscular Dystrophy, Facioscapulohumeral,D029424: Pulmonary Disease, Chronic Obstructive,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M5
P10275	NA	NA	NA	NA	NANDROLONE PHENPROPIONATE	Androgen Receptor agonist	AGONIST	1959	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D005128: Eye Diseases	AR	M5
P10275	NA	NA	NA	NA	OXANDROLONE	Androgen Receptor agonist	AGONIST	1964	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D002056: Burns,D003668: Pressure Ulcer,D005199: Fanconi Anemia,D007713: Klinefelter Syndrome,D009369: Neoplasms,D014424: Turner Syndrome,D044342: Malnutrition	AR	M5
P10275	NA	NA	NA	NA	OXYMETHOLONE	Androgen Receptor agonist	AGONIST	1972	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR	M5
P10275	NA	NA	NA	NA	ETHYLESTRENOL	Androgen Receptor agonist	AGONIST	1964	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR	M5
P10275	NA	NA	NA	NA	NANDROLONE DECANOATE	Androgen Receptor agonist	AGONIST	1983	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D005128: Eye Diseases,D006620: Hip Fractures,D019247: HIV Wasting Syndrome,D044342: Malnutrition	AR	M5
P10275	NA	NA	NA	NA	DROMOSTANOLONE PROPIONATE	Androgen Receptor agonist	AGONIST	1982	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR	M5
P10275	NA	NA	NA	NA	TESTOSTERONE CYPIONATE	Androgen Receptor agonist	AGONIST	1978	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D003929: Diabetic Neuropathies,D007006: Hypogonadism,D011471: Prostatic Neoplasms,D012735: Sexual Dysfunction, Physiological,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M5
P10275	NA	NA	NA	NA	STANOZOLOL	Androgen Receptor agonist	AGONIST	1962	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	NA	AR	M5
P10275	NA	NA	NA	NA	TESTOSTERONE UNDECANOATE	Androgen Receptor agonist	AGONIST	2014	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000375: Aging,D002292: Carcinoma, Renal Cell,D003327: Coronary Disease,D007006: Hypogonadism,D012131: Respiratory Insufficiency,D012735: Sexual Dysfunction, Physiological,D013119: Spinal Cord Injuries,D044342: Malnutrition	AR	M5
P10275	NA	NA	NA	NA	APALUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	2018	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D008107: Liver Diseases,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M5
P10275	NA	NA	NA	NA	CLASCOTERONE	Androgen Receptor antagonist	ANTAGONIST	2020	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D000152: Acne Vulgaris,D000505: Alopecia	AR	M5
P10275	NA	NA	NA	NA	DAROLUTAMIDE	Androgen Receptor antagonist	ANTAGONIST	2019	CHEMBL1871	56	P10275	Androgen receptor	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	AR	M5
P00918	CHEMBL17	1085	3038	DB01144	DICHLORPHENAMIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1958	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D005901: Glaucoma,D020513: Paralysis, Hyperkalemic Periodic,D020514: Hypokalemic Periodic Paralysis,D020967: Myotonic Disorders	CA2	M5
P00918	CHEMBL18	1096	3295	DB00311	ETHOXZOLAMIDE	Carbonic anhydrase inhibitor	INHIBITOR	1982	CHEMBL2095180	104764	P00918	Carbonic anhydrase 2	Homo sapiens	NA	CA2	M5
P00918	CHEMBL19	1124	NA	NA	METHAZOLAMIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1959	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D000532: Altitude Sickness,D002583: Uterine Cervical Neoplasms,D005901: Glaucoma	CA2	M5
P00918	NA	NA	NA	NA	ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1953	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D003551: Cysticercosis,D004487: Edema,D005901: Glaucoma,D006333: Heart Failure,D006528: Carcinoma, Hepatocellular,D006850: Hydrocephalus, Normal Pressure,D006976: Hypertension, Pulmonary,D007024: Hypotension, Orthostatic,D007674: Kidney Diseases,D008269: Macular Edema,D009103: Multiple Sclerosis,D011559: Pseudotumor Cerebri,D012640: Seizures,D013226: Status Epilepticus,D015812: Glaucoma, Angle-Closure,D016481: Helicobacter Infections,D018887: Landau-Kleffner Syndrome,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D050030: Andersen Syndrome,D055752: Small Cell Lung Carcinoma,D059350: Chronic Pain	CA2	M5
P00918	NA	NA	NA	NA	BRINZOLAMIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1998	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension,D056833: Central Serous Chorioretinopathy	CA2	M5
P00918	NA	NA	NA	NA	TOPIRAMATE	Carbonic anhydrase II inhibitor	INHIBITOR	1996	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	CA2	M5
P00918	CHEMBL1200814	674765	13290219, 90469712	NA	ACETAZOLAMIDE SODIUM	Carbonic anhydrase II inhibitor	INHIBITOR	1990	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D004487: Edema,D005901: Glaucoma,D012640: Seizures,D015812: Glaucoma, Angle-Closure	CA2	M5
P00918	NA	NA	NA	NA	DORZOLAMIDE HYDROCHLORIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1994	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension	CA2	M5
A4D0S4	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	A4D0S4	Laminin subunit beta-4	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMB4	M5
Q6PIU1	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q6PIU1	Potassium voltage-gated channel subfamily V member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNV1	M5
Q6PIU1	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q6PIU1	Potassium voltage-gated channel subfamily V member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNV1	M5
Q6PIU1	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q6PIU1	Potassium voltage-gated channel subfamily V member 1	Homo sapiens	NA	KCNV1	M5
Q6PIU1	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q6PIU1	Potassium voltage-gated channel subfamily V member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNV1	M5
P23786	NA	NA	NA	NA	PERHEXILINE MALEATE	Carnitine palmitoyltransferase 2 inhibitor	INHIBITOR	1974	CHEMBL3238	10765	P23786	Carnitine O-palmitoyltransferase 2, mitochondrial	Homo sapiens	NA	CPT2	M5
P08631	NA	NA	NA	NA	BOSUTINIB	Tyrosine-protein kinase HCK inhibitor	INHIBITOR	2010	CHEMBL3234	11785	P08631	Tyrosine-protein kinase HCK	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	HCK	M5
P08631	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P08631	Tyrosine-protein kinase HCK	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	HCK	M5
P51679	NA	NA	NA	NA	MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CROSS-LINKING AGENT	2018	CHEMBL2414	10579	P51679	C-C chemokine receptor type 4	Homo sapiens	D001249: Asthma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D006528: Carcinoma, Hepatocellular,D009182: Mycosis Fungoides,D009369: Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D015493: Paraparesis, Tropical Spastic,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral	CCR4	M5
Q9UIX4	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG1	M5
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG1	M5
Q9UIX4	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	NA	KCNG1	M5
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG1	M5
P20138	NA	NA	NA	NA	GEMTUZUMAB OZOGAMICIN	Myeloid cell surface antigen CD33 binding agent	BINDING AGENT	2000	CHEMBL1842	81	P20138	Myeloid cell surface antigen CD33	Homo sapiens	D007938: Leukemia,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile	CD33	M5
Q5XXA6	NA	NA	NA	NA	CROFELEMER	Anoctamin-1 blocker	BLOCKER	2012	CHEMBL2046267	104568	Q5XXA6	Anoctamin-1	Homo sapiens	D001943: Breast Neoplasms,D003967: Diarrhea,D043183: Irritable Bowel Syndrome	ANO1	M5
Q16790	CHEMBL18	1096	3295	DB00311	ETHOXZOLAMIDE	Carbonic anhydrase inhibitor	INHIBITOR	1982	CHEMBL2095180	104764	Q16790	Carbonic anhydrase 9	Homo sapiens	NA	CA9	M5
P25103	NA	NA	NA	NA	NETUPITANT	Neurokinin 1 receptor antagonist	ANTAGONIST	2014	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D009369: Neoplasms,D020250: Postoperative Nausea and Vomiting	TACR1	M5
P25103	NA	NA	NA	NA	APREPITANT	Neurokinin 1 receptor antagonist	ANTAGONIST	2003	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D000437: Alcoholism,D002189: Marijuana Abuse,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D005909: Glioblastoma,D006556: Heroin Dependence,D009101: Multiple Myeloma,D009293: Opioid-Related Disorders,D009325: Nausea,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010146: Pain,D011537: Pruritus,D014839: Vomiting,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D018589: Gastroparesis,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D045169: Severe Acute Respiratory Syndrome	TACR1	M5
P25103	NA	NA	NA	NA	FOSAPREPITANT DIMEGLUMINE	Neurokinin 1 receptor antagonist	ANTAGONIST	2008	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D012509: Sarcoma,D020250: Postoperative Nausea and Vomiting	TACR1	M5
P25103	NA	NA	NA	NA	ROLAPITANT HYDROCHLORIDE	Neurokinin 1 receptor antagonist	ANTAGONIST	2015	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D012509: Sarcoma,D020250: Postoperative Nausea and Vomiting	TACR1	M5
P25103	NA	NA	NA	NA	FOSNETUPITANT CHLORIDE HYDROCHLORIDE	Neurokinin 1 receptor antagonist	ANTAGONIST	2018	CHEMBL249	250	P25103	Substance-P receptor	Homo sapiens	D009325: Nausea,D014839: Vomiting	TACR1	M5
P48169	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRA4	M5
P48169	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRA4	M5
P48169	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRA4	M5
P48169	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy	GABRA4	M5
P48169	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRA4	M5
P48169	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRA4	M5
P48169	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D008881: Migraine Disorders	GABRA4	M5
P48169	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRA4	M5
P48169	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRA4	M5
P48169	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRA4	M5
P48169	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRA4	M5
P48169	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRA4	M5
P48169	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRA4	M5
P48169	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRA4	M5
P48169	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia	GABRA4	M5
P48169	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRA4	M5
P48169	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRA4	M5
P48169	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRA4	M5
P48169	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4	M5
P48169	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4	M5
P48169	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety	GABRA4	M5
P48169	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRA4	M5
P48169	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRA4	M5
P48169	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRA4	M5
P48169	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRA4	M5
P48169	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRA4	M5
P48169	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRA4	M5
P48169	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRA4	M5
P48169	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRA4	M5
P48169	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D000437: Alcoholism	GABRA4	M5
P48169	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P48169	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRA4	M5
P48169	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P48169	Gamma-aminobutyric acid receptor subunit alpha-4	Homo sapiens	NA	GABRA4	M5
P42685	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P42685	Tyrosine-protein kinase FRK	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FRK	M5
P42685	NA	NA	NA	NA	REGORAFENIB	Tyrosine-protein kinase FRK inhibitor	INHIBITOR	2012	CHEMBL4223	30012	P42685	Tyrosine-protein kinase FRK	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FRK	M5
Q96S37	NA	NA	NA	NA	SULFINPYRAZONE	Solute carrier family 22 member 12 inhibitor	INHIBITOR	1959	CHEMBL6120	102767	Q96S37	Solute carrier family 22 member 12	Homo sapiens	D006073: Gout	SLC22A12	M5
Q96S37	NA	NA	NA	NA	LESINURAD	Solute carrier family 22 member 12 inhibitor	INHIBITOR	2015	CHEMBL6120	102767	Q96S37	Solute carrier family 22 member 12	Homo sapiens	D006073: Gout,D033461: Hyperuricemia	SLC22A12	M5
P08235	NA	NA	NA	NA	SPIRONOLACTONE	Mineralocorticoid receptor antagonist	ANTAGONIST	1960	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D000152: Acne Vulgaris,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D002825: Chorioretinitis,D003920: Diabetes Mellitus,D003928: Diabetic Nephropathies,D005234: Fatty Liver,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007938: Leukemia,D008223: Lymphoma,D008268: Macular Degeneration,D008548: Melanosis,D009203: Myocardial Infarction,D009369: Neoplasms,D009404: Nephrotic Syndrome,D011085: Polycystic Ovary Syndrome,D011629: Puberty, Precocious,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D019571: Arrhythmogenic Right Ventricular Dysplasia,D020388: Muscular Dystrophy, Duchenne,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054144: Heart Failure, Diastolic,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	NR3C2	M5
P08235	NA	NA	NA	NA	NIMODIPINE	Mineralocorticoid receptor antagonist	ANTAGONIST	1988	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	NR3C2	M5
P08235	NA	NA	NA	NA	FELODIPINE	Mineralocorticoid receptor antagonist	ANTAGONIST	1991	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	NR3C2	M5
P08235	NA	NA	NA	NA	DROSPIRENONE	Mineralocorticoid receptor antagonist	ANTAGONIST	2001	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000152: Acne Vulgaris,D002032: Bulimia,D003866: Depressive Disorder,D004412: Dysmenorrhea,D011085: Polycystic Ovary Syndrome,D011293: Premenstrual Syndrome,D017497: Hidradenitis Suppurativa,D052018: Bulimia Nervosa	NR3C2	M5
P08235	NA	NA	NA	NA	EPLERENONE	Mineralocorticoid receptor antagonist	ANTAGONIST	2002	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D006333: Heart Failure,D006973: Hypertension,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D020388: Muscular Dystrophy, Duchenne,D049950: Hyperparathyroidism, Primary,D051436: Renal Insufficiency, Chronic,D056833: Central Serous Chorioretinopathy	NR3C2	M5
P08235	NA	NA	NA	NA	DESOXYCORTICOSTERONE ACETATE	Mineralocorticoid receptor agonist	AGONIST	1939	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	NA	NR3C2	M5
P08235	NA	NA	NA	NA	DESOXYCORTICOSTERONE PIVALATE	Mineralocorticoid receptor agonist	AGONIST	1982	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	NA	NR3C2	M5
P08235	NA	NA	NA	NA	FLUDROCORTISONE ACETATE	Mineralocorticoid receptor agonist	AGONIST	1955	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000224: Addison Disease,D000312: Adrenal Hyperplasia, Congenital,D003866: Depressive Disorder,D006319: Hearing Loss, Sensorineural,D008545: Melanoma,D010300: Parkinson Disease,D012772: Shock, Septic,D016471: Ovarian Hyperstimulation Syndrome,D047808: Adrenogenital Syndrome	NR3C2	M5
P08069	NA	NA	NA	NA	MECASERMIN RINFABATE	Insulin-like growth factor I receptor agonist	AGONIST	2005	CHEMBL1957	234	P08069	Insulin-like growth factor 1 receptor	Homo sapiens	D009223: Myotonic Dystrophy,D012178: Retinopathy of Prematurity,D046150: Laron Syndrome	IGF1R	M5
P08069	NA	NA	NA	NA	MECASERMIN	Insulin-like growth factor I receptor agonist	AGONIST	2005	CHEMBL1957	234	P08069	Insulin-like growth factor 1 receptor	Homo sapiens	D000375: Aging,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001847: Bone Diseases,D003424: Crohn Disease,D003920: Diabetes Mellitus,D006946: Hyperinsulinism,D009103: Multiple Sclerosis,D009634: Noonan Syndrome,D015518: Rett Syndrome,D039682: HIV-Associated Lipodystrophy Syndrome,D046150: Laron Syndrome,D052256: Tendinopathy	IGF1R	M5
P08069	NA	NA	NA	NA	TEPROTUMUMAB	Insulin-like growth factor I receptor antagonist	ANTAGONIST	2020	CHEMBL1957	234	P08069	Insulin-like growth factor 1 receptor	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009369: Neoplasms,D012509: Sarcoma,D045743: Scleroderma, Diffuse,D049970: Graves Ophthalmopathy	IGF1R	M5
P00374	NA	NA	NA	NA	METHOTREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000506: Alopecia Areata,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001168: Arthritis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002294: Carcinoma, Squamous Cell,D002318: Cardiovascular Diseases,D002583: Uterine Cervical Neoplasms,D002822: Choriocarcinoma,D003093: Colitis, Ulcerative,D003251: Constriction, Pathologic,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005199: Fanconi Anemia,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006319: Hearing Loss, Sensorineural,D006457: Hemoglobinuria, Paroxysmal,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006828: Hydatidiform Mole,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007249: Inflammation,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008105: Liver Cirrhosis, Biliary,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008269: Macular Edema,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009203: Myocardial Infarction,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D010003: Osteoarthritis,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010391: Pemphigoid, Bullous,D011087: Polycythemia Vera,D011271: Pregnancy, Ectopic,D011565: Psoriasis,D012507: Sarcoidosis,D012509: Sarcoma,D012516: Osteosarcoma,D012559: Schizophrenia,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014523: Urethral Neoplasms,D014581: Urticaria,D014605: Uveitis,D014657: Vasculitis,D014820: Vitiligo,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015658: HIV Infections,D015867: Uveitis, Intermediate,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016511: Severe Combined Immunodeficiency,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018242: Neuroectodermal Tumors, Primitive,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D056833: Central Serous Chorioretinopathy	DHFR	M5
P00374	NA	NA	NA	NA	PRALATREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	2009	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic	DHFR	M5
P00374	NA	NA	NA	NA	PEMETREXED DISODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	2004	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013945: Thymoma,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018287: Carcinoma, Large Cell,D031901: Gestational Trophoblastic Disease,D064129: Prostatic Neoplasms, Castration-Resistant	DHFR	M5
P00374	NA	NA	NA	NA	METHOTREXATE SODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	M5
P18089	NA	NA	NA	NA	METHYLDOPA	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D006973: Hypertension,D011225: Pre-Eclampsia	ADRA2B	M5
P18089	NA	NA	NA	NA	CLONIDINE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001930: Brain Injuries,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002318: Cardiovascular Diseases,D002545: Brain Ischemia,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D005242: Fecal Incontinence,D005901: Glaucoma,D006556: Heroin Dependence,D006939: Hyperemesis Gravidarum,D006973: Hypertension,D007024: Hypotension, Orthostatic,D008881: Migraine Disorders,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009369: Neoplasms,D010146: Pain,D011183: Postoperative Complications,D011247: Pregnancy,D012600: Scoliosis,D013280: Stomatitis,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D054971: Orthostatic Intolerance	ADRA2B	M5
P18089	NA	NA	NA	NA	MIRTAZAPINE	Adrenergic receptor alpha-2 antagonist	ANTAGONIST	1996	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	ADRA2B	M5
P18089	NA	NA	NA	NA	LEVONORDEFRIN	Adrenergic receptor alpha-2 agonist	AGONIST	1960	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRA2B	M5
P18089	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1985	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	CLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1974	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D006973: Hypertension,D010146: Pain	ADRA2B	M5
P18089	NA	NA	NA	NA	NAPHAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1971	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D003139: Common Cold,D007249: Inflammation,D007251: Influenza, Human,D011625: Pterygium	ADRA2B	M5
P18089	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRA2B	M5
P18089	NA	NA	NA	NA	TIZANIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001930: Brain Injuries,D008545: Melanoma,D009128: Muscle Spasticity,D011843: Radiculopathy	ADRA2B	M5
P18089	NA	NA	NA	NA	APRACLONIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1987	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	TETRAHYDROZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1979	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D007249: Inflammation,D011625: Pterygium	ADRA2B	M5
P18089	NA	NA	NA	NA	METHYLDOPATE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1962	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	GUANFACINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1986	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	ADRA2B	M5
P18089	NA	NA	NA	NA	GUANABENZ ACETATE	Adrenergic receptor alpha-2 agonist	AGONIST	1982	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	PHENOXYBENZAMINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	OXYMETAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1986	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D006255: Rhinitis, Allergic, Seasonal,D011305: Presbyopia,D012393: Rosacea	ADRA2B	M5
P18089	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	PHENTOLAMINE MESYLATE	Adrenergic receptor alpha antagonist	ANTAGONIST	1952	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA2B	M5
P18089	NA	NA	NA	NA	ALSEROXYLON	Adrenergic receptor alpha antagonist	ANTAGONIST	1982	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D010146: Pain	ADRA2B	M5
P18089	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRA2B	M5
P18089	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001249: Asthma	ADRA2B	M5
P18089	NA	NA	NA	NA	LOFEXIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	2018	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D009293: Opioid-Related Disorders,D013375: Substance Withdrawal Syndrome	ADRA2B	M5
P18089	NA	NA	NA	NA	BRIMONIDINE TARTRATE	Adrenergic receptor alpha-2 agonist	AGONIST	1996	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D005483: Flushing,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006940: Hyperemia,D007429: Intraocular Pressure,D009798: Ocular Hypertension,D012393: Rosacea,D015352: Dry Eye Syndromes,D015715: Corneal Edema,D019973: Alcohol-Related Disorders,D060831: Hand-Foot Syndrome	ADRA2B	M5
P18089	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRA2B	M5
P18089	NA	NA	NA	NA	DEXMEDETOMIDINE HYDROCHLORIDE	Adrenergic receptor alpha-2 agonist	AGONIST	1999	CHEMBL2095158	104743	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D000647: Amnesia,D001930: Brain Injuries,D010146: Pain,D011618: Psychotic Disorders,D012559: Schizophrenia	ADRA2B	M5
P18089	NA	NA	NA	NA	ERGOLOID MESYLATES	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	ADRA2B	M5
P18089	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Adrenergic receptor alpha agonist	AGONIST	1948	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D008881: Migraine Disorders	ADRA2B	M5
P18089	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P18089	Alpha-2B adrenergic receptor	Homo sapiens	NA	ADRA2B	M5
P18089	NA	NA	NA	NA	RAUWOLFIA SERPENTINA	Adrenergic receptor alpha antagonist	ANTAGONIST	1954	CHEMBL2095203	104787	P18089	Alpha-2B adrenergic receptor	Homo sapiens	D006331: Heart Diseases,D006973: Hypertension	ADRA2B	M5
P48167	NA	NA	NA	NA	HALOTHANE	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	1958	CHEMBL2363052	105747	P48167	Glycine receptor subunit beta	Homo sapiens	NA	GLRB	M5
P48167	NA	NA	NA	NA	ISOFLURANE	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	1979	CHEMBL2363052	105747	P48167	Glycine receptor subunit beta	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GLRB	M5
P48167	NA	NA	NA	NA	ENFLURANE	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	1972	CHEMBL2363052	105747	P48167	Glycine receptor subunit beta	Homo sapiens	NA	GLRB	M5
P48167	NA	NA	NA	NA	SEVOFLURANE	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	1995	CHEMBL2363052	105747	P48167	Glycine receptor subunit beta	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GLRB	M5
P48167	NA	NA	NA	NA	DESFLURANE	Glycine receptor (alpha-1/beta) positive modulator	POSITIVE MODULATOR	1992	CHEMBL2363052	105747	P48167	Glycine receptor subunit beta	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GLRB	M5
Q00534	NA	NA	NA	NA	PALBOCICLIB	CDK6/cyclin D1 inhibitor	INHIBITOR	2015	CHEMBL2111455	104977	Q00534	Cyclin-dependent kinase 6	Homo sapiens	D000230: Adenocarcinoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002817: Chordoma,D003110: Colonic Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008080: Liposarcoma,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012509: Sarcoma,D012512: Sarcoma, Ewing,D013953: Thymus Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018358: Neuroendocrine Tumors,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D044584: Carcinoma, Ductal,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	CDK6	M5
Q00534	NA	NA	NA	NA	ABEMACICLIB	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	2017	CHEMBL2508	10480	Q00534	Cyclin-dependent kinase 6	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D009837: Oligodendroglioma,D010190: Pancreatic Neoplasms,D012208: Rhabdomyosarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018335: Rhabdoid Tumor,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D064129: Prostatic Neoplasms, Castration-Resistant	CDK6	M5
Q00534	NA	NA	NA	NA	RIBOCICLIB	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	2017	CHEMBL2508	10480	Q00534	Cyclin-dependent kinase 6	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008080: Liposarcoma,D008223: Lymphoma,D008545: Melanoma,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013724: Teratoma,D013953: Thymus Neoplasms,D014594: Uterine Neoplasms,D018335: Rhabdoid Tumor,D018358: Neuroendocrine Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	CDK6	M5
Q00534	NA	NA	NA	NA	RIBOCICLIB SUCCINATE	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	2017	CHEMBL2508	10480	Q00534	Cyclin-dependent kinase 6	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms	CDK6	M5
Q00534	NA	NA	NA	NA	TRILACICLIB	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	2021	CHEMBL2508	10480	Q00534	Cyclin-dependent kinase 6	Homo sapiens	D001943: Breast Neoplasms,D006394: Hemangiosarcoma,D055752: Small Cell Lung Carcinoma,D064726: Triple Negative Breast Neoplasms	CDK6	M5
Q00534	NA	NA	NA	NA	TRILACICLIB DIHYDROCHLORIDE	Cyclin-dependent kinase 6 inhibitor	INHIBITOR	2021	CHEMBL2508	10480	Q00534	Cyclin-dependent kinase 6	Homo sapiens	D055752: Small Cell Lung Carcinoma	CDK6	M5
P35916	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M5
P35916	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M5
P35916	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M5
P35916	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M5
P35916	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M5
P35916	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M5
P35916	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FLT4	M5
P35916	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	FLT4	M5
P35916	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	NA	FLT4	M5
P07101	NA	NA	NA	NA	METYROSINE	Tyrosine 3-hydroxylase inhibitor	INHIBITOR	1979	CHEMBL1969	39	P07101	Tyrosine 3-monooxygenase	Homo sapiens	D006973: Hypertension,D011618: Psychotic Disorders	TH	M5
Q92847	NA	NA	NA	NA	MACIMORELIN	Ghrelin receptor agonist	AGONIST	2017	CHEMBL4616	11536	Q92847	Growth hormone secretagogue receptor type 1	Homo sapiens	D002100: Cachexia	GHSR	M5
Q92847	NA	NA	NA	NA	MACIMORELIN ACETATE	Ghrelin receptor agonist	AGONIST	2017	CHEMBL4616	11536	Q92847	Growth hormone secretagogue receptor type 1	Homo sapiens	NA	GHSR	M5
Q16620	NA	NA	NA	NA	ENTRECTINIB	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2019	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D008545: Melanoma,D009369: Neoplasms,D018275: Carcinoma, Lobular	NTRK2	M5
Q16620	NA	NA	NA	NA	LAROTRECTINIB	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2018	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D005910: Glioma,D009369: Neoplasms	NTRK2	M5
Q16620	NA	NA	NA	NA	LAROTRECTINIB SULFATE	Neurotrophic tyrosine kinase receptor inhibitor	INHIBITOR	2018	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D009362: Neoplasm Metastasis,D009369: Neoplasms	NTRK2	M5
Q16620	NA	NA	NA	NA	CENEGERMIN	Neurotrophic tyrosine kinase receptor agonist	AGONIST	2018	CHEMBL3559684	109739	Q16620	BDNF/NT-3 growth factors receptor	Homo sapiens	D005128: Eye Diseases,D007634: Keratitis	NTRK2	M5
P35408	NA	NA	NA	NA	DINOPROSTONE	Prostaglandin E2 receptor agonist	AGONIST	1977	CHEMBL2363068	105763	P35408	Prostaglandin E2 receptor EP4 subtype	Homo sapiens	D010146: Pain,D011247: Pregnancy	PTGER4	M5
Q09470	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA1	M5
Q09470	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA1	M5
Q09470	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	NA	KCNA1	M5
Q09470	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q09470	Potassium voltage-gated channel subfamily A member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA1	M5
Q9UGN5	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP2	M5
Q9UGN5	NA	NA	NA	NA	NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2017	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012512: Sarcoma, Ewing,D013274: Stomach Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP2	M5
Q9UGN5	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP2	M5
Q9UGN5	NA	NA	NA	NA	TALAZOPARIB TOSYLATE	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2018	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009369: Neoplasms,D015470: Leukemia, Myeloid, Acute,D064726: Triple Negative Breast Neoplasms	PARP2	M5
Q9UGN5	NA	NA	NA	NA	TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2018	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006394: Hemangiosarcoma,D007938: Leukemia,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP2	M5
Q9UGN5	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP2	M5
Q9UGN5	NA	NA	NA	NA	NIRAPARIB TOSYLATE	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2017	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D005185: Fallopian Tube Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms	PARP2	M5
P41145	CHEMBL128201	214599	10295681	NA	NALTREXONE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001883: Borderline Personality Disorder,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002659: Child Development Disorders, Pervasive,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D004715: Endometriosis,D005356: Fibromyalgia,D005715: Gambling,D006556: Heroin Dependence,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014256: Trichotillomania,D015352: Dry Eye Syndromes,D015658: HIV Infections,D018352: Coronavirus Infections,D018856: Cystitis, Interstitial,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRK1	M5
P41145	NA	NA	NA	NA	BUTORPHANOL TARTRATE	Kappa opioid receptor partial agonist	PARTIAL AGONIST	1978	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1	M5
P41145	NA	NA	NA	NA	BUPRENORPHINE	Kappa opioid receptor agonist	AGONIST	1981	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000755: Anemia, Sickle Cell,D001416: Back Pain,D002294: Carcinoma, Squamous Cell,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006526: Hepatitis C,D006556: Heroin Dependence,D009021: Morphine Dependence,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D013313: Stress Disorders, Post-Traumatic,D013375: Substance Withdrawal Syndrome,D014098: Toothache,D015658: HIV Infections,D017116: Low Back Pain,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain,D059787: Acute Pain	OPRK1	M5
P41145	NA	NA	NA	NA	DEZOCINE	Kappa opioid receptor antagonist	ANTAGONIST	1989	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	D010146: Pain	OPRK1	M5
P41145	NA	NA	NA	NA	NALOXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1971	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D003248: Constipation,D005715: Gambling,D007415: Intestinal Obstruction,D009293: Opioid-Related Disorders,D010146: Pain	OPRK1	M5
P41145	NA	NA	NA	NA	ANILERIDINE PHOSPHATE	Kappa opioid receptor agonist	AGONIST	1982	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1	M5
P41145	NA	NA	NA	NA	OXYMORPHONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1959	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D010146: Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRK1	M5
P41145	NA	NA	NA	NA	ANILERIDINE HYDROCHLORIDE	Kappa opioid receptor agonist	AGONIST	1982	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1	M5
P41145	NA	NA	NA	NA	CODEINE PHOSPHATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1952	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D003371: Cough,D008881: Migraine Disorders,D010146: Pain,D013035: Spasm,D015658: HIV Infections	OPRK1	M5
P41145	NA	NA	NA	NA	NALBUPHINE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1979	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D003693: Delirium,D008107: Liver Diseases,D009293: Opioid-Related Disorders,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D015470: Leukemia, Myeloid, Acute	OPRK1	M5
P41145	NA	NA	NA	NA	NALTREXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D001068: Feeding and Eating Disorders,D002607: Charcot-Marie-Tooth Disease,D009293: Opioid-Related Disorders,D010146: Pain,D019969: Amphetamine-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRK1	M5
P41145	NA	NA	NA	NA	NALMEFENE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1995	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D000437: Alcoholism	OPRK1	M5
P41145	NA	NA	NA	NA	CODEINE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1985	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D003371: Cough	OPRK1	M5
P41145	NA	NA	NA	NA	HYDROCODONE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1987	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1	M5
P41145	NA	NA	NA	NA	LEVALLORPHAN TARTRATE	Kappa opioid receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	NA	OPRK1	M5
P41145	NA	NA	NA	NA	BUPRENORPHINE HYDROCHLORIDE	Kappa opioid receptor agonist	AGONIST	1981	CHEMBL237	137	P41145	Kappa-type opioid receptor	Homo sapiens	D009293: Opioid-Related Disorders,D019966: Substance-Related Disorders	OPRK1	M5
P41145	NA	NA	NA	NA	BENZHYDROCODONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2018	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D059787: Acute Pain	OPRK1	M5
P41145	NA	NA	NA	NA	HYDROCODONE BITARTRATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1943	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D007674: Kidney Diseases,D008107: Liver Diseases,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D014947: Wounds and Injuries,D017116: Low Back Pain,D019966: Substance-Related Disorders,D059350: Chronic Pain,D059787: Acute Pain	OPRK1	M5
P41145	NA	NA	NA	NA	CODEINE SULFATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2009	CHEMBL2095181	104765	P41145	Kappa-type opioid receptor	Homo sapiens	D010146: Pain	OPRK1	M5
P20815	NA	NA	NA	NA	RITONAVIR	Cytochrome P450 3A inhibitor	INHIBITOR	1996	CHEMBL2364675	106175	P20815	Cytochrome P450 3A5	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000690: Amyotrophic Lateral Sclerosis,D003699: Hepatitis D,D005909: Glioblastoma,D006526: Hepatitis C,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007172: Erectile Dysfunction,D007239: Infections,D007333: Insulin Resistance,D008107: Liver Diseases,D008288: Malaria,D009362: Neoplasm Metastasis,D009369: Neoplasms,D011247: Pregnancy,D012128: Respiratory Distress Syndrome,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D014376: Tuberculosis,D014777: Virus Diseases,D015270: Mycobacterium avium-intracellulare Infection,D015658: HIV Infections,D018352: Coronavirus Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome	CYP3A5	M5
P20815	NA	NA	NA	NA	COBICISTAT	Cytochrome P450 3A inhibitor	INHIBITOR	2012	CHEMBL2364675	106175	P20815	Cytochrome P450 3A5	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D002289: Carcinoma, Non-Small-Cell Lung,D007239: Infections,D007333: Insulin Resistance,D008288: Malaria,D011020: Pneumonia, Pneumocystis,D015658: HIV Infections,D045169: Severe Acute Respiratory Syndrome	CYP3A5	M5
P16066	NA	NA	NA	NA	NESIRITIDE	Atrial natriuretic peptide receptor A agonist	AGONIST	2001	CHEMBL1988	244	P16066	Atrial natriuretic peptide receptor 1	Homo sapiens	D002318: Cardiovascular Diseases,D003920: Diabetes Mellitus,D004417: Dyspnea,D006330: Heart Defects, Congenital,D006333: Heart Failure,D006946: Hyperinsulinism,D006973: Hypertension,D007674: Kidney Diseases,D008545: Melanoma,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D009765: Obesity,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D058186: Acute Kidney Injury	NPR1	M5
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN POLISTIREX	Sigma opioid receptor agonist	AGONIST	1982	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D002659: Child Development Disorders, Pervasive	SIGMAR1	M5
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN HYDROBROMIDE	Sigma opioid receptor agonist	AGONIST	1984	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D003139: Common Cold,D003371: Cough,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006967: Hypersensitivity,D008881: Migraine Disorders,D009369: Neoplasms,D010146: Pain,D011471: Prostatic Neoplasms,D012852: Sinusitis	SIGMAR1	M5
Q99720	NA	NA	NA	NA	FENFLURAMINE HYDROCHLORIDE	Sigma opioid receptor antagonist	ANTAGONIST	2020	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D004831: Epilepsies, Myoclonic,D020195: Epilepsy, Reflex	SIGMAR1	M5
Q99720	NA	NA	NA	NA	PENTAZOCINE LACTATE	Sigma opioid receptor modulator	MODULATOR	1967	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	NA	SIGMAR1	M5
Q99720	NA	NA	NA	NA	PENTAZOCINE HYDROCHLORIDE	Sigma opioid receptor modulator	MODULATOR	1969	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D010146: Pain	SIGMAR1	M5
P00740	NA	NA	NA	NA	EMICIZUMAB	Coagulation factor IX and X other	OTHER	2017	CHEMBL2111424	104934	P00740	Coagulation factor IX	Homo sapiens	D006467: Hemophilia A,D006470: Hemorrhage	F9	M5
P06756	NA	NA	NA	NA	ABCIXIMAB	Integrin alpha-V/beta-3 inhibitor	INHIBITOR	1993	CHEMBL1907598	104292	P06756	Integrin alpha-V	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000208: Acute Disease,D000789: Angina, Unstable,D002545: Brain Ischemia,D009203: Myocardial Infarction,D013927: Thrombosis,D016893: Carotid Stenosis,D020521: Stroke,D060050: Angina, Stable	ITGAV	M5
P16444	NA	NA	NA	NA	CILASTATIN	Renal dipeptidase inhibitor	INHIBITOR	1985	CHEMBL1989	245	P16444	Dipeptidase 1	Homo sapiens	D001424: Bacterial Infections,D007239: Infections,D010019: Osteomyelitis,D011704: Pyelonephritis,D014552: Urinary Tract Infections,D018410: Pneumonia, Bacterial,D018805: Sepsis,D053717: Pneumonia, Ventilator-Associated	DPEP1	M5
P16444	NA	NA	NA	NA	CILASTATIN SODIUM	Renal dipeptidase inhibitor	INHIBITOR	1985	CHEMBL1989	245	P16444	Dipeptidase 1	Homo sapiens	D004696: Endocarditis,D007239: Infections,D011014: Pneumonia,D014552: Urinary Tract Infections,D018805: Sepsis,D059413: Intraabdominal Infections	DPEP1	M5
P06729	NA	NA	NA	NA	ALEFACEPT	T-cell surface antigen CD2 inhibitor	INHIBITOR	2003	CHEMBL2040	196	P06729	T-cell surface antigen CD2	Homo sapiens	D000741: Anemia, Aplastic,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008010: Lichen Planus,D008223: Lymphoma,D011565: Psoriasis,D015535: Arthritis, Psoriatic,D051437: Renal Insufficiency	CD2	M5
P00747	NA	NA	NA	NA	TRANEXAMIC ACID	Plasminogen inhibitor	INHIBITOR	1986	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000740: Anemia,D001254: Astrocytoma,D001416: Back Pain,D001749: Urinary Bladder Neoplasms,D001778: Blood Coagulation Disorders,D001859: Bone Neoplasms,D001930: Brain Injuries,D002543: Cerebral Hemorrhage,D003327: Coronary Disease,D004844: Epistaxis,D005265: Femoral Neck Fractures,D005910: Glioma,D006258: Head and Neck Neoplasms,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D006473: Postpartum Hemorrhage,D006620: Hip Fractures,D007022: Hypotension,D007592: Joint Diseases,D007889: Leiomyoma,D008548: Melanosis,D008579: Meningioma,D008595: Menorrhagia,D009298: Nasal Polyps,D009369: Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010921: Placenta Accreta,D010923: Placenta Previa,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D012878: Skin Neoplasms,D013345: Subarachnoid Hemorrhage,D013683: Telangiectasia, Hereditary Hemorrhagic,D013921: Thrombocytopenia,D014947: Wounds and Injuries,D017544: Aortic Aneurysm, Abdominal,D019337: Hematologic Neoplasms,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050723: Fractures, Bone,D054179: Angioedemas, Hereditary,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse	PLG	M5
P00747	NA	NA	NA	NA	AMINOCAPROIC ACID	Plasminogen inhibitor	INHIBITOR	1964	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001018: Aortic Diseases,D003398: Craniosynostoses,D006470: Hemorrhage,D007249: Inflammation,D012393: Rosacea	PLG	M5
P00747	NA	NA	NA	NA	ALTEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000038: Abscess,D000083242: Ischemic Stroke,D001991: Bronchitis,D002543: Cerebral Hemorrhage,D002544: Cerebral Infarction,D002545: Brain Ischemia,D004653: Empyema,D005128: Eye Diseases,D006333: Heart Failure,D006470: Hemorrhage,D009203: Myocardial Infarction,D009369: Neoplasms,D009422: Nervous System Diseases,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012170: Retinal Vein Occlusion,D013345: Subarachnoid Hemorrhage,D013924: Thrombophlebitis,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016055: Urinary Retention,D016724: Empyema, Pleural,D017202: Myocardial Ischemia,D018784: Abdominal Abscess,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D060050: Angina, Stable	PLG	M5
P00747	NA	NA	NA	NA	UROKINASE	Plasminogen activator	ACTIVATOR	2007	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D004653: Empyema,D007239: Infections,D011655: Pulmonary Embolism,D013927: Thrombosis,D016724: Empyema, Pleural,D020521: Stroke	PLG	M5
P00747	NA	NA	NA	NA	APROTININ	Plasminogen inhibitor	INHIBITOR	1993	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001943: Breast Neoplasms,D006470: Hemorrhage,D010195: Pancreatitis	PLG	M5
P00747	NA	NA	NA	NA	RETEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D009203: Myocardial Infarction,D013927: Thrombosis,D020521: Stroke	PLG	M5
P00747	NA	NA	NA	NA	STREPTOKINASE	Plasminogen activator	ACTIVATOR	1997	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000083242: Ischemic Stroke,D009203: Myocardial Infarction,D010195: Pancreatitis,D013927: Thrombosis,D017202: Myocardial Ischemia,D020246: Venous Thrombosis	PLG	M5
P00747	NA	NA	NA	NA	TENECTEPLASE	Plasminogen activator	ACTIVATOR	2000	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D002544: Cerebral Infarction,D002545: Brain Ischemia,D009203: Myocardial Infarction,D009422: Nervous System Diseases,D010996: Pleural Effusion,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016757: Death, Sudden, Cardiac,D020521: Stroke	PLG	M5
P00747	NA	NA	NA	NA	DEFIBROTIDE SODIUM	Plasminogen activator	ACTIVATOR	2016	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D006504: Hepatic Veno-Occlusive Disease	PLG	M5
P37288	NA	NA	NA	NA	VASOPRESSIN	Vasopressin receptor agonist	AGONIST	2014	CHEMBL2363078	105773	P37288	Vasopressin V1a receptor	Homo sapiens	D001321: Autistic Disorder,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003919: Diabetes Insipidus,D006323: Heart Arrest,D006331: Heart Diseases,D006976: Hypertension, Pulmonary,D007022: Hypotension,D007889: Leiomyoma,D009214: Myoma,D010146: Pain,D010996: Pleural Effusion,D012769: Shock,D012772: Shock, Septic,D016757: Death, Sudden, Cardiac,D018805: Sepsis,D055371: Acute Lung Injury,D065630: Hernias, Diaphragmatic, Congenital	AVPR1A	M5
P37288	NA	NA	NA	NA	DESMOPRESSIN ACETATE	Vasopressin receptor agonist	AGONIST	1978	CHEMBL2363078	105773	P37288	Vasopressin V1a receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D006470: Hemorrhage,D006973: Hypertension,D011183: Postoperative Complications	AVPR1A	M5
P37288	NA	NA	NA	NA	LYPRESSIN	Vasopressin receptor agonist	AGONIST	1982	CHEMBL2363078	105773	P37288	Vasopressin V1a receptor	Homo sapiens	NA	AVPR1A	M5
P37288	NA	NA	NA	NA	CONIVAPTAN HYDROCHLORIDE	Vasopressin V1a receptor antagonist	ANTAGONIST	2005	CHEMBL1889	134	P37288	Vasopressin V1a receptor	Homo sapiens	D007010: Hyponatremia,D008107: Liver Diseases	AVPR1A	M5
P37288	NA	NA	NA	NA	VASOPRESSIN TANNATE	Vasopressin V1a receptor agonist	AGONIST	1982	CHEMBL1889	134	P37288	Vasopressin V1a receptor	Homo sapiens	NA	AVPR1A	M5
P07942	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	P07942	Laminin subunit beta-1	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMB1	M5
P11047	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	P11047	Laminin subunit gamma-1	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMC1	M5
P07333	NA	NA	NA	NA	SUNITINIB MALATE	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	2006	CHEMBL1844	12840	P07333	Macrophage colony-stimulating factor 1 receptor	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CSF1R	M5
P07333	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	2009	CHEMBL1844	12840	P07333	Macrophage colony-stimulating factor 1 receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	CSF1R	M5
P07333	NA	NA	NA	NA	PEXIDARTINIB	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	2019	CHEMBL1844	12840	P07333	Macrophage colony-stimulating factor 1 receptor	Homo sapiens	D001172: Arthritis, Rheumatoid,D001943: Breast Neoplasms,D005870: Giant Cell Tumors,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D008107: Liver Diseases,D008545: Melanoma,D009369: Neoplasms,D009442: Neurilemmoma,D011471: Prostatic Neoplasms,D013586: Synovitis, Pigmented Villonodular,D015470: Leukemia, Myeloid, Acute,D046152: Gastrointestinal Stromal Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	CSF1R	M5
P07333	NA	NA	NA	NA	PEXIDARTINIB HYDROCHLORIDE	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	2019	CHEMBL1844	12840	P07333	Macrophage colony-stimulating factor 1 receptor	Homo sapiens	D000070779: Giant Cell Tumor of Tendon Sheath	CSF1R	M5
P10828	NA	NA	NA	NA	DEXTROTHYROXINE	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D002318: Cardiovascular Diseases,D004314: Down Syndrome	THRB	M5
P10828	NA	NA	NA	NA	LIOTHYRONINE	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D003866: Depressive Disorder,D007037: Hypothyroidism,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	THRB	M5
P10828	NA	NA	NA	NA	LIOTHYRONINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D006258: Head and Neck Neoplasms,D006330: Heart Defects, Congenital,D007037: Hypothyroidism,D009103: Multiple Sclerosis,D013964: Thyroid Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D065630: Hernias, Diaphragmatic, Congenital	THRB	M5
P10828	NA	NA	NA	NA	LEVOTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	2000	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001714: Bipolar Disorder,D003409: Congenital Hypothyroidism,D007037: Hypothyroidism,D010146: Pain,D013964: Thyroid Neoplasms	THRB	M5
P10828	NA	NA	NA	NA	DEXTROTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D009203: Myocardial Infarction,D017202: Myocardial Ischemia	THRB	M5
P12259	NA	NA	NA	NA	DROTRECOGIN ALFA (ACTIVATED)	Coagulation factor V inhibitor	INHIBITOR	2001	CHEMBL3618	11387	P12259	Coagulation factor V	Homo sapiens	D007022: Hypotension,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013927: Thrombosis,D018805: Sepsis,D020521: Stroke,D051436: Renal Insufficiency, Chronic	F5	M5
P54760	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54760	Ephrin type-B receptor 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHB4	M5
P11473	NA	NA	NA	NA	CALCITRIOL	Vitamin D receptor agonist	AGONIST	1978	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D005350: Fibroma,D006973: Hypertension,D006996: Hypocalcemia,D007011: Hypoparathyroidism,D007676: Kidney Failure, Chronic,D007713: Klinefelter Syndrome,D008180: Lupus Erythematosus, Systemic,D008545: Melanoma,D009062: Mouth Neoplasms,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D010024: Osteoporosis,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012080: Chronic Kidney Disease-Mineral and Bone Disorder,D015663: Osteoporosis, Postmenopausal,D016543: Central Nervous System Neoplasms,D018281: Cholangiocarcinoma,D018805: Sepsis,D051436: Renal Insufficiency, Chronic,D053098: Familial Hypophosphatemic Rickets,D058186: Acute Kidney Injury,D064129: Prostatic Neoplasms, Castration-Resistant	VDR	M5
P11473	NA	NA	NA	NA	CHOLECALCIFEROL	Vitamin D receptor agonist	AGONIST	1999	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000236: Adenoma,D000326: Adrenoleukodystrophy,D000375: Aging,D000740: Anemia,D000755: Anemia, Sickle Cell,D001171: Arthritis, Juvenile,D001249: Asthma,D001321: Autistic Disorder,D001471: Barrett Esophagus,D001851: Bone Diseases, Metabolic,D001943: Breast Neoplasms,D001988: Bronchiolitis,D002056: Burns,D002278: Carcinoma in Situ,D002285: Carcinoma, Intraductal, Noninfiltrating,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003139: Common Cold,D003233: Conjunctivitis, Allergic,D003424: Crohn Disease,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D005891: Gingivitis,D005909: Glioblastoma,D006333: Heart Failure,D006526: Hepatitis C,D006620: Hip Fractures,D006949: Hyperlipidemias,D006967: Hypersensitivity,D007006: Hypogonadism,D007239: Infections,D007248: Infertility, Male,D007251: Influenza, Human,D008180: Lupus Erythematosus, Systemic,D008545: Melanoma,D009103: Multiple Sclerosis,D009369: Neoplasms,D009456: Neurofibromatosis 1,D009765: Obesity,D009902: Optic Neuritis,D010001: Osteitis Deformans,D010024: Osteoporosis,D010051: Ovarian Neoplasms,D010212: Papilloma,D010300: Parkinson Disease,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011565: Psoriasis,D011618: Psychotic Disorders,D012004: Rectal Neoplasms,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012878: Skin Neoplasms,D013203: Staphylococcal Infections,D013978: Tibial Fractures,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014581: Urticaria,D014808: Vitamin D Deficiency,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D016481: Helicobacter Infections,D016640: Diabetes, Gestational,D018149: Glucose Intolerance,D018798: Anemia, Iron-Deficiency,D019337: Hematologic Neoplasms,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D043183: Irritable Bowel Syndrome,D044342: Malnutrition,D045169: Severe Acute Respiratory Syndrome,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D055623: Keratosis, Actinic,D055948: Sarcopenia,D060825: Cognitive Dysfunction,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	VDR	M5
P11473	NA	NA	NA	NA	ERGOCALCIFEROL	Vitamin D receptor agonist	AGONIST	1941	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000071698: Latent Autoimmune Diabetes in Adults,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001249: Asthma,D001778: Blood Coagulation Disorders,D001851: Bone Diseases, Metabolic,D001943: Breast Neoplasms,D002056: Burns,D002583: Uterine Cervical Neoplasms,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003929: Diabetic Neuropathies,D004211: Disseminated Intravascular Coagulation,D005265: Femoral Neck Fractures,D005870: Giant Cell Tumors,D006333: Heart Failure,D006526: Hepatitis C,D006620: Hip Fractures,D006966: Hyperprolactinemia,D006996: Hypocalcemia,D007011: Hypoparathyroidism,D007015: Hypophosphatemia, Familial,D007333: Insulin Resistance,D007938: Leukemia,D008175: Lung Neoplasms,D008178: Lupus Erythematosus, Cutaneous,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008593: Menopause,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009369: Neoplasms,D009765: Obesity,D009902: Optic Neuritis,D010001: Osteitis Deformans,D010013: Osteogenesis Imperfecta,D010024: Osteoporosis,D010146: Pain,D010411: Penile Induration,D011085: Polycystic Ovary Syndrome,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012148: Restless Legs Syndrome,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014808: Vitamin D Deficiency,D015179: Colorectal Neoplasms,D015212: Inflammatory Bowel Diseases,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D016640: Diabetes, Gestational,D016757: Death, Sudden, Cardiac,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019698: Hepatitis C, Chronic,D019964: Mood Disorders,D020370: Osteoarthritis, Knee,D044342: Malnutrition,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D049950: Hyperparathyroidism, Primary,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D053098: Familial Hypophosphatemic Rickets,D055948: Sarcopenia,D063730: Rickets, Hypophosphatemic,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	VDR	M5
P11473	NA	NA	NA	NA	PARICALCITOL	Vitamin D receptor agonist	AGONIST	1998	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000419: Albuminuria,D001943: Breast Neoplasms,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D005922: Glomerulonephritis, IGA,D006962: Hyperparathyroidism, Secondary,D006996: Hypocalcemia,D007674: Kidney Diseases,D009101: Multiple Myeloma,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D010279: Parathyroid Diseases,D011507: Proteinuria,D012004: Rectal Neoplasms,D017379: Hypertrophy, Left Ventricular,D021441: Carcinoma, Pancreatic Ductal,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	VDR	M5
P11473	NA	NA	NA	NA	CALCIPOTRIENE	Vitamin D receptor agonist	AGONIST	1993	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000152: Acne Vulgaris,D003876: Dermatitis, Atopic,D004485: Eczema,D011565: Psoriasis,D011855: Radiodermatitis,D012594: Scleroderma, Localized,D012871: Skin Diseases,D014820: Vitiligo,D055623: Keratosis, Actinic	VDR	M5
P11473	NA	NA	NA	NA	DOXERCALCIFEROL	Vitamin D receptor agonist	AGONIST	1999	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D009369: Neoplasms,D010279: Parathyroid Diseases,D011565: Psoriasis,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	VDR	M5
P11473	NA	NA	NA	NA	CALCIFEDIOL	Vitamin D receptor agonist	AGONIST	1980	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D006962: Hyperparathyroidism, Secondary,D009203: Myocardial Infarction,D010279: Parathyroid Diseases,D014808: Vitamin D Deficiency,D020181: Sleep Apnea, Obstructive,D045169: Severe Acute Respiratory Syndrome,D058186: Acute Kidney Injury	VDR	M5
P07949	NA	NA	NA	NA	VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2011	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	RET	M5
P07949	NA	NA	NA	NA	SUNITINIB MALATE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2006	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	RET	M5
P07949	NA	NA	NA	NA	SORAFENIB TOSYLATE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2005	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	RET	M5
P07949	NA	NA	NA	NA	REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2012	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	RET	M5
P07949	NA	NA	NA	NA	ALECTINIB HYDROCHLORIDE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2015	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	RET	M5
P07949	NA	NA	NA	NA	SELPERCATINIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2020	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D013964: Thyroid Neoplasms,D018276: Carcinoma, Medullary	RET	M5
P07949	NA	NA	NA	NA	PRALSETINIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2020	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D013964: Thyroid Neoplasms	RET	M5
Q9Y375	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q9Y375	Complex I intermediate-associated protein 30, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFAF1	M5
P05106	NA	NA	NA	NA	EPTIFIBATIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D009203: Myocardial Infarction,D011014: Pneumonia,D012772: Shock, Septic,D013927: Thrombosis,D020520: Brain Infarction,D020521: Stroke,D054058: Acute Coronary Syndrome	ITGB3	M5
P05106	NA	NA	NA	NA	ABCIXIMAB	Integrin alpha-V/beta-3 inhibitor	INHIBITOR	1993	CHEMBL1907598	104292	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000208: Acute Disease,D000789: Angina, Unstable,D002545: Brain Ischemia,D009203: Myocardial Infarction,D013927: Thrombosis,D016893: Carotid Stenosis,D020521: Stroke,D060050: Angina, Stable	ITGB3	M5
P05106	NA	NA	NA	NA	TIROFIBAN HYDROCHLORIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	NA	ITGB3	M5
P00797	NA	NA	NA	NA	ALISKIREN FUMARATE	Renin inhibitor	INHIBITOR	2007	CHEMBL286	11225	P00797	Renin	Homo sapiens	D006973: Hypertension	REN	M5
Q9NRF9	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	Q9NRF9	DNA polymerase epsilon subunit 3	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLE3	M5
Q9NRF9	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	Q9NRF9	DNA polymerase epsilon subunit 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLE3	M5
Q9NRF9	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	Q9NRF9	DNA polymerase epsilon subunit 3	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLE3	M5
Q9NRF9	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	Q9NRF9	DNA polymerase epsilon subunit 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLE3	M5
P42262	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	1996	CHEMBL2096670	104825	P42262	Glutamate receptor 2	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIA2	M5
P42262	NA	NA	NA	NA	PERAMPANEL	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	2012	CHEMBL2096670	104825	P42262	Glutamate receptor 2	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D008881: Migraine Disorders,D009437: Neuralgia,D010300: Parkinson Disease,D010523: Peripheral Nervous System Diseases,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014103: Torticollis,D020329: Essential Tremor,D065768: Lennox Gastaut Syndrome	GRIA2	M5
P54764	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54764	Ephrin type-A receptor 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA4	M5
Q9BQ31	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNS3	M5
Q9BQ31	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNS3	M5
Q9BQ31	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	NA	KCNS3	M5
Q9BQ31	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNS3	M5
P06748	NA	NA	NA	NA	CRIZOTINIB	NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)	INHIBITOR	2011	CHEMBL2111387	105079	P06748	Nucleophosmin	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000080443: Diffuse Intrinsic Pontine Glioma,D000230: Adenocarcinoma,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006104: Granuloma, Plasma Cell,D007674: Kidney Diseases,D008175: Lung Neoplasms,D009101: Multiple Myeloma,D009369: Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016518: Neurofibromatosis 2,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D064129: Prostatic Neoplasms, Castration-Resistant	NPM1	M5
P06748	NA	NA	NA	NA	CERITINIB	NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor)	INHIBITOR	2014	CHEMBL2111387	105079	P06748	Nucleophosmin	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006104: Granuloma, Plasma Cell,D008107: Liver Diseases,D008545: Melanoma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D013964: Thyroid Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma	NPM1	M5
P07550	NA	NA	NA	NA	TIMOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB2	M5
P07550	NA	NA	NA	NA	PINDOLOL	Beta-2 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB2	M5
P07550	NA	NA	NA	NA	NADOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB2	M5
P07550	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB2	M5
P07550	NA	NA	NA	NA	ALBUTEROL	Beta-2 adrenergic receptor agonist	AGONIST	1981	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D001988: Bronchiolitis,D003371: Cough,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D004402: Dysautonomia, Familial,D006009: Glycogen Storage Disease Type II,D006255: Rhinitis, Allergic, Seasonal,D006333: Heart Failure,D006967: Hypersensitivity,D006976: Hypertension, Pulmonary,D008171: Lung Diseases,D008173: Lung Diseases, Obstructive,D008569: Memory Disorders,D011654: Pulmonary Edema,D012131: Respiratory Insufficiency,D013119: Spinal Cord Injuries,D013224: Status Asthmaticus,D018192: Lymphangioleiomyomatosis,D020294: Myasthenic Syndromes, Congenital,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D062025: Organophosphate Poisoning,D065627: Familial Primary Pulmonary Hypertension	ADRB2	M5
P07550	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB2	M5
P07550	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB2	M5
P07550	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M5
P07550	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	SALMETEROL XINAFOATE	Beta-2 adrenergic receptor agonist	AGONIST	1994	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001989: Bronchiolitis Obliterans,D004646: Emphysema,D009765: Obesity,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M5
P07550	NA	NA	NA	NA	VILANTEROL TRIFENATATE	Beta-2 adrenergic receptor agonist	AGONIST	2013	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M5
P07550	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB2	M5
P07550	NA	NA	NA	NA	BITOLTEROL MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB2	M5
P07550	NA	NA	NA	NA	PIRBUTEROL ACETATE	Beta-2 adrenergic receptor agonist	AGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M5
P07550	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB2	M5
P07550	NA	NA	NA	NA	PROTOKYLOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	ISOETHARINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB2	M5
P07550	NA	NA	NA	NA	LEVALBUTEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1999	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001986: Bronchial Spasm	ADRB2	M5
P07550	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M5
P07550	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB2	M5
P07550	NA	NA	NA	NA	ISOETHARINE MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB2	M5
P07550	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB2	M5
P07550	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1990	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB2	M5
P07550	NA	NA	NA	NA	TERBUTALINE SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1974	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M5
P07550	NA	NA	NA	NA	RITODRINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1991	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB2	M5
P07550	NA	NA	NA	NA	ALBUTEROL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D002318: Cardiovascular Diseases,D008171: Lung Diseases,D012128: Respiratory Distress Syndrome,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M5
P07550	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M5
P07550	NA	NA	NA	NA	METAPROTERENOL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1973	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D019966: Substance-Related Disorders	ADRB2	M5
P07550	NA	NA	NA	NA	INDACATEROL MALEATE	Beta-2 adrenergic receptor agonist	AGONIST	2011	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M5
P07550	NA	NA	NA	NA	ARFORMOTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2006	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001991: Bronchitis,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M5
P07550	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB2	M5
P07550	NA	NA	NA	NA	OLODATEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	2014	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M5
P07550	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M5
P07550	NA	NA	NA	NA	LEVALBUTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2005	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm	ADRB2	M5
P07550	NA	NA	NA	NA	FORMOTEROL FUMARATE	Beta-2 adrenergic receptor agonist	AGONIST	2001	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm,D001987: Bronchiectasis,D001989: Bronchiolitis Obliterans,D001991: Bronchitis,D004646: Emphysema,D006967: Hypersensitivity,D008175: Lung Neoplasms,D012128: Respiratory Distress Syndrome,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D045169: Severe Acute Respiratory Syndrome	ADRB2	M5
Q13885	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB2A	M5
Q13885	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M5
Q13885	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M5
Q13885	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB2A	M5
Q13885	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M5
Q13885	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M5
Q13885	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M5
Q13885	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB2A	M5
Q13885	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB2A	M5
Q13885	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB2A	M5
Q13885	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB2A	M5
Q13885	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB2A	M5
Q13885	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB2A	M5
Q13885	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q13885	Tubulin beta-2A chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB2A	M5
P55157	NA	NA	NA	NA	LOMITAPIDE MESYLATE	Microsomal triglyceride transfer protein inhibitor	INHIBITOR	2012	CHEMBL2364681	106181	P55157	Microsomal triglyceride transfer protein large subunit	Homo sapiens	D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias	MTTP	M5
P54756	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54756	Ephrin type-A receptor 5	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA5	M5
Q9H3M0	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9H3M0	Potassium voltage-gated channel subfamily F member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNF1	M5
Q9H3M0	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9H3M0	Potassium voltage-gated channel subfamily F member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNF1	M5
Q9H3M0	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9H3M0	Potassium voltage-gated channel subfamily F member 1	Homo sapiens	NA	KCNF1	M5
Q9H3M0	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9H3M0	Potassium voltage-gated channel subfamily F member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNF1	M5
P12268	NA	NA	NA	NA	THIOGUANINE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1966	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001932: Brain Neoplasms,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	IMPDH2	M5
P12268	NA	NA	NA	NA	MYCOPHENOLIC ACID	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	2004	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D009404: Nephrotic Syndrome,D012595: Scleroderma, Systemic,D015352: Dry Eye Syndromes,D015470: Leukemia, Myeloid, Acute,D015867: Uveitis, Intermediate,D051436: Renal Insufficiency, Chronic	IMPDH2	M5
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1995	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000690: Amyotrophic Lateral Sclerosis,D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001327: Autoimmune Diseases,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D004062: DiGeorge Syndrome,D004820: Epidermolysis Bullosa,D005199: Fanconi Anemia,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006073: Gout,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006331: Heart Diseases,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006519: Hepatitis, Alcoholic,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006973: Hypertension,D007119: Immunoblastic Lymphadenopathy,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009472: Neuronal Ceroid-Lipofuscinoses,D010190: Pancreatic Neoplasms,D010390: Pemphigoid, Benign Mucous Membrane,D010391: Pemphigoid, Bullous,D010392: Pemphigus,D011087: Polycythemia Vera,D011128: Polyradiculopathy,D011565: Psoriasis,D011695: Purpura, Schoenlein-Henoch,D012010: Red-Cell Aplasia, Pure,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012859: Sjogren's Syndrome,D013625: Takayasu Arteritis,D014605: Uveitis,D014657: Vasculitis,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017563: Lung Diseases, Interstitial,D017565: Sarcoidosis, Pulmonary,D017728: Lymphoma, Large-Cell, Anaplastic,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D045743: Scleroderma, Diffuse,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D055953: Microscopic Polyangiitis,D056486: Chemical and Drug Induced Liver Injury,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	IMPDH2	M5
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1998	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	NA	IMPDH2	M5
P04035	NA	NA	NA	NA	LOVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1987	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D002537: Intracranial Arteriosclerosis,D002538: Intracranial Arteriovenous Malformations,D005600: Fragile X Syndrome,D006331: Heart Diseases,D006937: Hypercholesterolemia,D007249: Inflammation,D007383: Intermittent Claudication,D007859: Learning Disabilities,D008545: Melanoma,D008659: Metabolic Diseases,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010300: Parkinson Disease,D015470: Leukemia, Myeloid, Acute,D015518: Rett Syndrome,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D017499: Porokeratosis,D019294: Xanthomatosis, Cerebrotendinous,D020521: Stroke,D029424: Pulmonary Disease, Chronic Obstructive,D052439: Lipid Metabolism Disorders,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M5
P04035	NA	NA	NA	NA	PRAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003922: Diabetes Mellitus, Type 1,D006937: Hypercholesterolemia,D006950: Hyperlipidemia, Familial Combined,D007938: Leukemia,D008060: Lipodystrophy,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D015658: HIV Infections	HMGCR	M5
P04035	NA	NA	NA	NA	SIMVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000075222: Essential Hypertension,D000083242: Ischemic Stroke,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002311: Cardiomyopathy, Dilated,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002543: Cerebral Hemorrhage,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003550: Cystic Fibrosis,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D003930: Diabetic Retinopathy,D004827: Epilepsy,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007383: Intermittent Claudication,D007414: Intestinal Neoplasms,D007889: Leiomyoma,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D008881: Migraine Disorders,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009369: Neoplasms,D009634: Noonan Syndrome,D009902: Optic Neuritis,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010195: Pancreatitis,D010300: Parkinson Disease,D010518: Periodontitis,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012772: Shock, Septic,D012852: Sinusitis,D012893: Sleep Wake Disorders,D013274: Stomach Neoplasms,D013345: Subarachnoid Hemorrhage,D014605: Uveitis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015209: Cholangitis, Sclerosing,D015228: Hypertriglyceridemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D015794: Choroideremia,D016540: Smoking Cessation,D017202: Myocardial Ischemia,D018805: Sepsis,D019082: Smith-Lemli-Opitz Syndrome,D019694: Hepatitis B, Chronic,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D020786: Hemangioma, Cavernous, Central Nervous System,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D052016: Mucositis,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M5
P04035	NA	NA	NA	NA	ATORVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	1996	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D000082882: Bicuspid Aortic Valve Disease,D000083242: Ischemic Stroke,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D000787: Angina Pectoris,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002532: Intracranial Aneurysm,D002544: Cerebral Infarction,D003251: Constriction, Pathologic,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003424: Crohn Disease,D003919: Diabetes Insipidus,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004489: Edema, Cardiac,D004827: Epilepsy,D005909: Glioblastoma,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006333: Heart Failure,D006526: Hepatitis C,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006952: Hyperlipoproteinemia Type III,D006953: Hyperlipoproteinemia Type IV,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007251: Influenza, Human,D007674: Kidney Diseases,D007938: Leukemia,D008180: Lupus Erythematosus, Systemic,D008228: Lymphoma, Non-Hodgkin,D008268: Macular Degeneration,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009303: Nasopharyngeal Neoplasms,D009336: Necrosis,D009369: Neoplasms,D010020: Osteonecrosis,D010518: Periodontitis,D011085: Polycystic Ovary Syndrome,D011225: Pre-Eclampsia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012507: Sarcoidosis,D012594: Scleroderma, Localized,D012893: Sleep Wake Disorders,D014376: Tuberculosis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015228: Hypertriglyceridemia,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D056586: Acute Chest Syndrome,D058186: Acute Kidney Injury,D058922: Inflammatory Breast Neoplasms,D060050: Angina, Stable,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	HMGCR	M5
P04035	NA	NA	NA	NA	CERIVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1997	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	NA	HMGCR	M5
P04035	NA	NA	NA	NA	PITAVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2009	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006937: Hypercholesterolemia,D006949: Hyperlipidemias,D050171: Dyslipidemias,D052439: Lipid Metabolism Disorders	HMGCR	M5
P04035	NA	NA	NA	NA	ROSUVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2003	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D015228: Hypertriglyceridemia,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome	HMGCR	M5
P04035	NA	NA	NA	NA	FLUVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1993	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001943: Breast Neoplasms,D006937: Hypercholesterolemia	HMGCR	M5
P04035	NA	NA	NA	NA	PITAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M5
P04035	NA	NA	NA	NA	PITAVASTATIN MAGNESIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M5
P49841	NA	NA	NA	NA	LITHIUM CARBONATE	Glycogen synthase kinase-3 inhibitor	INHIBITOR	1970	CHEMBL2095188	104772	P49841	Glycogen synthase kinase-3 beta	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001714: Bipolar Disorder,D001924: Brain Concussion,D001932: Brain Neoplasms,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D013494: Supranuclear Palsy, Progressive,D016543: Central Nervous System Neoplasms,D017827: Machado-Joseph Disease,D018276: Carcinoma, Medullary,D018358: Neuroendocrine Tumors,D019578: Multiple System Atrophy,D019955: Conduct Disorder,D020521: Stroke,D020754: Spinocerebellar Ataxias,D050723: Fractures, Bone,D052556: Niemann-Pick Disease, Type C,D055752: Small Cell Lung Carcinoma,D057180: Frontotemporal Dementia,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	GSK3B	M5
P49841	NA	NA	NA	NA	LITHIUM CITRATE	Glycogen synthase kinase-3 inhibitor	INHIBITOR	1980	CHEMBL2095188	104772	P49841	Glycogen synthase kinase-3 beta	Homo sapiens	D011618: Psychotic Disorders	GSK3B	M5
O94806	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	O94806	Serine/threonine-protein kinase D3	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKD3	M5
O15399	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN2D	M5
O15399	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN2D	M5
O15399	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN2D	M5
O15399	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN2D	M5
O15399	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN2D	M5
O15399	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D010146: Pain	GRIN2D	M5
O15399	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D010300: Parkinson Disease	GRIN2D	M5
O15399	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D000437: Alcoholism	GRIN2D	M5
O15399	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	O15399	Glutamate receptor ionotropic, NMDA 2D	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN2D	M5
P02461	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02461	Collagen alpha-1(III) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL3A1	M5
P02461	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02461	Collagen alpha-1(III) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL3A1	M5
O43924	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6D	M5
O43924	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6D	M5
Q07001	NA	NA	NA	NA	SUCCINYLCHOLINE CHLORIDE	Muscle-type nicotinic acetylcholine receptor agonist	AGONIST	1952	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q07001	NA	NA	NA	NA	MIVACURIUM CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1992	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	D008107: Liver Diseases	CHRND	M5
Q07001	NA	NA	NA	NA	DECAMETHONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q07001	NA	NA	NA	NA	METOCURINE IODIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1982	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q07001	NA	NA	NA	NA	ATRACURIUM BESYLATE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1983	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	D009126: Muscle Relaxation	CHRND	M5
Q07001	NA	NA	NA	NA	RAPACURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1999	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q07001	NA	NA	NA	NA	VECURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1984	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q07001	NA	NA	NA	NA	CISATRACURIUM BESYLATE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1995	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	D012128: Respiratory Distress Syndrome	CHRND	M5
Q07001	NA	NA	NA	NA	ROCURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1994	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	D001416: Back Pain,D006323: Heart Arrest	CHRND	M5
Q07001	NA	NA	NA	NA	PIPECURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1990	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q07001	NA	NA	NA	NA	PANCURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1972	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q07001	NA	NA	NA	NA	GALLAMINE TRIETHIODIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1982	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q07001	NA	NA	NA	NA	DOXACURIUM CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1991	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q07001	NA	NA	NA	NA	TUBOCURARINE CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1945	CHEMBL2362997	105709	Q07001	Acetylcholine receptor subunit delta	Homo sapiens	NA	CHRND	M5
Q14524	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN5A	M5
Q14524	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN5A	M5
Q14524	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN5A	M5
Q14524	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN5A	M5
Q14524	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN5A	M5
Q14524	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN5A	M5
Q14524	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN5A	M5
Q14524	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN5A	M5
Q14524	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN5A	M5
Q14524	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN5A	M5
Q14524	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN5A	M5
Q14524	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN5A	M5
Q14524	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN5A	M5
Q14524	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN5A	M5
Q14524	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN5A	M5
Q14524	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN5A	M5
Q14524	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN5A	M5
Q14524	NA	NA	NA	NA	RANOLAZINE	Sodium channel protein type V alpha subunit blocker	BLOCKER	2006	CHEMBL1980	11480	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000787: Angina Pectoris,D001281: Atrial Fibrillation,D002311: Cardiomyopathy, Dilated,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003924: Diabetes Mellitus, Type 2,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D008133: Long QT Syndrome,D014652: Vascular Diseases,D017202: Myocardial Ischemia,D020967: Myotonic Disorders,D043183: Irritable Bowel Syndrome,D054058: Acute Coronary Syndrome,D054144: Heart Failure, Diastolic,D060050: Angina, Stable	SCN5A	M5
Q14524	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN5A	M5
Q14524	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D010146: Pain	SCN5A	M5
Q14524	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN5A	M5
Q14524	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN5A	M5
Q14524	NA	NA	NA	NA	DIBUCAINE HYDROCHLORIDE	Sodium channel protein type V alpha subunit blocker	BLOCKER	1982	CHEMBL1980	11480	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	FLECAINIDE ACETATE	Sodium channel protein type V alpha subunit blocker	BLOCKER	1985	CHEMBL1980	11480	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D010146: Pain	SCN5A	M5
Q14524	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN5A	M5
Q14524	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN5A	M5
Q14524	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN5A	M5
Q14524	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN5A	M5
Q14524	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN5A	M5
Q14524	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN5A	M5
Q14524	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN5A	M5
Q14524	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN5A	M5
Q14524	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN5A	M5
Q14524	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN5A	M5
Q14524	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M5
Q14524	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN5A	M5
Q14524	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN5A	M5
P47872	NA	NA	NA	NA	SECRETIN SYNTHETIC HUMAN	Secretin receptor agonist	AGONIST	2004	CHEMBL1925	147	P47872	Secretin receptor	Homo sapiens	D001321: Autistic Disorder,D009771: Obsessive-Compulsive Disorder	SCTR	M5
P47872	NA	NA	NA	NA	SECRETIN SYNTHETIC PORCINE	Secretin receptor agonist	AGONIST	2002	CHEMBL1925	147	P47872	Secretin receptor	Homo sapiens	D001321: Autistic Disorder	SCTR	M5
P47872	NA	NA	NA	NA	SECRETIN	Secretin receptor agonist	AGONIST	2002	CHEMBL1925	147	P47872	Secretin receptor	Homo sapiens	D001321: Autistic Disorder,D004415: Dyspepsia,D009765: Obesity,D010195: Pancreatitis,D012559: Schizophrenia,D050500: Pancreatitis, Chronic	SCTR	M5
P12821	NA	NA	NA	NA	RAMIPRIL	Angiotensin-converting enzyme inhibitor	INHIBITOR	1991	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D000419: Albuminuria,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001282: Atrial Flutter,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D005921: Glomerulonephritis,D006331: Heart Diseases,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D007674: Kidney Diseases,D008180: Lupus Erythematosus, Systemic,D008659: Metabolic Diseases,D009203: Myocardial Infarction,D017202: Myocardial Ischemia,D018149: Glucose Intolerance,D024821: Metabolic Syndrome,D045169: Severe Acute Respiratory Syndrome,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic	ACE	M5
P12821	NA	NA	NA	NA	LISINOPRIL	Angiotensin-converting enzyme inhibitor	INHIBITOR	1987	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D002318: Cardiovascular Diseases,D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction	ACE	M5
P12821	NA	NA	NA	NA	TRANDOLAPRIL	Angiotensin-converting enzyme inhibitor	INHIBITOR	1996	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D002318: Cardiovascular Diseases,D006333: Heart Failure,D006973: Hypertension	ACE	M5
P12821	NA	NA	NA	NA	CAPTOPRIL	Angiotensin-converting enzyme inhibitor	INHIBITOR	1981	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D003930: Diabetic Retinopathy,D005909: Glioblastoma,D006331: Heart Diseases,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D009203: Myocardial Infarction,D009369: Neoplasms,D011014: Pneumonia,D018487: Ventricular Dysfunction, Left,D045169: Severe Acute Respiratory Syndrome	ACE	M5
P12821	NA	NA	NA	NA	BENAZEPRIL HYDROCHLORIDE	Angiotensin-converting enzyme inhibitor	INHIBITOR	1991	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D006973: Hypertension,D007674: Kidney Diseases,D007863: Lecithin Cholesterol Acyltransferase Deficiency	ACE	M5
P12821	NA	NA	NA	NA	PERINDOPRIL ERBUMINE	Angiotensin-converting enzyme inhibitor	INHIBITOR	1993	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D000075222: Essential Hypertension,D003324: Coronary Artery Disease,D006973: Hypertension	ACE	M5
P12821	NA	NA	NA	NA	MOEXIPRIL HYDROCHLORIDE	Angiotensin-converting enzyme inhibitor	INHIBITOR	1995	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D006973: Hypertension	ACE	M5
P12821	NA	NA	NA	NA	ENALAPRIL MALEATE	Angiotensin-converting enzyme inhibitor	INHIBITOR	1985	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D001172: Arthritis, Rheumatoid,D002543: Cerebral Hemorrhage,D006973: Hypertension,D011225: Pre-Eclampsia,D011507: Proteinuria,D018487: Ventricular Dysfunction, Left	ACE	M5
P12821	NA	NA	NA	NA	SPIRAPRIL HYDROCHLORIDE	Angiotensin-converting enzyme inhibitor	INHIBITOR	1994	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	NA	ACE	M5
P12821	NA	NA	NA	NA	QUINAPRIL HYDROCHLORIDE	Angiotensin-converting enzyme inhibitor	INHIBITOR	1991	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D006973: Hypertension	ACE	M5
P12821	NA	NA	NA	NA	FOSINOPRIL SODIUM	Angiotensin-converting enzyme inhibitor	INHIBITOR	1991	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D006973: Hypertension	ACE	M5
P12821	NA	NA	NA	NA	PERINDOPRIL ARGININE	Angiotensin-converting enzyme inhibitor	INHIBITOR	2015	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D006973: Hypertension	ACE	M5
P12821	NA	NA	NA	NA	ENALAPRILAT	Angiotensin-converting enzyme inhibitor	INHIBITOR	1988	CHEMBL1808	69	P12821	Angiotensin-converting enzyme	Homo sapiens	D002311: Cardiomyopathy, Dilated,D006973: Hypertension	ACE	M5
P41595	NA	NA	NA	NA	AMISULPRIDE	Serotonin (5-HT) receptor antagonist	ANTAGONIST	2020	CHEMBL2096904	104841	P41595	5-hydroxytryptamine receptor 2B	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	HTR2B	M5
P41595	NA	NA	NA	NA	METHYLERGONOVINE MALEATE	Serotonin 2b (5-HT2b) receptor partial agonist	PARTIAL AGONIST	1946	CHEMBL1833	227	P41595	5-hydroxytryptamine receptor 2B	Homo sapiens	D006470: Hemorrhage	HTR2B	M5
P41595	NA	NA	NA	NA	METHYSERGIDE MALEATE	Serotonin 2b (5-HT2b) receptor antagonist	ANTAGONIST	1962	CHEMBL1833	227	P41595	5-hydroxytryptamine receptor 2B	Homo sapiens	NA	HTR2B	M5
P17980	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P17980	26S proteasome regulatory subunit 6A	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC3	M5
P17980	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P17980	26S proteasome regulatory subunit 6A	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC3	M5
P17980	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P17980	26S proteasome regulatory subunit 6A	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC3	M5
P28072	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB6	M5
P28072	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB6	M5
P28072	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB6	M5
Q9Y6F1	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP3	M5
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP3	M5
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP3	M5
P55036	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD4	M5
P55036	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD4	M5
P55036	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P55036	26S proteasome non-ATPase regulatory subunit 4	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD4	M5
Q9BQE3	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBA1C	M5
Q9BQE3	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBA1C	M5
Q9Y5Y9	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D010146: Pain	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	DIBUCAINE HYDROCHLORIDE	Sodium channel protein type X alpha subunit blocker	BLOCKER	1982	CHEMBL5451	18080	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	NA	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN10A	M5
Q9Y5Y9	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q9Y5Y9	Sodium channel protein type 10 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN10A	M5
P35498	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN1A	M5
P35498	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN1A	M5
P35498	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN1A	M5
P35498	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN1A	M5
P35498	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN1A	M5
P35498	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN1A	M5
P35498	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN1A	M5
P35498	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN1A	M5
P35498	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN1A	M5
P35498	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN1A	M5
P35498	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN1A	M5
P35498	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN1A	M5
P35498	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN1A	M5
P35498	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN1A	M5
P35498	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN1A	M5
P35498	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN1A	M5
P35498	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN1A	M5
P35498	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN1A	M5
P35498	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D010146: Pain	SCN1A	M5
P35498	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN1A	M5
P35498	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN1A	M5
P35498	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN1A	M5
P35498	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN1A	M5
P35498	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN1A	M5
P35498	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN1A	M5
P35498	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN1A	M5
P35498	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN1A	M5
P35498	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN1A	M5
P35498	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN1A	M5
P35498	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN1A	M5
P35498	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN1A	M5
P35498	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	NA	SCN1A	M5
P35498	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN1A	M5
P35498	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	P35498	Sodium channel protein type 1 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN1A	M5
P04626	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M5
P04626	NA	NA	NA	NA	NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006394: Hemangiosarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M5
P04626	NA	NA	NA	NA	LAPATINIB DITOSYLATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2007	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010190: Pancreatic Neoplasms,D013964: Thyroid Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M5
P04626	NA	NA	NA	NA	TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	1998	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D001005: Anus Neoplasms,D001063: Appendiceal Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001927: Brain Diseases,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D004806: Ependymoma,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D007340: Insulinoma,D007938: Leukemia,D008175: Lung Neoplasms,D008228: Lymphoma, Non-Hodgkin,D009182: Mycosis Fungoides,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010282: Parathyroid Neoplasms,D010490: Pericardial Effusion,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013005: Somatostatinoma,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018567: Breast Neoplasms, Male,D044584: Carcinoma, Ductal,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M5
P04626	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	ERBB2	M5
P04626	NA	NA	NA	NA	PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2012	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D018278: Carcinoma, Neuroendocrine,D018567: Breast Neoplasms, Male,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M5
P04626	NA	NA	NA	NA	AFATINIB DIMALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma	ERBB2	M5
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	ERBB2	M5
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001932: Brain Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008107: Liver Diseases,D008175: Lung Neoplasms,D009062: Mouth Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010412: Penile Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M5
P04626	NA	NA	NA	NA	MARGETUXIMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2	M5
P04626	NA	NA	NA	NA	TUCATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D006394: Hemangiosarcoma,D008107: Liver Diseases,D009369: Neoplasms	ERBB2	M5
P04626	NA	NA	NA	NA	NERATINIB MALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2	M5
P04626	NA	NA	NA	NA	TRASTUZUMAB DERUXTECAN	Receptor protein-tyrosine kinase erbB-2 binding agent	BINDING AGENT	2019	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004067: Digestive System Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M5
P42336	NA	NA	NA	NA	ALPELISIB	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	2019	CHEMBL4005	11362	P42336	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D006258: Head and Neck Neoplasms,D008107: Liver Diseases,D008579: Meningioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D046152: Gastrointestinal Stromal Tumors	PIK3CA	M5
P42336	NA	NA	NA	NA	COPANLISIB	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	2017	CHEMBL4005	11362	P42336	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	Homo sapiens	D001943: Breast Neoplasms,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D005706: Gallbladder Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D018281: Cholangiocarcinoma,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PIK3CA	M5
P42336	NA	NA	NA	NA	COPANLISIB HYDROCHLORIDE	PI3-kinase p110-alpha subunit inhibitor	INHIBITOR	2017	CHEMBL4005	11362	P42336	Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform	Homo sapiens	D001943: Breast Neoplasms,D008224: Lymphoma, Follicular,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse	PIK3CA	M5
P40259	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	B-cell antigen receptor complex-associated protein beta chain binding agent	BINDING AGENT	2019	CHEMBL3712852	114813	P40259	B-cell antigen receptor complex-associated protein beta chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	CD79B	M5
Q14654	NA	NA	NA	NA	GLYBURIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D000083242: Ischemic Stroke,D001930: Brain Injuries,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D013119: Spinal Cord Injuries,D016640: Diabetes, Gestational,D020521: Stroke,D060050: Angina, Stable	KCNJ11	M5
Q14654	NA	NA	NA	NA	CHLORPROPAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1958	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	KCNJ11	M5
Q14654	NA	NA	NA	NA	TOLBUTAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D008223: Lymphoma,D009369: Neoplasms,D019698: Hepatitis C, Chronic,D059350: Chronic Pain	KCNJ11	M5
Q14654	NA	NA	NA	NA	NATEGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	2000	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	KCNJ11	M5
Q14654	NA	NA	NA	NA	MINOXIDIL	Sulfonylurea receptor 2, Kir6.2 opener	OPENER	1979	CHEMBL2095198	104782	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D000505: Alopecia,D006973: Hypertension	KCNJ11	M5
Q14654	NA	NA	NA	NA	TOLAZAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1966	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2	KCNJ11	M5
Q14654	NA	NA	NA	NA	GLIPIZIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1984	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic	KCNJ11	M5
Q14654	NA	NA	NA	NA	REPAGLINIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1997	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003327: Coronary Disease,D003550: Cystic Fibrosis,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D010300: Parkinson Disease,D028361: Mitochondrial Diseases,D046152: Gastrointestinal Stromal Tumors,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	KCNJ11	M5
Q14654	NA	NA	NA	NA	DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 11 opener	OPENER	1973	CHEMBL1886	285	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006946: Hyperinsulinism,D006973: Hypertension,D007003: Hypoglycemia,D009765: Obesity	KCNJ11	M5
Q14654	NA	NA	NA	NA	GLIMEPIRIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1995	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D003327: Coronary Disease,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	KCNJ11	M5
Q14654	NA	NA	NA	NA	ACETOHEXAMIDE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1964	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D002386: Cataract,D003920: Diabetes Mellitus	KCNJ11	M5
Q14654	NA	NA	NA	NA	PINACIDIL	Sulfonylurea receptor 2, Kir6.2 opener	OPENER	1989	CHEMBL2095198	104782	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	D006973: Hypertension	KCNJ11	M5
Q14654	NA	NA	NA	NA	TOLBUTAMIDE SODIUM, STERILE	Sulfonylurea receptor 1, Kir6.2 blocker	BLOCKER	1961	CHEMBL2096972	104852	Q14654	ATP-sensitive inward rectifier potassium channel 11	Homo sapiens	NA	KCNJ11	M5
Q9UI09	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q9UI09	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFA12	M5
P51681	NA	NA	NA	NA	MARAVIROC	C-C chemokine receptor type 5 antagonist	ANTAGONIST	2007	CHEMBL274	10580	P51681	C-C chemokine receptor type 5	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001172: Arthritis, Rheumatoid,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007239: Infections,D008224: Lymphoma, Follicular,D009190: Myelodysplastic Syndromes,D012514: Sarcoma, Kaposi,D014777: Virus Diseases,D015228: Hypertriglyceridemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015526: AIDS Dementia Complex,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D019337: Hematologic Neoplasms,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome	CCR5	M5
P21860	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	P21860	Receptor tyrosine-protein kinase erbB-3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB3	M5
Q01668	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1D	M5
Q01668	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1D	M5
Q01668	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1D	M5
Q01668	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1D	M5
Q01668	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1D	M5
Q01668	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1D	M5
Q01668	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1D	M5
Q01668	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1D	M5
Q01668	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1D	M5
Q01668	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M5
Q01668	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1D	M5
Q01668	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1D	M5
Q01668	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M5
Q01668	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1D	M5
Q01668	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M5
Q01668	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M5
Q01668	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001281: Atrial Fibrillation	CACNA1D	M5
Q01668	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1D	M5
Q01668	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1D	M5
Q01668	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D006973: Hypertension	CACNA1D	M5
Q01668	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D006973: Hypertension	CACNA1D	M5
P14778	NA	NA	NA	NA	ANAKINRA	Interleukin-1 receptor antagonist	ANTAGONIST	2001	CHEMBL1959	198	P14778	Interleukin-1 receptor type 1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000690: Amyotrophic Lateral Sclerosis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001762: Blepharitis,D001930: Brain Injuries,D001943: Breast Neoplasms,D003882: Dermatomyositis,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004715: Endometriosis,D006073: Gout,D006105: Granulomatous Disease, Chronic,D006333: Heart Failure,D006519: Hepatitis, Alcoholic,D006976: Hypertension, Pulmonary,D007154: Immune System Diseases,D007239: Infections,D007718: Knee Injuries,D007759: Labyrinth Diseases,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009205: Myocarditis,D009369: Neoplasms,D010003: Osteoarthritis,D010190: Pancreatic Neoplasms,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011085: Polycystic Ovary Syndrome,D012507: Sarcoidosis,D013700: Giant Cell Arteritis,D014605: Uveitis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D015673: Fatigue Syndrome, Chronic,D016706: Still's Disease, Adult-Onset,D017497: Hidradenitis Suppurativa,D018979: Myositis, Inclusion Body,D024821: Metabolic Syndrome,D034381: Hearing Loss,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D055501: Macrophage Activation Syndrome,D056587: Cryopyrin-Associated Periodic Syndromes,D064129: Prostatic Neoplasms, Castration-Resistant	IL1R1	M5
Q16322	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q16322	Potassium voltage-gated channel subfamily A member 10	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA10	M5
Q16322	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q16322	Potassium voltage-gated channel subfamily A member 10	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA10	M5
Q16322	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q16322	Potassium voltage-gated channel subfamily A member 10	Homo sapiens	NA	KCNA10	M5
Q16322	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q16322	Potassium voltage-gated channel subfamily A member 10	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA10	M5
P22001	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA3	M5
P22001	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA3	M5
P22001	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	NA	KCNA3	M5
P22001	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P22001	Potassium voltage-gated channel subfamily A member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA3	M5
O95299	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O95299	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFA10	M5
Q99460	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD1	M5
Q99460	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD1	M5
Q99460	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD1	M5
Q02880	NA	NA	NA	NA	ETOPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1983	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000163: Acquired Immunodeficiency Syndrome,D000306: Adrenal Cortex Neoplasms,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002822: Choriocarcinoma,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005910: Glioma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006402: Hematologic Diseases,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008479: Mediastinal Neoplasms,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009396: Wilms Tumor,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009503: Neutropenia,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016393: Lymphoma, B-Cell,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018236: Carcinoma, Embryonal,D018239: Seminoma,D018240: Endodermal Sinus Tumor,D018242: Neuroectodermal Tumors, Primitive,D018273: Carcinoma, Islet Cell,D018278: Carcinoma, Neuroendocrine,D018302: Neoplasms, Neuroepithelial,D018305: Ganglioneuroblastoma,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020339: Optic Nerve Glioma,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TOP2B	M5
Q02880	NA	NA	NA	NA	TENIPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1992	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D007938: Leukemia,D008223: Lymphoma,D009369: Neoplasms,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	TOP2B	M5
P02452	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02452	Collagen alpha-1(I) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL1A1	M5
P02452	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02452	Collagen alpha-1(I) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL1A1	M5
P02708	NA	NA	NA	NA	SUCCINYLCHOLINE CHLORIDE	Muscle-type nicotinic acetylcholine receptor agonist	AGONIST	1952	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P02708	NA	NA	NA	NA	MIVACURIUM CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1992	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	D008107: Liver Diseases	CHRNA1	M5
P02708	NA	NA	NA	NA	DECAMETHONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P02708	NA	NA	NA	NA	METOCURINE IODIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1982	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P02708	NA	NA	NA	NA	ATRACURIUM BESYLATE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1983	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	D009126: Muscle Relaxation	CHRNA1	M5
P02708	NA	NA	NA	NA	RAPACURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1999	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P02708	NA	NA	NA	NA	VECURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1984	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P02708	NA	NA	NA	NA	CISATRACURIUM BESYLATE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1995	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	D012128: Respiratory Distress Syndrome	CHRNA1	M5
P02708	NA	NA	NA	NA	ROCURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1994	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	D001416: Back Pain,D006323: Heart Arrest	CHRNA1	M5
P02708	NA	NA	NA	NA	PIPECURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1990	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P02708	NA	NA	NA	NA	PANCURONIUM BROMIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1972	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P02708	NA	NA	NA	NA	GALLAMINE TRIETHIODIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1982	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P02708	NA	NA	NA	NA	DOXACURIUM CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1991	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P02708	NA	NA	NA	NA	TUBOCURARINE CHLORIDE	Muscle-type nicotinic acetylcholine receptor antagonist	ANTAGONIST	1945	CHEMBL2362997	105709	P02708	Acetylcholine receptor subunit alpha	Homo sapiens	NA	CHRNA1	M5
P18054	NA	NA	NA	NA	BENOXAPROFEN	Arachidonate 12-lipoxygenase inhibitor	INHIBITOR	1982	CHEMBL3687	11134	P18054	Polyunsaturated fatty acid lipoxygenase ALOX12	Homo sapiens	D012216: Rheumatic Diseases	ALOX12	M5
O43613	NA	NA	NA	NA	SUVOREXANT	Orexin receptor antagonist	ANTAGONIST	2014	CHEMBL3307226	108439	O43613	Orexin receptor type 1	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D003693: Delirium,D007319: Sleep Initiation and Maintenance Disorders,D009293: Opioid-Related Disorders,D012148: Restless Legs Syndrome,D012891: Sleep Apnea Syndromes,D012893: Sleep Wake Disorders,D014029: Tobacco Use Disorder,D016540: Smoking Cessation	HCRTR1	M5
O43613	NA	NA	NA	NA	LEMBOREXANT	Orexin receptor 1 antagonist	ANTAGONIST	2020	CHEMBL5113	10009	O43613	Orexin receptor type 1	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders,D007674: Kidney Diseases,D008107: Liver Diseases,D020178: Sleep Disorders, Circadian Rhythm,D020181: Sleep Apnea, Obstructive	HCRTR1	M5
P41143	CHEMBL128201	214599	10295681	NA	NALTREXONE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001883: Borderline Personality Disorder,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002659: Child Development Disorders, Pervasive,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D004715: Endometriosis,D005356: Fibromyalgia,D005715: Gambling,D006556: Heroin Dependence,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014256: Trichotillomania,D015352: Dry Eye Syndromes,D015658: HIV Infections,D018352: Coronavirus Infections,D018856: Cystitis, Interstitial,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRD1	M5
P41143	NA	NA	NA	NA	NALOXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1971	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D003248: Constipation,D005715: Gambling,D007415: Intestinal Obstruction,D009293: Opioid-Related Disorders,D010146: Pain	OPRD1	M5
P41143	NA	NA	NA	NA	OXYMORPHONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1959	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D010146: Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRD1	M5
P41143	NA	NA	NA	NA	CODEINE PHOSPHATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1952	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D003371: Cough,D008881: Migraine Disorders,D010146: Pain,D013035: Spasm,D015658: HIV Infections	OPRD1	M5
P41143	NA	NA	NA	NA	NALBUPHINE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1979	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D003693: Delirium,D008107: Liver Diseases,D009293: Opioid-Related Disorders,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D015470: Leukemia, Myeloid, Acute	OPRD1	M5
P41143	NA	NA	NA	NA	NALTREXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D001068: Feeding and Eating Disorders,D002607: Charcot-Marie-Tooth Disease,D009293: Opioid-Related Disorders,D010146: Pain,D019969: Amphetamine-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRD1	M5
P41143	NA	NA	NA	NA	NALMEFENE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1995	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D000437: Alcoholism	OPRD1	M5
P41143	NA	NA	NA	NA	CODEINE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1985	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D003371: Cough	OPRD1	M5
P41143	NA	NA	NA	NA	HYDROCODONE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1987	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	NA	OPRD1	M5
P41143	NA	NA	NA	NA	BENZHYDROCODONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2018	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D059787: Acute Pain	OPRD1	M5
P41143	NA	NA	NA	NA	HYDROCODONE BITARTRATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1943	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D007674: Kidney Diseases,D008107: Liver Diseases,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D014947: Wounds and Injuries,D017116: Low Back Pain,D019966: Substance-Related Disorders,D059350: Chronic Pain,D059787: Acute Pain	OPRD1	M5
P41143	NA	NA	NA	NA	CODEINE SULFATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2009	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D010146: Pain	OPRD1	M5
O60894	NA	NA	NA	NA	PRAMLINTIDE ACETATE	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	2005	CHEMBL2111189	104908	O60894	Receptor activity-modifying protein 1	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity	RAMP1	M5
P09769	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P09769	Tyrosine-protein kinase Fgr	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FGR	M5
P13612	NA	NA	NA	NA	NATALIZUMAB	Integrin alpha-4/beta-1 inhibitor	INHIBITOR	2004	CHEMBL1907599	104293	P13612	Integrin alpha-4	Homo sapiens	D000083242: Ischemic Stroke,D001172: Arthritis, Rheumatoid,D003424: Crohn Disease,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D012516: Osteosarcoma,D012559: Schizophrenia,D018979: Myositis, Inclusion Body,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	ITGA4	M5
P13612	NA	NA	NA	NA	VEDOLIZUMAB	Integrin alpha-4/beta-7 inhibitor	INHIBITOR	2014	CHEMBL2095184	104768	P13612	Integrin alpha-4	Homo sapiens	D002446: Celiac Disease,D003092: Colitis,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D007154: Immune System Diseases,D007239: Infections,D008545: Melanoma,D015212: Inflammatory Bowel Diseases,D015658: HIV Infections	ITGA4	M5
Q13698	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1S	M5
Q13698	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1S	M5
Q13698	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1S	M5
Q13698	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1S	M5
Q13698	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1S	M5
Q13698	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1S	M5
Q13698	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1S	M5
Q13698	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1S	M5
Q13698	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1S	M5
Q13698	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	NA	CACNA1S	M5
Q13698	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1S	M5
Q13698	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1S	M5
Q13698	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	NA	CACNA1S	M5
Q13698	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1S	M5
Q13698	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	NA	CACNA1S	M5
Q13698	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	NA	CACNA1S	M5
Q13698	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D001281: Atrial Fibrillation	CACNA1S	M5
Q13698	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1S	M5
Q13698	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1S	M5
Q13698	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D006973: Hypertension	CACNA1S	M5
Q13698	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13698	Voltage-dependent L-type calcium channel subunit alpha-1S	Homo sapiens	D006973: Hypertension	CACNA1S	M5
P12111	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12111	Collagen alpha-3(VI) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL6A3	M5
P12111	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12111	Collagen alpha-3(VI) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL6A3	M5
P28702	NA	NA	NA	NA	ETRETINATE	Retinoid receptor agonist	AGONIST	1986	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D011565: Psoriasis	RXRB	M6
P28702	NA	NA	NA	NA	ALITRETINOIN	Retinoid receptor agonist	AGONIST	1999	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D001943: Breast Neoplasms,D004485: Eczema,D006229: Hand Dermatoses,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D009369: Neoplasms,D011565: Psoriasis	RXRB	M6
P28702	NA	NA	NA	NA	BEXAROTENE	Retinoid X receptor agonist	AGONIST	1999	CHEMBL2363070	105765	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D000506: Alopecia Areata,D000544: Alzheimer Disease,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010267: Parapsoriasis,D011565: Psoriasis,D011618: Psychotic Disorders,D012559: Schizophrenia,D012751: Sezary Syndrome,D013964: Thyroid Neoplasms,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D017728: Lymphoma, Large-Cell, Anaplastic,D047748: Pituitary ACTH Hypersecretion	RXRB	M6
P28702	NA	NA	NA	NA	ACITRETIN	Retinoid receptor agonist	AGONIST	1996	CHEMBL2363071	105766	P28702	Retinoic acid receptor RXR-beta	Homo sapiens	D000544: Alzheimer Disease,D003872: Dermatitis,D008545: Melanoma,D011565: Psoriasis,D015658: HIV Infections	RXRB	M6
P09917	NA	NA	NA	NA	SULFASALAZINE	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	1950	CHEMBL215	55	P09917	Polyunsaturated fatty acid 5-lipoxygenase	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D005909: Glioblastoma,D006976: Hypertension, Pulmonary,D007415: Intestinal Obstruction,D009325: Nausea,D010019: Osteomyelitis,D010523: Peripheral Nervous System Diseases,D013167: Spondylitis, Ankylosing,D015209: Cholangitis, Sclerosing,D015535: Arthritis, Psoriatic	ALOX5	M6
P09917	NA	NA	NA	NA	ZILEUTON	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	1996	CHEMBL215	55	P09917	Polyunsaturated fatty acid 5-lipoxygenase	Homo sapiens	D000152: Acne Vulgaris,D000755: Anemia, Sickle Cell,D001249: Asthma,D007249: Inflammation,D008175: Lung Neoplasms,D014029: Tobacco Use Disorder,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis	ALOX5	M6
P09917	NA	NA	NA	NA	MESALAMINE	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	1987	CHEMBL215	55	P09917	Polyunsaturated fatty acid 5-lipoxygenase	Homo sapiens	D000076385: Diverticular Diseases,D000236: Adenoma,D001607: Berylliosis,D003092: Colitis,D003093: Colitis, Ulcerative,D003123: Colorectal Neoplasms, Hereditary Nonpolyposis,D003424: Crohn Disease,D004238: Diverticulitis,D004241: Diverticulum, Colon,D011349: Proctitis,D015179: Colorectal Neoplasms,D015658: HIV Infections,D043183: Irritable Bowel Syndrome,D044342: Malnutrition,D046729: Colitis, Collagenous,D046730: Colitis, Lymphocytic	ALOX5	M6
P09917	NA	NA	NA	NA	BALSALAZIDE DISODIUM	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	2000	CHEMBL215	55	P09917	Polyunsaturated fatty acid 5-lipoxygenase	Homo sapiens	D003093: Colitis, Ulcerative	ALOX5	M6
P09917	NA	NA	NA	NA	OLSALAZINE SODIUM	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	1990	CHEMBL215	55	P09917	Polyunsaturated fatty acid 5-lipoxygenase	Homo sapiens	D003093: Colitis, Ulcerative	ALOX5	M6
P09917	NA	NA	NA	NA	MECLOFENAMATE SODIUM	Arachidonate 5-lipoxygenase inhibitor	INHIBITOR	1980	CHEMBL215	55	P09917	Polyunsaturated fatty acid 5-lipoxygenase	Homo sapiens	NA	ALOX5	M6
P49720	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3	M6
P49720	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB3	M6
P49720	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P49720	Proteasome subunit beta type-3	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB3	M6
P43686	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC4	M6
P43686	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC4	M6
P43686	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC4	M6
Q96F46	NA	NA	NA	NA	BRODALUMAB	Interleukin-17 receptor A antagonist	ANTAGONIST	2017	CHEMBL3580485	109781	Q96F46	Interleukin-17 receptor A	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D003424: Crohn Disease,D007154: Immune System Diseases,D011565: Psoriasis,D012595: Scleroderma, Systemic,D013167: Spondylitis, Ankylosing,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa	IL17RA	M6
P39086	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	1996	CHEMBL2109241	104902	P39086	Glutamate receptor ionotropic, kainate 1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIK1	M6
P25100	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRA1D	M6
P25100	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1995	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA1D	M6
P25100	NA	NA	NA	NA	PRAZOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1976	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRA1D	M6
P25100	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1985	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M6
P25100	NA	NA	NA	NA	NAPHAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1971	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D003139: Common Cold,D007249: Inflammation,D007251: Influenza, Human,D011625: Pterygium	ADRA1D	M6
P25100	NA	NA	NA	NA	ALFUZOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	2003	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D007669: Kidney Calculi,D011470: Prostatic Hyperplasia,D053039: Ureterolithiasis	ADRA1D	M6
P25100	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRA1D	M6
P25100	NA	NA	NA	NA	PHENYLEPHRINE HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	1952	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D001145: Arrhythmias, Cardiac,D002318: Cardiovascular Diseases,D002386: Cataract,D003139: Common Cold,D006255: Rhinitis, Allergic, Seasonal,D007239: Infections,D012141: Respiratory Tract Infections,D012220: Rhinitis,D012223: Rhinitis, Vasomotor,D012852: Sinusitis,D013274: Stomach Neoplasms,D055371: Acute Lung Injury	ADRA1D	M6
P25100	NA	NA	NA	NA	TETRAHYDROZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1979	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D007249: Inflammation,D011625: Pterygium	ADRA1D	M6
P25100	NA	NA	NA	NA	MIDODRINE HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	1996	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D007024: Hypotension, Orthostatic,D012772: Shock, Septic,D018805: Sepsis,D020521: Stroke	ADRA1D	M6
P25100	NA	NA	NA	NA	DOXAZOSIN MESYLATE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1990	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRA1D	M6
P25100	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M6
P25100	NA	NA	NA	NA	PHENOXYBENZAMINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M6
P25100	NA	NA	NA	NA	OXYMETAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1986	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D006255: Rhinitis, Allergic, Seasonal,D011305: Presbyopia,D012393: Rosacea	ADRA1D	M6
P25100	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M6
P25100	NA	NA	NA	NA	PHENTOLAMINE MESYLATE	Adrenergic receptor alpha antagonist	ANTAGONIST	1952	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA1D	M6
P25100	NA	NA	NA	NA	TAMSULOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1997	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D001750: Urinary Bladder, Neurogenic,D006973: Hypertension,D011183: Postoperative Complications,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011472: Prostatitis,D016055: Urinary Retention	ADRA1D	M6
P25100	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1979	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M6
P25100	NA	NA	NA	NA	METHOXAMINE HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	1982	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D005242: Fecal Incontinence	ADRA1D	M6
P25100	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	2006	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRA1D	M6
P25100	NA	NA	NA	NA	ALSEROXYLON	Adrenergic receptor alpha antagonist	ANTAGONIST	1982	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M6
P25100	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D010146: Pain	ADRA1D	M6
P25100	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRA1D	M6
P25100	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D001249: Asthma	ADRA1D	M6
P25100	NA	NA	NA	NA	METARAMINOL BITARTRATE	Adrenergic receptor alpha-1 agonist	AGONIST	1954	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M6
P25100	NA	NA	NA	NA	PHENYLEPHRINE BITARTRATE	Adrenergic receptor alpha-1 agonist	AGONIST	1973	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M6
P25100	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRA1D	M6
P25100	NA	NA	NA	NA	ERGOLOID MESYLATES	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	ADRA1D	M6
P25100	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Adrenergic receptor alpha agonist	AGONIST	1948	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D008881: Migraine Disorders	ADRA1D	M6
P25100	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M6
P25100	NA	NA	NA	NA	RAUWOLFIA SERPENTINA	Adrenergic receptor alpha antagonist	ANTAGONIST	1954	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D006331: Heart Diseases,D006973: Hypertension	ADRA1D	M6
P25100	NA	NA	NA	NA	TERAZOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1987	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D003704: Dementia	ADRA1D	M6
P24530	NA	NA	NA	NA	SITAXENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D011507: Proteinuria,D051436: Renal Insufficiency, Chronic,D054144: Heart Failure, Diastolic	EDNRB	M6
P24530	NA	NA	NA	NA	BOSENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2001	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004541: Eisenmenger Complex,D005334: Fever,D005901: Glaucoma,D006333: Heart Failure,D006344: Heart Septal Defects, Atrial,D006973: Hypertension,D006976: Hypertension, Pulmonary,D008103: Liver Cirrhosis,D008545: Melanoma,D008946: Mitral Valve Stenosis,D010190: Pancreatic Neoplasms,D010547: Persistent Fetal Circulation Syndrome,D012595: Scleroderma, Systemic,D014456: Ulcer,D018636: Hypoplastic Left Heart Syndrome,D018917: Optic Neuropathy, Ischemic,D020065: Hepatopulmonary Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M6
P24530	NA	NA	NA	NA	AMBRISENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2007	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D000532: Altitude Sickness,D000755: Anemia, Sickle Cell,D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D014652: Vascular Diseases,D018636: Hypoplastic Left Heart Syndrome,D045169: Severe Acute Respiratory Syndrome,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension	EDNRB	M6
P24530	NA	NA	NA	NA	MACITENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2010	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D005909: Glioblastoma,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D012595: Scleroderma, Systemic,D014456: Ulcer,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M6
P24530	NA	NA	NA	NA	SITAXENTAN SODIUM	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	NA	EDNRB	M6
P21709	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P21709	Ephrin type-A receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA1	M6
P02462	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02462	Collagen alpha-1(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A1	M6
P02462	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02462	Collagen alpha-1(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A1	M6
P32245	NA	NA	NA	NA	BREMELANOTIDE	Melanocortin receptor 4 agonist	AGONIST	2019	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D009325: Nausea,D012735: Sexual Dysfunction, Physiological	MC4R	M6
P32245	NA	NA	NA	NA	SETMELANOTIDE	Melanocortin receptor 4 agonist	AGONIST	2020	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D009765: Obesity,D009767: Obesity, Morbid,D011218: Prader-Willi Syndrome,D051437: Renal Insufficiency,D058496: Smith-Magenis Syndrome	MC4R	M6
P32245	NA	NA	NA	NA	BREMELANOTIDE ACETATE	Melanocortin receptor 4 agonist	AGONIST	2019	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D020018: Sexual Dysfunctions, Psychological	MC4R	M6
P32245	NA	NA	NA	NA	SETMELANOTIDE ACETATE	Melanocortin receptor 4 agonist	AGONIST	2020	CHEMBL259	10142	P32245	Melanocortin receptor 4	Homo sapiens	D009765: Obesity	MC4R	M6
O75489	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O75489	NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFS3	M6
P00742	NA	NA	NA	NA	RIVAROXABAN	Coagulation factor X inhibitor	INHIBITOR	2011	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D000082862: Aortic Valve Disease,D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D001281: Atrial Fibrillation,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006331: Heart Diseases,D006406: Hematoma,D006470: Hemorrhage,D007511: Ischemia,D008103: Liver Cirrhosis,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D009767: Obesity, Morbid,D011655: Pulmonary Embolism,D012214: Rheumatic Heart Disease,D013921: Thrombocytopenia,D013923: Thromboembolism,D013927: Thrombosis,D016736: Antiphospholipid Syndrome,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D058729: Peripheral Arterial Disease	F10	M6
P00742	NA	NA	NA	NA	APIXABAN	Coagulation factor X inhibitor	INHIBITOR	2012	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D001282: Atrial Flutter,D006406: Hematoma,D006470: Hemorrhage,D007511: Ischemia,D009404: Nephrotic Syndrome,D011655: Pulmonary Embolism,D013923: Thromboembolism,D013927: Thrombosis,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054058: Acute Coronary Syndrome,D054092: Foramen Ovale, Patent,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054549: Takotsubo Cardiomyopathy,D054556: Venous Thromboembolism	F10	M6
P00742	NA	NA	NA	NA	BETRIXABAN	Coagulation factor X inhibitor	INHIBITOR	2017	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D001281: Atrial Fibrillation,D001282: Atrial Flutter,D006470: Hemorrhage,D007674: Kidney Diseases,D008107: Liver Diseases,D013923: Thromboembolism,D013927: Thrombosis,D054556: Venous Thromboembolism	F10	M6
P00742	NA	NA	NA	NA	EDOXABAN TOSYLATE	Coagulation factor X inhibitor	INHIBITOR	2015	CHEMBL244	194	P00742	Coagulation factor X	Homo sapiens	D001281: Atrial Fibrillation,D004617: Embolism,D011655: Pulmonary Embolism,D013927: Thrombosis,D020246: Venous Thrombosis,D020521: Stroke,D054556: Venous Thromboembolism	F10	M6
P00742	NA	NA	NA	NA	EMICIZUMAB	Coagulation factor IX and X other	OTHER	2017	CHEMBL2111424	104934	P00742	Coagulation factor X	Homo sapiens	D006467: Hemophilia A,D006470: Hemorrhage	F10	M6
P47871	NA	NA	NA	NA	GLUCAGON	Glucagon receptor agonist	AGONIST	1998	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003139: Common Cold,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D007003: Hypoglycemia,D009765: Obesity,D044903: Congenital Hyperinsulinism,D046768: Nesidioblastosis	GCGR	M6
P47871	NA	NA	NA	NA	GLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	AGONIST	1960	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D007003: Hypoglycemia	GCGR	M6
P47871	NA	NA	NA	NA	DASIGLUCAGON HYDROCHLORIDE	Glucagon receptor agonist	AGONIST	2021	CHEMBL1985	146	P47871	Glucagon receptor	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D007003: Hypoglycemia	GCGR	M6
Q13936	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1C	M6
Q13936	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1C	M6
Q13936	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1C	M6
Q13936	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1C	M6
Q13936	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1C	M6
Q13936	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C	M6
Q13936	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1C	M6
Q13936	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1C	M6
Q13936	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1C	M6
Q13936	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M6
Q13936	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1C	M6
Q13936	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1C	M6
Q13936	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M6
Q13936	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1C	M6
Q13936	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M6
Q13936	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	NA	CACNA1C	M6
Q13936	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D001281: Atrial Fibrillation	CACNA1C	M6
Q13936	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1C	M6
Q13936	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1C	M6
Q13936	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C	M6
Q13936	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q13936	Voltage-dependent L-type calcium channel subunit alpha-1C	Homo sapiens	D006973: Hypertension	CACNA1C	M6
Q14721	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNB1	M6
Q14721	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNB1	M6
Q14721	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	NA	KCNB1	M6
Q14721	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q14721	Potassium voltage-gated channel subfamily B member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNB1	M6
Q9BY41	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC8	M6
Q9BY41	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC8	M6
Q9BY41	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D009101: Multiple Myeloma	HDAC8	M6
P28223	NA	NA	NA	NA	CLOZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1989	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D003704: Dementia,D003866: Depressive Disorder,D008607: Intellectual Disability,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	HALOPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	HTR2A	M6
P28223	NA	NA	NA	NA	THIORIDAZINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1962	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	HTR2A	M6
P28223	NA	NA	NA	NA	CHLORPROMAZINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1957	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	HTR2A	M6
P28223	NA	NA	NA	NA	RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1993	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005879: Tourette Syndrome,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009293: Opioid-Related Disorders,D011618: Psychotic Disorders,D012559: Schizophrenia,D012569: Schizotypal Personality Disorder,D013313: Stress Disorders, Post-Traumatic,D015140: Dementia, Vascular,D015518: Rett Syndrome,D019955: Conduct Disorder,D019958: Attention Deficit and Disruptive Behavior Disorders,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome,D065886: Neurodevelopmental Disorders	HTR2A	M6
P28223	NA	NA	NA	NA	ILOPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D008107: Liver Diseases,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	HTR2A	M6
P28223	NA	NA	NA	NA	MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1996	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	HTR2A	M6
P28223	NA	NA	NA	NA	OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1996	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	HTR2A	M6
P28223	NA	NA	NA	NA	LOXAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1975	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	HTR2A	M6
P28223	NA	NA	NA	NA	CHLORPROTHIXENE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	DROPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	HTR2A	M6
P28223	NA	NA	NA	NA	ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2002	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000544: Alzheimer Disease,D000856: Anorexia Nervosa,D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005600: Fragile X Syndrome,D005879: Tourette Syndrome,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome	HTR2A	M6
P28223	NA	NA	NA	NA	THIOTHIXENE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders	HTR2A	M6
P28223	NA	NA	NA	NA	PIMOZIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1984	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	AMISULPRIDE	Serotonin (5-HT) receptor antagonist	ANTAGONIST	2020	CHEMBL2096904	104841	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	HTR2A	M6
P28223	NA	NA	NA	NA	PALIPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2006	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1957	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	MOLINDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1974	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1956	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	NEFAZODONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1994	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	CYCLOBENZAPRINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1977	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D002547: Cerebral Palsy,D008881: Migraine Disorders,D009128: Muscle Spasticity,D013035: Spasm,D013118: Spinal Cord Diseases,D063806: Myalgia	HTR2A	M6
P28223	NA	NA	NA	NA	TRAZODONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1981	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	HTR2A	M6
P28223	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1962	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1979	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	HALOPERIDOL DECANOATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1986	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	MESORIDAZINE BESYLATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1976	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	LOXAPINE SUCCINATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1975	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1959	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	ZIPRASIDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2001	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder	HTR2A	M6
P28223	NA	NA	NA	NA	LURASIDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2010	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	BREXPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2015	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012893: Sleep Wake Disorders,D013313: Stress Disorders, Post-Traumatic	HTR2A	M6
P28223	NA	NA	NA	NA	PALIPERIDONE PALMITATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	ARIPIPRAZOLE LAUROXIL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2015	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	CARPHENAZINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1982	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	PIMAVANSERIN TARTRATE	Serotonin 2a (5-HT2a) receptor inverse agonist	INVERSE AGONIST	2016	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000544: Alzheimer Disease,D010300: Parkinson Disease,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	QUETIAPINE FUMARATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1997	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000072861: Phobia, Social,D000437: Alcoholism,D001007: Anxiety,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009103: Multiple Sclerosis,D009497: Neurotic Disorders,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	HTR2A	M6
P28223	NA	NA	NA	NA	LUMATEPERONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2019	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000544: Alzheimer Disease,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	ASENAPINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	OLANZAPINE PAMOATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	THIOTHIXENE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M6
P28223	NA	NA	NA	NA	ZIPRASIDONE MESYLATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2002	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	HTR2A	M6
P28223	NA	NA	NA	NA	HALOPERIDOL LACTATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M6
P17658	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	P17658	Potassium voltage-gated channel subfamily A member 6	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNA6	M6
P17658	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P17658	Potassium voltage-gated channel subfamily A member 6	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNA6	M6
P17658	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	P17658	Potassium voltage-gated channel subfamily A member 6	Homo sapiens	NA	KCNA6	M6
P17658	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	P17658	Potassium voltage-gated channel subfamily A member 6	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNA6	M6
P62333	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6	M6
P62333	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC6	M6
P62333	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P62333	26S proteasome regulatory subunit 10B	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC6	M6
P32745	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR3	M6
P32745	NA	NA	NA	NA	PASIREOTIDE DIASPARTATE	Somatostatin receptor 3 agonist	AGONIST	2012	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	NA	SSTR3	M6
P32745	NA	NA	NA	NA	PASIREOTIDE PAMOATE	Somatostatin receptor 3 agonist	AGONIST	2014	CHEMBL2028	11261	P32745	Somatostatin receptor type 3	Homo sapiens	D000172: Acromegaly	SSTR3	M6
P32745	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P32745	Somatostatin receptor type 3	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR3	M6
Q9Y5N1	NA	NA	NA	NA	PITOLISANT	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D000437: Alcoholism,D007674: Kidney Diseases,D009290: Narcolepsy,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D019966: Substance-Related Disorders	HRH3	M6
Q9Y5N1	NA	NA	NA	NA	PITOLISANT HYDROCHLORIDE	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D006970: Disorders of Excessive Somnolence,D009290: Narcolepsy	HRH3	M6
P29274	NA	NA	NA	NA	ADENOSINE	Adenosine receptor agonist	AGONIST	1989	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D007249: Inflammation,D007511: Ischemia,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D009369: Neoplasms,D010146: Pain,D012128: Respiratory Distress Syndrome,D013614: Tachycardia, Paroxysmal,D013617: Tachycardia, Supraventricular,D014927: Wolff-Parkinson-White Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D023921: Coronary Stenosis,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	ADORA2A	M6
P29274	NA	NA	NA	NA	CAFFEINE	Adenosine receptor antagonist	ANTAGONIST	1948	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D000860: Hypoxia,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001943: Breast Neoplasms,D003093: Colitis, Ulcerative,D003139: Common Cold,D003141: Communicable Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004417: Dyspnea,D006261: Headache,D007024: Hypotension, Orthostatic,D007383: Intermittent Claudication,D008545: Melanoma,D008881: Migraine Disorders,D009290: Narcolepsy,D009369: Neoplasms,D009765: Obesity,D010146: Pain,D010300: Parkinson Disease,D011565: Psoriasis,D013119: Spinal Cord Injuries,D014832: Voice Disorders,D015658: HIV Infections,D017116: Low Back Pain,D018781: Tension-Type Headache,D019547: Neck Pain,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A	M6
P29274	NA	NA	NA	NA	PENTOXIFYLLINE	Adenosine A2 receptor antagonist	ANTAGONIST	1984	CHEMBL2094257	104729	P29274	Adenosine receptor A2a	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	ADORA2A	M6
P29274	NA	NA	NA	NA	ISTRADEFYLLINE	Adenosine A2a receptor antagonist	ANTAGONIST	2019	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D008107: Liver Diseases,D010300: Parkinson Disease,D019966: Substance-Related Disorders	ADORA2A	M6
P29274	NA	NA	NA	NA	THEOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	ADORA2A	M6
P29274	NA	NA	NA	NA	OXTRIPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1981	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D008173: Lung Diseases, Obstructive	ADORA2A	M6
P29274	NA	NA	NA	NA	CAFFEINE, CITRATED	Adenosine receptor antagonist	ANTAGONIST	1999	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D001049: Apnea,D008107: Liver Diseases,D010146: Pain,D012178: Retinopathy of Prematurity,D047928: Premature Birth	ADORA2A	M6
P29274	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Adenosine receptor antagonist	ANTAGONIST	1982	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	NA	ADORA2A	M6
P29274	NA	NA	NA	NA	AMINOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29274	Adenosine receptor A2a	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	ADORA2A	M6
P29274	NA	NA	NA	NA	REGADENOSON	Adenosine A2a receptor agonist	AGONIST	2008	CHEMBL251	252	P29274	Adenosine receptor A2a	Homo sapiens	D002318: Cardiovascular Diseases	ADORA2A	M6
Q02223	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tumor necrosis factor receptor superfamily member 17 binding agent	BINDING AGENT	2020	CHEMBL4523587	119306	Q02223	Tumor necrosis factor receptor superfamily member 17	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TNFRSF17	M6
Q16186	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q16186	Proteasomal ubiquitin receptor ADRM1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	ADRM1	M6
Q16186	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q16186	Proteasomal ubiquitin receptor ADRM1	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ADRM1	M6
Q16186	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q16186	Proteasomal ubiquitin receptor ADRM1	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	ADRM1	M6
Q9H4B7	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB1	M6
Q9H4B7	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9H4B7	Tubulin beta-1 chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB1	M6
Q8TCU5	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN3A	M6
Q8TCU5	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN3A	M6
Q8TCU5	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN3A	M6
Q8TCU5	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN3A	M6
Q8TCU5	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN3A	M6
Q8TCU5	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D010146: Pain	GRIN3A	M6
Q8TCU5	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D010300: Parkinson Disease	GRIN3A	M6
Q8TCU5	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D000437: Alcoholism	GRIN3A	M6
Q8TCU5	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q8TCU5	Glutamate receptor ionotropic, NMDA 3A	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN3A	M6
P21964	NA	NA	NA	NA	ENTACAPONE	Catechol O-methyltransferase inhibitor	INHIBITOR	1999	CHEMBL2023	91	P21964	Catechol O-methyltransferase	Homo sapiens	D004827: Epilepsy,D009765: Obesity,D010300: Parkinson Disease,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D046152: Gastrointestinal Stromal Tumors	COMT	M6
P21964	NA	NA	NA	NA	TOLCAPONE	Catechol O-methyltransferase inhibitor	INHIBITOR	1998	CHEMBL2023	91	P21964	Catechol O-methyltransferase	Homo sapiens	D000437: Alcoholism,D001930: Brain Injuries,D005715: Gambling,D009447: Neuroblastoma,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019970: Cocaine-Related Disorders,D020774: Pick Disease of the Brain	COMT	M6
P21964	NA	NA	NA	NA	OPICAPONE	Catechol O-methyltransferase inhibitor	INHIBITOR	2020	CHEMBL2023	91	P21964	Catechol O-methyltransferase	Homo sapiens	D010300: Parkinson Disease	COMT	M6
Q13882	NA	NA	NA	NA	VANDETANIB	Tyrosine-protein kinase BRK inhibitor	INHIBITOR	2011	CHEMBL4601	30026	Q13882	Protein-tyrosine kinase 6	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PTK6	M6
P28472	NA	NA	NA	NA	FLUMAZENIL	GABA-A receptor; anion channel allosteric antagonist	ALLOSTERIC ANTAGONIST	1991	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D005600: Fragile X Syndrome,D006970: Disorders of Excessive Somnolence,D007319: Sleep Initiation and Maintenance Disorders,D009290: Narcolepsy,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D019966: Substance-Related Disorders	GABRB3	M6
P28472	NA	NA	NA	NA	DIAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1963	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000070636: Rotator Cuff Injuries,D001007: Anxiety,D002547: Cerebral Palsy,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D010146: Pain,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D014947: Wounds and Injuries,D017029: Epilepsy, Complex Partial,D017116: Low Back Pain,D018887: Landau-Kleffner Syndrome	GABRB3	M6
P28472	NA	NA	NA	NA	PENTOBARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001930: Brain Injuries,D006331: Heart Diseases,D013226: Status Epilepticus,D019966: Substance-Related Disorders	GABRB3	M6
P28472	NA	NA	NA	NA	METHARBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy	GABRB3	M6
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D003865: Depressive Disorder, Major,D013375: Substance Withdrawal Syndrome	GABRB3	M6
P28472	NA	NA	NA	NA	CLONAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1975	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D002054: Burning Mouth Syndrome,D002189: Marijuana Abuse,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D013226: Status Epilepticus,D016584: Panic Disorder,D017036: Epilepsia Partialis Continua,D020187: REM Sleep Behavior Disorder	GABRB3	M6
P28472	NA	NA	NA	NA	BUTALBITAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1983	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D008881: Migraine Disorders	GABRB3	M6
P28472	NA	NA	NA	NA	PROPOFOL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1989	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003865: Depressive Disorder, Major,D004938: Esophageal Neoplasms,D006331: Heart Diseases,D006973: Hypertension,D007022: Hypotension,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007417: Intestinal Polyps,D007938: Leukemia,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008881: Migraine Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010020: Osteonecrosis,D010146: Pain,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011537: Pruritus,D011595: Psychomotor Agitation,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D013226: Status Epilepticus,D013285: Strabismus,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D051437: Renal Insufficiency,D061218: Depressive Disorder, Treatment-Resistant	GABRB3	M6
P28472	NA	NA	NA	NA	OXAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1965	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D015658: HIV Infections	GABRB3	M6
P28472	NA	NA	NA	NA	LORAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1977	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001008: Anxiety Disorders,D003693: Delirium,D003704: Dementia,D003863: Depression,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004827: Epilepsy,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus,D013375: Substance Withdrawal Syndrome,D014717: Vertigo,D014832: Voice Disorders,D017036: Epilepsia Partialis Continua,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex	GABRB3	M6
P28472	NA	NA	NA	NA	ETHCHLORVYNOL	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1961	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	TRIAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1978	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D012559: Schizophrenia,D019966: Substance-Related Disorders	GABRB3	M6
P28472	NA	NA	NA	NA	MIDAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000069076: Fractures, Multiple,D000083242: Ischemic Stroke,D000374: Aggression,D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D001007: Anxiety,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001930: Brain Injuries,D001943: Breast Neoplasms,D001946: Breech Presentation,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003141: Communicable Diseases,D003371: Cough,D003424: Crohn Disease,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004715: Endometriosis,D004827: Epilepsy,D005221: Fatigue,D005458: Fluoride Poisoning,D006333: Heart Failure,D006470: Hemorrhage,D006526: Hepatitis C,D006973: Hypertension,D007022: Hypotension,D007239: Infections,D007246: Infertility,D007251: Influenza, Human,D008103: Liver Cirrhosis,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009134: Muscular Atrophy, Spinal,D009325: Nausea,D009369: Neoplasms,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D011537: Pruritus,D011565: Psoriasis,D011618: Psychotic Disorders,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012640: Seizures,D012772: Shock, Septic,D012871: Skin Diseases,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013345: Subarachnoid Hemorrhage,D014029: Tobacco Use Disorder,D014069: Tonsillitis,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014565: Urogenital Neoplasms,D014947: Wounds and Injuries,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D017116: Low Back Pain,D018357: Respiratory Syncytial Virus Infections,D018805: Sepsis,D019547: Neck Pain,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020250: Postoperative Nausea and Vomiting,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D050197: Atherosclerosis,D050723: Fractures, Bone,D051437: Renal Insufficiency,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	GABRB3	M6
P28472	NA	NA	NA	NA	ALPRAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000072861: Phobia, Social,D001007: Anxiety,D001008: Anxiety Disorders,D003704: Dementia,D003866: Depressive Disorder,D003922: Diabetes Mellitus, Type 1,D004827: Epilepsy,D008881: Migraine Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D016584: Panic Disorder,D019966: Substance-Related Disorders	GABRB3	M6
P28472	NA	NA	NA	NA	ETOMIDATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006973: Hypertension,D012131: Respiratory Insufficiency,D020521: Stroke	GABRB3	M6
P28472	NA	NA	NA	NA	THIOPENTAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia	GABRB3	M6
P28472	NA	NA	NA	NA	METHOHEXITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	ESTAZOLAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1990	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D007319: Sleep Initiation and Maintenance Disorders	GABRB3	M6
P28472	NA	NA	NA	NA	PRIMIDONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1954	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D020521: Stroke	GABRB3	M6
P28472	NA	NA	NA	NA	HALOTHANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1958	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	TEMAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive	GABRB3	M6
P28472	NA	NA	NA	NA	PRAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M6
P28472	NA	NA	NA	NA	HALAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1981	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M6
P28472	NA	NA	NA	NA	PENTOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1973	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	MEPROBAMATE	GABA-A receptor; anion channel agonist	AGONIST	1955	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety	GABRB3	M6
P28472	NA	NA	NA	NA	CLOBAZAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2005	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D009437: Neuralgia,D010146: Pain,D012559: Schizophrenia,D017036: Epilepsia Partialis Continua,D017116: Low Back Pain,D065768: Lennox Gastaut Syndrome	GABRB3	M6
P28472	NA	NA	NA	NA	GLUTETHIMIDE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1976	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	ISOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1979	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	GABRB3	M6
P28472	NA	NA	NA	NA	ENFLURANE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	BREXANOLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2019	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001930: Brain Injuries,D003866: Depressive Disorder,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D020329: Essential Tremor	GABRB3	M6
P28472	NA	NA	NA	NA	TOPIRAMATE	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1996	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GABRB3	M6
P28472	NA	NA	NA	NA	ESZOPICLONE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D002189: Marijuana Abuse,D007319: Sleep Initiation and Maintenance Disorders,D020181: Sleep Apnea, Obstructive	GABRB3	M6
P28472	NA	NA	NA	NA	MIDAZOLAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000647: Amnesia,D003865: Depressive Disorder, Major,D003876: Dermatitis, Atopic,D009369: Neoplasms,D009422: Nervous System Diseases,D011125: Adenomatous Polyposis Coli,D013226: Status Epilepticus,D014376: Tuberculosis	GABRB3	M6
P28472	NA	NA	NA	NA	QUAZEPAM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1985	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	SEVOFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1995	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	GABRB3	M6
P28472	NA	NA	NA	NA	CHLORDIAZEPOXIDE HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1960	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	DESFLURANE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1992	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	GABRB3	M6
P28472	NA	NA	NA	NA	TRICLOFOS SODIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	METHYPRYLON	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	TALBUTAL	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	SECOBARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1950	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	BUTABARBITAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1939	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	THIAMYLAL SODIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1982	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	ACAMPROSATE CALCIUM	GABA-A receptor; anion channel positive modulator	POSITIVE MODULATOR	2004	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D000437: Alcoholism	GABRB3	M6
P28472	NA	NA	NA	NA	CLORAZEPATE DIPOTASSIUM	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1972	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	FLURAZEPAM HYDROCHLORIDE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	1970	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P28472	NA	NA	NA	NA	CENOBAMATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	GABRB3	M6
P28472	NA	NA	NA	NA	REMIMAZOLAM BESYLATE	GABA-A receptor; anion channel positive allosteric modulator	POSITIVE ALLOSTERIC MODULATOR	2020	CHEMBL2093872	104688	P28472	Gamma-aminobutyric acid receptor subunit beta-3	Homo sapiens	NA	GABRB3	M6
P05093	NA	NA	NA	NA	ABIRATERONE ACETATE	Cytochrome P450 17A1 inhibitor	INHIBITOR	2011	CHEMBL3522	12949	P05093	Steroid 17-alpha-hydroxylase/17,20 lyase	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D008107: Liver Diseases,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D051437: Renal Insufficiency,D064129: Prostatic Neoplasms, Castration-Resistant	CYP17A1	M6
P30872	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P30872	Somatostatin receptor type 1	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR1	M6
P30872	NA	NA	NA	NA	PASIREOTIDE DIASPARTATE	Somatostatin receptor 1 agonist	AGONIST	2012	CHEMBL1917	12786	P30872	Somatostatin receptor type 1	Homo sapiens	NA	SSTR1	M6
P30872	NA	NA	NA	NA	PASIREOTIDE PAMOATE	Somatostatin receptor 1 agonist	AGONIST	2014	CHEMBL1917	12786	P30872	Somatostatin receptor type 1	Homo sapiens	D000172: Acromegaly	SSTR1	M6
P30872	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P30872	Somatostatin receptor type 1	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR1	M6
P31391	NA	NA	NA	NA	OCTREOTIDE ACETATE	Somatostatin receptor agonist	AGONIST	1988	CHEMBL2111436	104951	P31391	Somatostatin receptor type 4	Homo sapiens	D000172: Acromegaly,D001943: Breast Neoplasms,D003248: Constipation,D003930: Diabetic Retinopathy,D003967: Diarrhea,D004751: Enteritis,D007415: Intestinal Obstruction,D008113: Liver Neoplasms,D008223: Lymphoma,D008303: Malignant Carcinoid Syndrome,D009369: Neoplasms,D009765: Obesity,D010911: Pituitary Neoplasms,D011218: Prader-Willi Syndrome,D013953: Thymus Neoplasms,D018358: Neuroendocrine Tumors,D044903: Congenital Hyperinsulinism,D064129: Prostatic Neoplasms, Castration-Resistant	SSTR4	M6
P31391	NA	NA	NA	NA	LUTETIUM DOTATATE LU-177	Somatostatin receptor binding agent	BINDING AGENT	2018	CHEMBL2111436	104951	P31391	Somatostatin receptor type 4	Homo sapiens	D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D008579: Meningioma,D009447: Neuroblastoma,D018278: Carcinoma, Neuroendocrine,D018358: Neuroendocrine Tumors	SSTR4	M6
P07948	NA	NA	NA	NA	BOSUTINIB	Tyrosine-protein kinase Lyn inhibitor	INHIBITOR	2010	CHEMBL3905	11842	P07948	Tyrosine-protein kinase Lyn	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	LYN	M6
P07948	NA	NA	NA	NA	DASATINIB	SRC inhibitor	INHIBITOR	2006	CHEMBL2363074	105769	P07948	Tyrosine-protein kinase Lyn	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	LYN	M6
P42345	NA	NA	NA	NA	PERHEXILINE MALEATE	Serine/threonine-protein kinase mTOR inhibitor	INHIBITOR	1974	CHEMBL2842	11400	P42345	Serine/threonine-protein kinase mTOR	Homo sapiens	NA	MTOR	M6
P07202	NA	NA	NA	NA	METHIMAZOLE	Thyroid peroxidase inhibitor	INHIBITOR	1950	CHEMBL1839	40	P07202	Thyroid peroxidase	Homo sapiens	D003882: Dermatomyositis,D005909: Glioblastoma,D013959: Thyroid Diseases,D049970: Graves Ophthalmopathy	TPO	M6
P07202	NA	NA	NA	NA	PROPYLTHIOURACIL	Thyroid peroxidase inhibitor	INHIBITOR	1947	CHEMBL1839	40	P07202	Thyroid peroxidase	Homo sapiens	D013959: Thyroid Diseases,D013971: Thyrotoxicosis,D049970: Graves Ophthalmopathy	TPO	M6
Q969S8	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC10	M6
Q969S8	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC10	M6
Q969S8	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q969S8	Polyamine deacetylase HDAC10	Homo sapiens	D009101: Multiple Myeloma	HDAC10	M6
Q9NRX3	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q9NRX3	NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFA4L2	M6
O43570	CHEMBL17	1085	3038	DB01144	DICHLORPHENAMIDE	Carbonic anhydrase XII inhibitor	INHIBITOR	1958	CHEMBL3242	12209	O43570	Carbonic anhydrase 12	Homo sapiens	D005901: Glaucoma,D020513: Paralysis, Hyperkalemic Periodic,D020514: Hypokalemic Periodic Paralysis,D020967: Myotonic Disorders	CA12	M6
O43570	CHEMBL18	1096	3295	DB00311	ETHOXZOLAMIDE	Carbonic anhydrase inhibitor	INHIBITOR	1982	CHEMBL2095180	104764	O43570	Carbonic anhydrase 12	Homo sapiens	NA	CA12	M6
O43570	NA	NA	NA	NA	ACETAZOLAMIDE	Carbonic anhydrase XII inhibitor	INHIBITOR	1953	CHEMBL3242	12209	O43570	Carbonic anhydrase 12	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D003551: Cysticercosis,D004487: Edema,D005901: Glaucoma,D006333: Heart Failure,D006528: Carcinoma, Hepatocellular,D006850: Hydrocephalus, Normal Pressure,D006976: Hypertension, Pulmonary,D007024: Hypotension, Orthostatic,D007674: Kidney Diseases,D008269: Macular Edema,D009103: Multiple Sclerosis,D011559: Pseudotumor Cerebri,D012640: Seizures,D013226: Status Epilepticus,D015812: Glaucoma, Angle-Closure,D016481: Helicobacter Infections,D018887: Landau-Kleffner Syndrome,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D050030: Andersen Syndrome,D055752: Small Cell Lung Carcinoma,D059350: Chronic Pain	CA12	M6
O43570	CHEMBL1200814	674765	13290219, 90469712	NA	ACETAZOLAMIDE SODIUM	Carbonic anhydrase XII inhibitor	INHIBITOR	1990	CHEMBL3242	12209	O43570	Carbonic anhydrase 12	Homo sapiens	D004487: Edema,D005901: Glaucoma,D012640: Seizures,D015812: Glaucoma, Angle-Closure	CA12	M6
P11387	NA	NA	NA	NA	SACITUZUMAB GOVITECAN	DNA topoisomerase I inhibitor	INHIBITOR	2020	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D016889: Endometrial Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TOP1	M6
P11387	NA	NA	NA	NA	IRINOTECAN HYDROCHLORIDE	DNA topoisomerase I inhibitor	INHIBITOR	1996	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001005: Anus Neoplasms,D001063: Appendiceal Neoplasms,D001254: Astrocytoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002276: Carcinoid Tumor,D002277: Carcinoma,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D003967: Diarrhea,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007012: Hypopharyngeal Neoplasms,D007119: Immunoblastic Lymphadenopathy,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008527: Medulloblastoma,D008545: Melanoma,D008579: Meningioma,D008637: Mesenchymoma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009503: Neutropenia,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018278: Carcinoma, Neuroendocrine,D018289: Carcinoma, Verrucous,D018304: Esthesioneuroblastoma, Olfactory,D018305: Ganglioneuroblastoma,D018308: Papilloma, Inverted,D018316: Gliosarcoma,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TOP1	M6
P11387	NA	NA	NA	NA	TRASTUZUMAB DERUXTECAN	DNA topoisomerase I inhibitor	INHIBITOR	2019	CHEMBL1781	62	P11387	DNA topoisomerase 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004067: Digestive System Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms	TOP1	M6
Q14123	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	Q14123	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE1C	M6
Q14123	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	Q14123	Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE1C	M6
Q99436	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M6
Q99436	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M6
Q99436	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB7	M6
Q7Z418	NA	NA	NA	NA	HALOTHANE	Potassium channel subfamily K member 18 opener	OPENER	1958	CHEMBL2331042	105638	Q7Z418	Potassium channel subfamily K member 18	Homo sapiens	NA	KCNK18	M6
Q7Z418	NA	NA	NA	NA	ISOFLURANE	Potassium channel subfamily K member 18 opener	OPENER	1979	CHEMBL2331042	105638	Q7Z418	Potassium channel subfamily K member 18	Homo sapiens	D006331: Heart Diseases,D006552: Hernia, Inguinal,D009293: Opioid-Related Disorders,D045169: Severe Acute Respiratory Syndrome	KCNK18	M6
Q7Z418	NA	NA	NA	NA	ENFLURANE	Potassium channel subfamily K member 18 opener	OPENER	1972	CHEMBL2331042	105638	Q7Z418	Potassium channel subfamily K member 18	Homo sapiens	NA	KCNK18	M6
Q7Z418	NA	NA	NA	NA	SEVOFLURANE	Potassium channel subfamily K member 18 opener	OPENER	1995	CHEMBL2331042	105638	Q7Z418	Potassium channel subfamily K member 18	Homo sapiens	D001416: Back Pain,D001930: Brain Injuries,D001943: Breast Neoplasms,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003693: Delirium,D004938: Esophageal Neoplasms,D005458: Fluoride Poisoning,D006331: Heart Diseases,D007249: Inflammation,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010146: Pain,D011183: Postoperative Complications,D012128: Respiratory Distress Syndrome,D012772: Shock, Septic,D013345: Subarachnoid Hemorrhage,D014069: Tonsillitis,D015179: Colorectal Neoplasms,D015427: Reperfusion Injury,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency,D058186: Acute Kidney Injury,D065630: Hernias, Diaphragmatic, Congenital	KCNK18	M6
Q7Z418	NA	NA	NA	NA	DESFLURANE	Potassium channel subfamily K member 18 opener	OPENER	1992	CHEMBL2331042	105638	Q7Z418	Potassium channel subfamily K member 18	Homo sapiens	D011183: Postoperative Complications,D051437: Renal Insufficiency	KCNK18	M6
Q8IZS8	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA2D3	M6
Q8IZS8	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA2D3	M6
Q8IZS8	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D002318: Cardiovascular Diseases	CACNA2D3	M6
Q8IZS8	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	NA	CACNA2D3	M6
Q8IZS8	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	NA	CACNA2D3	M6
Q8IZS8	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q8IZS8	Voltage-dependent calcium channel subunit alpha-2/delta-3	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA2D3	M6
P09237	NA	NA	NA	NA	DOXYCYCLINE	Matrix metalloproteinase 7 inhibitor	INHIBITOR	1967	CHEMBL4073	12738	P09237	Matrilysin	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D000544: Alzheimer Disease,D000686: Amyloidosis,D000783: Aneurysm,D000881: Anthrax,D001762: Blepharitis,D002289: Carcinoma, Non-Small-Cell Lung,D002690: Chlamydia Infections,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003550: Cystic Fibrosis,D003876: Dermatitis, Atopic,D003930: Diabetic Retinopathy,D004485: Eczema,D004605: Elephantiasis, Filarial,D005126: Eye Burns,D006470: Hemorrhage,D007239: Infections,D008193: Lyme Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008368: Mansonelliasis,D008382: Marfan Syndrome,D008545: Melanoma,D009182: Mycosis Fungoides,D009203: Myocardial Infarction,D009369: Neoplasms,D010003: Osteoarthritis,D010019: Osteomyelitis,D010146: Pain,D010190: Pancreatic Neoplasms,D010518: Periodontitis,D010930: Plague,D010996: Pleural Effusion,D011014: Pneumonia,D011125: Adenomatous Polyposis Coli,D012393: Rosacea,D012612: Scrub Typhus,D012640: Seizures,D012751: Sezary Syndrome,D012871: Skin Diseases,D013587: Syphilis,D014376: Tuberculosis,D014526: Urethritis,D015179: Colorectal Neoplasms,D015352: Dry Eye Syndromes,D015427: Reperfusion Injury,D016410: Lymphoma, T-Cell, Cutaneous,D016918: Arthritis, Reactive,D017544: Aortic Aneurysm, Abdominal,D017676: Lichen Planus, Oral,D017719: Diabetic Foot,D018923: Persian Gulf Syndrome,D028226: Amyloidosis, Familial,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D054990: Idiopathic Pulmonary Fibrosis	MMP7	M6
P09237	NA	NA	NA	NA	DOXYCYCLINE CALCIUM	Matrix metalloproteinase 7 inhibitor	INHIBITOR	1974	CHEMBL4073	12738	P09237	Matrilysin	Homo sapiens	D010019: Osteomyelitis	MMP7	M6
P09237	NA	NA	NA	NA	DOXYCYCLINE HYCLATE	Matrix metalloproteinase 7 inhibitor	INHIBITOR	1967	CHEMBL4073	12738	P09237	Matrilysin	Homo sapiens	D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D002690: Chlamydia Infections,D008268: Macular Degeneration,D010518: Periodontitis,D012393: Rosacea,D013683: Telangiectasia, Hereditary Hemorrhagic,D013716: Tennis Elbow,D015231: Sexually Transmitted Diseases, Bacterial,D052016: Mucositis	MMP7	M6
Q02156	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	Q02156	Protein kinase C epsilon type	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKCE	M6
P22888	NA	NA	NA	NA	CHORIOGONADOTROPIN ALFA	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	2000	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D007246: Infertility,D011085: Polycystic Ovary Syndrome,D016471: Ovarian Hyperstimulation Syndrome	LHCGR	M6
P22888	NA	NA	NA	NA	LUTROPIN ALFA	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	2004	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D007006: Hypogonadism,D007246: Infertility,D007247: Infertility, Female	LHCGR	M6
P22888	NA	NA	NA	NA	GONADOTROPIN, CHORIONIC	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	1973	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D000858: Anovulation,D001943: Breast Neoplasms,D006058: Gonadal Disorders,D007006: Hypogonadism,D007246: Infertility,D011085: Polycystic Ovary Syndrome,D011247: Pregnancy,D053713: Azoospermia	LHCGR	M6
P22888	NA	NA	NA	NA	LH (MENOTROPINS)	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	1975	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D007246: Infertility	LHCGR	M6
P22888	NA	NA	NA	NA	MENOTROPINS	Luteinizing hormone/Choriogonadotropin receptor agonist	AGONIST	1975	CHEMBL1854	95	P22888	Lutropin-choriogonadotropic hormone receptor	Homo sapiens	D006058: Gonadal Disorders,D007006: Hypogonadism,D007246: Infertility,D007247: Infertility, Female,D011085: Polycystic Ovary Syndrome,D011247: Pregnancy,D017436: Kallmann Syndrome,D053713: Azoospermia	LHCGR	M6
P08588	NA	NA	NA	NA	ATENOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1981	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002561: Cerebrovascular Disorders,D006331: Heart Diseases,D006333: Heart Failure,D006391: Hemangioma,D006973: Hypertension,D008382: Marfan Syndrome,D008946: Mitral Valve Stenosis,D009203: Myocardial Infarction,D010024: Osteoporosis,D013313: Stress Disorders, Post-Traumatic,D017202: Myocardial Ischemia,D017379: Hypertrophy, Left Ventricular,D060050: Angina, Stable	ADRB1	M6
P08588	NA	NA	NA	NA	TIMOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB1	M6
P08588	NA	NA	NA	NA	PINDOLOL	Beta-1 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB1	M6
P08588	NA	NA	NA	NA	NADOLOL	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB1	M6
P08588	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB1	M6
P08588	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB1	M6
P08588	NA	NA	NA	NA	DOPAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1974	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010300: Parkinson Disease	ADRB1	M6
P08588	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB1	M6
P08588	NA	NA	NA	NA	BETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension	ADRB1	M6
P08588	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1	M6
P08588	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB1	M6
P08588	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-1 adrenergic receptor agonist	AGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB1	M6
P08588	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	ACEBUTOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001145: Arrhythmias, Cardiac,D006973: Hypertension	ADRB1	M6
P08588	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	LEVOBETAXOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2000	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D009798: Ocular Hypertension	ADRB1	M6
P08588	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB1	M6
P08588	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB1	M6
P08588	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB1	M6
P08588	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB1	M6
P08588	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB1	M6
P08588	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB1	M6
P08588	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1990	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB1	M6
P08588	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB1	M6
P08588	NA	NA	NA	NA	BISOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D020388: Muscular Dystrophy, Duchenne	ADRB1	M6
P08588	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB1	M6
P08588	NA	NA	NA	NA	METOPROLOL TARTRATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006331: Heart Diseases,D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction	ADRB1	M6
P08588	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB1	M6
P08588	NA	NA	NA	NA	METOPROLOL SUCCINATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	D000787: Angina Pectoris,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D002312: Cardiomyopathy, Hypertrophic,D006333: Heart Failure,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008944: Mitral Valve Insufficiency,D029424: Pulmonary Disease, Chronic Obstructive	ADRB1	M6
P08588	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P08588	NA	NA	NA	NA	METOPROLOL FUMARATE	Beta-1 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL213	50	P08588	Beta-1 adrenergic receptor	Homo sapiens	NA	ADRB1	M6
P31785	NA	NA	NA	NA	DENILEUKIN DIFTITOX	Interleukin-2 receptor binding agent	BINDING AGENT	1999	CHEMBL2364167	106146	P31785	Cytokine receptor common subunit gamma	Homo sapiens	D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male	IL2RG	M6
P31785	NA	NA	NA	NA	BASILIXIMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1998	CHEMBL2364167	106146	P31785	Cytokine receptor common subunit gamma	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003093: Colitis, Ulcerative,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D004646: Emphysema,D005909: Glioblastoma,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007239: Infections,D007674: Kidney Diseases,D007683: Kidney Tubular Necrosis, Acute,D009101: Multiple Myeloma,D009369: Neoplasms,D014511: Uremia,D014605: Uveitis,D015427: Reperfusion Injury,D015470: Leukemia, Myeloid, Acute,D051436: Renal Insufficiency, Chronic	IL2RG	M6
P31785	NA	NA	NA	NA	ALDESLEUKIN	Interleukin-2 receptor agonist	AGONIST	1992	CHEMBL2364167	106146	P31785	Cytokine receptor common subunit gamma	Homo sapiens	D000026: Abortion, Habitual,D000081483: Squamous Intraepithelial Lesions,D000163: Acquired Immunodeficiency Syndrome,D000506: Alopecia Areata,D000690: Amyotrophic Lateral Sclerosis,D000744: Anemia, Hemolytic, Autoimmune,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001528: Behcet Syndrome,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003093: Colitis, Ulcerative,D003327: Coronary Disease,D003424: Crohn Disease,D003449: Cryoglobulinemia,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D004660: Encephalitis,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009220: Myositis,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011081: Polychondritis, Relapsing,D011111: Polymyalgia Rheumatica,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012751: Sezary Syndrome,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D019337: Hematologic Neoplasms,D030361: Papillomavirus Infections,D045169: Severe Acute Respiratory Syndrome,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055501: Macrophage Activation Syndrome,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	IL2RG	M6
P31785	NA	NA	NA	NA	DACLIZUMAB	Interleukin-2 receptor inhibitor	INHIBITOR	1997	CHEMBL2364167	106146	P31785	Cytokine receptor common subunit gamma	Homo sapiens	D000741: Anemia, Aplastic,D001249: Asthma,D003093: Colitis, Ulcerative,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004062: DiGeorge Syndrome,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D007674: Kidney Diseases,D007938: Leukemia,D008223: Lymphoma,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D011565: Psoriasis,D012010: Red-Cell Aplasia, Pure,D013921: Thrombocytopenia,D014605: Uveitis,D014890: Granulomatosis with Polyangiitis,D015658: HIV Infections,D020529: Multiple Sclerosis, Relapsing-Remitting,D051436: Renal Insufficiency, Chronic,D057135: Wet Macular Degeneration	IL2RG	M6
P11274	NA	NA	NA	NA	BOSUTINIB	Bcr/Abl fusion protein	INHIBITOR	2010	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	BCR	M6
P11274	NA	NA	NA	NA	DASATINIB	Bcr/Abl fusion protein	INHIBITOR	2006	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	BCR	M6
P11274	NA	NA	NA	NA	IMATINIB MESYLATE	Bcr/Abl fusion protein	INHIBITOR	2001	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D000755: Anemia, Sickle Cell,D001249: Asthma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002813: Chondrosarcoma,D003110: Colonic Neoplasms,D003922: Diabetes Mellitus, Type 1,D004802: Eosinophilia,D005185: Fallopian Tube Neoplasms,D005354: Fibrosarcoma,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006976: Hypertension, Pulmonary,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009103: Multiple Sclerosis,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009442: Neurilemmoma,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011668: Pulmonary Veno-Occlusive Disease,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012594: Scleroderma, Localized,D012595: Scleroderma, Systemic,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017681: Hypereosinophilic Syndrome,D018192: Lymphangioleiomyomatosis,D018222: Fibromatosis, Aggressive,D018223: Dermatofibrosarcoma,D018316: Gliosarcoma,D018318: Neurofibroma, Plexiform,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054989: Nephrogenic Fibrosing Dermopathy,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D057135: Wet Macular Degeneration,D064129: Prostatic Neoplasms, Castration-Resistant	BCR	M6
P11274	NA	NA	NA	NA	NILOTINIB HYDROCHLORIDE MONOHYDRATE	Bcr/Abl fusion protein	INHIBITOR	2007	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D001943: Breast Neoplasms,D010300: Parkinson Disease,D012595: Scleroderma, Systemic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive	BCR	M6
P11274	NA	NA	NA	NA	PONATINIB HYDROCHLORIDE	Bcr/Abl fusion protein inhibitor	INHIBITOR	2012	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D001752: Blast Crisis,D009369: Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	BCR	M6
P00918	CHEMBL17	1085	3038	DB01144	DICHLORPHENAMIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1958	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D005901: Glaucoma,D020513: Paralysis, Hyperkalemic Periodic,D020514: Hypokalemic Periodic Paralysis,D020967: Myotonic Disorders	CA2	M6
P00918	CHEMBL18	1096	3295	DB00311	ETHOXZOLAMIDE	Carbonic anhydrase inhibitor	INHIBITOR	1982	CHEMBL2095180	104764	P00918	Carbonic anhydrase 2	Homo sapiens	NA	CA2	M6
P00918	CHEMBL19	1124	NA	NA	METHAZOLAMIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1959	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D000532: Altitude Sickness,D002583: Uterine Cervical Neoplasms,D005901: Glaucoma	CA2	M6
P00918	NA	NA	NA	NA	ACETAZOLAMIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1953	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D003551: Cysticercosis,D004487: Edema,D005901: Glaucoma,D006333: Heart Failure,D006528: Carcinoma, Hepatocellular,D006850: Hydrocephalus, Normal Pressure,D006976: Hypertension, Pulmonary,D007024: Hypotension, Orthostatic,D007674: Kidney Diseases,D008269: Macular Edema,D009103: Multiple Sclerosis,D011559: Pseudotumor Cerebri,D012640: Seizures,D013226: Status Epilepticus,D015812: Glaucoma, Angle-Closure,D016481: Helicobacter Infections,D018887: Landau-Kleffner Syndrome,D020181: Sleep Apnea, Obstructive,D020521: Stroke,D050030: Andersen Syndrome,D055752: Small Cell Lung Carcinoma,D059350: Chronic Pain	CA2	M6
P00918	NA	NA	NA	NA	BRINZOLAMIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1998	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension,D056833: Central Serous Chorioretinopathy	CA2	M6
P00918	NA	NA	NA	NA	TOPIRAMATE	Carbonic anhydrase II inhibitor	INHIBITOR	1996	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	CA2	M6
P00918	CHEMBL1200814	674765	13290219, 90469712	NA	ACETAZOLAMIDE SODIUM	Carbonic anhydrase II inhibitor	INHIBITOR	1990	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D004487: Edema,D005901: Glaucoma,D012640: Seizures,D015812: Glaucoma, Angle-Closure	CA2	M6
P00918	NA	NA	NA	NA	DORZOLAMIDE HYDROCHLORIDE	Carbonic anhydrase II inhibitor	INHIBITOR	1994	CHEMBL205	15	P00918	Carbonic anhydrase 2	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension	CA2	M6
P49763	NA	NA	NA	NA	AFLIBERCEPT	Placenta growth factor inhibitor	INHIBITOR	2011	CHEMBL1697671	103950	P49763	Placenta growth factor	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003930: Diabetic Retinopathy,D005901: Glaucoma,D005910: Glioma,D006660: Histoplasmosis,D007938: Leukemia,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008268: Macular Degeneration,D008269: Macular Edema,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D011561: Pseudoxanthoma Elasticum,D012004: Rectal Neoplasms,D012164: Retinal Diseases,D012170: Retinal Vein Occlusion,D012178: Retinopathy of Prematurity,D013684: Telangiectasis,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014823: Vitreous Hemorrhage,D015179: Colorectal Neoplasms,D015355: Glaucoma, Neovascular,D015861: Retinal Neovascularization,D016510: Corneal Neovascularization,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D047728: Myopia, Degenerative,D049970: Graves Ophthalmopathy,D055752: Small Cell Lung Carcinoma,D056833: Central Serous Chorioretinopathy,D057135: Wet Macular Degeneration	PGF	M6
A4D0S4	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	A4D0S4	Laminin subunit beta-4	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMB4	M6
O60840	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1F	M6
O60840	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1F	M6
O60840	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1F	M6
O60840	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1F	M6
O60840	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1F	M6
O60840	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1F	M6
O60840	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1F	M6
O60840	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1F	M6
O60840	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1F	M6
O60840	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	NA	CACNA1F	M6
O60840	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1F	M6
O60840	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1F	M6
O60840	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	NA	CACNA1F	M6
O60840	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1F	M6
O60840	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	NA	CACNA1F	M6
O60840	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	NA	CACNA1F	M6
O60840	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D001281: Atrial Fibrillation	CACNA1F	M6
O60840	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1F	M6
O60840	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1F	M6
O60840	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D006973: Hypertension	CACNA1F	M6
O60840	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	O60840	Voltage-dependent L-type calcium channel subunit alpha-1F	Homo sapiens	D006973: Hypertension	CACNA1F	M6
O15554	NA	NA	NA	NA	CHLORZOXAZONE	Intermediate conductance calcium-activated potassium channel protein 4 opener	OPENER	1958	CHEMBL4305	10992	O15554	Intermediate conductance calcium-activated potassium channel protein 4	Homo sapiens	NA	KCNN4	M6
Q15139	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	Q15139	Serine/threonine-protein kinase D1	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKD1	M6
P23786	NA	NA	NA	NA	PERHEXILINE MALEATE	Carnitine palmitoyltransferase 2 inhibitor	INHIBITOR	1974	CHEMBL3238	10765	P23786	Carnitine O-palmitoyltransferase 2, mitochondrial	Homo sapiens	NA	CPT2	M6
P51679	NA	NA	NA	NA	MOGAMULIZUMAB	C-C chemokine receptor type 4 cross-linking agent	CROSS-LINKING AGENT	2018	CHEMBL2414	10579	P51679	C-C chemokine receptor type 4	Homo sapiens	D001249: Asthma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D006528: Carcinoma, Hepatocellular,D009182: Mycosis Fungoides,D009369: Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D015493: Paraparesis, Tropical Spastic,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral	CCR4	M6
Q9UIX4	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG1	M6
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG1	M6
Q9UIX4	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	NA	KCNG1	M6
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG1	M6
P05091	NA	NA	NA	NA	DISULFIRAM	Aldehyde dehydrogenase inhibitor	INHIBITOR	1951	CHEMBL1935	30	P05091	Aldehyde dehydrogenase, mitochondrial	Homo sapiens	D000437: Alcoholism,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004478: Ectoparasitic Infestations,D005909: Glioblastoma,D008545: Melanoma,D009101: Multiple Myeloma,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D015658: HIV Infections,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	ALDH2	M6
Q7LG56	NA	NA	NA	NA	HYDROXYUREA	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1967	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D000755: Anemia, Sickle Cell,D002277: Carcinoma,D004938: Esophageal Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006432: Hemochromatosis,D006450: Hemoglobin SC Disease,D006976: Hypertension, Pulmonary,D007822: Laryngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008579: Meningioma,D009062: Mouth Neoplasms,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010255: Paranasal Sinus Neoplasms,D010610: Pharyngeal Neoplasms,D011087: Polycythemia Vera,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D017086: beta-Thalassemia,D018222: Fibromatosis, Aggressive,D018316: Gliosarcoma,D020521: Stroke,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	RRM2B	M6
Q7LG56	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1996	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	RRM2B	M6
Q7LG56	NA	NA	NA	NA	CLOFARABINE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	2004	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	RRM2B	M6
Q7LG56	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	RRM2B	M6
Q7LG56	NA	NA	NA	NA	GALLIUM NITRATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	Q7LG56	Ribonucleoside-diphosphate reductase subunit M2 B	Homo sapiens	D003550: Cystic Fibrosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009164: Mycobacterium Infections,D009447: Neuroblastoma,D012509: Sarcoma	RRM2B	M6
Q9H2M3	NA	NA	NA	NA	BETAINE	Betaine-homocysteine S-methyltransferase substrate	SUBSTRATE	1996	CHEMBL3391661	109554	Q9H2M3	S-methylmethionine--homocysteine S-methyltransferase BHMT2	Homo sapiens	D003866: Depressive Disorder,D006526: Hepatitis C,D006712: Homocystinuria,D006960: Hyperoxaluria, Primary,D007248: Infertility, Male,D009765: Obesity,D019698: Hepatitis C, Chronic,D065626: Non-alcoholic Fatty Liver Disease	BHMT2	M6
O95168	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O95168	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFB4	M6
P35372	NA	NA	NA	NA	FENTANYL	Mu opioid receptor agonist	AGONIST	1968	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D000038: Abscess,D000236: Adenoma,D001930: Brain Injuries,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D003693: Delirium,D003929: Diabetic Neuropathies,D007021: Hypospadias,D007022: Hypotension,D008107: Liver Diseases,D008881: Migraine Disorders,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010146: Pain,D010190: Pancreatic Neoplasms,D011671: Pulpitis,D012128: Respiratory Distress Syndrome,D012131: Respiratory Insufficiency,D012600: Scoliosis,D013274: Stomach Neoplasms,D013345: Subarachnoid Hemorrhage,D017116: Low Back Pain,D020181: Sleep Apnea, Obstructive,D043183: Irritable Bowel Syndrome,D050723: Fractures, Bone,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M6
P35372	CHEMBL128201	214599	10295681	NA	NALTREXONE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001883: Borderline Personality Disorder,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002659: Child Development Disorders, Pervasive,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D004715: Endometriosis,D005356: Fibromyalgia,D005715: Gambling,D006556: Heroin Dependence,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014256: Trichotillomania,D015352: Dry Eye Syndromes,D015658: HIV Infections,D018352: Coronavirus Infections,D018856: Cystitis, Interstitial,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRM1	M6
P35372	NA	NA	NA	NA	OXYCODONE	Mu opioid receptor agonist	AGONIST	1950	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D001416: Back Pain,D003929: Diabetic Neuropathies,D007021: Hypospadias,D007592: Joint Diseases,D007669: Kidney Calculi,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009748: Nutrition Disorders,D010003: Osteoarthritis,D010146: Pain,D010300: Parkinson Disease,D011225: Pre-Eclampsia,D011537: Pruritus,D012131: Respiratory Insufficiency,D012148: Restless Legs Syndrome,D012852: Sinusitis,D013119: Spinal Cord Injuries,D014098: Toothache,D015179: Colorectal Neoplasms,D015207: Osteoarthritis, Hip,D017116: Low Back Pain,D019547: Neck Pain,D019966: Substance-Related Disorders,D020370: Osteoarthritis, Knee,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	OPRM1	M6
P35372	NA	NA	NA	NA	FENTANYL CITRATE	Mu opioid receptor agonist	AGONIST	1968	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D004417: Dyspnea,D009369: Neoplasms,D009437: Neuralgia,D010146: Pain,D011671: Pulpitis,D017116: Low Back Pain,D017563: Lung Diseases, Interstitial,D059350: Chronic Pain,D059390: Breakthrough Pain	OPRM1	M6
P35372	NA	NA	NA	NA	BUTORPHANOL TARTRATE	Mu opioid receptor partial agonist	PARTIAL AGONIST	1978	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	ALVIMOPAN	Mu opioid receptor antagonist	ANTAGONIST	2008	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003248: Constipation,D005185: Fallopian Tube Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms	OPRM1	M6
P35372	NA	NA	NA	NA	BUPRENORPHINE	Mu opioid receptor agonist	AGONIST	1981	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000755: Anemia, Sickle Cell,D001416: Back Pain,D002294: Carcinoma, Squamous Cell,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006526: Hepatitis C,D006556: Heroin Dependence,D009021: Morphine Dependence,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D013313: Stress Disorders, Post-Traumatic,D013375: Substance Withdrawal Syndrome,D014098: Toothache,D015658: HIV Infections,D017116: Low Back Pain,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	DEZOCINE	Mu opioid receptor partial agonist	PARTIAL AGONIST	1989	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M6
P35372	NA	NA	NA	NA	MEPERIDINE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1942	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D007022: Hypotension,D010146: Pain	OPRM1	M6
P35372	NA	NA	NA	NA	LOPERAMIDE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1976	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D003967: Diarrhea	OPRM1	M6
P35372	NA	NA	NA	NA	NALOXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1971	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D003248: Constipation,D005715: Gambling,D007415: Intestinal Obstruction,D009293: Opioid-Related Disorders,D010146: Pain	OPRM1	M6
P35372	NA	NA	NA	NA	ALFENTANIL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1986	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D000758: Anesthesia	OPRM1	M6
P35372	NA	NA	NA	NA	ANILERIDINE PHOSPHATE	Mu opioid receptor agonist	AGONIST	1982	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	DIFENOXIN HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1978	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	DIPHENOXYLATE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1960	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	OXYMORPHONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1959	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	LEVOMETHADYL ACETATE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1993	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	METHADONE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1947	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain,D015658: HIV Infections,D055959: Intervertebral Disc Degeneration,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	OXYCODONE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1950	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain,D010149: Pain, Postoperative,D015207: Osteoarthritis, Hip,D017116: Low Back Pain,D020370: Osteoarthritis, Knee,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	ANILERIDINE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1982	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	CODEINE PHOSPHATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1952	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D003371: Cough,D008881: Migraine Disorders,D010146: Pain,D013035: Spasm,D015658: HIV Infections	OPRM1	M6
P35372	NA	NA	NA	NA	REMIFENTANIL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1996	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	NALBUPHINE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1979	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D003693: Delirium,D008107: Liver Diseases,D009293: Opioid-Related Disorders,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D015470: Leukemia, Myeloid, Acute	OPRM1	M6
P35372	NA	NA	NA	NA	NALTREXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D001068: Feeding and Eating Disorders,D002607: Charcot-Marie-Tooth Disease,D009293: Opioid-Related Disorders,D010146: Pain,D019969: Amphetamine-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRM1	M6
P35372	NA	NA	NA	NA	NALMEFENE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1995	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D000437: Alcoholism	OPRM1	M6
P35372	NA	NA	NA	NA	FENTANYL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	2006	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M6
P35372	NA	NA	NA	NA	SUFENTANIL CITRATE	Mu opioid receptor agonist	AGONIST	1984	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	CODEINE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1985	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D003371: Cough	OPRM1	M6
P35372	NA	NA	NA	NA	HYDROCODONE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1987	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	METHYLNALTREXONE BROMIDE	Mu opioid receptor antagonist	ANTAGONIST	2008	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D003248: Constipation,D010190: Pancreatic Neoplasms	OPRM1	M6
P35372	NA	NA	NA	NA	TAPENTADOL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	2008	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D009437: Neuralgia,D010146: Pain,D017116: Low Back Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	HYDROMORPHONE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1984	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D001416: Back Pain,D008107: Liver Diseases,D009369: Neoplasms,D010146: Pain,D015207: Osteoarthritis, Hip,D019966: Substance-Related Disorders,D020370: Osteoarthritis, Knee,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	TRAMADOL HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1995	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D009369: Neoplasms,D010146: Pain,D014098: Toothache,D017116: Low Back Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	PROPOXYPHENE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1957	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M6
P35372	NA	NA	NA	NA	DIHYDROCODEINE BITARTRATE	Mu opioid receptor agonist	AGONIST	1983	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M6
P35372	NA	NA	NA	NA	LEVALLORPHAN TARTRATE	Mu opioid receptor antagonist	ANTAGONIST	1982	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	MORPHINE SULFATE	Mu opioid receptor agonist	AGONIST	1984	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D000755: Anemia, Sickle Cell,D006215: Hallux Valgus,D006976: Hypertension, Pulmonary,D009203: Myocardial Infarction,D009293: Opioid-Related Disorders,D009357: Neonatal Abstinence Syndrome,D009369: Neoplasms,D010146: Pain,D011537: Pruritus,D017116: Low Back Pain,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D054990: Idiopathic Pulmonary Fibrosis,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	NALDEMEDINE	Mu opioid receptor antagonist	ANTAGONIST	2017	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D003248: Constipation	OPRM1	M6
P35372	NA	NA	NA	NA	ELUXADOLINE	Mu opioid receptor agonist	AGONIST	2015	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D043183: Irritable Bowel Syndrome	OPRM1	M6
P35372	NA	NA	NA	NA	NALOXEGOL OXALATE	Mu opioid receptor antagonist	ANTAGONIST	2014	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	BUPRENORPHINE HYDROCHLORIDE	Mu opioid receptor agonist	AGONIST	1981	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D009293: Opioid-Related Disorders,D019966: Substance-Related Disorders	OPRM1	M6
P35372	NA	NA	NA	NA	OLICERIDINE	Mu opioid receptor agonist	AGONIST	2020	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	NALDEMEDINE TOSYLATE	Mu opioid receptor antagonist	ANTAGONIST	2017	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D003248: Constipation	OPRM1	M6
P35372	NA	NA	NA	NA	BENZHYDROCODONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2018	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	HYDROCODONE BITARTRATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1943	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D007674: Kidney Diseases,D008107: Liver Diseases,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D014947: Wounds and Injuries,D017116: Low Back Pain,D019966: Substance-Related Disorders,D059350: Chronic Pain,D059787: Acute Pain	OPRM1	M6
P35372	NA	NA	NA	NA	PROPOXYPHENE NAPSYLATE	Mu opioid receptor agonist	AGONIST	1971	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M6
P35372	NA	NA	NA	NA	LEVORPHANOL TARTRATE	Mu opioid receptor agonist	AGONIST	1991	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	NA	OPRM1	M6
P35372	NA	NA	NA	NA	OXYCODONE TEREPHTHALATE	Mu opioid receptor agonist	AGONIST	1950	CHEMBL233	129	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M6
P35372	NA	NA	NA	NA	CODEINE SULFATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2009	CHEMBL2095181	104765	P35372	Mu-type opioid receptor	Homo sapiens	D010146: Pain	OPRM1	M6
Q92953	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q92953	Potassium voltage-gated channel subfamily B member 2	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNB2	M6
Q92953	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q92953	Potassium voltage-gated channel subfamily B member 2	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNB2	M6
Q92953	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q92953	Potassium voltage-gated channel subfamily B member 2	Homo sapiens	NA	KCNB2	M6
Q92953	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q92953	Potassium voltage-gated channel subfamily B member 2	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNB2	M6
P07327	NA	NA	NA	NA	FOMEPIZOLE	Alcohol dehydrogenase class I inhibitor	INHIBITOR	1997	CHEMBL2363044	105739	P07327	Alcohol dehydrogenase 1A	Homo sapiens	D008268: Macular Degeneration	ADH1A	M6
Q05586	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN1	M6
Q05586	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN1	M6
Q05586	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN1	M6
Q05586	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN1	M6
Q05586	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN1	M6
Q05586	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D010146: Pain	GRIN1	M6
Q05586	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D010300: Parkinson Disease	GRIN1	M6
Q05586	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D000437: Alcoholism	GRIN1	M6
Q05586	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q05586	Glutamate receptor ionotropic, NMDA 1	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN1	M6
Q96S37	NA	NA	NA	NA	SULFINPYRAZONE	Solute carrier family 22 member 12 inhibitor	INHIBITOR	1959	CHEMBL6120	102767	Q96S37	Solute carrier family 22 member 12	Homo sapiens	D006073: Gout	SLC22A12	M6
Q96S37	NA	NA	NA	NA	LESINURAD	Solute carrier family 22 member 12 inhibitor	INHIBITOR	2015	CHEMBL6120	102767	Q96S37	Solute carrier family 22 member 12	Homo sapiens	D006073: Gout,D033461: Hyperuricemia	SLC22A12	M6
Q02763	NA	NA	NA	NA	VANDETANIB	Tyrosine-protein kinase TIE-2 inhibitor	INHIBITOR	2011	CHEMBL4128	12913	Q02763	Angiopoietin-1 receptor	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TEK	M6
Q02763	NA	NA	NA	NA	REGORAFENIB	Tyrosine-protein kinase TIE-2 inhibitor	INHIBITOR	2012	CHEMBL4128	12913	Q02763	Angiopoietin-1 receptor	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	TEK	M6
O00231	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	O00231	26S proteasome non-ATPase regulatory subunit 11	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD11	M6
O00231	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	O00231	26S proteasome non-ATPase regulatory subunit 11	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD11	M6
O00231	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	O00231	26S proteasome non-ATPase regulatory subunit 11	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD11	M6
Q9UM73	NA	NA	NA	NA	CRIZOTINIB	ALK tyrosine kinase receptor inhibitor	INHIBITOR	2011	CHEMBL4247	100417	Q9UM73	ALK tyrosine kinase receptor	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000080443: Diffuse Intrinsic Pontine Glioma,D000230: Adenocarcinoma,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006104: Granuloma, Plasma Cell,D007674: Kidney Diseases,D008175: Lung Neoplasms,D009101: Multiple Myeloma,D009369: Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016518: Neurofibromatosis 2,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D064129: Prostatic Neoplasms, Castration-Resistant	ALK	M6
Q9UM73	NA	NA	NA	NA	ENTRECTINIB	ALK tyrosine kinase receptor inhibitor	INHIBITOR	2019	CHEMBL4247	100417	Q9UM73	ALK tyrosine kinase receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D008545: Melanoma,D009369: Neoplasms,D018275: Carcinoma, Lobular	ALK	M6
Q9UM73	NA	NA	NA	NA	CERITINIB	ALK tyrosine kinase receptor inhibitor	INHIBITOR	2014	CHEMBL4247	100417	Q9UM73	ALK tyrosine kinase receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006104: Granuloma, Plasma Cell,D008107: Liver Diseases,D008545: Melanoma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D013964: Thyroid Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma	ALK	M6
Q9UM73	NA	NA	NA	NA	LORLATINIB	ALK tyrosine kinase receptor inhibitor	INHIBITOR	2018	CHEMBL4247	100417	Q9UM73	ALK tyrosine kinase receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D007674: Kidney Diseases,D009369: Neoplasms,D009447: Neuroblastoma,D017728: Lymphoma, Large-Cell, Anaplastic	ALK	M6
Q9UM73	NA	NA	NA	NA	BRIGATINIB	ALK tyrosine kinase receptor inhibitor	INHIBITOR	2017	CHEMBL4247	100417	Q9UM73	ALK tyrosine kinase receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D009369: Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic	ALK	M6
Q9UM73	NA	NA	NA	NA	ALECTINIB HYDROCHLORIDE	ALK tyrosine kinase receptor inhibitor	INHIBITOR	2015	CHEMBL4247	100417	Q9UM73	ALK tyrosine kinase receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	ALK	M6
P13637	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A3	M6
P13637	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3	M6
P13637	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A3	M6
P13637	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3	M6
P29459	NA	NA	NA	NA	USTEKINUMAB	Interleukin-12 inhibitor	INHIBITOR	2009	CHEMBL2364153	106132	P29459	Interleukin-12 subunit alpha	Homo sapiens	D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D003092: Colitis,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007057: Ichthyosis,D007154: Immune System Diseases,D008105: Liver Cirrhosis, Biliary,D008180: Lupus Erythematosus, Systemic,D009103: Multiple Sclerosis,D010391: Pemphigoid, Bullous,D011565: Psoriasis,D012507: Sarcoidosis,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014605: Uveitis,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa,D019337: Hematologic Neoplasms,D019449: Pouchitis	IL12A	M6
P00374	NA	NA	NA	NA	METHOTREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000506: Alopecia Areata,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001168: Arthritis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002294: Carcinoma, Squamous Cell,D002318: Cardiovascular Diseases,D002583: Uterine Cervical Neoplasms,D002822: Choriocarcinoma,D003093: Colitis, Ulcerative,D003251: Constriction, Pathologic,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005199: Fanconi Anemia,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006319: Hearing Loss, Sensorineural,D006457: Hemoglobinuria, Paroxysmal,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006828: Hydatidiform Mole,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007249: Inflammation,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008105: Liver Cirrhosis, Biliary,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008269: Macular Edema,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009203: Myocardial Infarction,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D010003: Osteoarthritis,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010391: Pemphigoid, Bullous,D011087: Polycythemia Vera,D011271: Pregnancy, Ectopic,D011565: Psoriasis,D012507: Sarcoidosis,D012509: Sarcoma,D012516: Osteosarcoma,D012559: Schizophrenia,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014523: Urethral Neoplasms,D014581: Urticaria,D014605: Uveitis,D014657: Vasculitis,D014820: Vitiligo,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015658: HIV Infections,D015867: Uveitis, Intermediate,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016511: Severe Combined Immunodeficiency,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018242: Neuroectodermal Tumors, Primitive,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D056833: Central Serous Chorioretinopathy	DHFR	M6
P00374	NA	NA	NA	NA	PRALATREXATE	Dihydrofolate reductase inhibitor	INHIBITOR	2009	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D012751: Sezary Syndrome,D015459: Leukemia-Lymphoma, Adult T-Cell,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic	DHFR	M6
P00374	NA	NA	NA	NA	PEMETREXED DISODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	2004	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013945: Thymoma,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018287: Carcinoma, Large Cell,D031901: Gestational Trophoblastic Disease,D064129: Prostatic Neoplasms, Castration-Resistant	DHFR	M6
P00374	NA	NA	NA	NA	METHOTREXATE SODIUM	Dihydrofolate reductase inhibitor	INHIBITOR	1953	CHEMBL202	6	P00374	Dihydrofolate reductase	Homo sapiens	D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	DHFR	M6
P04350	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB4A	M6
P04350	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M6
P04350	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M6
P04350	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBB4A	M6
P04350	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M6
P04350	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M6
P04350	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M6
P04350	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBB4A	M6
P04350	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBB4A	M6
P04350	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBB4A	M6
P04350	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBB4A	M6
P04350	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBB4A	M6
P04350	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBB4A	M6
P04350	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	P04350	Tubulin beta-4A chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBB4A	M6
P12107	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12107	Collagen alpha-1(XI) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL11A1	M6
P12107	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P12107	Collagen alpha-1(XI) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL11A1	M6
P35916	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M6
P35916	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M6
P35916	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M6
P35916	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M6
P35916	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M6
P35916	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M6
P35916	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FLT4	M6
P35916	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	FLT4	M6
P35916	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	NA	FLT4	M6
Q02750	NA	NA	NA	NA	SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	2020	CHEMBL3587	11409	Q02750	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens	D000230: Adenocarcinoma,D001254: Astrocytoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D005706: Gallbladder Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D009456: Neurofibromatosis 1,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018318: Neurofibroma, Plexiform,D020339: Optic Nerve Glioma,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064726: Triple Negative Breast Neoplasms	MAP2K1	M6
Q02750	NA	NA	NA	NA	SELUMETINIB SULFATE	Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor	INHIBITOR	2020	CHEMBL2111289	104912	Q02750	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens	D001254: Astrocytoma,D008545: Melanoma,D009456: Neurofibromatosis 1,D010190: Pancreatic Neoplasms	MAP2K1	M6
Q02750	NA	NA	NA	NA	TRAMETINIB DIMETHYL SULFOXIDE	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	2013	CHEMBL3587	11409	Q02750	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens	D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D031249: Erdheim-Chester Disease	MAP2K1	M6
Q02750	NA	NA	NA	NA	COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	2015	CHEMBL3587	11409	Q02750	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003397: Craniopharyngioma,D004938: Esophageal Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D021441: Carcinoma, Pancreatic Ductal	MAP2K1	M6
Q02750	NA	NA	NA	NA	COBIMETINIB FUMARATE	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	2015	CHEMBL3587	11409	Q02750	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens	D008545: Melanoma	MAP2K1	M6
Q02750	NA	NA	NA	NA	BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 1 inhibitor	INHIBITOR	2018	CHEMBL3587	11409	Q02750	Dual specificity mitogen-activated protein kinase kinase 1	Homo sapiens	D001172: Arthritis, Rheumatoid,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D006332: Cardiomegaly,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008107: Liver Diseases,D008175: Lung Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D046152: Gastrointestinal Stromal Tumors	MAP2K1	M6
P35408	NA	NA	NA	NA	DINOPROSTONE	Prostaglandin E2 receptor agonist	AGONIST	1977	CHEMBL2363068	105763	P35408	Prostaglandin E2 receptor EP4 subtype	Homo sapiens	D010146: Pain,D011247: Pregnancy	PTGER4	M6
Q9UGN5	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP2	M6
Q9UGN5	NA	NA	NA	NA	NIRAPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2017	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012512: Sarcoma, Ewing,D013274: Stomach Neoplasms,D014565: Urogenital Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP2	M6
Q9UGN5	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP2	M6
Q9UGN5	NA	NA	NA	NA	TALAZOPARIB TOSYLATE	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2018	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009369: Neoplasms,D015470: Leukemia, Myeloid, Acute,D064726: Triple Negative Breast Neoplasms	PARP2	M6
Q9UGN5	NA	NA	NA	NA	TALAZOPARIB	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2018	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006394: Hemangiosarcoma,D007938: Leukemia,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP2	M6
Q9UGN5	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP2	M6
Q9UGN5	NA	NA	NA	NA	NIRAPARIB TOSYLATE	Poly [ADP-ribose] polymerase 2 inhibitor	INHIBITOR	2017	CHEMBL5366	100933	Q9UGN5	Poly [ADP-ribose] polymerase 2	Homo sapiens	D005185: Fallopian Tube Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms	PARP2	M6
P36507	NA	NA	NA	NA	SELUMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2020	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D000230: Adenocarcinoma,D001254: Astrocytoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D005706: Gallbladder Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D009456: Neurofibromatosis 1,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018318: Neurofibroma, Plexiform,D020339: Optic Nerve Glioma,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064726: Triple Negative Breast Neoplasms	MAP2K2	M6
P36507	NA	NA	NA	NA	SELUMETINIB SULFATE	Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor	INHIBITOR	2020	CHEMBL2111289	104912	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D001254: Astrocytoma,D008545: Melanoma,D009456: Neurofibromatosis 1,D010190: Pancreatic Neoplasms	MAP2K2	M6
P36507	NA	NA	NA	NA	TRAMETINIB DIMETHYL SULFOXIDE	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2013	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D031249: Erdheim-Chester Disease	MAP2K2	M6
P36507	NA	NA	NA	NA	COBIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2015	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003397: Craniopharyngioma,D004938: Esophageal Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D021441: Carcinoma, Pancreatic Ductal	MAP2K2	M6
P36507	NA	NA	NA	NA	COBIMETINIB FUMARATE	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2015	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D008545: Melanoma	MAP2K2	M6
P36507	NA	NA	NA	NA	BINIMETINIB	Dual specificity mitogen-activated protein kinase kinase 2 inhibitor	INHIBITOR	2018	CHEMBL2964	11046	P36507	Dual specificity mitogen-activated protein kinase kinase 2	Homo sapiens	D001172: Arthritis, Rheumatoid,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D006332: Cardiomegaly,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D008107: Liver Diseases,D008175: Lung Neoplasms,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D046152: Gastrointestinal Stromal Tumors	MAP2K2	M6
O14561	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O14561	Acyl carrier protein, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFAB1	M6
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN POLISTIREX	Sigma opioid receptor agonist	AGONIST	1982	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D002659: Child Development Disorders, Pervasive	SIGMAR1	M6
Q99720	NA	NA	NA	NA	DEXTROMETHORPHAN HYDROBROMIDE	Sigma opioid receptor agonist	AGONIST	1984	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D003139: Common Cold,D003371: Cough,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006967: Hypersensitivity,D008881: Migraine Disorders,D009369: Neoplasms,D010146: Pain,D011471: Prostatic Neoplasms,D012852: Sinusitis	SIGMAR1	M6
Q99720	NA	NA	NA	NA	FENFLURAMINE HYDROCHLORIDE	Sigma opioid receptor antagonist	ANTAGONIST	2020	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D004831: Epilepsies, Myoclonic,D020195: Epilepsy, Reflex	SIGMAR1	M6
Q99720	NA	NA	NA	NA	PENTAZOCINE LACTATE	Sigma opioid receptor modulator	MODULATOR	1967	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	NA	SIGMAR1	M6
Q99720	NA	NA	NA	NA	PENTAZOCINE HYDROCHLORIDE	Sigma opioid receptor modulator	MODULATOR	1969	CHEMBL287	11272	Q99720	Sigma non-opioid intracellular receptor 1	Homo sapiens	D010146: Pain	SIGMAR1	M6
P42261	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	1996	CHEMBL2096670	104825	P42261	Glutamate receptor 1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIA1	M6
P42261	NA	NA	NA	NA	PERAMPANEL	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	2012	CHEMBL2096670	104825	P42261	Glutamate receptor 1	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D008881: Migraine Disorders,D009437: Neuralgia,D010300: Parkinson Disease,D010523: Peripheral Nervous System Diseases,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014103: Torticollis,D020329: Essential Tremor,D065768: Lennox Gastaut Syndrome	GRIA1	M6
P11802	NA	NA	NA	NA	PALBOCICLIB	Cyclin-dependent kinase 4/cyclin D1 inhibitor	INHIBITOR	2015	CHEMBL1907601	104295	P11802	Cyclin-dependent kinase 4	Homo sapiens	D000230: Adenocarcinoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002817: Chordoma,D003110: Colonic Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008080: Liposarcoma,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012509: Sarcoma,D012512: Sarcoma, Ewing,D013953: Thymus Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018358: Neuroendocrine Tumors,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D044584: Carcinoma, Ductal,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	CDK4	M6
P11802	NA	NA	NA	NA	ABEMACICLIB	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2017	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D009837: Oligodendroglioma,D010190: Pancreatic Neoplasms,D012208: Rhabdomyosarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018335: Rhabdoid Tumor,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D064129: Prostatic Neoplasms, Castration-Resistant	CDK4	M6
P11802	NA	NA	NA	NA	RIBOCICLIB	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2017	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007674: Kidney Diseases,D008080: Liposarcoma,D008223: Lymphoma,D008545: Melanoma,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013724: Teratoma,D013953: Thymus Neoplasms,D014594: Uterine Neoplasms,D018335: Rhabdoid Tumor,D018358: Neuroendocrine Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	CDK4	M6
P11802	NA	NA	NA	NA	RIBOCICLIB SUCCINATE	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2017	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms	CDK4	M6
P11802	NA	NA	NA	NA	TRILACICLIB	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2021	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D001943: Breast Neoplasms,D006394: Hemangiosarcoma,D055752: Small Cell Lung Carcinoma,D064726: Triple Negative Breast Neoplasms	CDK4	M6
P11802	NA	NA	NA	NA	TRILACICLIB DIHYDROCHLORIDE	Cyclin-dependent kinase 4 inhibitor	INHIBITOR	2021	CHEMBL331	12946	P11802	Cyclin-dependent kinase 4	Homo sapiens	D055752: Small Cell Lung Carcinoma	CDK4	M6
P06729	NA	NA	NA	NA	ALEFACEPT	T-cell surface antigen CD2 inhibitor	INHIBITOR	2003	CHEMBL2040	196	P06729	T-cell surface antigen CD2	Homo sapiens	D000741: Anemia, Aplastic,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008010: Lichen Planus,D008223: Lymphoma,D011565: Psoriasis,D015535: Arthritis, Psoriatic,D051437: Renal Insufficiency	CD2	M6
P10721	NA	NA	NA	NA	DASATINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M6
P10721	NA	NA	NA	NA	SUNITINIB MALATE	Stem cell growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M6
P10721	NA	NA	NA	NA	IMATINIB MESYLATE	Stem cell growth factor receptor inhibitor	INHIBITOR	2001	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000755: Anemia, Sickle Cell,D001249: Asthma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002813: Chondrosarcoma,D003110: Colonic Neoplasms,D003922: Diabetes Mellitus, Type 1,D004802: Eosinophilia,D005185: Fallopian Tube Neoplasms,D005354: Fibrosarcoma,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006976: Hypertension, Pulmonary,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009103: Multiple Sclerosis,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009442: Neurilemmoma,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011668: Pulmonary Veno-Occlusive Disease,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012594: Scleroderma, Localized,D012595: Scleroderma, Systemic,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017681: Hypereosinophilic Syndrome,D018192: Lymphangioleiomyomatosis,D018222: Fibromatosis, Aggressive,D018223: Dermatofibrosarcoma,D018316: Gliosarcoma,D018318: Neurofibroma, Plexiform,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054989: Nephrogenic Fibrosing Dermopathy,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D057135: Wet Macular Degeneration,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M6
P10721	NA	NA	NA	NA	MIDOSTAURIN	Stem cell growth factor receptor inhibitor	INHIBITOR	2017	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	KIT	M6
P10721	NA	NA	NA	NA	SORAFENIB TOSYLATE	Stem cell growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M6
P10721	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Stem cell growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M6
P10721	NA	NA	NA	NA	REGORAFENIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	KIT	M6
P10721	NA	NA	NA	NA	PEXIDARTINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2019	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D001172: Arthritis, Rheumatoid,D001943: Breast Neoplasms,D005870: Giant Cell Tumors,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D008107: Liver Diseases,D008545: Melanoma,D009369: Neoplasms,D009442: Neurilemmoma,D011471: Prostatic Neoplasms,D013586: Synovitis, Pigmented Villonodular,D015470: Leukemia, Myeloid, Acute,D046152: Gastrointestinal Stromal Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	KIT	M6
P10721	NA	NA	NA	NA	PEXIDARTINIB HYDROCHLORIDE	Stem cell growth factor receptor inhibitor	INHIBITOR	2019	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D000070779: Giant Cell Tumor of Tendon Sheath	KIT	M6
P10721	NA	NA	NA	NA	AVAPRITINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D005910: Glioma,D007946: Leukemia, Mast-Cell,D009369: Neoplasms,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors	KIT	M6
P10721	NA	NA	NA	NA	RIPRETINIB	Stem cell growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL1936	238	P10721	Mast/stem cell growth factor receptor Kit	Homo sapiens	D009369: Neoplasms,D046152: Gastrointestinal Stromal Tumors	KIT	M6
P24043	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	P24043	Laminin subunit alpha-2	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMA2	M6
P00747	NA	NA	NA	NA	TRANEXAMIC ACID	Plasminogen inhibitor	INHIBITOR	1986	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000740: Anemia,D001254: Astrocytoma,D001416: Back Pain,D001749: Urinary Bladder Neoplasms,D001778: Blood Coagulation Disorders,D001859: Bone Neoplasms,D001930: Brain Injuries,D002543: Cerebral Hemorrhage,D003327: Coronary Disease,D004844: Epistaxis,D005265: Femoral Neck Fractures,D005910: Glioma,D006258: Head and Neck Neoplasms,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D006473: Postpartum Hemorrhage,D006620: Hip Fractures,D007022: Hypotension,D007592: Joint Diseases,D007889: Leiomyoma,D008548: Melanosis,D008579: Meningioma,D008595: Menorrhagia,D009298: Nasal Polyps,D009369: Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010921: Placenta Accreta,D010923: Placenta Previa,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D012878: Skin Neoplasms,D013345: Subarachnoid Hemorrhage,D013683: Telangiectasia, Hereditary Hemorrhagic,D013921: Thrombocytopenia,D014947: Wounds and Injuries,D017544: Aortic Aneurysm, Abdominal,D019337: Hematologic Neoplasms,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050723: Fractures, Bone,D054179: Angioedemas, Hereditary,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse	PLG	M6
P00747	NA	NA	NA	NA	AMINOCAPROIC ACID	Plasminogen inhibitor	INHIBITOR	1964	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001018: Aortic Diseases,D003398: Craniosynostoses,D006470: Hemorrhage,D007249: Inflammation,D012393: Rosacea	PLG	M6
P00747	NA	NA	NA	NA	ALTEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000038: Abscess,D000083242: Ischemic Stroke,D001991: Bronchitis,D002543: Cerebral Hemorrhage,D002544: Cerebral Infarction,D002545: Brain Ischemia,D004653: Empyema,D005128: Eye Diseases,D006333: Heart Failure,D006470: Hemorrhage,D009203: Myocardial Infarction,D009369: Neoplasms,D009422: Nervous System Diseases,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012170: Retinal Vein Occlusion,D013345: Subarachnoid Hemorrhage,D013924: Thrombophlebitis,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016055: Urinary Retention,D016724: Empyema, Pleural,D017202: Myocardial Ischemia,D018784: Abdominal Abscess,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D060050: Angina, Stable	PLG	M6
P00747	NA	NA	NA	NA	UROKINASE	Plasminogen activator	ACTIVATOR	2007	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D004653: Empyema,D007239: Infections,D011655: Pulmonary Embolism,D013927: Thrombosis,D016724: Empyema, Pleural,D020521: Stroke	PLG	M6
P00747	NA	NA	NA	NA	APROTININ	Plasminogen inhibitor	INHIBITOR	1993	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001943: Breast Neoplasms,D006470: Hemorrhage,D010195: Pancreatitis	PLG	M6
P00747	NA	NA	NA	NA	RETEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D009203: Myocardial Infarction,D013927: Thrombosis,D020521: Stroke	PLG	M6
P00747	NA	NA	NA	NA	STREPTOKINASE	Plasminogen activator	ACTIVATOR	1997	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000083242: Ischemic Stroke,D009203: Myocardial Infarction,D010195: Pancreatitis,D013927: Thrombosis,D017202: Myocardial Ischemia,D020246: Venous Thrombosis	PLG	M6
P00747	NA	NA	NA	NA	TENECTEPLASE	Plasminogen activator	ACTIVATOR	2000	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D002544: Cerebral Infarction,D002545: Brain Ischemia,D009203: Myocardial Infarction,D009422: Nervous System Diseases,D010996: Pleural Effusion,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016757: Death, Sudden, Cardiac,D020521: Stroke	PLG	M6
P00747	NA	NA	NA	NA	DEFIBROTIDE SODIUM	Plasminogen activator	ACTIVATOR	2016	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D006504: Hepatic Veno-Occlusive Disease	PLG	M6
O95139	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O95139	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFB6	M6
P54753	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54753	Ephrin type-B receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHB3	M6
P08912	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	1986	CHEMBL2094109	104691	P08912	Muscarinic acetylcholine receptor M5	Homo sapiens	NA	CHRM5	M6
P20839	NA	NA	NA	NA	THIOGUANINE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1966	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001932: Brain Neoplasms,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	IMPDH1	M6
P20839	NA	NA	NA	NA	MYCOPHENOLIC ACID	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	2004	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D009404: Nephrotic Syndrome,D012595: Scleroderma, Systemic,D015352: Dry Eye Syndromes,D015470: Leukemia, Myeloid, Acute,D015867: Uveitis, Intermediate,D051436: Renal Insufficiency, Chronic	IMPDH1	M6
P20839	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1995	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000690: Amyotrophic Lateral Sclerosis,D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001327: Autoimmune Diseases,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D004062: DiGeorge Syndrome,D004820: Epidermolysis Bullosa,D005199: Fanconi Anemia,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006073: Gout,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006331: Heart Diseases,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006519: Hepatitis, Alcoholic,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006973: Hypertension,D007119: Immunoblastic Lymphadenopathy,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009472: Neuronal Ceroid-Lipofuscinoses,D010190: Pancreatic Neoplasms,D010390: Pemphigoid, Benign Mucous Membrane,D010391: Pemphigoid, Bullous,D010392: Pemphigus,D011087: Polycythemia Vera,D011128: Polyradiculopathy,D011565: Psoriasis,D011695: Purpura, Schoenlein-Henoch,D012010: Red-Cell Aplasia, Pure,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012859: Sjogren's Syndrome,D013625: Takayasu Arteritis,D014605: Uveitis,D014657: Vasculitis,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017563: Lung Diseases, Interstitial,D017565: Sarcoidosis, Pulmonary,D017728: Lymphoma, Large-Cell, Anaplastic,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D045743: Scleroderma, Diffuse,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D055953: Microscopic Polyangiitis,D056486: Chemical and Drug Induced Liver Injury,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	IMPDH1	M6
P20839	NA	NA	NA	NA	RIBAVIRIN	Inosine-5'-monophosphate dehydrogenase 1 inhibitor	INHIBITOR	1985	CHEMBL1822	84	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	D001943: Breast Neoplasms,D003699: Hepatitis D,D003866: Depressive Disorder,D004672: Encephalitis, Japanese,D005355: Fibrosis,D006480: Hemorrhagic Fever with Renal Syndrome,D006505: Hepatitis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D008103: Liver Cirrhosis,D009369: Neoplasms,D013921: Thrombocytopenia,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D018357: Respiratory Syncytial Virus Infections,D019142: Hemorrhagic Fever, Ebola,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome	IMPDH1	M6
P20839	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1998	CHEMBL2111369	105058	P20839	Inosine-5'-monophosphate dehydrogenase 1	Homo sapiens	NA	IMPDH1	M6
P11047	NA	NA	NA	NA	OCRIPLASMIN	Laminin hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364187	106166	P11047	Laminin subunit gamma-1	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	LAMC1	M6
P07333	NA	NA	NA	NA	SUNITINIB MALATE	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	2006	CHEMBL1844	12840	P07333	Macrophage colony-stimulating factor 1 receptor	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CSF1R	M6
P07333	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	2009	CHEMBL1844	12840	P07333	Macrophage colony-stimulating factor 1 receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	CSF1R	M6
P07333	NA	NA	NA	NA	PEXIDARTINIB	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	2019	CHEMBL1844	12840	P07333	Macrophage colony-stimulating factor 1 receptor	Homo sapiens	D001172: Arthritis, Rheumatoid,D001943: Breast Neoplasms,D005870: Giant Cell Tumors,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D008107: Liver Diseases,D008545: Melanoma,D009369: Neoplasms,D009442: Neurilemmoma,D011471: Prostatic Neoplasms,D013586: Synovitis, Pigmented Villonodular,D015470: Leukemia, Myeloid, Acute,D046152: Gastrointestinal Stromal Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	CSF1R	M6
P07333	NA	NA	NA	NA	PEXIDARTINIB HYDROCHLORIDE	Macrophage colony stimulating factor receptor inhibitor	INHIBITOR	2019	CHEMBL1844	12840	P07333	Macrophage colony-stimulating factor 1 receptor	Homo sapiens	D000070779: Giant Cell Tumor of Tendon Sheath	CSF1R	M6
P35462	NA	NA	NA	NA	HALOPERIDOL	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	DRD3	M6
P35462	NA	NA	NA	NA	THIORIDAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	DRD3	M6
P35462	NA	NA	NA	NA	CHLORPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	DRD3	M6
P35462	NA	NA	NA	NA	OLANZAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1996	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	DRD3	M6
P35462	NA	NA	NA	NA	LOXAPINE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	DRD3	M6
P35462	NA	NA	NA	NA	CHLORPROTHIXENE	Dopamine D3 receptor antagonist	ANTAGONIST	1967	CHEMBL234	130	P35462	D(3) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M6
P35462	NA	NA	NA	NA	LEVODOPA	Dopamine D3 receptor agonist	AGONIST	1970	CHEMBL234	130	P35462	D(3) dopamine receptor	Homo sapiens	D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D001037: Aphasia,D001249: Asthma,D001930: Brain Injuries,D002659: Child Development Disorders, Pervasive,D005879: Tourette Syndrome,D007024: Hypotension, Orthostatic,D008268: Macular Degeneration,D010146: Pain,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D012174: Retinitis Pigmentosa,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D016115: Albinism, Oculocutaneous,D017204: Angelman Syndrome,D019970: Cocaine-Related Disorders,D020521: Stroke	DRD3	M6
P35462	NA	NA	NA	NA	DROPERIDOL	D2-like dopamine receptor antagonist	ANTAGONIST	1970	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	DRD3	M6
P35462	NA	NA	NA	NA	AMOXAPINE	Dopamine receptor antagonist	ANTAGONIST	1980	CHEMBL2096905	104842	P35462	D(3) dopamine receptor	Homo sapiens	D003866: Depressive Disorder	DRD3	M6
P35462	NA	NA	NA	NA	PERGOLIDE MESYLATE	Dopamine receptor agonist	AGONIST	1988	CHEMBL2096905	104842	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M6
P35462	NA	NA	NA	NA	ROTIGOTINE	D2-like dopamine receptor agonist	AGONIST	2007	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000544: Alzheimer Disease,D005356: Fibromyalgia,D010300: Parkinson Disease,D012148: Restless Legs Syndrome,D020521: Stroke	DRD3	M6
P35462	NA	NA	NA	NA	PIMOZIDE	Dopamine receptor antagonist	ANTAGONIST	1984	CHEMBL2096905	104842	P35462	D(3) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M6
P35462	NA	NA	NA	NA	AMISULPRIDE	Dopamine receptors; D2 & D3 antagonist	ANTAGONIST	2020	CHEMBL2095169	104754	P35462	D(3) dopamine receptor	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	DRD3	M6
P35462	NA	NA	NA	NA	APOMORPHINE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	2004	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D009369: Neoplasms,D010024: Osteoporosis,D010300: Parkinson Disease	DRD3	M6
P35462	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1957	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M6
P35462	NA	NA	NA	NA	LEVOMEPROMAZINE	D2-like dopamine receptor antagonist	ANTAGONIST	1982	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M6
P35462	NA	NA	NA	NA	ROPINIROLE HYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D010300: Parkinson Disease	DRD3	M6
P35462	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1956	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M6
P35462	NA	NA	NA	NA	BROMOCRIPTINE MESYLATE	D2-like dopamine receptor agonist	AGONIST	1978	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000172: Acromegaly,D003924: Diabetes Mellitus, Type 2,D006966: Hyperprolactinemia,D007006: Hypogonadism,D007246: Infertility,D010300: Parkinson Disease	DRD3	M6
P35462	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1962	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M6
P35462	NA	NA	NA	NA	HALOPERIDOL DECANOATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1986	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M6
P35462	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1976	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M6
P35462	NA	NA	NA	NA	LOXAPINE SUCCINATE	D2-like dopamine receptor antagonist	ANTAGONIST	1975	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M6
P35462	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	D2-like dopamine receptor antagonist	ANTAGONIST	1959	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	NA	DRD3	M6
P35462	NA	NA	NA	NA	CARIPRAZINE HYDROCHLORIDE	Dopamine D3 receptor modulator	MODULATOR	2015	CHEMBL234	130	P35462	D(3) dopamine receptor	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	DRD3	M6
P35462	NA	NA	NA	NA	ERGOLOID MESYLATES	Dopamine receptor agonist	AGONIST	1953	CHEMBL2096905	104842	P35462	D(3) dopamine receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	DRD3	M6
P35462	NA	NA	NA	NA	PRAMIPEXOLE DIHYDROCHLORIDE	D2-like dopamine receptor agonist	AGONIST	1997	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D010300: Parkinson Disease	DRD3	M6
P35462	NA	NA	NA	NA	OLANZAPINE PAMOATE	D2-like dopamine receptor antagonist	ANTAGONIST	2009	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D012559: Schizophrenia	DRD3	M6
P35462	NA	NA	NA	NA	HALOPERIDOL LACTATE	D2-like dopamine receptor inverse agonist	INVERSE AGONIST	1967	CHEMBL2331075	105671	P35462	D(3) dopamine receptor	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	DRD3	M6
P08581	NA	NA	NA	NA	CRIZOTINIB	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000080443: Diffuse Intrinsic Pontine Glioma,D000230: Adenocarcinoma,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006104: Granuloma, Plasma Cell,D007674: Kidney Diseases,D008175: Lung Neoplasms,D009101: Multiple Myeloma,D009369: Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016518: Neurofibromatosis 2,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D064129: Prostatic Neoplasms, Castration-Resistant	MET	M6
P08581	NA	NA	NA	NA	CABOZANTINIB S-MALATE	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D001254: Astrocytoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005909: Glioblastoma,D005910: Glioma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010673: Pheochromocytoma,D013964: Thyroid Neoplasms,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018288: Carcinoma, Small Cell,D018316: Gliosarcoma	MET	M6
P08581	NA	NA	NA	NA	CAPMATINIB	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008107: Liver Diseases,D008175: Lung Neoplasms,D008545: Melanoma,D009369: Neoplasms,D012509: Sarcoma	MET	M6
P08581	NA	NA	NA	NA	TEPOTINIB	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D006528: Carcinoma, Hepatocellular,D008107: Liver Diseases,D009369: Neoplasms,D015179: Colorectal Neoplasms	MET	M6
P08581	NA	NA	NA	NA	CAPMATINIB HYDROCHLORIDE	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2020	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	MET	M6
P08581	NA	NA	NA	NA	TEPOTINIB HYDROCHLORIDE	Hepatocyte growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL3717	11451	P08581	Hepatocyte growth factor receptor	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D009369: Neoplasms	MET	M6
Q8TDN2	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q8TDN2	Potassium voltage-gated channel subfamily V member 2	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNV2	M6
Q8TDN2	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TDN2	Potassium voltage-gated channel subfamily V member 2	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNV2	M6
Q8TDN2	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q8TDN2	Potassium voltage-gated channel subfamily V member 2	Homo sapiens	NA	KCNV2	M6
Q8TDN2	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q8TDN2	Potassium voltage-gated channel subfamily V member 2	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNV2	M6
Q9Y6M9	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	Q9Y6M9	NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFB9	M6
Q92731	NA	NA	NA	NA	RALOXIFENE HYDROCHLORIDE	Estrogen receptor beta modulator	MODULATOR	1997	CHEMBL242	174	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D011471: Prostatic Neoplasms	ESR2	M6
Q92731	NA	NA	NA	NA	FULVESTRANT	Estrogen receptor antagonist	ANTAGONIST	2002	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005359: Fibrous Dysplasia, Polyostotic,D005833: Genital Neoplasms, Female,D006976: Hypertension, Pulmonary,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018203: Sarcoma, Endometrial Stromal,D018275: Carcinoma, Lobular,D044584: Carcinoma, Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	ESR2	M6
Q92731	NA	NA	NA	NA	DIETHYLSTILBESTROL DIPHOSPHATE	Estrogen receptor agonist	AGONIST	1982	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D009369: Neoplasms	ESR2	M6
Q92731	NA	NA	NA	NA	TOREMIFENE CITRATE	Estrogen receptor modulator	MODULATOR	1997	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D010024: Osteoporosis,D050723: Fractures, Bone	ESR2	M6
Q92731	NA	NA	NA	NA	ESTRAMUSTINE PHOSPHATE SODIUM	Estrogen receptor beta modulator	MODULATOR	1981	CHEMBL242	174	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D007680: Kidney Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ESR2	M6
Q92731	NA	NA	NA	NA	CHLOROTRIANISENE	Estrogen receptor beta modulator	MODULATOR	1982	CHEMBL242	174	Q92731	Estrogen receptor beta	Homo sapiens	D006528: Carcinoma, Hepatocellular,D008113: Liver Neoplasms	ESR2	M6
Q92731	NA	NA	NA	NA	QUINESTROL	Estrogen receptor agonist	AGONIST	1982	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	NA	ESR2	M6
Q92731	NA	NA	NA	NA	ESTROGENS, CONJUGATED SYNTHETIC A	Estrogen receptor agonist	AGONIST	1999	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	NA	ESR2	M6
Q92731	NA	NA	NA	NA	ESTROGENS, ESTERIFIED	Estrogen receptor agonist	AGONIST	1977	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D008593: Menopause	ESR2	M6
Q92731	NA	NA	NA	NA	SYNTHETIC CONJUGATED ESTROGENS, B	Estrogen receptor agonist	AGONIST	2004	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D008593: Menopause	ESR2	M6
Q92731	NA	NA	NA	NA	ESTROGENS, CONJUGATED	Estrogen receptor agonist	AGONIST	1942	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D000544: Alzheimer Disease,D000789: Angina, Unstable,D000856: Anorexia Nervosa,D001851: Bone Diseases, Metabolic,D001930: Brain Injuries,D001943: Breast Neoplasms,D003110: Colonic Neoplasms,D003327: Coronary Disease,D003920: Diabetes Mellitus,D004714: Endometrial Hyperplasia,D006937: Hypercholesterolemia,D006973: Hypertension,D008180: Lupus Erythematosus, Systemic,D008569: Memory Disorders,D008593: Menopause,D009203: Myocardial Infarction,D010024: Osteoporosis,D011471: Prostatic Neoplasms,D012769: Shock,D013927: Thrombosis,D014424: Turner Syndrome,D015427: Reperfusion Injury,D015663: Osteoporosis, Postmenopausal,D016649: Primary Ovarian Insufficiency,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019584: Hot Flashes,D020521: Stroke,D053201: Urinary Bladder, Overactive,D064129: Prostatic Neoplasms, Castration-Resistant	ESR2	M6
Q92731	NA	NA	NA	NA	ESTETROL	Estrogen receptor agonist	AGONIST	2021	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001943: Breast Neoplasms,D008593: Menopause,D011247: Pregnancy,D011471: Prostatic Neoplasms,D045169: Severe Acute Respiratory Syndrome	ESR2	M6
Q92731	NA	NA	NA	NA	OSPEMIFENE	Estrogen receptor modulator	MODULATOR	2013	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D001284: Atrophy,D004414: Dyspareunia,D010145: Paget Disease, Extramammary	ESR2	M6
Q92731	NA	NA	NA	NA	BAZEDOXIFENE ACETATE	Estrogen receptor modulator	MODULATOR	2009	CHEMBL2093866	104682	Q92731	Estrogen receptor beta	Homo sapiens	D008593: Menopause,D010024: Osteoporosis,D015663: Osteoporosis, Postmenopausal,D020529: Multiple Sclerosis, Relapsing-Remitting	ESR2	M6
P48443	NA	NA	NA	NA	ETRETINATE	Retinoid receptor agonist	AGONIST	1986	CHEMBL2363071	105766	P48443	Retinoic acid receptor RXR-gamma	Homo sapiens	D011565: Psoriasis	RXRG	M6
P48443	NA	NA	NA	NA	ALITRETINOIN	Retinoid receptor agonist	AGONIST	1999	CHEMBL2363071	105766	P48443	Retinoic acid receptor RXR-gamma	Homo sapiens	D001943: Breast Neoplasms,D004485: Eczema,D006229: Hand Dermatoses,D008010: Lichen Planus,D008178: Lupus Erythematosus, Cutaneous,D009369: Neoplasms,D011565: Psoriasis	RXRG	M6
P48443	NA	NA	NA	NA	BEXAROTENE	Retinoid X receptor agonist	AGONIST	1999	CHEMBL2363070	105765	P48443	Retinoic acid receptor RXR-gamma	Homo sapiens	D000506: Alopecia Areata,D000544: Alzheimer Disease,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010267: Parapsoriasis,D011565: Psoriasis,D011618: Psychotic Disorders,D012559: Schizophrenia,D012751: Sezary Syndrome,D013964: Thyroid Neoplasms,D015470: Leukemia, Myeloid, Acute,D016410: Lymphoma, T-Cell, Cutaneous,D017728: Lymphoma, Large-Cell, Anaplastic,D047748: Pituitary ACTH Hypersecretion	RXRG	M6
P48443	NA	NA	NA	NA	ACITRETIN	Retinoid receptor agonist	AGONIST	1996	CHEMBL2363071	105766	P48443	Retinoic acid receptor RXR-gamma	Homo sapiens	D000544: Alzheimer Disease,D003872: Dermatitis,D008545: Melanoma,D011565: Psoriasis,D015658: HIV Infections	RXRG	M6
Q15413	NA	NA	NA	NA	DANTROLENE SODIUM	Ryanodine receptor 3 antagonist	ANTAGONIST	1974	CHEMBL2062	223	Q15413	Ryanodine receptor 3	Homo sapiens	D014929: Wolfram Syndrome,D018883: Heat Stroke	RYR3	M6
P10828	NA	NA	NA	NA	DEXTROTHYROXINE	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D002318: Cardiovascular Diseases,D004314: Down Syndrome	THRB	M6
P10828	NA	NA	NA	NA	LIOTHYRONINE	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D003866: Depressive Disorder,D007037: Hypothyroidism,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	THRB	M6
P10828	NA	NA	NA	NA	LIOTHYRONINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1956	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D006258: Head and Neck Neoplasms,D006330: Heart Defects, Congenital,D007037: Hypothyroidism,D009103: Multiple Sclerosis,D013964: Thyroid Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D065630: Hernias, Diaphragmatic, Congenital	THRB	M6
P10828	NA	NA	NA	NA	LEVOTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	2000	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D001714: Bipolar Disorder,D003409: Congenital Hypothyroidism,D007037: Hypothyroidism,D010146: Pain,D013964: Thyroid Neoplasms	THRB	M6
P10828	NA	NA	NA	NA	DEXTROTHYROXINE SODIUM	Thyroid hormone receptor agonist	AGONIST	1967	CHEMBL2111462	104987	P10828	Thyroid hormone receptor beta	Homo sapiens	D009203: Myocardial Infarction,D017202: Myocardial Ischemia	THRB	M6
P50993	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A2	M6
P50993	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A2	M6
P50993	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A2	M6
P50993	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P50993	Sodium/potassium-transporting ATPase subunit alpha-2	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A2	M6
O95180	NA	NA	NA	NA	TRIMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1946	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D004827: Epilepsy	CACNA1H	M6
O95180	NA	NA	NA	NA	ETHOSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1960	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D003866: Depressive Disorder,D004827: Epilepsy,D004832: Epilepsy, Absence,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome	CACNA1H	M6
O95180	NA	NA	NA	NA	METHSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1957	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D004827: Epilepsy	CACNA1H	M6
O95180	NA	NA	NA	NA	PHENSUXIMIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1982	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D004827: Epilepsy	CACNA1H	M6
O95180	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1H	M6
O95180	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1H	M6
O95180	NA	NA	NA	NA	PARAMETHADIONE	Voltage-gated T-type calcium channel blocker	BLOCKER	1949	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D004827: Epilepsy	CACNA1H	M6
O95180	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1H	M6
O95180	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	NA	CACNA1H	M6
O95180	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	NA	CACNA1H	M6
O95180	NA	NA	NA	NA	MIBEFRADIL DIHYDROCHLORIDE	Voltage-gated T-type calcium channel blocker	BLOCKER	1997	CHEMBL2362995	105707	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	NA	CACNA1H	M6
O95180	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O95180	Voltage-dependent T-type calcium channel subunit alpha-1H	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1H	M6
P62937	NA	NA	NA	NA	CYCLOSPORINE	Cyclophilin A modulator	MODULATOR	1983	CHEMBL1949	180	P62937	Peptidyl-prolyl cis-trans isomerase A	Homo sapiens	D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001228: Aspergillosis,D001528: Behcet Syndrome,D001930: Brain Injuries,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D003233: Conjunctivitis, Allergic,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004062: DiGeorge Syndrome,D004485: Eczema,D004694: Endocardial Cushion Defects,D004820: Epidermolysis Bullosa,D005128: Eye Diseases,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005901: Glaucoma,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006105: Granulomatous Disease, Chronic,D006323: Heart Arrest,D006331: Heart Diseases,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007239: Infections,D007249: Inflammation,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007766: Lacrimal Apparatus Diseases,D007918: Leprosy,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008171: Lung Diseases,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D009083: Mucopolysaccharidoses,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009203: Myocardial Infarction,D009205: Myocarditis,D009220: Myositis,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009503: Neutropenia,D010013: Osteogenesis Imperfecta,D010051: Ovarian Neoplasms,D010518: Periodontitis,D011565: Psoriasis,D011625: Pterygium,D011697: Purpura, Thrombotic Thrombocytopenic,D012010: Red-Cell Aplasia, Pure,D012175: Retinoblastoma,D012509: Sarcoma,D012751: Sezary Syndrome,D012878: Skin Neoplasms,D013262: Stevens-Johnson Syndrome,D014581: Urticaria,D014605: Uveitis,D015179: Colorectal Neoplasms,D015352: Dry Eye Syndromes,D015427: Reperfusion Injury,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015493: Paraparesis, Tropical Spastic,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016483: Lymphoma, AIDS-Related,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017544: Aortic Aneurysm, Abdominal,D018302: Neoplasms, Neuroepithelial,D018357: Respiratory Syncytial Virus Infections,D018746: Systemic Inflammatory Response Syndrome,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D019693: Hepatitis, Autoimmune,D019698: Hepatitis C, Chronic,D020522: Lymphoma, Mantle-Cell,D029242: Optic Atrophy, Hereditary, Leber,D029424: Pulmonary Disease, Chronic Obstructive,D031300: Retinal Vasculitis,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054179: Angioedemas, Hereditary,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054556: Venous Thromboembolism,D058186: Acute Kidney Injury,D064129: Prostatic Neoplasms, Castration-Resistant	PPIA	M6
P08922	NA	NA	NA	NA	ENTRECTINIB	Proto-oncogene tyrosine-protein kinase ROS inhibitor	INHIBITOR	2019	CHEMBL5568	101019	P08922	Proto-oncogene tyrosine-protein kinase ROS	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D005910: Glioma,D008545: Melanoma,D009369: Neoplasms,D018275: Carcinoma, Lobular	ROS1	M6
P20701	NA	NA	NA	NA	EFALIZUMAB	Integrin alpha-L/beta-2 (LFA-1) inhibitor	INHIBITOR	2003	CHEMBL2364172	106151	P20701	Integrin alpha-L	Homo sapiens	D000505: Alopecia,D001172: Arthritis, Rheumatoid,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D007154: Immune System Diseases,D008268: Macular Degeneration,D011565: Psoriasis,D012859: Sjogren's Syndrome,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa,D051436: Renal Insufficiency, Chronic	ITGAL	M6
P20701	NA	NA	NA	NA	LIFITEGRAST	Integrin alpha-L/beta-2 (LFA-1) antagonist	ANTAGONIST	2016	CHEMBL2364172	106151	P20701	Integrin alpha-L	Homo sapiens	D003233: Conjunctivitis, Allergic,D005128: Eye Diseases,D006086: Graft vs Host Disease,D015352: Dry Eye Syndromes	ITGAL	M6
Q8WUI4	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q8WUI4	Histone deacetylase 7	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC7	M6
Q8WUI4	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q8WUI4	Histone deacetylase 7	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC7	M6
Q8WUI4	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q8WUI4	Histone deacetylase 7	Homo sapiens	D009101: Multiple Myeloma	HDAC7	M6
P07949	NA	NA	NA	NA	VANDETANIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2011	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	RET	M6
P07949	NA	NA	NA	NA	SUNITINIB MALATE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2006	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	RET	M6
P07949	NA	NA	NA	NA	SORAFENIB TOSYLATE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2005	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	RET	M6
P07949	NA	NA	NA	NA	REGORAFENIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2012	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	RET	M6
P07949	NA	NA	NA	NA	ALECTINIB HYDROCHLORIDE	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2015	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	RET	M6
P07949	NA	NA	NA	NA	SELPERCATINIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2020	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D013964: Thyroid Neoplasms,D018276: Carcinoma, Medullary	RET	M6
P07949	NA	NA	NA	NA	PRALSETINIB	Tyrosine-protein kinase receptor RET inhibitor	INHIBITOR	2020	CHEMBL2041	100079	P07949	Proto-oncogene tyrosine-protein kinase receptor Ret	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D013964: Thyroid Neoplasms	RET	M6
P11362	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	2009	CHEMBL3650	10266	P11362	Fibroblast growth factor receptor 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	FGFR1	M6
P11362	NA	NA	NA	NA	REGORAFENIB	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	2012	CHEMBL3650	10266	P11362	Fibroblast growth factor receptor 1	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FGFR1	M6
P11362	NA	NA	NA	NA	NINTEDANIB ESYLATE	Fibroblast growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095217	104793	P11362	Fibroblast growth factor receptor 1	Homo sapiens	NA	FGFR1	M6
P11362	NA	NA	NA	NA	ERDAFITINIB	Fibroblast growth factor receptor inhibitor	INHIBITOR	2019	CHEMBL2095217	104793	P11362	Fibroblast growth factor receptor 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D006528: Carcinoma, Hepatocellular,D008107: Liver Diseases,D008223: Lymphoma,D009101: Multiple Myeloma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D014565: Urogenital Neoplasms	FGFR1	M6
P11362	NA	NA	NA	NA	PEMIGATINIB	Fibroblast growth factor receptor 1 inhibitor	INHIBITOR	2020	CHEMBL3650	10266	P11362	Fibroblast growth factor receptor 1	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D014565: Urogenital Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma	FGFR1	M6
P16109	NA	NA	NA	NA	CRIZANLIZUMAB	P-selectin blocker	BLOCKER	2019	CHEMBL5378	12723	P16109	P-selectin	Homo sapiens	D000755: Anemia, Sickle Cell,D011317: Priapism,D045169: Severe Acute Respiratory Syndrome,D055728: Primary Myelofibrosis	SELP	M6
P49005	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2	M6
P49005	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLD2	M6
P49005	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLD2	M6
P49005	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2	M6
Q9BQ31	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNS3	M6
Q9BQ31	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNS3	M6
Q9BQ31	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	NA	KCNS3	M6
Q9BQ31	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9BQ31	Potassium voltage-gated channel subfamily S member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNS3	M6
P35968	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M6
P35968	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M6
P35968	NA	NA	NA	NA	MIDOSTAURIN	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	2017	CHEMBL279	10980	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	KDR	M6
P35968	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M6
P35968	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M6
P35968	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M6
P35968	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M6
P35968	NA	NA	NA	NA	RAMUCIRUMAB	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	2014	CHEMBL279	10980	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D000230: Adenocarcinoma,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005706: Gallbladder Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013945: Thymoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D020522: Lymphoma, Mantle-Cell,D058405: Desmoplastic Small Round Cell Tumor,D064129: Prostatic Neoplasms, Castration-Resistant	KDR	M6
P35968	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	KDR	M6
P35968	NA	NA	NA	NA	CABOZANTINIB S-MALATE	Vascular endothelial growth factor receptor 2 inhibitor	INHIBITOR	2012	CHEMBL279	10980	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D001254: Astrocytoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005909: Glioblastoma,D005910: Glioma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010673: Pheochromocytoma,D013964: Thyroid Neoplasms,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018288: Carcinoma, Small Cell,D018316: Gliosarcoma	KDR	M6
P35968	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	KDR	M6
P35968	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P35968	Vascular endothelial growth factor receptor 2	Homo sapiens	NA	KDR	M6
P49642	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	P49642	DNA primase small subunit	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	PRIM1	M6
P49642	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	P49642	DNA primase small subunit	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PRIM1	M6
P49642	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	P49642	DNA primase small subunit	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRIM1	M6
P49642	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	P49642	DNA primase small subunit	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	PRIM1	M6
P07550	NA	NA	NA	NA	TIMOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB2	M6
P07550	NA	NA	NA	NA	PINDOLOL	Beta-2 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB2	M6
P07550	NA	NA	NA	NA	NADOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB2	M6
P07550	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB2	M6
P07550	NA	NA	NA	NA	ALBUTEROL	Beta-2 adrenergic receptor agonist	AGONIST	1981	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D001988: Bronchiolitis,D003371: Cough,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D004402: Dysautonomia, Familial,D006009: Glycogen Storage Disease Type II,D006255: Rhinitis, Allergic, Seasonal,D006333: Heart Failure,D006967: Hypersensitivity,D006976: Hypertension, Pulmonary,D008171: Lung Diseases,D008173: Lung Diseases, Obstructive,D008569: Memory Disorders,D011654: Pulmonary Edema,D012131: Respiratory Insufficiency,D013119: Spinal Cord Injuries,D013224: Status Asthmaticus,D018192: Lymphangioleiomyomatosis,D020294: Myasthenic Syndromes, Congenital,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D062025: Organophosphate Poisoning,D065627: Familial Primary Pulmonary Hypertension	ADRB2	M6
P07550	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB2	M6
P07550	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB2	M6
P07550	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M6
P07550	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	SALMETEROL XINAFOATE	Beta-2 adrenergic receptor agonist	AGONIST	1994	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001989: Bronchiolitis Obliterans,D004646: Emphysema,D009765: Obesity,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M6
P07550	NA	NA	NA	NA	VILANTEROL TRIFENATATE	Beta-2 adrenergic receptor agonist	AGONIST	2013	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M6
P07550	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB2	M6
P07550	NA	NA	NA	NA	BITOLTEROL MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB2	M6
P07550	NA	NA	NA	NA	PIRBUTEROL ACETATE	Beta-2 adrenergic receptor agonist	AGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M6
P07550	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB2	M6
P07550	NA	NA	NA	NA	PROTOKYLOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	ISOETHARINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB2	M6
P07550	NA	NA	NA	NA	LEVALBUTEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1999	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001986: Bronchial Spasm	ADRB2	M6
P07550	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M6
P07550	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB2	M6
P07550	NA	NA	NA	NA	ISOETHARINE MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB2	M6
P07550	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB2	M6
P07550	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1990	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB2	M6
P07550	NA	NA	NA	NA	TERBUTALINE SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1974	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M6
P07550	NA	NA	NA	NA	RITODRINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1991	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB2	M6
P07550	NA	NA	NA	NA	ALBUTEROL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D002318: Cardiovascular Diseases,D008171: Lung Diseases,D012128: Respiratory Distress Syndrome,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M6
P07550	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M6
P07550	NA	NA	NA	NA	METAPROTERENOL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1973	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D019966: Substance-Related Disorders	ADRB2	M6
P07550	NA	NA	NA	NA	INDACATEROL MALEATE	Beta-2 adrenergic receptor agonist	AGONIST	2011	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M6
P07550	NA	NA	NA	NA	ARFORMOTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2006	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001991: Bronchitis,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M6
P07550	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB2	M6
P07550	NA	NA	NA	NA	OLODATEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	2014	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M6
P07550	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M6
P07550	NA	NA	NA	NA	LEVALBUTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2005	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm	ADRB2	M6
P07550	NA	NA	NA	NA	FORMOTEROL FUMARATE	Beta-2 adrenergic receptor agonist	AGONIST	2001	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm,D001987: Bronchiectasis,D001989: Bronchiolitis Obliterans,D001991: Bronchitis,D004646: Emphysema,D006967: Hypersensitivity,D008175: Lung Neoplasms,D012128: Respiratory Distress Syndrome,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D045169: Severe Acute Respiratory Syndrome	ADRB2	M6
P54756	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54756	Ephrin type-A receptor 5	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA5	M6
P18545	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	P18545	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6G	M6
P18545	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	P18545	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6G	M6
P23975	NA	NA	NA	NA	AMPHETAMINE	Norepinephrine transporter releasing agent	RELEASING AGENT	1955	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D019970: Cocaine-Related Disorders	SLC6A2	M6
P23975	NA	NA	NA	NA	AMPHETAMINE SULFATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1960	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy,D019970: Cocaine-Related Disorders	SLC6A2	M6
P23975	NA	NA	NA	NA	DEXTROAMPHETAMINE	Norepinephrine transporter releasing agent	RELEASING AGENT	1955	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001714: Bipolar Disorder,D005910: Glioma,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D012559: Schizophrenia,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020521: Stroke	SLC6A2	M6
P23975	NA	NA	NA	NA	MAZINDOL	Monoamine transporter inhibitor	INHIBITOR	1973	CHEMBL2363064	105759	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009765: Obesity,D019970: Cocaine-Related Disorders	SLC6A2	M6
P23975	NA	NA	NA	NA	METHYLPHENIDATE	Norepinephrine transporter inhibitor	INHIBITOR	1955	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001289: Attention Deficit Disorder with Hyperactivity,D001714: Bipolar Disorder,D001930: Brain Injuries,D001932: Brain Neoplasms,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005221: Fatigue,D007024: Hypotension, Orthostatic,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D010300: Parkinson Disease,D011183: Postoperative Complications,D011471: Prostatic Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D019337: Hematologic Neoplasms,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D064129: Prostatic Neoplasms, Castration-Resistant	SLC6A2	M6
P23975	NA	NA	NA	NA	DEXMETHYLPHENIDATE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2001	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	SLC6A2	M6
P23975	NA	NA	NA	NA	AMOXAPINE	Norepinephrine transporter inhibitor	INHIBITOR	1980	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A2	M6
P23975	NA	NA	NA	NA	DESVENLAFAXINE	Norepinephrine transporter inhibitor	INHIBITOR	2008	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D019698: Hepatitis C, Chronic	SLC6A2	M6
P23975	NA	NA	NA	NA	GUANETHIDINE MONOSULFATE	Norepinephrine transporter substrate	SUBSTRATE	1960	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	PHENTERMINE	Norepinephrine transporter releasing agent	RELEASING AGENT	1959	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003920: Diabetes Mellitus,D007674: Kidney Diseases,D008107: Liver Diseases,D009765: Obesity,D009767: Obesity, Morbid,D019966: Substance-Related Disorders,D052018: Bulimia Nervosa	SLC6A2	M6
P23975	NA	NA	NA	NA	IMIPRAMINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1959	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003866: Depressive Disorder	SLC6A2	M6
P23975	NA	NA	NA	NA	DIETHYLPROPION HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1959	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	DESIPRAMINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1964	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001416: Back Pain,D003866: Depressive Disorder,D055752: Small Cell Lung Carcinoma	SLC6A2	M6
P23975	NA	NA	NA	NA	BUPROPION HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1985	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006527: Hepatolenticular Degeneration,D008175: Lung Neoplasms,D009765: Obesity,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D016574: Seasonal Affective Disorder,D019964: Mood Disorders	SLC6A2	M6
P23975	NA	NA	NA	NA	ATOMOXETINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2002	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000544: Alzheimer Disease,D001289: Attention Deficit Disorder with Hyperactivity,D019958: Attention Deficit and Disruptive Behavior Disorders,D019969: Amphetamine-Related Disorders	SLC6A2	M6
P23975	NA	NA	NA	NA	METHYLPHENIDATE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1955	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D003866: Depressive Disorder,D005221: Fatigue,D009369: Neoplasms,D012893: Sleep Wake Disorders,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	SLC6A2	M6
P23975	NA	NA	NA	NA	BRETYLIUM TOSYLATE	Norepinephrine transporter substrate	SUBSTRATE	1986	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001145: Arrhythmias, Cardiac	SLC6A2	M6
P23975	NA	NA	NA	NA	DULOXETINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2004	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001007: Anxiety,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D005356: Fibromyalgia,D009103: Multiple Sclerosis,D010003: Osteoarthritis,D010146: Pain,D013313: Stress Disorders, Post-Traumatic,D014549: Urinary Incontinence,D015179: Colorectal Neoplasms	SLC6A2	M6
P23975	NA	NA	NA	NA	PROTRIPTYLINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1967	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	AMPHETAMINE ASPARTATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1996	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	SLC6A2	M6
P23975	NA	NA	NA	NA	AMPHETAMINE ADIPATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1975	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	ORPHENADRINE CITRATE	Norepinephrine transporter inhibitor	INHIBITOR	1959	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D010146: Pain	SLC6A2	M6
P23975	NA	NA	NA	NA	PHENMETRAZINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1982	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	NEFAZODONE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1994	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	PHENYLPROPANOLAMINE HYDROCHLORIDE	Norepinephrine transporter releasing agent	RELEASING AGENT	1958	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	PSEUDOEPHEDRINE HYDROCHLORIDE	Norepinephrine transporter releasing agent	RELEASING AGENT	1975	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003139: Common Cold,D003371: Cough,D006255: Rhinitis, Allergic, Seasonal,D006967: Hypersensitivity,D007251: Influenza, Human,D008881: Migraine Disorders,D010146: Pain,D012852: Sinusitis	SLC6A2	M6
P23975	NA	NA	NA	NA	DEXTROAMPHETAMINE ADIPATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1975	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	PHENTERMINE HYDROCHLORIDE	Norepinephrine transporter releasing agent	RELEASING AGENT	1973	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D009765: Obesity	SLC6A2	M6
P23975	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Norepinephrine transporter inhibitor	INHIBITOR	1979	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	METHAMPHETAMINE HYDROCHLORIDE	Monoamine transporter inhibitor	INHIBITOR	1943	CHEMBL2363064	105759	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	AMITRIPTYLINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1961	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003866: Depressive Disorder,D010523: Peripheral Nervous System Diseases,D011537: Pruritus	SLC6A2	M6
P23975	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1957	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D010300: Parkinson Disease	SLC6A2	M6
P23975	NA	NA	NA	NA	VENLAFAXINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1993	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000072861: Phobia, Social,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D008575: Meniere Disease,D009437: Neuralgia,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D011471: Prostatic Neoplasms,D012559: Schizophrenia,D013119: Spinal Cord Injuries,D016584: Panic Disorder,D019547: Neck Pain,D019584: Hot Flashes,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	SLC6A2	M6
P23975	NA	NA	NA	NA	NORTRIPTYLINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1964	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003876: Dermatitis, Atopic,D011565: Psoriasis,D018288: Carcinoma, Small Cell,D018589: Gastroparesis	SLC6A2	M6
P23975	NA	NA	NA	NA	LISDEXAMFETAMINE DIMESYLATE	Norepinephrine transporter releasing agent	RELEASING AGENT	2007	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001068: Feeding and Eating Disorders,D001289: Attention Deficit Disorder with Hyperactivity,D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D009765: Obesity,D012559: Schizophrenia,D052018: Bulimia Nervosa,D056912: Binge-Eating Disorder	SLC6A2	M6
P23975	NA	NA	NA	NA	PHENYLPROPANOLAMINE POLISTIREX	Norepinephrine transporter releasing agent	RELEASING AGENT	1984	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	PSEUDOEPHEDRINE POLISTIREX	Norepinephrine transporter releasing agent	RELEASING AGENT	1987	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	DESVENLAFAXINE SUCCINATE	Norepinephrine transporter inhibitor	INHIBITOR	2008	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D005356: Fibromyalgia,D008593: Menopause,D019584: Hot Flashes	SLC6A2	M6
P23975	NA	NA	NA	NA	BUPROPION HYDROBROMIDE	Norepinephrine transporter inhibitor	INHIBITOR	2008	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder	SLC6A2	M6
P23975	NA	NA	NA	NA	TAPENTADOL HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2008	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D009437: Neuralgia,D010146: Pain,D017116: Low Back Pain,D059350: Chronic Pain,D059787: Acute Pain	SLC6A2	M6
P23975	NA	NA	NA	NA	MAPROTILINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1980	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	NOMIFENSINE MALEATE	Monoamine transporter inhibitor	INHIBITOR	1984	CHEMBL2363064	105759	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	IOBENGUANE I 131	Norepinephrine transporter substrate	SUBSTRATE	2018	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D002276: Carcinoid Tumor,D009447: Neuroblastoma,D010235: Paraganglioma,D010673: Pheochromocytoma	SLC6A2	M6
P23975	NA	NA	NA	NA	DOXEPIN HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	1969	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D010146: Pain,D013280: Stomatitis	SLC6A2	M6
P23975	NA	NA	NA	NA	PHENDIMETRAZINE TARTRATE	Norepinephrine transporter inhibitor	INHIBITOR	1976	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	LEVOMILNACIPRAN HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2013	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D000083242: Ischemic Stroke,D003865: Depressive Disorder, Major	SLC6A2	M6
P23975	NA	NA	NA	NA	VILOXAZINE HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2021	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	SLC6A2	M6
P23975	NA	NA	NA	NA	BETHANIDINE SULFATE	Norepinephrine transporter substrate	SUBSTRATE	1982	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	GUANADREL SULFATE	Norepinephrine transporter substrate	SUBSTRATE	1982	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	BENZPHETAMINE HYDROCHLORIDE	Norepinephrine transporter releasing agent	RELEASING AGENT	1960	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	DEXTROAMPHETAMINE SULFATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1960	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC6A2	M6
P23975	NA	NA	NA	NA	SIBUTRAMINE HYDROCHLORIDE	Monoamine transporter inhibitor	INHIBITOR	1997	CHEMBL2363064	105759	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D009765: Obesity	SLC6A2	M6
P23975	NA	NA	NA	NA	DEXTROAMPHETAMINE SACCHARATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1996	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D009290: Narcolepsy	SLC6A2	M6
P23975	NA	NA	NA	NA	IMIPRAMINE PAMOATE	Norepinephrine transporter inhibitor	INHIBITOR	1973	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	NA	SLC6A2	M6
P23975	NA	NA	NA	NA	PSEUDOEPHEDRINE SULFATE	Norepinephrine transporter releasing agent	RELEASING AGENT	1963	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal	SLC6A2	M6
P23975	NA	NA	NA	NA	DESVENLAFAXINE FUMARATE	Norepinephrine transporter inhibitor	INHIBITOR	2013	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D003865: Depressive Disorder, Major	SLC6A2	M6
P23975	NA	NA	NA	NA	MILNACIPRAN HYDROCHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2009	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001416: Back Pain,D005356: Fibromyalgia	SLC6A2	M6
P23975	NA	NA	NA	NA	SERDEXMETHYLPHENIDATE CHLORIDE	Norepinephrine transporter inhibitor	INHIBITOR	2021	CHEMBL222	100	P23975	Sodium-dependent noradrenaline transporter	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity	SLC6A2	M6
P12268	NA	NA	NA	NA	THIOGUANINE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1966	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001932: Brain Neoplasms,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	IMPDH2	M6
P12268	NA	NA	NA	NA	MYCOPHENOLIC ACID	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	2004	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D009404: Nephrotic Syndrome,D012595: Scleroderma, Systemic,D015352: Dry Eye Syndromes,D015470: Leukemia, Myeloid, Acute,D015867: Uveitis, Intermediate,D051436: Renal Insufficiency, Chronic	IMPDH2	M6
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1995	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	D000081003: Shwachman-Diamond Syndrome,D000690: Amyotrophic Lateral Sclerosis,D000741: Anemia, Aplastic,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001327: Autoimmune Diseases,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002318: Cardiovascular Diseases,D003424: Crohn Disease,D003586: Cytomegalovirus Infections,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D004062: DiGeorge Syndrome,D004820: Epidermolysis Bullosa,D005199: Fanconi Anemia,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006073: Gout,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006331: Heart Diseases,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006519: Hepatitis, Alcoholic,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D006973: Hypertension,D007119: Immunoblastic Lymphadenopathy,D007674: Kidney Diseases,D007680: Kidney Neoplasms,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007946: Leukemia, Mast-Cell,D008072: Hyperlipoproteinemia Type I,D008107: Liver Diseases,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008268: Macular Degeneration,D008545: Melanoma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009157: Myasthenia Gravis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009404: Nephrotic Syndrome,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009472: Neuronal Ceroid-Lipofuscinoses,D010190: Pancreatic Neoplasms,D010390: Pemphigoid, Benign Mucous Membrane,D010391: Pemphigoid, Bullous,D010392: Pemphigus,D011087: Polycythemia Vera,D011128: Polyradiculopathy,D011565: Psoriasis,D011695: Purpura, Schoenlein-Henoch,D012010: Red-Cell Aplasia, Pure,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D012859: Sjogren's Syndrome,D013625: Takayasu Arteritis,D014605: Uveitis,D014657: Vasculitis,D014890: Granulomatosis with Polyangiitis,D014923: Wiskott-Aldrich Syndrome,D015433: Glomerulonephritis, Membranous,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D016553: Purpura, Thrombocytopenic, Idiopathic,D017086: beta-Thalassemia,D017563: Lung Diseases, Interstitial,D017565: Sarcoidosis, Pulmonary,D017728: Lymphoma, Large-Cell, Anaplastic,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018856: Cystitis, Interstitial,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D045743: Scleroderma, Diffuse,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D055953: Microscopic Polyangiitis,D056486: Chemical and Drug Induced Liver Injury,D056648: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis	IMPDH2	M6
P12268	NA	NA	NA	NA	MYCOPHENOLATE MOFETIL HYDROCHLORIDE	Inosine-5'-monophosphate dehydrogenase (IMPDH) inhibitor	INHIBITOR	1998	CHEMBL2111369	105058	P12268	Inosine-5'-monophosphate dehydrogenase 2	Homo sapiens	NA	IMPDH2	M6
O60359	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNG3	M6
O60359	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNG3	M6
O60359	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D002318: Cardiovascular Diseases	CACNG3	M6
O60359	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	NA	CACNG3	M6
O60359	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	NA	CACNG3	M6
O60359	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	O60359	Voltage-dependent calcium channel gamma-3 subunit	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNG3	M6
P23921	NA	NA	NA	NA	HYDROXYUREA	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1967	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D000755: Anemia, Sickle Cell,D002277: Carcinoma,D004938: Esophageal Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006432: Hemochromatosis,D006450: Hemoglobin SC Disease,D006976: Hypertension, Pulmonary,D007822: Laryngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008579: Meningioma,D009062: Mouth Neoplasms,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010255: Paranasal Sinus Neoplasms,D010610: Pharyngeal Neoplasms,D011087: Polycythemia Vera,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D017086: beta-Thalassemia,D018222: Fibromatosis, Aggressive,D018316: Gliosarcoma,D020521: Stroke,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	RRM1	M6
P23921	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1996	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	RRM1	M6
P23921	NA	NA	NA	NA	CLOFARABINE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	2004	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	RRM1	M6
P23921	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	RRM1	M6
P23921	NA	NA	NA	NA	GALLIUM NITRATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P23921	Ribonucleoside-diphosphate reductase large subunit	Homo sapiens	D003550: Cystic Fibrosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009164: Mycobacterium Infections,D009447: Neuroblastoma,D012509: Sarcoma	RRM1	M6
P04035	NA	NA	NA	NA	LOVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1987	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D002537: Intracranial Arteriosclerosis,D002538: Intracranial Arteriovenous Malformations,D005600: Fragile X Syndrome,D006331: Heart Diseases,D006937: Hypercholesterolemia,D007249: Inflammation,D007383: Intermittent Claudication,D007859: Learning Disabilities,D008545: Melanoma,D008659: Metabolic Diseases,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010300: Parkinson Disease,D015470: Leukemia, Myeloid, Acute,D015518: Rett Syndrome,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D017499: Porokeratosis,D019294: Xanthomatosis, Cerebrotendinous,D020521: Stroke,D029424: Pulmonary Disease, Chronic Obstructive,D052439: Lipid Metabolism Disorders,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M6
P04035	NA	NA	NA	NA	PRAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003922: Diabetes Mellitus, Type 1,D006937: Hypercholesterolemia,D006950: Hyperlipidemia, Familial Combined,D007938: Leukemia,D008060: Lipodystrophy,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D015658: HIV Infections	HMGCR	M6
P04035	NA	NA	NA	NA	SIMVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000075222: Essential Hypertension,D000083242: Ischemic Stroke,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002311: Cardiomyopathy, Dilated,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002543: Cerebral Hemorrhage,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003550: Cystic Fibrosis,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D003930: Diabetic Retinopathy,D004827: Epilepsy,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007383: Intermittent Claudication,D007414: Intestinal Neoplasms,D007889: Leiomyoma,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D008881: Migraine Disorders,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009369: Neoplasms,D009634: Noonan Syndrome,D009902: Optic Neuritis,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010195: Pancreatitis,D010300: Parkinson Disease,D010518: Periodontitis,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012772: Shock, Septic,D012852: Sinusitis,D012893: Sleep Wake Disorders,D013274: Stomach Neoplasms,D013345: Subarachnoid Hemorrhage,D014605: Uveitis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015209: Cholangitis, Sclerosing,D015228: Hypertriglyceridemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D015794: Choroideremia,D016540: Smoking Cessation,D017202: Myocardial Ischemia,D018805: Sepsis,D019082: Smith-Lemli-Opitz Syndrome,D019694: Hepatitis B, Chronic,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D020786: Hemangioma, Cavernous, Central Nervous System,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D052016: Mucositis,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M6
P04035	NA	NA	NA	NA	ATORVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	1996	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D000082882: Bicuspid Aortic Valve Disease,D000083242: Ischemic Stroke,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D000787: Angina Pectoris,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002532: Intracranial Aneurysm,D002544: Cerebral Infarction,D003251: Constriction, Pathologic,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003424: Crohn Disease,D003919: Diabetes Insipidus,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004489: Edema, Cardiac,D004827: Epilepsy,D005909: Glioblastoma,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006333: Heart Failure,D006526: Hepatitis C,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006952: Hyperlipoproteinemia Type III,D006953: Hyperlipoproteinemia Type IV,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007251: Influenza, Human,D007674: Kidney Diseases,D007938: Leukemia,D008180: Lupus Erythematosus, Systemic,D008228: Lymphoma, Non-Hodgkin,D008268: Macular Degeneration,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009303: Nasopharyngeal Neoplasms,D009336: Necrosis,D009369: Neoplasms,D010020: Osteonecrosis,D010518: Periodontitis,D011085: Polycystic Ovary Syndrome,D011225: Pre-Eclampsia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012507: Sarcoidosis,D012594: Scleroderma, Localized,D012893: Sleep Wake Disorders,D014376: Tuberculosis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015228: Hypertriglyceridemia,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D056586: Acute Chest Syndrome,D058186: Acute Kidney Injury,D058922: Inflammatory Breast Neoplasms,D060050: Angina, Stable,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	HMGCR	M6
P04035	NA	NA	NA	NA	CERIVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1997	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	NA	HMGCR	M6
P04035	NA	NA	NA	NA	PITAVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2009	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006937: Hypercholesterolemia,D006949: Hyperlipidemias,D050171: Dyslipidemias,D052439: Lipid Metabolism Disorders	HMGCR	M6
P04035	NA	NA	NA	NA	ROSUVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2003	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D015228: Hypertriglyceridemia,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome	HMGCR	M6
P04035	NA	NA	NA	NA	FLUVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1993	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001943: Breast Neoplasms,D006937: Hypercholesterolemia	HMGCR	M6
P04035	NA	NA	NA	NA	PITAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M6
P04035	NA	NA	NA	NA	PITAVASTATIN MAGNESIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M6
Q7Z2W7	NA	NA	NA	NA	MENTHOL	Transient receptor potential cation channel subfamily M member 8 opener	OPENER	2008	CHEMBL1075319	103167	Q7Z2W7	Transient receptor potential cation channel subfamily M member 8	Homo sapiens	D001168: Arthritis,D001416: Back Pain,D002062: Bursitis,D003139: Common Cold,D003371: Cough,D003680: Deglutition Disorders,D003929: Diabetic Neuropathies,D006973: Hypertension,D009120: Muscle Cramp,D010003: Osteoarthritis,D010146: Pain,D010612: Pharyngitis,D013274: Stomach Neoplasms,D014029: Tobacco Use Disorder,D052256: Tendinopathy,D063806: Myalgia	TRPM8	M6
O94806	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	O94806	Serine/threonine-protein kinase D3	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKD3	M6
O43924	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6D	M6
O43924	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6D	M6
P21554	NA	NA	NA	NA	DRONABINOL	Cannabinoid CB1 receptor agonist	AGONIST	1985	CHEMBL218	87	P21554	Cannabinoid receptor 1	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D002189: Marijuana Abuse,D003704: Dementia,D005879: Tourette Syndrome,D007592: Joint Diseases,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009325: Nausea,D010146: Pain,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D014103: Torticollis,D014256: Trichotillomania,D015535: Arthritis, Psoriatic,D015658: HIV Infections,D019966: Substance-Related Disorders,D020181: Sleep Apnea, Obstructive,D020325: Migraine with Aura,D020326: Migraine without Aura,D020329: Essential Tremor,D020370: Osteoarthritis, Knee,D043183: Irritable Bowel Syndrome,D059350: Chronic Pain,D060825: Cognitive Dysfunction	CNR1	M6
P21554	NA	NA	NA	NA	RIMONABANT	Cannabinoid CB1 receptor antagonist	ANTAGONIST	2006	CHEMBL218	87	P21554	Cannabinoid receptor 1	Homo sapiens	D000428: Alcohol Drinking,D001161: Arteriosclerosis,D002189: Marijuana Abuse,D002318: Cardiovascular Diseases,D003324: Coronary Artery Disease,D003924: Diabetes Mellitus, Type 2,D005234: Fatty Liver,D009765: Obesity,D010146: Pain,D011218: Prader-Willi Syndrome,D011236: Prediabetic State,D014029: Tobacco Use Disorder,D015431: Weight Loss,D016540: Smoking Cessation,D024821: Metabolic Syndrome,D052439: Lipid Metabolism Disorders	CNR1	M6
P21554	NA	NA	NA	NA	CANNABIDIOL	Cannabinoid CB1 receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2018	CHEMBL218	87	P21554	Cannabinoid receptor 1	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002189: Marijuana Abuse,D002659: Child Development Disorders, Pervasive,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004831: Epilepsies, Myoclonic,D004832: Epilepsy, Absence,D005234: Fatty Liver,D005356: Fibromyalgia,D005600: Fragile X Syndrome,D006086: Graft vs Host Disease,D006333: Heart Failure,D006816: Huntington Disease,D008175: Lung Neoplasms,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D010300: Parkinson Disease,D010523: Peripheral Nervous System Diseases,D011218: Prader-Willi Syndrome,D011471: Prostatic Neoplasms,D011618: Psychotic Disorders,D011843: Radiculopathy,D012559: Schizophrenia,D012640: Seizures,D013036: Spasms, Infantile,D013226: Status Epilepticus,D013313: Stress Disorders, Post-Traumatic,D013341: Sturge-Weber Syndrome,D014029: Tobacco Use Disorder,D014098: Toothache,D015518: Rett Syndrome,D015535: Arthritis, Psoriatic,D015658: HIV Infections,D018856: Cystitis, Interstitial,D019693: Hepatitis, Autoimmune,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	CNR1	M6
P21554	NA	NA	NA	NA	NABILONE	Cannabinoid CB1 receptor agonist	AGONIST	1985	CHEMBL218	87	P21554	Cannabinoid receptor 1	Homo sapiens	D002189: Marijuana Abuse,D003929: Diabetic Neuropathies,D005356: Fibromyalgia,D009128: Muscle Spasticity,D009325: Nausea,D009437: Neuralgia,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D020250: Postoperative Nausea and Vomiting,D059020: Suicidal Ideation	CNR1	M6
P20309	NA	NA	NA	NA	CARBACHOL	Muscarinic acetylcholine receptor M3 agonist	AGONIST	1972	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D005901: Glaucoma,D011305: Presbyopia	CHRM3	M6
P20309	NA	NA	NA	NA	PILOCARPINE	Muscarinic acetylcholine receptor M3 agonist	AGONIST	1974	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D009798: Ocular Hypertension,D011305: Presbyopia,D014549: Urinary Incontinence,D014987: Xerostomia	CHRM3	M6
P20309	NA	NA	NA	NA	OXYBUTYNIN CHLORIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1975	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D011471: Prostatic Neoplasms,D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM3	M6
P20309	NA	NA	NA	NA	ACETYLCHOLINE CHLORIDE	Muscarinic acetylcholine receptor M3 agonist	AGONIST	1973	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	OXYBUTYNIN	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1975	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D001750: Urinary Bladder, Neurogenic,D006255: Rhinitis, Allergic, Seasonal,D006945: Hyperhidrosis,D010145: Paget Disease, Extramammary,D011115: Polyneuropathies,D011141: Polyuria,D012891: Sleep Apnea Syndromes,D014549: Urinary Incontinence,D020181: Sleep Apnea, Obstructive,D053201: Urinary Bladder, Overactive	CHRM3	M6
P20309	NA	NA	NA	NA	PROPANTHELINE BROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1953	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM3	M6
P20309	NA	NA	NA	NA	ATROPINE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1960	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D001778: Blood Coagulation Disorders,D001919: Bradycardia,D001943: Breast Neoplasms,D004066: Digestive System Diseases,D004393: Dwarfism, Pituitary,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006470: Hemorrhage,D007003: Hypoglycemia,D007021: Hypospadias,D007024: Hypotension, Orthostatic,D007333: Insulin Resistance,D009216: Myopia,D010146: Pain,D011183: Postoperative Complications,D011236: Prediabetic State,D013285: Strabismus,D053717: Pneumonia, Ventilator-Associated,D054971: Orthostatic Intolerance	CHRM3	M6
P20309	NA	NA	NA	NA	ANISOTROPINE METHYLBROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1962	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	UMECLIDINIUM BROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	2013	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D001249: Asthma,D004646: Emphysema,D008173: Lung Diseases, Obstructive,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	CHRM3	M6
P20309	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	1986	CHEMBL2094109	104691	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	MEPENZOLATE BROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1956	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	ACLIDINIUM BROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	2012	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D001986: Bronchial Spasm,D004646: Emphysema,D008173: Lung Diseases, Obstructive,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	CHRM3	M6
P20309	NA	NA	NA	NA	BETHANECHOL CHLORIDE	Muscarinic acetylcholine receptor M3 agonist	AGONIST	1948	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	PILOCARPINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M3 agonist	AGONIST	1984	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D006258: Head and Neck Neoplasms	CHRM3	M6
P20309	NA	NA	NA	NA	ISOPROPAMIDE IODIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1957	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	CYCLOPENTOLATE HYDROCHLORIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1974	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	DICYCLOMINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1950	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	TROPICAMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1960	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D005128: Eye Diseases,D010300: Parkinson Disease,D012798: Sialorrhea	CHRM3	M6
P20309	NA	NA	NA	NA	METHACHOLINE CHLORIDE	Muscarinic acetylcholine receptor M3 agonist	AGONIST	1986	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D001249: Asthma	CHRM3	M6
P20309	NA	NA	NA	NA	TRIDIHEXETHYL CHLORIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1954	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	SOLIFENACIN SUCCINATE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	2004	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D011470: Prostatic Hyperplasia,D053201: Urinary Bladder, Overactive	CHRM3	M6
P20309	NA	NA	NA	NA	DIPHEMANIL METHYLSULFATE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1982	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	OXYPHENCYCLIMINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1982	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	OXYPHENONIUM BROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1982	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	DARIFENACIN HYDROBROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	2004	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	CLIDINIUM BROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1982	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D004066: Digestive System Diseases	CHRM3	M6
P20309	NA	NA	NA	NA	GLYCOPYRROLATE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1961	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D001249: Asthma,D002056: Burns,D003866: Depressive Disorder,D004066: Digestive System Diseases,D006945: Hyperhidrosis,D007674: Kidney Diseases,D008173: Lung Diseases, Obstructive,D012798: Sialorrhea,D029424: Pulmonary Disease, Chronic Obstructive	CHRM3	M6
P20309	NA	NA	NA	NA	FESOTERODINE FUMARATE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	2008	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM3	M6
P20309	NA	NA	NA	NA	METHSCOPOLAMINE BROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1953	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	HEXOCYCLIUM METHYLSULFATE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1982	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	TOLTERODINE TARTRATE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1998	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM3	M6
P20309	NA	NA	NA	NA	IPRATROPIUM BROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1986	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm,D003139: Common Cold,D004402: Dysautonomia, Familial,D004646: Emphysema,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D010300: Parkinson Disease,D012798: Sialorrhea,D015508: Nasal Obstruction,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	CHRM3	M6
P20309	NA	NA	NA	NA	ATROPINE SULFATE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	1960	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal,D009216: Myopia,D010300: Parkinson Disease,D010437: Peptic Ulcer,D011183: Postoperative Complications,D015878: Mydriasis,D062025: Organophosphate Poisoning	CHRM3	M6
P20309	NA	NA	NA	NA	CEVIMELINE HYDROCHLORIDE	Muscarinic acetylcholine receptor M3 agonist	AGONIST	2000	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	NA	CHRM3	M6
P20309	NA	NA	NA	NA	TROSPIUM CHLORIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	2004	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D053201: Urinary Bladder, Overactive	CHRM3	M6
P20309	NA	NA	NA	NA	TIOTROPIUM BROMIDE	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	2004	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm,D003550: Cystic Fibrosis,D004646: Emphysema,D008173: Lung Diseases, Obstructive,D013119: Spinal Cord Injuries,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D051437: Renal Insufficiency	CHRM3	M6
P20309	NA	NA	NA	NA	REVEFENACIN	Muscarinic acetylcholine receptor M3 antagonist	ANTAGONIST	2018	CHEMBL245	219	P20309	Muscarinic acetylcholine receptor M3	Homo sapiens	D007674: Kidney Diseases,D008107: Liver Diseases,D008173: Lung Diseases, Obstructive,D029424: Pulmonary Disease, Chronic Obstructive	CHRM3	M6
Q02641	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q02641	Voltage-dependent L-type calcium channel subunit beta-1	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNB1	M6
Q02641	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q02641	Voltage-dependent L-type calcium channel subunit beta-1	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNB1	M6
Q02641	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q02641	Voltage-dependent L-type calcium channel subunit beta-1	Homo sapiens	D002318: Cardiovascular Diseases	CACNB1	M6
Q02641	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q02641	Voltage-dependent L-type calcium channel subunit beta-1	Homo sapiens	NA	CACNB1	M6
Q02641	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q02641	Voltage-dependent L-type calcium channel subunit beta-1	Homo sapiens	NA	CACNB1	M6
Q02641	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q02641	Voltage-dependent L-type calcium channel subunit beta-1	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNB1	M6
Q15842	NA	NA	NA	NA	DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 8 opener	OPENER	1973	CHEMBL4770	10891	Q15842	ATP-sensitive inward rectifier potassium channel 8	Homo sapiens	D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006946: Hyperinsulinism,D006973: Hypertension,D007003: Hypoglycemia,D009765: Obesity	KCNJ8	M6
P28072	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB6	M6
P28072	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB6	M6
P28072	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P28072	Proteasome subunit beta type-6	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB6	M6
Q9Y6F1	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP3	M6
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP3	M6
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP3	M6
Q9BQE3	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBA1C	M6
Q9BQE3	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBA1C	M6
P04626	NA	NA	NA	NA	VANDETANIB	Epidermal growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2363049	105744	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M6
P04626	NA	NA	NA	NA	NERATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005909: Glioblastoma,D006394: Hemangiosarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M6
P04626	NA	NA	NA	NA	LAPATINIB DITOSYLATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2007	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010190: Pancreatic Neoplasms,D013964: Thyroid Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M6
P04626	NA	NA	NA	NA	TRASTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	1998	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D001005: Anus Neoplasms,D001063: Appendiceal Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001927: Brain Diseases,D001943: Breast Neoplasms,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D004806: Ependymoma,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006689: Hodgkin Disease,D007340: Insulinoma,D007938: Leukemia,D008175: Lung Neoplasms,D008228: Lymphoma, Non-Hodgkin,D009182: Mycosis Fungoides,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010282: Parathyroid Neoplasms,D010490: Pericardial Effusion,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013005: Somatostatinoma,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018263: Adenocarcinoma, Follicular,D018281: Cholangiocarcinoma,D018567: Breast Neoplasms, Male,D044584: Carcinoma, Ductal,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M6
P04626	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	ERBB2	M6
P04626	NA	NA	NA	NA	PERTUZUMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2012	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms,D018278: Carcinoma, Neuroendocrine,D018567: Breast Neoplasms, Male,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	ERBB2	M6
P04626	NA	NA	NA	NA	AFATINIB DIMALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2013	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma	ERBB2	M6
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung	ERBB2	M6
P04626	NA	NA	NA	NA	DACOMITINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2018	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001932: Brain Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D008107: Liver Diseases,D008175: Lung Neoplasms,D009062: Mouth Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D010412: Penile Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M6
P04626	NA	NA	NA	NA	MARGETUXIMAB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2	M6
P04626	NA	NA	NA	NA	TUCATINIB	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2020	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D006394: Hemangiosarcoma,D008107: Liver Diseases,D009369: Neoplasms	ERBB2	M6
P04626	NA	NA	NA	NA	NERATINIB MALEATE	Receptor protein-tyrosine kinase erbB-2 inhibitor	INHIBITOR	2017	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms	ERBB2	M6
P04626	NA	NA	NA	NA	TRASTUZUMAB DERUXTECAN	Receptor protein-tyrosine kinase erbB-2 binding agent	BINDING AGENT	2019	CHEMBL1824	188	P04626	Receptor tyrosine-protein kinase erbB-2	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D004067: Digestive System Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D015179: Colorectal Neoplasms	ERBB2	M6
P54284	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNB3	M6
P54284	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNB3	M6
P54284	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases	CACNB3	M6
P54284	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	NA	CACNB3	M6
P54284	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	NA	CACNB3	M6
P54284	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNB3	M6
P30559	NA	NA	NA	NA	OXYTOCIN	Oxytocin receptor agonist	AGONIST	1980	CHEMBL2049	116	P30559	Oxytocin receptor	Homo sapiens	D000072861: Phobia, Social,D000375: Aging,D000437: Alcoholism,D000856: Anorexia Nervosa,D001145: Arrhythmias, Cardiac,D001284: Atrophy,D001289: Attention Deficit Disorder with Hyperactivity,D001321: Autistic Disorder,D001523: Mental Disorders,D002285: Carcinoma, Intraductal, Noninfiltrating,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003919: Diabetes Insipidus,D004420: Dystocia,D005600: Fragile X Syndrome,D006470: Hemorrhage,D006473: Postpartum Hemorrhage,D007249: Inflammation,D008569: Memory Disorders,D009203: Myocardial Infarction,D009293: Opioid-Related Disorders,D009437: Neuralgia,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011218: Prader-Willi Syndrome,D011225: Pre-Eclampsia,D011618: Psychotic Disorders,D012559: Schizophrenia,D012735: Sexual Dysfunction, Physiological,D012891: Sleep Apnea Syndromes,D013313: Stress Disorders, Post-Traumatic,D013375: Substance Withdrawal Syndrome,D015430: Weight Gain,D018589: Gastroparesis,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D057180: Frontotemporal Dementia,D059268: Atrophic Vaginitis,D059350: Chronic Pain,D065886: Neurodevelopmental Disorders	OXTR	M6
P28908	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tumor necrosis factor receptor superfamily member 8 inhibitor	INHIBITOR	2011	CHEMBL2364161	106140	P28908	Tumor necrosis factor receptor superfamily member 8	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TNFRSF8	M6
P40259	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	B-cell antigen receptor complex-associated protein beta chain binding agent	BINDING AGENT	2019	CHEMBL3712852	114813	P40259	B-cell antigen receptor complex-associated protein beta chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	CD79B	M6
P56524	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC4	M6
P56524	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC4	M6
P56524	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	P56524	Histone deacetylase 4	Homo sapiens	D009101: Multiple Myeloma	HDAC4	M6
P29322	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P29322	Ephrin type-A receptor 8	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA8	M6
Q01668	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNA1D	M6
Q01668	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNA1D	M6
Q01668	NA	NA	NA	NA	VERAPAMIL HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D006333: Heart Failure,D006689: Hodgkin Disease,D006973: Hypertension	CACNA1D	M6
Q01668	NA	NA	NA	NA	NIMODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	CACNA1D	M6
Q01668	NA	NA	NA	NA	FELODIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1991	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	CACNA1D	M6
Q01668	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1D	M6
Q01668	NA	NA	NA	NA	NIFEDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1981	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000312: Adrenal Hyperplasia, Congenital,D002318: Cardiovascular Diseases,D003928: Diabetic Nephropathies,D004828: Epilepsies, Partial,D005401: Fissure in Ano,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007669: Kidney Calculi,D010923: Placenta Previa,D011507: Proteinuria,D011928: Raynaud Disease,D017202: Myocardial Ischemia,D019966: Substance-Related Disorders,D047928: Premature Birth,D051436: Renal Insufficiency, Chronic	CACNA1D	M6
Q01668	NA	NA	NA	NA	ISRADIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1990	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001714: Bipolar Disorder,D002318: Cardiovascular Diseases,D006973: Hypertension,D009293: Opioid-Related Disorders,D010300: Parkinson Disease,D014029: Tobacco Use Disorder,D016540: Smoking Cessation,D019966: Substance-Related Disorders	CACNA1D	M6
Q01668	NA	NA	NA	NA	DILTIAZEM HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1982	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000787: Angina Pectoris,D001281: Atrial Fibrillation,D003248: Constipation,D005401: Fissure in Ano,D006333: Heart Failure,D006973: Hypertension,D012871: Skin Diseases,D015658: HIV Infections,D060050: Angina, Stable	CACNA1D	M6
Q01668	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M6
Q01668	NA	NA	NA	NA	NISOLDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	1995	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases	CACNA1D	M6
Q01668	NA	NA	NA	NA	NICARDIPINE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	1988	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D006973: Hypertension,D020301: Vasospasm, Intracranial	CACNA1D	M6
Q01668	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M6
Q01668	NA	NA	NA	NA	AMLODIPINE BESYLATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1992	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000075222: Essential Hypertension,D000787: Angina Pectoris,D000788: Angina Pectoris, Variant,D003324: Coronary Artery Disease,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006973: Hypertension,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009203: Myocardial Infarction,D011507: Proteinuria,D020521: Stroke,D060050: Angina, Stable	CACNA1D	M6
Q01668	NA	NA	NA	NA	DILTIAZEM MALATE	Voltage-gated L-type calcium channel blocker	BLOCKER	1996	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M6
Q01668	NA	NA	NA	NA	AMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2003	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	NA	CACNA1D	M6
Q01668	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Voltage-gated L-type calcium channel blocker	BLOCKER	2009	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D001281: Atrial Fibrillation	CACNA1D	M6
Q01668	NA	NA	NA	NA	CLEVIDIPINE	Voltage-gated L-type calcium channel blocker	BLOCKER	2008	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D002318: Cardiovascular Diseases,D006973: Hypertension,D006974: Hypertension, Malignant,D012600: Scoliosis,D014652: Vascular Diseases	CACNA1D	M6
Q01668	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNA1D	M6
Q01668	NA	NA	NA	NA	AMLODIPINE BENZOATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D006973: Hypertension	CACNA1D	M6
Q01668	NA	NA	NA	NA	LEVAMLODIPINE MALEATE	Voltage-gated L-type calcium channel blocker	BLOCKER	2019	CHEMBL2095229	104801	Q01668	Voltage-dependent L-type calcium channel subunit alpha-1D	Homo sapiens	D006973: Hypertension	CACNA1D	M6
P27487	NA	NA	NA	NA	ALOGLIPTIN BENZOATE	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2013	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D003924: Diabetes Mellitus, Type 2	DPP4	M6
P27487	NA	NA	NA	NA	LINAGLIPTIN	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2011	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004938: Esophageal Neoplasms,D006973: Hypertension,D012140: Respiratory Tract Diseases,D012559: Schizophrenia,D013274: Stomach Neoplasms,D045169: Severe Acute Respiratory Syndrome,D051437: Renal Insufficiency	DPP4	M6
P27487	NA	NA	NA	NA	SITAGLIPTIN PHOSPHATE	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2006	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D006949: Hyperlipidemias,D009203: Myocardial Infarction,D020521: Stroke,D051437: Renal Insufficiency	DPP4	M6
P27487	NA	NA	NA	NA	SAXAGLIPTIN HYDROCHLORIDE	Dipeptidyl peptidase IV inhibitor	INHIBITOR	2009	CHEMBL284	11140	P27487	Dipeptidyl peptidase 4	Homo sapiens	D003924: Diabetes Mellitus, Type 2	DPP4	M6
Q9H244	NA	NA	NA	NA	TICAGRELOR	Purinergic receptor P2Y12 negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2011	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D007511: Ischemia,D007674: Kidney Diseases,D009203: Myocardial Infarction,D011014: Pneumonia,D013927: Thrombosis,D016893: Carotid Stenosis,D017544: Aortic Aneurysm, Abdominal,D020521: Stroke,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D058729: Peripheral Arterial Disease,D060050: Angina, Stable	P2RY12	M6
Q9H244	NA	NA	NA	NA	TICLOPIDINE HYDROCHLORIDE	Purinergic receptor P2Y12 antagonist	ANTAGONIST	1991	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	NA	P2RY12	M6
Q9H244	NA	NA	NA	NA	CANGRELOR TETRASODIUM	Purinergic receptor P2Y12 antagonist	ANTAGONIST	2015	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D009203: Myocardial Infarction,D013927: Thrombosis	P2RY12	M6
Q9H244	NA	NA	NA	NA	CLOPIDOGREL BISULFATE	Purinergic receptor P2Y12 antagonist	ANTAGONIST	1997	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D000789: Angina, Unstable,D001943: Breast Neoplasms,D003327: Coronary Disease,D006471: Gastrointestinal Hemorrhage,D007511: Ischemia,D009203: Myocardial Infarction,D020521: Stroke,D054058: Acute Coronary Syndrome,D058729: Peripheral Arterial Disease	P2RY12	M6
Q9H244	NA	NA	NA	NA	PRASUGREL HYDROCHLORIDE	Purinergic receptor P2Y12 antagonist	ANTAGONIST	2009	CHEMBL2001	176	Q9H244	P2Y purinoceptor 12	Homo sapiens	D054058: Acute Coronary Syndrome	P2RY12	M6
P18054	NA	NA	NA	NA	BENOXAPROFEN	Arachidonate 12-lipoxygenase inhibitor	INHIBITOR	1982	CHEMBL3687	11134	P18054	Polyunsaturated fatty acid lipoxygenase ALOX12	Homo sapiens	D012216: Rheumatic Diseases	ALOX12	M6
P41143	CHEMBL128201	214599	10295681	NA	NALTREXONE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001883: Borderline Personality Disorder,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002659: Child Development Disorders, Pervasive,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003929: Diabetic Neuropathies,D004715: Endometriosis,D005356: Fibromyalgia,D005715: Gambling,D006556: Heroin Dependence,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D011565: Psoriasis,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014256: Trichotillomania,D015352: Dry Eye Syndromes,D015658: HIV Infections,D018352: Coronavirus Infections,D018856: Cystitis, Interstitial,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D019973: Alcohol-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRD1	M6
P41143	NA	NA	NA	NA	NALOXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1971	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D003248: Constipation,D005715: Gambling,D007415: Intestinal Obstruction,D009293: Opioid-Related Disorders,D010146: Pain	OPRD1	M6
P41143	NA	NA	NA	NA	OXYMORPHONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1959	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D010146: Pain,D059350: Chronic Pain,D059787: Acute Pain	OPRD1	M6
P41143	NA	NA	NA	NA	CODEINE PHOSPHATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1952	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D003371: Cough,D008881: Migraine Disorders,D010146: Pain,D013035: Spasm,D015658: HIV Infections	OPRD1	M6
P41143	NA	NA	NA	NA	NALBUPHINE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1979	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D003693: Delirium,D008107: Liver Diseases,D009293: Opioid-Related Disorders,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D015470: Leukemia, Myeloid, Acute	OPRD1	M6
P41143	NA	NA	NA	NA	NALTREXONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1984	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D001068: Feeding and Eating Disorders,D002607: Charcot-Marie-Tooth Disease,D009293: Opioid-Related Disorders,D010146: Pain,D019969: Amphetamine-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D059350: Chronic Pain	OPRD1	M6
P41143	NA	NA	NA	NA	NALMEFENE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta antagonist	ANTAGONIST	1995	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D000437: Alcoholism	OPRD1	M6
P41143	NA	NA	NA	NA	CODEINE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1985	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D003371: Cough	OPRD1	M6
P41143	NA	NA	NA	NA	HYDROCODONE POLISTIREX	Opioid receptors; mu/kappa/delta agonist	AGONIST	1987	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	NA	OPRD1	M6
P41143	NA	NA	NA	NA	BENZHYDROCODONE HYDROCHLORIDE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2018	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D059787: Acute Pain	OPRD1	M6
P41143	NA	NA	NA	NA	HYDROCODONE BITARTRATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	1943	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D007674: Kidney Diseases,D008107: Liver Diseases,D009437: Neuralgia,D010003: Osteoarthritis,D010146: Pain,D014947: Wounds and Injuries,D017116: Low Back Pain,D019966: Substance-Related Disorders,D059350: Chronic Pain,D059787: Acute Pain	OPRD1	M6
P41143	NA	NA	NA	NA	CODEINE SULFATE	Opioid receptors; mu/kappa/delta agonist	AGONIST	2009	CHEMBL2095181	104765	P41143	Delta-type opioid receptor	Homo sapiens	D010146: Pain	OPRD1	M6
P29275	NA	NA	NA	NA	ADENOSINE	Adenosine receptor agonist	AGONIST	1989	CHEMBL2111329	105024	P29275	Adenosine receptor A2b	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D007249: Inflammation,D007511: Ischemia,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D009369: Neoplasms,D010146: Pain,D012128: Respiratory Distress Syndrome,D013614: Tachycardia, Paroxysmal,D013617: Tachycardia, Supraventricular,D014927: Wolff-Parkinson-White Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D023921: Coronary Stenosis,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	ADORA2B	M6
P29275	NA	NA	NA	NA	CAFFEINE	Adenosine receptor antagonist	ANTAGONIST	1948	CHEMBL2111329	105024	P29275	Adenosine receptor A2b	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D000740: Anemia,D000860: Hypoxia,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001943: Breast Neoplasms,D003093: Colitis, Ulcerative,D003139: Common Cold,D003141: Communicable Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004417: Dyspnea,D006261: Headache,D007024: Hypotension, Orthostatic,D007383: Intermittent Claudication,D008545: Melanoma,D008881: Migraine Disorders,D009290: Narcolepsy,D009369: Neoplasms,D009765: Obesity,D010146: Pain,D010300: Parkinson Disease,D011565: Psoriasis,D013119: Spinal Cord Injuries,D014832: Voice Disorders,D015658: HIV Infections,D017116: Low Back Pain,D018781: Tension-Type Headache,D019547: Neck Pain,D019698: Hepatitis C, Chronic,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura,D020529: Multiple Sclerosis, Relapsing-Remitting,D028361: Mitochondrial Diseases,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ADORA2B	M6
P29275	NA	NA	NA	NA	PENTOXIFYLLINE	Adenosine A2 receptor antagonist	ANTAGONIST	1984	CHEMBL2094257	104729	P29275	Adenosine receptor A2b	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	ADORA2B	M6
P29275	NA	NA	NA	NA	THEOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29275	Adenosine receptor A2b	Homo sapiens	D000532: Altitude Sickness,D001049: Apnea,D001249: Asthma,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D007938: Leukemia,D008173: Lung Diseases, Obstructive,D011471: Prostatic Neoplasms,D011547: Pseudohypoparathyroidism,D012131: Respiratory Insufficiency,D014777: Virus Diseases,D015470: Leukemia, Myeloid, Acute,D029424: Pulmonary Disease, Chronic Obstructive,D051436: Renal Insufficiency, Chronic	ADORA2B	M6
P29275	NA	NA	NA	NA	OXTRIPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1981	CHEMBL2111329	105024	P29275	Adenosine receptor A2b	Homo sapiens	D008173: Lung Diseases, Obstructive	ADORA2B	M6
P29275	NA	NA	NA	NA	CAFFEINE, CITRATED	Adenosine receptor antagonist	ANTAGONIST	1999	CHEMBL2111329	105024	P29275	Adenosine receptor A2b	Homo sapiens	D001049: Apnea,D008107: Liver Diseases,D010146: Pain,D012178: Retinopathy of Prematurity,D047928: Premature Birth	ADORA2B	M6
P29275	NA	NA	NA	NA	THEOPHYLLINE SODIUM GLYCINATE	Adenosine receptor antagonist	ANTAGONIST	1982	CHEMBL2111329	105024	P29275	Adenosine receptor A2b	Homo sapiens	NA	ADORA2B	M6
P29275	NA	NA	NA	NA	AMINOPHYLLINE	Adenosine receptor antagonist	ANTAGONIST	1940	CHEMBL2111329	105024	P29275	Adenosine receptor A2b	Homo sapiens	D000532: Altitude Sickness,D001249: Asthma,D001749: Urinary Bladder Neoplasms,D006261: Headache,D006323: Heart Arrest,D006976: Hypertension, Pulmonary,D008173: Lung Diseases, Obstructive,D047928: Premature Birth,D058186: Acute Kidney Injury	ADORA2B	M6
O60894	NA	NA	NA	NA	PRAMLINTIDE ACETATE	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	2005	CHEMBL2111189	104908	O60894	Receptor activity-modifying protein 1	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity	RAMP1	M6
P28221	NA	NA	NA	NA	SUMATRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1992	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders,D009765: Obesity,D020325: Migraine with Aura,D020326: Migraine without Aura	HTR1D	M6
P28221	NA	NA	NA	NA	ZOLMITRIPTAN	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1997	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders	HTR1D	M6
P28221	NA	NA	NA	NA	AMISULPRIDE	Serotonin (5-HT) receptor antagonist	ANTAGONIST	2020	CHEMBL2096904	104841	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	HTR1D	M6
P28221	NA	NA	NA	NA	DIHYDROERGOTAMINE MESYLATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1946	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders	HTR1D	M6
P28221	NA	NA	NA	NA	ALMOTRIPTAN MALATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	2001	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders	HTR1D	M6
P28221	NA	NA	NA	NA	NARATRIPTAN HYDROCHLORIDE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1998	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D006261: Headache,D008881: Migraine Disorders	HTR1D	M6
P28221	NA	NA	NA	NA	ELETRIPTAN HYDROBROMIDE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	2002	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	NA	HTR1D	M6
P28221	NA	NA	NA	NA	RIZATRIPTAN BENZOATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1998	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura	HTR1D	M6
P28221	NA	NA	NA	NA	SUMATRIPTAN SUCCINATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1992	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders,D020325: Migraine with Aura,D020326: Migraine without Aura	HTR1D	M6
P28221	NA	NA	NA	NA	FENFLURAMINE HYDROCHLORIDE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	2020	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D004831: Epilepsies, Myoclonic,D020195: Epilepsy, Reflex	HTR1D	M6
P28221	NA	NA	NA	NA	FROVATRIPTAN SUCCINATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	2001	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	NA	HTR1D	M6
P28221	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Serotonin 1d (5-HT1d) receptor agonist	AGONIST	1948	CHEMBL1983	105	P28221	5-hydroxytryptamine receptor 1D	Homo sapiens	D008881: Migraine Disorders	HTR1D	M6
P38484	NA	NA	NA	NA	INTERFERON GAMMA-1B	Interferon gamma receptor agonist	AGONIST	1999	CHEMBL2364171	106150	P38484	Interferon gamma receptor 2	Homo sapiens	D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D003550: Cystic Fibrosis,D005185: Fallopian Tube Neoplasms,D005621: Friedreich Ataxia,D006105: Granulomatous Disease, Chronic,D007938: Leukemia,D008103: Liver Cirrhosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009164: Mycobacterium Infections,D009182: Mycosis Fungoides,D009369: Neoplasms,D009447: Neuroblastoma,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011565: Psoriasis,D011658: Pulmonary Fibrosis,D012162: Retinal Degeneration,D012208: Rhabdomyosarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D014605: Uveitis,D014606: Uveitis, Anterior,D014987: Xerostomia,D015270: Mycobacterium avium-intracellulare Infection,D015658: HIV Infections,D016918: Arthritis, Reactive,D016919: Meningitis, Cryptococcal,D018370: Leukocyte-Adhesion Deficiency Syndrome,D019698: Hepatitis C, Chronic,D054990: Idiopathic Pulmonary Fibrosis,D058387: Candidemia,D064129: Prostatic Neoplasms, Castration-Resistant	IFNGR2	M9
P28065	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9	M9
P28065	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB9	M9
P28065	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P28065	Proteasome subunit beta type-9	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB9	M9
P43686	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC4	M9
P43686	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMC4	M9
P43686	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P43686	26S proteasome regulatory subunit 6B	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMC4	M9
P25100	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRA1D	M9
P25100	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1995	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA1D	M9
P25100	NA	NA	NA	NA	PRAZOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1976	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRA1D	M9
P25100	NA	NA	NA	NA	TOLAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1985	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M9
P25100	NA	NA	NA	NA	NAPHAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1971	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D003139: Common Cold,D007249: Inflammation,D007251: Influenza, Human,D011625: Pterygium	ADRA1D	M9
P25100	NA	NA	NA	NA	ALFUZOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	2003	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D007669: Kidney Calculi,D011470: Prostatic Hyperplasia,D053039: Ureterolithiasis	ADRA1D	M9
P25100	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRA1D	M9
P25100	NA	NA	NA	NA	PHENYLEPHRINE HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	1952	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D001145: Arrhythmias, Cardiac,D002318: Cardiovascular Diseases,D002386: Cataract,D003139: Common Cold,D006255: Rhinitis, Allergic, Seasonal,D007239: Infections,D012141: Respiratory Tract Infections,D012220: Rhinitis,D012223: Rhinitis, Vasomotor,D012852: Sinusitis,D013274: Stomach Neoplasms,D055371: Acute Lung Injury	ADRA1D	M9
P25100	NA	NA	NA	NA	TETRAHYDROZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1979	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D007249: Inflammation,D011625: Pterygium	ADRA1D	M9
P25100	NA	NA	NA	NA	MIDODRINE HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	1996	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D007024: Hypotension, Orthostatic,D012772: Shock, Septic,D018805: Sepsis,D020521: Stroke	ADRA1D	M9
P25100	NA	NA	NA	NA	DOXAZOSIN MESYLATE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1990	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRA1D	M9
P25100	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M9
P25100	NA	NA	NA	NA	PHENOXYBENZAMINE HYDROCHLORIDE	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M9
P25100	NA	NA	NA	NA	OXYMETAZOLINE HYDROCHLORIDE	Adrenergic receptor alpha agonist	AGONIST	1986	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D003233: Conjunctivitis, Allergic,D004890: Erythema,D006255: Rhinitis, Allergic, Seasonal,D011305: Presbyopia,D012393: Rosacea	ADRA1D	M9
P25100	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M9
P25100	NA	NA	NA	NA	PHENTOLAMINE MESYLATE	Adrenergic receptor alpha antagonist	ANTAGONIST	1952	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D064129: Prostatic Neoplasms, Castration-Resistant	ADRA1D	M9
P25100	NA	NA	NA	NA	TAMSULOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1997	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D001750: Urinary Bladder, Neurogenic,D006973: Hypertension,D011183: Postoperative Complications,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011472: Prostatitis,D016055: Urinary Retention	ADRA1D	M9
P25100	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1979	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M9
P25100	NA	NA	NA	NA	METHOXAMINE HYDROCHLORIDE	Adrenergic receptor alpha-1 agonist	AGONIST	1982	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D005242: Fecal Incontinence	ADRA1D	M9
P25100	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	2006	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRA1D	M9
P25100	NA	NA	NA	NA	ALSEROXYLON	Adrenergic receptor alpha antagonist	ANTAGONIST	1982	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M9
P25100	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D010146: Pain	ADRA1D	M9
P25100	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRA1D	M9
P25100	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D001249: Asthma	ADRA1D	M9
P25100	NA	NA	NA	NA	METARAMINOL BITARTRATE	Adrenergic receptor alpha-1 agonist	AGONIST	1954	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M9
P25100	NA	NA	NA	NA	PHENYLEPHRINE BITARTRATE	Adrenergic receptor alpha-1 agonist	AGONIST	1973	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M9
P25100	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRA1D	M9
P25100	NA	NA	NA	NA	ERGOLOID MESYLATES	Adrenergic receptor alpha antagonist	ANTAGONIST	1953	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D015140: Dementia, Vascular	ADRA1D	M9
P25100	NA	NA	NA	NA	ERGOTAMINE TARTRATE	Adrenergic receptor alpha agonist	AGONIST	1948	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D008881: Migraine Disorders	ADRA1D	M9
P25100	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P25100	Alpha-1D adrenergic receptor	Homo sapiens	NA	ADRA1D	M9
P25100	NA	NA	NA	NA	RAUWOLFIA SERPENTINA	Adrenergic receptor alpha antagonist	ANTAGONIST	1954	CHEMBL2095203	104787	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D006331: Heart Diseases,D006973: Hypertension	ADRA1D	M9
P25100	NA	NA	NA	NA	TERAZOSIN HYDROCHLORIDE	Adrenergic receptor alpha-1 antagonist	ANTAGONIST	1987	CHEMBL2094251	104723	P25100	Alpha-1D adrenergic receptor	Homo sapiens	D003704: Dementia	ADRA1D	M9
P24530	NA	NA	NA	NA	SITAXENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D011507: Proteinuria,D051436: Renal Insufficiency, Chronic,D054144: Heart Failure, Diastolic	EDNRB	M9
P24530	NA	NA	NA	NA	BOSENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2001	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D001249: Asthma,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004541: Eisenmenger Complex,D005334: Fever,D005901: Glaucoma,D006333: Heart Failure,D006344: Heart Septal Defects, Atrial,D006973: Hypertension,D006976: Hypertension, Pulmonary,D008103: Liver Cirrhosis,D008545: Melanoma,D008946: Mitral Valve Stenosis,D010190: Pancreatic Neoplasms,D010547: Persistent Fetal Circulation Syndrome,D012595: Scleroderma, Systemic,D014456: Ulcer,D018636: Hypoplastic Left Heart Syndrome,D018917: Optic Neuropathy, Ischemic,D020065: Hepatopulmonary Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M9
P24530	NA	NA	NA	NA	AMBRISENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2007	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D000532: Altitude Sickness,D000755: Anemia, Sickle Cell,D001249: Asthma,D006973: Hypertension,D006976: Hypertension, Pulmonary,D014652: Vascular Diseases,D018636: Hypoplastic Left Heart Syndrome,D045169: Severe Acute Respiratory Syndrome,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension	EDNRB	M9
P24530	NA	NA	NA	NA	MACITENTAN	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2010	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	D005909: Glioblastoma,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D012595: Scleroderma, Systemic,D014456: Ulcer,D054990: Idiopathic Pulmonary Fibrosis,D065627: Familial Primary Pulmonary Hypertension,D065630: Hernias, Diaphragmatic, Congenital	EDNRB	M9
P24530	NA	NA	NA	NA	SITAXENTAN SODIUM	Endothelin receptor, ET-A/ET-B antagonist	ANTAGONIST	2006	CHEMBL2096678	104833	P24530	Endothelin receptor type B	Homo sapiens	NA	EDNRB	M9
P21709	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P21709	Ephrin type-A receptor 1	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA1	M9
P05108	NA	NA	NA	NA	AMINOGLUTETHIMIDE	Cytochrome P450 11A1 inhibitor	INHIBITOR	1980	CHEMBL2033	32	P05108	Cholesterol side-chain cleavage enzyme, mitochondrial	Homo sapiens	D001943: Breast Neoplasms,D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CYP11A1	M9
P05108	NA	NA	NA	NA	MITOTANE	Cytochrome P450 11A1 inhibitor	INHIBITOR	1970	CHEMBL2033	32	P05108	Cholesterol side-chain cleavage enzyme, mitochondrial	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D002277: Carcinoma,D009369: Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	CYP11A1	M9
Q9BY41	NA	NA	NA	NA	ROMIDEPSIN	Histone deacetylase inhibitor	INHIBITOR	2009	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D008080: Liposarcoma,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D018263: Adenocarcinoma, Follicular,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	HDAC8	M9
Q9BY41	NA	NA	NA	NA	BELINOSTAT	Histone deacetylase inhibitor	INHIBITOR	2014	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D000230: Adenocarcinoma,D001752: Blast Crisis,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010534: Peritoneal Neoplasms,D012509: Sarcoma,D013945: Thymoma,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D055752: Small Cell Lung Carcinoma	HDAC8	M9
Q9BY41	NA	NA	NA	NA	PANOBINOSTAT LACTATE	Histone deacetylase inhibitor	INHIBITOR	2015	CHEMBL2093865	104681	Q9BY41	Histone deacetylase 8	Homo sapiens	D009101: Multiple Myeloma	HDAC8	M9
P28223	NA	NA	NA	NA	CLOZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1989	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D003704: Dementia,D003866: Depressive Disorder,D008607: Intellectual Disability,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	HALOPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D006816: Huntington Disease,D009325: Nausea,D011183: Postoperative Complications,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019955: Conduct Disorder,D019964: Mood Disorders,D019969: Amphetamine-Related Disorders,D020323: Tics	HTR2A	M9
P28223	NA	NA	NA	NA	THIORIDAZINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1962	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D015470: Leukemia, Myeloid, Acute	HTR2A	M9
P28223	NA	NA	NA	NA	CHLORPROMAZINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1957	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D003693: Delirium,D005909: Glioblastoma,D009357: Neonatal Abstinence Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia,D045169: Severe Acute Respiratory Syndrome	HTR2A	M9
P28223	NA	NA	NA	NA	RISPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1993	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000544: Alzheimer Disease,D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002658: Developmental Disabilities,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005879: Tourette Syndrome,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009293: Opioid-Related Disorders,D011618: Psychotic Disorders,D012559: Schizophrenia,D012569: Schizotypal Personality Disorder,D013313: Stress Disorders, Post-Traumatic,D015140: Dementia, Vascular,D015518: Rett Syndrome,D019955: Conduct Disorder,D019958: Attention Deficit and Disruptive Behavior Disorders,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome,D065886: Neurodevelopmental Disorders	HTR2A	M9
P28223	NA	NA	NA	NA	ILOPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D008107: Liver Diseases,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	HTR2A	M9
P28223	NA	NA	NA	NA	MIRTAZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1996	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000855: Anorexia,D001007: Anxiety,D002100: Cachexia,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005356: Fibromyalgia,D006556: Heroin Dependence,D009325: Nausea,D012559: Schizophrenia,D015431: Weight Loss,D019966: Substance-Related Disorders,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020181: Sleep Apnea, Obstructive,D020250: Postoperative Nausea and Vomiting	HTR2A	M9
P28223	NA	NA	NA	NA	OLANZAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1996	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D000856: Anorexia Nervosa,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001321: Autistic Disorder,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D002658: Developmental Disabilities,D003693: Delirium,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D004409: Dyskinesia, Drug-Induced,D005715: Gambling,D006816: Huntington Disease,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D008607: Intellectual Disability,D009325: Nausea,D009369: Neoplasms,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014839: Vomiting,D015430: Weight Gain,D015431: Weight Loss,D019964: Mood Disorders,D020250: Postoperative Nausea and Vomiting,D061218: Depressive Disorder, Treatment-Resistant	HTR2A	M9
P28223	NA	NA	NA	NA	LOXAPINE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1975	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001249: Asthma,D008881: Migraine Disorders,D009437: Neuralgia,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive	HTR2A	M9
P28223	NA	NA	NA	NA	CHLORPROTHIXENE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	DROPERIDOL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D010146: Pain,D011618: Psychotic Disorders	HTR2A	M9
P28223	NA	NA	NA	NA	ARIPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2002	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000544: Alzheimer Disease,D000856: Anorexia Nervosa,D001007: Anxiety,D001289: Attention Deficit Disorder with Hyperactivity,D001321: Autistic Disorder,D001714: Bipolar Disorder,D002659: Child Development Disorders, Pervasive,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D005600: Fragile X Syndrome,D005879: Tourette Syndrome,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic,D019052: Depression, Postpartum,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020817: Asperger Syndrome	HTR2A	M9
P28223	NA	NA	NA	NA	THIOTHIXENE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders	HTR2A	M9
P28223	NA	NA	NA	NA	PIMOZIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1984	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D005879: Tourette Syndrome,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	AMISULPRIDE	Serotonin (5-HT) receptor antagonist	ANTAGONIST	2020	CHEMBL2096904	104841	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000856: Anorexia Nervosa,D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009325: Nausea,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia,D020250: Postoperative Nausea and Vomiting	HTR2A	M9
P28223	NA	NA	NA	NA	PALIPERIDONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2006	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001007: Anxiety,D001321: Autistic Disorder,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D009771: Obsessive-Compulsive Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	CHLORPROMAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1957	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	MOLINDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1974	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	PROMAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1956	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	NEFAZODONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1994	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	CYCLOBENZAPRINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1977	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D002547: Cerebral Palsy,D008881: Migraine Disorders,D009128: Muscle Spasticity,D013035: Spasm,D013118: Spinal Cord Diseases,D063806: Myalgia	HTR2A	M9
P28223	NA	NA	NA	NA	TRAZODONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1981	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	HTR2A	M9
P28223	NA	NA	NA	NA	THIORIDAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1962	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	TRIMIPRAMINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1979	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	HALOPERIDOL DECANOATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1986	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D003693: Delirium,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	MESORIDAZINE BESYLATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	LOXAPINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1976	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	LOXAPINE SUCCINATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1975	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	TRIFLUOPERAZINE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1959	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	ZIPRASIDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2001	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder	HTR2A	M9
P28223	NA	NA	NA	NA	LURASIDONE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2010	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	BREXPIPRAZOLE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2015	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000437: Alcoholism,D000544: Alzheimer Disease,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D012893: Sleep Wake Disorders,D013313: Stress Disorders, Post-Traumatic	HTR2A	M9
P28223	NA	NA	NA	NA	PALIPERIDONE PALMITATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	ARIPIPRAZOLE LAUROXIL	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2015	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	CARPHENAZINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1982	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	PIMAVANSERIN TARTRATE	Serotonin 2a (5-HT2a) receptor inverse agonist	INVERSE AGONIST	2016	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000544: Alzheimer Disease,D010300: Parkinson Disease,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	QUETIAPINE FUMARATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1997	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000072861: Phobia, Social,D000437: Alcoholism,D001007: Anxiety,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D003704: Dementia,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009103: Multiple Sclerosis,D009497: Neurotic Disorders,D009771: Obsessive-Compulsive Disorder,D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia,D013313: Stress Disorders, Post-Traumatic	HTR2A	M9
P28223	NA	NA	NA	NA	LUMATEPERONE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2019	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D000544: Alzheimer Disease,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	ASENAPINE MALEATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	OLANZAPINE PAMOATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2009	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	THIOTHIXENE HYDROCHLORIDE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1970	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	NA	HTR2A	M9
P28223	NA	NA	NA	NA	ZIPRASIDONE MESYLATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	2002	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D001714: Bipolar Disorder,D012559: Schizophrenia	HTR2A	M9
P28223	NA	NA	NA	NA	HALOPERIDOL LACTATE	Serotonin 2a (5-HT2a) receptor antagonist	ANTAGONIST	1967	CHEMBL224	107	P28223	5-hydroxytryptamine receptor 2A	Homo sapiens	D011595: Psychomotor Agitation,D011618: Psychotic Disorders,D012559: Schizophrenia	HTR2A	M9
Q9Y5N1	NA	NA	NA	NA	PITOLISANT	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D000437: Alcoholism,D007674: Kidney Diseases,D009290: Narcolepsy,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D019966: Substance-Related Disorders	HRH3	M9
Q9Y5N1	NA	NA	NA	NA	PITOLISANT HYDROCHLORIDE	Histamine H3 receptor inverse agonist	INVERSE AGONIST	2019	CHEMBL264	10280	Q9Y5N1	Histamine H3 receptor	Homo sapiens	D006970: Disorders of Excessive Somnolence,D009290: Narcolepsy	HRH3	M9
P21964	NA	NA	NA	NA	ENTACAPONE	Catechol O-methyltransferase inhibitor	INHIBITOR	1999	CHEMBL2023	91	P21964	Catechol O-methyltransferase	Homo sapiens	D004827: Epilepsy,D009765: Obesity,D010300: Parkinson Disease,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D046152: Gastrointestinal Stromal Tumors	COMT	M9
P21964	NA	NA	NA	NA	TOLCAPONE	Catechol O-methyltransferase inhibitor	INHIBITOR	1998	CHEMBL2023	91	P21964	Catechol O-methyltransferase	Homo sapiens	D000437: Alcoholism,D001930: Brain Injuries,D005715: Gambling,D009447: Neuroblastoma,D009771: Obsessive-Compulsive Disorder,D010300: Parkinson Disease,D012559: Schizophrenia,D014029: Tobacco Use Disorder,D019970: Cocaine-Related Disorders,D020774: Pick Disease of the Brain	COMT	M9
P21964	NA	NA	NA	NA	OPICAPONE	Catechol O-methyltransferase inhibitor	INHIBITOR	2020	CHEMBL2023	91	P21964	Catechol O-methyltransferase	Homo sapiens	D010300: Parkinson Disease	COMT	M9
P08123	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08123	Collagen alpha-2(I) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL1A2	M9
P08123	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P08123	Collagen alpha-2(I) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL1A2	M9
P60900	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	P60900	Proteasome subunit alpha type-6	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA6	M9
P60900	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	P60900	Proteasome subunit alpha type-6	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMA6	M9
P60900	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	P60900	Proteasome subunit alpha type-6	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMA6	M9
P29400	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P29400	Collagen alpha-5(IV) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL4A5	M9
P29400	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P29400	Collagen alpha-5(IV) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL4A5	M9
Q99436	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M9
Q99436	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMB7	M9
Q99436	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99436	Proteasome subunit beta type-7	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMB7	M9
P07451	CHEMBL18	1096	3295	DB00311	ETHOXZOLAMIDE	Carbonic anhydrase inhibitor	INHIBITOR	1982	CHEMBL2095180	104764	P07451	Carbonic anhydrase 3	Homo sapiens	NA	CA3	M9
Q14003	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q14003	Potassium voltage-gated channel subfamily C member 3	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNC3	M9
Q14003	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q14003	Potassium voltage-gated channel subfamily C member 3	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNC3	M9
Q14003	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q14003	Potassium voltage-gated channel subfamily C member 3	Homo sapiens	NA	KCNC3	M9
Q14003	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q14003	Potassium voltage-gated channel subfamily C member 3	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNC3	M9
P11274	NA	NA	NA	NA	BOSUTINIB	Bcr/Abl fusion protein	INHIBITOR	2010	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001749: Urinary Bladder Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003704: Dementia,D005909: Glioblastoma,D007938: Leukemia,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	BCR	M9
P11274	NA	NA	NA	NA	DASATINIB	Bcr/Abl fusion protein	INHIBITOR	2006	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000544: Alzheimer Disease,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007951: Leukemia, Myeloid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010871: Pinealoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012208: Rhabdomyosarcoma,D012594: Scleroderma, Localized,D012751: Sezary Syndrome,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D020522: Lymphoma, Mantle-Cell,D034721: Mastocytosis, Systemic,D046152: Gastrointestinal Stromal Tumors,D051436: Renal Insufficiency, Chronic,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054990: Idiopathic Pulmonary Fibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	BCR	M9
P11274	NA	NA	NA	NA	IMATINIB MESYLATE	Bcr/Abl fusion protein	INHIBITOR	2001	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D000755: Anemia, Sickle Cell,D001249: Asthma,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002813: Chondrosarcoma,D003110: Colonic Neoplasms,D003922: Diabetes Mellitus, Type 1,D004802: Eosinophilia,D005185: Fallopian Tube Neoplasms,D005354: Fibrosarcoma,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006976: Hypertension, Pulmonary,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009103: Multiple Sclerosis,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009442: Neurilemmoma,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011668: Pulmonary Veno-Occlusive Disease,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012594: Scleroderma, Localized,D012595: Scleroderma, Systemic,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013964: Thyroid Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015456: Leukemia, Biphenotypic, Acute,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D017681: Hypereosinophilic Syndrome,D018192: Lymphangioleiomyomatosis,D018222: Fibromatosis, Aggressive,D018223: Dermatofibrosarcoma,D018316: Gliosarcoma,D018318: Neurofibroma, Plexiform,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054989: Nephrogenic Fibrosing Dermopathy,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D057135: Wet Macular Degeneration,D064129: Prostatic Neoplasms, Castration-Resistant	BCR	M9
P11274	NA	NA	NA	NA	NILOTINIB HYDROCHLORIDE MONOHYDRATE	Bcr/Abl fusion protein	INHIBITOR	2007	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D001943: Breast Neoplasms,D010300: Parkinson Disease,D012595: Scleroderma, Systemic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive	BCR	M9
P11274	NA	NA	NA	NA	PONATINIB HYDROCHLORIDE	Bcr/Abl fusion protein inhibitor	INHIBITOR	2012	CHEMBL2096618	104811	P11274	Breakpoint cluster region protein	Homo sapiens	D001752: Blast Crisis,D009369: Neoplasms,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	BCR	M9
P06401	NA	NA	NA	NA	PROGESTERONE	Progesterone receptor agonist	AGONIST	1976	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000544: Alzheimer Disease,D000568: Amenorrhea,D000789: Angina, Unstable,D000856: Anorexia Nervosa,D001851: Bone Diseases, Metabolic,D001930: Brain Injuries,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D004714: Endometrial Hyperplasia,D004827: Epilepsy,D006937: Hypercholesterolemia,D006973: Hypertension,D007246: Infertility,D007247: Infertility, Female,D007724: Vulvar Lichen Sclerosus,D007889: Leiomyoma,D008569: Memory Disorders,D008593: Menopause,D010024: Osteoporosis,D010923: Placenta Previa,D011085: Polycystic Ovary Syndrome,D011225: Pre-Eclampsia,D011247: Pregnancy,D013927: Thrombosis,D014029: Tobacco Use Disorder,D014592: Uterine Hemorrhage,D015658: HIV Infections,D016471: Ovarian Hyperstimulation Syndrome,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D018290: Cervical Intraepithelial Neoplasia,D019052: Depression, Postpartum,D019970: Cocaine-Related Disorders,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D052018: Bulimia Nervosa,D054971: Orthostatic Intolerance	PGR	M9
P06401	NA	NA	NA	NA	MEDROXYPROGESTERONE ACETATE	Progesterone receptor agonist	AGONIST	1959	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000544: Alzheimer Disease,D002292: Carcinoma, Renal Cell,D003327: Coronary Disease,D003920: Diabetes Mellitus,D004714: Endometrial Hyperplasia,D004715: Endometriosis,D006331: Heart Diseases,D006470: Hemorrhage,D006937: Hypercholesterolemia,D006973: Hypertension,D007246: Infertility,D007680: Kidney Neoplasms,D008180: Lupus Erythematosus, Systemic,D008593: Menopause,D008595: Menorrhagia,D009369: Neoplasms,D010024: Osteoporosis,D010146: Pain,D011247: Pregnancy,D011471: Prostatic Neoplasms,D012891: Sleep Apnea Syndromes,D013927: Thrombosis,D014424: Turner Syndrome,D015658: HIV Infections,D016649: Primary Ovarian Insufficiency,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019584: Hot Flashes	PGR	M9
P06401	NA	NA	NA	NA	NORETHINDRONE	Progesterone receptor agonist	AGONIST	1962	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D004412: Dysmenorrhea,D004715: Endometriosis,D006526: Hepatitis C,D008593: Menopause,D009369: Neoplasms,D010146: Pain,D012735: Sexual Dysfunction, Physiological,D015427: Reperfusion Injury,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	PGR	M9
P06401	NA	NA	NA	NA	NORETHYNODREL	Progesterone receptor agonist	AGONIST	1961	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	NA	PGR	M9
P06401	NA	NA	NA	NA	LEVONORGESTREL	Progesterone receptor agonist	AGONIST	1982	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000856: Anorexia Nervosa,D001851: Bone Diseases, Metabolic,D003924: Diabetes Mellitus, Type 2,D004412: Dysmenorrhea,D004714: Endometrial Hyperplasia,D004715: Endometriosis,D006470: Hemorrhage,D008595: Menorrhagia,D008881: Migraine Disorders,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019698: Hepatitis C, Chronic,D062788: Adenomyosis	PGR	M9
P06401	NA	NA	NA	NA	DANAZOL	Progesterone receptor agonist	AGONIST	1976	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000741: Anemia, Aplastic,D004715: Endometriosis,D005199: Fanconi Anemia,D005348: Fibrocystic Breast Disease,D007246: Infertility,D009190: Myelodysplastic Syndromes,D011697: Purpura, Thrombotic Thrombocytopenic,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D019871: Dyskeratosis Congenita,D059373: Mastodynia	PGR	M9
P06401	NA	NA	NA	NA	DROSPIRENONE	Progesterone receptor agonist	AGONIST	2001	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000152: Acne Vulgaris,D002032: Bulimia,D003866: Depressive Disorder,D004412: Dysmenorrhea,D011085: Polycystic Ovary Syndrome,D011293: Premenstrual Syndrome,D017497: Hidradenitis Suppurativa,D052018: Bulimia Nervosa	PGR	M9
P06401	NA	NA	NA	NA	ETONOGESTREL	Progesterone receptor agonist	AGONIST	2001	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D004412: Dysmenorrhea,D011470: Prostatic Hyperplasia,D015658: HIV Infections	PGR	M9
P06401	NA	NA	NA	NA	DESOGESTREL	Progesterone receptor agonist	AGONIST	1992	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000568: Amenorrhea,D006470: Hemorrhage,D011085: Polycystic Ovary Syndrome,D020182: Sleep Apnea, Central	PGR	M9
P06401	NA	NA	NA	NA	ULIPRISTAL ACETATE	Progesterone receptor modulator	MODULATOR	2010	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D001943: Breast Neoplasms,D002607: Charcot-Marie-Tooth Disease,D003866: Depressive Disorder,D006470: Hemorrhage,D007889: Leiomyoma,D008593: Menopause,D011293: Premenstrual Syndrome,D062788: Adenomyosis	PGR	M9
P06401	NA	NA	NA	NA	ETHYNODIOL DIACETATE	Progesterone receptor agonist	AGONIST	1966	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	NA	PGR	M9
P06401	NA	NA	NA	NA	NORELGESTROMIN	Progesterone receptor agonist	AGONIST	2001	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D008796: Metrorrhagia,D011247: Pregnancy,D015658: HIV Infections	PGR	M9
P06401	NA	NA	NA	NA	HYDROXYPROGESTERONE CAPROATE	Progesterone receptor agonist	AGONIST	1975	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D011247: Pregnancy,D047928: Premature Birth	PGR	M9
P06401	NA	NA	NA	NA	DYDROGESTERONE	Progesterone receptor agonist	AGONIST	1982	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000026: Abortion, Habitual,D004714: Endometrial Hyperplasia,D007246: Infertility,D007247: Infertility, Female,D008593: Menopause,D010048: Ovarian Cysts,D011247: Pregnancy,D047928: Premature Birth	PGR	M9
P06401	NA	NA	NA	NA	NORGESTIMATE	Progesterone receptor agonist	AGONIST	1989	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000152: Acne Vulgaris,D003550: Cystic Fibrosis,D006526: Hepatitis C,D008796: Metrorrhagia,D008881: Migraine Disorders,D009436: Neural Tube Defects,D010024: Osteoporosis,D015658: HIV Infections	PGR	M9
P06401	NA	NA	NA	NA	MEGESTROL ACETATE	Progesterone receptor agonist	AGONIST	1971	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000855: Anorexia,D001943: Breast Neoplasms,D002100: Cachexia,D002278: Carcinoma in Situ,D003704: Dementia,D004714: Endometrial Hyperplasia,D006258: Head and Neck Neoplasms,D008113: Liver Neoplasms,D009369: Neoplasms,D014594: Uterine Neoplasms,D016889: Endometrial Neoplasms,D019247: HIV Wasting Syndrome,D019584: Hot Flashes,D029424: Pulmonary Disease, Chronic Obstructive	PGR	M9
P06401	NA	NA	NA	NA	NORETHINDRONE ACETATE	Progesterone receptor agonist	AGONIST	1973	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000152: Acne Vulgaris,D001943: Breast Neoplasms,D003550: Cystic Fibrosis,D004714: Endometrial Hyperplasia,D004715: Endometriosis,D006470: Hemorrhage,D007006: Hypogonadism,D007889: Leiomyoma,D008223: Lymphoma,D010146: Pain,D011247: Pregnancy,D016649: Primary Ovarian Insufficiency	PGR	M9
P06401	NA	NA	NA	NA	MIFEPRISTONE	Progesterone receptor antagonist	ANTAGONIST	2000	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D000022: Abortion, Spontaneous,D000437: Alcoholism,D000544: Alzheimer Disease,D001007: Anxiety,D001714: Bipolar Disorder,D001883: Borderline Personality Disorder,D001943: Breast Neoplasms,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D003480: Cushing Syndrome,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D004715: Endometriosis,D005185: Fallopian Tube Neoplasms,D006526: Hepatitis C,D007889: Leiomyoma,D008579: Meningioma,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015658: HIV Infections,D016889: Endometrial Neoplasms,D018567: Breast Neoplasms, Male,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D047748: Pituitary ACTH Hypersecretion,D056833: Central Serous Chorioretinopathy,D062788: Adenomyosis,D064129: Prostatic Neoplasms, Castration-Resistant	PGR	M9
P06401	NA	NA	NA	NA	NORGESTREL	Progesterone receptor agonist	AGONIST	1968	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	D016889: Endometrial Neoplasms	PGR	M9
P06401	NA	NA	NA	NA	SEGESTERONE ACETATE	Progesterone receptor agonist	AGONIST	2018	CHEMBL208	36	P06401	Progesterone receptor	Homo sapiens	NA	PGR	M9
Q9UIX4	CHEMBL188566	312898	11282181	NA	DALFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2010	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D000083242: Ischemic Stroke,D002547: Cerebral Palsy,D009103: Multiple Sclerosis,D009128: Muscle Spasticity,D009134: Muscular Atrophy, Spinal,D009902: Optic Neuritis,D013119: Spinal Cord Injuries,D016472: Motor Neuron Disease,D020181: Sleep Apnea, Obstructive,D020196: Trauma, Nervous System,D020275: Guillain-Barre Syndrome,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D051437: Renal Insufficiency	KCNG1	M9
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D001906: Botulism,D009103: Multiple Sclerosis,D015624: Lambert-Eaton Myasthenic Syndrome	KCNG1	M9
Q9UIX4	NA	NA	NA	NA	GUANIDINE HYDROCHLORIDE	Voltage-gated potassium channel blocker	BLOCKER	1939	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	NA	KCNG1	M9
Q9UIX4	NA	NA	NA	NA	AMIFAMPRIDINE PHOSPHATE	Voltage-gated potassium channel blocker	BLOCKER	2018	CHEMBL2362996	105708	Q9UIX4	Potassium voltage-gated channel subfamily G member 1	Homo sapiens	D009133: Muscular Atrophy,D009134: Muscular Atrophy, Spinal,D009157: Myasthenia Gravis,D015624: Lambert-Eaton Myasthenic Syndrome,D053840: Brugada Syndrome	KCNG1	M9
Q08209	NA	NA	NA	NA	VOCLOSPORIN	Serine/threonine protein phosphatase 2B catalytic subunit, alpha isoform inhibitor	INHIBITOR	2021	CHEMBL4445	12579	Q08209	Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform	Homo sapiens	D005923: Glomerulosclerosis, Focal Segmental,D007154: Immune System Diseases,D007674: Kidney Diseases,D008181: Lupus Nephritis,D011565: Psoriasis,D014605: Uveitis,D015352: Dry Eye Syndromes,D015866: Uveitis, Posterior,D015867: Uveitis, Intermediate	PPP3CA	M9
P07327	NA	NA	NA	NA	FOMEPIZOLE	Alcohol dehydrogenase class I inhibitor	INHIBITOR	1997	CHEMBL2363044	105739	P07327	Alcohol dehydrogenase 1A	Homo sapiens	D008268: Macular Degeneration	ADH1A	M9
Q96S37	NA	NA	NA	NA	SULFINPYRAZONE	Solute carrier family 22 member 12 inhibitor	INHIBITOR	1959	CHEMBL6120	102767	Q96S37	Solute carrier family 22 member 12	Homo sapiens	D006073: Gout	SLC22A12	M9
Q96S37	NA	NA	NA	NA	LESINURAD	Solute carrier family 22 member 12 inhibitor	INHIBITOR	2015	CHEMBL6120	102767	Q96S37	Solute carrier family 22 member 12	Homo sapiens	D006073: Gout,D033461: Hyperuricemia	SLC22A12	M9
P13637	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A3	M9
P13637	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3	M9
P13637	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A3	M9
P13637	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P13637	Sodium/potassium-transporting ATPase subunit alpha-3	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A3	M9
P08235	NA	NA	NA	NA	SPIRONOLACTONE	Mineralocorticoid receptor antagonist	ANTAGONIST	1960	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D000152: Acne Vulgaris,D001281: Atrial Fibrillation,D002318: Cardiovascular Diseases,D002543: Cerebral Hemorrhage,D002825: Chorioretinitis,D003920: Diabetes Mellitus,D003928: Diabetic Nephropathies,D005234: Fatty Liver,D006333: Heart Failure,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007938: Leukemia,D008223: Lymphoma,D008268: Macular Degeneration,D008548: Melanosis,D009203: Myocardial Infarction,D009369: Neoplasms,D009404: Nephrotic Syndrome,D011085: Polycystic Ovary Syndrome,D011629: Puberty, Precocious,D015470: Leukemia, Myeloid, Acute,D016891: Polycystic Kidney, Autosomal Dominant,D019571: Arrhythmogenic Right Ventricular Dysplasia,D020388: Muscular Dystrophy, Duchenne,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054144: Heart Failure, Diastolic,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	NR3C2	M9
P08235	NA	NA	NA	NA	NIMODIPINE	Mineralocorticoid receptor antagonist	ANTAGONIST	1988	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D002318: Cardiovascular Diseases,D002532: Intracranial Aneurysm,D002561: Cerebrovascular Disorders,D007246: Infertility,D009442: Neurilemmoma,D012559: Schizophrenia,D013345: Subarachnoid Hemorrhage,D019970: Cocaine-Related Disorders,D020521: Stroke	NR3C2	M9
P08235	NA	NA	NA	NA	FELODIPINE	Mineralocorticoid receptor antagonist	ANTAGONIST	1991	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D006937: Hypercholesterolemia,D006973: Hypertension,D050197: Atherosclerosis	NR3C2	M9
P08235	NA	NA	NA	NA	DROSPIRENONE	Mineralocorticoid receptor antagonist	ANTAGONIST	2001	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000152: Acne Vulgaris,D002032: Bulimia,D003866: Depressive Disorder,D004412: Dysmenorrhea,D011085: Polycystic Ovary Syndrome,D011293: Premenstrual Syndrome,D017497: Hidradenitis Suppurativa,D052018: Bulimia Nervosa	NR3C2	M9
P08235	NA	NA	NA	NA	EPLERENONE	Mineralocorticoid receptor antagonist	ANTAGONIST	2002	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D006333: Heart Failure,D006973: Hypertension,D009202: Cardiomyopathies,D009203: Myocardial Infarction,D020388: Muscular Dystrophy, Duchenne,D049950: Hyperparathyroidism, Primary,D051436: Renal Insufficiency, Chronic,D056833: Central Serous Chorioretinopathy	NR3C2	M9
P08235	NA	NA	NA	NA	DESOXYCORTICOSTERONE ACETATE	Mineralocorticoid receptor agonist	AGONIST	1939	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	NA	NR3C2	M9
P08235	NA	NA	NA	NA	DESOXYCORTICOSTERONE PIVALATE	Mineralocorticoid receptor agonist	AGONIST	1982	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	NA	NR3C2	M9
P08235	NA	NA	NA	NA	FLUDROCORTISONE ACETATE	Mineralocorticoid receptor agonist	AGONIST	1955	CHEMBL1994	48	P08235	Mineralocorticoid receptor	Homo sapiens	D000224: Addison Disease,D000312: Adrenal Hyperplasia, Congenital,D003866: Depressive Disorder,D006319: Hearing Loss, Sensorineural,D008545: Melanoma,D010300: Parkinson Disease,D012772: Shock, Septic,D016471: Ovarian Hyperstimulation Syndrome,D047808: Adrenogenital Syndrome	NR3C2	M9
P29459	NA	NA	NA	NA	USTEKINUMAB	Interleukin-12 inhibitor	INHIBITOR	2009	CHEMBL2364153	106132	P29459	Interleukin-12 subunit alpha	Homo sapiens	D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D003092: Colitis,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003882: Dermatomyositis,D003922: Diabetes Mellitus, Type 1,D006086: Graft vs Host Disease,D007057: Ichthyosis,D007154: Immune System Diseases,D008105: Liver Cirrhosis, Biliary,D008180: Lupus Erythematosus, Systemic,D009103: Multiple Sclerosis,D010391: Pemphigoid, Bullous,D011565: Psoriasis,D012507: Sarcoidosis,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014605: Uveitis,D015535: Arthritis, Psoriatic,D017497: Hidradenitis Suppurativa,D019337: Hematologic Neoplasms,D019449: Pouchitis	IL12A	M9
P42263	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	1996	CHEMBL2096670	104825	P42263	Glutamate receptor 3	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIA3	M9
P42263	NA	NA	NA	NA	PERAMPANEL	Glutamate receptor ionotropic AMPA antagonist	ANTAGONIST	2012	CHEMBL2096670	104825	P42263	Glutamate receptor 3	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004830: Epilepsy, Tonic-Clonic,D008881: Migraine Disorders,D009437: Neuralgia,D010300: Parkinson Disease,D010523: Peripheral Nervous System Diseases,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014103: Torticollis,D020329: Essential Tremor,D065768: Lennox Gastaut Syndrome	GRIA3	M9
P35916	NA	NA	NA	NA	VANDETANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2011	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M9
P35916	NA	NA	NA	NA	SUNITINIB MALATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2006	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006528: Carcinoma, Hepatocellular,D006623: von Hippel-Lindau Disease,D007012: Hypopharyngeal Neoplasms,D007516: Adenoma, Islet Cell,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D018263: Adenocarcinoma, Follicular,D018273: Carcinoma, Islet Cell,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018358: Neuroendocrine Tumors,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M9
P35916	NA	NA	NA	NA	SORAFENIB TOSYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2005	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013964: Thyroid Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018222: Fibromatosis, Aggressive,D018263: Adenocarcinoma, Follicular,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D023981: Sarcoma, Myeloid,D046152: Gastrointestinal Stromal Tumors,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M9
P35916	NA	NA	NA	NA	PAZOPANIB HYDROCHLORIDE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2009	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006394: Hemangiosarcoma,D006623: von Hippel-Lindau Disease,D008175: Lung Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M9
P35916	NA	NA	NA	NA	TIVOZANIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2021	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D009369: Neoplasms,D010051: Ovarian Neoplasms,D012509: Sarcoma,D015179: Colorectal Neoplasms,D018281: Cholangiocarcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M9
P35916	NA	NA	NA	NA	AXITINIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001661: Biliary Tract Neoplasms,D001752: Blast Crisis,D001943: Breast Neoplasms,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003528: Carcinoma, Adenoid Cystic,D004715: Endometriosis,D005909: Glioblastoma,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008545: Melanoma,D008654: Mesothelioma,D009190: Myelodysplastic Syndromes,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016889: Endometrial Neoplasms,D018234: Sarcoma, Alveolar Soft Part,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D064129: Prostatic Neoplasms, Castration-Resistant	FLT4	M9
P35916	NA	NA	NA	NA	REGORAFENIB	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2012	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D001650: Bile Duct Neoplasms,D001661: Biliary Tract Neoplasms,D002277: Carcinoma,D002292: Carcinoma, Renal Cell,D003110: Colonic Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D008080: Liposarcoma,D008268: Macular Degeneration,D008545: Melanoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D012004: Rectal Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D018281: Cholangiocarcinoma,D029424: Pulmonary Disease, Chronic Obstructive,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma	FLT4	M9
P35916	NA	NA	NA	NA	LENVATINIB MESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2015	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	D002289: Carcinoma, Non-Small-Cell Lung,D008545: Melanoma,D009369: Neoplasms,D013964: Thyroid Neoplasms,D018281: Cholangiocarcinoma	FLT4	M9
P35916	NA	NA	NA	NA	NINTEDANIB ESYLATE	Vascular endothelial growth factor receptor inhibitor	INHIBITOR	2014	CHEMBL2095227	104799	P35916	Vascular endothelial growth factor receptor 3	Homo sapiens	NA	FLT4	M9
P07101	NA	NA	NA	NA	METYROSINE	Tyrosine 3-hydroxylase inhibitor	INHIBITOR	1979	CHEMBL1969	39	P07101	Tyrosine 3-monooxygenase	Homo sapiens	D006973: Hypertension,D011618: Psychotic Disorders	TH	M9
Q16099	NA	NA	NA	NA	TOPIRAMATE	Glutamate receptor ionotropic kainate antagonist	ANTAGONIST	1996	CHEMBL2109241	104902	Q16099	Glutamate receptor ionotropic, kainate 4	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	GRIK4	M9
O14561	NA	NA	NA	NA	METFORMIN HYDROCHLORIDE	Mitochondrial complex I (NADH dehydrogenase) inhibitor	INHIBITOR	1995	CHEMBL2363065	105760	O14561	Acyl carrier protein, mitochondrial	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000080362: Stargardt Disease,D001201: Ascites,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003110: Colonic Neoplasms,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006946: Hyperinsulinism,D007249: Inflammation,D009101: Multiple Myeloma,D009765: Obesity,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010996: Pleural Effusion,D011085: Polycystic Ovary Syndrome,D011471: Prostatic Neoplasms,D016640: Diabetes, Gestational,D017719: Diabetic Foot,D018269: Carcinoma, Endometrioid,D018293: Cystadenoma, Serous,D018316: Gliosarcoma,D021441: Carcinoma, Pancreatic Ductal,D024821: Metabolic Syndrome,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	NDUFAB1	M9
P05556	NA	NA	NA	NA	NATALIZUMAB	Integrin alpha-4/beta-1 inhibitor	INHIBITOR	2004	CHEMBL1907599	104293	P05556	Integrin beta-1	Homo sapiens	D000083242: Ischemic Stroke,D001172: Arthritis, Rheumatoid,D003424: Crohn Disease,D006086: Graft vs Host Disease,D007154: Immune System Diseases,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D012516: Osteosarcoma,D012559: Schizophrenia,D018979: Myositis, Inclusion Body,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting	ITGB1	M9
P30530	NA	NA	NA	NA	GILTERITINIB FUMARATE	Tyrosine-protein kinase receptor UFO inhibitor	INHIBITOR	2018	CHEMBL4895	100410	P30530	Tyrosine-protein kinase receptor UFO	Homo sapiens	D015470: Leukemia, Myeloid, Acute	AXL	M9
P30530	NA	NA	NA	NA	GILTERITINIB	Tyrosine-protein kinase receptor UFO inhibitor	INHIBITOR	2018	CHEMBL4895	100410	P30530	Tyrosine-protein kinase receptor UFO	Homo sapiens	D001752: Blast Crisis,D002289: Carcinoma, Non-Small-Cell Lung,D007674: Kidney Diseases,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D015470: Leukemia, Myeloid, Acute	AXL	M9
P00747	NA	NA	NA	NA	TRANEXAMIC ACID	Plasminogen inhibitor	INHIBITOR	1986	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000740: Anemia,D001254: Astrocytoma,D001416: Back Pain,D001749: Urinary Bladder Neoplasms,D001778: Blood Coagulation Disorders,D001859: Bone Neoplasms,D001930: Brain Injuries,D002543: Cerebral Hemorrhage,D003327: Coronary Disease,D004844: Epistaxis,D005265: Femoral Neck Fractures,D005910: Glioma,D006258: Head and Neck Neoplasms,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D006473: Postpartum Hemorrhage,D006620: Hip Fractures,D007022: Hypotension,D007592: Joint Diseases,D007889: Leiomyoma,D008548: Melanosis,D008579: Meningioma,D008595: Menorrhagia,D009298: Nasal Polyps,D009369: Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010921: Placenta Accreta,D010923: Placenta Previa,D012600: Scoliosis,D012769: Shock,D012772: Shock, Septic,D012878: Skin Neoplasms,D013345: Subarachnoid Hemorrhage,D013683: Telangiectasia, Hereditary Hemorrhagic,D013921: Thrombocytopenia,D014947: Wounds and Injuries,D017544: Aortic Aneurysm, Abdominal,D019337: Hematologic Neoplasms,D020370: Osteoarthritis, Knee,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050723: Fractures, Bone,D054179: Angioedemas, Hereditary,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse	PLG	M9
P00747	NA	NA	NA	NA	AMINOCAPROIC ACID	Plasminogen inhibitor	INHIBITOR	1964	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001018: Aortic Diseases,D003398: Craniosynostoses,D006470: Hemorrhage,D007249: Inflammation,D012393: Rosacea	PLG	M9
P00747	NA	NA	NA	NA	ALTEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000038: Abscess,D000083242: Ischemic Stroke,D001991: Bronchitis,D002543: Cerebral Hemorrhage,D002544: Cerebral Infarction,D002545: Brain Ischemia,D004653: Empyema,D005128: Eye Diseases,D006333: Heart Failure,D006470: Hemorrhage,D009203: Myocardial Infarction,D009369: Neoplasms,D009422: Nervous System Diseases,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D012170: Retinal Vein Occlusion,D013345: Subarachnoid Hemorrhage,D013924: Thrombophlebitis,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016055: Urinary Retention,D016724: Empyema, Pleural,D017202: Myocardial Ischemia,D018784: Abdominal Abscess,D020246: Venous Thrombosis,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D060050: Angina, Stable	PLG	M9
P00747	NA	NA	NA	NA	UROKINASE	Plasminogen activator	ACTIVATOR	2007	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D004653: Empyema,D007239: Infections,D011655: Pulmonary Embolism,D013927: Thrombosis,D016724: Empyema, Pleural,D020521: Stroke	PLG	M9
P00747	NA	NA	NA	NA	APROTININ	Plasminogen inhibitor	INHIBITOR	1993	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D001943: Breast Neoplasms,D006470: Hemorrhage,D010195: Pancreatitis	PLG	M9
P00747	NA	NA	NA	NA	RETEPLASE	Plasminogen activator	ACTIVATOR	1996	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D009203: Myocardial Infarction,D013927: Thrombosis,D020521: Stroke	PLG	M9
P00747	NA	NA	NA	NA	STREPTOKINASE	Plasminogen activator	ACTIVATOR	1997	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000083242: Ischemic Stroke,D009203: Myocardial Infarction,D010195: Pancreatitis,D013927: Thrombosis,D017202: Myocardial Ischemia,D020246: Venous Thrombosis	PLG	M9
P00747	NA	NA	NA	NA	TENECTEPLASE	Plasminogen activator	ACTIVATOR	2000	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D002544: Cerebral Infarction,D002545: Brain Ischemia,D009203: Myocardial Infarction,D009422: Nervous System Diseases,D010996: Pleural Effusion,D011655: Pulmonary Embolism,D012128: Respiratory Distress Syndrome,D013927: Thrombosis,D015356: Retinal Artery Occlusion,D016757: Death, Sudden, Cardiac,D020521: Stroke	PLG	M9
P00747	NA	NA	NA	NA	DEFIBROTIDE SODIUM	Plasminogen activator	ACTIVATOR	2016	CHEMBL1801	12	P00747	Plasminogen	Homo sapiens	D006504: Hepatic Veno-Occlusive Disease	PLG	M9
P54753	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54753	Ephrin type-B receptor 3	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHB3	M9
O95263	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	O95263	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE8B	M9
O95263	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	O95263	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE8B	M9
O95263	NA	NA	NA	NA	FLAVOXATE HYDROCHLORIDE	Phosphodiesterase 8 inhibitor	INHIBITOR	1970	CHEMBL2363067	105762	O95263	High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B	Homo sapiens	NA	PDE8B	M9
P24723	NA	NA	NA	NA	MIDOSTAURIN	Protein kinase C (PKC) inhibitor	INHIBITOR	2017	CHEMBL2093867	104683	P24723	Protein kinase C eta type	Homo sapiens	D001752: Blast Crisis,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008107: Liver Diseases,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D012004: Rectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D034721: Mastocytosis, Systemic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PRKCH	M9
P11473	NA	NA	NA	NA	CALCITRIOL	Vitamin D receptor agonist	AGONIST	1978	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D001943: Breast Neoplasms,D002280: Carcinoma, Basal Cell,D002289: Carcinoma, Non-Small-Cell Lung,D003424: Crohn Disease,D003876: Dermatitis, Atopic,D003922: Diabetes Mellitus, Type 1,D003928: Diabetic Nephropathies,D005350: Fibroma,D006973: Hypertension,D006996: Hypocalcemia,D007011: Hypoparathyroidism,D007676: Kidney Failure, Chronic,D007713: Klinefelter Syndrome,D008180: Lupus Erythematosus, Systemic,D008545: Melanoma,D009062: Mouth Neoplasms,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D010024: Osteoporosis,D010190: Pancreatic Neoplasms,D011125: Adenomatous Polyposis Coli,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012080: Chronic Kidney Disease-Mineral and Bone Disorder,D015663: Osteoporosis, Postmenopausal,D016543: Central Nervous System Neoplasms,D018281: Cholangiocarcinoma,D018805: Sepsis,D051436: Renal Insufficiency, Chronic,D053098: Familial Hypophosphatemic Rickets,D058186: Acute Kidney Injury,D064129: Prostatic Neoplasms, Castration-Resistant	VDR	M9
P11473	NA	NA	NA	NA	CHOLECALCIFEROL	Vitamin D receptor agonist	AGONIST	1999	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000236: Adenoma,D000326: Adrenoleukodystrophy,D000375: Aging,D000740: Anemia,D000755: Anemia, Sickle Cell,D001171: Arthritis, Juvenile,D001249: Asthma,D001321: Autistic Disorder,D001471: Barrett Esophagus,D001851: Bone Diseases, Metabolic,D001943: Breast Neoplasms,D001988: Bronchiolitis,D002056: Burns,D002278: Carcinoma in Situ,D002285: Carcinoma, Intraductal, Noninfiltrating,D002318: Cardiovascular Diseases,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003139: Common Cold,D003233: Conjunctivitis, Allergic,D003424: Crohn Disease,D003866: Depressive Disorder,D003876: Dermatitis, Atopic,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D005891: Gingivitis,D005909: Glioblastoma,D006333: Heart Failure,D006526: Hepatitis C,D006620: Hip Fractures,D006949: Hyperlipidemias,D006967: Hypersensitivity,D007006: Hypogonadism,D007239: Infections,D007248: Infertility, Male,D007251: Influenza, Human,D008180: Lupus Erythematosus, Systemic,D008545: Melanoma,D009103: Multiple Sclerosis,D009369: Neoplasms,D009456: Neurofibromatosis 1,D009765: Obesity,D009902: Optic Neuritis,D010001: Osteitis Deformans,D010024: Osteoporosis,D010051: Ovarian Neoplasms,D010212: Papilloma,D010300: Parkinson Disease,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011565: Psoriasis,D011618: Psychotic Disorders,D012004: Rectal Neoplasms,D012131: Respiratory Insufficiency,D012559: Schizophrenia,D012878: Skin Neoplasms,D013203: Staphylococcal Infections,D013978: Tibial Fractures,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014581: Urticaria,D014808: Vitamin D Deficiency,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D016481: Helicobacter Infections,D016640: Diabetes, Gestational,D018149: Glucose Intolerance,D018798: Anemia, Iron-Deficiency,D019337: Hematologic Neoplasms,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D043183: Irritable Bowel Syndrome,D044342: Malnutrition,D045169: Severe Acute Respiratory Syndrome,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D055623: Keratosis, Actinic,D055948: Sarcopenia,D060825: Cognitive Dysfunction,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	VDR	M9
P11473	NA	NA	NA	NA	ERGOCALCIFEROL	Vitamin D receptor agonist	AGONIST	1941	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000071698: Latent Autoimmune Diabetes in Adults,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001249: Asthma,D001778: Blood Coagulation Disorders,D001851: Bone Diseases, Metabolic,D001943: Breast Neoplasms,D002056: Burns,D002583: Uterine Cervical Neoplasms,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003424: Crohn Disease,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003929: Diabetic Neuropathies,D004211: Disseminated Intravascular Coagulation,D005265: Femoral Neck Fractures,D005870: Giant Cell Tumors,D006333: Heart Failure,D006526: Hepatitis C,D006620: Hip Fractures,D006966: Hyperprolactinemia,D006996: Hypocalcemia,D007011: Hypoparathyroidism,D007015: Hypophosphatemia, Familial,D007333: Insulin Resistance,D007938: Leukemia,D008175: Lung Neoplasms,D008178: Lupus Erythematosus, Cutaneous,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008593: Menopause,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009369: Neoplasms,D009765: Obesity,D009902: Optic Neuritis,D010001: Osteitis Deformans,D010013: Osteogenesis Imperfecta,D010024: Osteoporosis,D010146: Pain,D010411: Penile Induration,D011085: Polycystic Ovary Syndrome,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012148: Restless Legs Syndrome,D014376: Tuberculosis,D014397: Tuberculosis, Pulmonary,D014808: Vitamin D Deficiency,D015179: Colorectal Neoplasms,D015212: Inflammatory Bowel Diseases,D015658: HIV Infections,D015663: Osteoporosis, Postmenopausal,D016640: Diabetes, Gestational,D016757: Death, Sudden, Cardiac,D016889: Endometrial Neoplasms,D017202: Myocardial Ischemia,D019698: Hepatitis C, Chronic,D019964: Mood Disorders,D020370: Osteoarthritis, Knee,D044342: Malnutrition,D045169: Severe Acute Respiratory Syndrome,D047928: Premature Birth,D049950: Hyperparathyroidism, Primary,D050723: Fractures, Bone,D051436: Renal Insufficiency, Chronic,D052439: Lipid Metabolism Disorders,D053098: Familial Hypophosphatemic Rickets,D055948: Sarcopenia,D063730: Rickets, Hypophosphatemic,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	VDR	M9
P11473	NA	NA	NA	NA	PARICALCITOL	Vitamin D receptor agonist	AGONIST	1998	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000419: Albuminuria,D001943: Breast Neoplasms,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D005922: Glomerulonephritis, IGA,D006962: Hyperparathyroidism, Secondary,D006996: Hypocalcemia,D007674: Kidney Diseases,D009101: Multiple Myeloma,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D010279: Parathyroid Diseases,D011507: Proteinuria,D012004: Rectal Neoplasms,D017379: Hypertrophy, Left Ventricular,D021441: Carcinoma, Pancreatic Ductal,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	VDR	M9
P11473	NA	NA	NA	NA	CALCIPOTRIENE	Vitamin D receptor agonist	AGONIST	1993	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D000152: Acne Vulgaris,D003876: Dermatitis, Atopic,D004485: Eczema,D011565: Psoriasis,D011855: Radiodermatitis,D012594: Scleroderma, Localized,D012871: Skin Diseases,D014820: Vitiligo,D055623: Keratosis, Actinic	VDR	M9
P11473	NA	NA	NA	NA	DOXERCALCIFEROL	Vitamin D receptor agonist	AGONIST	1999	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D009369: Neoplasms,D010279: Parathyroid Diseases,D011565: Psoriasis,D051436: Renal Insufficiency, Chronic,D064129: Prostatic Neoplasms, Castration-Resistant	VDR	M9
P11473	NA	NA	NA	NA	CALCIFEDIOL	Vitamin D receptor agonist	AGONIST	1980	CHEMBL1977	64	P11473	Vitamin D3 receptor	Homo sapiens	D006962: Hyperparathyroidism, Secondary,D009203: Myocardial Infarction,D010279: Parathyroid Diseases,D014808: Vitamin D Deficiency,D020181: Sleep Apnea, Obstructive,D045169: Severe Acute Respiratory Syndrome,D058186: Acute Kidney Injury	VDR	M9
P05106	NA	NA	NA	NA	EPTIFIBATIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000083242: Ischemic Stroke,D000755: Anemia, Sickle Cell,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D009203: Myocardial Infarction,D011014: Pneumonia,D012772: Shock, Septic,D013927: Thrombosis,D020520: Brain Infarction,D020521: Stroke,D054058: Acute Coronary Syndrome	ITGB3	M9
P05106	NA	NA	NA	NA	ABCIXIMAB	Integrin alpha-V/beta-3 inhibitor	INHIBITOR	1993	CHEMBL1907598	104292	P05106	Integrin beta-3	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000208: Acute Disease,D000789: Angina, Unstable,D002545: Brain Ischemia,D009203: Myocardial Infarction,D013927: Thrombosis,D016893: Carotid Stenosis,D020521: Stroke,D060050: Angina, Stable	ITGB3	M9
P05106	NA	NA	NA	NA	TIROFIBAN HYDROCHLORIDE	Integrin alpha-IIb/beta-3 inhibitor	INHIBITOR	1998	CHEMBL2093869	104685	P05106	Integrin beta-3	Homo sapiens	NA	ITGB3	M9
P61812	NA	NA	NA	NA	LUSPATERCEPT	Transforming growth factor beta inhibitor	INHIBITOR	2019	CHEMBL3988637	117291	P61812	Transforming growth factor beta-2 proprotein	Homo sapiens	D000740: Anemia,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D011087: Polycythemia Vera,D013789: Thalassemia,D017086: beta-Thalassemia,D055728: Primary Myelofibrosis	TGFB2	M9
P63027	NA	NA	NA	NA	BOTULINUM TOXIN TYPE B	Vesicle-associated membrane protein 2 inhibitor	INHIBITOR	2000	CHEMBL2364160	106139	P63027	Vesicle-associated membrane protein 2	Homo sapiens	D001281: Atrial Fibrillation,D002349: Carpal Tunnel Syndrome,D002547: Cerebral Palsy,D003704: Dementia,D006945: Hyperhidrosis,D012798: Sialorrhea,D012883: Skin Ulcer,D014103: Torticollis	VAMP2	M9
P54764	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54764	Ephrin type-A receptor 4	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA4	M9
P08172	NA	NA	NA	NA	OXYBUTYNIN CHLORIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1975	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D011471: Prostatic Neoplasms,D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM2	M9
P08172	NA	NA	NA	NA	OXYBUTYNIN	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1975	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D001750: Urinary Bladder, Neurogenic,D006255: Rhinitis, Allergic, Seasonal,D006945: Hyperhidrosis,D010145: Paget Disease, Extramammary,D011115: Polyneuropathies,D011141: Polyuria,D012891: Sleep Apnea Syndromes,D014549: Urinary Incontinence,D020181: Sleep Apnea, Obstructive,D053201: Urinary Bladder, Overactive	CHRM2	M9
P08172	NA	NA	NA	NA	PROPANTHELINE BROMIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1953	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM2	M9
P08172	NA	NA	NA	NA	ATROPINE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1960	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D000550: Amblyopia,D000690: Amyotrophic Lateral Sclerosis,D001778: Blood Coagulation Disorders,D001919: Bradycardia,D001943: Breast Neoplasms,D004066: Digestive System Diseases,D004393: Dwarfism, Pituitary,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006470: Hemorrhage,D007003: Hypoglycemia,D007021: Hypospadias,D007024: Hypotension, Orthostatic,D007333: Insulin Resistance,D009216: Myopia,D010146: Pain,D011183: Postoperative Complications,D011236: Prediabetic State,D013285: Strabismus,D053717: Pneumonia, Ventilator-Associated,D054971: Orthostatic Intolerance	CHRM2	M9
P08172	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Muscarinic acetylcholine receptor antagonist	ANTAGONIST	1986	CHEMBL2094109	104691	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2	M9
P08172	NA	NA	NA	NA	BETHANECHOL CHLORIDE	Muscarinic acetylcholine receptor M2 agonist	AGONIST	1948	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2	M9
P08172	NA	NA	NA	NA	SOLIFENACIN SUCCINATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D011470: Prostatic Hyperplasia,D053201: Urinary Bladder, Overactive	CHRM2	M9
P08172	NA	NA	NA	NA	DARIFENACIN HYDROBROMIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	NA	CHRM2	M9
P08172	NA	NA	NA	NA	FESOTERODINE FUMARATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2008	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D014549: Urinary Incontinence,D053201: Urinary Bladder, Overactive	CHRM2	M9
P08172	NA	NA	NA	NA	TOLTERODINE TARTRATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1998	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D053201: Urinary Bladder, Overactive	CHRM2	M9
P08172	NA	NA	NA	NA	ATROPINE SULFATE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	1960	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D006255: Rhinitis, Allergic, Seasonal,D009216: Myopia,D010300: Parkinson Disease,D010437: Peptic Ulcer,D011183: Postoperative Complications,D015878: Mydriasis,D062025: Organophosphate Poisoning	CHRM2	M9
P08172	NA	NA	NA	NA	TROSPIUM CHLORIDE	Muscarinic acetylcholine receptor M2 antagonist	ANTAGONIST	2004	CHEMBL211	47	P08172	Muscarinic acetylcholine receptor M2	Homo sapiens	D012559: Schizophrenia,D029424: Pulmonary Disease, Chronic Obstructive,D053201: Urinary Bladder, Overactive	CHRM2	M9
Q02643	NA	NA	NA	NA	SERMORELIN ACETATE	Growth hormone-releasing hormone receptor agonist	AGONIST	1990	CHEMBL2032	158	Q02643	Growth hormone-releasing hormone receptor	Homo sapiens	NA	GHRHR	M9
Q02643	NA	NA	NA	NA	TESAMORELIN ACETATE	Growth hormone-releasing hormone receptor agonist	AGONIST	2010	CHEMBL2032	158	Q02643	Growth hormone-releasing hormone receptor	Homo sapiens	D039682: HIV-Associated Lipodystrophy Syndrome	GHRHR	M9
P49005	NA	NA	NA	NA	CYTARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1969	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000505: Alopecia,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001752: Blast Crisis,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D004915: Leukemia, Erythroblastic, Acute,D005909: Glioblastoma,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008288: Malaria,D008527: Medulloblastoma,D008545: Melanoma,D008582: Meningitis, Aseptic,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009471: Neuromyelitis Optica,D009503: Neutropenia,D010051: Ovarian Neoplasms,D011087: Polycythemia Vera,D012509: Sarcoma,D013920: Thrombocythemia, Essential,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D051436: Renal Insufficiency, Chronic,D053201: Urinary Bladder, Overactive,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2	M9
P49005	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1996	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	POLD2	M9
P49005	NA	NA	NA	NA	CLOFARABINE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	2004	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	POLD2	M9
P49005	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	DNA polymerase (alpha/delta/epsilon) inhibitor	INHIBITOR	1991	CHEMBL2363042	105737	P49005	DNA polymerase delta subunit 2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	POLD2	M9
Q12879	NA	NA	NA	NA	FELBAMATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1993	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D001714: Bipolar Disorder,D004827: Epilepsy	GRIN2A	M9
Q12879	NA	NA	NA	NA	ESKETAMINE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006255: Rhinitis, Allergic, Seasonal,D007674: Kidney Diseases,D008107: Liver Diseases,D009369: Neoplasms,D019966: Substance-Related Disorders	GRIN2A	M9
Q12879	NA	NA	NA	NA	AMANTADINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1968	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D001930: Brain Injuries,D002537: Intracranial Arteriosclerosis,D006526: Hepatitis C,D007239: Infections,D007251: Influenza, Human,D009103: Multiple Sclerosis,D010300: Parkinson Disease,D010301: Parkinson Disease, Postencephalitic,D010302: Parkinson Disease, Secondary,D011618: Psychotic Disorders,D012559: Schizophrenia,D019964: Mood Disorders	GRIN2A	M9
Q12879	NA	NA	NA	NA	MEMANTINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2003	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000755: Anemia, Sickle Cell,D001321: Autistic Disorder,D003704: Dementia,D005715: Gambling,D005910: Glioma,D007251: Influenza, Human,D007859: Learning Disabilities,D018316: Gliosarcoma,D020817: Asperger Syndrome,D057180: Frontotemporal Dementia	GRIN2A	M9
Q12879	NA	NA	NA	NA	KETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	1970	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D000374: Aggression,D000437: Alcoholism,D000856: Anorexia Nervosa,D001714: Bipolar Disorder,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D009293: Opioid-Related Disorders,D009369: Neoplasms,D011537: Pruritus,D014012: Tinnitus,D014947: Wounds and Injuries,D018923: Persian Gulf Syndrome,D019970: Cocaine-Related Disorders,D050723: Fractures, Bone,D059020: Suicidal Ideation,D060825: Cognitive Dysfunction	GRIN2A	M9
Q12879	NA	NA	NA	NA	ORPHENADRINE CITRATE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1959	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D010146: Pain	GRIN2A	M9
Q12879	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Glutamate [NMDA] receptor antagonist	ANTAGONIST	1957	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D010300: Parkinson Disease	GRIN2A	M9
Q12879	NA	NA	NA	NA	DEXTROMETHORPHAN POLISTIREX	Glutamate [NMDA] receptor subunit epsilon 1 antagonist	ANTAGONIST	1982	CHEMBL1972	166	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D002659: Child Development Disorders, Pervasive	GRIN2A	M9
Q12879	NA	NA	NA	NA	DEXTROMETHORPHAN HYDROBROMIDE	Glutamate [NMDA] receptor subunit epsilon 1 antagonist	ANTAGONIST	1984	CHEMBL1972	166	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D003139: Common Cold,D003371: Cough,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006967: Hypersensitivity,D008881: Migraine Disorders,D009369: Neoplasms,D010146: Pain,D011471: Prostatic Neoplasms,D012852: Sinusitis	GRIN2A	M9
Q12879	NA	NA	NA	NA	ACAMPROSATE CALCIUM	Glutamate [NMDA] receptor antagonist	ANTAGONIST	2004	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D000437: Alcoholism	GRIN2A	M9
Q12879	NA	NA	NA	NA	ESKETAMINE HYDROCHLORIDE	Glutamate [NMDA] receptor negative allosteric modulator	NEGATIVE ALLOSTERIC MODULATOR	2019	CHEMBL2094124	104706	Q12879	Glutamate receptor ionotropic, NMDA 2A	Homo sapiens	D003865: Depressive Disorder, Major,D010146: Pain,D014012: Tinnitus	GRIN2A	M9
P07550	NA	NA	NA	NA	TIMOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D008545: Melanoma,D008881: Migraine Disorders,D009798: Ocular Hypertension,D013683: Telangiectasia, Hereditary Hemorrhagic,D014647: Varicose Ulcer,D014947: Wounds and Injuries,D017889: Exfoliation Syndrome,D057135: Wet Macular Degeneration	ADRB2	M9
P07550	NA	NA	NA	NA	PINDOLOL	Beta-2 adrenergic receptor partial agonist	PARTIAL AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases,D003865: Depressive Disorder, Major,D003866: Depressive Disorder	ADRB2	M9
P07550	NA	NA	NA	NA	NADOLOL	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D002318: Cardiovascular Diseases,D006391: Hemangioma,D006973: Hypertension,D016540: Smoking Cessation	ADRB2	M9
P07550	NA	NA	NA	NA	EPINEPHRINE	Adrenergic receptor agonist	AGONIST	1976	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000070636: Rotator Cuff Injuries,D000799: Angioedema,D001064: Appendicitis,D001249: Asthma,D001943: Breast Neoplasms,D001986: Bronchial Spasm,D001988: Bronchiolitis,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D005901: Glaucoma,D006255: Rhinitis, Allergic, Seasonal,D006323: Heart Arrest,D006333: Heart Failure,D006469: Hemoptysis,D006470: Hemorrhage,D006471: Gastrointestinal Hemorrhage,D007021: Hypospadias,D007239: Infections,D008173: Lung Diseases, Obstructive,D009214: Myoma,D009369: Neoplasms,D010146: Pain,D010282: Parathyroid Neoplasms,D011671: Pulpitis,D012221: Rhinitis, Allergic, Perennial,D012713: Serum Sickness,D012769: Shock,D012772: Shock, Septic,D012852: Sinusitis,D012878: Skin Neoplasms,D013274: Stomach Neoplasms,D014581: Urticaria,D014693: Ventricular Fibrillation,D014947: Wounds and Injuries,D015508: Nasal Obstruction,D016757: Death, Sudden, Cardiac,D017180: Tachycardia, Ventricular,D020370: Osteoarthritis, Knee,D055371: Acute Lung Injury,D060825: Cognitive Dysfunction	ADRB2	M9
P07550	NA	NA	NA	NA	ALBUTEROL	Beta-2 adrenergic receptor agonist	AGONIST	1981	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D001988: Bronchiolitis,D003371: Cough,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D004402: Dysautonomia, Familial,D006009: Glycogen Storage Disease Type II,D006255: Rhinitis, Allergic, Seasonal,D006333: Heart Failure,D006967: Hypersensitivity,D006976: Hypertension, Pulmonary,D008171: Lung Diseases,D008173: Lung Diseases, Obstructive,D008569: Memory Disorders,D011654: Pulmonary Edema,D012131: Respiratory Insufficiency,D013119: Spinal Cord Injuries,D013224: Status Asthmaticus,D018192: Lymphangioleiomyomatosis,D020294: Myasthenic Syndromes, Congenital,D029424: Pulmonary Disease, Chronic Obstructive,D054990: Idiopathic Pulmonary Fibrosis,D062025: Organophosphate Poisoning,D065627: Familial Primary Pulmonary Hypertension	ADRB2	M9
P07550	NA	NA	NA	NA	CARVEDILOL	Adrenergic receptor beta antagonist	ANTAGONIST	1995	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000075222: Essential Hypertension,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004932: Esophageal and Gastric Varices,D005909: Glioblastoma,D006333: Heart Failure,D006937: Hypercholesterolemia,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007003: Hypoglycemia,D007674: Kidney Diseases,D007945: Leukemia, Lymphoid,D008223: Lymphoma,D009101: Multiple Myeloma,D009203: Myocardial Infarction,D009369: Neoplasms,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D014652: Vascular Diseases,D015470: Leukemia, Myeloid, Acute,D017379: Hypertrophy, Left Ventricular,D018487: Ventricular Dysfunction, Left,D019970: Cocaine-Related Disorders,D050197: Atherosclerosis,D064129: Prostatic Neoplasms, Castration-Resistant	ADRB2	M9
P07550	NA	NA	NA	NA	PROPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1967	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001749: Urinary Bladder Neoplasms,D003924: Diabetes Mellitus, Type 2,D004932: Esophageal and Gastric Varices,D006391: Hemangioma,D006973: Hypertension,D008103: Liver Cirrhosis,D008545: Melanoma,D008881: Migraine Disorders,D009069: Movement Disorders,D010190: Pancreatic Neoplasms,D011471: Prostatic Neoplasms,D012509: Sarcoma,D013313: Stress Disorders, Post-Traumatic,D013771: Tetralogy of Fallot,D015179: Colorectal Neoplasms,D019970: Cocaine-Related Disorders	ADRB2	M9
P07550	NA	NA	NA	NA	SOTALOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1992	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M9
P07550	NA	NA	NA	NA	ISOPROTERENOL HYDROCHLORIDE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	SALMETEROL XINAFOATE	Beta-2 adrenergic receptor agonist	AGONIST	1994	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001989: Bronchiolitis Obliterans,D004646: Emphysema,D009765: Obesity,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M9
P07550	NA	NA	NA	NA	VILANTEROL TRIFENATATE	Beta-2 adrenergic receptor agonist	AGONIST	2013	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M9
P07550	NA	NA	NA	NA	LABETALOL HYDROCHLORIDE	Adrenergic receptor antagonist	ANTAGONIST	1984	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002543: Cerebral Hemorrhage,D011225: Pre-Eclampsia	ADRB2	M9
P07550	NA	NA	NA	NA	BITOLTEROL MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	DOBUTAMINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D002318: Cardiovascular Diseases	ADRB2	M9
P07550	NA	NA	NA	NA	PIRBUTEROL ACETATE	Beta-2 adrenergic receptor agonist	AGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M9
P07550	NA	NA	NA	NA	HYDROXYAMPHETAMINE HYDROBROMIDE	Adrenergic receptor agonist	AGONIST	1969	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	OXPRENOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1983	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	DIPIVEFRIN HYDROCHLORIDE	Adrenergic receptor agonist	AGONIST	1980	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	TIMOLOL MALEATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1978	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005901: Glaucoma,D005902: Glaucoma, Open-Angle,D006391: Hemangioma,D006975: Hypertension, Portal,D009798: Ocular Hypertension,D015715: Corneal Edema,D018917: Optic Neuropathy, Ischemic	ADRB2	M9
P07550	NA	NA	NA	NA	PROTOKYLOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	ISOETHARINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1979	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	METIPRANOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	CARTEOLOL HYDROCHLORIDE	Adrenergic receptor beta antagonist	ANTAGONIST	1988	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D005902: Glaucoma, Open-Angle	ADRB2	M9
P07550	NA	NA	NA	NA	LEVALBUTEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1999	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001986: Bronchial Spasm	ADRB2	M9
P07550	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1989	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	ADRB2	M9
P07550	NA	NA	NA	NA	ESMOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1986	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010048: Ovarian Cysts,D012772: Shock, Septic,D017719: Diabetic Foot,D060825: Cognitive Dysfunction	ADRB2	M9
P07550	NA	NA	NA	NA	ISOETHARINE MESYLATE	Beta-2 adrenergic receptor agonist	AGONIST	1984	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	CARVEDILOL PHOSPHATE	Adrenergic receptor beta antagonist	ANTAGONIST	2006	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006333: Heart Failure,D006973: Hypertension,D009203: Myocardial Infarction,D018487: Ventricular Dysfunction, Left	ADRB2	M9
P07550	NA	NA	NA	NA	LEVOBUNOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1985	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	NEBIVOLOL HYDROCHLORIDE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	2007	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D006973: Hypertension	ADRB2	M9
P07550	NA	NA	NA	NA	DILEVALOL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1990	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	EPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1965	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D010146: Pain	ADRB2	M9
P07550	NA	NA	NA	NA	TERBUTALINE SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1974	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M9
P07550	NA	NA	NA	NA	RITODRINE HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	1991	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	NOREPINEPHRINE BITARTRATE	Adrenergic receptor agonist	AGONIST	1950	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D000083242: Ischemic Stroke,D002318: Cardiovascular Diseases,D018805: Sepsis,D051437: Renal Insufficiency,D055371: Acute Lung Injury	ADRB2	M9
P07550	NA	NA	NA	NA	ALBUTEROL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1982	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001250: Asthma, Exercise-Induced,D001986: Bronchial Spasm,D002318: Cardiovascular Diseases,D008171: Lung Diseases,D012128: Respiratory Distress Syndrome,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M9
P07550	NA	NA	NA	NA	EPHEDRINE SULFATE	Adrenergic receptor agonist	AGONIST	2016	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma	ADRB2	M9
P07550	NA	NA	NA	NA	METAPROTERENOL SULFATE	Beta-2 adrenergic receptor agonist	AGONIST	1973	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D019966: Substance-Related Disorders	ADRB2	M9
P07550	NA	NA	NA	NA	INDACATEROL MALEATE	Beta-2 adrenergic receptor agonist	AGONIST	2011	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M9
P07550	NA	NA	NA	NA	ARFORMOTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2006	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001991: Bronchitis,D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic	ADRB2	M9
P07550	NA	NA	NA	NA	DROXIDOPA	Adrenergic receptor agonist	AGONIST	2014	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001289: Attention Deficit Disorder with Hyperactivity,D002318: Cardiovascular Diseases,D005356: Fibromyalgia,D007022: Hypotension,D007024: Hypotension, Orthostatic,D010300: Parkinson Disease,D019578: Multiple System Atrophy	ADRB2	M9
P07550	NA	NA	NA	NA	OLODATEROL HYDROCHLORIDE	Beta-2 adrenergic receptor agonist	AGONIST	2014	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D004646: Emphysema,D029424: Pulmonary Disease, Chronic Obstructive	ADRB2	M9
P07550	NA	NA	NA	NA	PENBUTOLOL SULFATE	Beta-2 adrenergic receptor antagonist	ANTAGONIST	1987	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	MEPHENTERMINE SULFATE	Adrenergic receptor agonist	AGONIST	1951	CHEMBL2331074	105670	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	ISOPROTERENOL SULFATE	Adrenergic receptor beta agonist	AGONIST	1956	CHEMBL2094118	104700	P07550	Beta-2 adrenergic receptor	Homo sapiens	NA	ADRB2	M9
P07550	NA	NA	NA	NA	LEVALBUTEROL TARTRATE	Beta-2 adrenergic receptor agonist	AGONIST	2005	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm	ADRB2	M9
P07550	NA	NA	NA	NA	FORMOTEROL FUMARATE	Beta-2 adrenergic receptor agonist	AGONIST	2001	CHEMBL210	43	P07550	Beta-2 adrenergic receptor	Homo sapiens	D001249: Asthma,D001986: Bronchial Spasm,D001987: Bronchiectasis,D001989: Bronchiolitis Obliterans,D001991: Bronchitis,D004646: Emphysema,D006967: Hypersensitivity,D008175: Lung Neoplasms,D012128: Respiratory Distress Syndrome,D014029: Tobacco Use Disorder,D029424: Pulmonary Disease, Chronic Obstructive,D029481: Bronchitis, Chronic,D045169: Severe Acute Respiratory Syndrome	ADRB2	M9
P55157	NA	NA	NA	NA	LOMITAPIDE MESYLATE	Microsomal triglyceride transfer protein inhibitor	INHIBITOR	2012	CHEMBL2364681	106181	P55157	Microsomal triglyceride transfer protein large subunit	Homo sapiens	D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias	MTTP	M9
P49286	NA	NA	NA	NA	RAMELTEON	Melatonin receptor agonist	AGONIST	2005	CHEMBL2094268	104733	P49286	Melatonin receptor type 1B	Homo sapiens	D001714: Bipolar Disorder,D002056: Burns,D002189: Marijuana Abuse,D003866: Depressive Disorder,D007319: Sleep Initiation and Maintenance Disorders,D012893: Sleep Wake Disorders,D014029: Tobacco Use Disorder,D019966: Substance-Related Disorders,D020181: Sleep Apnea, Obstructive,D020325: Migraine with Aura,D020326: Migraine without Aura,D029424: Pulmonary Disease, Chronic Obstructive	MTNR1B	M9
P49286	NA	NA	NA	NA	TASIMELTEON	Melatonin receptor agonist	AGONIST	2014	CHEMBL2094268	104733	P49286	Melatonin receptor type 1B	Homo sapiens	D003865: Depressive Disorder, Major,D007319: Sleep Initiation and Maintenance Disorders,D007674: Kidney Diseases,D008107: Liver Diseases,D012893: Sleep Wake Disorders,D020178: Sleep Disorders, Circadian Rhythm,D058496: Smith-Magenis Syndrome	MTNR1B	M9
P54756	NA	NA	NA	NA	VANDETANIB	Ephrin receptor inhibitor	INHIBITOR	2011	CHEMBL2363043	105738	P54756	Ephrin type-A receptor 5	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008654: Mesothelioma,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015470: Leukemia, Myeloid, Acute,D016543: Central Nervous System Neoplasms,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	EPHA5	M9
P04035	NA	NA	NA	NA	LOVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1987	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001172: Arthritis, Rheumatoid,D001249: Asthma,D001943: Breast Neoplasms,D002318: Cardiovascular Diseases,D002537: Intracranial Arteriosclerosis,D002538: Intracranial Arteriovenous Malformations,D005600: Fragile X Syndrome,D006331: Heart Diseases,D006937: Hypercholesterolemia,D007249: Inflammation,D007383: Intermittent Claudication,D007859: Learning Disabilities,D008545: Melanoma,D008659: Metabolic Diseases,D009456: Neurofibromatosis 1,D010051: Ovarian Neoplasms,D010300: Parkinson Disease,D015470: Leukemia, Myeloid, Acute,D015518: Rett Syndrome,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D017499: Porokeratosis,D019294: Xanthomatosis, Cerebrotendinous,D020521: Stroke,D029424: Pulmonary Disease, Chronic Obstructive,D052439: Lipid Metabolism Disorders,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M9
P04035	NA	NA	NA	NA	PRAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003922: Diabetes Mellitus, Type 1,D006937: Hypercholesterolemia,D006950: Hyperlipidemia, Familial Combined,D007938: Leukemia,D008060: Lipodystrophy,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D015658: HIV Infections	HMGCR	M9
P04035	NA	NA	NA	NA	SIMVASTATIN	HMG-CoA reductase inhibitor	INHIBITOR	1991	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000075222: Essential Hypertension,D000083242: Ischemic Stroke,D000506: Alopecia Areata,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D001024: Aortic Valve Stenosis,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001714: Bipolar Disorder,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002311: Cardiomyopathy, Dilated,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002543: Cerebral Hemorrhage,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003550: Cystic Fibrosis,D003865: Depressive Disorder, Major,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D003928: Diabetic Nephropathies,D003930: Diabetic Retinopathy,D004827: Epilepsy,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D006975: Hypertension, Portal,D006976: Hypertension, Pulmonary,D007249: Inflammation,D007319: Sleep Initiation and Maintenance Disorders,D007383: Intermittent Claudication,D007414: Intestinal Neoplasms,D007889: Leiomyoma,D008103: Liver Cirrhosis,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D008881: Migraine Disorders,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009369: Neoplasms,D009634: Noonan Syndrome,D009902: Optic Neuritis,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010195: Pancreatitis,D010300: Parkinson Disease,D010518: Periodontitis,D011014: Pneumonia,D011085: Polycystic Ovary Syndrome,D011236: Prediabetic State,D011471: Prostatic Neoplasms,D012004: Rectal Neoplasms,D012772: Shock, Septic,D012852: Sinusitis,D012893: Sleep Wake Disorders,D013274: Stomach Neoplasms,D013345: Subarachnoid Hemorrhage,D014605: Uveitis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015209: Cholangitis, Sclerosing,D015228: Hypertriglyceridemia,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D015794: Choroideremia,D016540: Smoking Cessation,D017202: Myocardial Ischemia,D018805: Sepsis,D019082: Smith-Lemli-Opitz Syndrome,D019694: Hepatitis B, Chronic,D020521: Stroke,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D020786: Hemangioma, Cavernous, Central Nervous System,D024821: Metabolic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D052016: Mucositis,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D059350: Chronic Pain,D061218: Depressive Disorder, Treatment-Resistant,D064129: Prostatic Neoplasms, Castration-Resistant	HMGCR	M9
P04035	NA	NA	NA	NA	ATORVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	1996	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000075222: Essential Hypertension,D000082882: Bicuspid Aortic Valve Disease,D000083242: Ischemic Stroke,D000544: Alzheimer Disease,D000755: Anemia, Sickle Cell,D000787: Angina Pectoris,D001172: Arthritis, Rheumatoid,D001249: Asthma,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002292: Carcinoma, Renal Cell,D002312: Cardiomyopathy, Hypertrophic,D002318: Cardiovascular Diseases,D002340: Carotid Artery Diseases,D002532: Intracranial Aneurysm,D002544: Cerebral Infarction,D003251: Constriction, Pathologic,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003424: Crohn Disease,D003919: Diabetes Insipidus,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D004489: Edema, Cardiac,D004827: Epilepsy,D005909: Glioblastoma,D005922: Glomerulonephritis, IGA,D005923: Glomerulosclerosis, Focal Segmental,D006086: Graft vs Host Disease,D006333: Heart Failure,D006526: Hepatitis C,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006952: Hyperlipoproteinemia Type III,D006953: Hyperlipoproteinemia Type IV,D006973: Hypertension,D006976: Hypertension, Pulmonary,D007251: Influenza, Human,D007674: Kidney Diseases,D007938: Leukemia,D008180: Lupus Erythematosus, Systemic,D008228: Lymphoma, Non-Hodgkin,D008268: Macular Degeneration,D009080: Mucocutaneous Lymph Node Syndrome,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009203: Myocardial Infarction,D009303: Nasopharyngeal Neoplasms,D009336: Necrosis,D009369: Neoplasms,D010020: Osteonecrosis,D010518: Periodontitis,D011085: Polycystic Ovary Syndrome,D011225: Pre-Eclampsia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012507: Sarcoidosis,D012594: Scleroderma, Localized,D012893: Sleep Wake Disorders,D014376: Tuberculosis,D014652: Vascular Diseases,D014820: Vitiligo,D015179: Colorectal Neoplasms,D015228: Hypertriglyceridemia,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D016553: Purpura, Thrombocytopenic, Idiopathic,D016889: Endometrial Neoplasms,D018805: Sepsis,D020181: Sleep Apnea, Obstructive,D020370: Osteoarthritis, Knee,D020521: Stroke,D020529: Multiple Sclerosis, Relapsing-Remitting,D024821: Metabolic Syndrome,D045169: Severe Acute Respiratory Syndrome,D046648: Hematoma, Subdural, Intracranial,D050171: Dyslipidemias,D050197: Atherosclerosis,D051436: Renal Insufficiency, Chronic,D051437: Renal Insufficiency,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome,D054556: Venous Thromboembolism,D056586: Acute Chest Syndrome,D058186: Acute Kidney Injury,D058922: Inflammatory Breast Neoplasms,D060050: Angina, Stable,D060825: Cognitive Dysfunction,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	HMGCR	M9
P04035	NA	NA	NA	NA	CERIVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1997	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	NA	HMGCR	M9
P04035	NA	NA	NA	NA	PITAVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2009	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006937: Hypercholesterolemia,D006949: Hyperlipidemias,D050171: Dyslipidemias,D052439: Lipid Metabolism Disorders	HMGCR	M9
P04035	NA	NA	NA	NA	ROSUVASTATIN CALCIUM	HMG-CoA reductase inhibitor	INHIBITOR	2003	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D000083242: Ischemic Stroke,D003324: Coronary Artery Disease,D003327: Coronary Disease,D003920: Diabetes Mellitus,D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D006333: Heart Failure,D006937: Hypercholesterolemia,D006938: Hyperlipoproteinemia Type II,D006949: Hyperlipidemias,D006950: Hyperlipidemia, Familial Combined,D006973: Hypertension,D015228: Hypertriglyceridemia,D052439: Lipid Metabolism Disorders,D054058: Acute Coronary Syndrome	HMGCR	M9
P04035	NA	NA	NA	NA	FLUVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	1993	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D001943: Breast Neoplasms,D006937: Hypercholesterolemia	HMGCR	M9
P04035	NA	NA	NA	NA	PITAVASTATIN SODIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M9
P04035	NA	NA	NA	NA	PITAVASTATIN MAGNESIUM	HMG-CoA reductase inhibitor	INHIBITOR	2017	CHEMBL402	24	P04035	3-hydroxy-3-methylglutaryl-coenzyme A reductase	Homo sapiens	D006949: Hyperlipidemias,D050171: Dyslipidemias	HMGCR	M9
O43924	NA	NA	NA	NA	PENTOXIFYLLINE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1984	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000071074: Neonatal Sepsis,D000740: Anemia,D001528: Behcet Syndrome,D001656: Biliary Atresia,D001714: Bipolar Disorder,D001927: Brain Diseases,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003865: Depressive Disorder, Major,D003928: Diabetic Nephropathies,D004374: Ductus Arteriosus, Patent,D004715: Endometriosis,D005234: Fatty Liver,D005355: Fibrosis,D005921: Glomerulonephritis,D006258: Head and Neck Neoplasms,D006519: Hepatitis, Alcoholic,D007246: Infertility,D007896: Leishmaniasis,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D009369: Neoplasms,D009404: Nephrotic Syndrome,D010020: Osteonecrosis,D010195: Pancreatitis,D012559: Schizophrenia,D014947: Wounds and Injuries,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D016773: Leishmaniasis, Cutaneous,D016778: Malaria, Falciparum,D017093: Liver Failure,D017565: Sarcoidosis, Pulmonary,D020065: Hepatopulmonary Syndrome,D020345: Enterocolitis, Necrotizing,D020388: Muscular Dystrophy, Duchenne,D020516: Brachial Plexus Neuropathies,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D058186: Acute Kidney Injury,D065626: Non-alcoholic Fatty Liver Disease	PDE6D	M9
O43924	NA	NA	NA	NA	DIPYRIDAMOLE	3',5'-cyclic phosphodiesterase inhibitor	INHIBITOR	1961	CHEMBL2363066	105761	O43924	Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta	Homo sapiens	D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D003324: Coronary Artery Disease,D003327: Coronary Disease,D006331: Heart Diseases,D006973: Hypertension,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D013927: Thrombosis,D015658: HIV Infections,D016893: Carotid Stenosis,D017202: Myocardial Ischemia,D020521: Stroke,D045169: Severe Acute Respiratory Syndrome,D054549: Takotsubo Cardiomyopathy,D060050: Angina, Stable	PDE6D	M9
P05023	NA	NA	NA	NA	DIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P05023	Sodium/potassium-transporting ATPase subunit alpha-1	Homo sapiens	D002318: Cardiovascular Diseases,D003550: Cystic Fibrosis	ATP1A1	M9
P05023	NA	NA	NA	NA	DESLANOSIDE	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P05023	Sodium/potassium-transporting ATPase subunit alpha-1	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A1	M9
P05023	NA	NA	NA	NA	DIGOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1975	CHEMBL2095186	104770	P05023	Sodium/potassium-transporting ATPase subunit alpha-1	Homo sapiens	D000075222: Essential Hypertension,D001172: Arthritis, Rheumatoid,D001281: Atrial Fibrillation,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002318: Cardiovascular Diseases,D003586: Cytomegalovirus Infections,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D006258: Head and Neck Neoplasms,D006333: Heart Failure,D006526: Hepatitis C,D006623: von Hippel-Lindau Disease,D007249: Inflammation,D007251: Influenza, Human,D008545: Melanoma,D009190: Myelodysplastic Syndromes,D009325: Nausea,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D012514: Sarcoma, Kaposi,D013617: Tachycardia, Supraventricular,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D019966: Substance-Related Disorders,D054179: Angioedemas, Hereditary,D064129: Prostatic Neoplasms, Castration-Resistant,D065626: Non-alcoholic Fatty Liver Disease	ATP1A1	M9
P05023	NA	NA	NA	NA	ACETYLDIGITOXIN	Sodium/potassium-transporting ATPase inhibitor	INHIBITOR	1982	CHEMBL2095186	104770	P05023	Sodium/potassium-transporting ATPase subunit alpha-1	Homo sapiens	D002318: Cardiovascular Diseases	ATP1A1	M9
Q14524	NA	NA	NA	NA	PHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000740: Anemia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D007938: Leukemia,D008223: Lymphoma,D009447: Neuroblastoma,D009902: Optic Neuritis,D010190: Pancreatic Neoplasms,D011115: Polyneuropathies,D012559: Schizophrenia,D012640: Seizures,D013789: Thalassemia,D014947: Wounds and Injuries,D019970: Cocaine-Related Disorders	SCN5A	M9
Q14524	NA	NA	NA	NA	LIDOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000070607: Morton Neuroma,D001007: Anxiety,D001145: Arrhythmias, Cardiac,D001168: Arthritis,D001289: Attention Deficit Disorder with Hyperactivity,D001416: Back Pain,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002062: Bursitis,D002277: Carcinoma,D002294: Carcinoma, Squamous Cell,D002349: Carpal Tunnel Syndrome,D002578: Uterine Cervical Dysplasia,D003139: Common Cold,D003371: Cough,D003929: Diabetic Neuropathies,D004412: Dysmenorrhea,D005356: Fibromyalgia,D005909: Glioblastoma,D006009: Glycogen Storage Disease Type II,D006261: Headache,D006323: Heart Arrest,D006331: Heart Diseases,D006470: Hemorrhage,D006484: Hemorrhoids,D006562: Herpes Zoster,D006810: Humeral Fractures,D006976: Hypertension, Pulmonary,D007246: Infertility,D007249: Inflammation,D007889: Leiomyoma,D008175: Lung Neoplasms,D008268: Macular Degeneration,D008881: Migraine Disorders,D009120: Muscle Cramp,D009135: Muscular Diseases,D009209: Myofascial Pain Syndromes,D009369: Neoplasms,D009437: Neuralgia,D009463: Neuroma,D009748: Nutrition Disorders,D009765: Obesity,D009767: Obesity, Morbid,D010003: Osteoarthritis,D010145: Paget Disease, Extramammary,D010146: Pain,D010279: Parathyroid Diseases,D010282: Parathyroid Neoplasms,D010489: Periarthritis,D010523: Peripheral Nervous System Diseases,D010612: Pharyngitis,D011225: Pre-Eclampsia,D011247: Pregnancy,D011537: Pruritus,D011671: Pulpitis,D012253: Rib Fractures,D012594: Scleroderma, Localized,D012600: Scoliosis,D012772: Shock, Septic,D012852: Sinusitis,D012871: Skin Diseases,D012878: Skin Neoplasms,D013180: Sprains and Strains,D013280: Stomatitis,D013705: Temporomandibular Joint Disorders,D013716: Tennis Elbow,D013923: Thromboembolism,D014012: Tinnitus,D014277: Trigeminal Neuralgia,D014549: Urinary Incontinence,D014552: Urinary Tract Infections,D014947: Wounds and Injuries,D015179: Colorectal Neoplasms,D015663: Osteoporosis, Postmenopausal,D016103: Spinal Fractures,D017116: Low Back Pain,D018856: Cystitis, Interstitial,D019534: Shoulder Impingement Syndrome,D019970: Cocaine-Related Disorders,D020069: Shoulder Pain,D020370: Osteoarthritis, Knee,D020521: Stroke,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D047928: Premature Birth,D052256: Tendinopathy,D053159: Dysuria,D053201: Urinary Bladder, Overactive,D055623: Keratosis, Actinic,D056844: Renal Colic,D059350: Chronic Pain,D060825: Cognitive Dysfunction,D063806: Myalgia	SCN5A	M9
Q14524	NA	NA	NA	NA	CARBAMAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	1968	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001007: Anxiety,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009325: Nausea,D012559: Schizophrenia,D012640: Seizures,D014277: Trigeminal Neuralgia,D015658: HIV Infections,D019694: Hepatitis B, Chronic,D019970: Cocaine-Related Disorders,D020195: Epilepsy, Reflex,D020435: Glossopharyngeal Nerve Diseases	SCN5A	M9
Q14524	NA	NA	NA	NA	PROCAINAMIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN5A	M9
Q14524	NA	NA	NA	NA	TETRACAINE	Sodium channel alpha subunit blocker	BLOCKER	2005	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D002349: Carpal Tunnel Syndrome,D002386: Cataract,D006484: Hemorrhoids,D006562: Herpes Zoster,D009209: Myofascial Pain Syndromes,D010003: Osteoarthritis,D010146: Pain,D011537: Pruritus,D012871: Skin Diseases,D014947: Wounds and Injuries,D019534: Shoulder Impingement Syndrome,D052256: Tendinopathy	SCN5A	M9
Q14524	NA	NA	NA	NA	LAMOTRIGINE	Sodium channel alpha subunit blocker	BLOCKER	1994	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001523: Mental Disorders,D001714: Bipolar Disorder,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D004832: Epilepsy, Absence,D006562: Herpes Zoster,D007863: Lecithin Cholesterol Acyltransferase Deficiency,D009293: Opioid-Related Disorders,D009456: Neurofibromatosis 1,D009765: Obesity,D010146: Pain,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D015658: HIV Infections,D019964: Mood Disorders,D019966: Substance-Related Disorders,D019970: Cocaine-Related Disorders,D020528: Multiple Sclerosis, Chronic Progressive,D020529: Multiple Sclerosis, Relapsing-Remitting,D060825: Cognitive Dysfunction,D065768: Lennox Gastaut Syndrome	SCN5A	M9
Q14524	NA	NA	NA	NA	RILUZOLE	Sodium channel alpha subunit blocker	BLOCKER	1995	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000544: Alzheimer Disease,D000690: Amyotrophic Lateral Sclerosis,D001714: Bipolar Disorder,D001943: Breast Neoplasms,D002524: Cerebellar Ataxia,D002659: Child Development Disorders, Pervasive,D003865: Depressive Disorder, Major,D003866: Depressive Disorder,D006816: Huntington Disease,D008545: Melanoma,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009771: Obsessive-Compulsive Disorder,D010523: Peripheral Nervous System Diseases,D013118: Spinal Cord Diseases,D013119: Spinal Cord Injuries,D013313: Stress Disorders, Post-Traumatic,D013494: Supranuclear Palsy, Progressive,D019578: Multiple System Atrophy,D020528: Multiple Sclerosis, Chronic Progressive,D020754: Spinocerebellar Ataxias	SCN5A	M9
Q14524	NA	NA	NA	NA	ZONISAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000437: Alcoholism,D001068: Feeding and Eating Disorders,D004827: Epilepsy,D006317: Hearing Loss, Noise-Induced,D008881: Migraine Disorders,D009765: Obesity,D010300: Parkinson Disease,D011618: Psychotic Disorders,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015430: Weight Gain,D016540: Smoking Cessation,D017029: Epilepsy, Complex Partial,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D034381: Hearing Loss	SCN5A	M9
Q14524	NA	NA	NA	NA	PRIMIDONE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy,D020521: Stroke	SCN5A	M9
Q14524	NA	NA	NA	NA	MEPHENYTOIN	Sodium channel alpha subunit blocker	BLOCKER	1946	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN5A	M9
Q14524	NA	NA	NA	NA	PHENACEMIDE	Sodium channel alpha subunit blocker	BLOCKER	1951	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN5A	M9
Q14524	NA	NA	NA	NA	FOSPHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	ERLOSAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000437: Alcoholism,D000690: Amyotrophic Lateral Sclerosis,D001007: Anxiety,D001932: Brain Neoplasms,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D005910: Glioma,D006562: Herpes Zoster,D007674: Kidney Diseases,D008881: Migraine Disorders,D009437: Neuralgia,D010003: Osteoarthritis,D010523: Peripheral Nervous System Diseases,D012559: Schizophrenia,D012640: Seizures,D013226: Status Epilepticus	SCN5A	M9
Q14524	NA	NA	NA	NA	CHLOROPROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1955	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000758: Anesthesia,D010146: Pain	SCN5A	M9
Q14524	NA	NA	NA	NA	OXCARBAZEPINE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000374: Aggression,D001007: Anxiety,D003704: Dementia,D003866: Depressive Disorder,D004827: Epilepsy,D004828: Epilepsies, Partial,D009103: Multiple Sclerosis,D009369: Neoplasms,D009437: Neuralgia,D011595: Psychomotor Agitation,D012559: Schizophrenia,D012640: Seizures	SCN5A	M9
Q14524	NA	NA	NA	NA	ESLICARBAZEPINE ACETATE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006562: Herpes Zoster,D008881: Migraine Disorders,D009437: Neuralgia,D012640: Seizures,D017029: Epilepsy, Complex Partial	SCN5A	M9
Q14524	NA	NA	NA	NA	ETHOTOIN	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy	SCN5A	M9
Q14524	NA	NA	NA	NA	PRILOCAINE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D002294: Carcinoma, Squamous Cell,D006562: Herpes Zoster,D010146: Pain,D011247: Pregnancy,D012871: Skin Diseases,D055623: Keratosis, Actinic	SCN5A	M9
Q14524	NA	NA	NA	NA	RANOLAZINE	Sodium channel protein type V alpha subunit blocker	BLOCKER	2006	CHEMBL1980	11480	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D000787: Angina Pectoris,D001281: Atrial Fibrillation,D002311: Cardiomyopathy, Dilated,D002318: Cardiovascular Diseases,D003327: Coronary Disease,D003424: Crohn Disease,D003924: Diabetes Mellitus, Type 2,D006976: Hypertension, Pulmonary,D007674: Kidney Diseases,D008133: Long QT Syndrome,D014652: Vascular Diseases,D017202: Myocardial Ischemia,D020967: Myotonic Disorders,D043183: Irritable Bowel Syndrome,D054058: Acute Coronary Syndrome,D054144: Heart Failure, Diastolic,D060050: Angina, Stable	SCN5A	M9
Q14524	NA	NA	NA	NA	TOPIRAMATE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000428: Alcohol Drinking,D000437: Alcoholism,D001007: Anxiety,D001068: Feeding and Eating Disorders,D001714: Bipolar Disorder,D002032: Bulimia,D002189: Marijuana Abuse,D002545: Brain Ischemia,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003924: Diabetes Mellitus, Type 2,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005715: Gambling,D005879: Tourette Syndrome,D006261: Headache,D006949: Hyperlipidemias,D006973: Hypertension,D008107: Liver Diseases,D008881: Migraine Disorders,D009103: Multiple Sclerosis,D009765: Obesity,D009771: Obsessive-Compulsive Disorder,D010146: Pain,D010300: Parkinson Disease,D011218: Prader-Willi Syndrome,D012559: Schizophrenia,D012585: Sciatica,D012640: Seizures,D013313: Stress Disorders, Post-Traumatic,D014029: Tobacco Use Disorder,D015228: Hypertriglyceridemia,D016540: Smoking Cessation,D019969: Amphetamine-Related Disorders,D019970: Cocaine-Related Disorders,D020329: Essential Tremor,D024821: Metabolic Syndrome,D052018: Bulimia Nervosa,D060825: Cognitive Dysfunction,D065630: Hernias, Diaphragmatic, Congenital,D065768: Lennox Gastaut Syndrome	SCN5A	M9
Q14524	NA	NA	NA	NA	PHENYTOIN SODIUM	Sodium channel alpha subunit blocker	BLOCKER	1956	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	PROPOXYCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	MORICIZINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1990	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	INDECAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	ORPHENADRINE CITRATE	Sodium channel alpha subunit blocker	BLOCKER	1959	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D010146: Pain	SCN5A	M9
Q14524	NA	NA	NA	NA	LIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1948	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000070636: Rotator Cuff Injuries,D000758: Anesthesia,D001416: Back Pain,D003920: Diabetes Mellitus,D006261: Headache,D006484: Hemorrhoids,D006973: Hypertension,D008113: Liver Neoplasms,D009369: Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D011247: Pregnancy,D011471: Prostatic Neoplasms,D011537: Pruritus,D014947: Wounds and Injuries,D052016: Mucositis	SCN5A	M9
Q14524	NA	NA	NA	NA	QUINIDINE GLUCONATE	Sodium channel alpha subunit blocker	BLOCKER	1950	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	MEPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1960	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	PROPARACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1953	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	DYCLONINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	PRILOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1965	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	ETIDOCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1976	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	MEXILETINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1985	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D010523: Peripheral Nervous System Diseases	SCN5A	M9
Q14524	NA	NA	NA	NA	DIBUCAINE HYDROCHLORIDE	Sodium channel protein type V alpha subunit blocker	BLOCKER	1982	CHEMBL1980	11480	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	BENOXINATE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	HEXYLCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	TOCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1984	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	ARTICAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2000	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	FLECAINIDE ACETATE	Sodium channel protein type V alpha subunit blocker	BLOCKER	1985	CHEMBL1980	11480	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D010146: Pain	SCN5A	M9
Q14524	NA	NA	NA	NA	PROCAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1954	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D015658: HIV Infections	SCN5A	M9
Q14524	NA	NA	NA	NA	DISOPYRAMIDE PHOSPHATE	Sodium channel alpha subunit blocker	BLOCKER	1977	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN5A	M9
Q14524	NA	NA	NA	NA	PHENAZOPYRIDINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1987	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D014552: Urinary Tract Infections	SCN5A	M9
Q14524	NA	NA	NA	NA	ORPHENADRINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1957	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D010300: Parkinson Disease	SCN5A	M9
Q14524	NA	NA	NA	NA	PROPAFENONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1989	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation,D006333: Heart Failure	SCN5A	M9
Q14524	NA	NA	NA	NA	QUINIDINE POLYGALACTURONATE	Sodium channel alpha subunit blocker	BLOCKER	1982	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001145: Arrhythmias, Cardiac	SCN5A	M9
Q14524	NA	NA	NA	NA	DRONEDARONE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2009	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D001281: Atrial Fibrillation	SCN5A	M9
Q14524	NA	NA	NA	NA	RUFINAMIDE	Sodium channel alpha subunit blocker	BLOCKER	2008	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy,D010146: Pain,D012640: Seizures,D065768: Lennox Gastaut Syndrome	SCN5A	M9
Q14524	NA	NA	NA	NA	TETRACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	2016	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000758: Anesthesia	SCN5A	M9
Q14524	NA	NA	NA	NA	ROPIVACAINE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1996	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D006258: Head and Neck Neoplasms,D006552: Hernia, Inguinal,D010003: Osteoarthritis,D010146: Pain,D050723: Fractures, Bone,D059787: Acute Pain	SCN5A	M9
Q14524	NA	NA	NA	NA	ENCAINIDE HYDROCHLORIDE	Sodium channel alpha subunit blocker	BLOCKER	1986	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	NA	SCN5A	M9
Q14524	NA	NA	NA	NA	QUINIDINE SULFATE	Sodium channel alpha subunit blocker	BLOCKER	1962	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D000690: Amyotrophic Lateral Sclerosis,D001321: Autistic Disorder	SCN5A	M9
Q14524	NA	NA	NA	NA	CENOBAMATE	Sodium channel alpha subunit inhibitor	INHIBITOR	2020	CHEMBL2331043	105639	Q14524	Sodium channel protein type 5 subunit alpha	Homo sapiens	D004827: Epilepsy,D004828: Epilepsies, Partial,D008107: Liver Diseases,D012640: Seizures	SCN5A	M9
Q01344	NA	NA	NA	NA	BENRALIZUMAB	Interleukin-5 receptor subunit alpha inhibitor	INHIBITOR	2017	CHEMBL3580483	109779	Q01344	Interleukin-5 receptor subunit alpha	Homo sapiens	D001249: Asthma,D003876: Dermatitis, Atopic,D006402: Hematologic Diseases,D008173: Lung Diseases, Obstructive,D009298: Nasal Polyps,D010391: Pemphigoid, Bullous,D012852: Sinusitis,D014581: Urticaria,D017681: Hypereosinophilic Syndrome,D029424: Pulmonary Disease, Chronic Obstructive,D057765: Eosinophilic Esophagitis	IL5RA	M9
Q96SW2	NA	NA	NA	NA	THALIDOMIDE	CRL4(CRBN) E3 ubiquitin ligase inhibitor	INHIBITOR	1998	CHEMBL3833061	116917	Q96SW2	Protein cereblon	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D000544: Alzheimer Disease,D000686: Amyloidosis,D000690: Amyotrophic Lateral Sclerosis,D001063: Appendiceal Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D003093: Colitis, Ulcerative,D003110: Colonic Neoplasms,D003371: Cough,D003424: Crohn Disease,D004715: Endometriosis,D004827: Epilepsy,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006103: Granuloma, Lethal Midline,D006258: Head and Neck Neoplasms,D006526: Hepatitis C,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008179: Lupus Erythematosus, Discoid,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010146: Pain,D010534: Peritoneal Neoplasms,D011349: Proctitis,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012192: Retroviridae Infections,D012507: Sarcoidosis,D012509: Sarcoma,D012595: Scleroderma, Systemic,D013167: Spondylitis, Ankylosing,D013789: Thalassemia,D015179: Colorectal Neoplasms,D015209: Cholangitis, Sclerosing,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016403: Lymphoma, Large B-Cell, Diffuse,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D018358: Neuroendocrine Tumors,D018442: Lymphoma, B-Cell, Marginal Zone,D019247: HIV Wasting Syndrome,D020295: Brain Stem Neoplasms,D020522: Lymphoma, Mantle-Cell,D028226: Amyloidosis, Familial,D045169: Severe Acute Respiratory Syndrome,D050500: Pancreatitis, Chronic,D054079: Vascular Malformations,D054990: Idiopathic Pulmonary Fibrosis,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	CRBN	M9
Q96SW2	NA	NA	NA	NA	POMALIDOMIDE	CRL4(CRBN) E3 ubiquitin ligase inhibitor	INHIBITOR	2013	CHEMBL3833061	116917	Q96SW2	Protein cereblon	Homo sapiens	D000686: Amyloidosis,D000755: Anemia, Sickle Cell,D005871: Castleman Disease,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007952: Leukemia, Plasma Cell,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010190: Pancreatic Neoplasms,D010954: Plasmacytoma,D011087: Polycythemia Vera,D011658: Pulmonary Fibrosis,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D012595: Scleroderma, Systemic,D013683: Telangiectasia, Hereditary Hemorrhagic,D016403: Lymphoma, Large B-Cell, Diffuse,D017563: Lung Diseases, Interstitial,D028226: Amyloidosis, Familial,D055728: Primary Myelofibrosis,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	CRBN	M9
Q96SW2	NA	NA	NA	NA	LENALIDOMIDE	CRL4(CRBN) E3 ubiquitin ligase inhibitor	INHIBITOR	2005	CHEMBL3833061	116917	Q96SW2	Protein cereblon	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000080443: Diffuse Intrinsic Pontine Glioma,D000686: Amyloidosis,D000740: Anemia,D001254: Astrocytoma,D001321: Autistic Disorder,D001749: Urinary Bladder Neoplasms,D002051: Burkitt Lymphoma,D002100: Cachexia,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003110: Colonic Neoplasms,D003424: Crohn Disease,D005185: Fallopian Tube Neoplasms,D005910: Glioma,D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011843: Radiculopathy,D012004: Rectal Neoplasms,D012514: Sarcoma, Kaposi,D013920: Thrombocythemia, Essential,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015658: HIV Infections,D016393: Lymphoma, B-Cell,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D016543: Central Nervous System Neoplasms,D016878: POEMS Syndrome,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020031: Epstein-Barr Virus Infections,D020522: Lymphoma, Mantle-Cell,D020918: Complex Regional Pain Syndromes,D021441: Carcinoma, Pancreatic Ductal,D028226: Amyloidosis, Familial,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	CRBN	M9
Q15842	NA	NA	NA	NA	DIAZOXIDE	Potassium channel, inwardly rectifying, subfamily J, member 8 opener	OPENER	1973	CHEMBL4770	10891	Q15842	ATP-sensitive inward rectifier potassium channel 8	Homo sapiens	D003866: Depressive Disorder,D003924: Diabetes Mellitus, Type 2,D006946: Hyperinsulinism,D006973: Hypertension,D007003: Hypoglycemia,D009765: Obesity	KCNJ8	M9
Q9Y6F1	NA	NA	NA	NA	OLAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2014	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001650: Bile Duct Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006976: Hypertension, Pulmonary,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018281: Cholangiocarcinoma,D018358: Neuroendocrine Tumors,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	PARP3	M9
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D001661: Biliary Tract Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D007890: Leiomyosarcoma,D008654: Mesothelioma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012192: Retroviridae Infections,D013274: Stomach Neoplasms,D016889: Endometrial Neoplasms,D021441: Carcinoma, Pancreatic Ductal,D055752: Small Cell Lung Carcinoma,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	PARP3	M9
Q9Y6F1	NA	NA	NA	NA	RUCAPARIB CAMSYLATE	PARP 1, 2 and 3 inhibitor	INHIBITOR	2016	CHEMBL3390820	109545	Q9Y6F1	Protein mono-ADP-ribosyltransferase PARP3	Homo sapiens	D009369: Neoplasms,D010051: Ovarian Neoplasms,D011471: Prostatic Neoplasms	PARP3	M9
Q9BQE3	NA	NA	NA	NA	PACLITAXEL	Tubulin inhibitor	INHIBITOR	1992	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000071960: Breast Carcinoma In Situ,D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000306: Adrenal Cortex Neoplasms,D000740: Anemia,D001005: Anus Neoplasms,D001172: Arthritis, Rheumatoid,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003251: Constriction, Pathologic,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D005833: Genital Neoplasms, Female,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006394: Hemangiosarcoma,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007511: Ischemia,D007680: Kidney Neoplasms,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D008654: Mesothelioma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010146: Pain,D010190: Pancreatic Neoplasms,D010412: Penile Neoplasms,D010523: Peripheral Nervous System Diseases,D010534: Peritoneal Neoplasms,D011470: Prostatic Hyperplasia,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012004: Rectal Neoplasms,D012192: Retroviridae Infections,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012514: Sarcoma, Kaposi,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013964: Thyroid Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015658: HIV Infections,D016491: Peripheral Vascular Diseases,D016543: Central Nervous System Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018281: Cholangiocarcinoma,D018287: Carcinoma, Large Cell,D018288: Carcinoma, Small Cell,D018289: Carcinoma, Verrucous,D018290: Cervical Intraepithelial Neoplasia,D018293: Cystadenoma, Serous,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D018323: Hemangioendothelioma, Epithelioid,D018567: Breast Neoplasms, Male,D021441: Carcinoma, Pancreatic Ductal,D023903: Coronary Restenosis,D031901: Gestational Trophoblastic Disease,D044584: Carcinoma, Ductal,D046152: Gastrointestinal Stromal Tumors,D054364: Solitary Fibrous Tumors,D055623: Keratosis, Actinic,D055752: Small Cell Lung Carcinoma,D058729: Peripheral Arterial Disease,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	COLCHICINE	Tubulin inhibitor	INHIBITOR	1961	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000072657: ST Elevation Myocardial Infarction,D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001145: Arrhythmias, Cardiac,D001249: Asthma,D001281: Atrial Fibrillation,D001528: Behcet Syndrome,D003327: Coronary Disease,D003928: Diabetic Nephropathies,D006073: Gout,D006331: Heart Diseases,D006333: Heart Failure,D008103: Liver Cirrhosis,D008105: Liver Cirrhosis, Biliary,D008171: Lung Diseases,D009203: Myocardial Infarction,D010003: Osteoarthritis,D010493: Pericarditis,D010505: Familial Mediterranean Fever,D011024: Pneumonia, Viral,D011185: Postpericardiotomy Syndrome,D013281: Stomatitis, Aphthous,D014652: Vascular Diseases,D014657: Vasculitis,D018281: Cholangiocarcinoma,D018630: Vitreoretinopathy, Proliferative,D019698: Hepatitis C, Chronic,D045169: Severe Acute Respiratory Syndrome,D051436: Renal Insufficiency, Chronic,D054058: Acute Coronary Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	VINBLASTINE SULFATE	Tubulin inhibitor	INHIBITOR	1965	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D002583: Uterine Cervical Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008654: Mesothelioma,D009373: Neoplasms, Germ Cell and Embryonal,D010051: Ovarian Neoplasms,D012509: Sarcoma,D013736: Testicular Neoplasms,D014523: Urethral Neoplasms,D018222: Fibromatosis, Aggressive,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	VINCRISTINE SULFATE	Tubulin inhibitor	INHIBITOR	1963	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000163: Acquired Immunodeficiency Syndrome,D001254: Astrocytoma,D001752: Blast Crisis,D001932: Brain Neoplasms,D002051: Burkitt Lymphoma,D002277: Carcinoma,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008527: Medulloblastoma,D008545: Melanoma,D008637: Mesenchymoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009369: Neoplasms,D009396: Wilms Tumor,D009447: Neuroblastoma,D009456: Neurofibromatosis 1,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018241: Neuroectodermal Tumors, Primitive, Peripheral,D018242: Neuroectodermal Tumors, Primitive,D020522: Lymphoma, Mantle-Cell,D051359: Lymphohistiocytosis, Hemophagocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	VINORELBINE TARTRATE	Tubulin inhibitor	INHIBITOR	1994	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009369: Neoplasms,D009447: Neuroblastoma,D012509: Sarcoma,D014625: Vaginal Neoplasms,D016411: Lymphoma, T-Cell, Peripheral,D016889: Endometrial Neoplasms,D018232: Rhabdomyosarcoma, Alveolar,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	CABAZITAXEL	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000306: Adrenal Cortex Neoplasms,D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D005909: Glioblastoma,D005910: Glioma,D006258: Head and Neck Neoplasms,D008080: Liposarcoma,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010412: Penile Neoplasms,D011471: Prostatic Neoplasms,D013274: Stomach Neoplasms,D013736: Testicular Neoplasms,D015179: Colorectal Neoplasms,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	IXABEPILONE	Tubulin inhibitor	INHIBITOR	2007	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D005185: Fallopian Tube Neoplasms,D006258: Head and Neck Neoplasms,D007012: Hypopharyngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008545: Melanoma,D009369: Neoplasms,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D014062: Tongue Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D016889: Endometrial Neoplasms,D017728: Lymphoma, Large-Cell, Anaplastic,D018289: Carcinoma, Verrucous,D018316: Gliosarcoma,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	ERIBULIN MESYLATE	Tubulin inhibitor	INHIBITOR	2010	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D002583: Uterine Cervical Neoplasms,D006258: Head and Neck Neoplasms,D008223: Lymphoma,D009369: Neoplasms,D011471: Prostatic Neoplasms,D012468: Salivary Gland Neoplasms,D012509: Sarcoma,D012516: Osteosarcoma,D014523: Urethral Neoplasms,D018567: Breast Neoplasms, Male,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	BRENTUXIMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2011	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007938: Leukemia,D007946: Leukemia, Mast-Cell,D008180: Lupus Erythematosus, Systemic,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008654: Mesothelioma,D009182: Mycosis Fungoides,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015459: Leukemia-Lymphoma, Adult T-Cell,D015470: Leukemia, Myeloid, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016410: Lymphoma, T-Cell, Cutaneous,D016411: Lymphoma, T-Cell, Peripheral,D017728: Lymphoma, Large-Cell, Anaplastic,D019337: Hematologic Neoplasms,D045743: Scleroderma, Diffuse,D058527: Enteropathy-Associated T-Cell Lymphoma	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	TRASTUZUMAB EMTANSINE	Tubulin inhibitor	INHIBITOR	2013	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D009101: Multiple Myeloma,D009362: Neoplasm Metastasis,D009369: Neoplasms,D012468: Salivary Gland Neoplasms,D013274: Stomach Neoplasms	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	POLATUZUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009369: Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D016403: Lymphoma, Large B-Cell, Diffuse	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	ENFORTUMAB VEDOTIN	Tubulin inhibitor	INHIBITOR	2019	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D001749: Urinary Bladder Neoplasms,D009369: Neoplasms,D014565: Urogenital Neoplasms,D064129: Prostatic Neoplasms, Castration-Resistant	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	DOCETAXEL	Tubulin inhibitor	INHIBITOR	1996	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000077195: Squamous Cell Carcinoma of Head and Neck,D000230: Adenocarcinoma,D000855: Anorexia,D001005: Anus Neoplasms,D001661: Biliary Tract Neoplasms,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002100: Cachexia,D002277: Carcinoma,D002285: Carcinoma, Intraductal, Noninfiltrating,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002295: Carcinoma, Transitional Cell,D002583: Uterine Cervical Neoplasms,D003110: Colonic Neoplasms,D004066: Digestive System Diseases,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005221: Fatigue,D005834: Genital Neoplasms, Male,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006967: Hypersensitivity,D007012: Hypopharyngeal Neoplasms,D007680: Kidney Neoplasms,D007822: Laryngeal Neoplasms,D007890: Leiomyosarcoma,D007938: Leukemia,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008479: Mediastinal Neoplasms,D008545: Melanoma,D009062: Mouth Neoplasms,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009325: Nausea,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009503: Neutropenia,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010255: Paranasal Sinus Neoplasms,D010412: Penile Neoplasms,D010534: Peritoneal Neoplasms,D010610: Pharyngeal Neoplasms,D011471: Prostatic Neoplasms,D012192: Retroviridae Infections,D012509: Sarcoma,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013584: Sarcoma, Synovial,D013736: Testicular Neoplasms,D014067: Tonsillar Neoplasms,D014523: Urethral Neoplasms,D014565: Urogenital Neoplasms,D014594: Uterine Neoplasms,D014625: Vaginal Neoplasms,D014846: Vulvar Neoplasms,D015179: Colorectal Neoplasms,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018278: Carcinoma, Neuroendocrine,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D046152: Gastrointestinal Stromal Tumors,D055752: Small Cell Lung Carcinoma,D058922: Inflammatory Breast Neoplasms,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms,D065646: Thyroid Carcinoma, Anaplastic	TUBA1C	M9
Q9BQE3	NA	NA	NA	NA	BELANTAMAB MAFODOTIN	Tubulin inhibitor	INHIBITOR	2020	CHEMBL2095182	104766	Q9BQE3	Tubulin alpha-1C chain	Homo sapiens	D009101: Multiple Myeloma,D009369: Neoplasms,D016403: Lymphoma, Large B-Cell, Diffuse,D028226: Amyloidosis, Familial	TUBA1C	M9
P54284	NA	NA	NA	NA	GABAPENTIN	Voltage-gated calcium channel modulator	MODULATOR	1993	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000022: Abortion, Spontaneous,D000070636: Rotator Cuff Injuries,D000428: Alcohol Drinking,D000437: Alcoholism,D000505: Alopecia,D000755: Anemia, Sickle Cell,D001007: Anxiety,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002349: Carpal Tunnel Syndrome,D002659: Child Development Disorders, Pervasive,D003693: Delirium,D003704: Dementia,D003866: Depressive Disorder,D003929: Diabetic Neuropathies,D004415: Dyspepsia,D004827: Epilepsy,D004828: Epilepsies, Partial,D005356: Fibromyalgia,D006258: Head and Neck Neoplasms,D006562: Herpes Zoster,D006939: Hyperemesis Gravidarum,D007319: Sleep Initiation and Maintenance Disorders,D007405: Intervertebral Disc Displacement,D008103: Liver Cirrhosis,D009103: Multiple Sclerosis,D009293: Opioid-Related Disorders,D009369: Neoplasms,D009437: Neuralgia,D009959: Oropharyngeal Neoplasms,D010145: Paget Disease, Extramammary,D010146: Pain,D011183: Postoperative Complications,D011537: Pruritus,D011618: Psychotic Disorders,D012559: Schizophrenia,D012600: Scoliosis,D012640: Seizures,D013375: Substance Withdrawal Syndrome,D014012: Tinnitus,D014029: Tobacco Use Disorder,D014202: Tremor,D014839: Vomiting,D014947: Wounds and Injuries,D017116: Low Back Pain,D019584: Hot Flashes,D019966: Substance-Related Disorders,D020250: Postoperative Nausea and Vomiting,D047928: Premature Birth,D052016: Mucositis,D053713: Azoospermia,D055959: Intervertebral Disc Degeneration,D056887: Pelvic Organ Prolapse,D059350: Chronic Pain,D064129: Prostatic Neoplasms, Castration-Resistant	CACNB3	M9
P54284	NA	NA	NA	NA	PREGABALIN	Voltage-gated calcium channel modulator	MODULATOR	2004	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000437: Alcoholism,D001007: Anxiety,D001943: Breast Neoplasms,D002189: Marijuana Abuse,D002294: Carcinoma, Squamous Cell,D003371: Cough,D003704: Dementia,D003866: Depressive Disorder,D003920: Diabetes Mellitus,D003929: Diabetic Neuropathies,D004827: Epilepsy,D004828: Epilepsies, Partial,D004830: Epilepsy, Tonic-Clonic,D005356: Fibromyalgia,D006562: Herpes Zoster,D007319: Sleep Initiation and Maintenance Disorders,D008881: Migraine Disorders,D009120: Muscle Cramp,D009293: Opioid-Related Disorders,D009325: Nausea,D009437: Neuralgia,D009497: Neurotic Disorders,D009959: Oropharyngeal Neoplasms,D010003: Osteoarthritis,D010146: Pain,D010523: Peripheral Nervous System Diseases,D011247: Pregnancy,D011472: Prostatitis,D011537: Pruritus,D011843: Radiculopathy,D012030: Refractive Errors,D012148: Restless Legs Syndrome,D012559: Schizophrenia,D012640: Seizures,D014029: Tobacco Use Disorder,D015352: Dry Eye Syndromes,D017029: Epilepsy, Complex Partial,D020329: Essential Tremor,D020422: Mononeuropathies,D020918: Complex Regional Pain Syndromes,D043183: Irritable Bowel Syndrome,D050500: Pancreatitis, Chronic,D050723: Fractures, Bone,D053201: Urinary Bladder, Overactive,D055959: Intervertebral Disc Degeneration,D059350: Chronic Pain	CACNB3	M9
P54284	NA	NA	NA	NA	SULOCTIDIL	Voltage-gated calcium channel blocker	BLOCKER	1979	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D002318: Cardiovascular Diseases	CACNB3	M9
P54284	NA	NA	NA	NA	TERODILINE HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1986	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	NA	CACNB3	M9
P54284	NA	NA	NA	NA	BEPRIDIL HYDROCHLORIDE	Voltage-gated calcium channel blocker	BLOCKER	1990	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	NA	CACNB3	M9
P54284	NA	NA	NA	NA	GABAPENTIN ENACARBIL	Voltage-gated calcium channel modulator	MODULATOR	2011	CHEMBL2363032	105734	P54284	Voltage-dependent L-type calcium channel subunit beta-3	Homo sapiens	D000437: Alcoholism,D003929: Diabetic Neuropathies,D004827: Epilepsy,D007674: Kidney Diseases,D008881: Migraine Disorders,D012148: Restless Legs Syndrome,D051474: Neuralgia, Postherpetic	CACNB3	M9
P45452	NA	NA	NA	NA	DOXYCYCLINE	Matrix metalloproteinase 13 inhibitor	INHIBITOR	1967	CHEMBL280	11024	P45452	Collagenase 3	Homo sapiens	D000077195: Squamous Cell Carcinoma of Head and Neck,D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D000544: Alzheimer Disease,D000686: Amyloidosis,D000783: Aneurysm,D000881: Anthrax,D001762: Blepharitis,D002289: Carcinoma, Non-Small-Cell Lung,D002690: Chlamydia Infections,D003093: Colitis, Ulcerative,D003424: Crohn Disease,D003550: Cystic Fibrosis,D003876: Dermatitis, Atopic,D003930: Diabetic Retinopathy,D004485: Eczema,D004605: Elephantiasis, Filarial,D005126: Eye Burns,D006470: Hemorrhage,D007239: Infections,D008193: Lyme Disease,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008368: Mansonelliasis,D008382: Marfan Syndrome,D008545: Melanoma,D009182: Mycosis Fungoides,D009203: Myocardial Infarction,D009369: Neoplasms,D010003: Osteoarthritis,D010019: Osteomyelitis,D010146: Pain,D010190: Pancreatic Neoplasms,D010518: Periodontitis,D010930: Plague,D010996: Pleural Effusion,D011014: Pneumonia,D011125: Adenomatous Polyposis Coli,D012393: Rosacea,D012612: Scrub Typhus,D012640: Seizures,D012751: Sezary Syndrome,D012871: Skin Diseases,D013587: Syphilis,D014376: Tuberculosis,D014526: Urethritis,D015179: Colorectal Neoplasms,D015352: Dry Eye Syndromes,D015427: Reperfusion Injury,D016410: Lymphoma, T-Cell, Cutaneous,D016918: Arthritis, Reactive,D017544: Aortic Aneurysm, Abdominal,D017676: Lichen Planus, Oral,D017719: Diabetic Foot,D018923: Persian Gulf Syndrome,D028226: Amyloidosis, Familial,D029424: Pulmonary Disease, Chronic Obstructive,D045169: Severe Acute Respiratory Syndrome,D049970: Graves Ophthalmopathy,D054990: Idiopathic Pulmonary Fibrosis	MMP13	M9
P45452	NA	NA	NA	NA	DOXYCYCLINE CALCIUM	Matrix metalloproteinase 13 inhibitor	INHIBITOR	1974	CHEMBL280	11024	P45452	Collagenase 3	Homo sapiens	D010019: Osteomyelitis	MMP13	M9
P45452	NA	NA	NA	NA	DOXYCYCLINE HYCLATE	Matrix metalloproteinase 13 inhibitor	INHIBITOR	1967	CHEMBL280	11024	P45452	Collagenase 3	Homo sapiens	D000152: Acne Vulgaris,D000292: Pelvic Inflammatory Disease,D002690: Chlamydia Infections,D008268: Macular Degeneration,D010518: Periodontitis,D012393: Rosacea,D013683: Telangiectasia, Hereditary Hemorrhagic,D013716: Tennis Elbow,D015231: Sexually Transmitted Diseases, Bacterial,D052016: Mucositis	MMP13	M9
Q99460	NA	NA	NA	NA	BORTEZOMIB	26S proteosome inhibitor	INHIBITOR	2003	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D000075122: Smoldering Multiple Myeloma,D000077192: Adenocarcinoma of Lung,D000686: Amyloidosis,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D001989: Bronchiolitis Obliterans,D002051: Burkitt Lymphoma,D002282: Adenocarcinoma, Bronchiolo-Alveolar,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D003528: Carcinoma, Adenoid Cystic,D004672: Encephalitis, Japanese,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005909: Glioblastoma,D005910: Glioma,D006086: Graft vs Host Disease,D006258: Head and Neck Neoplasms,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008232: Lymphoproliferative Disorders,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009136: Muscular Dystrophies,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009837: Oligodendroglioma,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D011471: Prostatic Neoplasms,D012010: Red-Cell Aplasia, Pure,D012509: Sarcoma,D012751: Sezary Syndrome,D013274: Stomach Neoplasms,D013964: Thyroid Neoplasms,D014511: Uremia,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016553: Purpura, Thrombocytopenic, Idiopathic,D017728: Lymphoma, Large-Cell, Anaplastic,D018263: Adenocarcinoma, Follicular,D018276: Carcinoma, Medullary,D018281: Cholangiocarcinoma,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D023981: Sarcoma, Myeloid,D028226: Amyloidosis, Familial,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD1	M9
Q99460	NA	NA	NA	NA	CARFILZOMIB	26S proteosome inhibitor	INHIBITOR	2009	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D000686: Amyloidosis,D006086: Graft vs Host Disease,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009369: Neoplasms,D010954: Plasmacytoma,D012751: Sezary Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015463: Leukemia, Prolymphocytic,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D018278: Carcinoma, Neuroendocrine,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	PSMD1	M9
Q99460	NA	NA	NA	NA	IXAZOMIB CITRATE	26S proteosome inhibitor	INHIBITOR	2015	CHEMBL2364701	106197	Q99460	26S proteasome non-ATPase regulatory subunit 1	Homo sapiens	D001943: Breast Neoplasms,D005909: Glioblastoma,D006086: Graft vs Host Disease,D007952: Leukemia, Plasma Cell,D008223: Lymphoma,D008258: Waldenstrom Macroglobulinemia,D009101: Multiple Myeloma,D009369: Neoplasms,D010954: Plasmacytoma,D012514: Sarcoma, Kaposi,D015470: Leukemia, Myeloid, Acute,D020522: Lymphoma, Mantle-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	PSMD1	M9
P31350	NA	NA	NA	NA	HYDROXYUREA	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1967	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D000755: Anemia, Sickle Cell,D002277: Carcinoma,D004938: Esophageal Neoplasms,D005909: Glioblastoma,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006432: Hemochromatosis,D006450: Hemoglobin SC Disease,D006976: Hypertension, Pulmonary,D007822: Laryngeal Neoplasms,D007938: Leukemia,D008175: Lung Neoplasms,D008223: Lymphoma,D008545: Melanoma,D008579: Meningioma,D009062: Mouth Neoplasms,D009103: Multiple Sclerosis,D009134: Muscular Atrophy, Spinal,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D010255: Paranasal Sinus Neoplasms,D010610: Pharyngeal Neoplasms,D011087: Polycythemia Vera,D013274: Stomach Neoplasms,D013920: Thrombocythemia, Essential,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015658: HIV Infections,D016543: Central Nervous System Neoplasms,D017086: beta-Thalassemia,D018222: Fibromatosis, Aggressive,D018316: Gliosarcoma,D020521: Stroke,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055728: Primary Myelofibrosis	RRM2	M9
P31350	NA	NA	NA	NA	GEMCITABINE HYDROCHLORIDE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1996	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D002583: Uterine Cervical Neoplasms,D005185: Fallopian Tube Neoplasms,D005706: Gallbladder Neoplasms,D006258: Head and Neck Neoplasms,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008232: Lymphoproliferative Disorders,D008654: Mesothelioma,D009101: Multiple Myeloma,D009182: Mycosis Fungoides,D009303: Nasopharyngeal Neoplasms,D009369: Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D010954: Plasmacytoma,D012192: Retroviridae Infections,D012509: Sarcoma,D013274: Stomach Neoplasms,D013923: Thromboembolism,D014516: Ureteral Neoplasms,D014523: Urethral Neoplasms,D014594: Uterine Neoplasms,D015179: Colorectal Neoplasms,D016399: Lymphoma, T-Cell,D016889: Endometrial Neoplasms,D018269: Carcinoma, Endometrioid,D018281: Cholangiocarcinoma,D018285: Klatskin Tumor,D018293: Cystadenoma, Serous,D018567: Breast Neoplasms, Male,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D061325: Hereditary Breast and Ovarian Cancer Syndrome,D064129: Prostatic Neoplasms, Castration-Resistant,D064726: Triple Negative Breast Neoplasms	RRM2	M9
P31350	NA	NA	NA	NA	CLOFARABINE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	2004	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D006086: Graft vs Host Disease,D006402: Hematologic Diseases,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007938: Leukemia,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D009101: Multiple Myeloma,D009190: Myelodysplastic Syndromes,D009369: Neoplasms,D010022: Osteopetrosis,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015473: Leukemia, Promyelocytic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D016399: Lymphoma, T-Cell,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	RRM2	M9
P31350	NA	NA	NA	NA	FLUDARABINE PHOSPHATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D000080443: Diffuse Intrinsic Pontine Glioma,D000080983: Bone Marrow Failure Disorders,D000081003: Shwachman-Diamond Syndrome,D000740: Anemia,D000741: Anemia, Aplastic,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D000755: Anemia, Sickle Cell,D001172: Arthritis, Rheumatoid,D001752: Blast Crisis,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002292: Carcinoma, Renal Cell,D002294: Carcinoma, Squamous Cell,D003424: Crohn Disease,D004820: Epidermolysis Bullosa,D004915: Leukemia, Erythroblastic, Acute,D004938: Esophageal Neoplasms,D005185: Fallopian Tube Neoplasms,D005199: Fanconi Anemia,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006105: Granulomatous Disease, Chronic,D006258: Head and Neck Neoplasms,D006402: Hematologic Diseases,D006457: Hemoglobinuria, Paroxysmal,D006528: Carcinoma, Hepatocellular,D006646: Histiocytosis, Langerhans-Cell,D006689: Hodgkin Disease,D007119: Immunoblastic Lymphadenopathy,D007154: Immune System Diseases,D007680: Kidney Neoplasms,D007938: Leukemia,D007943: Leukemia, Hairy Cell,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008113: Liver Neoplasms,D008175: Lung Neoplasms,D008180: Lupus Erythematosus, Systemic,D008181: Lupus Nephritis,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008545: Melanoma,D008654: Mesothelioma,D009101: Multiple Myeloma,D009103: Multiple Sclerosis,D009182: Mycosis Fungoides,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009303: Nasopharyngeal Neoplasms,D009362: Neoplasm Metastasis,D009369: Neoplasms,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D010022: Osteopetrosis,D010051: Ovarian Neoplasms,D010534: Peritoneal Neoplasms,D011087: Polycythemia Vera,D011471: Prostatic Neoplasms,D011565: Psoriasis,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012516: Osteosarcoma,D012595: Scleroderma, Systemic,D012751: Sezary Syndrome,D013789: Thalassemia,D013964: Thyroid Neoplasms,D014657: Vasculitis,D014923: Wiskott-Aldrich Syndrome,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015461: Leukemia, Prolymphocytic, T-Cell,D015463: Leukemia, Prolymphocytic,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015535: Arthritis, Psoriatic,D015614: Histiocytosis,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016511: Severe Combined Immunodeficiency,D017086: beta-Thalassemia,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018302: Neoplasms, Neuroepithelial,D018316: Gliosarcoma,D018442: Lymphoma, B-Cell, Marginal Zone,D019337: Hematologic Neoplasms,D020522: Lymphoma, Mantle-Cell,D021441: Carcinoma, Pancreatic Ductal,D051437: Renal Insufficiency,D054066: Leukemia, Large Granular Lymphocytic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054403: Leukemia, Prolymphocytic, B-Cell,D054429: Leukemia, Myelomonocytic, Juvenile,D055728: Primary Myelofibrosis,D064129: Prostatic Neoplasms, Castration-Resistant	RRM2	M9
P31350	NA	NA	NA	NA	GALLIUM NITRATE	Ribonucleoside-diphosphate reductase RR1 inhibitor	INHIBITOR	1991	CHEMBL2095215	104791	P31350	Ribonucleoside-diphosphate reductase subunit M2	Homo sapiens	D003550: Cystic Fibrosis,D008223: Lymphoma,D008228: Lymphoma, Non-Hodgkin,D009164: Mycobacterium Infections,D009447: Neuroblastoma,D012509: Sarcoma	RRM2	M9
P11926	NA	NA	NA	NA	EFLORNITHINE HYDROCHLORIDE	Ornithine decarboxylase inhibitor	INHIBITOR	1990	CHEMBL1869	272	P11926	Ornithine decarboxylase	Homo sapiens	D009447: Neuroblastoma,D011125: Adenomatous Polyposis Coli,D018305: Ganglioneuroblastoma	ODC1	M9
Q02880	NA	NA	NA	NA	ETOPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1983	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D000077192: Adenocarcinoma of Lung,D000163: Acquired Immunodeficiency Syndrome,D000306: Adrenal Cortex Neoplasms,D000753: Anemia, Refractory,D000754: Anemia, Refractory, with Excess of Blasts,D001254: Astrocytoma,D001932: Brain Neoplasms,D001943: Breast Neoplasms,D002051: Burkitt Lymphoma,D002276: Carcinoid Tumor,D002277: Carcinoma,D002289: Carcinoma, Non-Small-Cell Lung,D002294: Carcinoma, Squamous Cell,D002822: Choriocarcinoma,D004806: Ependymoma,D004915: Leukemia, Erythroblastic, Acute,D005185: Fallopian Tube Neoplasms,D005871: Castleman Disease,D005910: Glioma,D006086: Graft vs Host Disease,D006103: Granuloma, Lethal Midline,D006402: Hematologic Diseases,D006528: Carcinoma, Hepatocellular,D006689: Hodgkin Disease,D007680: Kidney Neoplasms,D007938: Leukemia,D007945: Leukemia, Lymphoid,D007947: Leukemia, Megakaryoblastic, Acute,D007948: Leukemia, Monocytic, Acute,D007952: Leukemia, Plasma Cell,D008175: Lung Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008258: Waldenstrom Macroglobulinemia,D008479: Mediastinal Neoplasms,D008527: Medulloblastoma,D009101: Multiple Myeloma,D009157: Myasthenia Gravis,D009190: Myelodysplastic Syndromes,D009196: Myeloproliferative Disorders,D009369: Neoplasms,D009373: Neoplasms, Germ Cell and Embryonal,D009396: Wilms Tumor,D009447: Neuroblastoma,D009471: Neuromyelitis Optica,D009503: Neutropenia,D009837: Oligodendroglioma,D009959: Oropharyngeal Neoplasms,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010534: Peritoneal Neoplasms,D012175: Retinoblastoma,D012208: Rhabdomyosarcoma,D012509: Sarcoma,D012512: Sarcoma, Ewing,D012514: Sarcoma, Kaposi,D012516: Osteosarcoma,D013274: Stomach Neoplasms,D013724: Teratoma,D013736: Testicular Neoplasms,D013945: Thymoma,D013953: Thymus Neoplasms,D015179: Colorectal Neoplasms,D015266: Carcinoma, Merkel Cell,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015459: Leukemia-Lymphoma, Adult T-Cell,D015464: Leukemia, Myelogenous, Chronic, BCR-ABL Positive,D015470: Leukemia, Myeloid, Acute,D015471: Leukemia, Basophilic, Acute,D015477: Leukemia, Myelomonocytic, Chronic,D015479: Leukemia, Myelomonocytic, Acute,D015658: HIV Infections,D016393: Lymphoma, B-Cell,D016399: Lymphoma, T-Cell,D016403: Lymphoma, Large B-Cell, Diffuse,D016411: Lymphoma, T-Cell, Peripheral,D016483: Lymphoma, AIDS-Related,D016543: Central Nervous System Neoplasms,D016545: Choroid Plexus Neoplasms,D016750: Stiff-Person Syndrome,D017728: Lymphoma, Large-Cell, Anaplastic,D018197: Hepatoblastoma,D018232: Rhabdomyosarcoma, Alveolar,D018233: Rhabdomyosarcoma, Embryonal,D018236: Carcinoma, Embryonal,D018239: Seminoma,D018240: Endodermal Sinus Tumor,D018242: Neuroectodermal Tumors, Primitive,D018273: Carcinoma, Islet Cell,D018278: Carcinoma, Neuroendocrine,D018302: Neoplasms, Neuroepithelial,D018305: Ganglioneuroblastoma,D018312: Sex Cord-Gonadal Stromal Tumors,D018316: Gliosarcoma,D019337: Hematologic Neoplasms,D020277: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating,D020339: Optic Nerve Glioma,D020522: Lymphoma, Mantle-Cell,D020529: Multiple Sclerosis, Relapsing-Remitting,D023981: Sarcoma, Myeloid,D031901: Gestational Trophoblastic Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D053578: Opsoclonus-Myoclonus Syndrome,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D054218: Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,D055752: Small Cell Lung Carcinoma,D064129: Prostatic Neoplasms, Castration-Resistant	TOP2B	M9
Q02880	NA	NA	NA	NA	TENIPOSIDE	DNA topoisomerase II inhibitor	INHIBITOR	1992	CHEMBL2094255	104727	Q02880	DNA topoisomerase 2-beta	Homo sapiens	D007938: Leukemia,D008223: Lymphoma,D009369: Neoplasms,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma	TOP2B	M9
P02452	NA	NA	NA	NA	OCRIPLASMIN	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02452	Collagen alpha-1(I) chain	Homo sapiens	D005128: Eye Diseases,D008268: Macular Degeneration,D012167: Retinal Perforations,D012170: Retinal Vein Occlusion,D014605: Uveitis,D020246: Venous Thrombosis,D020521: Stroke	COL1A1	M9
P02452	NA	NA	NA	NA	COLLAGENASE CLOSTRIDIUM HISTOLYTICUM	Collagen hydrolytic enzyme	HYDROLYTIC ENZYME	2010	CHEMBL2364188	106167	P02452	Collagen alpha-1(I) chain	Homo sapiens	D002062: Bursitis,D003286: Contracture,D003668: Pressure Ulcer,D004387: Dupuytren Contracture,D008067: Lipoma,D010411: Penile Induration,D012883: Skin Ulcer,D014456: Ulcer,D014525: Urethral Stricture,D017719: Diabetic Foot,D052256: Tendinopathy	COL1A1	M9
P08887	NA	NA	NA	NA	TOCILIZUMAB	Interleukin-6 receptor alpha subunit inhibitor	INHIBITOR	2005	CHEMBL2364155	106134	P08887	Interleukin-6 receptor subunit alpha	Homo sapiens	D000072658: Non-ST Elevated Myocardial Infarction,D000690: Amyotrophic Lateral Sclerosis,D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D001528: Behcet Syndrome,D001749: Urinary Bladder Neoplasms,D001943: Breast Neoplasms,D002289: Carcinoma, Non-Small-Cell Lung,D003865: Depressive Disorder, Major,D003882: Dermatomyositis,D003922: Diabetes Mellitus, Type 1,D005334: Fever,D005357: Fibrous Dysplasia of Bone,D005871: Castleman Disease,D005909: Glioblastoma,D006086: Graft vs Host Disease,D006528: Carcinoma, Hepatocellular,D006976: Hypertension, Pulmonary,D007154: Immune System Diseases,D007938: Leukemia,D008113: Liver Neoplasms,D008223: Lymphoma,D008224: Lymphoma, Follicular,D008228: Lymphoma, Non-Hodgkin,D008545: Melanoma,D009101: Multiple Myeloma,D009369: Neoplasms,D009471: Neuromyelitis Optica,D010051: Ovarian Neoplasms,D010190: Pancreatic Neoplasms,D010505: Familial Mediterranean Fever,D011014: Pneumonia,D011024: Pneumonia, Viral,D011081: Polychondritis, Relapsing,D011111: Polymyalgia Rheumatica,D011471: Prostatic Neoplasms,D012128: Respiratory Distress Syndrome,D012559: Schizophrenia,D012595: Scleroderma, Systemic,D013167: Spondylitis, Ankylosing,D013625: Takayasu Arteritis,D013700: Giant Cell Arteritis,D014605: Uveitis,D015179: Colorectal Neoplasms,D015451: Leukemia, Lymphocytic, Chronic, B-Cell,D015456: Leukemia, Biphenotypic, Acute,D015470: Leukemia, Myeloid, Acute,D015658: HIV Infections,D015866: Uveitis, Posterior,D015867: Uveitis, Intermediate,D016403: Lymphoma, Large B-Cell, Diffuse,D016706: Still's Disease, Adult-Onset,D019337: Hematologic Neoplasms,D031249: Erdheim-Chester Disease,D045169: Severe Acute Respiratory Syndrome,D051359: Lymphohistiocytosis, Hemophagocytic,D051436: Renal Insufficiency, Chronic,D054198: Precursor Cell Lymphoblastic Leukemia-Lymphoma,D055501: Macrophage Activation Syndrome	IL6R	M9
P08887	NA	NA	NA	NA	SARILUMAB	Interleukin-6 receptor alpha subunit antagonist	ANTAGONIST	2017	CHEMBL2364155	106134	P08887	Interleukin-6 receptor subunit alpha	Homo sapiens	D001171: Arthritis, Juvenile,D001172: Arthritis, Rheumatoid,D007154: Immune System Diseases,D011111: Polymyalgia Rheumatica,D012594: Scleroderma, Localized,D013167: Spondylitis, Ankylosing,D013700: Giant Cell Arteritis,D014605: Uveitis,D034721: Mastocytosis, Systemic,D045169: Severe Acute Respiratory Syndrome	IL6R	M9
P08887	NA	NA	NA	NA	SATRALIZUMAB	IL6Ralpha/GP130 antagonist	ANTAGONIST	2020	CHEMBL3137266	108122	P08887	Interleukin-6 receptor subunit alpha	Homo sapiens	D007154: Immune System Diseases,D009471: Neuromyelitis Optica	IL6R	M9
O60894	NA	NA	NA	NA	PRAMLINTIDE ACETATE	Amylin receptor AMY1, CALCR/RAMP1 agonist	AGONIST	2005	CHEMBL2111189	104908	O60894	Receptor activity-modifying protein 1	Homo sapiens	D003922: Diabetes Mellitus, Type 1,D003924: Diabetes Mellitus, Type 2,D009765: Obesity	RAMP1	M9
